protein_id,name,type,uniprot_id,gene_name,organism,general_function,specific_function,cellular_location,actions,source,match_type
BE0000048,Prothrombin,target,P00734,F2,Humans,"Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. Activates coagulation factor XI (F11); activation is promoted by the contact with negatively charged surfaces (PubMed:2019570, PubMed:21976677). Triggers the production of pro-inflammatory cytokines, such as MCP-1/CCL2 and IL8/CXCL8, in endothelial cells (PubMed:3056",calcium ion binding,"Secreted, extracellular space",inhibitor,DrugBank,drugbank_id
BE0000767,Epidermal growth factor receptor,target,P00533,EGFR,Humans,"Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:10805725, PubMed:27153536, PubMed:2790960, PubMed:35538033). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:12297049, PubMed:15611079, PubMed:17909029, PubMed:20837704, PubMed:27153536, PubMed:2790960, PubMed:7679104, PubMed:8144591, PubM",actin filament binding,Cell membrane,binder,DrugBank,drugbank_id
BE0000901,Low affinity immunoglobulin gamma Fc region receptor III-B,target,O75015,FCGR3B,Humans,"Receptor for the Fc region of immunoglobulins gamma. Low affinity receptor. Binds complexed or aggregated IgG and also monomeric IgG. Contrary to III-A, is not capable to mediate antibody-dependent cytotoxicity and phagocytosis. May serve as a trap for immune complexes in the peripheral circulation which does not activate neutrophils",GPI anchor binding,Cell membrane,binder,DrugBank,drugbank_id
BE0002094,Complement C1q subcomponent subunit A,target,P02745,C1QA,Humans,"Core component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:12847249, PubMed:19006321, PubMed:24626930, PubMed:29449492, PubMed:3258649, PubMed:34155115, PubMed:6249812, PubMed:6776418). The classical complement pathway is initiated by the C1Q subcomplex of the C1 complex, which specifi",amyloid-beta binding,Secreted,binder,DrugBank,drugbank_id
BE0002095,Complement C1q subcomponent subunit B,target,P02746,C1QB,Humans,"Core component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:12847249, PubMed:19006321, PubMed:24626930, PubMed:29449492, PubMed:3258649, PubMed:34155115, PubMed:6249812, PubMed:6776418). The classical complement pathway is initiated by the C1Q subcomplex of the C1 complex, which specifi",,Secreted,binder,DrugBank,drugbank_id
BE0002096,Complement C1q subcomponent subunit C,target,P02747,C1QC,Humans,"Core component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:12847249, PubMed:19006321, PubMed:24626930, PubMed:29449492, PubMed:3258649, PubMed:34155115, PubMed:6249812, PubMed:6776418). The classical complement pathway is initiated by the C1Q subcomplex of the C1 complex, which specifi",,Secreted,binder,DrugBank,drugbank_id
BE0002097,Low affinity immunoglobulin gamma Fc region receptor III-A,target,P08637,FCGR3A,Humans,"Receptor for the invariable Fc fragment of immunoglobulin gamma (IgG). Optimally activated upon binding of clustered antigen-IgG complexes displayed on cell surfaces, triggers lysis of antibody-coated cells, a process known as antibody-dependent cellular cytotoxicity (ADCC). Does not bind free monomeric IgG, thus avoiding inappropriate effector cell activation in the absence of antigenic trigger (PubMed:11711607, PubMed:21768335, PubMed:22023369, PubMed:24412922, PubMed:25786175, PubMed:25816339",IgG binding,Cell membrane,binder,DrugBank,drugbank_id
BE0000710,High affinity immunoglobulin gamma Fc receptor I,target,P12314,FCGR1A,Humans,High affinity receptor for the Fc region of immunoglobulins gamma. Functions in both innate and adaptive immune responses. Mediates IgG effector functions on monocytes triggering antibody-dependent cellular cytotoxicity (ADCC) of virus-infected cells,high-affinity IgG receptor activity,Cell membrane,binder,DrugBank,drugbank_id
BE0002098,Low affinity immunoglobulin gamma Fc region receptor II-a,target,P12318,FCGR2A,Humans,Binds to the Fc region of immunoglobulins gamma. Low affinity receptor. By binding to IgG it initiates cellular responses against pathogens and soluble antigens. Promotes phagocytosis of opsonized antigens,IgG binding,Cell membrane,binder,DrugBank,drugbank_id
BE0000658,Interleukin-2 receptor subunit alpha,target,P01589,IL2RA,Humans,Receptor for interleukin-2. The receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells,interleukin-2 binding,Membrane,ligand,DrugBank,drugbank_id
BE0000651,Interleukin-2 receptor subunit beta,target,P14784,IL2RB,Humans,"Receptor for interleukin-2. This beta subunit is involved in receptor mediated endocytosis and transduces the mitogenic signals of IL2. Probably in association with IL15RA, involved in the stimulation of neutrophil phagocytosis by IL15 (PubMed:15123770, PubMed:31040185)",coreceptor activity,Cell membrane,ligand,DrugBank,drugbank_id
BE0000704,Tumor necrosis factor,target,P01375,TNF,Humans,"Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Impairs regulatory T-cells (Treg) function in individuals with rheumatoid arthritis via FOXP3 dephosphorylation",cytokine activity,Cell membrane,inhibitor|antibody,DrugBank,drugbank_id
BE0001087,Lymphotoxin-alpha,target,P01374,LTA,Humans,"Cytokine that in its homotrimeric form binds to TNFRSF1A/TNFR1, TNFRSF1B/TNFBR and TNFRSF14/HVEM (PubMed:9462508). In its heterotrimeric form with LTB binds to TNFRSF3/LTBR (PubMed:24248355). Lymphotoxin is produced by lymphocytes and is cytotoxic for a wide range of tumor cells in vitro and in vivo",cytokine activity,Secreted,antibody,DrugBank,drugbank_id
BE0002099,Low affinity immunoglobulin gamma Fc region receptor II-b,target,P31994,FCGR2B,Humans,"Receptor for the Fc region of complexed or aggregated immunoglobulins gamma. Low affinity receptor. Involved in a variety of effector and regulatory functions such as phagocytosis of immune complexes and modulation of antibody production by B-cells. Binding to this receptor results in down-modulation of previous state of cell activation triggered via antigen receptors on B-cells (BCR), T-cells (TCR) or via another Fc receptor. Isoform IIB1 fails to mediate endocytosis or phagocytosis. Isoform II",amyloid-beta binding,Cell membrane,ligand,DrugBank,drugbank_id
BE0002100,Low affinity immunoglobulin gamma Fc region receptor II-c,target,P31995,FCGR2C,Humans,Receptor for the Fc region of complexed immunoglobulins gamma. Low affinity receptor. Involved in a variety of effector and regulatory functions such as phagocytosis of immune complexes and modulation of antibody production by B-cells,IgG binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009995,Complement component 1q (C1q),target,P02745,C1QA,Humans,"Core component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:12847249, PubMed:19006321, PubMed:24626930, PubMed:29449492, PubMed:3258649, PubMed:34155115, PubMed:6249812, PubMed:6776418). The classical complement pathway is initiated by the C1Q subcomplex of the C1 complex, which specifi",amyloid-beta binding,Secreted,ligand,DrugBank,drugbank_id
BE0001075,Myeloperoxidase,enzyme,P05164,MPO,Humans,"Part of the host defense system of polymorphonuclear leukocytes. It is responsible for microbicidal activity against a wide range of organisms. In the stimulated PMN, MPO catalyzes the production of hypohalous acids, primarily hypochlorous acid in physiologic situations, and other toxic intermediates that greatly enhance PMN microbicidal activity (PubMed:9922160). Mediates the proteolytic cleavage of alpha-1-microglobulin to form t-alpha-1-microglobulin, which potently inhibits oxidation of low-",chromatin binding,Lysosome,inhibitor,DrugBank,drugbank_id
BE0000203,Gonadotropin-releasing hormone receptor,target,P30968,GNRHR,Humans,Receptor for gonadotropin releasing hormone (GnRH) that mediates the action of GnRH to stimulate the secretion of the gonadotropic hormones luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This receptor mediates its action by association with G-proteins that activate a phosphatidylinositol-calcium second messenger system. Isoform 2 may act as an inhibitor of GnRH-R signaling,gonadotropin-releasing hormone receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0010526,Progonadoliberin-1,target,P01148,GNRH1,Humans,Stimulates the secretion of gonadotropins; it stimulates the secretion of both luteinizing and follicle-stimulating hormones,gonadotropin hormone-releasing hormone activity,Secreted,activator,DrugBank,drugbank_id
BE0000385,Interferon alpha/beta receptor 2,target,P48551,IFNAR2,Humans,"Together with IFNAR1, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa) (PubMed:10049744, PubMed:10556041, PubMed:21854986, PubMed:26424569, PubMed:28165510, PubMed:32972995, PubMed:7665574, PubMed:7759950, PubMed:8181059, PubMed:8798579, PubMed:8969169). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effector",cytokine binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000661,Interferon alpha/beta receptor 1,target,P17181,IFNAR1,Humans,"Together with IFNAR2, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa) (PubMed:10049744, PubMed:14532120, PubMed:15337770, PubMed:2153461, PubMed:21854986, PubMed:24075985, PubMed:31270247, PubMed:33252644, PubMed:35442418, PubMed:7813427). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the inter",cytokine binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0003450,Interferon alpha-2,target,P01563,IFNA2,Humans,"Produced by macrophages, IFN-alpha have antiviral activities",cytokine activity,Secreted,modulator,DrugBank,drugbank_id
BE0002433,Cytochrome P450 1A2,enzyme,P05177,CYP1A2,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins (PubMed:10681376, PubMed:11555828, PubMed:12865317, PubMed:19965576, PubMed:9435160). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:10681376, PubMed:11555828, PubMe",caffeine oxidase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000211,Plasminogen,target,P00747,PLG,Humans,"Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1, C4 and C5 (PubMed:6447255). Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombosp",apolipoprotein binding,Secreted,activator,DrugBank,drugbank_id
BE0000538,Fibrinogen alpha chain,target,P02671,FGA,Humans,"Cleaved by the protease thrombin to yield monomers which, together with fibrinogen beta (FGB) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using an",extracellular matrix structural constituent,Secreted,binder,DrugBank,drugbank_id
BE0002092,Fibrinogen gamma chain,target,P02679,FGG,Humans,"Together with fibrinogen alpha (FGA) and fibrinogen beta (FGB), polymerizes to form an insoluble fibrin matrix. Has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However, subsequent studies have shown that ",cell adhesion molecule binding,Secreted,binder,DrugBank,drugbank_id
BE0000240,Plasminogen activator inhibitor 1,target,P05121,SERPINE1,Humans,"Serine protease inhibitor. Inhibits TMPRSS7 (PubMed:15853774). Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase-type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots (PubMed:17912461, PubMed:8481516, PubMed:9207454, PubMed:21925150). As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading (PubMed:9175705). Acts as a regulator ",protease binding,Secreted,,DrugBank,drugbank_id
BE0000654,Erythropoietin receptor,target,P19235,EPOR,Humans,"Receptor for erythropoietin, which mediates erythropoietin-induced erythroblast proliferation and differentiation (PubMed:10388848, PubMed:2163695, PubMed:2163696, PubMed:8662939, PubMed:9774108). Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade (By similarity). In some cell types, can also activate STAT1 and STAT3 (PubMed:11756159). May also activate the LYN tyrosine kinase (By similarity)",erythropoietin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000717,Urokinase plasminogen activator surface receptor,target,Q03405,PLAUR,Humans,Acts as a receptor for urokinase plasminogen activator (PubMed:15677461). Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA. It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form,enzyme binding,Cell membrane,inducer|modulator,DrugBank,drugbank_id
BE0000969,Plasminogen activator inhibitor 2,target,P05120,SERPINB2,Humans,Inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1,serine-type endopeptidase inhibitor activity,Cytoplasm,substrate|inducer,DrugBank,drugbank_id
BE0000895,Urokinase-type plasminogen activator,target,P00749,PLAU,Humans,Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin,serine-type endopeptidase activity,Secreted,modulator,DrugBank,drugbank_id
BE0002112,Plasma serine protease inhibitor,target,P05154,SERPINA5,Humans,Heparin-dependent serine protease inhibitor acting in body fluids and secretions. Inactivates serine proteases by binding irreversibly to their serine activation site. Involved in the regulation of intravascular and extravascular proteolytic activities. Plays hemostatic roles in the blood plasma. Acts as a procoagulant and pro-inflammatory factor by inhibiting the anticoagulant activated protein C factor as well as the generation of activated protein C factor by the thrombin/thrombomodulin compl,acrosin binding,"Secreted, extracellular space",substrate,DrugBank,drugbank_id
BE0000942,Low-density lipoprotein receptor-related protein 2,target,P98164,LRP2,Humans,"Multiligand endocytic receptor (By similarity). Acts together with CUBN to mediate endocytosis of high-density lipoproteins (By similarity). Mediates receptor-mediated uptake of polybasic drugs such as aprotinin, aminoglycosides and polymyxin B (By similarity). In the kidney, mediates the tubular uptake and clearance of leptin (By similarity). Also mediates transport of leptin across the blood-brain barrier through endocytosis at the choroid plexus epithelium (By similarity). Endocytosis of lept",calcium ion binding,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0001656,Suppressor of tumorigenicity 14 protein,target,Q9Y5Y6,ST14,Humans,Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site (PubMed:10373424). Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing (PubMed:18843291). Proteolytically cleaves and therefore activates TMPRSS13 (PubMed:28710277),serine-type endopeptidase activity,Membrane,substrate,DrugBank,drugbank_id
BE0002113,Nidogen-1,target,P14543,NID1,Humans,Sulfated glycoprotein widely distributed in basement membranes and tightly associated with laminin. Also binds to collagen IV and perlecan. It probably has a role in cell-extracellular matrix interactions,calcium ion binding,"Secreted, extracellular space, extracellular matrix, basement membrane",ligand,DrugBank,drugbank_id
BE0001198,Macrophage metalloelastase,enzyme,P39900,MMP12,Humans,"May be involved in tissue injury and remodeling. Has significant elastolytic activity. Can accept large and small amino acids at the P1' site, but has a preference for leucine. Aromatic or hydrophobic residues are preferred at the P1 site, with small hydrophobic residues (preferably alanine) occupying P3",calcium ion binding,"Secreted, extracellular space, extracellular matrix",substrate,DrugBank,drugbank_id
BE0000134,Lutropin-choriogonadotropic hormone receptor,target,P22888,LHCGR,Humans,Receptor for lutropin-choriogonadotropic hormone (PubMed:11847099). The activity of this receptor is mediated by G proteins which activate adenylate cyclase (PubMed:11847099),choriogonadotropin hormone binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000431,Calcitonin receptor,target,P30988,CALCR,Humans,"G protein-coupled receptor activated by ligand peptides amylin (IAPP), calcitonin (CT/CALCA) and calcitonin gene-related peptide type 1 (CGRP1/CALCA) (PubMed:35324283, PubMed:38603770). CALCR interacts with receptor-activity-modifying proteins RAMP1, 2 and 3 to form receptor complexes AMYR1, 2 and 3, respectively (PubMed:35324283, PubMed:38603770). IAPP, CT and CGRP1 activate CALCR and AMYRs with distinct modes of receptor activation resulting in specific phenotypes (PubMed:35324283, PubMed:3860",amylin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000793,Granulocyte colony-stimulating factor receptor,target,Q99062,CSF3R,Humans,"Receptor for granulocyte colony-stimulating factor (CSF3), essential for granulocytic maturation. Plays a crucial role in the proliferation, differentiation and survival of cells along the neutrophilic lineage. In addition it may function in some adhesion or recognition events at the cell surface",cytokine binding,Secreted,agonist,DrugBank,drugbank_id
BE0000394,Neutrophil elastase,enzyme,P08246,ELANE,Humans,"Serine protease that modifies the functions of natural killer cells, monocytes and granulocytes. Inhibits C5a-dependent neutrophil enzyme release and chemotaxis (PubMed:15140022). Promotes cleavage of GSDMB, thereby inhibiting pyroptosis (PubMed:36899106). Promotes blood coagulation (PubMed:20676107). Through the activation of the platelet fibrinogen receptor integrin alpha-IIb/beta-3, potentiates platelet aggregation induced by a threshold concentration of cathepsin G (CTSG) (PubMed:25211214, P",cytokine binding,"Cytoplasmic vesicle, phagosome",substrate,DrugBank,drugbank_id
BE0000628,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,target,P15509,CSF2RA,Humans,"Low affinity receptor for granulocyte-macrophage colony-stimulating factor. Transduces a signal that results in the proliferation, differentiation, and functional activation of hematopoietic cells",cytokine binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0001036,Interleukin-3 receptor subunit alpha,target,P26951,IL3RA,Humans,"Cell surface receptor for IL3 expressed on hematopoietic progenitor cells, monocytes and B-lymphocytes that controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells (PubMed:10527461). Ligand stimulation rapidly induces hetrodimerization with IL3RB, phosphorylation and enzyme activity of effector proteins such as JAK2 and PI3K that play a role in signaling cell proliferation and differentiation. Activation of JAK2 leads to STAT5-mediated transcri",cytokine binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0002115,Cytokine receptor common subunit beta,target,P32927,CSF2RB,Humans,"Cell surface receptor that plays a role in immune response and controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells. Acts by forming an heterodimeric receptor through interaction with different partners such as IL3RA, IL5RA or CSF2RA (PubMed:1495999). In turn, participates in various signaling pathways including interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor/CSF2 pathways. In unstimulated conditions, intera",coreceptor activity,Membrane,agonist,DrugBank,drugbank_id
BE0002116,Syndecan-2,target,P34741,SDC2,Humans,Cell surface proteoglycan which regulates dendritic arbor morphogenesis,identical protein binding,Membrane,agonist,DrugBank,drugbank_id
BE0002363,Cytochrome P450 2D6,enzyme,P10635,CYP2D6,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of fatty acids, steroids and retinoids (PubMed:18698000, PubMed:19965576, PubMed:20972997, PubMed:21289075, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:18698000, PubMed:19965576, PubMed:20972997, PubMed:21289075, PubMed:21576599). ","anandamide 11,12 epoxidase activity",Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0002793,Cytochrome P450 2C9,enzyme,P11712,CYP2C9,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids and steroids (PubMed:12865317, PubMed:15766564, PubMed:19965576, PubMed:21576599, PubMed:7574697, PubMed:9435160, PubMed:9866708). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:12865317, PubMed:1",(R)-limonene 6-monooxygenase activity,Endoplasmic reticulum membrane,inducer,DrugBank,drugbank_id
BE0004798,L-asparagine,target,,,Humans,,,,other/unknown,DrugBank,drugbank_id
BE0000537,Thyroxine-binding globulin,carrier,P05543,SERPINA7,Humans,Major thyroid hormone transport protein in serum,serine-type endopeptidase inhibitor activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0000490,Thyrotropin receptor,target,P16473,TSHR,Humans,"Receptor for the thyroid-stimulating hormone (TSH) or thyrotropin (PubMed:11847099, PubMed:12045258). Also acts as a receptor for the heterodimeric glycoprotein hormone (GPHA2:GPHB5) or thyrostimulin (PubMed:12045258). The activity of this receptor is mediated by G proteins which activate adenylate cyclase (PubMed:11847099). Plays a central role in controlling thyroid cell metabolism (By similarity)",G protein-coupled peptide receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000216,Coagulation factor X,target,P00742,F10,Humans,"Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting (PubMed:22409427). Factor Xa activates pro-inflammatory signaling pathways in a protease-activated receptor (PAR)-dependent manner (PubMed:24041930, PubMed:30568593, PubMed:34831181, PubMed:18202198). Up-regulates expression of protease-activated receptors (PARs) F2R, F2RL1 and F2RL2 in dermal microvascular endothelial cells (PubMed:35",calcium ion binding,Secreted,activator,DrugBank,drugbank_id
BE0000364,Coagulation factor IX,target,P00740,F9,Humans,"Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca(2+) ions, phospholipids, and factor VIIIa",calcium ion binding,Secreted,cofactor,DrugBank,drugbank_id
BE0001043,von Willebrand factor,target,P04275,VWF,Humans,"Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma",collagen binding,Secreted,binder,DrugBank,drugbank_id
BE0002117,"Phytanoyl-CoA dioxygenase, peroxisomal",target,O14832,PHYH,Humans,"Catalyzes the 2-hydroxylation of not only racemic phytanoyl-CoA and the isomers of 3-methylhexadecanoyl-CoA, but also a variety of other mono-branched 3-methylacyl-CoA esters (with a chain length of at least seven carbon atoms) and straight-chain acyl-CoA esters (with a chain length longer than four carbon atoms) (PubMed:10744784, PubMed:12031666, PubMed:12923223, PubMed:9326939). Does not hydroxylate long and very long straight chain acyl-CoAs or 2-methyl- and 4-methyl-branched acyl-CoAs (PubMe",carboxylic acid binding,Peroxisome,antagonist,DrugBank,drugbank_id
BE0002118,Asialoglycoprotein receptor 2,target,P07307,ASGR2,Humans,"Mediates the endocytosis of plasma glycoproteins to which the terminal sialic acid residue on their complex carbohydrate moieties has been removed. The receptor recognizes terminal galactose and N-acetylgalactosamine units. After ligand binding to the receptor, the resulting complex is internalized and transported to a sorting organelle, where receptor and ligand are disassociated. The receptor then returns to the cell membrane surface",asialoglycoprotein receptor activity,Membrane,binder,DrugBank,drugbank_id
BE0001098,Endoplasmic reticulum chaperone BiP,target,P11021,HSPA5,Humans,"Endoplasmic reticulum chaperone that plays a key role in protein folding and quality control in the endoplasmic reticulum lumen (PubMed:2294010, PubMed:23769672, PubMed:23990668, PubMed:28332555). Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10/ERdj5, probably to facilitate the release of DNAJC10/ERdj5 from its substrate (By similarity). Acts as a key repressor of the EIF2AK3/PERK and ERN1/IRE1-mediated unfolded protein response ",ATP binding,Endoplasmic reticulum lumen,chaperone,DrugBank,drugbank_id
BE0002109,Calreticulin,target,P27797,CALR,Humans,"Calcium-binding chaperone that promotes folding, oligomeric assembly and quality control in the endoplasmic reticulum (ER) via the calreticulin/calnexin cycle. This lectin interacts transiently with almost all of the monoglucosylated glycoproteins that are synthesized in the ER (PubMed:7876246). Interacts with the DNA-binding domain of NR3C1 and mediates its nuclear export (PubMed:11149926). Involved in maternal gene expression regulation. May participate in oocyte maturation via the regulation ",calcium ion binding,Endoplasmic reticulum lumen,chaperone,DrugBank,drugbank_id
BE0001011,Calnexin,target,P27824,CANX,Humans,"Calcium-binding protein that interacts with newly synthesized monoglucosylated glycoproteins in the endoplasmic reticulum. It may act in assisting protein assembly and/or in the retention within the ER of unassembled protein subunits. It seems to play a major role in the quality control apparatus of the ER by the retention of incorrectly folded proteins. Associated with partial T-cell antigen receptor complexes that escape the ER of immature thymocytes, it may function as a signaling complex reg",calcium ion binding,Endoplasmic reticulum membrane,chaperone,DrugBank,drugbank_id
BE0002119,Protein ERGIC-53,target,P49257,LMAN1,Humans,"Mannose-specific lectin. May recognize sugar residues of glycoproteins, glycolipids, or glycosylphosphatidyl inositol anchors and may be involved in the sorting or recycling of proteins, lipids, or both. The LMAN1-MCFD2 complex forms a specific cargo receptor for the ER-to-Golgi transport of selected proteins",D-mannose binding,Endoplasmic reticulum-Golgi intermediate compartment membrane,binder|transporter,DrugBank,drugbank_id
BE0002110,Prolow-density lipoprotein receptor-related protein 1,target,Q07954,LRP1,Humans,"Endocytic receptor involved in endocytosis and in phagocytosis of apoptotic cells (PubMed:11907044, PubMed:12713657). Required for early embryonic development (By similarity). Involved in cellular lipid homeostasis. Involved in the plasma clearance of chylomicron remnants and activated LRPAP1 (alpha 2-macroglobulin), as well as the local metabolism of complexes between plasminogen activators and their endogenous inhibitors. Acts as an LRPAP1 alpha-2-macroglobulin receptor (PubMed:1702392, PubMed",alpha-2 macroglobulin receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0002120,Multiple coagulation factor deficiency protein 2,target,Q8NI22,MCFD2,Humans,The MCFD2-LMAN1 complex forms a specific cargo receptor for the ER-to-Golgi transport of selected proteins. Plays a role in the secretion of coagulation factors,calcium ion binding,Endoplasmic reticulum-Golgi intermediate compartment,modulator,DrugBank,drugbank_id
BE0000380,Vitamin K-dependent protein C,enzyme,P04070,PROC,Humans,Protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids (PubMed:25618265). Exerts a protective effect on the endothelial cell barrier function (PubMed:25651845),calcium ion binding,Secreted,substrate,DrugBank,drugbank_id
BE0000565,Interleukin-1 receptor type 1,target,P14778,IL1R1,Humans,"Receptor for IL1A, IL1B and IL1RN (PubMed:2950091, PubMed:37315560). After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and bindin",interleukin-1 binding,Membrane,antagonist,DrugBank,drugbank_id
BE0000803,Dihydropteroate synthase,target,P0AC13,folP,Escherichia coli (strain K12),"Catalyzes the condensation of para-aminobenzoate (pABA) with 6-hydroxymethyl-7,8-dihydropterin diphosphate (DHPt-PP) to form 7,8-dihydropteroate (H2Pte), the immediate precursor of folate derivatives.",dihydropteroate synthase activity,,binder,DrugBank,drugbank_id
BE0001032,ATP-dependent translocase ABCB1,transporter,P08183,ABCB1,Humans,"Translocates drugs and phospholipids across the membrane (PubMed:2897240, PubMed:35970996, PubMed:8898203, PubMed:9038218, PubMed:35507548). Catalyzes the flop of phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane. Participates mainly to the flop of phosphatidylcholine, phosphatidylethanolamine, beta-D-glucosylceramides and sphingomyelins (PubMed:8898203). Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells (PubMe",ABC-type xenobiotic transporter activity,Cell membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0004684,Putative high affinity immunoglobulin gamma Fc receptor IB,target,Q92637,FCGR1BP,Humans,May bind to the Fc region of immunoglobulins gamma with a low affinity compared to FCGR1A. May function in the humoral immune response,IgG binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003455,Complement C3,target,P01024,C3,Humans,"Precursor of non-enzymatic components of the classical, alternative, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system",C5L2 anaphylatoxin chemotactic receptor binding,Secreted,binder,DrugBank,drugbank_id
BE0004685,Complement C4-A,target,P0C0L4,C4A,Humans,"Precursor of non-enzymatic components of the classical, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system",complement component C1q complex binding,Secreted,binder,DrugBank,drugbank_id
BE0004686,Complement C4-B,target,P0C0L5,C4B,Humans,"Precursor of non-enzymatic components of the classical, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system",carbohydrate binding,Secreted,binder,DrugBank,drugbank_id
BE0000855,Complement C5,target,P01031,C5,Humans,"Precursor of the C5a anaphylatoxin and complement C5b components of the complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:12878586, PubMed:18204047, PubMed:30643019, PubMed:6554279). Activated downstream of classical, alternative, lectin and GZMK complement pathways (PubMed:12878586, PubMed:18204047, PubMed:30643019, PubMed:6554279)",chemokine activity,Secreted,binder,DrugBank,drugbank_id
BE0000033,Insulin receptor,target,P06213,INSR,Humans,"Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory su",amyloid-beta binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000858,Insulin-like growth factor 1 receptor,target,P08069,IGF1R,Humans,"Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins incl",ATP binding,Cell membrane,activator,DrugBank,drugbank_id
BE0001123,Carboxypeptidase E,target,P16870,CPE,Humans,"Sorting receptor that directs prohormones to the regulated secretory pathway. Also acts as a prohormone processing enzyme in neuro/endocrine cells, removing dibasic residues from the C-terminal end of peptide hormone precursors after initial endoprotease cleavage",carboxypeptidase activity,"Cytoplasmic vesicle, secretory vesicle",modulator|product of,DrugBank,drugbank_id
BE0001147,CCN family member 3,target,P48745,CCN3,Humans,"Immediate-early protein playing a role in various cellular processes including proliferation, adhesion, migration, differentiation and survival (PubMed:12050162, PubMed:12695522, PubMed:15181016, PubMed:15611078, PubMed:21344378). Acts by binding to integrins or membrane receptors such as NOTCH1 (PubMed:12695522, PubMed:15611078, PubMed:21344378). Essential regulator of hematopoietic stem and progenitor cell function (PubMed:17463287). Inhibits myogenic differentiation through the activation of ",growth factor activity,Secreted,downregulator,DrugBank,drugbank_id
BE0002126,Insulin-like growth factor-binding protein 7,target,Q16270,IGFBP7,Humans,Binds IGF1 and IGF2 with a relatively low affinity. Stimulates prostacyclin (PGI2) production. Stimulates cell adhesion. Acts as a ligand for CD93 to play a role in angiogenesis (PubMed:38218180),insulin-like growth factor binding,Secreted,inhibitor|binder,DrugBank,drugbank_id
BE0001183,Insulin-degrading enzyme,enzyme,P14735,IDE,Humans,"Plays a role in the cellular breakdown of insulin, APP peptides, IAPP peptides, natriuretic peptides, glucagon, bradykinin, kallidin, and other peptides, and thereby plays a role in intercellular peptide signaling (PubMed:10684867, PubMed:17051221, PubMed:17613531, PubMed:18986166, PubMed:19321446, PubMed:21098034, PubMed:2293021, PubMed:23922390, PubMed:24847884, PubMed:26394692, PubMed:26968463, PubMed:29596046). Substrate binding induces important conformation changes, making it possible to b",amyloid-beta binding,"Cytoplasm, cytosol",substrate|cleavage,DrugBank,drugbank_id
BE0002124,Neuroendocrine convertase 2,enzyme,P16519,PCSK2,Humans,Serine endopeptidase which is involved in the processing of hormone and other protein precursors at sites comprised of pairs of basic amino acid residues. Responsible for the release of glucagon from proglucagon in pancreatic A cells,serine-type endopeptidase activity,"Cytoplasmic vesicle, secretory vesicle",activator,DrugBank,drugbank_id
BE0002125,Neuroendocrine convertase 1,enzyme,P29120,PCSK1,Humans,"Involved in the processing of hormone and other protein precursors at sites comprised of pairs of basic amino acid residues. Substrates include POMC, renin, enkephalin, dynorphin, somatostatin, insulin and AGRP",identical protein binding,"Cytoplasmic vesicle, secretory vesicle",activator,DrugBank,drugbank_id
BE0000711,Interferon gamma receptor 1,target,P15260,IFNGR1,Humans,"Receptor subunit for interferon gamma/INFG that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation (PubMed:20015550). Associates with transmembrane accessory factor IFNGR2 to form a functional receptor (PubMed:10986460, PubMed:2971451, PubMed:7615558, PubMed:7617032, PubMed:7673114). Upon ligand binding, the intracellular domain of IFNGR1 opens out to allow association of downstream signaling components ",cytokine binding,Cell membrane,binder,DrugBank,drugbank_id
BE0000467,Interferon gamma receptor 2,target,P38484,IFNGR2,Humans,"Associates with IFNGR1 to form a receptor for the cytokine interferon gamma (IFNG) (PubMed:7615558, PubMed:7673114, PubMed:8124716). Ligand binding stimulates activation of the JAK/STAT signaling pathway (PubMed:15356148, PubMed:7673114, PubMed:8124716). Required for signal transduction in contrast to other receptor subunit responsible for ligand binding (PubMed:7673114)",cytokine receptor activity,Cell membrane,binder,DrugBank,drugbank_id
BE0000293,Vasopressin V2 receptor,target,P30518,AVPR2,Humans,Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. Involved in renal water reabsorption,vasopressin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000165,Vasopressin V1a receptor,target,P37288,AVPR1A,Humans,"Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. Has been involved in social behaviors, including affiliation and attachment",peptide hormone binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000773,Vasopressin V1b receptor,target,P47901,AVPR1B,Humans,Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system,protein kinase C binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000844,Oxytocin receptor,target,P30559,OXTR,Humans,Receptor for oxytocin. The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system,oxytocin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000262,Prostaglandin G/H synthase 2,enzyme,P35354,PTGS2,Humans,"Dual cyclooxygenase and peroxidase in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate, AA, C20:4(n-6)), with a particular role in the inflammatory response (PubMed:11939906, PubMed:16373578, PubMed:19540099, PubMed:22942274, PubMed:26859324, PubMed:27226593, PubMed:7592599, PubMed:7947975, PubMed:9261177). The cyclooxygenase activity oxygenates AA to the hydroperoxy endoperoxide prostaglandin G2 (PGG2), and the",enzyme binding,Microsome membrane,inducer,DrugBank,drugbank_id
BE0000017,Prostaglandin G/H synthase 1,enzyme,P23219,PTGS1,Humans,"Dual cyclooxygenase and peroxidase that plays an important role in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate, AA, C20:4(n-6)), with a particular role in the inflammatory response. The cyclooxygenase activity oxygenates AA to the hydroperoxy endoperoxide prostaglandin G2 (PGG2), and the peroxidase activity reduces PGG2 to the hydroxy endoperoxide prostaglandin H2 (PGH2), the precursor of all 2-series prost",heme binding,Microsome membrane,inducer,DrugBank,drugbank_id
BE0001178,Tissue factor,target,P13726,F3,Humans,Initiates blood coagulation by forming a complex with circulating factor VII or VIIa. The [TF:VIIa] complex activates factors IX or X by specific limited proteolysis. TF plays a role in normal hemostasis by initiating the cell-surface assembly and propagation of the coagulation protease cascade,cytokine receptor activity,Membrane,binder,DrugBank,drugbank_id
BE0000748,Fibroblast growth factor receptor 2,target,P21802,FGFR2,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is ",ATP binding,Cell membrane,agonist|binder,DrugBank,drugbank_id
BE0002131,Fibroblast growth factor receptor 1,target,P11362,FGFR1,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activati",ATP binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0001031,Basement membrane-specific heparan sulfate proteoglycan core protein,target,P98160,HSPG2,Humans,"Integral component of basement membranes. Component of the glomerular basement membrane (GBM), responsible for the fixed negative electrostatic membrane charge, and which provides a barrier which is both size- and charge-selective. It serves as an attachment substrate for cells. Plays essential roles in vascularization. Critical for normal heart development and for regulating the vascular response to injury. Also required for avascular cartilage development",amyloid-beta binding,"Secreted, extracellular space, extracellular matrix, basement membrane",ligand,DrugBank,drugbank_id
BE0000527,Glucagon receptor,target,P47871,GCGR,Humans,"G-protein coupled receptor for glucagon that plays a central role in the regulation of blood glucose levels and glucose homeostasis. Regulates the rate of hepatic glucose production by promoting glycogen hydrolysis and gluconeogenesis. Plays an important role in mediating the responses to fasting. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. ",glucagon receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0002134,Glucagon-like peptide 2 receptor,target,O95838,GLP2R,Humans,This is a receptor for glucagon-like peptide 2. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase,G protein-coupled receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000857,Glucagon-like peptide 1 receptor,target,P43220,GLP1R,Humans,"G-protein coupled receptor for glucagon-like peptide 1 (GLP-1) (PubMed:19861722, PubMed:26308095, PubMed:27196125, PubMed:28514449, PubMed:7517895, PubMed:8216285, PubMed:8405712). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels (PubMed:19861722, PubMed:26308095, PubMed:27196125, PubMed:28514449, PubMed:7517895, PubMed:8216285, PubMed:8405712). Plays a role in regulating insulin secretion in respon",glucagon receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0002102,Cytokine receptor common subunit gamma,target,P31785,IL2RG,Humans,"Common subunit for the receptors for a variety of interleukins. Probably in association with IL15RA, involved in the stimulation of neutrophil phagocytosis by IL15 (PubMed:15123770)",coreceptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0001029,Interleukin-2,target,P60568,IL2,Humans,"Cytokine produced by activated CD4-positive helper T-cells and to a lesser extend activated CD8-positive T-cells and natural killer (NK) cells that plays pivotal roles in the immune response and tolerance (PubMed:6438535). Binds to a receptor complex composed of either the high-affinity trimeric IL-2R (IL2RA/CD25, IL2RB/CD122 and IL2RG/CD132) or the low-affinity dimeric IL-2R (IL2RB and IL2RG) (PubMed:16293754, PubMed:16477002). Interaction with the receptor leads to oligomerization and conforma",carbohydrate binding,Secreted,modulator,DrugBank,drugbank_id
BE0000657,Cytosolic phospholipase A2,enzyme,P47712,PLA2G4A,Humans,"Has primarily calcium-dependent phospholipase and lysophospholipase activities, with a major role in membrane lipid remodeling and biosynthesis of lipid mediators of the inflammatory response (PubMed:10358058, PubMed:14709560, PubMed:16617059, PubMed:17472963, PubMed:18451993, PubMed:27642067, PubMed:7794891, PubMed:8619991, PubMed:8702602, PubMed:9425121). Plays an important role in embryo implantation and parturition through its ability to trigger prostanoid production (By similarity). Prefere",calcium ion binding,Cytoplasm,inducer,DrugBank,drugbank_id
BE0002638,Cytochrome P450 3A4,enzyme,P08684,CYP3A4,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed:10681376, PubMed:11093772, PubMed:11555828, PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:19965576, PubMed:20702771, PubMed:21490593, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase","1,8-cineole 2-exo-monooxygenase activity",Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0002204,Xanthine dehydrogenase/oxidase,enzyme,P47989,XDH,Humans,Key enzyme in purine degradation. Catalyzes the oxidation of hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric acid. Contributes to the generation of reactive oxygen species. Has also low oxidase activity towards aldehydes (in vitro),"2 iron, 2 sulfur cluster binding",Cytoplasm,inducer,DrugBank,drugbank_id
BE0003533,Cytochrome P450 2E1,enzyme,P05181,CYP2E1,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of fatty acids (PubMed:10553002, PubMed:18577768). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:10553002, PubMed:18577768). Catalyzes the hydroxylation of carbon-hydrogen bonds. Hydroxylates fatty acids specifically at the omega-1 position displaying",4-nitrophenol 2-monooxygenase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0002137,Vesicle-associated membrane protein 2,target,P63027,VAMP2,Humans,Involved in the targeting and/or fusion of transport vesicles to their target membrane (By similarity). Major SNARE protein of synaptic vesicles which mediates fusion of synaptic vesicles to release neurotransmitters. Essential for fast vesicular exocytosis and activity-dependent neurotransmitter release as well as fast endocytosis that mediates rapid reuse of synaptic vesicles (By similarity) (PubMed:30929742). Modulates the gating characteristics of the delayed rectifier voltage-dependent pota,calcium-dependent protein binding,"Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane",binder,DrugBank,drugbank_id
BE0002136,Vesicle-associated membrane protein 1,target,P23763,VAMP1,Humans,Involved in the targeting and/or fusion of transport vesicles to their target membrane,SNAP receptor activity,"Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane",binder,DrugBank,drugbank_id
BE0002138,Synaptotagmin-2,target,Q8N9I0,SYT2,Humans,Exhibits calcium-dependent phospholipid and inositol polyphosphate binding properties (By similarity). May have a regulatory role in the membrane interactions during trafficking of synaptic vesicles at the active zone of the synapse (By similarity). Plays a role in dendrite formation by melanocytes (PubMed:23999003),calcium ion sensor activity,"Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane",inhibitor|cleavage,DrugBank,drugbank_id
BE0010138,Immunoglobulin heavy constant epsilon,target,P01854,IGHE,Humans,"Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which resu",antigen binding,Secreted,antibody|neutralizer,DrugBank,drugbank_id
BE0000049,High affinity immunoglobulin epsilon receptor subunit gamma,target,P30273,FCER1G,Humans,"Adapter protein containing an immunoreceptor tyrosine-based activation motif (ITAM) that transduces activation signals from various immunoreceptors. As a component of the high-affinity immunoglobulin E (IgE) receptor, mediates allergic inflammatory signaling in mast cells. As a constitutive component of interleukin-3 receptor complex, selectively mediates interleukin 4/IL4 production by basophils, priming T-cells toward effector T-helper 2 subset. Associates with pattern recognition receptors CL",identical protein binding,Cell membrane,modulator,DrugBank,drugbank_id
BE0003491,Insulin,target,P01308,INS,Humans,"Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver",hormone activity,Secreted,modulator,DrugBank,drugbank_id
BE0000025,Collagen alpha-1(I) chain,target,P02452,COL1A1,Humans,Type I collagen is a member of group I collagen (fibrillar forming collagen),extracellular matrix structural constituent conferring tensile strength,"Secreted, extracellular space, extracellular matrix",cleavage,DrugBank,drugbank_id
BE0002140,Collagen alpha-1(II) chain,target,P02458,COL2A1,Humans,"Type II collagen is specific for cartilaginous tissues. It is essential for the normal embryonic development of the skeleton, for linear growth and for the ability of cartilage to resist compressive forces",extracellular matrix structural constituent conferring tensile strength,"Secreted, extracellular space, extracellular matrix",cleavage,DrugBank,drugbank_id
BE0002130,Collagen alpha-1(III) chain,target,P02461,COL3A1,Humans,Collagen type III occurs in most soft connective tissues along with type I collagen. Involved in regulation of cortical development. Is the major ligand of ADGRG1 in the developing brain and binding to ADGRG1 inhibits neuronal migration and activates the RhoA pathway by coupling ADGRG1 to GNA13 and possibly GNA12,extracellular matrix structural constituent,"Secreted, extracellular space, extracellular matrix",cleavage,DrugBank,drugbank_id
BE0004823,Uric acid,target,,,Humans,,,,metabolizer,DrugBank,drugbank_id
BE0000075,Growth hormone receptor,target,P10912,GHR,Humans,"Receptor for pituitary gland growth hormone (GH1) involved in regulating postnatal body growth (PubMed:1549776, PubMed:2825030, PubMed:8943276). On ligand binding, couples to the JAK2/STAT5 pathway (PubMed:1549776, PubMed:15690087, PubMed:2825030, PubMed:8943276)",cytokine binding,Cell membrane,ligand,DrugBank,drugbank_id
BE0000345,Prolactin receptor,target,P16471,PRLR,Humans,This is a receptor for the anterior pituitary hormone prolactin (PRL). Acts as a prosurvival factor for spermatozoa by inhibiting sperm capacitation through suppression of SRC kinase activation and stimulation of AKT. Isoform 4 is unable to transduce prolactin signaling. Isoform 6 is unable to transduce prolactin signaling,cytokine binding,Membrane,ligand,DrugBank,drugbank_id
BE0003536,Cytochrome P450 2C19,enzyme,P33261,CYP2C19,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of polyunsaturated fatty acids (PUFA) (PubMed:18577768, PubMed:19965576, PubMed:20972997). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:18577768, PubMed:19965576, PubMed:20972997). Catalyzes the hydroxylation of carbon-hydrogen bonds. Hydroxylates PU",(R)-limonene 6-monooxygenase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0001155,Integrin beta-3,target,P05106,ITGB3,Humans,"Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3 (ITGA2B:ITGB3) is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Integrin alpha-IIb/beta-3 recognizes the s",cell adhesion molecule binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000439,Integrin alpha-IIb,target,P08514,ITGA2B,Humans,"Integrin alpha-IIb/beta-3 is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. It recognizes the sequence R-G-D in a wide array of ligands. It recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain (By similarity). Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen (PubMed:9111081). This step leads to rapid platelet aggregation which physically plugs r",extracellular matrix binding,Membrane,antagonist,DrugBank,drugbank_id
BE0001068,Vitronectin,target,P04004,VTN,Humans,Vitronectin is a cell adhesion and spreading factor found in serum and tissues. Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway,collagen binding,"Secreted, extracellular space",,DrugBank,drugbank_id
BE0000016,Coagulation factor VIII,target,P00451,F8,Humans,"Factor VIII, along with calcium and phospholipid, acts as a cofactor for F9/factor IXa when it converts F10/factor X to the activated form, factor Xa",copper ion binding,"Secreted, extracellular space",inhibitor,DrugBank,drugbank_id
BE0000041,Coagulation factor V,target,P12259,F5,Humans,Central regulator of hemostasis. It serves as a critical cofactor for the prothrombinase activity of factor Xa that results in the activation of prothrombin to thrombin,copper ion binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0001151,Thrombomodulin,target,P07204,THBD,Humans,"Endothelial cell receptor that plays a critical role in regulating several physiological processes including hemostasis, coagulation, fibrinolysis, inflammation, and angiogenesis (PubMed:10761923). Acts as a cofactor for thrombin activation of protein C/PROC on the surface of vascular endothelial cells leading to initiation of the activated protein C anticoagulant pathway (PubMed:29323190, PubMed:33836597, PubMed:9395524). Also accelerates the activation of the plasma carboxypeptidase B2/CPB2, w",calcium ion binding,Membrane,,DrugBank,drugbank_id
BE0000943,Vitamin K-dependent protein S,target,P07225,PROS1,Humans,Anticoagulant plasma protein; it is a cofactor to activated protein C in the degradation of coagulation factors Va and VIIIa. It helps to prevent coagulation and stimulating fibrinolysis,calcium ion binding,Secreted,,DrugBank,drugbank_id
BE0001129,Platelet factor 4,target,P02776,PF4,Humans,"Chemokine released during platelet aggregation that plays a role in different biological processes including hematopoiesis, cell proliferation, differentiation, and activation (PubMed:29930254, PubMed:9531587). Acts via different functional receptors including CCR1, CXCR3A or CXCR3B (PubMed:18174362, PubMed:29930254). Upon interaction with CXCR3A receptor, induces activated T-lymphocytes migration mediated via downstream Ras/extracellular signal-regulated kinase (ERK) signaling (PubMed:18174362,",chemokine activity,Secreted,,DrugBank,drugbank_id
BE0002142,Serpin B6,target,P35237,SERPINB6,Humans,"May be involved in the regulation of serine proteinases present in the brain or extravasated from the blood (By similarity). Inhibitor of cathepsin G, kallikrein-8 and thrombin. May play an important role in the inner ear in the protection against leakage of lysosomal content during stress and loss of this protection results in cell death and sensorineural hearing loss",protease binding,Cytoplasm,,DrugBank,drugbank_id
BE0001161,Endothelial protein C receptor,target,Q9UNN8,PROCR,Humans,Binds activated protein C. Enhances protein C activation by the thrombin-thrombomodulin complex; plays a role in the protein C pathway controlling blood coagulation,signaling receptor activity,Membrane,,DrugBank,drugbank_id
BE0000674,Myeloid cell surface antigen CD33,target,P20138,CD33,Humans,"Sialic-acid-binding immunoglobulin-like lectin (Siglec) that plays a role in mediating cell-cell interactions and in maintaining immune cells in a resting state (PubMed:10611343, PubMed:11320212, PubMed:15597323). Preferentially recognizes and binds alpha-2,3- and more avidly alpha-2,6-linked sialic acid-bearing glycans (PubMed:7718872). Upon engagement of ligands such as C1q or syalylated glycoproteins, two immunoreceptor tyrosine-based inhibitory motifs (ITIMs) located in CD33 cytoplasmic tail",carbohydrate binding,Cell membrane,antibody|regulator,DrugBank,drugbank_id
BE0004842,Tumor-associated glycoprotein 72 (TAG-72),target,,,Humans,,,,other/unknown,DrugBank,drugbank_id
BE0000926,Interferon beta,target,P01574,IFNB1,Humans,"Type I interferon cytokine that plays a key role in the innate immune response to infection, developing tumors and other inflammatory stimuli (PubMed:10049744, PubMed:10556041, PubMed:6157094, PubMed:6171735, PubMed:7665574, PubMed:8027027, PubMed:8969169). Signals via binding to high-affinity (IFNAR2) and low-affinity (IFNAR1) heterodimeric receptor, activating the canonical Jak-STAT signaling pathway resulting in transcriptional activation or repression of interferon-regulated genes that encod",chloramphenicol O-acetyltransferase activity,Secreted,modulator,DrugBank,drugbank_id
BE0004828,Adenosine,target,,,Humans,,,,metabolizer,DrugBank,drugbank_id
BE0000917,Growth factor receptor-bound protein 2,target,P62993,GRB2,Humans,"Non-enzymatic adapter protein that plays a pivotal role in precisely regulated signaling cascades from cell surface receptors to cellular responses, including signaling transduction and gene expression (PubMed:11726515, PubMed:37626338). Thus, participates in many biological processes including regulation of innate and adaptive immunity, autophagy, DNA repair or necroptosis (PubMed:35831301, PubMed:37626338, PubMed:38182563). Controls signaling complexes at the T-cell antigen receptor to facilit",ephrin receptor binding,Nucleus,binder,DrugBank,drugbank_id
BE0009351,Voltage-dependent N-type calcium channel,target,P54289,CACNA2D1,Humans,The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity),metal ion binding,Membrane,antagonist,DrugBank,drugbank_id
BE0000387,Follicle-stimulating hormone receptor,target,P23945,FSHR,Humans,"G protein-coupled receptor for follitropin, the follicle-stimulating hormone (PubMed:11847099, PubMed:24058690, PubMed:24692546). Through cAMP production activates the downstream PI3K-AKT and ERK1/ERK2 signaling pathways (PubMed:24058690)",follicle-stimulating hormone receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0001069,ATP-binding cassette sub-family C member 2,transporter,Q92887,ABCC2,Humans,"ATP-dependent transporter of the ATP-binding cassette (ABC) family that binds and hydrolyzes ATP to enable active transport of various substrates including many drugs, toxicants and endogenous compound across cell membranes. Transports a wide variety of conjugated organic anions such as sulfate-, glucuronide- and glutathione (GSH)-conjugates of endo- and xenobiotics substrates (PubMed:10220572, PubMed:10421658, PubMed:11500505, PubMed:16332456). Mediates hepatobiliary excretion of mono- and bis-",ABC-type glutathione S-conjugate transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0000984,Transforming growth factor beta-1 proprotein,target,P01137,TGFB1,Humans,"Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively",cytokine activity,"Secreted, extracellular space, extracellular matrix",inhibitor,DrugBank,drugbank_id
BE0000530,Albumin,carrier,P02768,ALB,Humans,"Binds water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs (Probable). Its main function is the regulation of the colloidal osmotic pressure of blood (Probable). Major zinc transporter in plasma, typically binds about 80% of all plasma zinc (PubMed:19021548). Major calcium and magnesium transporter in plasma, binds approximately 45% of circulating calcium and magnesium in plasma (By similarity). Potentially has more than two calcium-binding sites and might additionally bind cal",antioxidant activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0000511,Receptor tyrosine-protein kinase erbB-2,target,P04626,ERBB2,Humans,"Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell memb",ATP binding,Cell membrane,binder|antibody,DrugBank,drugbank_id
BE0000066,B-lymphocyte antigen CD20,target,P11836,MS4A1,Humans,"B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes (PubMed:12920111, PubMed:3925015, PubMed:7684739). Functions as a store-operated calcium (SOC) channel component promoting calcium influx after activation by the B-cell receptor/BCR (PubMed:12920111, PubMed:18474602, PubMed:7684739)",epidermal growth factor receptor binding,Cell membrane,antibody|regulator,DrugBank,drugbank_id
BE0003456,T-cell surface glycoprotein CD3 delta chain,target,P04234,CD3D,Humans,"Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinase",identical protein binding,Cell membrane,,DrugBank,drugbank_id
BE0000274,T-cell surface glycoprotein CD3 epsilon chain,target,P07766,CD3E,Humans,"Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinase",identical protein binding,Cell membrane,binder,DrugBank,drugbank_id
BE0003457,T-cell surface glycoprotein CD3 gamma chain,target,P09693,CD3G,Humans,"Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinase",identical protein binding,Cell membrane,,DrugBank,drugbank_id
BE0003458,T-cell surface glycoprotein CD3 zeta chain,target,P20963,CD247,Humans,"Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinase",identical protein binding,Cell membrane,,DrugBank,drugbank_id
BE0004837,Digoxin,target,,,Humans,,,,neutralizer,DrugBank,drugbank_id
BE0010021,Cytoplasmic membrane,target,,,Bacteria,,,,incorporation into and destabilization,DrugBank,drugbank_id
BE0000925,Alpha-1-acid glycoprotein 1,carrier,P02763,ORM1,Humans,Functions as a transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in the body. Appears to function in modulating the activity of the immune system during the acute-phase reaction,,Secreted,binder,DrugBank,drugbank_id
BE0000952,Alpha-1-antitrypsin,carrier,P01009,SERPINA1,Humans,"Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin",identical protein binding,Secreted,binder,DrugBank,drugbank_id
BE0000499,Low-density lipoprotein receptor,carrier,P01130,LDLR,Humans,"Binds low density lipoprotein /LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Forms a ternary complex with PGRMC1 and TMEM97 receptors which increases LDLR-mediated LDL internalization (PubMed:30443021)",amyloid-beta binding,Cell membrane,binder,DrugBank,drugbank_id
BE0000685,Sex hormone-binding globulin,carrier,P04278,SHBG,Humans,"Functions as an androgen transport protein, but may also be involved in receptor mediated processes. Each dimer binds one molecule of steroid. Specific for 5-alpha-dihydrotestosterone, testosterone, and 17-beta-estradiol. Regulates the plasma metabolic clearance rate of steroid hormones by controlling their plasma concentration",androgen binding,Secreted,binder,DrugBank,drugbank_id
BE0009909,Hemopexin,carrier,P02790,HPX,Humans,"Binds heme and transports it to the liver for breakdown and iron recovery, after which the free hemopexin returns to the circulation",heme transmembrane transporter activity,Secreted,binder,DrugBank,drugbank_id
BE0000549,"Sterol 26-hydroxylase, mitochondrial",enzyme,Q02318,CYP27A1,Humans,"Cytochrome P450 monooxygenase that catalyzes regio- and stereospecific hydroxylation of cholesterol and its derivatives. Hydroxylates (with R stereochemistry) the terminal methyl group of cholesterol side-chain in a three step reaction to yield at first a C26 alcohol, then a C26 aldehyde and finally a C26 acid (PubMed:12077124, PubMed:21411718, PubMed:28190002, PubMed:9660774). Regulates cholesterol homeostasis by catalyzing the conversion of excess cholesterol to bile acids via both the 'neutra",cholestanetetraol 26-dehydrogenase activity,Mitochondrion inner membrane,inducer,DrugBank,drugbank_id
BE0002240,Glutamine synthetase,enzyme,P15104,GLUL,Humans,"Glutamine synthetase that catalyzes the ATP-dependent conversion of glutamate and ammonia to glutamine (PubMed:16267323, PubMed:30158707, PubMed:36289327). Its role depends on tissue localization: in the brain, it regulates the levels of toxic ammonia and converts neurotoxic glutamate to harmless glutamine, whereas in the liver, it is one of the enzymes responsible for the removal of ammonia (By similarity). Plays a key role in ammonium detoxification during erythropoiesis: the glutamine synthet",ATP binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0002180,Cholinesterase,enzyme,P06276,BCHE,Humans,Esterase with broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters,acetylcholinesterase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0000421,Cytochrome P450 4A11,enzyme,Q02928,CYP4A11,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of fatty acids and their oxygenated derivatives (oxylipins) (PubMed:10553002, PubMed:10660572, PubMed:15611369, PubMed:1739747, PubMed:7679927, PubMed:8914854). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:10553002, PubMed:10660572, PubMed:1",alkane 1-monooxygenase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000390,Synaptosomal-associated protein 25,target,P60880,SNAP25,Humans,t-SNARE involved in the molecular regulation of neurotransmitter release. May play an important role in the synaptic function of specific neuronal systems. Associates with proteins involved in vesicle docking and membrane fusion. Regulates plasma membrane recycling through its interaction with CENPF. Modulates the gating characteristics of the delayed rectifier voltage-dependent potassium channel KCNB1 in pancreatic beta cells,calcium-dependent protein binding,"Cytoplasm, perinuclear region",inhibitor,DrugBank,drugbank_id
BE0003572,Rho-related GTP-binding protein RhoB,target,P62745,RHOB,Humans,Mediates apoptosis in neoplastically transformed cells after DNA damage. Not essential for development but affects cell adhesion and growth factor signaling in transformed cells. Plays a negative role in tumorigenesis as deletion causes tumor formation. Involved in intracellular protein trafficking of a number of proteins. Targets PKN1 to endosomes and is involved in trafficking of the EGF receptor from late endosomes to lysosomes. Also required for stability and nuclear trafficking of AKT1/AKT ,GDP binding,Late endosome membrane,inhibitor,DrugBank,drugbank_id
BE0004834,Dietary fat,target,,,Humans,,,,cleavage,DrugBank,drugbank_id
BE0004835,Dietary protein,target,,,Humans,,,,cleavage,DrugBank,drugbank_id
BE0004836,Dietary starch,target,,,Humans,,,,cleavage,DrugBank,drugbank_id
BE0000928,Proteinase-activated receptor 1,target,P25116,F2R,Humans,"High affinity receptor that binds the activated thrombin, leading to calcium release from intracellular stores (PubMed:1672265, PubMed:8136362). The thrombin-activated receptor signaling pathway is mediated through PTX-insensitive G proteins, activation of phospholipase C resulting in the production of 1D-myo-inositol 1,4,5-trisphosphate (InsP3) which binds to InsP3 receptors causing calcium release from the stores (By similarity). In astrocytes, the calcium released into the cytosol allows the ",G protein-coupled receptor activity,Cell membrane,activator,DrugBank,drugbank_id
BE0000083,CAMPATH-1 antigen,target,P31358,CD52,Humans,"May play a role in carrying and orienting carbohydrate, as well as having a more specific role",,Cell membrane,antibody,DrugBank,drugbank_id
BE0000568,Glutamate carboxypeptidase 2,target,Q04609,FOLH1,Humans,"Has both folate hydrolase and N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity. Has a preference for tri-alpha-glutamate peptides. In the intestine, required for the uptake of folate. In the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, N-aceylaspartylglutamate (NAAG), thereby releasing glutamate. Involved in prostate tumor progression",Ac-Asp-Glu binding,Cell membrane,other/unknown,DrugBank,drugbank_id
BE0000379,Guided entry of tail-anchored proteins factor CAMLG,target,P49069,CAMLG,Humans,"Required for the post-translational delivery of tail-anchored (TA) proteins to the endoplasmic reticulum (PubMed:23041287, PubMed:24392163, PubMed:27226539). Together with GET1/WRB, acts as a membrane receptor for soluble GET3/TRC40, which recognizes and selectively binds the transmembrane domain of TA proteins in the cytosol (PubMed:23041287, PubMed:24392163, PubMed:27226539). Required for the stability of GET1 (PubMed:32187542). Stimulates calcium signaling in T cells through its involvement i",ubiquitin protein ligase binding,Endoplasmic reticulum membrane,binder,DrugBank,drugbank_id
BE0002143,Calcineurin subunit B type 2,target,Q96LZ3,PPP3R2,Humans,"Regulatory subunit of calcineurin, a calcium-dependent, calmodulin stimulated protein phosphatase. Confers calcium sensitivity",calcium ion binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0001014,Peptidyl-prolyl cis-trans isomerase A,target,P62937,PPIA,Humans,"Catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides (PubMed:2001362, PubMed:20676357, PubMed:21245143, PubMed:21593166, PubMed:25678563). Exerts a strong chemotactic effect on leukocytes partly through activation of one of its membrane receptors BSG/CD147, initiating a signaling cascade that culminates in MAPK/ERK activation (PubMed:11943775, PubMed:21245143). Activates endothelial cells (ECs) in a pro-inflammatory manner by stimulating activation of NF-kappa-B",cyclosporin A binding,Cytoplasm,inhibitor|binder,DrugBank,drugbank_id
BE0001399,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",target,P30405,PPIF,Humans,PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding (PubMed:20676357). Involved in regulation of the mitochondrial permeability transition pore (mPTP) (PubMed:26387735). It is proposed that its association with the mPTP is masking a binding site for inhibiting inorganic phosphate (Pi) and promotes the open probability of the mPTP leading to apoptosis or necrosis; the requirement of the PPIase activity for thi,cyclosporin A binding,Mitochondrion matrix,binder,DrugBank,drugbank_id
BE0004238,Protein phosphatase 3 catalytic subunit alpha,target,Q08209,PPP3CA,Humans,"Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:15671020, PubMed:18838687, PubMed:19154138, PubMed:23468591, PubMed:30254215). Many of the substrates contain a PxIxIT motif and/or a LxVP motif (PubMed:17498738, PubMed:17502104, PubMed:22343722, PubMed:23468591, PubMed:27974827). In response to increased Ca(2+) levels, dephosphorylates and activates phosphatase SSH1 which results in cof",ATPase binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002362,Cytochrome P450 3A5,enzyme,P20815,CYP3A5,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of steroid hormones and vitamins (PubMed:10681376, PubMed:11093772, PubMed:12865317, PubMed:2732228). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed:10681376, PubMed:11093772, PubMed:12865317, PubMe",estrogen 16-alpha-hydroxylase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000703,Bile salt export pump,transporter,O95342,ABCB11,Humans,"Catalyzes the transport of the major hydrophobic bile salts, such as taurine and glycine-conjugated cholic acid across the canalicular membrane of hepatocytes in an ATP-dependent manner, therefore participates in hepatic bile acid homeostasis and consequently to lipid homeostasis through regulation of biliary lipid secretion in a bile salts dependent manner (PubMed:15791618, PubMed:16332456, PubMed:18985798, PubMed:19228692, PubMed:20010382, PubMed:20398791, PubMed:22262466, PubMed:24711118, Pub",ABC-type bile acid transporter activity,Apical cell membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0003643,Ileal sodium/bile acid cotransporter,transporter,Q12908,SLC10A2,Humans,"Plays a critical role in the sodium-dependent reabsorption of bile acids from the lumen of the small intestine (PubMed:7592981, PubMed:9458785, PubMed:9856990). Transports various bile acids, unconjugated or conjugated, such as cholate and taurocholate (PubMed:7592981, PubMed:9458785, PubMed:9856990). Also responsible for bile acid transport in the renal proximal tubules, a salvage mechanism that helps conserve bile acids (Probable). Works collaboratively with the Na(+)-taurocholate cotransporti",bile acid,Membrane,inhibitor,DrugBank,drugbank_id
BE0003644,Hepatic sodium/bile acid cotransporter,transporter,Q14973,SLC10A1,Humans,"As a major transporter of conjugated bile salts from plasma into the hepatocyte, it plays a key role in the enterohepatic circulation of bile salts necessary for the solubilization and absorption of dietary fat and fat-soluble vitamins (PubMed:14660639, PubMed:24867799, PubMed:34060352, PubMed:8132774). It is strictly dependent on the extracellular presence of sodium (PubMed:14660639, PubMed:24867799, PubMed:34060352, PubMed:8132774). It exhibits broad substrate specificity and transports variou",bile acid transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001066,Solute carrier family 22 member 6,transporter,Q4U2R8,SLC22A6,Humans,"Secondary active transporter that functions as a Na(+)-independent organic anion (OA)/dicarboxylate antiporter where the uptake of one molecule of OA into the cell is coupled with an efflux of one molecule of intracellular dicarboxylate such as 2-oxoglutarate or glutarate (PubMed:11669456, PubMed:11907186, PubMed:14675047, PubMed:22108572, PubMed:23832370, PubMed:28534121, PubMed:9950961). Mediates the uptake of OA across the basolateral side of proximal tubule epithelial cells, thereby contribu",alpha-ketoglutarate transmembrane transporter activity,Basolateral cell membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0003651,ATP-binding cassette sub-family C member 10,transporter,Q5T3U5,ABCC10,Humans,"ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Lipophilic anion transporter that mediates ATP-dependent transport of glucuronide conjugates such as estradiol-17-beta-o-glucuronide and GSH conjugates such as leukotriene C4 (LTC4) (PubMed:12527806, PubMed:15256465). May contribute to regulate the transport of organic compounds in testes across the blood-testis-barrier (Probable). Mediates multidrug resi",ABC-type glutathione S-conjugate transporter activity,Cell membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0001067,Broad substrate specificity ATP-binding cassette transporter ABCG2,transporter,Q9UNQ0,ABCG2,Humans,"Broad substrate specificity ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes a wide variety of physiological compounds, dietary toxins and xenobiotics from cells (PubMed:11306452, PubMed:12958161, PubMed:19506252, PubMed:20705604, PubMed:28554189, PubMed:30405239, PubMed:31003562). Involved in porphyrin homeostasis, mediating the export of protoporphyrin IX (PPIX) from both mitochondria to cytosol and cytosol to extracellular space, it also functions in t",ABC-type xenobiotic transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001004,Solute carrier organic anion transporter family member 1B1,transporter,Q9Y6L6,SLCO1B1,Humans,"Mediates the Na(+)-independent uptake of organic anions (PubMed:10358072, PubMed:15159445, PubMed:17412826). Shows broad substrate specificity, can transport both organic anions such as bile acid taurocholate (cholyltaurine) and conjugated steroids (dehydroepiandrosterone 3-sulfate, 17-beta-glucuronosyl estradiol, and estrone 3-sulfate), as well as eicosanoids (prostaglandin E2, thromboxane B2, leukotriene C4, and leukotriene E4), and thyroid hormones (T4/L-thyroxine, and T3/3,3',5'-triiodo-L-th",bile acid transmembrane transporter activity,Basolateral cell membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0003659,Solute carrier organic anion transporter family member 1B3,transporter,Q9NPD5,SLCO1B3,Humans,"Mediates the Na(+)-independent uptake of organic anions (PubMed:10779507, PubMed:15159445, PubMed:17412826). Shows broad substrate specificity, can transport both organic anions such as bile acid taurocholate (cholyltaurine) and conjugated steroids (17-beta-glucuronosyl estradiol, dehydroepiandrosterone sulfate (DHEAS), and estrone 3-sulfate), as well as eicosanoid leukotriene C4, prostaglandin E2 and L-thyroxine (T4) (PubMed:10779507, PubMed:11159893, PubMed:12568656, PubMed:15159445, PubMed:17",bile acid transmembrane transporter activity,Basolateral cell membrane,inhibitor,DrugBank,drugbank_id
BE0000719,T-cell surface antigen CD2,target,P06729,CD2,Humans,"CD2 interacts with lymphocyte function-associated antigen CD58 (LFA-3) and CD48/BCM1 to mediate adhesion between T-cells and other cell types. CD2 is implicated in the triggering of T-cells, the cytoplasmic domain is implicated in the signaling function",identical protein binding,Cell membrane,inhibitor|antibody|regulator,DrugBank,drugbank_id
BE0010569,Lymphocyte function-associated antigen 3,target,P19256,CD58,Humans,"Ligand of the T-lymphocyte CD2 glycoprotein. This interaction is important in mediating thymocyte interactions with thymic epithelial cells, antigen-independent and -dependent interactions of T-lymphocytes with target cells and antigen-presenting cells and the T-lymphocyte rosetting with erythrocytes. In addition, the LFA-3/CD2 interaction may prime response by both the CD2+ and LFA-3+ cells",signaling receptor binding,Cell membrane,modulator,DrugBank,drugbank_id
BE0009967,Integrin alpha-X,target,P20702,ITGAX,Humans,Integrin alpha-X/beta-2 is a receptor for fibrinogen. It recognizes the sequence G-P-R in fibrinogen. It mediates cell-cell interaction during inflammatory responses. It is especially important in monocyte adhesion and chemotaxis,integrin binding,Membrane,antibody,DrugBank,drugbank_id
BE0000516,Integrin alpha-L,target,P20701,ITGAL,Humans,"Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. Integrin ITGAL/ITGB2 is a receptor for F11R (PubMed:11812992, PubMed:15528364). Integrin ITGAL/ITGB2 is a receptor for the secreted form of ubiquitin-like protein ISG15; the interaction is mediated by ITGAL (PubMed:29100055). Involved in a variety of immune phenomena including leukocyte-endothelial cell interaction, cytotoxic T-cell mediated killing, and antibody dependent killing by granulocytes and monocytes. Contributes to ",cell adhesion molecule binding,Cell membrane,antibody,DrugBank,drugbank_id
BE0003573,Major histocompatibility complex class I-related protein 1,target,Q95460,MR1,Humans,"Antigen-presenting molecule specialized in displaying microbial pyrimidine-based metabolites to alpha-beta T cell receptors (TCR) on innate-type mucosal-associated invariant T (MAIT) cells (PubMed:19416870, PubMed:23457030, PubMed:22692454, PubMed:23051753, PubMed:24101382, PubMed:23846752, PubMed:26795251). In complex with B2M preferentially presents riboflavin-derived metabolites to semi-invariant TRAV1.2 TCRs on MAIT cells, guiding immune surveillance of the microbial metabolome at mucosal ep",beta-2-microglobulin binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000846,T-lymphocyte activation antigen CD86,target,P42081,CD86,Humans,"Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4 (PubMed:12196291). May play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation (PubMed:7527824). Also involved in the regulation of B cells function, plays a role in regulating the level of IgG(1) produced. Upon C",coreceptor activity,Cell membrane,binder,DrugBank,drugbank_id
BE0003576,Integrin alpha-V,target,P06756,ITGAV,Humans,"The alpha-V (ITGAV) integrins are receptors for vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin and vWF. They recognize the sequence R-G-D in a wide array of ligands. ITGAV:ITGB3 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415). ITGAV:ITGB3 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:2",coreceptor activity,Cell membrane,inducer,DrugBank,drugbank_id
BE0003575,Integrin beta-1,target,P05556,ITGB1,Humans,"Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibr",actin binding,Cell membrane,inducer,DrugBank,drugbank_id
BE0000598,T-cell surface glycoprotein CD1a,target,P06126,CD1A,Humans,Antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells,endogenous lipid antigen binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003488,T-cell surface glycoprotein CD4,target,P01730,CD4,Humans,"Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class II molecule:peptide complex. The antigens presented by class II peptides are derived from extracellular proteins while class I peptides are derived from cytosolic proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class II presented by anti",coreceptor activity,Cell membrane,inducer,DrugBank,drugbank_id
BE0001021,Coagulation factor XI,target,P03951,F11,Humans,Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX,heparin binding,Secreted,ligand,DrugBank,drugbank_id
BE0000333,Coagulation factor VII,target,P08709,F7,Humans,"Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa also converts factor IX to factor IXa in the presence of tissue factor and calcium (PubMed:271951)",calcium ion binding,Secreted,ligand,DrugBank,drugbank_id
BE0000403,Vitamin K-dependent gamma-carboxylase,target,P38435,GGCX,Humans,"Mediates the vitamin K-dependent carboxylation of glutamate residues to calcium-binding gamma-carboxyglutamate (Gla) residues with the concomitant conversion of the reduced hydroquinone form of vitamin K to vitamin K epoxide (PubMed:17073445). Catalyzes gamma-carboxylation of various proteins, such as blood coagulation factors (F2, F7, F9 and F10), osteocalcin (BGLAP) or matrix Gla protein (MGP) (PubMed:17073445)",gamma-glutamyl carboxylase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0004830,Globotriaosylceramide,target,,,Humans,,,,metabolizer|ligand,DrugBank,drugbank_id
BE0004494,Cation-dependent mannose-6-phosphate receptor,transporter,P20645,M6PR,Humans,Transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes. Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelyosomal compartment where the low pH mediates the dissociation of the complex,protein domain specific binding,Lysosome membrane,substrate,DrugBank,drugbank_id
BE0010008,Somatostatin receptor,target,,,Humans,,,,agonist,DrugBank,drugbank_id
BE0003528,Somatostatin receptor type 2,target,P30874,SSTR2,Humans,Receptor for somatostatin-14 and -28. This receptor is coupled via pertussis toxin sensitive G proteins to inhibition of adenylyl cyclase. In addition it stimulates phosphotyrosine phosphatase and PLC via pertussis toxin insensitive as well as sensitive G proteins. Inhibits calcium entry by suppressing voltage-dependent calcium channels. Acts as the functionally dominant somatostatin receptor in pancreatic alpha- and beta-cells where it mediates the inhibitory effect of somatostatin-14 on hormon,neuropeptide binding,Cell membrane,binder,DrugBank,drugbank_id
BE0002148,Prolyl endopeptidase,enzyme,P48147,PREP,Humans,Cleaves peptide bonds on the C-terminal side of prolyl residues within peptides that are up to approximately 30 amino acids long,metallocarboxypeptidase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0010031,Leucyl-cystinyl aminopeptidase,enzyme,Q9UIQ6,LNPEP,Humans,"Release of an N-terminal amino acid, cleaves before cysteine, leucine as well as other amino acids. Degrades peptide hormones such as oxytocin, vasopressin and angiotensin III, and plays a role in maintaining homeostasis during pregnancy. May be involved in the inactivation of neuronal peptides in the brain. Cleaves Met-enkephalin and dynorphin. Binds angiotensin IV and may be the angiotensin IV receptor in the brain",aminopeptidase activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000751,Oxytocin-neurophysin 1,carrier,P01178,OXT,Humans,Neurophysin 1 specifically binds oxytocin,neurohypophyseal hormone activity,Secreted,binder,DrugBank,drugbank_id
BE0010032,Advanced glycosylation end product-specific receptor,transporter,Q15109,AGER,Humans,"Cell surface pattern recognition receptor that senses endogenous stress signals with a broad ligand repertoire including advanced glycation end products, S100 proteins, high-mobility group box 1 protein/HMGB1, amyloid beta/APP oligomers, nucleic acids, histones, phospholipids and glycosaminoglycans (PubMed:27572515, PubMed:28515150, PubMed:34743181, PubMed:35974093, PubMed:24081950). Advanced glycosylation end products are nonenzymatically glycosylated proteins which accumulate in vascular tissu",advanced glycation end-product receptor activity,Cell membrane,binder,DrugBank,drugbank_id
BE0000590,Integrin alpha-4,target,P13612,ITGA4,Humans,Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are receptors for fibronectin. They recognize one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. They are also receptors for VCAM1. Integrin alpha-4/beta-1 recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-4/beta-7 is also a receptor for MADCAM1. It recognizes the sequence L-D-T in MADCAM1. On activated endothelial cells integrin VLA-4 triggers homotypic aggregation for most VLA-4-positive leukocyt,cell adhesion molecule binding,Membrane,antibody,DrugBank,drugbank_id
BE0001085,Intercellular adhesion molecule 1,target,P05362,ICAM1,Humans,"ICAM proteins are ligands for the leukocyte adhesion protein LFA-1 (integrin alpha-L/beta-2). During leukocyte trans-endothelial migration, ICAM1 engagement promotes the assembly of endothelial apical cups through ARHGEF26/SGEF and RHOG activation",integrin binding,Membrane,ligand,DrugBank,drugbank_id
BE0000686,Fusion glycoprotein F0,target,P13843,F,Human respiratory syncytial virus B (strain 18537),"Fusion glycoprotein F0
    Inactive precursor that is cleaved at two sites by a furin-like protease to give rise to the mature F1 and F2 fusion glycoproteins.",,Virion membrane,binder,DrugBank,drugbank_id
BE0002093,Complement C1r subcomponent,target,P00736,C1R,Humans,"Serine protease component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:17996945, PubMed:19473974, PubMed:29449492). C1R catalyzes the first enzymatic step in the classical complement pathway: it is activated by the C1Q subcomplex of the C1 complex, which associates with IgG or IgM immun",calcium ion binding,Secreted,activator,DrugBank,drugbank_id
BE0010205,Fusion glycoprotein F0,target,P03420,F,Human respiratory syncytial virus A (strain A2),"Fusion glycoprotein F0
    Inactive precursor that is cleaved at two sites by a furin-like protease to give rise to the mature F1 and F2 fusion glycoproteins.",identical protein binding,Host Golgi apparatus membrane,modulator,DrugBank,drugbank_id
BE0000163,"Vascular endothelial growth factor A, long form",target,P15692,VEGFA,Humans,Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A (PubMed:35455969). Involved in protecting cells from hypoxia-mediated cell death (By similarity),chemoattractant activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000107,Cell adhesion molecule CEACAM1,target,P13688,CEACAM1,Humans,"Cell adhesion protein that mediates homophilic cell adhesion in a calcium-independent manner (By similarity). Plays a role as coinhibitory receptor in immune response, insulin action and also functions as an activator during angiogenesis (PubMed:18424730, PubMed:23696226, PubMed:25363763). Its coinhibitory receptor function is phosphorylation- and PTPN6 -dependent, which in turn, suppress signal transduction of associated receptors by dephosphorylation of their downstream effectors. Plays a role",actin binding,Cell membrane,other/unknown,DrugBank,drugbank_id
BE0000734,Methionine synthase,target,Q99707,MTR,Humans,"Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol (PubMed:16769880, PubMed:17288554, PubMed:27771510). MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate (PubMed:16769880, PubMed:17288554, PubMed:27771510). The processing of cobalamin in the",cobalamin binding,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0000777,"Methylmalonyl-CoA mutase, mitochondrial",target,P22033,MMUT,Humans,"Catalyzes the reversible isomerization of methylmalonyl-CoA (MMCoA) (generated from branched-chain amino acid metabolism and degradation of dietary odd chain fatty acids and cholesterol) to succinyl-CoA (3-carboxypropionyl-CoA), a key intermediate of the tricarboxylic acid cycle",cobalamin binding,Mitochondrion matrix,cofactor,DrugBank,drugbank_id
BE0000763,Methionine synthase reductase,target,Q9UBK8,MTRR,Humans,"Key enzyme in methionine and folate homeostasis responsible for the reactivation of methionine synthase (MTR/MS) activity by catalyzing the reductive methylation of MTR-bound cob(II)alamin (PubMed:17892308). Cobalamin (vitamin B12) forms a complex with MTR to serve as an intermediary in methyl transfer reactions that cycles between MTR-bound methylcob(III)alamin and MTR bound-cob(I)alamin forms, and occasional oxidative escape of the cob(I)alamin intermediate during the catalytic cycle leads to ",[methionine synthase] reductase (NADPH) activity,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0000320,"Methylmalonic aciduria type A protein, mitochondrial",target,Q8IVH4,MMAA,Humans,"GTPase, binds and hydrolyzes GTP (PubMed:20876572, PubMed:21138732, PubMed:28497574, PubMed:28943303). Involved in intracellular vitamin B12 metabolism, mediates the transport of cobalamin (Cbl) into mitochondria for the final steps of adenosylcobalamin (AdoCbl) synthesis (PubMed:20876572, PubMed:28497574). Functions as a G-protein chaperone that assists AdoCbl cofactor delivery from MMAB to the methylmalonyl-CoA mutase (MMUT) (PubMed:20876572, PubMed:28497574). Plays a dual role as both a prote",GTP binding,Mitochondrion,binder,DrugBank,drugbank_id
BE0002175,Cyanocobalamin reductase / alkylcobalamin dealkylase,target,Q9Y4U1,MMACHC,Humans,"Cobalamin (vitamin B12) cytosolic chaperone that catalyzes the reductive decyanation of cyanocob(III)alamin (cyanocobalamin, CNCbl) to yield cob(II)alamin and cyanide, using FAD or FMN as cofactors and NADPH as cosubstrate (PubMed:18779575, PubMed:19700356, PubMed:21697092, PubMed:25809485). Cyanocobalamin constitutes the inactive form of vitamin B12 introduced from the diet, and is converted into the active cofactors methylcobalamin (MeCbl) involved in methionine biosynthesis, and 5'-deoxyadeno",cobalamin binding,"Cytoplasm, cytosol",cofactor,DrugBank,drugbank_id
BE0002176,Methylenetetrahydrofolate reductase (NADPH),target,P42898,MTHFR,Humans,"Catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a cosubstrate for homocysteine remethylation to methionine (PubMed:29891918). Represents a key regulatory connection between the folate and methionine cycles (Probable)",FAD binding,,cofactor,DrugBank,drugbank_id
BE0000456,Corrinoid adenosyltransferase MMAB,enzyme,Q96EY8,MMAB,Humans,"Converts cob(I)alamin to adenosylcobalamin (adenosylcob(III)alamin), a coenzyme for methylmalonyl-CoA mutase, therefore participates in the final step of the vitamin B12 conversion (PubMed:12514191). Generates adenosylcobalamin (AdoCbl) and directly delivers the cofactor to MUT in a transfer that is stimulated by ATP-binding to MMAB and gated by MMAA (Probable)",ATP binding,Mitochondrion,substrate,DrugBank,drugbank_id
BE0002668,Bifunctional adenosylcobalamin biosynthesis protein CobU,enzyme,Q05599,cobU,Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720),Catalyzes ATP-dependent phosphorylation of adenosylcobinamide and addition of GMP to adenosylcobinamide phosphate.,adenosylcobinamide kinase (ATP-specific) activity,,product of,DrugBank,drugbank_id
BE0009637,Pancreatic proteases,enzyme,,,,,,,substrate,DrugBank,drugbank_id
BE0000340,Protein amnionless,transporter,Q9BXJ7,AMN,Humans,"Membrane-bound component of the endocytic receptor formed by AMN and CUBN (PubMed:14576052, PubMed:29402915, PubMed:30523278). Required for normal CUBN glycosylation and trafficking to the cell surface (PubMed:14576052, PubMed:29402915). The complex formed by AMN and CUBN is required for efficient absorption of vitamin B12 (PubMed:12590260, PubMed:14576052, PubMed:26040326). Required for normal CUBN-mediated protein transport in the kidney (Probable)",cargo receptor activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0000238,Transcobalamin-1,transporter,P20061,TCN1,Humans,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,cargo receptor ligand activity,Secreted,substrate,DrugBank,drugbank_id
BE0000362,Transcobalamin-2,transporter,P20062,TCN2,Humans,Primary vitamin B12-binding and transport protein. Delivers cobalamin to cells,cargo receptor ligand activity,Secreted,substrate,DrugBank,drugbank_id
BE0004690,Cobalamin binding intrinsic factor,transporter,P27352,CBLIF,Humans,"Promotes absorption of the essential vitamin cobalamin (Cbl) in the ileum. After interaction with CUBN, the CBLIF-cobalamin complex is internalized via receptor-mediated endocytosis",cargo receptor ligand activity,Secreted,substrate,DrugBank,drugbank_id
BE0000936,Cubilin,transporter,O60494,CUBN,Humans,"Endocytic receptor which plays a role in lipoprotein, vitamin and iron metabolism by facilitating their uptake (PubMed:10371504, PubMed:11606717, PubMed:11717447, PubMed:14576052, PubMed:9572993). Acts together with LRP2 to mediate endocytosis of high-density lipoproteins, GC, hemoglobin, ALB, TF and SCGB1A1. Acts together with AMN to mediate endocytosis of the CBLIF-cobalamin complex (PubMed:14576052, PubMed:9572993). Binds to ALB, MB, Kappa and lambda-light chains, TF, hemoglobin, GC, SCGB1A1,",calcium ion binding,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0000785,Multidrug resistance-associated protein 1,transporter,P33527,ABCC1,Humans,"Mediates export of organic anions and drugs from the cytoplasm (PubMed:10064732, PubMed:11114332, PubMed:16230346, PubMed:7961706, PubMed:9281595). Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs and other xenobiotics (PubMed:10064732, PubMed:11114332, PubMed:16230346, PubMed:7961706, PubMed:9281595). Confers resistance to anticancer drugs by decreasing accumulation of drug in cells, and by",ABC-type glutathione S-conjugate transporter activity,Cell membrane,,DrugBank,drugbank_id
BE0000617,"C-1-tetrahydrofolate synthase, cytoplasmic",target,P11586,MTHFD1,Humans,"Trifunctional enzyme that catalyzes the interconversion of three forms of one-carbon-substituted tetrahydrofolate: (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, 5,10-methenyltetrahydrofolate and (6S)-10-formyltetrahydrofolate (PubMed:10828945, PubMed:18767138, PubMed:1881876). These derivatives of tetrahydrofolate are differentially required in nucleotide and amino acid biosynthesis, (6S)-10-formyltetrahydrofolate being required for purine biosynthesis while (6R)-5,10-methylene-5,6,7,8-tetrahydr",ATP binding,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0000268,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",target,P13995,MTHFD2,Humans,"Although its dehydrogenase activity is NAD-specific, it can also utilize NADP at a reduced efficiency",magnesium ion binding,Mitochondrion,cofactor,DrugBank,drugbank_id
BE0000010,"Aminomethyltransferase, mitochondrial",target,P48728,AMT,Humans,The glycine cleavage system catalyzes the degradation of glycine,aminomethyltransferase activity,Mitochondrion,cofactor,DrugBank,drugbank_id
BE0000933,Cytosolic 10-formyltetrahydrofolate dehydrogenase,target,O75891,ALDH1L1,Humans,"Cytosolic 10-formyltetrahydrofolate dehydrogenase that catalyzes the NADP(+)-dependent conversion of 10-formyltetrahydrofolate to tetrahydrofolate and carbon dioxide (PubMed:19933275, PubMed:21238436). May also have an NADP(+)-dependent aldehyde dehydrogenase activity towards formaldehyde, acetaldehyde, propionaldehyde, and benzaldehyde (By similarity)",aldehyde dehydrogenase (NAD+) activity,"Cytoplasm, cytosol",cofactor,DrugBank,drugbank_id
BE0000822,Formimidoyltransferase-cyclodeaminase,target,O95954,FTCD,Humans,"Folate-dependent enzyme, that displays both transferase and deaminase activity. Serves to channel one-carbon units from formiminoglutamate to the folate pool",folic acid binding,"Cytoplasm, cytosol",cofactor,DrugBank,drugbank_id
BE0001240,Bifunctional purine biosynthesis protein ATIC,target,P31939,ATIC,Humans,"Bifunctional enzyme that catalyzes the last two steps of purine biosynthesis (PubMed:11948179, PubMed:14756554). Acts as a transformylase that incorporates a formyl group to the AMP analog AICAR (5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide) to produce the intermediate formyl-AICAR (FAICAR) (PubMed:10985775, PubMed:11948179, PubMed:9378707). Can use both 10-formyldihydrofolate and 10-formyltetrahydrofolate as the formyl donor in this reaction (PubMed:10985775). Also catalyzes the ",cadherin binding,"Cytoplasm, cytosol",cofactor,DrugBank,drugbank_id
BE0000331,"Serine hydroxymethyltransferase, cytosolic",target,P34896,SHMT1,Humans,"Interconversion of serine and glycine (PubMed:24698160, PubMed:8505317)",aldehyde-lyase activity,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0000292,"Serine hydroxymethyltransferase, mitochondrial",target,P34897,SHMT2,Humans,"Catalyzes the cleavage of serine to glycine accompanied with the production of 5,10-methylenetetrahydrofolate, an essential intermediate for purine biosynthesis (PubMed:24075985, PubMed:25619277, PubMed:29364879, PubMed:33015733). Serine provides the major source of folate one-carbon in cells by catalyzing the transfer of one carbon from serine to tetrahydrofolate (PubMed:25619277). Contributes to the de novo mitochondrial thymidylate biosynthesis pathway via its role in glycine and tetrahydrofo",amino acid binding,Mitochondrion,cofactor,DrugBank,drugbank_id
BE0002154,Serine hydroxymethyltransferase,target,Q53ET4,,Humans,Interconversion of serine and glycine.,cobalt ion binding,,cofactor,DrugBank,drugbank_id
BE0002177,"Methionyl-tRNA formyltransferase, mitochondrial",target,Q96DP5,MTFMT,Humans,Methionyl-tRNA formyltransferase that formylates methionyl-tRNA in mitochondria and is crucial for translation initiation,methionyl-tRNA formyltransferase activity,Mitochondrion,cofactor,DrugBank,drugbank_id
BE0002089,Catechol O-methyltransferase,target,P21964,COMT,Humans,"Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol",catechol O-methyltransferase activity,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0008997,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,target,Q8N1G2,CMTR1,Humans,S-adenosyl-L-methionine-dependent methyltransferase that mediates mRNA cap1 2'-O-ribose methylation to the 5'-cap structure of mRNAs. Methylates the ribose of the first nucleotide of a m(7)GpppG-capped mRNA and small nuclear RNA (snRNA) to produce m(7)GpppRm (cap1). Displays a preference for cap0 transcripts. Cap1 modification is linked to higher levels of translation. May be involved in the interferon response pathway,mRNA (nucleoside-2'-O-)-methyltransferase activity,Nucleus,,DrugBank,drugbank_id
BE0005015,Arsenite methyltransferase,target,Q9HBK9,AS3MT,Humans,"Catalyzes the transfer of a methyl group from AdoMet to trivalent arsenicals producing methylated and dimethylated arsenicals (PubMed:16407288, PubMed:25997655). It methylates arsenite to form methylarsonate, Me-AsO(3)H(2), which is reduced by methylarsonate reductase to methylarsonite, Me-As(OH)2 (PubMed:16407288, PubMed:25997655). Methylarsonite is also a substrate and it is converted into the much less toxic compound dimethylarsinate (cacodylate), Me(2)As(O)-OH (PubMed:16407288, PubMed:259976",arsenite methyltransferase activity,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0000372,Glycine N-methyltransferase,target,Q14749,GNMT,Humans,"Catalyzes the methylation of glycine by using S-adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine) with the concomitant production of S-adenosylhomocysteine (AdoHcy), a reaction regulated by the binding of 5-methyltetrahydrofolate. Plays an important role in the regulation of methyl group metabolism by regulating the ratio between S-adenosyl-L-methionine and S-adenosyl-L-homocysteine",folic acid binding,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0000101,S-adenosylmethionine decarboxylase proenzyme,target,P17707,AMD1,Humans,"Essential for biosynthesis of the polyamines spermidine and spermine. Promotes maintenance and self-renewal of embryonic stem cells, by maintaining spermine levels",adenosylmethionine decarboxylase activity,,cofactor,DrugBank,drugbank_id
BE0000304,S-adenosylmethionine synthase isoform type-2,target,P31153,MAT2A,Humans,"Catalyzes the formation of S-adenosylmethionine from methionine and ATP. The reaction comprises two steps that are both catalyzed by the same enzyme: formation of S-adenosylmethionine (AdoMet) and triphosphate, and subsequent hydrolysis of the triphosphate",ATP binding,,cofactor,DrugBank,drugbank_id
BE0000323,Cystathionine beta-synthase,target,P35520,CBS,Humans,"Hydro-lyase catalyzing the first step of the transsulfuration pathway, where the hydroxyl group of L-serine is displaced by L-homocysteine in a beta-replacement reaction to form L-cystathionine, the precursor of L-cysteine. This catabolic route allows the elimination of L-methionine and the toxic metabolite L-homocysteine (PubMed:20506325, PubMed:23974653, PubMed:23981774). Also involved in the production of hydrogen sulfide, a gasotransmitter with signaling and cytoprotective effects on neurons",carbon monoxide binding,Cytoplasm,activator,DrugBank,drugbank_id
BE0000407,S-adenosylmethionine synthase isoform type-1,target,Q00266,MAT1A,Humans,"Catalyzes the formation of S-adenosylmethionine from methionine and ATP. The reaction comprises two steps that are both catalyzed by the same enzyme: formation of S-adenosylmethionine (AdoMet) and triphosphate, and subsequent hydrolysis of the triphosphate",ATP binding,,cofactor,DrugBank,drugbank_id
BE0000300,Spermidine synthase,enzyme,P19623,SRM,Humans,"Catalyzes the production of spermidine from putrescine and decarboxylated S-adenosylmethionine (dcSAM). Has a strong preference for putrescine as substrate, and has very low activity towards 1,3-diaminopropane. Has extremely low activity towards spermidine",identical protein binding,,substrate,DrugBank,drugbank_id
BE0000614,Tyrosine 3-monooxygenase,target,P07101,TH,Humans,"Catalyzes the conversion of L-tyrosine to L-dihydroxyphenylalanine (L-Dopa), the rate-limiting step in the biosynthesis of catecholamines, dopamine, noradrenaline, and adrenaline. Uses tetrahydrobiopterin and molecular oxygen to convert tyrosine to L-Dopa (PubMed:15287903, PubMed:1680128, PubMed:17391063, PubMed:24753243, PubMed:34922205, PubMed:8528210, Ref.18). In addition to tyrosine, is able to catalyze the hydroxylation of phenylalanine and tryptophan with lower specificity (By similarity).",enzyme binding,"Cytoplasm, perinuclear region",binder,DrugBank,drugbank_id
BE0000692,Tyrosine aminotransferase,target,P17735,TAT,Humans,"Transaminase involved in tyrosine breakdown. Converts tyrosine to p-hydroxyphenylpyruvate. Can catalyze the reverse reaction, using glutamic acid, with 2-oxoglutarate as cosubstrate (in vitro). Has much lower affinity and transaminase activity towards phenylalanine",amino acid binding,,,DrugBank,drugbank_id
BE0000789,Large neutral amino acids transporter small subunit 2,target,Q9UHI5,SLC7A8,Humans,"Associates with SLC3A2 to form a functional heterodimeric complex that translocates small and large neutral amino acids with broad specificity and a stoichiometry of 1:1. Functions as amino acid antiporter mediating the influx of extracellular essential amino acids mainly in exchange with the efflux of highly concentrated intracellular amino acids (PubMed:10391915, PubMed:11311135, PubMed:11847106, PubMed:12716892, PubMed:15081149, PubMed:15918515, PubMed:29355479, PubMed:33298890, PubMed:348485",amino acid transmembrane transporter activity,Cell membrane,,DrugBank,drugbank_id
BE0000038,Phenylalanine--tRNA ligase alpha subunit,target,Q9Y285,FARSA,Humans,,ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0000753,Phenylalanine-4-hydroxylase,target,P00439,PAH,Humans,Catalyzes the hydroxylation of L-phenylalanine to L-tyrosine,iron ion binding,,,DrugBank,drugbank_id
BE0000028,"Phenylalanine--tRNA ligase, mitochondrial",target,O95363,FARS2,Humans,"Is responsible for the charging of tRNA(Phe) with phenylalanine in mitochondrial translation. To a lesser extent, also catalyzes direct attachment of m-Tyr (an oxidized version of Phe) to tRNA(Phe), thereby opening the way for delivery of the misacylated tRNA to the ribosome and incorporation of ROS-damaged amino acid into proteins",ATP binding,Mitochondrion matrix,,DrugBank,drugbank_id
BE0000561,Phenylalanine--tRNA ligase beta subunit,target,Q9NSD9,FARSB,Humans,,ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0003654,Monocarboxylate transporter 10,transporter,Q8TF71,SLC16A10,Humans,"Sodium- and proton-independent thyroid hormones and aromatic acids transporter (PubMed:11827462, PubMed:18337592, PubMed:28754537). Mediates both uptake and efflux of 3,5,3'-triiodothyronine (T3) and 3,5,3',5'-tetraiodothyronine (T4) with high affinity, suggesting a role in the homeostasis of thyroid hormone levels (PubMed:18337592). Responsible for low affinity bidirectional transport of the aromatic amino acids, such as phenylalanine, tyrosine, tryptophan and L-3,4-dihydroxyphenylalanine (L-do",amino acid transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000738,Neuronal acetylcholine receptor subunit alpha-2,target,Q15822,CHRNA2,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine receptor activity,Synaptic cell membrane,inhibitor,DrugBank,drugbank_id
BE0002341,Neuronal acetylcholine receptor subunit alpha-7,target,P36544,CHRNA7,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine binding,Postsynaptic cell membrane,agonist,DrugBank,drugbank_id
BE0000494,Choline-phosphate cytidylyltransferase B,target,Q9Y5K3,PCYT1B,Humans,Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis,choline-phosphate cytidylyltransferase activity,Cytoplasm,product of,DrugBank,drugbank_id
BE0002190,Choline/ethanolaminephosphotransferase 1,enzyme,Q9Y6K0,CEPT1,Humans,"Catalyzes both phosphatidylcholine and phosphatidylethanolamine biosynthesis from CDP-choline and CDP-ethanolamine, respectively (PubMed:10191259, PubMed:10893425, PubMed:12216837, PubMed:37137909). Involved in protein-dependent process of phospholipid transport to distribute phosphatidyl choline to the lumenal surface (PubMed:10191259, PubMed:10893425, PubMed:12216837). Has a higher cholinephosphotransferase activity than ethanolaminephosphotransferase activity (PubMed:10191259, PubMed:12216837",1-alkenyl-2-acylglycerol choline phosphotransferase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000237,Choline/ethanolamine kinase,enzyme,Q9Y259,CHKB,Humans,"Has a key role in phospholipid metabolism, and catalyzes the first step of phosphatidylethanolamine and phosphatidylcholine biosynthesis",ATP binding,,substrate,DrugBank,drugbank_id
BE0000519,Choline O-acetyltransferase,enzyme,P28329,CHAT,Humans,Catalyzes the reversible synthesis of acetylcholine (ACh) from acetyl CoA and choline at cholinergic synapses,choline O-acetyltransferase activity,,substrate,DrugBank,drugbank_id
BE0000784,Choline kinase alpha,enzyme,P35790,CHKA,Humans,"Plays a key role in phospholipid biosynthesis by catalyzing the phosphorylation of free choline to phosphocholine, the first step in phosphatidylcholine biosynthesis (PubMed:17007874, PubMed:19915674, PubMed:23416529, PubMed:34077757). Also phosphorylates ethanolamine, thereby contributing to phosphatidylethanolamine biosynthesis (PubMed:17007874, PubMed:19915674). Has higher activity with choline (PubMed:17007874, PubMed:19915674). May contribute to tumor cell growth (PubMed:19915674)",ATP binding,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0000636,"Choline dehydrogenase, mitochondrial",enzyme,Q8NE62,CHDH,Humans,,choline dehydrogenase activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000426,Acetylcholinesterase,enzyme,P22303,ACHE,Humans,Hydrolyzes rapidly the acetylcholine neurotransmitter released into the synaptic cleft allowing to terminate the signal transduction at the neuromuscular junction. Role in neuronal apoptosis,acetylcholine binding,Synapse,product of,DrugBank,drugbank_id
BE0000615,Choline-phosphate cytidylyltransferase A,enzyme,P49585,PCYT1A,Humans,Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis,calmodulin binding,"Cytoplasm, cytosol",product of,DrugBank,drugbank_id
BE0002181,Phospholipase D1,enzyme,Q13393,PLD1,Humans,"Function as phospholipase selective for phosphatidylcholine (PubMed:25936805, PubMed:8530346, PubMed:9582313). Implicated as a critical step in numerous cellular pathways, including signal transduction, membrane trafficking, and the regulation of mitosis. May be involved in the regulation of perinuclear intravesicular membrane traffic (By similarity)",phosphatidylinositol binding,"Cytoplasm, perinuclear region",product of,DrugBank,drugbank_id
BE0002179,Phospholipase D2,enzyme,O14939,PLD2,Humans,Function as phospholipase selective for phosphatidylcholine (PubMed:9582313). May have a role in signal-induced cytoskeletal regulation and/or endocytosis (By similarity),phosphatidylinositol binding,Cell membrane,product of,DrugBank,drugbank_id
BE0002186,Phosphoethanolamine/phosphocholine phosphatase,enzyme,Q8TCT1,PHOSPHO1,Humans,"Phosphatase that has a high activity toward phosphoethanolamine (PEA) and phosphocholine (PCho) (PubMed:15175005). Involved in the generation of inorganic phosphate for bone mineralization (By similarity). Acts in a non-redundant manner with PHOSPHO1 in skeletal mineralization: while PHOSPHO1 mediates the initiation of hydroxyapatite crystallization in the matrix vesicles (MVs), ALPL/TNAP catalyzes the spread of hydroxyapatite crystallization in the extracellular matrix (By similarity)",metal ion binding,Extracellular vesicle,product of,DrugBank,drugbank_id
BE0003647,Solute carrier family 22 member 2,transporter,O15244,SLC22A2,Humans,"Electrogenic voltage-dependent transporter that mediates the transport of a variety of organic cations such as endogenous bioactive amines, cationic drugs and xenobiotics (PubMed:9260930, PubMed:9687576). Functions as a Na(+)-independent, bidirectional uniporter (PubMed:21128598, PubMed:9687576). Cation cellular uptake or release is driven by the electrochemical potential, i.e. membrane potential and concentration gradient (PubMed:15212162, PubMed:9260930, PubMed:9687576). However, may also enga",acetylcholine transmembrane transporter activity,Basolateral cell membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0003648,Solute carrier family 22 member 1,transporter,O15245,SLC22A1,Humans,"Electrogenic voltage-dependent transporter that mediates the transport of a variety of organic cations such as endogenous bioactive amines, cationic drugs and xenobiotics (PubMed:11388889, PubMed:11408531, PubMed:12439218, PubMed:12719534, PubMed:15389554, PubMed:16263091, PubMed:16272756, PubMed:16581093, PubMed:19536068, PubMed:21128598, PubMed:23680637, PubMed:24961373, PubMed:34040533, PubMed:9187257, PubMed:9260930, PubMed:9655880). Functions as a pH- and Na(+)-independent, bidirectional tr",(R)-carnitine transmembrane transporter activity,Basolateral cell membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0003650,Solute carrier family 22 member 3,transporter,O75751,SLC22A3,Humans,"Electrogenic voltage-dependent transporter that mediates the transport of a variety of organic cations such as endogenous bioactive amines, cationic drugs and xenobiotics (PubMed:10196521, PubMed:10966924, PubMed:12538837, PubMed:17460754, PubMed:20858707). Cation cellular uptake or release is driven by the electrochemical potential, i.e. membrane potential and concentration gradient (PubMed:10966924). Functions as a Na(+)- and Cl(-)-independent, bidirectional uniporter (PubMed:12538837). Implic",monoamine transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000106,Organic cation/carnitine transporter 2,transporter,O76082,SLC22A5,Humans,"Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine (PubMed:10454528, PubMed:10525100, PubMed:10966938, PubMed:17509700, PubMed:20722056, PubMed:33124720). Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Relative uptake activity ratio of carnitine to TEA is 11.3 (PubMed:10454528, PubMed:10525100, PubMed:10966938). In intestinal e",(R)-carnitine transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000757,Solute carrier family 22 member 4,transporter,Q9H015,SLC22A4,Humans,"Transporter that mediates the transport of endogenous and microbial zwitterions and organic cations (PubMed:10215651, PubMed:15107849, PubMed:15795384, PubMed:16729965, PubMed:20601551, PubMed:22206629, PubMed:22569296, PubMed:29530864). Functions as a Na(+)-dependent and pH-dependent high affinity microbial symporter of potent food-derived antioxidant ergothioeine (PubMed:15795384, PubMed:29530864, PubMed:33124720). Transports one sodium ion with one ergothioeine molecule (By similarity). Invol",acetylcholine transmembrane transporter activity,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0001059,Choline transporter-like protein 1,transporter,Q8WWI5,SLC44A1,Humans,"Choline/H+ antiporter (PubMed:19357133, PubMed:23651124, PubMed:31855247, PubMed:33789160). Also acts as a high-affinity ethanolamine/H+ antiporter, regulating the supply of extracellular ethanolamine (Etn) for the CDP-Etn pathway, redistribute intracellular Etn and balance the CDP-Cho and CDP-Etn arms of the Kennedy pathway (PubMed:33789160). Involved in membrane synthesis and myelin production (PubMed:31855247)",antiporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0002182,Choline transporter-like protein 4,transporter,Q53GD3,SLC44A4,Humans,"Choline transporter that plays a role in the choline-acetylcholine system and is required to the efferent innervation of hair cells in the olivocochlear bundle for the maintenance of physiological function of outer hair cells and the protection of hair cells from acoustic injury (By similarity) (PubMed:23651124, PubMed:28013291). Also described as a thiamine pyrophosphate transporter in colon, may mediate the absorption of microbiota-generated thiamine pyrophosphate and contribute to host thiami",antiporter activity,Membrane,substrate,DrugBank,drugbank_id
BE0002183,Choline transporter-like protein 2,transporter,Q8IWA5,SLC44A2,Humans,"Choline/H+ antiporter, mainly in mitochodria (PubMed:10677542, PubMed:20665236, PubMed:23651124, PubMed:33789160). Also acts as a low-affinity ethanolamine/H+ antiporter, regulating the supply of extracellular ethanolamine (Etn) for the CDP-Etn pathway, redistribute intracellular Etn and balance the CDP-Cho and CDP-Etn arms of the Kennedy pathway (PubMed:33789160)",antiporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0002184,Choline transporter-like protein 3,transporter,Q8N4M1,SLC44A3,Humans,,choline transmembrane transporter activity,Membrane,substrate,DrugBank,drugbank_id
BE0000696,High affinity choline transporter 1,transporter,Q9GZV3,SLC5A7,Humans,"High-affinity Na(+)-coupled choline transmembrane symporter (PubMed:11027560, PubMed:11068039, PubMed:12237312, PubMed:12969261, PubMed:17005849, PubMed:23132865, PubMed:23141292, PubMed:27569547). Functions as an electrogenic, voltage-dependent transporter with variable charge/choline stoichiometry (PubMed:17005849). Choline uptake and choline-induced current is also Cl(-)-dependent where Cl(-) is likely a regulatory ion rather than cotransported ion (PubMed:11068039, PubMed:12237312, PubMed:17",choline binding,Presynaptic cell membrane,substrate,DrugBank,drugbank_id
BE0000168,Solute carrier family 23 member 1,target,Q9UHI7,SLC23A1,Humans,"Sodium:ascorbate cotransporter. Mediates electrogenic uptake of vitamin C, with a stoichiometry of 2 Na(+) for each ascorbate (PubMed:10556483, PubMed:10556521, PubMed:10631088, PubMed:36749388). Has retained some ancestral activity toward nucleobases such as urate, an oxidized purine. Low-affinity high-capacity sodium:urate cotransporter, may regulate serum urate levels by serving as a renal urate re-absorber (PubMed:36749388)",dehydroascorbic acid transmembrane transporter activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0009869,Solute carrier family 23 member 2,target,Q9UGH3,SLC23A2,Humans,"Sodium/ascorbate cotransporter (PubMed:10471399, PubMed:10556521). Mediates electrogenic uptake of vitamin C, with a stoichiometry of 2 Na(+) for each ascorbate (PubMed:10471399)",L-ascorbate,Cell membrane,modulator,DrugBank,drugbank_id
BE0001361,Hyaluronate lyase,target,Q54873,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),,carbohydrate binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0004796,DNA,target,,,Humans,,,,cleavage,DrugBank,drugbank_id
BE0001225,Xylose isomerase,target,P24300,xylA,Streptomyces rubiginosus,Involved in D-xylose catabolism.,identical protein binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0002192,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",target,O00469,PLOD2,Humans,Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links,iron ion binding,Rough endoplasmic reticulum membrane,cofactor,DrugBank,drugbank_id
BE0002195,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3,target,O60568,PLOD3,Humans,"Multifunctional enzyme that catalyzes a series of essential post-translational modifications on Lys residues in procollagen (PubMed:11956192, PubMed:12475640, PubMed:18298658, PubMed:18834968, PubMed:30089812). Plays a redundant role in catalyzing the formation of hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens (PubMed:11956192, PubMed:12475640, PubMed:18298658, PubMed:18834968, PubMed:30089812, PubMed:9582318, PubMed:9724729). Plays a redundant role in catalyzing the transfer of ",iron ion binding,Rough endoplasmic reticulum,cofactor,DrugBank,drugbank_id
BE0002197,Gamma-butyrobetaine dioxygenase,target,O75936,BBOX1,Humans,Catalyzes the formation of L-carnitine from gamma-butyrobetaine,gamma-butyrobetaine dioxygenase activity,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0000138,Dopamine beta-hydroxylase,target,P09172,DBH,Humans,"Catalyzes the hydroxylation of dopamine to noradrenaline (also known as norepinephrine), and is thus vital for regulation of these neurotransmitters",catalytic activity,"Cytoplasmic vesicle, secretory vesicle lumen",cofactor,DrugBank,drugbank_id
BE0002200,Peptidyl-glycine alpha-amidating monooxygenase,target,P19021,PAM,Humans,"Bifunctional enzyme that catalyzes amidation of the C-terminus of proteins (PubMed:12699694, PubMed:2357221). Alpha-amidation is present at the C-terminus of many endocrine hormones and neuropeptides and is required for their activity (PubMed:1575450). C-terminal amidation also takes place in response to protein fragmentation triggered by oxidative stress, promoting degradation of amidated protein fragments by the proteasome (PubMed:2207077). Alpha-amidation involves two sequential reactions, bo",calcium ion binding,"Cytoplasmic vesicle, secretory vesicle membrane",cofactor,DrugBank,drugbank_id
BE0002202,Prolyl 3-hydroxylase 1,target,Q32P28,P3H1,Humans,"Basement membrane-associated chondroitin sulfate proteoglycan (CSPG). Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens, especially types IV and V. May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts",iron ion binding,Endoplasmic reticulum,cofactor,DrugBank,drugbank_id
BE0002206,Prolyl 3-hydroxylase 2,target,Q8IVL5,P3H2,Humans,"Prolyl 3-hydroxylase that catalyzes the post-translational formation of 3-hydroxyproline on collagens (PubMed:18487197). Contributes to proline 3-hydroxylation of collagen COL4A1 and COL1A1 in tendons, the eye sclera and in the eye lens capsule (By similarity). Has high activity with the type IV collagen COL4A1, and lower activity with COL1A1 (PubMed:18487197). Catalyzes hydroxylation of the first Pro in Gly-Pro-Hyp sequences where Hyp is 4-hydroxyproline (PubMed:18487197). Has no activity on su",iron ion binding,Endoplasmic reticulum,cofactor,DrugBank,drugbank_id
BE0002208,Prolyl 3-hydroxylase 3,target,Q8IVL6,P3H3,Humans,"Part of a complex composed of PLOD1, P3H3 and P3H4 that catalyzes hydroxylation of lysine residues in collagen alpha chains and is required for normal assembly and cross-linkling of collagen fibrils. Required for normal hydroxylation of lysine residues in type I collagen chains in skin, bone, tendon, aorta and cornea. Required for normal skin stability via its role in hydroxylation of lysine residues in collagen alpha chains and in collagen fibril assembly. Apparently not required for normal pro",iron ion binding,Endoplasmic reticulum,cofactor,DrugBank,drugbank_id
BE0000060,Prolyl 4-hydroxylase subunit alpha-1,target,P13674,P4HA1,Humans,Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins,identical protein binding,Endoplasmic reticulum lumen,cofactor,DrugBank,drugbank_id
BE0002210,Prolyl 3-hydroxylase OGFOD1,target,Q8N543,OGFOD1,Humans,"Prolyl 3-hydroxylase that catalyzes 3-hydroxylation of 'Pro-62' of small ribosomal subunit uS12 (RPS23), thereby regulating protein translation termination efficiency. Involved in stress granule formation",iron ion binding,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0002203,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,target,Q6N063,OGFOD2,Humans,,dioxygenase activity,,cofactor,DrugBank,drugbank_id
BE0002205,DNA oxidative demethylase ALKBH2,target,Q6NS38,ALKBH2,Humans,"Dioxygenase that repairs alkylated nucleic acid bases by direct reversal oxidative dealkylation. Can process both double-stranded (ds) and single-stranded (ss) DNA substrates, with a strong preference for dsDNA (PubMed:12486230, PubMed:12594517, PubMed:16174769, PubMed:20714506, PubMed:23972994, PubMed:25797601). Uses molecular oxygen, 2-oxoglutarate and iron as cofactors to oxidize the alkyl groups that are subsequently released as aldehydes, regenerating the undamaged bases. Probes the base pa",broad specificity oxidative DNA demethylase activity,Nucleus,activator,DrugBank,drugbank_id
BE0002213,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,target,Q96Q83,ALKBH3,Humans,"Dioxygenase that mediates demethylation of DNA and RNA containing 1-methyladenosine (m1A) (PubMed:12486230, PubMed:12594517, PubMed:16174769, PubMed:26863196, PubMed:26863410). Repairs alkylated DNA containing 1-methyladenosine (m1A) and 3-methylcytosine (m3C) by oxidative demethylation (PubMed:12486230, PubMed:12594517, PubMed:16174769, PubMed:25944111). Has a strong preference for single-stranded DNA (PubMed:12486230, PubMed:12594517, PubMed:16174769, PubMed:20714506). Able to process alkylate",broad specificity oxidative DNA demethylase activity,Nucleus,activator,DrugBank,drugbank_id
BE0002215,Lysine-specific demethylase 5D,target,Q9BY66,KDM5D,Humans,"Histone demethylase that specifically demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9', H3 'Lys-27', H3 'Lys-36', H3 'Lys-79' or H4 'Lys-20'. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-4'. May play a role in spermatogenesis. Involved in transcriptional repression of diverse metastasis-associated genes; in this function seems to cooperate with ZMYND8. Suppresses prostate cancer cell invasion",DNA binding,Nucleus,cofactor,DrugBank,drugbank_id
BE0000087,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",target,Q02809,PLOD1,Humans,"Part of a complex composed of PLOD1, P3H3 and P3H4 that catalyzes hydroxylation of lysine residues in collagen alpha chains and is required for normal assembly and cross-linkling of collagen fibrils (By similarity). Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens (PubMed:10686424, PubMed:15854030, PubMed:8621606). These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links (Probable)",iron ion binding,Rough endoplasmic reticulum membrane,cofactor,DrugBank,drugbank_id
BE0002221,"Trimethyllysine dioxygenase, mitochondrial",target,Q9NVH6,TMLHE,Humans,"Converts trimethyllysine (TML) into hydroxytrimethyllysine (HTML) (PubMed:11431483, PubMed:23092983)",iron ion binding,Mitochondrion matrix,cofactor,DrugBank,drugbank_id
BE0002223,Transmembrane prolyl 4-hydroxylase,target,Q9NXG6,P4HTM,Humans,"Catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates HIF1A at 'Pro-402' and 'Pro-564'. May function as a cellular oxygen sensor and, under normoxic conditions, may target HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitination complex",2-oxoglutarate-dependent dioxygenase activity,Endoplasmic reticulum membrane,cofactor,DrugBank,drugbank_id
BE0002217,Egl nine homolog 1,target,Q9GZT9,EGLN1,Humans,"Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A. Has a preference for the CODD site for both HIF1A and HIF1B. Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquiti",2-oxoglutarate-dependent dioxygenase activity,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0002211,Prolyl hydroxylase EGLN2,target,Q96KS0,EGLN2,Humans,"Prolyl hydroxylase that mediates hydroxylation of proline residues in target proteins, such as ATF4, IKBKB, CEP192 and HIF1A (PubMed:11595184, PubMed:12039559, PubMed:15925519, PubMed:16509823, PubMed:17114296, PubMed:23932902). Target proteins are preferentially recognized via a LXXLAP motif (PubMed:11595184, PubMed:12039559, PubMed:15925519). Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) ",2-oxoglutarate-dependent dioxygenase activity,Nucleus,cofactor,DrugBank,drugbank_id
BE0002219,Prolyl hydroxylase EGLN3,target,Q9H6Z9,EGLN3,Humans,"Prolyl hydroxylase that mediates hydroxylation of proline residues in target proteins, such as PKM, TELO2, ATF4 and HIF1A (PubMed:19584355, PubMed:20978507, PubMed:21483450, PubMed:21575608, PubMed:21620138, PubMed:22797300). Target proteins are preferentially recognized via a LXXLAP motif. Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins (PubMed:11595184, PubMed:12181324). Hydr",2-oxoglutarate-dependent dioxygenase activity,Nucleus,cofactor,DrugBank,drugbank_id
BE0001979,"Thioredoxin reductase 1, cytoplasmic",enzyme,Q16881,TXNRD1,Humans,"Reduces disulfideprotein thioredoxin (Trx) to its dithiol-containing form (PubMed:8577704). Homodimeric flavoprotein involved in the regulation of cellular redox reactions, growth and differentiation. Contains a selenocysteine residue at the C-terminal active site that is essential for catalysis (Probable). Also has reductase activity on hydrogen peroxide (H2O2) (PubMed:10849437)",FAD binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0001057,"Solute carrier family 2, facilitated glucose transporter member 1",transporter,P11166,SLC2A1,Humans,"Facilitative glucose transporter, which is responsible for constitutive or basal glucose uptake (PubMed:10227690, PubMed:10954735, PubMed:18245775, PubMed:19449892, PubMed:25982116, PubMed:27078104, PubMed:32860739). Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses (PubMed:18245775, PubMed:19449892). Most important energy carrier of the brain: present at the blood-brain barrier and assures the energy-independent, facilitative trans",D-glucose transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0004707,"Solute carrier family 2, facilitated glucose transporter member 3",transporter,P11169,SLC2A3,Humans,"Facilitative glucose transporter (PubMed:26176916, PubMed:32860739, PubMed:9477959). Can also mediate the uptake of various other monosaccharides across the cell membrane (PubMed:26176916, PubMed:9477959). Mediates the uptake of glucose, 2-deoxyglucose, galactose, mannose, xylose and fucose, and probably also dehydroascorbate (PubMed:26176916, PubMed:9477959). Does not mediate fructose transport (PubMed:26176916, PubMed:9477959). Required for mesendoderm differentiation (By similarity)",D-glucose binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0000893,"Solute carrier family 2, facilitated glucose transporter member 4",transporter,P14672,SLC2A4,Humans,"Insulin-regulated facilitative glucose transporter, which plays a key role in removal of glucose from circulation. Response to insulin is regulated by its intracellular localization: in the absence of insulin, it is efficiently retained intracellularly within storage compartments in muscle and fat cells. Upon insulin stimulation, translocates from these compartments to the cell surface where it transports glucose from the extracellular milieu into the cell",D-glucose transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000964,Spermine synthase,target,P52788,SMS,Humans,Catalyzes the production of spermine from spermidine and decarboxylated S-adenosylmethionine (dcSAM),spermine synthase activity,,ligand,DrugBank,drugbank_id
BE0000566,Spermine oxidase,target,Q9NWM0,SMOX,Humans,"Flavoenzyme which catalyzes the oxidation of spermine to spermidine. Can also use N(1)-acetylspermine and spermidine as substrates, with different affinity depending on the isoform (isozyme) and on the experimental conditions. Plays an important role in the regulation of polyamine intracellular concentration and has the potential to act as a determinant of cellular sensitivity to the antitumor polyamine analogs. May contribute to beta-alanine production via aldehyde dehydrogenase conversion of 3",polyamine oxidase activity,Cytoplasm,ligand,DrugBank,drugbank_id
BE0003634,Carbonic anhydrase 14,target,Q9ULX7,CA14,Humans,Reversible hydration of carbon dioxide,carbonate dehydratase activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0003628,Carbonic anhydrase 6,target,P23280,CA6,Humans,Reversible hydration of carbon dioxide. Its role in saliva is unknown,carbonate dehydratase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0002437,Carbonic anhydrase 9,target,Q16790,CA9,Humans,Catalyzes the interconversion between carbon dioxide and water and the dissociated ions of carbonic acid (i.e. bicarbonate and hydrogen ions),carbonate dehydratase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000365,"Glutamate receptor ionotropic, NMDA 1",target,Q05586,GRIN1,Humans,"Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:21376300, PubMed:26875626, PubMed:26919761, PubMed:28126851, PubMed:28228639, PubMed:36959261, PubMed:7679115, PubMed:7681588, PubMed:7685113). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the long-term potentiation (LTP) (PubMed:26875626). Channel ",amyloid-beta binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000535,Carbonic anhydrase 4,target,P22748,CA4,Humans,"Catalyzes the reversible hydration of carbon dioxide into bicarbonate and protons and thus is essential to maintaining intracellular and extracellular pH (PubMed:15563508, PubMed:16686544, PubMed:16807956, PubMed:17127057, PubMed:17314045, PubMed:17652713, PubMed:17705204, PubMed:18618712, PubMed:19186056, PubMed:19206230, PubMed:7625839). May stimulate the sodium/bicarbonate transporter activity of SLC4A4 that acts in pH homeostasis (PubMed:15563508). It is essential for acid overload removal f",carbonate dehydratase activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000760,"Glutamate receptor ionotropic, NMDA 2A",target,Q12879,GRIN2A,Humans,"Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:20890276, PubMed:23933818, PubMed:23933819, PubMed:23933820, PubMed:24504326, PubMed:26875626, PubMed:26919761, PubMed:28242877, PubMed:36117210, PubMed:38538865, PubMed:8768735). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the slow phase of excita",amyloid-beta binding,"Cell projection, dendritic spine",inhibitor,DrugBank,drugbank_id
BE0000404,Ornithine decarboxylase,target,P11926,ODC1,Humans,"Catalyzes the first and rate-limiting step of polyamine biosynthesis that converts ornithine into putrescine, which is the precursor for the polyamines, spermidine and spermine. Polyamines are essential for cell proliferation and are implicated in cellular processes, ranging from DNA replication to apoptosis",ornithine decarboxylase activity,,product of,DrugBank,drugbank_id
BE0000509,Extracellular calcium-sensing receptor,target,P41180,CASR,Humans,"G-protein-coupled receptor that senses changes in the extracellular concentration of calcium ions and plays a key role in maintaining calcium homeostasis (PubMed:17555508, PubMed:19789209, PubMed:21566075, PubMed:22114145, PubMed:22789683, PubMed:23966241, PubMed:25104082, PubMed:25292184, PubMed:25766501, PubMed:26386835, PubMed:32817431, PubMed:33603117, PubMed:34194040, PubMed:34467854, PubMed:7759551, PubMed:8636323, PubMed:8702647, PubMed:8878438). Senses fluctuations in the circulating cal",amino acid binding,Cell membrane,,DrugBank,drugbank_id
BE0000172,Beta-1 adrenergic receptor,target,P08588,ADRB1,Humans,Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling. Involved in the regulation of sleep/wake behaviors (PubMed:31473062),alpha-2A adrenergic receptor binding,Cell membrane,,DrugBank,drugbank_id
BE0000694,Beta-2 adrenergic receptor,target,P07550,ADRB2,Humans,Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine,adenylate cyclase binding,Cell membrane,,DrugBank,drugbank_id
BE0000111,Diamine acetyltransferase 1,enzyme,P21673,SAT1,Humans,"Enzyme which catalyzes the acetylation of polyamines (PubMed:15283699, PubMed:16455797, PubMed:17516632). Substrate specificity: norspermidine = spermidine >> spermine > N(1)-acetylspermine (PubMed:17516632). This highly regulated enzyme allows a fine attenuation of the intracellular concentration of polyamines (PubMed:16455797). Also involved in the regulation of polyamine transport out of cells (PubMed:16455797). Also acts on 1,3-diaminopropane and 1,5-diaminopentane (PubMed:16455797, PubMed:1",diamine N-acetyltransferase activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0000275,Thialysine N-epsilon-acetyltransferase,enzyme,Q96F10,SAT2,Humans,"Catalyzes the N-acetylation of the amino acid thialysine (S-(2-aminoethyl)-L-cysteine), a L-lysine analog with the 4-methylene group substituted with a sulfur (PubMed:15283699). May also catalyze acetylation of polyamines, such as norspermidine, spermidine or spermine (PubMed:12803540). However, ability to acetylate polyamines is weak, suggesting that it does not act as a diamine acetyltransferase in vivo (PubMed:15283699)",diamine N-acetyltransferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000779,Vitamin D3 receptor,target,P11473,VDR,Humans,"Nuclear receptor for calcitriol, the active form of vitamin D3 which mediates the action of this vitamin on cells (PubMed:10678179, PubMed:15728261, PubMed:16913708, PubMed:28698609, PubMed:37478846). Enters the nucleus upon vitamin D3 binding where it forms heterodimers with the retinoid X receptor/RXR (PubMed:28698609). The VDR-RXR heterodimers bind to specific response elements on DNA and activate the transcription of vitamin D3-responsive target genes (PubMed:28698609). Plays a central role ",bile acid nuclear receptor activity,Nucleus,agonist,DrugBank,drugbank_id
BE0008987,Homeobox protein Hox-A10,target,P31260,HOXA10,Humans,Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds to the DNA sequence 5'-AA[AT]TTTTATTAC-3',"DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,upregulator,DrugBank,drugbank_id
BE0002250,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",enzyme,Q07973,CYP24A1,Humans,"A cytochrome P450 monooxygenase with a key role in vitamin D catabolism and calcium homeostasis. Via C24- and C23-oxidation pathways, catalyzes the inactivation of both the vitamin D precursor calcidiol (25-hydroxyvitamin D(3)) and the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) (PubMed:11012668, PubMed:15574355, PubMed:16617161, PubMed:24893882, PubMed:29461981, PubMed:8679605). With initial hydroxylation at C-24 (via C24-oxidation pathway), performs a sequential 6-step oxidati","1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity",Mitochondrion,substrate|inducer,DrugBank,drugbank_id
BE0001141,Vitamin D-binding protein,carrier,P02774,GC,Humans,"Involved in vitamin D transport and storage, scavenging of extracellular G-actin, enhancement of the chemotactic activity of C5 alpha for neutrophils in inflammation and macrophage activation",actin binding,Secreted,binder,DrugBank,drugbank_id
BE0000152,"Succinate-semialdehyde dehydrogenase, mitochondrial",target,P51649,ALDH5A1,Humans,Catalyzes one step in the degradation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA),identical protein binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0002258,Succinate receptor 1,target,Q9BXA5,SUCNR1,Humans,"G protein-coupled receptor for succinate able to mediate signaling through Gq/GNAQ or Gi/GNAI second messengers depending on the cell type and the processes regulated (By similarity) (PubMed:15141213, PubMed:23770096, PubMed:34133934). Succinate-SUCNR1 signaling serves as a link between metabolic stress, inflammation and energy homeostasis (PubMed:18820681, PubMed:34133934). In macrophages, plays a range of immune-regulatory roles. During inflammation, succinate-SUCNR1 signaling may act as an an",G protein-coupled receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",enzyme,Q99643,SDHC,Humans,"Membrane-anchoring subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q) (PubMed:9533030). SDH also oxidizes malate to the non-canonical enol form of oxaloacetate, enol-oxaloacetate (By similarity). Enol-oxaloacetate, which is a potent inhibitor of the succinate dehydrogenase activity, is further isomerized into keto-oxaloacetate (By similarity)",electron transfer activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",enzyme,P31040,SDHA,Humans,"Flavoprotein (FP) subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q) (PubMed:10746566, PubMed:24781757). SDH also oxidizes malate to the non-canonical enol form of oxaloacetate, enol-oxaloacetate (By similarity). Enol-oxaloacetate, which is a potent inhibitor of the succinate dehydrogenase activity, is further isomerized into keto-oxaloacetate",electron transfer activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000355,"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial",enzyme,Q96I99,SUCLG2,Humans,"GTP-specific succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The beta subunit provides nucleotide specificity of the enzyme and binds the substrate succinate, while the binding sites for coenzyme A and phosphate are found in the alpha subunit",ATP binding,Mitochondrion,product of,DrugBank,drugbank_id
BE0009980,Prolyl 4-hydroxylase,enzyme,P13674,P4HA1,Humans,Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins,identical protein binding,Endoplasmic reticulum lumen,product of,DrugBank,drugbank_id
BE0002256,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",enzyme,P55809,OXCT1,Humans,"Key enzyme for ketone body catabolism. Catalyzes the first, rate-limiting step of ketone body utilization in extrahepatic tissues, by transferring coenzyme A (CoA) from a donor thiolester species (succinyl-CoA) to an acceptor carboxylate (acetoacetate), and produces acetoacetyl-CoA. Acetoacetyl-CoA is further metabolized by acetoacetyl-CoA thiolase into two acetyl-CoA molecules which enter the citric acid cycle for energy production (PubMed:10964512). Forms a dimeric enzyme where both of the sub",identical protein binding,Mitochondrion,product of,DrugBank,drugbank_id
BE0000528,Aspartyl/asparaginyl beta-hydroxylase,enzyme,Q12797,ASPH,Humans,Specifically hydroxylates an Asp or Asn residue in certain epidermal growth factor-like (EGF) domains of a number of proteins,calcium ion binding,Endoplasmic reticulum membrane,product of,DrugBank,drugbank_id
BE0003645,Organic anion transporter 3,transporter,Q8TCC7,SLC22A8,Humans,"Functions as an organic anion/dicarboxylate exchanger that couples organic anion uptake indirectly to the sodium gradient (PubMed:14586168, PubMed:15644426, PubMed:15846473, PubMed:16455804, PubMed:31553721). Transports organic anions such as estrone 3-sulfate (E1S) and urate in exchange for dicarboxylates such as glutarate or ketoglutarate (2-oxoglutarate) (PubMed:14586168, PubMed:15846473, PubMed:15864504, PubMed:22108572, PubMed:23832370). Plays an important role in the excretion of endogenou",organic anion transmembrane transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0002261,Mitochondrial dicarboxylate carrier,transporter,Q9UBX3,SLC25A10,Humans,"Catalyzes the electroneutral exchange or flux of physiologically important metabolites such as dicarboxylates (malonate, malate, succinate), inorganic sulfur-containing anions, and phosphate, across mitochondrial inner membrane (PubMed:29211846). Plays an important role in gluconeogenesis, fatty acid metabolism, urea synthesis, and sulfur metabolism, particularly in liver, by supplying the substrates for the different metabolic processes. Regulates fatty acid release from adipocytes, and contrib",antiporter activity,Mitochondrion inner membrane,ligand,DrugBank,drugbank_id
BE0000022,Solute carrier family 13 member 1,transporter,Q9BZW2,SLC13A1,Humans,Sodium:sulfate symporter that mediates sulfate reabsorption in the kidney and small intestine (PubMed:11161786). Can also mediate the transport of selenate and thiosulfate (By similarity),monoatomic anion,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0000447,Solute carrier family 13 member 2,transporter,Q13183,SLC13A2,Humans,"Low-affinity sodium-dicarboxylate cotransporter, that mediates the entry of citric acid cycle intermediates, such as succinate, citrate, fumarate and alpha-ketoglutarate (2-oxoglutarate) into the small intestine and renal proximal tubule (PubMed:10894787, PubMed:8967342, PubMed:9668069). Transports the dicarboxylate into the cell with a probable stoichiometry of 3 Na(+) for 1 divalent dicarboxylate, rendering the process electrogenic (PubMed:10894787, PubMed:8967342, PubMed:9668069). Citrate is ",alpha-ketoglutarate transmembrane transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0000611,Na(+)/dicarboxylate cotransporter 3,transporter,Q8WWT9,SLC13A3,Humans,"High-affinity sodium-dicarboxylate cotransporter that accepts a range of substrates with 4-6 carbon atoms, such as the citric acid cycle intermediates succinate and alpha-ketoglutarate (2-oxoglutarate), as well as other compounds including N-acetyl-L-aspartate (PubMed:10794676, PubMed:10992006, PubMed:15561973, PubMed:17356845, PubMed:17426067, PubMed:24247155, PubMed:30635937). Transports the dicarboxylate into the cell with a probable stoichiometry of 3 Na(+) for 1 divalent dicarboxylate, rend",alpha-ketoglutarate transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000370,Riboflavin kinase,target,Q969G6,RFK,Humans,"Catalyzes the phosphorylation of riboflavin (vitamin B2) to form flavin-mononucleotide (FMN), hence rate-limiting enzyme in the synthesis of FAD. Essential for TNF-induced reactive oxygen species (ROS) production. Through its interaction with both TNFRSF1A and CYBA, physically and functionally couples TNFRSF1A to NADPH oxidase. TNF-activation of RFK may enhance the incorporation of FAD in NADPH oxidase, a critical step for the assembly and activation of NADPH oxidase",ATP binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0003327,Riboflavin synthase,target,P0AFU8,ribC,Escherichia coli (strain K12),"Catalyzes the dismutation of two molecules of 6,7-dimethyl-8-ribityllumazine, resulting in the formation of riboflavin and 5-amino-6-(D-ribitylamino)uracil.",riboflavin synthase activity,,other,DrugBank,drugbank_id
BE0000595,Flavin reductase (NADPH),target,P30043,BLVRB,Humans,"Enzyme that can both act as a NAD(P)H-dependent reductase and a S-nitroso-CoA-dependent nitrosyltransferase (PubMed:10620517, PubMed:18241201, PubMed:27207795, PubMed:38056462, PubMed:7929092). Promotes fetal heme degradation during development (PubMed:10858451, PubMed:18241201, PubMed:7929092). Also expressed in adult tissues, where it acts as a regulator of hematopoiesis, intermediary metabolism (glutaminolysis, glycolysis, TCA cycle and pentose phosphate pathway) and insulin signaling (PubMed",biliverdin reductase [NAD(P)+] activity,Cytoplasm,product of,DrugBank,drugbank_id
BE0002198,Amine oxidase [flavin-containing] A,enzyme,P21397,MAOA,Humans,"Catalyzes the oxidative deamination of primary and some secondary amine such as neurotransmitters, with concomitant reduction of oxygen to hydrogen peroxide and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues (PubMed:18391214, PubMed:20493079, PubMed:24169519, PubMed:8316221). Preferentially oxidizes serotonin (PubMed:20493079, PubMed:24169519). Also catalyzes the oxidative deamination of kynuramine to 3-(2-amino",flavin adenine dinucleotide binding,Mitochondrion outer membrane,cofactor,DrugBank,drugbank_id
BE0000824,Metabotropic glutamate receptor 1,target,Q13255,GRM1,Humans,"G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system. May participate in the central action of glutamate in the CNS, such as long-term potentiation in the hippocampus and long-term depression in the cerebellum (PubMed:24603153, PubMed:28886343, PubMed:7476890). ",adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000833,Metabotropic glutamate receptor 4,target,Q14833,GRM4,Humans,G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000827,"Glutamate receptor ionotropic, kainate 4",target,Q16099,GRIK4,Humans,"Ionotropic glutamate receptor that functions as a cation-permeable ligand-gated ion channel. Cannot form functional channels on its own (PubMed:8263508). Shows channel activity only in heteromeric assembly with GRIK1, GRIK2 and GRIK3 subunits (By similarity)",kainate selective glutamate receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000828,"Glutamate receptor ionotropic, kainate 5",target,Q16478,GRIK5,Humans,"Ionotropic glutamate receptor that functions as a cation-permeable ligand-gated ion channel, gated by L-glutamate and the glutamatergic agonist kainic acid. Cannot form functional channels on its own and produces channel activity only in heteromeric assembly with GRIK1 and GRIK2 subunits (PubMed:1321949, PubMed:14511640, PubMed:8730589). Can form functional heteromeric receptors with GRIK3 (By similarity)",kainate selective glutamate receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000834,Metabotropic glutamate receptor 7,target,Q14831,GRM7,Humans,"G-protein coupled receptor activated by glutamate that regulates axon outgrowth through the MAPK-cAMP-PKA signaling pathway during neuronal development (PubMed:33500274). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase that it inhibits (PubMed:9473604)",adenylate cyclase inhibitor activity,Cell membrane,,DrugBank,drugbank_id
BE0000835,Metabotropic glutamate receptor 8,target,O00222,GRM8,Humans,"G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity",G protein-coupled receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0002267,Excitatory amino acid transporter 5,target,O00341,SLC1A7,Humans,"Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate. Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion (PubMed:9108121). Acts primarily as an inhibitory glutamate-gated chloride channel being a major inhibitory presynaptic receptor at mammalian rod bipolar cell axon terminals. Glutamate binding ",extracellularly glutamate-gated chloride channel activity,Photoreceptor inner segment membrane,,DrugBank,drugbank_id
BE0002268,5-oxoprolinase,target,O14841,OPLAH,Humans,Catalyzes the cleavage of 5-oxo-L-proline to form L-glutamate coupled to the hydrolysis of ATP to ADP and inorganic phosphate,5-oxoprolinase (ATP-hydrolyzing) activity,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0002235,Phosphoribosylformylglycinamidine synthase,target,O15067,PFAS,Humans,Phosphoribosylformylglycinamidine synthase involved in the purines biosynthetic pathway. Catalyzes the ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) and glutamine to yield formylglycinamidine ribonucleotide (FGAM) and glutamate,ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0000721,"Branched-chain-amino-acid aminotransferase, mitochondrial",target,O15382,BCAT2,Humans,"Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine (PubMed:17050531, PubMed:25653144, PubMed:8702755). May also function as a transporter of branched chain alpha-keto acids (By similarity)",branched-chain-amino-acid transaminase activity,Mitochondrion,,DrugBank,drugbank_id
BE0000396,"Glutamate receptor ionotropic, NMDA 2D",target,O15399,GRIN2D,Humans,"Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:26875626, PubMed:27616483, PubMed:28126851, PubMed:9489750). Participates in synaptic plasticity for learning and memory formation (By similarity). Channel activation requires binding of the neurotransmitter L-glutamate to the GluN2 subunit, glycine or D-serine binding to the GluN1 subunit, plus me",glutamate binding,Cell membrane,,DrugBank,drugbank_id
BE0000825,"Glutaminase kidney isoform, mitochondrial",target,O94925,GLS,Humans,"Catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Plays a role in maintaining acid-base homeostasis. Regulates the levels of the neurotransmitter glutamate, the main excitatory neurotransmitter in the brain (PubMed:30239721, PubMed:30575854, PubMed:30970188)",glutaminase activity,Mitochondrion,,DrugBank,drugbank_id
BE0000383,"Aspartate aminotransferase, mitochondrial",target,P00505,GOT2,Humans,"Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). As a member of the malate-aspartate shuttle, it has a key role in the intracellular NAD(H) redox balance. Is important for metabolite exchange between mitochondria and cytosol, and for amino acid metabolism. Facilitates cellular uptake of long-chain free fatty acids",kynurenine-oxoglutarate transaminase activity,Mitochondrion matrix,,DrugBank,drugbank_id
BE0000188,Bifunctional glutamate/proline--tRNA ligase,target,P07814,EPRS1,Humans,"Multifunctional protein which primarily functions within the aminoacyl-tRNA synthetase multienzyme complex, also known as multisynthetase complex. Within the complex it catalyzes the attachment of both L-glutamate and L-proline to their cognate tRNAs in a two-step reaction where the amino acid is first activated by ATP to form a covalent intermediate with AMP. Subsequently, the activated amino acid is transferred to the acceptor end of the cognate tRNA to form L-glutamyl-tRNA(Glu) and L-prolyl-t",ATP binding,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0000219,Asparagine synthetase [glutamine-hydrolyzing],target,P08243,ASNS,Humans,,asparagine synthase (glutamine-hydrolyzing) activity,,,DrugBank,drugbank_id
BE0000529,"Aspartate aminotransferase, cytoplasmic",target,P17174,GOT1,Humans,"Biosynthesis of L-glutamate from L-aspartate or L-cysteine (PubMed:21900944). Important regulator of levels of glutamate, the major excitatory neurotransmitter of the vertebrate central nervous system. Acts as a scavenger of glutamate in brain neuroprotection. The aspartate aminotransferase activity is involved in hepatic glucose synthesis during development and in adipocyte glyceroneogenesis. Using L-cysteine as substrate, regulates levels of mercaptopyruvate, an important source of hydrogen su",carboxylic acid binding,Cytoplasm,,DrugBank,drugbank_id
BE0000667,Alanine aminotransferase 1,target,P24298,GPT,Humans,Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. Participates in cellular nitrogen metabolism and also in liver gluconeogenesis starting with precursors transported from skeletal muscles (By similarity),L-alanine,Cytoplasm,,DrugBank,drugbank_id
BE0001115,Excitatory amino acid transporter 1,target,P43003,SLC1A3,Humans,"Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate (PubMed:20477940, PubMed:26690923, PubMed:28032905, PubMed:28424515, PubMed:7521911, PubMed:8123008). Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion (PubMed:20477940). Mediates Cl(-) flux that is not coupled to amino acid transport; this avo",glutamate binding,Cell membrane,,DrugBank,drugbank_id
BE0000884,Excitatory amino acid transporter 2,target,P43004,SLC1A2,Humans,"Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate (PubMed:14506254, PubMed:15265858, PubMed:26690923, PubMed:7521911). Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion (PubMed:14506254). Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative ",cysteine transmembrane transporter activity,Cell membrane,,DrugBank,drugbank_id
BE0001054,Excitatory amino acid transporter 3,target,P43005,SLC1A1,Humans,"Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate (PubMed:21123949, PubMed:26690923, PubMed:33658209, PubMed:7521911, PubMed:7914198, PubMed:8857541). Can also transport L-cysteine (PubMed:21123949). Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion (PubMed:26690923, PubMed:33658209, PubMed:75",chloride transmembrane transporter activity,Cell membrane,,DrugBank,drugbank_id
BE0000166,Glutamate--cysteine ligase catalytic subunit,target,P48506,GCLC,Humans,Catalyzes the ATP-dependent ligation of L-glutamate and L-cysteine and participates in the first and rate-limiting step in glutathione biosynthesis,ADP binding,,substrate,DrugBank,drugbank_id
BE0002270,Excitatory amino acid transporter 4,target,P48664,SLC1A6,Humans,"Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate (PubMed:26690923, PubMed:7791878). Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion. Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative charges due to aspartate and Na(+) symport (PubMed:7",glutamate,Cell membrane,,DrugBank,drugbank_id
BE0000755,"Glutamate dehydrogenase 2, mitochondrial",target,P49448,GLUD2,Humans,"Important for recycling the chief excitatory neurotransmitter, glutamate, during neurotransmission",ADP binding,Mitochondrion matrix,substrate,DrugBank,drugbank_id
BE0000321,GMP synthase [glutamine-hydrolyzing],target,P49915,GMPS,Humans,Catalyzes the conversion of xanthine monophosphate (XMP) to GMP in the presence of glutamine and ATP through an adenyl-XMP intermediate,ATP binding,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0000517,"Branched-chain-amino-acid aminotransferase, cytosolic",target,P54687,BCAT1,Humans,"Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine",branched-chain-amino-acid transaminase activity,Cytoplasm,,DrugBank,drugbank_id
BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",target,P80404,ABAT,Humans,"Catalyzes the conversion of gamma-aminobutyrate and L-beta-aminoisobutyrate to succinate semialdehyde and methylmalonate semialdehyde, respectively (PubMed:10407778, PubMed:15528998). Can also convert delta-aminovalerate and beta-alanine (By similarity)",(S)-3-amino-2-methylpropionate transaminase activity,Mitochondrion matrix,,DrugBank,drugbank_id
BE0000700,"Folylpolyglutamate synthase, mitochondrial",target,Q05932,FPGS,Humans,"Catalyzes conversion of folates to polyglutamate derivatives allowing concentration of folate compounds in the cell and the intracellular retention of these cofactors, which are important substrates for most of the folate-dependent enzymes that are involved in one-carbon transfer reactions involved in purine, pyrimidine and amino acid synthesis. Unsubstituted reduced folates are the preferred substrates. Metabolizes methotrexate (MTX) to polyglutamates",ATP binding,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0002271,Glutamyl aminopeptidase,target,Q07075,ENPEP,Humans,Regulates central hypertension through its calcium-modulated preference to cleave N-terminal acidic residues from peptides such as angiotensin II,aminopeptidase activity,Cell membrane,,DrugBank,drugbank_id
BE0000417,"Glutamate receptor ionotropic, NMDA 2B",target,Q13224,GRIN2B,Humans,"Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:24272827, PubMed:24863970, PubMed:26875626, PubMed:26919761, PubMed:27839871, PubMed:28095420, PubMed:28126851, PubMed:38538865, PubMed:8768735). Participates in synaptic plasticity for learning and memory formation by contributing to the long-term depression (LTD) of hippocampus membrane currents ",amyloid-beta binding,Cell membrane,,DrugBank,drugbank_id
BE0000454,"Glutamate receptor ionotropic, NMDA 2C",target,Q14957,GRIN2C,Humans,"Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:26875626, PubMed:36309015). Participates in synaptic plasticity for learning and memory formation by contributing to the slow phase of excitatory postsynaptic current and long-term synaptic potentiation (By similarity). Channel activation requires binding of the neurotransmitter L-glutamate to the ",monoatomic cation channel activity,Cell membrane,,DrugBank,drugbank_id
BE0002272,"Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial",target,Q5JPH6,EARS2,Humans,"Non-discriminating glutamyl-tRNA synthetase that catalyzes aminoacylation of both mitochondrial tRNA(Glu) and tRNA(Gln) and participates in RNA aminoacylation for mitochondrial protein translation (PubMed:19805282). Attachs glutamate to tRNA(Glu) or tRNA(Gln) in a two-step reaction: glutamate is first activated by ATP to form Glu-AMP and then transferred to the acceptor end of tRNA(Glu) or tRNA(Gln) (PubMed:19805282). In vitro, cytoplasmic tRNA(Gln) is slightly glutamylated, but with low activit",ATP binding,Mitochondrion matrix,,DrugBank,drugbank_id
BE0002244,Glutamine-dependent NAD(+) synthetase,target,Q6IA69,NADSYN1,Humans,"Catalyzes the final step of the nicotinamide adenine dinucleotide (NAD) de novo synthesis pathway, the ATP-dependent amidation of deamido-NAD using L-glutamine as a nitrogen source",ATP binding,,product of,DrugBank,drugbank_id
BE0002274,"N-acetylglutamate synthase, mitochondrial",target,Q8N159,NAGS,Humans,"Plays a role in the regulation of ureagenesis by producing the essential cofactor N-acetylglutamate (NAG), thus modulating carbamoylphosphate synthase I (CPS1) activity",L-glutamate N-acetyltransferase activity,Mitochondrion matrix,,DrugBank,drugbank_id
BE0000727,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",target,Q8N5Z0,AADAT,Humans,"Transaminase with broad substrate specificity. Has transaminase activity towards aminoadipate, kynurenine, methionine and glutamate. Shows activity also towards tryptophan, aspartate and hydroxykynurenine. Accepts a variety of oxo-acids as amino-group acceptors, with a preference for 2-oxoglutarate, 2-oxocaproic acid, phenylpyruvate and alpha-oxo-gamma-methiol butyric acid. Can also use glyoxylate as amino-group acceptor (in vitro)",2-aminoadipate transaminase activity,Mitochondrion,,DrugBank,drugbank_id
BE0000641,"Glutamate receptor ionotropic, NMDA 3A",target,Q8TCU5,GRIN3A,Humans,"Component of a non-conventional N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with low calcium permeability and low voltage-dependent block by Mg(2+) (By similarity). During the development of neural circuits, participates in the synaptic refinement period, restricting spine maturation and growth (By similarity). Forms glutamatergic receptor complexes with GluN1 and GluN2 subunits which are activated by glycine binding to the GluN1",calcium channel activity,Cell membrane,,DrugBank,drugbank_id
BE0002166,Alanine aminotransferase 2,target,Q8TD30,GPT2,Humans,Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate,L-alanine,,substrate|product of,DrugBank,drugbank_id
BE0000073,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",target,Q9UDR5,AASS,Humans,Bifunctional enzyme that catalyzes the first two steps in lysine degradation,histone binding,Mitochondrion,,DrugBank,drugbank_id
BE0000003,"Glutaminase liver isoform, mitochondrial",target,Q9UI32,GLS2,Humans,Plays an important role in the regulation of glutamine catabolism. Promotes mitochondrial respiration and increases ATP generation in cells by catalyzing the synthesis of glutamate and alpha-ketoglutarate. Increases cellular anti-oxidant function via NADH and glutathione production. May play a role in preventing tumor proliferation,glutaminase activity,Mitochondrion,,DrugBank,drugbank_id
BE0002277,Aspartyl aminopeptidase,target,Q9ULA0,DNPEP,Humans,Aminopeptidase with specificity towards an acidic amino acid at the N-terminus. Likely to play an important role in intracellular protein and peptide metabolism,aminopeptidase activity,Cytoplasm,,DrugBank,drugbank_id
BE0000030,Cystine/glutamate transporter,target,Q9UPY5,SLC7A11,Humans,"Heterodimer with SLC3A2, that functions as an antiporter by mediating the exchange of extracellular anionic L-cystine and intracellular L-glutamate across the cellular plasma membrane (PubMed:11133847, PubMed:11417227, PubMed:14722095, PubMed:15151999, PubMed:34880232, PubMed:35245456, PubMed:35352032). Provides L-cystine for the maintenance of the redox balance between extracellular L-cystine and L-cysteine and for the maintenance of the intracellular levels of glutathione that is essential for",cystine,Cell membrane,,DrugBank,drugbank_id
BE0004640,Carboxypeptidase Q,target,Q9Y646,CPQ,Humans,Carboxypeptidase that may play an important role in the hydrolysis of circulating peptides. Catalyzes the hydrolysis of dipeptides with unsubstituted terminals into amino acids. May play a role in the liberation of thyroxine hormone from its thyroglobulin (Tg) precursor,carboxypeptidase activity,Endoplasmic reticulum,,DrugBank,drugbank_id
BE0000603,Phosphoserine aminotransferase,target,Q9Y617,PSAT1,Humans,"Involved in L-serine biosynthesis via the phosphorylated pathway, a three-step pathway converting the glycolytic intermediate 3-phospho-D-glycerate into L-serine. Catalyzes the second step, that is the pyridoxal 5'-phosphate-dependent transamination of 3-phosphohydroxypyruvate and L-glutamate to O-phosphoserine (OPS) and alpha-ketoglutarate",identical protein binding,,,DrugBank,drugbank_id
BE0000180,"Glutamate dehydrogenase 1, mitochondrial",target,P00367,GLUD1,Humans,"Mitochondrial glutamate dehydrogenase that catalyzes the conversion of L-glutamate into alpha-ketoglutarate. Plays a key role in glutamine anaplerosis by producing alpha-ketoglutarate, an important intermediate in the tricarboxylic acid cycle (PubMed:11032875, PubMed:11254391, PubMed:16023112, PubMed:16959573). Plays a role in insulin homeostasis (PubMed:11297618, PubMed:9571255). May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter gluta",ADP binding,Mitochondrion,,DrugBank,drugbank_id
BE0000346,"Glutamate receptor ionotropic, kainate 1",target,P39086,GRIK1,Humans,"Ionotropic glutamate receptor that functions as a cation-permeable ligand-gated ion channel, gated by L-glutamate and the glutamatergic agonist kainic acid. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and en",glutamate-gated calcium ion channel activity,Cell membrane,,DrugBank,drugbank_id
BE0000640,Glutamate receptor 1,target,P42261,GRIA1,Humans,"Ionotropic glutamate receptor that functions as a ligand-gated cation channel, gated by L-glutamate and glutamatergic agonists such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualic acid, and kainic acid (PubMed:1311100, PubMed:20805473, PubMed:21172611, PubMed:28628100, PubMed:35675825). L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation chan",adenylate cyclase binding,Cell membrane,,DrugBank,drugbank_id
BE0000606,Glutamate--cysteine ligase regulatory subunit,target,P48507,GCLM,Humans,,glutamate-cysteine ligase activity,,,DrugBank,drugbank_id
BE0000602,Glutamate decarboxylase 2,target,Q05329,GAD2,Humans,Catalyzes the production of GABA,glutamate decarboxylase activity,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0000378,Glutamate decarboxylase 1,target,Q99259,GAD1,Humans,Catalyzes the synthesis of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) with pyridoxal 5'-phosphate as cofactor,glutamate decarboxylase activity,,,DrugBank,drugbank_id
BE0000829,Glutamate receptor 2,target,P42262,GRIA2,Humans,"Ionotropic glutamate receptor that functions as a ligand-gated cation channel, gated by L-glutamate and glutamatergic agonists such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualic acid, and kainic acid (PubMed:20614889, PubMed:31300657, PubMed:8003671). L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system and plays an important role in fast excitatory synaptic transmission (PubMed:14687553). Binding of the excitatory neu",AMPA glutamate receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000831,Glutamate receptor 3,target,P42263,GRIA3,Humans,"Ionotropic glutamate receptor that functions as a ligand-gated cation channel, gated by L-glutamate and glutamatergic agonists such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualic acid, and kainic acid (By similarity). L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system and plays an important role in fast excitatory synaptic transmission by inducing long-term potentiation (By similarity). Binding of the excitatory neuro",AMPA glutamate receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000830,Glutamate receptor 4,target,P48058,GRIA4,Humans,"Ionotropic glutamate receptor that functions as a ligand-gated cation channel, gated by L-glutamate and glutamatergic agonists such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualic acid, and kainic acid (By similarity). L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system and plays an important role in fast excitatory synaptic transmission (By similarity). Binding of the excitatory neurotransmitter L-glutamate induces a c",AMPA glutamate receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000823,Delta-1-pyrroline-5-carboxylate synthase,target,P54886,ALDH18A1,Humans,"Bifunctional enzyme that converts glutamate to glutamate 5-semialdehyde, an intermediate in the biosynthesis of proline, ornithine and arginine",ATP binding,Mitochondrion,,DrugBank,drugbank_id
BE0000826,"Glutamate receptor ionotropic, kainate 2",target,Q13002,GRIK2,Humans,"Ionotropic glutamate receptor that functions as a cation permeable ligand-gated ion channel, gated by L-glutamate and the glutamatergic agonist kainic acid. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and en",extracellularly glutamate-gated ion channel activity,Cell membrane,,DrugBank,drugbank_id
BE0000832,"Glutamate receptor ionotropic, kainate 3",target,Q13003,GRIK3,Humans,"Ionotropic glutamate receptor that functions as a cation-permeable ligand-gated ion channel, gated by L-glutamate and the glutamatergic agonist kainic acid. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist (PubMed:7719709). I",adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0010222,Aspartate aminotransferase,target,P17174,GOT1,Humans,"Biosynthesis of L-glutamate from L-aspartate or L-cysteine (PubMed:21900944). Important regulator of levels of glutamate, the major excitatory neurotransmitter of the vertebrate central nervous system. Acts as a scavenger of glutamate in brain neuroprotection. The aspartate aminotransferase activity is involved in hepatic glucose synthesis during development and in adipocyte glyceroneogenesis. Using L-cysteine as substrate, regulates levels of mercaptopyruvate, an important source of hydrogen su",carboxylic acid binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000669,Monocarboxylate transporter 1,transporter,P53985,SLC16A1,Humans,"Bidirectional proton-coupled monocarboxylate transporter (PubMed:12946269, PubMed:32946811, PubMed:33333023). Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, acetate and the ketone bodies acetoacetate and beta-hydroxybutyrate, and thus contributes to the maintenance of intracellular pH (PubMed:12946269, PubMed:33333023). The transport direction is determined by the proton motive force and the concentration gradient of the substrate mon",carboxylic acid transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0002275,Mitochondrial glutamate carrier 2,transporter,Q9H1K4,SLC25A18,Humans,Responsible for the transport of glutamate from the cytosol into the mitochondrial matrix with the concomitant import of a proton (symport system),amino acid,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0002276,Mitochondrial glutamate carrier 1,transporter,Q9H936,SLC25A22,Humans,Mitochondrial glutamate/H(+) symporter. Responsible for the transport of glutamate from the cytosol into the mitochondrial matrix with the concomitant import of a proton (PubMed:11897791). Plays a role in the control of glucose-stimulated insulin secretion (By similarity),amino acid,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0000518,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",target,O75600,GCAT,Humans,"Pyridoxal phosphate (PLP) dependent enzyme, which catalyzes the cleavage of 2-amino-3-oxobutanoate to glycine and acetyl-CoA",glycine C-acetyltransferase activity,Mitochondrion,substrate,DrugBank,drugbank_id
BE0000409,"5-aminolevulinate synthase, non-specific, mitochondrial",target,P13196,ALAS1,Humans,"Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-products",5-aminolevulinate synthase activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000898,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",target,P22557,ALAS2,Humans,"Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-products (PubMed:14643893, PubMed:21252495, PubMed:21309041, PubMed:21653323, PubMed:32499479, PubMed:34492704). Contributes significantly to heme formation during erythropoiesis (PubMed:2050125)",5-aminolevulinate synthase activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000998,Glycine--tRNA ligase,target,P41250,GARS1,Humans,"Catalyzes the ATP-dependent ligation of glycine to the 3'-end of its cognate tRNA, via the formation of an aminoacyl-adenylate intermediate (Gly-AMP) (PubMed:17544401, PubMed:24898252, PubMed:28675565). Also produces diadenosine tetraphosphate (Ap4A), a universal pleiotropic signaling molecule needed for cell regulation pathways, by direct condensation of 2 ATPs. Thereby, may play a special role in Ap4A homeostasis (PubMed:19710017)",ATP binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0002303,Bile acid-CoA:amino acid N-acyltransferase,target,Q14032,BAAT,Humans,"Catalyzes the amidation of bile acids (BAs) with the amino acids taurine and glycine (PubMed:12239217, PubMed:12810727, PubMed:2037576, PubMed:8034703). More than 95% of the BAs are N-acyl amidates with glycine and taurine (PubMed:8034703). Amidation of BAs in the liver with glycine or taurine prior to their excretion into bile is an important biochemical event in bile acid metabolism (PubMed:12810727). This conjugation (or amidation) plays several important biological roles in that it promotes ",acyltransferase activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0002304,N-arachidonyl glycine receptor,target,Q14330,GPR18,Humans,"G protein-coupled receptor (GPCR) that plays a role in diverse physiological processes particularly within the immune and nervous systems (PubMed:21732409, PubMed:26195725). Becomes active when triggered by various endogenous ligands including endocannabinoid N-arachidonyl glycine (NAGly), delta-9-tetrahydrocannabinol or resolvin D2/RvD2 derived from the omega-3 fatty acid docosahexaenoic acid (DHA) (PubMed:16844083, PubMed:24762058, PubMed:26195725, PubMed:27572937). Upon RvD2 binding, facilita",G protein-coupled receptor activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000185,Glutathione synthetase,target,P48637,GSS,Humans,"Catalyzes the production of glutathione from gamma-glutamylcysteine and glycine in an ATP-dependent manner (PubMed:7646467, PubMed:9215686). Glutathione (gamma-glutamylcysteinylglycine, GSH) is the most abundant intracellular thiol in living aerobic cells and is required for numerous processes including the protection of cells against oxidative damage, amino acid transport, the detoxification of foreign compounds, the maintenance of protein sulfhydryl groups in a reduced state and acts as a cofa",ATP binding,,substrate,DrugBank,drugbank_id
BE0002305,Glycine N-acyltransferase,target,Q6IB77,GLYAT,Humans,"Mitochondrial acyltransferase which transfers an acyl group to the N-terminus of glycine and glutamine, although much less efficiently. Can conjugate numerous substrates to form a variety of N-acylglycines, with a preference for benzoyl-CoA over phenylacetyl-CoA as acyl donors. Thereby detoxify xenobiotics, such as benzoic acid or salicylic acid, and endogenous organic acids, such as isovaleric acid",acyltransferase activity,Mitochondrion,substrate,DrugBank,drugbank_id
BE0002306,Glycine N-acyltransferase-like protein 2,target,Q8WU03,GLYATL2,Humans,"Mitochondrial acyltransferase which transfers the acyl group to the N-terminus of glycine (PubMed:20305126, PubMed:22475485). Conjugates numerous substrates, such as arachidonoyl-CoA and saturated medium and long-chain acyl-CoAs ranging from chain-length C8:0-CoA to C18:0-CoA, to form a variety of N-acylglycines. Shows a preference for monounsaturated fatty acid oleoyl-CoA (C18:1-CoA) as an acyl donor. Does not exhibit any activity toward C22:6-CoA and chenodeoxycholoyl-CoA, nor toward serine or",glycine N-acyltransferase activity,Endoplasmic reticulum,substrate,DrugBank,drugbank_id
BE0002307,Glycine N-acyltransferase-like protein 1,target,Q969I3,GLYATL1,Humans,Acyltransferase which transfers an acyl group to the N-terminus of glutamine. Can use phenylacetyl-CoA as an acyl donor,glutamine N-acyltransferase activity,,substrate,DrugBank,drugbank_id
BE0000102,"Alanine--glyoxylate aminotransferase 2, mitochondrial",target,Q9BYV1,AGXT2,Humans,"Multifunctional aminotransferase with a broad substrate specificity (PubMed:20018850, PubMed:23023372, PubMed:24586340). Catalyzes the conversion of glyoxylate to glycine using alanine as the amino donor (By similarity). Catalyzes metabolism of not L- but the D-isomer of D-beta-aminoisobutyric acid to generate 2-methyl-3-oxopropanoate and alanine (PubMed:24586340). Catalyzes the transfer of the amino group from beta-alanine to pyruvate to yield L-alanine and 3-oxopropanoate (By similarity). Can ",(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,Mitochondrion,product of,DrugBank,drugbank_id
BE0002309,Peroxisomal sarcosine oxidase,target,Q9P0Z9,PIPOX,Humans,Metabolizes sarcosine and L-pipecolic acid,flavin adenine dinucleotide binding,Peroxisome,product of,DrugBank,drugbank_id
BE0000534,"Glutamate receptor ionotropic, NMDA 3B",target,O60391,GRIN3B,Humans,"Component of a non-conventional N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with low calcium permeability and low voltage-dependent block by Mg(2+) (By similarity). Forms glutamatergic receptor complexes with GluN1 and GluN2 subunits which are activated by glycine binding to the GluN1 and GluN3 subunits and L-glutamate binding to GluN2 subunits (By similarity). Forms excitatory glycinergic receptor complexes with GluN1 alone whic",calcium channel activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000433,Glycine receptor subunit alpha-1,target,P23415,GLRA1,Humans,"Subunit of heteromeric glycine-gated chloride channels (PubMed:14551753, PubMed:23994010, PubMed:25730860, PubMed:37821459). Plays an important role in the down-regulation of neuronal excitability (PubMed:8298642, PubMed:9009272). Contributes to the generation of inhibitory postsynaptic currents (PubMed:25445488). Channel activity is potentiated by ethanol (PubMed:25973519). Potentiation of channel activity by intoxicating levels of ethanol contribute to the sedative effects of ethanol (By simil",extracellularly glycine-gated chloride channel activity,Postsynaptic cell membrane,ligand,DrugBank,drugbank_id
BE0000316,Alanine--glyoxylate aminotransferase,target,P21549,AGXT,Humans,"Peroxisomal aminotransferase that catalyzes the transamination of glyoxylate to glycine and contributes to the glyoxylate detoxification (PubMed:10960483, PubMed:12777626, PubMed:23229545, PubMed:24055001, PubMed:26149463). Also catalyzes the transamination between L-serine and pyruvate and contributes to gluconeogenesis from the L-serine metabolism (PubMed:10347152)",alanine-glyoxylate transaminase activity,Peroxisome,substrate,DrugBank,drugbank_id
BE0000055,Glycine receptor subunit beta,target,P48167,GLRB,Humans,"Subunit of heteromeric glycine-gated chloride channels (PubMed:11929858, PubMed:15302677, PubMed:16144831, PubMed:22715885, PubMed:23238346, PubMed:25445488, PubMed:34473954, PubMed:8717357). Plays an important role in the down-regulation of neuronal excitability (PubMed:11929858, PubMed:23238346). Contributes to the generation of inhibitory postsynaptic currents (PubMed:25445488)",extracellularly glycine-gated chloride channel activity,Postsynaptic cell membrane,ligand,DrugBank,drugbank_id
BE0000414,Glycine receptor subunit alpha-3,target,O75311,GLRA3,Humans,"Glycine receptors are ligand-gated chloride channels. Channel opening is triggered by extracellular glycine (PubMed:26416729, PubMed:9677400). Channel characteristics depend on the subunit composition; heteropentameric channels display faster channel closure (By similarity). Plays an important role in the down-regulation of neuronal excitability (By similarity). Contributes to the generation of inhibitory postsynaptic currents (By similarity). Contributes to increased pain perception in response",extracellularly glycine-gated chloride channel activity,Postsynaptic cell membrane,ligand,DrugBank,drugbank_id
BE0000745,Glycine receptor subunit alpha-2,target,P23416,GLRA2,Humans,"Subunit of heteromeric glycine-gated chloride channels (PubMed:15302677, PubMed:16144831, PubMed:2155780, PubMed:23895467, PubMed:25445488, PubMed:26370147, PubMed:34473954). Plays a role in synaptic plasticity (By similarity). Contributes to the generation of inhibitory postsynaptic currents, and is involved in the down-regulation of neuronal excitability (PubMed:25445488). Plays a role in cellular responses to ethanol (PubMed:23895467)",extracellularly glycine-gated chloride channel activity,Postsynaptic cell membrane,ligand,DrugBank,drugbank_id
BE0000347,"Glycine amidinotransferase, mitochondrial",target,P50440,GATM,Humans,"Transamidinase that catalyzes the transfer of the amidino group of L-arginine onto the amino moiety of acceptor metabolites such as glycine, beta-alanine, gamma-aminobutyric acid (GABA) and taurine yielding the corresponding guanidine derivatives (PubMed:16820567, PubMed:27233232, PubMed:36543883, PubMed:3800397). Catalyzes the rate-limiting step of creatine biosynthesis, namely the transfer of the amidino group from L-arginine to glycine to generate guanidinoacetate, which is then methylated by",amidinotransferase activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000618,"Glycine dehydrogenase (decarboxylating), mitochondrial",enzyme,P23378,GLDC,Humans,The glycine cleavage system catalyzes the degradation of glycine. The P protein (GLDC) binds the alpha-amino group of glycine through its pyridoxal phosphate cofactor; CO(2) is released and the remaining methylamine moiety is then transferred to the lipoamide cofactor of the H protein (GCSH),electron transfer activity,Mitochondrion,substrate,DrugBank,drugbank_id
BE0000737,"Dihydrolipoyl dehydrogenase, mitochondrial",enzyme,P09622,DLD,Humans,"Lipoamide dehydrogenase is a component of the glycine cleavage system as well as an E3 component of three alpha-ketoacid dehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, and branched-chain amino acid-dehydrogenase complex) (PubMed:15712224, PubMed:16442803, PubMed:16770810, PubMed:17404228, PubMed:20160912, PubMed:20385101). The 2-oxoglutarate dehydrogenase complex is mainly active in the mitochondrion (PubMed:29211711). A fraction of the 2-oxoglutarate dehydrogenase complex also locali",dihydrolipoyl dehydrogenase (NADH) activity,Mitochondrion matrix,substrate,DrugBank,drugbank_id
BE0002302,"Glycine cleavage system H protein, mitochondrial",enzyme,P23434,GCSH,Humans,"The glycine cleavage system catalyzes the degradation of glycine. The H protein (GCSH) shuttles the methylamine group of glycine from the P protein (GLDC) to the T protein (GCST). Has a pivotal role in the lipoylation of enzymes involved in cellular energetics such as the mitochondrial dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (DLAT), and the mitochondrial dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase com",,Mitochondrion,substrate,DrugBank,drugbank_id
BE0000536,Proton-coupled amino acid transporter 1,transporter,Q7Z2H8,SLC36A1,Humans,"Electrogenic proton/amino acid symporter with selectivity for small apolar L-amino acids, their D-enantiomers and selected amino acid derivatives such as 4-aminobutanoate/GABA (PubMed:12527723, PubMed:12809675, PubMed:19549785). May be involved in the efflux from the lysosomal compartment of neutral amino acids resulting from proteolysis (By similarity). May play a role in specifying sites for exocytosis in neurons (By similarity)",ABC-type taurine transporter transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0002308,Vesicular inhibitory amino acid transporter,transporter,Q9H598,SLC32A1,Humans,"Antiporter that exchanges vesicular protons for cytosolic 4-aminobutanoate or to a lesser extend glycine, thus allowing their secretion from nerve terminals. The transport is equally dependent on the chemical and electrical components of the proton gradient (By similarity). May also transport beta-alanine (By similarity). Acidification of GABAergic synaptic vesicles is a prerequisite for 4-aminobutanoate uptake (By similarity)",amino acid transmembrane transporter activity,Cytoplasmic vesicle membrane,substrate,DrugBank,drugbank_id
BE0002310,Sodium- and chloride-dependent glycine transporter 2,transporter,Q9Y345,SLC6A5,Humans,"Sodium- and chloride-dependent glycine transporter (PubMed:10381548, PubMed:10606742, PubMed:16751771, PubMed:31370103, PubMed:9845349). Terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals (PubMed:9845349). May be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses (PubMed:9845349)",glycine,Cell membrane,substrate,DrugBank,drugbank_id
BE0000940,Sodium- and chloride-dependent glycine transporter 1,transporter,P48067,SLC6A9,Humans,Sodium- and chloride-dependent glycine transporter (PubMed:8183239). Essential for regulating glycine concentrations at inhibitory glycinergic synapses,amino acid,Cell membrane,substrate,DrugBank,drugbank_id
BE0000443,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",enzyme,O15528,CYP27B1,Humans,"A cytochrome P450 monooxygenase involved in vitamin D metabolism and in calcium and phosphorus homeostasis. Catalyzes the rate-limiting step in the activation of vitamin D in the kidney, namely the hydroxylation of 25-hydroxyvitamin D3/calcidiol at the C1alpha-position to form the hormonally active form of vitamin D3, 1alpha,25-dihydroxyvitamin D3/calcitriol that acts via the vitamin D receptor (VDR) (PubMed:10518789, PubMed:10566658, PubMed:12050193, PubMed:22862690, PubMed:9486994). Has 1alpha",calcidiol 1-monooxygenase activity,Mitochondrion membrane,substrate,DrugBank,drugbank_id
BE0000693,"Indoleamine 2,3-dioxygenase 1",target,P14902,IDO1,Humans,"Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway (PubMed:17671174). Involved in the peripheral immune tolerance, contributing to maintain homeostasis by preventing autoimmunity or immunopathology that would result from uncontrolled and overreacting immune responses (PubMed:25691885). Tryptophan shortage inhibits T lymphocytes division and accumulation of tryptophan catabolites induces T-cell apoptosis and differentia",electron transfer activity,"Cytoplasm, cytosol",binder,DrugBank,drugbank_id
BE0000228,"Tryptophan--tRNA ligase, cytoplasmic",target,P23381,WARS1,Humans,Catalyzes the attachment of tryptophan to tRNA(Trp) in a two-step reaction: tryptophan is first activated by ATP to form Trp-AMP and then transferred to the acceptor end of the tRNA(Trp),ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001343,Tryptophan--tRNA ligase,target,P00953,trpS,Geobacillus stearothermophilus,Catalyzes the attachment of tryptophan to tRNA(Trp).,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002311,"Tryptophan--tRNA ligase, mitochondrial",target,Q9UGM6,WARS2,Humans,Catalyzes the attachment of tryptophan to tRNA(Trp) in a two-step reaction: tryptophan is first activated by ATP to form Trp-AMP and then transferred to the acceptor end of tRNA(Trp),ATP binding,Mitochondrion matrix,inhibitor,DrugBank,drugbank_id
BE0000121,Tryptophan 5-hydroxylase 1,enzyme,P17752,TPH1,Humans,Oxidizes L-tryptophan to 5-hydroxy-l-tryptophan in the rate-determining step of serotonin biosynthesis,iron ion binding,,substrate,DrugBank,drugbank_id
BE0000080,Tryptophan 5-hydroxylase 2,enzyme,Q8IWU9,TPH2,Humans,,iron ion binding,,substrate,DrugBank,drugbank_id
BE0003532,"Tryptophan 2,3-dioxygenase",enzyme,P48775,TDO2,Humans,Heme-dependent dioxygenase that catalyzes the oxidative cleavage of the L-tryptophan (L-Trp) pyrrole ring and converts L-tryptophan to N-formyl-L-kynurenine. Catalyzes the oxidative cleavage of the indole moiety,amino acid binding,,substrate,DrugBank,drugbank_id
BE0002151,Aromatic-L-amino-acid decarboxylase,enzyme,P20711,DDC,Humans,"Catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine and L-5-hydroxytryptophan to serotonin",5-hydroxy-L-tryptophan decarboxylase activity,,substrate,DrugBank,drugbank_id
BE0000178,Monocarboxylate transporter 8,transporter,P36021,SLC16A2,Humans,"Specific thyroid hormone transmembrane transporter, that mediates both uptake and efflux of thyroid hormones across the cell membrane independently of pH or a Na(+) gradient. Major substrates are the iodothyronines T3 and T4 and to a lesser extent rT3 and 3,3-diiodothyronine (3,3'-T2) (PubMed:16887882, PubMed:18337592, PubMed:20628049, PubMed:23550058, PubMed:26426690, PubMed:27805744, PubMed:31436139). Acts as an important mediator of thyroid hormone transport, especially T3, through the blood-",amino acid transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000157,Thiamine pyrophosphokinase 1,target,Q9H3S4,TPK1,Humans,"Catalyzes the phosphorylation of thiamine to thiamine pyrophosphate (TPP) utilizing UTP and therefore links the biosynthesis of TPP to pyrimidines metabolism (PubMed:38547260). By producing thiamine pyrophosphate, a cofactor of the mitochondrial pyruvate dehydrogenase indirectly regulates pyruvate oxidation and lipogenesis (PubMed:38547260). Although it can also catalyze thiamine phosphorylation using ATP and CTP in vitro, it does so with significantly lower efficiency and without physiological ",ATP binding,,substrate,DrugBank,drugbank_id
BE0002003,Pyruvate dehydrogenase E1 component,target,P0AFG8,aceE,Escherichia coli (strain K12),"Component of the pyruvate dehydrogenase (PDH) complex, that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2).",identical protein binding,,cofactor,DrugBank,drugbank_id
BE0004673,Cytochrome P450 4B1,enzyme,P13584,CYP4B1,Humans,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics",heme binding,Endoplasmic reticulum membrane,inducer,DrugBank,drugbank_id
BE0009876,Nucleoside diphosphate phosphatase ENTPD5,enzyme,O75356,ENTPD5,Humans,"Hydrolyzes nucleoside diphosphates with a preference for GDP, IDP and UDP compared to ADP and CDP (PubMed:10400613, PubMed:15698960). In the lumen of the endoplasmic reticulum, hydrolyzes UDP that acts as an end-product feedback inhibitor of the UDP-Glc:glycoprotein glucosyltransferases. UMP can be transported back by an UDP-sugar antiporter to the cytosol where it is consumed to regenerate UDP-glucose. Therefore, it positively regulates protein reglucosylation by clearing UDP from the ER lumen ",ADP phosphatase activity,Endoplasmic reticulum,substrate,DrugBank,drugbank_id
BE0009877,Thiamine-triphosphatase,enzyme,Q9BU02,THTPA,Humans,Hydrolase highly specific for thiamine triphosphate (ThTP),hydrolase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0003530,Thiamine transporter 1,transporter,O60779,SLC19A2,Humans,"High-affinity transporter for the intake of thiamine (PubMed:10391222, PubMed:10542220, PubMed:21836059, PubMed:33008889, PubMed:35512554, PubMed:35724964). Mediates H(+)-dependent pyridoxine transport (PubMed:33008889, PubMed:35512554, PubMed:35724964)",folic acid transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000963,Thiamine transporter 2,transporter,Q9BZV2,SLC19A3,Humans,"Mediates high affinity thiamine uptake, probably via a proton anti-port mechanism (PubMed:11731220, PubMed:33008889, PubMed:35512554, PubMed:35724964). Has no folate transport activity (PubMed:11731220). Mediates H(+)-dependent pyridoxine transport (PubMed:33008889, PubMed:35512554, PubMed:35724964, PubMed:36456177)",thiamine transmembrane transporter activity,Membrane,substrate,DrugBank,drugbank_id
BE0004902,Voltage-dependent calcium channel,target,Q06432,CACNG1,Humans,Regulatory subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Regulates channel inactivation kinetics,calcium channel regulator activity,"Cell membrane, sarcolemma",inducer,DrugBank,drugbank_id
BE0009671,Ribulose-phosphate 3-epimerase,enzyme,Q96AT9,RPE,Humans,Catalyzes the reversible epimerization of D-ribulose 5-phosphate to D-xylulose 5-phosphate,D-ribulose-phosphate 3-epimerase activity,,substrate,DrugBank,drugbank_id
BE0003537,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,P05108,CYP11A1,Humans,"A cytochrome P450 monooxygenase that catalyzes the side-chain hydroxylation and cleavage of cholesterol to pregnenolone, the precursor of most steroid hormones (PubMed:21636783). Catalyzes three sequential oxidation reactions of cholesterol, namely the hydroxylation at C22 followed with the hydroxylation at C20 to yield 20R,22R-hydroxycholesterol that is further cleaved between C20 and C22 to yield the C21-steroid pregnenolone and 4-methylpentanal (PubMed:21636783). Mechanistically, uses molecul",cholesterol monooxygenase (side-chain-cleaving) activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000524,Vitamin D 25-hydroxylase,enzyme,Q6VVX0,CYP2R1,Humans,"A cytochrome P450 monooxygenase involved in activation of vitamin D precursors. Catalyzes hydroxylation at C-25 of both forms of vitamin D, vitamin D(2) and D(3) (calciol) (PubMed:12867411, PubMed:15465040, PubMed:18511070). Can metabolize vitamin D analogs/prodrugs 1alpha-hydroxyvitamin D(2) (doxercalciferol) and 1alpha-hydroxyvitamin D(3) (alfacalcidol) forming 25-hydroxy derivatives (PubMed:15465040, PubMed:18511070). Mechanistically, uses molecular oxygen inserting one oxygen atom into a sub",D3 vitamins binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000263,Nitric oxide synthase 3,target,P29474,NOS3,Humans,Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway (PubMed:1378832). NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,actin monomer binding,Cell membrane,,DrugBank,drugbank_id
BE0000671,Argininosuccinate synthase,target,P00966,ASS1,Humans,"One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues",amino acid binding,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0000608,Putative hydrolase DDAH2,target,O95865,DDAH2,Humans,"Putative hydrolase with unknown substrate (Probable). Does not hydrolyze N(G),N(G)-dimethyl-L-arginine (ADMA) which acts as an inhibitor of NOS (PubMed:21493890, PubMed:37296100). In endothelial cells, induces expression of vascular endothelial growth factor (VEGF) via phosphorylation of the transcription factor SP1 by PKA in a process that is independent of NO and NO synthase (By similarity). Similarly, enhances pancreatic insulin secretion through SP1-mediated transcriptional up-regulation of ",hydrolase activity,Cytoplasm,,DrugBank,drugbank_id
BE0000766,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",target,O94760,DDAH1,Humans,"Hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS. Has therefore a role in the regulation of nitric oxide generation",amino acid binding,,,DrugBank,drugbank_id
BE0000306,"Ornithine transcarbamylase, mitochondrial",target,P00480,OTC,Humans,"Catalyzes the second step of the urea cycle, the condensation of carbamoyl phosphate with L-ornithine to form L-citrulline (PubMed:2556444, PubMed:6372096, PubMed:8112735). The urea cycle ensures the detoxification of ammonia by converting it to urea for excretion (PubMed:2556444)",amino acid binding,Mitochondrion matrix,,DrugBank,drugbank_id
BE0000067,Nitric oxide synthase 1,target,P29475,NOS1,Humans,"Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In the brain and peripheral nervous system, NO displays many properties of a neurotransmitter. Probably has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such SRR",arginine binding,"Cell membrane, sarcolemma",,DrugBank,drugbank_id
BE0000005,"Nitric oxide synthase, inducible",target,P35228,NOS2,Humans,"Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body (PubMed:7504305, PubMed:7531687, PubMed:7544004, PubMed:7682706). In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such PTGS2/COX2 (By similarity). As component of the iNOS-S100A8/9 transnitrosylase complex involved in the selective inflammatory stimulus-dependent S-nitrosylation of ",arginine binding,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0001092,Protein-arginine deiminase type-4,target,Q9UM07,PADI4,Humans,"Catalyzes the citrullination/deimination of arginine residues of proteins such as histones, thereby playing a key role in histone code and regulation of stem cell maintenance (PubMed:15339660, PubMed:15345777, PubMed:16567635, PubMed:21245532). Citrullinates histone H1 at 'Arg-54' (to form H1R54ci), histone H3 at 'Arg-2', 'Arg-8', 'Arg-17' and/or 'Arg-26' (to form H3R2ci, H3R8ci, H3R17ci, H3R26ci, respectively) and histone H4 at 'Arg-3' (to form H4R3ci) (PubMed:15339660, PubMed:15345777, PubMed:",calcium ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0002313,Inactive protein-arginine deiminase type-6,target,Q6TGC4,PADI6,Humans,"Structural constituent of cytoplasmic lattices, which plays a key role in early embryonic development (PubMed:37922900). Cytoplasmic lattices consist in fibrous structures found in the cytoplasm of oocytes and preimplantation embryos (PubMed:37922900). They are required to store maternal proteins critical for embryonic development, such as ribosomal proteins and proteins that control epigenetic reprogramming of the preimplantation embryo, and prevent their degradation or activation (PubMed:37922",calcium ion binding,Cytoplasm,product of,DrugBank,drugbank_id
BE0002314,Protein-arginine deiminase type-1,target,Q9ULC6,PADI1,Humans,Catalyzes the deimination of arginine residues of proteins,calcium ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0002315,Protein-arginine deiminase type-3,target,Q9ULW8,PADI3,Humans,Catalyzes the deimination of arginine residues of proteins,calcium ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0002316,Protein-arginine deiminase type-2,target,Q9Y2J8,PADI2,Humans,Catalyzes the deimination of arginine residues of proteins,calcium ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0004711,Reduced folate transporter,target,P41440,SLC19A1,Humans,"Antiporter that mediates the import of reduced folates or a subset of cyclic dinucleotides, driven by the export of organic anions (PubMed:10787414, PubMed:15337749, PubMed:16115875, PubMed:22554803, PubMed:31126740, PubMed:31511694, PubMed:32276275, PubMed:36071163, PubMed:36265513, PubMed:36575193, PubMed:7826387, PubMed:9041240). Acts as an importer of immunoreactive cyclic dinucleotides, such as cyclic GMP-AMP (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in the cytoso","2',3'-cyclic GMP-AMP binding",Cell membrane,modulator,DrugBank,drugbank_id
BE0001048,Proton-coupled folate transporter,target,Q96NT5,SLC46A1,Humans,"Proton-coupled folate symporter that mediates folate absorption using an H(+) gradient as a driving force (PubMed:17129779, PubMed:17446347, PubMed:17475902, PubMed:19389703, PubMed:19762432, PubMed:25504888, PubMed:29344585, PubMed:30858177, PubMed:31494288, PubMed:31792273, PubMed:32893190, PubMed:34619546). Involved in the intestinal absorption of folates at the brush-border membrane of the proximal jejunum, and the transport from blood to cerebrospinal fluid across the choroid plexus (PubMed",folic acid binding,Cell membrane,modulator,DrugBank,drugbank_id
BE0000652,Folate receptor gamma,target,P41439,FOLR3,Humans,Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells. Isoform Short does not bind folate,folic acid binding,Secreted,binder,DrugBank,drugbank_id
BE0000271,Folate receptor beta,target,P14207,FOLR2,Humans,Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells. Has high affinity for folate and folic acid analogs at neutral pH. Exposure to slightly acidic pH after receptor endocytosis triggers a conformation change that strongly reduces its affinity for folates and mediates their release,folic acid binding,Cell membrane,binder,DrugBank,drugbank_id
BE0003405,Folate receptor alpha,target,P15328,FOLR1,Humans,"Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells (PubMed:19074442, PubMed:23851396, PubMed:23934049, PubMed:2527252, PubMed:8033114, PubMed:8567728). Has high affinity for folate and folic acid analogs at neutral pH (PubMed:23851396, PubMed:23934049, PubMed:2527252, PubMed:8033114, PubMed:8567728). Exposure to slightly acidic pH after receptor endocytosis triggers a conformation change that strongly",folic acid binding,Cell membrane,binder,DrugBank,drugbank_id
BE0000265,Gamma-glutamyl hydrolase,enzyme,Q92820,GGH,Humans,"Hydrolyzes the polyglutamate sidechains of pteroylpolyglutamates. Progressively removes gamma-glutamyl residues from pteroylpoly-gamma-glutamate to yield pteroyl-alpha-glutamate (folic acid) and free glutamate (PubMed:11005824, PubMed:8816764). May play an important role in the bioavailability of dietary pteroylpolyglutamates and in the metabolism of pteroylpolyglutamates and antifolates",exopeptidase activity,"Secreted, extracellular space",substrate,DrugBank,drugbank_id
BE0000330,Dihydrofolate reductase,enzyme,P00374,DHFR,Humans,"Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis. Binds its own mRNA and that of DHFR2",dihydrofolate reductase activity,Mitochondrion,substrate,DrugBank,drugbank_id
BE0003658,ATP-binding cassette sub-family C member 11,transporter,Q96J66,ABCC11,Humans,"ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds and xenobiotics from cells. Plays a role in physiological processes involving bile acids, conjugated steroids and cyclic nucleotides, including cAMP and cGMP (PubMed:12764137, PubMed:15537867). Mediates the ATP-dependent efflux of a range of physiological lipophilic anions, including the glutathione S-conjugates leukotriene C4 and dinitrophenyl S-glutathione, steroid sulfates, such a",ABC-type bile acid transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0001061,ATP-binding cassette sub-family C member 3,transporter,O15438,ABCC3,Humans,"ATP-dependent transporter of the ATP-binding cassette (ABC) family that binds and hydrolyzes ATP to enable active transport of various substrates including many drugs, toxicants and endogenous compound across cell membranes (PubMed:10359813, PubMed:11581266, PubMed:15083066). Transports glucuronide conjugates such as bilirubin diglucuronide, estradiol-17-beta-o-glucuronide and GSH conjugates such as leukotriene C4 (LTC4) (PubMed:11581266, PubMed:15083066). Transports also various bile salts (tau",ABC-type bile acid transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0001188,ATP-binding cassette sub-family C member 4,transporter,O15439,ABCC4,Humans,"ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds and xenobiotics from cells. Transports a range of endogenous molecules that have a key role in cellular communication and signaling, including cyclic nucleotides such as cyclic AMP (cAMP) and cyclic GMP (cGMP), bile acids, steroid conjugates, urate, and prostaglandins (PubMed:11856762, PubMed:12523936, PubMed:12835412, PubMed:12883481, PubMed:15364914, PubMed:15454390, PubMed:1628236",15-hydroxyprostaglandin dehydrogenase (NAD+) activity,Basolateral cell membrane,inhibitor,DrugBank,drugbank_id
BE0000730,Solute carrier family 25 member 32,transporter,Q9H2D1,SLC25A32,Humans,"Facilitates flavin adenine dinucleotide (FAD) translocation across the mitochondrial inner membrane into the mitochondrial matrix where it acts as a redox cofactor to assist flavoenzyme activities in fundamental metabolic processes including fatty acid beta-oxidation, amino acid and choline metabolism as well as mitochondrial electron transportation. In particular, provides FAD to DLD dehydrogenase of the glycine cleavage system, part of mitochondrial one-carbon metabolic pathway involved in neu",FAD transmembrane transporter activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000215,Peroxisome proliferator-activated receptor gamma,target,P37231,PPARG,Humans,"Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhanc",alpha-actinin binding,Nucleus,agonist|regulator,DrugBank,drugbank_id
BE0001007,Peroxisome proliferator-activated receptor delta,target,Q03181,PPARD,Humans,"Ligand-activated transcription factor key mediator of energy metabolism in adipose tissues (PubMed:35675826). Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ",DNA binding,Nucleus,agonist,DrugBank,drugbank_id
BE0000688,Free fatty acid receptor 1,target,O14842,FFAR1,Humans,"G-protein coupled receptor for medium and long chain saturated and unsaturated fatty acids that plays an important role in glucose homeostasis. Fatty acid binding increases glucose-stimulated insulin secretion, and may also enhance the secretion of glucagon-like peptide 1 (GLP-1). May also play a role in bone homeostasis; receptor signaling activates pathways that inhibit osteoclast differentiation (By similarity). Ligand binding leads to a conformation change that triggers signaling via G-prote",bioactive lipid receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000986,Sodium/calcium exchanger 1,target,P32418,SLC8A1,Humans,"Mediates the exchange of one Ca(2+) ion against three to four Na(+) ions across the cell membrane, and thereby contributes to the regulation of cytoplasmic Ca(2+) levels and Ca(2+)-dependent cellular processes (PubMed:11241183, PubMed:1374913, PubMed:1476165). Contributes to Ca(2+) transport during excitation-contraction coupling in muscle (PubMed:11241183, PubMed:1374913, PubMed:1476165). In a first phase, voltage-gated channels mediate the rapid increase of cytoplasmic Ca(2+) levels due to rel",ankyrin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001821,"Fatty acid-binding protein, brain",target,O15540,FABP7,Humans,"B-FABP could be involved in the transport of a so far unknown hydrophobic ligand with potential morphogenic activity during CNS development. It is required for the establishment of the radial glial fiber system in developing brain, a system that is necessary for the migration of immature neurons to establish cortical layers (By similarity)",fatty acid binding,Cytoplasm,agonist,DrugBank,drugbank_id
BE0000888,Acyl-CoA (8-3)-desaturase,target,O60427,FADS1,Humans,"Acts as a front-end fatty acyl-coenzyme A (CoA) desaturase that introduces a cis double bond at carbon 5 located between a preexisting double bond and the carboxyl end of the fatty acyl chain. Involved in biosynthesis of highly unsaturated fatty acids (HUFA) from the essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3) precursors. Specifically, desaturates dihomo-gamma-linoleoate (DGLA) (20:3n-6) and eicosatetraenoate (ETA) (20:4n-3) ",acyl-CoA (8-3)-desaturase activity,Endoplasmic reticulum membrane,agonist,DrugBank,drugbank_id
BE0000996,Long-chain-fatty-acid--CoA ligase 4,target,O60488,ACSL4,Humans,"Catalyzes the conversion of long-chain fatty acids to their active form acyl-CoA for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:21242590, PubMed:22633490, PubMed:24269233). Preferentially activates arachidonate and eicosapentaenoate as substrates (PubMed:21242590). Preferentially activates 8,9-EET > 14,15-EET > 5,6-EET > 11,12-EET. Modulates glucose-stimulated insulin secretion by regulating the levels of unesterified EETs (By similarity). Modulates prostagland",arachidonate-CoA ligase activity,Mitochondrion outer membrane,inducer,DrugBank,drugbank_id
BE0001023,Transient receptor potential cation channel subfamily V member 1,target,Q8NER1,TRPV1,Humans,"Non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli (PubMed:11050376, PubMed:11243859, PubMed:11226139, PubMed:12077606). Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. Involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Activated by vanilloid",ATP binding,Postsynaptic cell membrane,inducer,DrugBank,drugbank_id
BE0000071,Peroxisome proliferator-activated receptor alpha,target,Q07869,PPARA,Humans,"Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as a transcription activator for the ACOX1 and P450 genes. Transactivation activit",DNA binding,Nucleus,activator,DrugBank,drugbank_id
BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,target,P09917,ALOX5,Humans,"Catalyzes the oxygenation of arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) to 5-hydroperoxyeicosatetraenoate (5-HPETE) followed by the dehydration to 5,6- epoxyeicosatetraenoate (Leukotriene A4/LTA4), the first two steps in the biosynthesis of leukotrienes, which are potent mediators of inflammation (PubMed:19022417, PubMed:21233389, PubMed:22516296, PubMed:23246375, PubMed:24282679, PubMed:24893149, PubMed:31664810, PubMed:8615788, PubMed:8631361). Also catalyzes the oxygenation of arachidon",arachidonate 12(S)-lipoxygenase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000076,SEC14-like protein 4,target,Q9UDX3,SEC14L4,Humans,"Probable hydrophobic ligand-binding protein; may play a role in the transport of hydrophobic ligands like tocopherol, squalene and phospholipids",lipid binding,,,DrugBank,drugbank_id
BE0000339,SEC14-like protein 3,target,Q9UDX4,SEC14L3,Humans,"Probable hydrophobic ligand-binding protein; may play a role in the transport of hydrophobic ligands like tocopherol, squalene and phospholipids",lipid binding,,,DrugBank,drugbank_id
BE0000256,SEC14-like protein 2,target,O76054,SEC14L2,Humans,"Carrier protein. Binds to some hydrophobic molecules and promotes their transfer between the different cellular sites. Binds with high affinity to alpha-tocopherol. Also binds with a weaker affinity to other tocopherols and to tocotrienols. May have a transcriptional activatory activity via its association with alpha-tocopherol. Probably recognizes and binds some squalene structure, suggesting that it may regulate cholesterol biosynthesis by increasing the transfer of squalene to a metabolic act",phospholipid binding,Cytoplasm,,DrugBank,drugbank_id
BE0000956,Nuclear receptor subfamily 1 group I member 2,target,O75469,NR1I2,Humans,"Nuclear receptor that binds and is activated by variety of endogenous and xenobiotic compounds. Transcription factor that activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs and endogenous compounds. Activated by the antibiotic rifampicin and various plant metabolites, such as hyperforin, guggulipid, colupulone, and isoflavones. Response to specific ligands is species-specific. Activated by naturally occurring steroids,","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,,DrugBank,drugbank_id
BE0000872,Protein kinase C beta type,target,P05771,PRKCB,Humans,"Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) ",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0001132,Protein kinase C alpha type,target,P17252,PRKCA,Humans,"Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0002324,Diacylglycerol kinase alpha,target,P23743,DGKA,Humans,"Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids (PubMed:15544348, PubMed:2175712). Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (PubMed:15544348, PubMed:2175712). Also plays an important role in the biosynthesis of complex lipids (Probable). Ca",alkylglycerol kinase activity,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0002325,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,target,P62714,PPP2CB,Humans,"Catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of a wide variety of enzymes, signal transduction pathways, and cellular events (Probable). PP2A can modulate the activity of phosphorylase B kinase, casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase. Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multipl",metal ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0002326,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,target,P67775,PPP2CA,Humans,"Catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of a wide variety of enzymes, signal transduction pathways, and cellular events (PubMed:10801873, PubMed:12473674, PubMed:17245430, PubMed:22613722, PubMed:33243860, PubMed:34004147, PubMed:9920888). PP2A is the major phosphatase for microtubule-associated proteins (MAPs) (PubMed:22613722). PP2A can modulate the activity of phosphorylase B kinase casein kinase 2, mitogen-stimulated S6 ki",GABA receptor binding,Cytoplasm,,DrugBank,drugbank_id
BE0000814,Glutathione S-transferase P,enzyme,P09211,GSTP1,Humans,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2) (PubMed:9084911). Participates in the formation of novel hepoxilin regioisomers (PubMed:21046276). Negatively regulates CDK5 activity via p25/p35 translocation to prevent neurodegeneration,dinitrosyl-iron complex binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000815,Glutathione S-transferase omega-1,enzyme,P78417,GSTO1,Humans,Exhibits glutathione-dependent thiol transferase and dehydroascorbate reductase activities. Has S-(phenacyl)glutathione reductase activity. Also has glutathione S-transferase activity. Participates in the biotransformation of inorganic arsenic and reduces monomethylarsonic acid (MMA) and dimethylarsonic acid,glutathione dehydrogenase (ascorbate) activity,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0000810,Glutathione S-transferase Mu 3,enzyme,P21266,GSTM3,Humans,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. May govern uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers,enzyme binding,Cytoplasm,inducer,DrugBank,drugbank_id
BE0001184,NAD(P)H dehydrogenase [quinone] 1,enzyme,P15559,NQO1,Humans,"Flavin-containing quinone reductase that catalyzes two-electron reduction of quinones to hydroquinones using either NADH or NADPH as electron donors. In a ping-pong kinetic mechanism, the electrons are sequentially transferred from NAD(P)H to flavin cofactor and then from reduced flavin to the quinone, bypassing the formation of semiquinone and reactive oxygen species (By similarity) (PubMed:8999809, PubMed:9271353). Regulates cellular redox state primarily through quinone detoxification. Reduce","cytochrome-b5 reductase activity, acting on NAD(P)H","Cytoplasm, cytosol",inducer,DrugBank,drugbank_id
BE0000735,Heme oxygenase 1,enzyme,P09601,HMOX1,Humans,"Catalyzes the oxidative cleavage of heme at the alpha-methene bridge carbon, released as carbon monoxide (CO), to generate biliverdin IXalpha, while releasing the central heme iron chelate as ferrous iron (PubMed:11121422, PubMed:19556236, PubMed:7703255). Affords protection against programmed cell death and this cytoprotective effect relies on its ability to catabolize free heme and prevent it from sensitizing cells to undergo apoptosis (PubMed:20055707)",enzyme binding,Endoplasmic reticulum membrane,inducer,DrugBank,drugbank_id
BE0002390,Superoxide dismutase [Cu-Zn],enzyme,P00441,SOD1,Humans,Destroys radicals which are normally produced within the cells and which are toxic to biological systems,copper ion binding,Cytoplasm,inducer,DrugBank,drugbank_id
BE0002189,Glutathione S-transferase A2,enzyme,P09210,GSTA2,Humans,Catalyzes the conjugation of glutathione to a large variety of electrophilic compounds,glutathione transferase activity,Cytoplasm,inducer,DrugBank,drugbank_id
BE0009656,Phospholipid transfer protein,carrier,P55058,PLTP,Humans,"Mediates the transfer of phospholipids and free cholesterol from triglyceride-rich lipoproteins (low density lipoproteins or LDL and very low density lipoproteins or VLDL) into high-density lipoproteins (HDL) as well as the exchange of phospholipids between triglyceride-rich lipoproteins themselves (PubMed:11013307, PubMed:19321130, PubMed:21515415, PubMed:29883800, PubMed:7654777, PubMed:9132017). Facilitates the transfer of a spectrum of different lipid molecules, including diacylglycerol, pho",ceramide binding,Secreted,binder,DrugBank,drugbank_id
BE0000643,Alpha-tocopherol transfer protein,carrier,P49638,TTPA,Humans,"Binds alpha-tocopherol, enhances its transfer between separate membranes, and stimulates its release from liver cells (PubMed:7887897). Binds both phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 4,5-bisphosphate; the resulting conformation change is important for the release of the bound alpha-tocopherol (By similarity)",lipid transfer activity,Cytoplasm,binder,DrugBank,drugbank_id
BE0000189,Scavenger receptor class B member 1,transporter,Q8WTV0,SCARB1,Humans,"Receptor for different ligands such as phospholipids, cholesterol ester, lipoproteins, phosphatidylserine and apoptotic cells (PubMed:12016218, PubMed:12519372, PubMed:21226579). Receptor for HDL, mediating selective uptake of cholesteryl ether and HDL-dependent cholesterol efflux (PubMed:26965621). Also facilitates the flux of free and esterified cholesterol between the cell surface and apoB-containing lipoproteins and modified lipoproteins, although less efficiently than HDL. May be involved i",1-phosphatidylinositol binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0000119,Phospholipid-transporting ATPase ABCA1,transporter,O95477,ABCA1,Humans,"Catalyzes the translocation of specific phospholipids from the cytoplasmic to the extracellular/lumenal leaflet of membrane coupled to the hydrolysis of ATP (PubMed:24097981, PubMed:35974019). Thereby, participates in phospholipid transfer to apolipoproteins to form nascent high density lipoproteins/HDLs (PubMed:14754908). Transports preferentially phosphatidylcholine over phosphatidylserine (PubMed:24097981). May play a similar role in the efflux of intracellular cholesterol to apolipoproteins ",ABC-type transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000802,NPC1-like intracellular cholesterol transporter 1,transporter,Q9UHC9,NPC1L1,Humans,"Plays a major role in cholesterol homeostasis (PubMed:22095670). Critical for the uptake of cholesterol across the plasma membrane of the intestinal enterocyte (PubMed:22095670). Involved in plant sterol absorption, it transports sitosterol, although at lower rates than cholesterol (By similarity). Is the direct molecular target of ezetimibe, a drug that inhibits cholesterol absorption and is approved for the treatment of hypercholesterolemia (PubMed:15928087). May have a function in the transpo",cholesterol binding,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0001168,ATP-binding cassette sub-family G member 1,transporter,P45844,ABCG1,Humans,"Catalyzes the efflux of phospholipids such as sphingomyelin, cholesterol and its oxygenated derivatives like 7beta-hydroxycholesterol and this transport is coupled to hydrolysis of ATP (PubMed:17408620, PubMed:24576892). The lipid efflux is ALB-dependent (PubMed:16702602). Is an active component of the macrophage lipid export complex. Could also be involved in intracellular lipid transport processes. The role in cellular lipid homeostasis may not be limited to macrophages. Prevents cell death by",ABC-type sterol transporter activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000042,Pyridoxal kinase,target,O00764,PDXK,Humans,"Catalyzes the phosphorylation of the dietary vitamin B6 vitamers pyridoxal (PL), pyridoxine (PN) and pyridoxamine (PM) to form pyridoxal 5'-phosphate (PLP), pyridoxine 5'-phosphate (PNP) and pyridoxamine 5'-phosphate (PMP), respectively (Probable) (PubMed:10987144, PubMed:17766369, PubMed:19351586, PubMed:31187503, PubMed:9099727). PLP is the active form of vitamin B6, and acts as a cofactor for over 140 different enzymatic reactions",ATP binding,"Cytoplasm, cytosol",ligand,DrugBank,drugbank_id
BE0003543,Cytochrome P450 1A1,enzyme,P04798,CYP1A1,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins (PubMed:10681376, PubMed:11555828, PubMed:12865317, PubMed:14559847, PubMed:15041462, PubMed:15805301, PubMed:18577768, PubMed:19965576, PubMed:20972997). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (N",arachidonate monooxygenase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000278,Chronophin,enzyme,Q96GD0,PDXP,Humans,"Functions as a pyridoxal phosphate (PLP) phosphatase, which also catalyzes the dephosphorylation of pyridoxine 5'-phosphate (PNP) and pyridoxamine 5'-phosphate (PMP), with order of substrate preference PLP > PNP > PMP and therefore plays a role in vitamin B6 metabolism (PubMed:14522954, PubMed:8132548). Also functions as a protein serine phosphatase that specifically dephosphorylates 'Ser-3' in proteins of the actin-depolymerizing factor (ADF)/cofilin family like CFL1 and DSTN. Thereby, regulate",heat shock protein binding,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0003546,"Alkaline phosphatase, tissue-nonspecific isozyme",enzyme,P05186,ALPL,Humans,"Alkaline phosphatase that metabolizes various phosphate compounds and plays a key role in skeletal mineralization and adaptive thermogenesis (PubMed:12162492, PubMed:23688511, PubMed:25982064). Has broad substrate specificity and can hydrolyze a considerable variety of compounds: however, only a few substrates, such as diphosphate (inorganic pyrophosphate; PPi), pyridoxal 5'-phosphate (PLP) and N-phosphocreatine are natural substrates (PubMed:12162492, PubMed:2220817). Plays an essential role in",ADP phosphatase activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000040,"Lipoyl amidotransferase LIPT1, mitochondrial",target,Q9Y234,LIPT1,Humans,"Lipoyl amidotransferase that catalyzes the transfer of lipoyl moieties from lipoyl-protein H of the glycine cleavage system (lipoyl-GCSH) to E2 subunits of the pyruvate dehydrogenase complex (PDCE2) (PubMed:29987032). Unable to catalyze the transfer of octanoyl from octanoyl-GCSH to PDCE2 (PubMed:29987032). In vitro, it is also able to catalyze the transfer of the lipoyl group from lipoyl-AMP to the specific lysine residue of lipoyl domains of lipoate-dependent enzymes but this reaction may not ",lipoyltransferase activity,Mitochondrion,,DrugBank,drugbank_id
BE0000094,Sodium-dependent multivitamin transporter,target,Q9Y289,SLC5A6,Humans,"Sodium-dependent multivitamin transporter that mediates the electrogenic transport of pantothenate, biotin, lipoate and iodide (PubMed:10329687, PubMed:15561972, PubMed:19211916, PubMed:20980265, PubMed:21570947, PubMed:22015582, PubMed:25809983, PubMed:25971966, PubMed:27904971, PubMed:28052864, PubMed:31754459). Functions as a Na(+)-coupled substrate symporter where the stoichiometry of Na(+):substrate is 2:1, creating an electrochemical Na(+) gradient used as driving force for substrate uptak",biotin transmembrane transporter activity,Cell membrane,,DrugBank,drugbank_id
BE0002327,"Lipoyl synthase, mitochondrial",target,O43766,LIAS,Humans,"Catalyzes the radical-mediated insertion of two sulfur atoms into the C-6 and C-8 positions of the octanoyl moiety bound to the lipoyl domains of lipoate-dependent enzymes, thereby converting the octanoylated domains into lipoylated derivatives","4 iron, 4 sulfur cluster binding",Mitochondrion,,DrugBank,drugbank_id
BE0002364,NADPH--cytochrome P450 reductase,enzyme,P16435,POR,Humans,This enzyme is required for electron transfer from NADP to cytochrome P450 in microsomes. It can also provide electron transfer to heme oxygenase and cytochrome B5,"cytochrome-b5 reductase activity, acting on NAD(P)H",Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000582,Taste receptor type 1 member 3,target,Q7RTX0,TAS1R3,Humans,Putative taste receptor. TAS1R1/TAS1R3 responds to the umami taste stimulus (the taste of monosodium glutamate). TAS1R2/TAS1R3 recognizes diverse natural and synthetic sweeteners. TAS1R3 is essential for the recognition and response to the disaccharide trehalose (By similarity). Sequence differences within and between species can significantly influence the selectivity and specificity of taste responses,G protein-coupled receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000395,Taste receptor type 1 member 2,target,Q8TE23,TAS1R2,Humans,Putative taste receptor. TAS1R2/TAS1R3 recognizes diverse natural and synthetic sweeteners,G protein-coupled receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000879,Solute carrier family 22 member 11,transporter,Q9NSA0,SLC22A11,Humans,"Antiporter that mediates the transport of conjugated steroids and other specific organic anions at the basal membrane of syncytiotrophoblast and at the apical membrane of proximal tubule epithelial cells, in exchange for anionic compounds (PubMed:10660625, PubMed:11907186, PubMed:15037815, PubMed:15102942, PubMed:15291761, PubMed:15576633, PubMed:17229912, PubMed:18501590, PubMed:26277985, PubMed:28027879). May be responsible for placental absorption of fetal-derived steroid sulfates such as est",organic anion transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003683,Cytochrome P450 2J2,enzyme,P51589,CYP2J2,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of polyunsaturated fatty acids (PUFA) in the cardiovascular system (PubMed:19965576, PubMed:8631948). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:19965576, PubMed:8631948). Catalyzes the epoxidation of double bonds of PUFA (PubMed:19965576, PubMed:8","arachidonate 11,12-epoxygenase activity",Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0002887,Cytochrome P450 2C8,enzyme,P10632,CYP2C8,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins (PubMed:11093772, PubMed:14559847, PubMed:15766564, PubMed:19965576, PubMed:7574697). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:11093772, PubMed:14559847, PubMe",arachidonate epoxygenase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000713,Vitamin K epoxide reductase complex subunit 1,target,Q9BQB6,VKORC1,Humans,"Involved in vitamin K metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K. Vitamin K is required for the gamma-carboxylation of various proteins, including clotting factors, and is required for normal blood coagulation, but also for normal bone development",quinone binding,Endoplasmic reticulum membrane,cofactor,DrugBank,drugbank_id
BE0002329,Vitamin K epoxide reductase complex subunit 1-like protein 1,target,Q8N0U8,VKORC1L1,Humans,"Involved in vitamin K metabolism. Can reduce inactive vitamin K 2,3-epoxide to active vitamin K, and may contribute to vitamin K-mediated protection against oxidative stress. Plays a role in vitamin K-dependent gamma-carboxylation of Glu residues in target proteins",quinone binding,Endoplasmic reticulum membrane,cofactor,DrugBank,drugbank_id
BE0003539,Aldehyde oxidase,target,Q06278,AOX1,Humans,"Oxidase with broad substrate specificity, oxidizing aromatic azaheterocycles, such as N1-methylnicotinamide, N-methylphthalazinium and phthalazine, as well as aldehydes, such as benzaldehyde, retinal, pyridoxal, and vanillin. Plays a key role in the metabolism of xenobiotics and drugs containing aromatic azaheterocyclic substituents. Participates in the bioactivation of prodrugs such as famciclovir, catalyzing the oxidation step from 6-deoxypenciclovir to penciclovir, which is a potent antiviral","2 iron, 2 sulfur cluster binding",Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],target,P16083,NQO2,Humans,The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinones involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis,chloride ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0000724,Osteocalcin,target,P02818,BGLAP,Humans,"Bone protein that constitutes 1-2% of the total bone protein, and which acts as a negative regulator of bone formation (PubMed:3019668, PubMed:6967872). Functions to limit bone formation without impairing bone resorption or mineralization (By similarity). It binds strongly to apatite and calcium (PubMed:6967872)",calcium ion binding,Secreted,agonist,DrugBank,drugbank_id
BE0003336,Cytochrome P450 2A6,enzyme,P11509,CYP2A6,Humans,"Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1,4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity",arachidonate epoxygenase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0001111,Cytochrome P450 1B1,enzyme,Q16678,CYP1B1,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins (PubMed:10681376, PubMed:11555828, PubMed:12865317, PubMed:15258110, PubMed:20972997). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:10681376, PubMed:11555828, PubM",estrogen 16-alpha-hydroxylase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0003549,Cytochrome P450 2B6,enzyme,P20813,CYP2B6,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of endocannabinoids and steroids (PubMed:12865317, PubMed:21289075). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the epoxidation of double bonds of arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanola","anandamide 11,12 epoxidase activity",Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0003612,Cytochrome P450 3A7,enzyme,P24462,CYP3A7,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of steroid hormones and vitamins during embryogenesis (PubMed:11093772, PubMed:12865317, PubMed:14559847, PubMed:17178770, PubMed:9555064). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:11093772, PubMed:12865317, PubMed:14559847, PubMed:17178770, PubM",all-trans retinoic acid 18-hydroxylase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000115,Adenine phosphoribosyltransferase,target,P07741,APRT,Humans,"Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis",adenine binding,Cytoplasm,,DrugBank,drugbank_id
BE0001128,S-methyl-5'-thioadenosine phosphorylase,target,Q13126,MTAP,Humans,"Catalyzes the reversible phosphorylation of S-methyl-5'-thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate. Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis. Responsible for the first step in the methionine salvage pathway after MTA has been generated from S-adenosylmethionine. Has broad substrate specificity with 6-aminopurine nucleosides as preferred substrates","1,4-alpha-oligoglucan phosphorylase activity",Cytoplasm,,DrugBank,drugbank_id
BE0001229,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,Q05603,cobT,Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720),"Catalyzes the synthesis of alpha-ribazole-5'-phosphate from nicotinate mononucleotide (NAMN) and 5,6-dimethylbenzimidazole (DMB) (PubMed:10587435, PubMed:11441022, PubMed:24121107, PubMed:8206834, Ref.7). Able to use a variety of other nucleotide bases as substrate to create alternative lower ligands for cobamide (PubMed:11441022, PubMed:24121107, Ref.7).",nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase activity,,,DrugBank,drugbank_id
BE0000702,Acetyl-CoA carboxylase 2,target,O00763,ACACB,Humans,"Mitochondrial enzyme that catalyzes the carboxylation of acetyl-CoA to malonyl-CoA and plays a central role in fatty acid metabolism (PubMed:16854592, PubMed:19236960, PubMed:19900410, PubMed:20457939, PubMed:20952656, PubMed:26976583). Catalyzes a 2 steps reaction starting with the ATP-dependent carboxylation of the biotin carried by the biotin carboxyl carrier (BCC) domain followed by the transfer of the carboxyl group from carboxylated biotin to acetyl-CoA (PubMed:19236960, PubMed:20457939, P",acetyl-CoA carboxylase activity,Mitochondrion,,DrugBank,drugbank_id
BE0003786,Low molecular weight phosphotyrosine protein phosphatase,target,P24666,ACP1,Humans,"Acts on tyrosine phosphorylated proteins, low-MW aryl phosphates and natural and synthetic acyl phosphates with differences in substrate specificity between isoform 1 and isoform 2",acid phosphatase activity,Cytoplasm,,DrugBank,drugbank_id
BE0002007,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,target,P0AF12,mtnN,Escherichia coli (strain K12),"Catalyzes the irreversible cleavage of the glycosidic bond in both 5'-methylthioadenosine (MTA) and S-adenosylhomocysteine (SAH/AdoHcy) to adenine and the corresponding thioribose, 5'-methylthioribose and S-ribosylhomocysteine, respectively (PubMed:16101288, PubMed:3911944). Also cleaves 5'-deoxyadenosine, a toxic by-product of radical S-adenosylmethionine (SAM) enzymes, into 5-deoxyribose and adenine. Thus, is required for in vivo function of the radical SAM enzymes biotin synthase and lipoic a",adenosylhomocysteine nucleosidase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0002791,Peroxisomal trans-2-enoyl-CoA reductase,target,Q9BY49,PECR,Humans,"Participates in chain elongation of fatty acids. Catalyzes the reduction of trans-2-enoyl-CoAs of varying chain lengths from 6:1 to 16:1, having maximum activity with 10:1 CoA. Has no 2,4-dienoyl-CoA reductase activity",signaling receptor binding,Peroxisome,,DrugBank,drugbank_id
BE0002755,Adenine DNA glycosylase,target,P17802,mutY,Escherichia coli (strain K12),"Adenine glycosylase active on G-A mispairs. MutY also corrects error-prone DNA synthesis past GO lesions which are due to the oxidatively damaged form of guanine: 7,8-dihydro-8-oxoguanine (8-oxo-dGTP).","4 iron, 4 sulfur cluster binding",Cytoplasmic,,DrugBank,drugbank_id
BE0002706,Nucleoside 2-deoxyribosyltransferase,target,Q8RLY5,ptd,Lactobacillus helveticus,,nucleoside deoxyribosyltransferase activity,,,DrugBank,drugbank_id
BE0004323,SRSF protein kinase 2,target,P78362,SRPK2,Humans,"Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing (PubMed:18559500, PubMed:21056976, PubMed:9472028). Promotes neuronal apoptosis by up-regulating cyclin-D1 (CCND1) expression (PubMed:19592491). This is done by the phosphorylation of SRSF2, leading to the suppression o",14-3-3 protein binding,Cytoplasm,,DrugBank,drugbank_id
BE0002792,Holliday junction branch migration complex subunit RuvB,target,Q5SL87,ruvB,Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579),"The RuvA-RuvB-RuvC complex processes Holliday junction (HJ) DNA during genetic recombination and DNA repair, while the RuvA-RuvB complex plays an important role in the rescue of blocked DNA replication forks via replication fork reversal (RFR). RuvA specifically binds to HJ cruciform DNA, conferring on it an open structure. The RuvB hexamer acts as an ATP-dependent pump, pulling dsDNA into and through the RuvAB complex. RuvB forms 2 homohexamers on either side of HJ DNA bound by 1 or 2 RuvA tetr",ATP binding,Cytoplasmic,,DrugBank,drugbank_id
BE0003541,UDP-glucuronosyltransferase 1A1,enzyme,P22309,UGT1A1,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:12181437, PubMed:15472229, PubMed:18004206, PubMed:18004212, PubMed:18719240, PubMed:19830808, PubMed:23288867, PubMed:15231852, PubMed:21422672, PubMed:38211441). Essential for the elimination and detoxification of drugs, xenobiot",enzyme binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,P04035,HMGCR,Humans,"Catalyzes the conversion of (3S)-hydroxy-3-methylglutaryl-CoA (HMG-CoA) to mevalonic acid, the rate-limiting step in the synthesis of cholesterol and other isoprenoids, thus plays a critical role in cellular cholesterol homeostasis (PubMed:21357570, PubMed:2991281, PubMed:36745799, PubMed:6995544). HMGCR is the main target of statins, a class of cholesterol-lowering drugs (PubMed:11349148, PubMed:18540668, PubMed:36745799)",coenzyme A binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0002366,Histone deacetylase 2,target,Q92769,HDAC2,Humans,"Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:28497810). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (By similarity). Histone deacetylases act via the formation of large multiprotein complexes (By similarity). Forms transcriptional repressor complexes by associating with MAD, ",chromatin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0001042,Solute carrier organic anion transporter family member 2B1,transporter,O94956,SLCO2B1,Humans,"Mediates the Na(+)-independent transport of steroid sulfate conjugates and other specific organic anions (PubMed:10873595, PubMed:11159893, PubMed:11932330, PubMed:12724351, PubMed:14610227, PubMed:16908597, PubMed:18501590, PubMed:20507927, PubMed:22201122, PubMed:23531488, PubMed:25132355, PubMed:26383540, PubMed:27576593, PubMed:28408210, PubMed:29871943, PubMed:34628357). Responsible for the transport of estrone 3-sulfate (E1S) through the basal membrane of syncytiotrophoblast, highlighting ",bile acid transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0003642,Solute carrier organic anion transporter family member 1A2,transporter,P46721,SLCO1A2,Humans,"Na(+)-independent transporter that mediates the cellular uptake of a broad range of organic anions such as the endogenous bile salts cholate and deoxycholate, either in their unconjugated or conjugated forms (taurocholate and glycocholate), at the plasmam membrane (PubMed:19129463, PubMed:7557095). Responsible for intestinal absorption of bile acids (By similarity). Transports dehydroepiandrosterone 3-sulfate (DHEAS), a major circulating steroid secreted by the adrenal cortex, as well as estrone",bile acid transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0003646,Solute carrier family 22 member 7,transporter,Q9Y694,SLC22A7,Humans,"Functions as a Na(+)-independent bidirectional multispecific transporter (PubMed:11327718, PubMed:18216183, PubMed:21446918, PubMed:28945155). Contributes to the renal and hepatic elimination of endogenous organic compounds from the systemic circulation into the urine and bile, respectively (PubMed:11327718, PubMed:25904762). Capable of transporting a wide range of purine and pyrimidine nucleobases, nucleosides and nucleotides, with cGMP, 2'deoxyguanosine and GMP being the preferred substrates (",alpha-ketoglutarate transmembrane transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0000749,Sodium-dependent serotonin transporter,target,P31645,SLC6A4,Humans,"Serotonin transporter that cotransports serotonin with one Na(+) ion in exchange for one K(+) ion and possibly one proton in an overall electroneutral transport cycle. Transports serotonin across the plasma membrane from the extracellular compartment to the cytosol thus limiting serotonin intercellular signaling (PubMed:10407194, PubMed:12869649, PubMed:21730057, PubMed:27049939, PubMed:27756841, PubMed:34851672). Essential for serotonin homeostasis in the central nervous system. In the developi",actin filament binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,target,Q12809,KCNH2,Humans,"Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel (PubMed:10219239, PubMed:10753933, PubMed:10790218, PubMed:10837251, PubMed:11997281, PubMed:12063277, PubMed:18559421, PubMed:22314138, PubMed:22359612, PubMed:26363003, PubMed:27916661, PubMed:9230439, PubMed:9351446, PubMed:9765245). Channel properties are modulated by cAMP and subunit assembly (PubMed:10837251). Characterized by unusual gating kinetics by producing relatively small outward currents during mem",delayed rectifier potassium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004866,Cytochrome P450 3A Subfamily,enzyme,P08684,CYP3A4,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed:10681376, PubMed:11093772, PubMed:11555828, PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:19965576, PubMed:20702771, PubMed:21490593, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase","1,8-cineole 2-exo-monooxygenase activity",Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000062,Type-1 angiotensin II receptor,target,P30556,AGTR1,Humans,"Receptor for angiotensin II, a vasoconstricting peptide, which acts as a key regulator of blood pressure and sodium retention by the kidney (PubMed:15611106, PubMed:1567413, PubMed:25913193, PubMed:26420482, PubMed:30639100, PubMed:32079768, PubMed:8987975). The activated receptor in turn couples to G-alpha proteins G(q) (GNAQ, GNA11, GNA14 or GNA15) and thus activates phospholipase C and increases the cytosolic Ca(2+) concentrations, which in turn triggers cellular responses such as stimulation",angiotensin type I receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000221,Angiotensin-converting enzyme,target,P12821,ACE,Humans,"Dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of a variety of circulating hormones, such as angiotensin I, bradykinin or enkephalins, thereby playing a key role in the regulation of blood pressure, electrolyte homeostasis or synaptic plasticity (PubMed:15615692, PubMed:20826823, PubMed:2558109, PubMed:4322742, PubMed:7523412, PubMed:7683654). Composed of two similar catalytic domains, each possessing a functional active site, with different selectivity for substrates (P",actin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0005831,B1 bradykinin receptor,target,P46663,BDKRB1,Humans,This is a receptor for bradykinin. Could be a factor in chronic pain and inflammation,bradykinin receptor activity,Cell membrane,activator,DrugBank,drugbank_id
BE0001018,Solute carrier family 15 member 1,transporter,P46059,SLC15A1,Humans,"Electrogenic proton-coupled amino-acid transporter that transports oligopeptides of 2 to 4 amino acids with a preference for dipeptides. Transports neutral and monovalently charged peptides with a proton to peptide stoichiometry of 1:1 or 2:1 (By similarity) (PubMed:15521010, PubMed:18367661, PubMed:19685173, PubMed:26320580, PubMed:7896779, PubMed:8914574, PubMed:9835627). Primarily responsible for the absorption of dietary di- and tripeptides from the small intestinal lumen (By similarity). Me",dipeptide transmembrane transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0001134,Solute carrier family 15 member 2,transporter,Q16348,SLC15A2,Humans,"Proton-coupled amino-acid transporter that transports oligopeptides of 2 to 4 amino acids with a preference for dipeptides (PubMed:16434549, PubMed:18367661, PubMed:7756356). Transports neutral and anionic dipeptides with a proton to peptide stoichiometry of 2:1 or 3:1 (By similarity). In kidney, involved in the absorption of circulating di- and tripeptides from the glomerular filtrate (PubMed:7756356). Can also transport beta-lactam antibiotics, such as the aminocephalosporin cefadroxil, and ot",dipeptide transmembrane transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0004624,Transient receptor potential cation channel subfamily M member 7,target,Q96QT4,TRPM7,Humans,"Bifunctional protein that combines an ion channel with an intrinsic kinase domain, enabling it to modulate cellular functions either by conducting ions through the pore or by phosphorylating downstream proteins via its kinase domain. The channel is highly permeable to divalent cations, specifically calcium (Ca2+), magnesium (Mg2+) and zinc (Zn2+) and mediates their influx (PubMed:11385574, PubMed:12887921, PubMed:15485879, PubMed:24316671, PubMed:35561741, PubMed:36027648). Controls a wide range",actin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000794,Glucocorticoid receptor,target,P04150,NR3C1,Humans,"Receptor for glucocorticoids (GC) (PubMed:27120390, PubMed:37478846). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors (PubMed:28139699). Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling (PubMed:9590696). Plays a role in rapid mRNA degradation by binding to the 5' UTR of ta",core promoter sequence-specific DNA binding,Cytoplasm,agonist,DrugBank,drugbank_id
BE0000209,Corticosteroid-binding globulin,carrier,P08185,SERPINA6,Humans,Major transport protein for glucocorticoids and progestins in the blood of almost all vertebrate species,molecular carrier activity,Secreted,binder,DrugBank,drugbank_id
BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,target,O75899,GABBR2,Humans,"Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2 (PubMed:15617512, PubMed:18165688, PubMed:22660477, PubMed:24305054, PubMed:9872316, PubMed:9872744). Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins (PubMed:18165688). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream e",G protein-coupled GABA receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,target,Q9UBS5,GABBR1,Humans,"Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2 (PubMed:15617512, PubMed:18165688, PubMed:22660477, PubMed:24305054, PubMed:36103875, PubMed:9872316, PubMed:9872744). Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins (PubMed:18165688). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity",extracellular matrix protein binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000919,C-X-C chemokine receptor type 4,target,P61073,CXCR4,Humans,"Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ion levels and enhancing MAPK1/MAPK3 activation (PubMed:10452968, PubMed:18799424, PubMed:24912431, PubMed:28978524). Involved in the AKT signaling cascade (PubMed:24912431). Plays a role in regulation of cell migration, e.g. during wound healing (PubMed:28978524). Acts as a receptor for extracellular ubiquitin; leading to enhanced intracellular calcium ions and reduced cellular cAMP levels",actin binding,Cell membrane,allosteric modulator,DrugBank,drugbank_id
BE0000118,Synaptic vesicular amine transporter,target,Q05940,SLC18A2,Humans,"Electrogenic antiporter that exchanges one cationic monoamine with two intravesicular protons across the membrane of secretory and synaptic vesicles. Uses the electrochemical proton gradient established by the V-type proton-pump ATPase to accumulate high concentrations of monoamines inside the vesicles prior to their release via exocytosis. Transports a variety of catecholamines such as dopamine, adrenaline and noradrenaline, histamine, and indolamines such as serotonin (PubMed:23363473, PubMed:",monoamine transmembrane transporter activity,"Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane",inhibitor,DrugBank,drugbank_id
BE0000647,Sodium-dependent dopamine transporter,target,Q01959,SLC6A3,Humans,"Mediates sodium- and chloride-dependent transport of dopamine (PubMed:10375632, PubMed:11093780, PubMed:1406597, PubMed:15505207, PubMed:19478460, PubMed:39112701, PubMed:39112703, PubMed:39112705, PubMed:8302271). Also mediates sodium- and chloride-dependent transport of norepinephrine (also known as noradrenaline) (By similarity). Regulator of light-dependent retinal hyaloid vessel regression, downstream of OPN5 signaling (By similarity)",amine binding,Cell membrane,negative modulator,DrugBank,drugbank_id
BE0000867,Cocaine- and amphetamine-regulated transcript protein,target,Q16568,CARTPT,Humans,Satiety factor closely associated with the actions of leptin and neuropeptide Y; this anorectic peptide inhibits both normal and starvation-induced feeding and completely blocks the feeding response induced by neuropeptide Y and regulated by leptin in the hypothalamus. It promotes neuronal development and survival in vitro,neuropeptide hormone activity,Secreted,agonist,DrugBank,drugbank_id
BE0001044,Trace amine-associated receptor 1,target,Q96RJ0,TAAR1,Humans,"Intracellular G-protein coupled receptor for trace amines, which recognizes endogenous amine-containing metabolites such as beta-phenylethylamine (beta-PEA), 3-iodothyronamine (T1AM), isoamylamine (IAA), cadaverine (CAD), cyclohexylamine (CHA), p-tyramine (p-TYR), trimethylamine (TMA), octopamine and tryptamine (PubMed:11459929, PubMed:11723224, PubMed:15718104, PubMed:31399635, PubMed:36100653, PubMed:37935376, PubMed:37935377, PubMed:37963465, PubMed:38168118). Also functions as a receptor for",G protein-coupled receptor activity,Endomembrane system,agonist,DrugBank,drugbank_id
BE0004909,Monoamine oxidase,target,P21397,MAOA,Humans,"Catalyzes the oxidative deamination of primary and some secondary amine such as neurotransmitters, with concomitant reduction of oxygen to hydrogen peroxide and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues (PubMed:18391214, PubMed:20493079, PubMed:24169519, PubMed:8316221). Preferentially oxidizes serotonin (PubMed:20493079, PubMed:24169519). Also catalyzes the oxidative deamination of kynuramine to 3-(2-amino",flavin adenine dinucleotide binding,Mitochondrion outer membrane,inhibitor,DrugBank,drugbank_id
BE0000486,Sodium-dependent noradrenaline transporter,target,P23975,SLC6A2,Humans,"Mediates sodium- and chloride-dependent transport of norepinephrine (also known as noradrenaline), the primary signaling neurotransmitter in the autonomic sympathetic nervous system (PubMed:2008212, PubMed:8125921, PubMed:38750358). Is responsible for norepinephrine re-uptake and clearance from the synaptic cleft, thus playing a crucial role in norepinephrine inactivation and homeostasis (By similarity). Can also mediate sodium- and chloride-dependent transport of dopamine (PubMed:11093780, PubM",actin binding,Cell membrane,agonist|substrate,DrugBank,drugbank_id
BE0004888,Alpha adrenergic receptor,target,P35348,ADRA1A,Humans,This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine(PE)-stimulated ERK signaling in cardiac myocytes,alpha1-adrenergic receptor activity,Nucleus membrane,agonist,DrugBank,drugbank_id
BE0004872,Beta adrenergic receptor,target,P08588,ADRB1,Humans,Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling. Involved in the regulation of sleep/wake behaviors (PubMed:31473062),alpha-2A adrenergic receptor binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000756,D(2) dopamine receptor,target,P14416,DRD2,Humans,"Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (PubMed:21645528). Positively regulates postnatal regression of retinal hyaloid vessels via suppression of VEGFR2/KDR activity, downstream of OPN5 (By similarity)",dopamine binding,Cell membrane,binder,DrugBank,drugbank_id
BE0002196,Amine oxidase [flavin-containing] B,target,P27338,MAOB,Humans,"Catalyzes the oxidative deamination of primary and some secondary amines such as neurotransmitters, and exogenous amines including the tertiary amine, neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), with concomitant reduction of oxygen to hydrogen peroxide and participates in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues (PubMed:11049757, PubMed:11134050, PubMed:20493079, PubMed:8316221, PubMed:8665924). Preferentially de",electron transfer activity,Mitochondrion outer membrane,inhibitor,DrugBank,drugbank_id
BE0000849,Neuronal acetylcholine receptor subunit alpha-4,target,P43681,CHRNA4,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine binding,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0000850,Neuronal acetylcholine receptor subunit beta-2,target,P17787,CHRNB2,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine binding,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0003585,Neuronal acetylcholine receptor subunit alpha-3,target,P32297,CHRNA3,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine binding,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0003586,Neuronal acetylcholine receptor subunit alpha-5,target,P30532,CHRNA5,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine receptor activity,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0003587,Neuronal acetylcholine receptor subunit alpha-6,target,Q15825,CHRNA6,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine receptor activity,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0002343,Neuronal acetylcholine receptor subunit alpha-9,target,Q9UGM1,CHRNA9,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine-gated monoatomic cation-selective channel activity,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0000411,Neuronal acetylcholine receptor subunit alpha-10,target,Q9GZZ6,CHRNA10,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, cation permeability, and binding to allosteric modulators (Probable). Forms heteropentamers with CHRNA9. Expr",acetylcholine-gated monoatomic cation-selective channel activity,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0003588,Neuronal acetylcholine receptor subunit beta-3,target,Q05901,CHRNB3,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine binding,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0003584,Neuronal acetylcholine receptor subunit beta-4,target,P30926,CHRNB4,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti",acetylcholine receptor activity,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0002090,Aromatase,target,P11511,CYP19A1,Humans,"A cytochrome P450 monooxygenase that catalyzes the conversion of C19 androgens, androst-4-ene-3,17-dione (androstenedione) and testosterone to the C18 estrogens, estrone and estradiol, respectively (PubMed:27702664, PubMed:2848247). Catalyzes three successive oxidations of C19 androgens: two conventional oxidations at C19 yielding 19-hydroxy and 19-oxo/19-aldehyde derivatives, followed by a third oxidative aromatization step that involves C1-beta hydrogen abstraction combined with cleavage of th",aromatase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0003534,Cytochrome P450 2A13,enzyme,Q16696,CYP2A13,Humans,"Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N,N-dimethylaniline, 2'-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Possesses phenacetin O-deethylation activity",arachidonate epoxygenase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000045,Muscarinic acetylcholine receptor M3,target,P20309,CHRM3,Humans,"The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover",acetylcholine binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000092,Muscarinic acetylcholine receptor M1,target,P11229,CHRM1,Humans,"The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover",G protein-coupled acetylcholine receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0003609,Flavin-containing monooxygenase 1,enzyme,Q01740,FMO1,Humans,"Broad spectrum monooxygenase that catalyzes the oxygenation of a wide variety of nitrogen- and sulfur-containing compounds including xenobiotics (PubMed:32156684). Catalyzes the S-oxygenation of hypotaurine to produce taurine, an organic osmolyte involved in cell volume regulation as well as a variety of cytoprotective and developmental processes (PubMed:32156684). In vitro, catalyzes the N-oxygenation of trimethylamine (TMA) to produce trimethylamine N-oxide (TMAO) and could therefore participa",flavin adenine dinucleotide binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0004797,GABA(A) Receptor,target,P14867,GABRA1,Humans,"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:23909897, PubMed:25489750, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725, PubMed:30602789). When activated by GA",GABA-A receptor activity,Postsynaptic cell membrane,positive allosteric modulator,DrugBank,drugbank_id
BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,target,P14867,GABRA1,Humans,"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:23909897, PubMed:25489750, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725, PubMed:30602789). When activated by GA",GABA-A receptor activity,Postsynaptic cell membrane,ligand,DrugBank,drugbank_id
BE0000736,Translocator protein,target,P30536,TSPO,Humans,"Can bind protoporphyrin IX and may play a role in the transport of porphyrins and heme (By similarity). Promotes the transport of cholesterol across mitochondrial membranes and may play a role in lipid metabolism (PubMed:24814875), but its precise physiological role is controversial. It is apparently not required for steroid hormone biosynthesis. Was initially identified as peripheral-type benzodiazepine receptor; can also bind isoquinoline carboxamides (PubMed:1847678)",androgen binding,Mitochondrion membrane,modulator,DrugBank,drugbank_id
BE0004696,UDP-glucuronosyltransferase 2B15,enzyme,P54855,UGT2B15,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:16595710, PubMed:18719240, PubMed:23288867, PubMed:7835232, PubMed:9295060). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:7835232). Catalyzes the glucuronidation of endogen",glucuronosyltransferase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0002348,Proteasome subunit beta type-5,target,P28074,PSMB5,Humans,"Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged protein",endopeptidase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002347,Proteasome subunit beta type-1,target,P20618,PSMB1,Humans,"Non-catalytic component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or d",,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001739,Serine protease 1,target,P07477,PRSS1,Humans,"Has activity against the synthetic substrates Boc-Phe-Ser-Arg-Mec, Boc-Leu-Thr-Arg-Mec, Boc-Gln-Ala-Arg-Mec and Boc-Val-Pro-Arg-Mec. The single-chain form is more active than the two-chain form against all of these substrates",metal ion binding,"Secreted, extracellular space",inhibitor,DrugBank,drugbank_id
BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,target,P14867,GABRA1,Humans,"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:23909897, PubMed:25489750, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725, PubMed:30602789). When activated by GA",GABA-A receptor activity,Postsynaptic cell membrane,antagonist,DrugBank,drugbank_id
BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,target,P47870,GABRB2,Humans,"Beta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:19763268, PubMed:27789573, PubMed:29950725, PubMed:8264558). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725). When activated by GABA, GABAARs selecti",chloride channel activity,Postsynaptic cell membrane,antagonist,DrugBank,drugbank_id
BE0003476,Pro-neuropeptide Y,target,P01303,NPY,Humans,NPY is implicated in the control of feeding and in secretion of gonadotrophin-release hormone,calcium channel regulator activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0000770,Mu-type opioid receptor,target,P35372,OPRM1,Humans,"Receptor for endogenous opioids such as beta-endorphin and endomorphin (PubMed:10529478, PubMed:12589820, PubMed:7891175, PubMed:7905839, PubMed:7957926, PubMed:9689128). Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone (PubMed:10529478, PubMed:10836142, PubMed:12589820, PubMed:19300905, PubMed:7891175, PubMed:7905839, PubMed:7957926, PubMed:9689128). Also activated by enkephalin peptides, such as Met-enkephalin or Met-",beta-endorphin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0002081,Sodium channel protein type 2 subunit alpha,target,Q99250,SCN2A,Humans,"Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient (PubMed:1325650, PubMed:17021166, PubMed:28256214, PubMed:29844171). Implicated in the regulation of hippocampal replay occurring within sharp wave ripples (SPW-R) important for memory (By simi",calmodulin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000632,Kappa-type opioid receptor,target,P41145,OPRK1,Humans,"G-protein coupled opioid receptor that functions as a receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as a receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition o",dynorphin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000420,Delta-type opioid receptor,target,P41143,OPRD1,Humans,"G-protein coupled receptor that functions as a receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a",G protein-coupled enkephalin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0004956,NMDA receptor,target,Q05586,GRIN1,Humans,"Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:21376300, PubMed:26875626, PubMed:26919761, PubMed:28126851, PubMed:28228639, PubMed:36959261, PubMed:7679115, PubMed:7681588, PubMed:7685113). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the long-term potentiation (LTP) (PubMed:26875626). Channel ",amyloid-beta binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000013,Adenosine receptor A1,target,P30542,ADORA1,Humans,Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase,G protein-coupled adenosine receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0004864,Alpha-2 adrenergic receptors,target,P08913,ADRA2A,Humans,"Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol",alpha-1B adrenergic receptor binding,Cell membrane,inducer,DrugBank,drugbank_id
BE0000533,5-hydroxytryptamine receptor 2C,target,P28335,HTR2C,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:12970106, PubMed:18703043, PubMed:19057895, PubMed:29398112, PubMed:7895773). Also functions as a receptor for various drugs and psychoactive substances, including ergot alkaloid derivatives, 1-2,5,-dimethoxy-4-iodophenyl-2-aminopropane (DOI) and lysergic acid diethylamide (LSD) (PubMed:19057895, PubMed:29398112). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G pr","1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding",Cell membrane,antagonist,DrugBank,drugbank_id
BE0000384,Substance-P receptor,target,P25103,TACR1,Humans,This is a receptor for the tachykinin neuropeptide substance P. It is probably associated with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinity of this receptor to tachykinins is: substance P > substance K > neuromedin-K,substance P receptor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000233,Lanosterol 14-alpha demethylase,target,P10613,ERG11,Yeast,"Sterol 14alpha-demethylase that plays a critical role in the third module of ergosterol biosynthesis pathway, being ergosterol the major sterol component in fungal membranes that participates in a variety of functions (PubMed:10393548, PubMed:28258218, PubMed:8647850, PubMed:9559662). The third module or late pathway involves the ergosterol synthesis itself through consecutive reactions that mainly occur in the endoplasmic reticulum (ER) membrane (By similarity). In filamentous fungi, during the",heme binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0002088,Estrogen-related receptor gamma,target,P62508,ESRRG,Humans,Orphan receptor that acts as a transcription activator in the absence of bound ligand. Binds specifically to an estrogen response element and activates reporter genes controlled by estrogen response elements (By similarity). Induces the expression of PERM1 in the skeletal muscle,AF-2 domain binding,Nucleus,inverse agonist,DrugBank,drugbank_id
BE0003722,Steroid hormone receptor ERR1,target,P11474,ESRRA,Humans,"Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism. Induces the expression of PERM1 in the skeletal muscle","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,inverse agonist,DrugBank,drugbank_id
BE0001204,Equilibrative nucleoside transporter 1,target,Q99808,SLC29A1,Humans,"Uniporter involved in the facilitative transport of nucleosides and nucleobases, and contributes to maintaining their cellular homeostasis (PubMed:10722669, PubMed:10755314, PubMed:12527552, PubMed:14759222, PubMed:15037197, PubMed:17379602, PubMed:21795683, PubMed:26406980, PubMed:27995448, PubMed:35790189, PubMed:8986748). Functions as a Na(+)-independent transporter (PubMed:8986748). Involved in the transport of nucleosides such as adenosine, guanosine, inosine, uridine, thymidine and cytidin",adenine transmembrane transporter activity,Basolateral cell membrane,inhibitor,DrugBank,drugbank_id
BE0003677,UDP-glucuronosyltransferase 1A3,enzyme,P35503,UGT1A3,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:15472229, PubMed:18674515, PubMed:18719240, PubMed:23288867, PubMed:23756265, PubMed:24641623, PubMed:21422672). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:23756265). Cat",enzyme binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0003544,UDP-glucuronosyltransferase 1A4,enzyme,P22310,UGT1A4,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:18177842, PubMed:24641623, PubMed:15231852). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:18177842). Involved in the glucuronidation of calcidiol, which is the major circul",enzyme binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0004694,UDP-glucuronosyltransferase 1A6,enzyme,P19224,UGT1A6,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to facilitate their inactivation and excretion from the body (PubMed:15231852, PubMed:21422672). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:15231852, PubMed:21422672). Involved in the glucuronidation of arachidonic acid (AA) and AA-derived eicosanoids including 15-HETE and 20-HETE (Pub",enzyme binding,Microsome,substrate|inhibitor,DrugBank,drugbank_id
BE0004695,UDP-glucuronosyltransferase 1A7,enzyme,Q9HAW7,UGT1A7,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:12181437, PubMed:15470161, PubMed:18004212, PubMed:18052087, PubMed:18674515, PubMed:18719240, PubMed:20610558, PubMed:23360619, PubMed:21422672, PubMed:38211441). Essential for the elimination and detoxification of drugs, xenobiot",enzyme binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0003682,UDP-glucuronosyltransferase 1A8,enzyme,Q9HAW9,UGT1A8,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:15472229, PubMed:16595710, PubMed:18004212, PubMed:18052087, PubMed:18674515, PubMed:18719240, PubMed:19545173, PubMed:23288867, PubMed:21422672). Essential for the elimination and detoxification of drugs, xenobiotics and endogenou",enzyme binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0003538,UDP-glucuronosyltransferase 1A9,enzyme,O60656,UGT1A9,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:12181437, PubMed:15470161, PubMed:15472229, PubMed:18004212, PubMed:18052087, PubMed:18674515, PubMed:19545173, PubMed:15231852, PubMed:21422672, PubMed:38211441). Essential for the elimination and detoxification of drugs, xenobiot",enzyme binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0003678,UDP-glucuronosyltransferase 1A10,enzyme,Q9HAW8,UGT1A10,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:12181437, PubMed:18004212, PubMed:18052087, PubMed:18674515, PubMed:18719240, PubMed:19545173, PubMed:23288867, PubMed:26220143, PubMed:15231852, PubMed:21422672). Essential for the elimination and detoxification of drugs, xenobiot",enzyme binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0003679,UDP-glucuronosyltransferase 2B7,enzyme,P16662,UGT2B7,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:10702251, PubMed:15470161, PubMed:15472229, PubMed:17442341, PubMed:18674515, PubMed:18719240, PubMed:19022937, PubMed:23288867, PubMed:23756265, PubMed:26220143, PubMed:15231852, PubMed:21422672, PubMed:38211441). Essential for th",glucuronosyltransferase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000584,Neuraminidase,target,P11485,NA,Influenza A virus (strain A/Chile/1/1983 H1N1),"Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates. Cleaves off the terminal sialic acids on the glycosylated HA during virus budding to facilitate virus release. Additionally helps virus spread through the circulation by further removing sialic acids from the cell surface. These cleavages prevent self-aggregation and ensure the efficient spread of the progeny virus from cell to cell. Otherwise, infection would be limited to one round of replication. D",exo-alpha-(2->3)-sialidase activity,Virion membrane,inhibitor,DrugBank,drugbank_id
BE0000914,Sialidase-1,target,Q99519,NEU1,Humans,"Catalyzes the removal of sialic acid (N-acetylneuraminic acid) moieties from glycoproteins and glycolipids. To be active, it is strictly dependent on its presence in the multienzyme complex. Appears to have a preference for alpha 2-3 and alpha 2-6 sialyl linkage",alpha-sialidase activity,Lysosome membrane,inhibitor,DrugBank,drugbank_id
BE0003200,Sialidase-2,target,Q9Y3R4,NEU2,Humans,"Exo-alpha-sialidase that catalyzes the hydrolytic cleavage of the terminal sialic acid (N-acetylneuraminic acid, Neu5Ac) of a glycan moiety in the catabolism of glycolipids, glycoproteins and oligosacharides (PubMed:14613940, PubMed:22228546). Recognizes sialyl linkage positions of the glycan moiety as well as the supramolecular organization of the sialoglycoconjugate. Displays preference for alpha-(2->3)-sialylated GD1a and GT1B gangliosides over alpha-(2->8)-sialylated GD1b, in both monomeric ",exo-alpha-sialidase activity,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0002705,Liver carboxylesterase 1,enzyme,P23141,CES1,Humans,"Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs (PubMed:18762277, PubMed:7980644, PubMed:9169443, PubMed:9490062). Hydrolyzes aromatic and aliphatic esters, but has no catalytic activity toward amides or a fatty acyl-CoA ester (PubMed:18762277, PubMed:7980644, PubMed:9169443, PubMed:9490062). Hydrolyzes the methyl ester group of cocaine to form benzoylecgonine (PubMed:7980644). Catalyzes the transesterification of cocaine to form cocaethylene (PubM",carboxylesterase activity,Endoplasmic reticulum lumen,substrate,DrugBank,drugbank_id
BE0004800,23S ribosomal RNA,target,,,Enteric bacteria and other eubacteria,,,,inhibitor,DrugBank,drugbank_id
BE0003521,Motilin receptor,target,O43193,MLNR,Humans,Receptor for motilin,G protein-coupled peptide receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000924,Adenosine receptor A2a,target,P29274,ADORA2A,Humans,Receptor for adenosine (By similarity). The activity of this receptor is mediated by G proteins which activate adenylyl cyclase (By similarity),alpha-actinin binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000241,Adenosine receptor A2b,target,P29275,ADORA2B,Humans,Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase,G protein-coupled adenosine receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000354,Adenosine receptor A3,target,P0DMS8,ADORA3,Humans,Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibits adenylyl cyclase (PubMed:8234299),G protein-coupled adenosine receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0009789,Phosphodiesterase enzymes,target,Q08499,PDE4D,Humans,"Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes","3',5'-cyclic-AMP phosphodiesterase activity",Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0001096,5'-nucleotidase,target,P21589,NT5E,Humans,"Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside, with AMP being the preferred substrate (PubMed:21933152, PubMed:22997138, PubMed:23142347, PubMed:24887587, PubMed:34403084). Shows a preference for ribonucleotide monophosphates over their equivalent deoxyribose forms (PubMed:34403084). Other substrates include IMP, UMP, GMP, CMP, dAMP, dCMP, dTMP, NAD and NMN (PubMed:21933152, PubMed:22997138, PubMed:23142347, PubMed:24887587,",5'-deoxynucleotidase activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",target,Q07343,PDE4B,Humans,"Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes (PubMed:15260978). May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents","3',5'-cyclic-AMP phosphodiesterase activity",Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000739,Ryanodine receptor 1,target,P21817,RYR1,Humans,"Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol and thereby plays a key role in triggering muscle contraction following depolarization of T-tubules (PubMed:11741831, PubMed:16163667, PubMed:18268335, PubMed:18650434, PubMed:26115329). Repeated very high-level exercise increases the open probability of the channel and leads to Ca(2+) leaking into the cytoplasm (PubMed:18268335). Can also mediate the release of Ca(2+)",ATP binding,Sarcoplasmic reticulum membrane,activator,DrugBank,drugbank_id
BE0004922,Cyclic nucleotide phosphodiesterase,target,P27815,PDE4A,Humans,"Hydrolyzes the second messenger 3',5'-cyclic AMP (cAMP), which is a key regulator of many important physiological processes","3',5'-cyclic-AMP phosphodiesterase activity","Cytoplasm, perinuclear region",inhibitor,DrugBank,drugbank_id
BE0002385,DNA-dependent protein kinase catalytic subunit,target,P78527,PRKDC,Humans,"Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234). Involved in DNA non-homologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234, PubMed:34352203). Must be bound to DNA to express its catalytic properties (PubMed:11955432). Promotes processing of hairpin DNA structures in V(D)J recombination",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",target,O00329,PIK3CD,Humans,"Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides (PubMed:9235916). Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) (PubMed:15135396). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growt",1-phosphatidylinositol-3-kinase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",target,P42336,PIK3CA,Humans,"Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides (PubMed:15135396, PubMed:23936502, PubMed:28676499). Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) (PubMed:15135396, PubMed:28676499). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, ",1-phosphatidylinositol-3-kinase activity,,inhibitor,DrugBank,drugbank_id
BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",target,P42338,PIK3CB,Humans,"Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol derivatives at position 3 of the inositol ring to produce 3-phosphoinositides (PubMed:15135396). Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) (PubMed:15135396). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation,",1-phosphatidylinositol-3-kinase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004914,"Inositol 1,4,5-trisphosphate receptor",target,Q14643,ITPR1,Humans,"Inositol 1,4,5-trisphosphate-gated calcium channel that, upon inositol 1,4,5-trisphosphate binding, mediates calcium release from the endoplasmic reticulum (ER) (PubMed:10620513, PubMed:27108797). Undergoes conformational changes upon ligand binding, suggesting structural flexibility that allows the channel to switch from a closed state, capable of interacting with its ligands such as 1,4,5-trisphosphate and calcium, to an open state, capable of transferring calcium ions across the ER membrane (",ATP binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0004874,Serine-protein kinase ATM,target,Q13315,ATM,Humans,"Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor (PubMed:10550055, PubMed:10839545, PubMed:10910365, PubMed:12556884, PubMed:14871926, PubMed:15064416, PubMed:15448695, PubMed:15456891, PubMed:15790808, PubMed:15916964, PubMed:17923702, PubMed:21757780, PubMed:24534091, PubMed:35076389, PubMed:9733514). Recognizes the substrate c",1-phosphatidylinositol-3-kinase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009927,Neuronal Acetylcholine (nACh) Receptor Subunits,target,Q9GZZ6,CHRNA10,Humans,"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, cation permeability, and binding to allosteric modulators (Probable). Forms heteropentamers with CHRNA9. Expr",acetylcholine-gated monoatomic cation-selective channel activity,Synaptic cell membrane,agonist,DrugBank,drugbank_id
BE0000560,Muscarinic acetylcholine receptor M2,target,P08172,CHRM2,Humans,"The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is adenylate cyclase inhibition. Signaling promotes phospholipase C activity, leading to the release of inositol trisphosphate (IP3); this then triggers calcium ion release into the cytosol",arrestin family protein binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,O76074,PDE5A,Humans,"Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP (PubMed:15489334, PubMed:9714779). Specifically regulates nitric-oxide-generated cGMP (PubMed:15489334)","3',5'-cyclic-AMP phosphodiesterase activity",,inhibitor,DrugBank,drugbank_id
BE0002458,Plasma protease C1 inhibitor,target,P05155,SERPING1,Humans,"Serine protease inhibitor, which acrs as a regulator of the classical complement pathway (PubMed:10946292, PubMed:11527969, PubMed:3458172, PubMed:6416294). Forms a proteolytically inactive stoichiometric complex with the C1r or C1s proteases (PubMed:10946292, PubMed:3458172, PubMed:6416294). May also regulate blood coagulation, fibrinolysis and the generation of kinins (PubMed:8495195). Very efficient inhibitor of FXIIa. Inhibits chymotrypsin and kallikrein (PubMed:8495195)",serine-type endopeptidase inhibitor activity,Secreted,modulator,DrugBank,drugbank_id
BE0003556,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",target,P18545,PDE6G,Humans,Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones,"3',5'-cyclic-GMP phosphodiesterase activity",,inhibitor,DrugBank,drugbank_id
BE0003557,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",target,Q13956,PDE6H,Humans,Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones,"3',5'-cyclic-GMP phosphodiesterase activity",,inhibitor,DrugBank,drugbank_id
BE0003441,Programmed cell death 1 ligand 1,target,Q9NZQ7,CD274,Humans,"Plays a critical role in induction and maintenance of immune tolerance to self (PubMed:11015443, PubMed:28813410, PubMed:28813417, PubMed:31399419). As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response (PubMed:11015443, PubMed:28813410, PubMed:28813417, PubMed:36727298). Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (PubMed:10581077). Can a",receptor ligand activity,Cell membrane,downregulator,DrugBank,drugbank_id
BE0003639,ATP-binding cassette sub-family C member 5,transporter,O15440,ABCC5,Humans,"ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Mediates ATP-dependent transport of endogenous metabolites such as cAMP and cGMP, folic acid and N-lactoyl-amino acids (in vitro) (PubMed:10893247, PubMed:12637526, PubMed:12695538, PubMed:15899835, PubMed:17229149, PubMed:25964343). Also acts as a general glutamate conjugate and analog transporter that can limit the brain levels of endogenous metabolites",ABC-type xenobiotic transporter activity,Basolateral cell membrane,inhibitor,DrugBank,drugbank_id
BE0000210,Potassium channel subfamily K member 2,target,O95069,KCNK2,Humans,"K(+) channel that conducts voltage-dependent outward rectifying currents upon membrane depolarization. Voltage sensing is coupled to K(+) electrochemical gradient in an 'ion flux gating' mode where outward but not inward ion flow opens the gate. Converts to voltage-independent 'leak' conductance mode upon stimulation by various stimuli including mechanical membrane stretch, acidic pH, heat and lipids. Reversibly converts between a voltage-insensitive K(+) 'leak' channel and a voltage-dependent o",identical protein binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001131,ATP-sensitive inward rectifier potassium channel 12,target,Q14500,KCNJ12,Humans,Inward rectifying potassium channel that probably participates in controlling the resting membrane potential in electrically excitable cells. Probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potass,inward rectifier potassium channel activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0000563,Bifunctional dihydrofolate reductase-thymidylate synthase,target,P13922,,Plasmodium falciparum (isolate K1 / Thailand),"Bifunctional enzyme. Involved in de novo dTMP biosynthesis. Key enzyme in folate metabolism. Catalyzes an essential reaction for de novo glycine and purine synthesis, DNA precursor synthesis, and for the conversion of dUMP to dTMP.",dihydrofolate reductase activity,,inhibitor,DrugBank,drugbank_id
BE0001153,Beta-hexosaminidase subunit beta,target,P07686,HEXB,Humans,"Hydrolyzes the non-reducing end N-acetyl-D-hexosamine and/or sulfated N-acetyl-D-hexosamine of glycoconjugates, such as the oligosaccharide moieties from proteins and neutral glycolipids, or from certain mucopolysaccharides (PubMed:11707436, PubMed:8123671, PubMed:8672428, PubMed:9694901). The isozyme B does not hydrolyze each of these substrates, however hydrolyzes efficiently neutral oligosaccharide (PubMed:11707436). Only the isozyme A is responsible for the degradation of GM2 gangliosides in",acetylglucosaminyltransferase activity,Lysosome,inhibitor,DrugBank,drugbank_id
BE0003657,Multidrug and toxin extrusion protein 1,transporter,Q96FL8,SLC47A1,Humans,"Multidrug efflux pump that functions as a H(+)/organic cation antiporter (PubMed:16330770, PubMed:17509534). Plays a physiological role in the excretion of cationic compounds including endogenous metabolites, drugs, toxins through the kidney and liver, into urine and bile respectively (PubMed:16330770, PubMed:17495125, PubMed:17509534, PubMed:17582384, PubMed:18305230, PubMed:19158817, PubMed:21128598, PubMed:24961373). Mediates the efflux of endogenous compounds such as creatinine, vitamin B1/t",antiporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004752,Multidrug and toxin extrusion protein 2,transporter,Q86VL8,SLC47A2,Humans,"Multidrug efflux pump that functions as a H(+)/organic cation antiporter. Mediates the efflux of cationic compounds, such as the model cations, tetraethylammonium (TEA) and 1-methyl-4-phenylpyridinium (MPP+), the platinum-based drug oxaliplatin or weak bases that are positively charged at physiological pH, cimetidine, the platinum-based drugs cisplatin and oxaliplatin or the antidiabetic drug metformin. Mediates the efflux of endogenous compounds such as, creatinine, thiamine and estrone-3-sulfa",antiporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004674,Chromaffin granule amine transporter,target,P54219,SLC18A1,Humans,"Electrogenic antiporter that exchanges one cationic monoamine with two intravesicular protons across the membrane of secretory and synaptic vesicles. Uses the electrochemical proton gradient established by the V-type proton-pump ATPase to accumulate high concentrations of monoamines inside the vesicles prior to their release via exocytosis. Transports catecholamines and indolamines with higher affinity for serotonin (PubMed:16326835, PubMed:23337945, PubMed:8643547). Regulates the transvesicular",monoamine transmembrane transporter activity,"Cytoplasmic vesicle, secretory vesicle membrane",inhibitor,DrugBank,drugbank_id
BE0003408,Baculoviral IAP repeat-containing protein 5,target,O15392,BIRC5,Humans,"Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis (PubMed:20627126, PubMed:21364656, PubMed:25778398, PubMed:28218735, PubMed:9859993). Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis (PubMed:16322459). Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prome",cobalt ion binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0000110,P2Y purinoceptor 12,target,Q9H244,P2RY12,Humans,Receptor for ADP and ATP coupled to G-proteins that inhibit the adenylyl cyclase second messenger system. Not activated by UDP and UTP. Required for normal platelet aggregation and blood coagulation,G protein-coupled adenosine receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0005561,Platelet-activating factor receptor,target,P25105,PTAFR,Humans,"Receptor for platelet activating factor, a chemotactic phospholipid mediator that possesses potent inflammatory, smooth-muscle contractile and hypotensive activity. Seems to mediate its action via a G protein that activates a phosphatidylinositol-calcium second messenger system",G protein-coupled purinergic nucleotide receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0000247,Muscarinic acetylcholine receptor M5,target,P08912,CHRM5,Humans,"The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover",G protein-coupled acetylcholine receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000501,Alpha-1A adrenergic receptor,target,P35348,ADRA1A,Humans,This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine(PE)-stimulated ERK signaling in cardiac myocytes,alpha1-adrenergic receptor activity,Nucleus membrane,agonist,DrugBank,drugbank_id
BE0000575,Alpha-1B adrenergic receptor,target,P35368,ADRA1B,Humans,This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes,alpha1-adrenergic receptor activity,Nucleus membrane,agonist,DrugBank,drugbank_id
BE0000715,Alpha-1D adrenergic receptor,target,P25100,ADRA1D,Humans,This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium,alpha1-adrenergic receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000270,Renin,target,P00797,REN,Humans,"Renin is a highly specific endopeptidase, whose only known function is to generate angiotensin I from angiotensinogen in the plasma, initiating a cascade of reactions that produce an elevation of blood pressure and increased sodium retention by the kidney",aspartic-type endopeptidase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0000349,Potassium-transporting ATPase alpha chain 1,target,P20648,ATP4A,Humans,"The catalytic subunit of the gastric H(+)/K(+) ATPase pump which transports H(+) ions in exchange for K(+) ions across the apical membrane of parietal cells. Uses ATP as an energy source to pump H(+) ions to the gastric lumen while transporting K(+) ion from the lumen into the cell (By similarity). Remarkably generates a million-fold proton gradient across the gastric parietal cell membrane, acidifying the gastric juice down to pH 1 (By similarity). Within a transport cycle, the transfer of a H(",ATP binding,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0000619,Potassium-transporting ATPase subunit beta,target,P51164,ATP4B,Humans,"The beta subunit of the gastric H(+)/K(+) ATPase pump which transports H(+) ions in exchange for K(+) ions across the apical membrane of parietal cells. Plays a structural and regulatory role in the assembly and membrane targeting of a functionally active pump (By similarity). Within a transport cycle, the transfer of a H(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation of the alpha subunit that shifts the pump conformation from inward-fa",ATPase activator activity,Apical cell membrane,modulator,DrugBank,drugbank_id
BE0000281,Solute carrier family 12 member 2,target,P55011,SLC12A2,Humans,"Cation-chloride cotransporter which mediates the electroneutral transport of chloride, potassium and/or sodium ions across the membrane (PubMed:16669787, PubMed:32081947, PubMed:32294086, PubMed:33597714, PubMed:35585053, PubMed:36239040, PubMed:36306358, PubMed:7629105). Plays a vital role in the regulation of ionic balance and cell volume (PubMed:16669787, PubMed:32081947, PubMed:32294086, PubMed:7629105)",ammonium channel activity,Basolateral cell membrane,inhibitor,DrugBank,drugbank_id
BE0000502,Solute carrier family 12 member 1,target,Q13621,SLC12A1,Humans,"Renal sodium, potassium and chloride ion cotransporter that mediates the transepithelial NaCl reabsorption in the thick ascending limb and plays an essential role in the urinary concentration and volume regulation (PubMed:21321328). Electrically silent transporter system (By similarity)",sodium,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0000442,Histamine H1 receptor,target,P35367,HRH1,Humans,"G-protein-coupled receptor for histamine, a biogenic amine that functions as an immune modulator and a neurotransmitter (PubMed:33828102, PubMed:8280179). Through the H1 receptor, histamine mediates the contraction of smooth muscles and increases capillary permeability due to contraction of terminal venules. Also mediates neurotransmission in the central nervous system and thereby regulates circadian rhythms, emotional and locomotor activities as well as cognitive functions (By similarity)",histamine receptor activity,Cell membrane,binder,DrugBank,drugbank_id
BE0000797,5-hydroxytryptamine receptor 1B,target,P28222,HTR1B,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:10452531, PubMed:1315531, PubMed:1328844, PubMed:1348246, PubMed:1351684, PubMed:1559993, PubMed:1565658, PubMed:1610347, PubMed:23519210, PubMed:23519215, PubMed:29925951, PubMed:8218242). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances, such as lysergic acid diethylamide (LSD) (PubMed:23519210, PubMed:23519215, PubMed:29925951). Ligan",G protein-coupled serotonin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000659,5-hydroxytryptamine receptor 1D,target,P28221,HTR1D,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:10452531, PubMed:1565658, PubMed:1652050, PubMed:33762731). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances (PubMed:10452531, PubMed:1565658, PubMed:1652050, PubMed:33762731). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream ",G protein-coupled serotonin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000460,5-hydroxytryptamine receptor 1F,target,P30939,HTR1F,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:21422162, PubMed:34239069, PubMed:8380639, PubMed:8384716). Also functions as a receptor for various alkaloids and psychoactive substances (PubMed:21422162, PubMed:8380639, PubMed:8384716). Receptor for lasmiditan, a drug for the treatment of acute migraine (PubMed:34239069). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of d",G protein-coupled serotonin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000291,5-hydroxytryptamine receptor 1A,target,P08908,HTR1A,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:37935376, PubMed:37935377, PubMed:8138923, PubMed:8393041). Also functions as a receptor for various drugs and psychoactive substances (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:38552625, PubMed:8138923, PubMed:8393041). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the acti",G protein-coupled serotonin receptor activity,Cell membrane,partial agonist,DrugBank,drugbank_id
BE0000476,5-hydroxytryptamine receptor 1E,target,P28566,HTR1E,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:14744596, PubMed:1513320, PubMed:1608964, PubMed:1733778, PubMed:21422162, PubMed:33762731). Also functions as a receptor for various alkaloids and psychoactive substances (PubMed:14744596, PubMed:1513320, PubMed:1608964, PubMed:1733778, PubMed:21422162, PubMed:33762731). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downs",G protein-coupled receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0000393,5-hydroxytryptamine receptor 2B,target,P41595,HTR2B,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:18703043, PubMed:23519210, PubMed:7926008, PubMed:8078486, PubMed:8143856, PubMed:8882600). Also functions as a receptor for various ergot alkaloid derivatives and psychoactive substances (PubMed:12970106, PubMed:18703043, PubMed:23519210, PubMed:23519215, PubMed:24357322, PubMed:28129538, PubMed:30127358, PubMed:36087581, PubMed:7926008, PubMed:8078486, PubMed:8143856). Ligand binding causes a conformation change that trigge",G protein-coupled serotonin receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0000650,5-hydroxytryptamine receptor 7,target,P34969,HTR7,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone and a mitogen (PubMed:35714614, PubMed:8226867). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors (PubMed:35714614, PubMed:8226867). HTR7 is coupled to G(s) G alpha proteins and mediates activation of adenylate cyclase activity (PubMed:35714614)",G protein-coupled serotonin receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0000644,ATP-sensitive inward rectifier potassium channel 1,target,P48048,KCNJ1,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This channel is activated by internal ATP and can be blocked by exte",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000366,DNA gyrase subunit A,target,P43700,gyrA,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to modulate DNA topology and maintain chromosomes in an underwound state. Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Also able to catalyze the interconversion of other topological isomers of dsDNA rings, including catenanes and knotted rings. Type II topoisomerases break an",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000429,DNA topoisomerase 4 subunit A,target,P43702,parC,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),Topoisomerase IV is essential for chromosome segregation. It relaxes supercoiled DNA. Performs the decatenation events required during the replication of a circular DNA molecule.,ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002388,DNA gyrase subunit B,target,P0A0K8,gyrB,Staphylococcus aureus,"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to modulate DNA topology and maintain chromosomes in an underwound state. Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Also able to catalyze the interconversion of other topological isomers of dsDNA rings, including catenanes and knotted rings. Type II topoisomerases break an",ATP binding,Cytoplasm,modulator,DrugBank,drugbank_id
BE0008385,DNA gyrase subunit A,target,P20831,gyrA,Staphylococcus aureus,"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to modulate DNA topology and maintain chromosomes in an underwound state. Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Also able to catalyze the interconversion of other topological isomers of dsDNA rings, including catenanes and knotted rings. Type II topoisomerases break an",ATP binding,Cytoplasm,modulator,DrugBank,drugbank_id
BE0000742,DNA topoisomerase 2-alpha,target,P11388,TOP2A,Humans,"Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand (PubMed:17567603, PubMed:18790802, PubMed:22013166, PubMed:22323612). May play a role in regulating the period length of BMAL1 transcriptional oscillation (By similarity)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000930,Serum paraoxonase/arylesterase 1,target,P27169,PON1,Humans,"Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation",acyl-L-homoserine-lactone lactonohydrolase activity,"Secreted, extracellular space",inhibitor,DrugBank,drugbank_id
BE0000787,Gag-Pol polyprotein,target,P03369,gag-pol,HIV-1,"Gag-Pol polyprotein
    Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi). Gag-Pol polyprotein may regulate its own translation, by the binding genomic RNA in the 5'-UTR. At low concentration, the polyprotein would promote transla",aspartic-type endopeptidase activity,Host cell membrane,inhibitor,DrugBank,drugbank_id
BE0000708,ATP-sensitive inward rectifier potassium channel 11,target,Q14654,KCNJ11,Humans,"Inward rectifier potassium channel that forms the pore of ATP-sensitive potassium channels (KATP), regulating potassium permeability as a function of cytoplasmic ATP and ADP concentrations in many different cells (PubMed:29286281, PubMed:34815345). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is",ankyrin binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0000207,ATP-binding cassette sub-family C member 8,target,Q09428,ABCC8,Humans,"Regulator subunit of pancreatic ATP-sensitive potassium channel (KATP), playing a major role in the regulation of insulin release. In pancreatic cells, it forms KATP channels with KCNJ11; KCNJ11 forms the channel pore while ABCC8 is required for activation and regulation",ABC-type transporter activity,Cell membrane,inducer,DrugBank,drugbank_id
BE0000469,ATP-binding cassette sub-family C member 9,target,O60706,ABCC9,Humans,Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with KCNJ11. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation (PubMed:9831708). Can form a sulfonylurea-sensitive but ATP-insensitive potassium channel with KCNJ8 (By similarity),ABC-type transporter activity,Membrane,blocker,DrugBank,drugbank_id
BE0003997,Phospholipase A2,target,P04054,PLA2G1B,Humans,"Secretory calcium-dependent phospholipase A2 that primarily targets dietary phospholipids in the intestinal tract (PubMed:10681567, PubMed:1420353, PubMed:17603006). Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity) with preference for phosphatidylethanolamines and phosphatidylglycerols over phosphatidylcholines (PubMed:10681567, PubMed:1420353, PubMed:17603006). May play a role in the biosynthesis of N-acyl ethanolamines tha",bile acid binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0004854,Pol polyprotein,target,Q72874,pol,Human immunodeficiency virus 1,,aspartic-type endopeptidase activity,,inhibitor,DrugBank,drugbank_id
BE0002050,Gag-Pol polyprotein,target,P03366,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate HXB2),"Gag-Pol polyprotein
    Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi). Gag-Pol polyprotein may regulate its own translation, by the binding genomic RNA in the 5'-UTR. At low concentration, the polyprotein would promote transla",aspartic-type endopeptidase activity,Host cell membrane,inhibitor,DrugBank,drugbank_id
BE0003562,Serum paraoxonase/lactonase 3,enzyme,Q15166,PON3,Humans,Has low activity towards the organophosphate paraxon and aromatic carboxylic acid esters. Rapidly hydrolyzes lactones such as statin prodrugs (e.g. lovastatin). Hydrolyzes aromatic lactones and 5- or 6-member ring lactones with aliphatic substituents but not simple lactones or those with polar substituents,acyl-L-homoserine-lactone lactonohydrolase activity,"Secreted, extracellular space",substrate,DrugBank,drugbank_id
BE0009847,Voltage-gated Potassium Channels,target,Q9NSA2,KCND1,,"A-type voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes in the brain (PubMed:15454437). Mediates A-type current I(SA) in suprachiasmatic nucleus (SCN) neurons. Exhibits a low-threshold A-type current with a hyperpolarized steady-state inactivation midpoint and the recovery process was steeply voltage-dependent, with recovery being markedly faster at more negative potentials. May regulates repetitive firing rates in the suprachiasmatic nucleus",A-type (transient outward) potassium channel activity,Cell membrane,inhibitor|activator,DrugBank,drugbank_id
BE0000218,Calcium-transporting ATPase type 2C member 1,target,P98194,ATP2C1,Humans,"ATP-driven pump that supplies the Golgi apparatus with Ca(2+) and Mn(2+) ions, both essential cofactors for processing and trafficking of newly synthesized proteins in the secretory pathway (PubMed:12707275, PubMed:16192278, PubMed:20439740, PubMed:21187401, PubMed:30923126). Within a catalytic cycle, acquires Ca(2+) or Mn(2+) ions on the cytoplasmic side of the membrane and delivers them to the lumenal side. The transfer of ions across the membrane is coupled to ATP hydrolysis and is associated",ATP binding,"Golgi apparatus, trans-Golgi network membrane",inhibitor,DrugBank,drugbank_id
BE0004852,Glutamate (NMDA) receptor,target,Q05586,GRIN1,Humans,"Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:21376300, PubMed:26875626, PubMed:26919761, PubMed:28126851, PubMed:28228639, PubMed:36959261, PubMed:7679115, PubMed:7681588, PubMed:7685113). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the long-term potentiation (LTP) (PubMed:26875626). Channel ",amyloid-beta binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,target,O14983,ATP2A1,Humans,Key regulator of striated muscle performance by acting as the major Ca(2+) ATPase responsible for the reuptake of cytosolic Ca(2+) into the sarcoplasmic reticulum. Catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen (By similarity). Contributes to calcium sequestration involved in muscular excitation/contraction (PubMed:10914677),ATP binding,Endoplasmic reticulum membrane,inhibitor|stimulator,DrugBank,drugbank_id
BE0000576,Penicillin-binding protein 1A,target,Q8XJ01,pbpA,Clostridium perfringens (strain 13 / Type A),Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid intermediates. The enzyme has a penicillin-insensitive transglycosylase N-terminal domain (formation of linear glycan strands) and a penicillin-sensitive transpeptidase C-terminal domain (cross-linking of the peptide subunits).,penicillin binding,Cell membrane,inducer,DrugBank,drugbank_id
BE0002393,"Peptidoglycan D,D-transpeptidase FtsI",target,P0AD68,ftsI,Escherichia coli (strain K12),"Essential cell division protein that catalyzes cross-linking of the peptidoglycan cell wall at the division septum (PubMed:1103132, PubMed:3531167, PubMed:6450748, PubMed:7030331, PubMed:9614966). Required for localization of FtsN (PubMed:9282742).",penicillin binding,Cell inner membrane,binder,DrugBank,drugbank_id
BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,P54289,CACNA2D1,Humans,The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity),metal ion binding,Membrane,modulator,DrugBank,drugbank_id
BE0000222,Large neutral amino acids transporter small subunit 1,transporter,Q01650,SLC7A5,Humans,"The heterodimer with SLC3A2 functions as a sodium-independent, high-affinity transporter that mediates uptake of large neutral amino acids such as phenylalanine, tyrosine, leucine, histidine, methionine, tryptophan, valine, isoleucine and alanine (PubMed:10049700, PubMed:10574970, PubMed:11557028, PubMed:11564694, PubMed:12117417, PubMed:12225859, PubMed:15769744, PubMed:18262359, PubMed:25998567, PubMed:30867591, PubMed:9751058). The heterodimer with SLC3A2 mediates the uptake of L-DOPA (By sim",amino acid transmembrane transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0000267,Carbonic anhydrase 1,target,P00915,CA1,Humans,"Catalyzes the reversible hydration of carbon dioxide (PubMed:10550681, PubMed:16506782, PubMed:16686544, PubMed:16807956, PubMed:17127057, PubMed:17314045, PubMed:17407288, PubMed:18618712, PubMed:19186056, PubMed:19206230). Can hydrate cyanamide to urea (PubMed:10550681)",arylesterase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000322,Carbonic anhydrase 2,target,P00918,CA2,Humans,"Catalyzes the reversible hydration of carbon dioxide (PubMed:11327835, PubMed:11802772, PubMed:11831900, PubMed:12056894, PubMed:12171926, PubMed:1336460, PubMed:14736236, PubMed:15300855, PubMed:15453828, PubMed:15667203, PubMed:15865431, PubMed:16106378, PubMed:16214338, PubMed:16290146, PubMed:16686544, PubMed:16759856, PubMed:16807956, PubMed:17127057, PubMed:17251017, PubMed:17314045, PubMed:17330962, PubMed:17346964, PubMed:17540563, PubMed:17588751, PubMed:17705204, PubMed:18024029, PubMe",arylesterase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004655,Inhibitor of nuclear factor kappa-B kinase subunit alpha,target,O15111,CHUK,Humans,"Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues (PubMed:18626576, PubMed:35952808, PubMed:9244310, PubM",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003768,Group IIE secretory phospholipase A2,target,Q9NZK7,PLA2G2E,Humans,"Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids (PubMed:10681567, PubMed:11922621, PubMed:28883454). Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity), releasing various unsaturated fatty acids including oleoate, linoleoate, arachidonate, docosahexaenoate and lysophosphatidylethanolamines in preference to lysophosphatidylcholines (PubMed:10681567, PubMed:28883454). In response t",calcium ion binding,Secreted,unknown,DrugBank,drugbank_id
BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",target,Q14432,PDE3A,Humans,"Cyclic nucleotide phosphodiesterase with specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (PubMed:1315035, PubMed:25961942, PubMed:8155697, PubMed:8695850). Also has activity toward cUMP (PubMed:27975297). Independently of its catalytic activity it is part of an E2/17beta-estradiol-induced pro-apoptotic signaling pathway. E2 stabilizes the PDE3A/SLFN12 complex in the cytosol, promoting the dephosphorylation of SLFN12 and acti","3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity",Membrane,inhibitor,DrugBank,drugbank_id
BE0004136,Reverse transcriptase/RNaseH,target,Q72547,pol,Human immunodeficiency virus 1,,aspartic-type endopeptidase activity,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0004668,Lanosterol synthase,target,Q04782,ERG7,Yeast,"Lanosterol synthase; part of the third module of ergosterol biosynthesis pathway that includes the late steps of the pathway (PubMed:2185141, PubMed:8486282). ERG7 catalyzes the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that forms the sterol core (PubMed:2185141). The third module or late pathway involves the ergosterol synthesis itself through consecutive reactions that mainly occur in the endoplasmic reticulum (ER) membrane. Firstly, the squalene synthase ERG9 catalyzes th",lanosterol synthase activity,,inhibitor,DrugBank,drugbank_id
BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,target,P47869,GABRA2,Humans,"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:10449790, PubMed:29961870, PubMed:31032849). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interfaces (By similarity). When activated by GABA, GABAARs selectively allow the flow",benzodiazepine receptor activity,Postsynaptic cell membrane,potentiator,DrugBank,drugbank_id
BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,target,P34903,GABRA3,Humans,"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:16412217, PubMed:29053855). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride an",benzodiazepine receptor activity,Postsynaptic cell membrane,potentiator,DrugBank,drugbank_id
BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,target,P48169,GABRA4,Humans,"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:35355020). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:35355020). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the",benzodiazepine receptor activity,Cell membrane,potentiator,DrugBank,drugbank_id
BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,target,P31644,GABRA5,Humans,"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:29961870, PubMed:30140029, PubMed:31056671). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:30140029). When activated by GABA, GABAARs selec",GABA receptor binding,Postsynaptic cell membrane,potentiator,DrugBank,drugbank_id
BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,target,Q16445,GABRA6,Humans,"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:8632757). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the ce",benzodiazepine receptor activity,Postsynaptic cell membrane,potentiator,DrugBank,drugbank_id
BE0000325,Ribonucleoside-diphosphate reductase large subunit,target,P23921,RRM1,Humans,Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002450,Ribonucleoside-diphosphate reductase subunit M2,target,P31350,RRM2,Humans,Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. Inhibits Wnt signaling,ferric iron binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003613,Ribonucleoside-diphosphate reductase subunit M2 B,target,Q7LG56,RRM2B,Humans,Plays a pivotal role in cell survival by repairing damaged DNA in a p53/TP53-dependent manner. Supplies deoxyribonucleotides for DNA repair in cells arrested at G1 or G2. Contains an iron-tyrosyl free radical center required for catalysis. Forms an active ribonucleotide reductase (RNR) complex with RRM1 which is expressed both in resting and proliferating cells in response to DNA damage,identical protein binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000546,DNA polymerase alpha catalytic subunit,target,P09884,POLA1,Humans,"Catalytic subunit of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which plays an essential role in the initiation of DNA synthesis. During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, a regulatory subunit POLA2 and two primase subunits PRIM1 and PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1. The primase subunit of the polymerase alpha complex ",chromatin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0003614,DNA polymerase epsilon catalytic subunit A,target,Q07864,POLE,Humans,"Catalytic component of the DNA polymerase epsilon complex (PubMed:10801849). Participates in chromosomal DNA replication (By similarity). Required during synthesis of the leading DNA strands at the replication fork, binds at/or near replication origins and moves along DNA with the replication fork (By similarity). Has 3'-5' proofreading exonuclease activity that corrects errors arising during DNA replication (By similarity). Involved in DNA synthesis during DNA repair (PubMed:20227374, PubMed:27","4 iron, 4 sulfur cluster binding",Nucleus,inhibitor,DrugBank,drugbank_id
BE0003615,DNA polymerase epsilon subunit 2,target,P56282,POLE2,Humans,Accessory component of the DNA polymerase epsilon complex (PubMed:10801849). Participates in DNA repair and in chromosomal DNA replication (By similarity),DNA binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0003617,DNA polymerase epsilon subunit 3,target,Q9NRF9,POLE3,Humans,"Accessory component of the DNA polymerase epsilon complex (PubMed:10801849). Participates in DNA repair and in chromosomal DNA replication (By similarity). Forms a complex with CHRAC1 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome-remodeling activity of ISWI/SNF2H and ACF1 (PubMed:10801849). Does not enhance nucleosome sliding activity of the ACF-5 ISWI chromatin remodeling complex (PubMed:14759371)",chromatin DNA binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0003616,DNA polymerase epsilon subunit 4,target,Q9NR33,POLE4,Humans,Accessory component of the DNA polymerase epsilon complex (PubMed:10801849). Participates in DNA repair and in chromosomal DNA replication (By similarity),DNA binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000250,Purine nucleoside phosphorylase,target,P00491,PNP,Humans,"Catalyzes the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate (PubMed:23438750, PubMed:9305964). Preferentially acts on 6-oxopurine nucleosides including inosine and guanosine (PubMed:9305964)",guanosine phosphorylase activity,Cytoplasm,inducer,DrugBank,drugbank_id
BE0002214,Adenosine deaminase,target,P00813,ADA,Humans,"Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine (PubMed:16670267, PubMed:23193172, PubMed:26166670, PubMed:8452534, PubMed:9361033). Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4 (PubMed:20959412). Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion (",2'-deoxyadenosine deaminase activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001717,Poly [ADP-ribose] polymerase 1,target,P09874,PARP1,Humans,"Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair (PubMed:17177976, PubMed:18055453, PubMed:18172500, PubMed:19344625, PubMed:19661379, PubMed:20388712, PubMed:21680843, PubMed:22582261, PubMed:23230272, PubMed:25043379, PubMed:26344098, PubMed:26626479, PubMed:26626480, PubMed:30104678, PubMed:31796734, PubMed:32028527, PubMed:32241924, PubMed:32358582, PubMed:33186521, PubMed:34465625, PubMed:34737271). Mediates glutamate, aspartate,",chromatin binding,Chromosome,inducer,DrugBank,drugbank_id
BE0002804,Deoxycytidine kinase,enzyme,P27707,DCK,Humans,"Phosphorylates the deoxyribonucleosides deoxycytidine, deoxyguanosine and deoxyadenosine (PubMed:12808445, PubMed:18377927, PubMed:19159229, PubMed:1996353, PubMed:20614893, PubMed:20637175). Has broad substrate specificity, and does not display selectivity based on the chirality of the substrate. It is also an essential enzyme for the phosphorylation of numerous nucleoside analogs widely employed as antiviral and chemotherapeutic agents (PubMed:12808445)",ATP binding,Nucleus,substrate,DrugBank,drugbank_id
BE0003589,"Deoxyguanosine kinase, mitochondrial",enzyme,Q16854,DGUOK,Humans,"Phosphorylates deoxyguanosine and deoxyadenosine in the mitochondrial matrix, with the highest efficiency for deoxyguanosine (PubMed:11687801, PubMed:17073823, PubMed:23043144, PubMed:8692979, PubMed:8706825). In non-replicating cells, where cytosolic dNTP synthesis is down-regulated, mtDNA synthesis depends solely on DGUOK and TK2. Phosphorylates certain nucleoside analogs (By similarity). Widely used as target of antiviral and chemotherapeutic agents",ATP binding,Mitochondrion,substrate,DrugBank,drugbank_id
BE0003672,Solute carrier family 28 member 3,transporter,Q9HAS3,SLC28A3,Humans,"Sodium-dependent, pyrimidine- and purine-selective (PubMed:11032837, PubMed:15861042, PubMed:16446384, PubMed:17140564, PubMed:21998139). Involved in the homeostasis of endogenous nucleosides (PubMed:11032837, PubMed:15861042). Exhibits the transport characteristics of the nucleoside transport system cib or N3 subtype (N3/cib) (with marked transport of both thymidine and inosine) (PubMed:11032837). Employs a 2:1 sodium/nucleoside ratio (PubMed:11032837). Transports uridine (PubMed:21795683). Als",nucleoside,Cell membrane,substrate,DrugBank,drugbank_id
BE0004901,Sodium channel protein,target,P35498,SCN1A,Humans,"Pore-forming subunit of Nav1.1, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.",voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009631,Inward rectifier potassium channel,target,Q14500,KCNJ12,Humans,Inward rectifying potassium channel that probably participates in controlling the resting membrane potential in electrically excitable cells. Probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potass,inward rectifier potassium channel activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0009739,Voltage gated L-type calcium channel,target,Q13936,CACNA1C,Humans,"Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:12181424, PubMed:15454078, PubMed:15863612, PubMed:16299511, PubMed:17224476, PubMed:20953164, PubMed:23677916, PubMed:24728418, PubMed:26253506, PubMed:27218670, PubMed:29078335, PubMed:29742403, PubMed:30023270, PubMed:30172029, PubMed:34163037, PubMed:8099908). Mediates influx of calcium ions into the cytoplasm, and thereby triggers calcium release from the sarcoplasm (By sim",alpha-actinin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004863,Alpha-1 adrenergic receptors,target,P35348,ADRA1A,Humans,This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine(PE)-stimulated ERK signaling in cardiac myocytes,alpha1-adrenergic receptor activity,Nucleus membrane,antagonist,DrugBank,drugbank_id
BE0009632,Fatty acid,target,,,,,,,other/unknown,DrugBank,drugbank_id
BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,target,O14920,IKBKB,Humans,"Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:30337470, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation (PubMed:9346484). Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues (PubMed:204",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003608,Arylamine N-acetyltransferase 1,enzyme,P18440,NAT1,Humans,Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,arylamine N-acetyltransferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000451,5-hydroxytryptamine receptor 2A,target,P28223,HTR2A,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:1330647, PubMed:18703043, PubMed:19057895, PubMed:21645528, PubMed:22300836, PubMed:35084960, PubMed:38552625). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD) (PubMed:28129538, PubMed:35084960). Ligand binding causes a conformation change that triggers signaling via guanine nuc","1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding",Cell membrane,antagonist,DrugBank,drugbank_id
BE0000020,D(1A) dopamine receptor,target,P21728,DRD1,Humans,Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase,arrestin family protein binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000145,D(1B) dopamine receptor,target,P21918,DRD5,Humans,Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase,dopamine binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000581,D(3) dopamine receptor,target,P35462,DRD3,Humans,Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase. Promotes cell proliferation,"dopamine neurotransmitter receptor activity, coupled via Gi/Go",Cell membrane,antagonist,DrugBank,drugbank_id
BE0000389,D(4) dopamine receptor,target,P21917,DRD4,Humans,"Dopamine receptor responsible for neuronal signaling in the mesolimbic system of the brain, an area of the brain that regulates emotion and complex behavior. Activated by dopamine, but also by epinephrine and norepinephrine, and by numerous synthetic agonists and drugs (PubMed:16423344, PubMed:27659709, PubMed:29051383, PubMed:9003072). Agonist binding triggers signaling via G proteins that inhibit adenylyl cyclase (PubMed:16423344, PubMed:27659709, PubMed:29051383, PubMed:7512953, PubMed:764309",dopamine binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000945,5-hydroxytryptamine receptor 6,target,P50406,HTR6,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone and a mitogen (PubMed:35714614, PubMed:36989299, PubMed:37327704, PubMed:8522988). Also has a high affinity for tricyclic psychotropic drugs (By similarity). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors (PubMed:35714614). HTR6 is coupled to G",G protein-coupled serotonin receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000289,Alpha-2A adrenergic receptor,target,P08913,ADRA2A,Humans,"Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol",alpha-1B adrenergic receptor binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000572,Alpha-2B adrenergic receptor,target,P18089,ADRA2B,Humans,"Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is clonidine > norepinephrine > epinephrine = oxymetazoline > dopamine > p-tyramine = phenylephrine > serotonin > p-synephrine / p-octopamine. For antagonists, the rank order is yohimbine > chlorpromazine > phentolamine > mianserine > spiperone > prazosin > alprenolol > propanolol > pindolol",alpha2-adrenergic receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000342,Alpha-2C adrenergic receptor,target,P18825,ADRA2C,Humans,Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins,alpha-2A adrenergic receptor binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000405,Muscarinic acetylcholine receptor M4,target,P08173,CHRM4,Humans,"The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is inhibition of adenylate cyclase",G protein-coupled acetylcholine receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0009860,5-hydroxytryptamine 3 receptor,target,P46098,HTR3A,Humans,"Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons",excitatory extracellular ligand-gated monoatomic ion channel activity,Postsynaptic cell membrane,antagonist,DrugBank,drugbank_id
BE0004688,5-hydroxytryptamine receptor 5A,target,P47898,HTR5A,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone and a mitogen (PubMed:35610220, PubMed:35835867, PubMed:9865521). Also functions as a receptor for ergot alkaloid derivatives and other psychoactive substances (PubMed:35835867). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors (PubMed:35610220, ",G protein-coupled serotonin receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004889,D(1) dopamine receptor,target,P21728,DRD1,Humans,Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase,arrestin family protein binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0002087,Inactive dihydropteroate synthase 2,target,P0C0X2,folP2,Mycobacterium leprae (strain TN),"Has very low affinity for the DHPS substrate 6-hydroxymethyl-7,8-dihydropterin-pyrophosphate, but can bind the inhibitor dapsone. Seems to lack dihydropteroate synthase activity, and does probably not function in folate metabolism (By similarity).",dihydropteroate synthase activity,,inhibitor,DrugBank,drugbank_id
BE0002086,Dihydropteroate synthase,target,P0C0X1,folP1,Mycobacterium leprae (strain TN),"Catalyzes the condensation of para-aminobenzoate (pABA) with 6-hydroxymethyl-7,8-dihydropterin diphosphate (DHPt-PP) to form 7,8-dihydropteroate, the immediate precursor of folate derivatives.",dihydropteroate synthase activity,,inhibitor,DrugBank,drugbank_id
BE0003611,Cytochrome P450 2C18,enzyme,P33260,CYP2C18,Humans,"A cytochrome P450 monooxygenase involved in retinoid metabolism. Hydroxylates all trans-retinoic acid (atRA) to 4-hydroxyretinoate and may modulate atRA signaling and clearance. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase)",arachidonate epoxygenase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0003606,Flavin-containing monooxygenase 3,enzyme,P31513,FMO3,Humans,"Essential hepatic enzyme that catalyzes the oxygenation of a wide variety of nitrogen- and sulfur-containing compounds including drugs as well as dietary compounds (PubMed:10759686, PubMed:30381441, PubMed:32156684). Plays an important role in the metabolism of trimethylamine (TMA), via the production of trimethylamine N-oxide (TMAO) metabolite (PubMed:9776311). TMA is generated by the action of gut microbiota using dietary precursors such as choline, choline containing compounds, betaine or L-c",albendazole monooxygenase activity,Microsome membrane,substrate,DrugBank,drugbank_id
BE0003607,Arylamine N-acetyltransferase 2,enzyme,P11245,NAT2,Humans,"Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates (PubMed:12222688, PubMed:7915226). Participates in the detoxification of a plethora of hydrazine and arylamine drugs, and is able to bioactivate several known carcinogens",arylamine N-acetyltransferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000197,Sodium channel protein type 5 subunit alpha,target,Q14524,SCN5A,Humans,"Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.",ankyrin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000141,Sodium channel protein type 1 subunit alpha,target,P35498,SCN1A,Humans,"Pore-forming subunit of Nav1.1, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.",voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0008715,Voltage-dependent L-type calcium channel,target,Q13936,CACNA1C,Humans,"Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:12181424, PubMed:15454078, PubMed:15863612, PubMed:16299511, PubMed:17224476, PubMed:20953164, PubMed:23677916, PubMed:24728418, PubMed:26253506, PubMed:27218670, PubMed:29078335, PubMed:29742403, PubMed:30023270, PubMed:30172029, PubMed:34163037, PubMed:8099908). Mediates influx of calcium ions into the cytoplasm, and thereby triggers calcium release from the sarcoplasm (By sim",alpha-actinin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002084,Sodium channel protein type 8 subunit alpha,target,Q9UQD0,SCN8A,Humans,"Pore-forming subunit of a voltage-gated sodium channel complex assuming opened or closed conformations in response to the voltage difference across membranes and through which sodium ions selectively pass along their electrochemical gradient (PubMed:24874546, PubMed:25239001, PubMed:25725044, PubMed:26900580, PubMed:29726066, PubMed:33245860, PubMed:36696443, PubMed:36823201). Contributes to neuronal excitability by regulating action potential threshold and propagation (PubMed:24874546, PubMed:2",sodium ion binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003635,Sodium channel regulatory subunit beta-1,target,Q07699,SCN1B,Humans,"Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provoke",sodium channel inhibitor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002082,Sodium channel protein type 3 subunit alpha,target,Q9NY46,SCN3A,Humans,"Pore-forming subunit of Nav1.3, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.",voltage-gated sodium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000731,"Cytochrome P450 11B1, mitochondrial",enzyme,P15538,CYP11B1,Humans,"A cytochrome P450 monooxygenase involved in the biosynthesis of adrenal corticoids (PubMed:12530636, PubMed:1518866, PubMed:1775135, PubMed:18215163, PubMed:23322723). Catalyzes a variety of reactions that are essential for many species, including detoxification, defense, and the formation of endogenous chemicals like steroid hormones. Steroid 11beta, 18- and 19-hydroxylase with preferred regioselectivity at 11beta, then 18, and lastly 19 (By similarity). Catalyzes the hydroxylation of 11-deoxyc",corticosterone 18-monooxygenase activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0009565,Epoxide hydrolase 1,enzyme,P07099,EPHX1,Humans,Biotransformation enzyme that catalyzes the hydrolysis of arene and aliphatic epoxides to less reactive and more water soluble dihydrodiols by the trans addition of water (By similarity). Plays a role in the metabolism of endogenous lipids such as epoxide-containing fatty acids (PubMed:22798687). Metabolizes the abundant endocannabinoid 2-arachidonoylglycerol (2-AG) to free arachidonic acid (AA) and glycerol (PubMed:24958911). Binds 20(S)-hydroxycholesterol (20(S)-OHC) (By similarity),cis-stilbene-oxide hydrolase activity,Microsome membrane,substrate,DrugBank,drugbank_id
BE0003660,Solute carrier organic anion transporter family member 1C1,transporter,Q9NYB5,SLCO1C1,Humans,"Mediates the Na(+)-independent high affinity transport of organic anions such as the thyroid hormones L-thyroxine (T4), L-thyroxine sulfate (T4S), and 3,3',5'-triiodo-L-thyronine (reverse T3, rT3) at the plasma membrane (PubMed:12351693, PubMed:18566113, PubMed:19129463). Regulates T4 levels in different brain regions by transporting T4, and also by serving as an export pump for T4S, which is a source of T4 after hydrolysis by local sulfatases (PubMed:18566113). Increases the access of these sub",bile acid transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0005001,Steroid hormone receptor ERR2,target,O95718,ESRRB,Humans,"Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity (PubMed:17920186, PubMed:19755138). Plays a role, in a LIF-independent manner, in maintainance of self-renewal and pluripotency of embryonic and trophoblast stem cells through different signaling pathways including FGF signaling pathway and Wnt signaling pathways. Involved in morula development",cis-regulatory region sequence-specific DNA binding,Nucleus,modulator,DrugBank,drugbank_id
BE0009998,30S ribosomal protein,target,,,,,,,inhibitor,DrugBank,drugbank_id
BE0002369,ATP-binding cassette sub-family B member 5,transporter,Q2M3G0,ABCB5,Humans,"Energy-dependent efflux transporter responsible for decreased drug accumulation in multidrug-resistant cells (PubMed:12960149, PubMed:15205344, PubMed:15899824, PubMed:22306008). Specifically present in limbal stem cells, where it plays a key role in corneal development and repair (By similarity)",ABC-type xenobiotic transporter activity,Cell membrane,inducer,DrugBank,drugbank_id
BE0000792,Estrogen receptor beta,target,Q92731,ESR2,Humans,"Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1/ER-alpha, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent manner (PubMed:20074560)",DNA binding,Nucleus,agonist,DrugBank,drugbank_id
BE0000123,Estrogen receptor,target,P03372,ESR1,Humans,"Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand bindin",14-3-3 protein binding,Nucleus,agonist,DrugBank,drugbank_id
BE0003740,Nuclear receptor coactivator 2,target,Q15596,NCOA2,Humans,"Transcriptional coactivator for steroid receptors and nuclear receptors (PubMed:23508108, PubMed:8670870, PubMed:9430642, PubMed:22504882, PubMed:26553876). Coactivator of the steroid binding domain (AF-2) but not of the modulating N-terminal domain (AF-1) (PubMed:23508108, PubMed:8670870, PubMed:9430642). Required with NCOA1 to control energy balance between white and brown adipose tissues (PubMed:23508108, PubMed:8670870, PubMed:9430642). Critical regulator of glucose metabolism regulation, ac",aryl hydrocarbon receptor binding,Nucleus,,DrugBank,drugbank_id
BE0000132,Androgen receptor,target,P10275,AR,Humans,"Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues (PubMed:19022849). Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Tran",androgen binding,Nucleus,antagonist,DrugBank,drugbank_id
BE0000337,Transthyretin,carrier,P02766,TTR,Humans,Thyroid hormone-binding protein. Probably transports thyroxine from the bloodstream to the brain,hormone activity,Secreted,,DrugBank,drugbank_id
BE0000019,Small ribosomal subunit protein uS4,target,P0A7V8,rpsD,Escherichia coli (strain K12),"One of two assembly initiator proteins for the 30S subunit, it binds directly to 16S rRNA where it nucleates assembly of the body of the 30S subunit.",mRNA 5'-UTR binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0000415,Intermediate conductance calcium-activated potassium channel protein 4,target,O15554,KCNN4,Humans,"Intermediate conductance calcium-activated potassium channel that mediates the voltage-independent transmembrane transfer of potassium across the cell membrane through a constitutive interaction with calmodulin which binds the intracellular calcium allowing its opening (PubMed:10026195, PubMed:10961988, PubMed:11425865, PubMed:15831468, PubMed:17157250, PubMed:18796614, PubMed:26148990, PubMed:9326665, PubMed:9380751, PubMed:9407042). The current is characterized by a voltage-independent activat",calcium-activated potassium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004803,Ergosterol,target,,,Candida albicans,,,,inhibitor,DrugBank,drugbank_id
BE0010516,C-X-C chemokine receptor type 2,target,P25025,CXCR2,Humans,"Receptor for interleukin-8 which is a powerful neutrophil chemotactic factor (PubMed:1891716). Binding of IL-8 to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system (PubMed:8662698). Binds to IL-8 with high affinity. Also binds with high affinity to CXCL3, GRO/MGSA and NAP-2",C-C chemokine binding,Cell membrane,modulator,DrugBank,drugbank_id
BE0000635,Hydroxycarboxylic acid receptor 2,target,Q8TDS4,HCAR2,Humans,Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may,nicotinic acid receptor activity,Cell membrane,partial agonist,DrugBank,drugbank_id
BE0004815,Phosphate,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0000733,D-alanine--D-alanine ligase A,target,P0A6J8,ddlA,Escherichia coli (strain K12),Cell wall formation.,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000806,Alanine racemase,target,Q9L888,alr,Mycobacterium avium,Catalyzes the interconversion of L-alanine and D-alanine.,alanine racemase activity,,inhibitor,DrugBank,drugbank_id
BE0004704,Proton-coupled amino acid transporter 2,transporter,Q495M3,SLC36A2,Humans,"Electrogenic proton/amino acid symporter with a high selectivity for the small side chains amino acids glycine, alanine and proline, where both L- and D-enantiomers are transported. Extension of the backbone length, as in beta-alanine and 4-aminobutanoate or methylation of the amino group, as in sarcosine and N,N-dimethylglycine, are also tolerated but decrease transport efficiency. A free carboxyl group is preferred",amino acid transmembrane transporter activity,Cell membrane,,DrugBank,drugbank_id
BE0004810,RNA,target,,,Humans,,,,cross-linking/alkylation,DrugBank,drugbank_id
BE0000648,"Glutathione reductase, mitochondrial",target,P00390,GSR,Humans,Catalyzes the reduction of glutathione disulfide (GSSG) to reduced glutathione (GSH). Constitutes the major mechanism to maintain a high GSH:GSSG ratio in the cytosol,electron transfer activity,Mitochondrion,allosteric modulator,DrugBank,drugbank_id
BE0001185,Quinone oxidoreductase,target,Q08257,CRYZ,Humans,"Does not have alcohol dehydrogenase activity. Binds NADP and acts through a one-electron transfer process. Orthoquinones, such as 1,2-naphthoquinone or 9,10-phenanthrenequinone, are the best substrates (in vitro). May act in the detoxification of xenobiotics. Interacts with (AU)-rich elements (ARE) in the 3'-UTR of target mRNA species. Enhances the stability of mRNA coding for BCL2. NADPH binding interferes with mRNA binding",identical protein binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009371,Cytochrome P450 2C6,enzyme,P05178,Cyp2c6,Rat,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.","arachidonic acid 11,12-epoxygenase activity",Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009372,Cytochrome P450 2C11,enzyme,P08683,Cyp2c11,Rat,"A cytochrome P450 monooxygenase involved in the metabolism of steroid hormones and fatty acids. Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes testosterone to 2alpha- and 16alpha-hydroxytestosterone (PubMed:2434473). Catalyzes the epoxidation of double bonds of polyunsaturated fatty acids (PUFAs) (PubMed:10491410, PubMed:15766564). Converts arachidonic acid (ARA, C20:4(n-6)) primarily to epoxyeicosatrienoic acid (EET) regioisomers, 8,9-, 11,12-, and 14,15-EET, with both R,S an","arachidonic acid 11,12-epoxygenase activity",Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,target,Q13936,CACNA1C,Humans,"Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:12181424, PubMed:15454078, PubMed:15863612, PubMed:16299511, PubMed:17224476, PubMed:20953164, PubMed:23677916, PubMed:24728418, PubMed:26253506, PubMed:27218670, PubMed:29078335, PubMed:29742403, PubMed:30023270, PubMed:30172029, PubMed:34163037, PubMed:8099908). Mediates influx of calcium ions into the cytoplasm, and thereby triggers calcium release from the sarcoplasm (By sim",alpha-actinin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,target,Q08289,CACNB2,Humans,"Beta subunit of voltage-dependent calcium channels which contributes to the function of the calcium channel by increasing peak calcium current (By similarity). Plays a role in shifting voltage dependencies of activation and inactivation of the channel (By similarity). May modulate G protein inhibition (By similarity). May contribute to beta-adrenergic augmentation of Ca(2+) influx in cardiomyocytes, thereby regulating increases in heart rate and contractile force (PubMed:36424916). Involved in m",actin filament binding,"Cell membrane, sarcolemma",inhibitor,DrugBank,drugbank_id
BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,target,O95180,CACNA1H,Humans,"Voltage-sensitive calcium channel that gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group. A particularity of this type of channel is an opening at quite negative potentials, and a voltage-dependent inactivation (PubMed:27149520, PubMed:9670923, PubMed:9930755). T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle (Probabl",low voltage-gated calcium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,target,Q9NY47,CACNA2D2,Humans,"The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. Acts as a regulatory subunit for P/Q-type calcium channel (CACNA1A), N-type (CACNA1B), L-type (CACNA1C OR CACNA1D) and possibly T-type (CACNA1G) (PubMed:15111129, PubMed:23339110). Overexpression induces apoptosis",metal ion binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,target,Q01668,CACNA1D,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1D gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkyla",alpha-actinin binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,target,Q13698,CACNA1S,Humans,"Pore-forming, alpha-1S subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Calcium channels containing the alpha-1S subunit play an important role in excitation-contraction coupling in skeletal muscle via their interaction with RYR1, which triggers Ca(2+) release from the sarcoplasmic reticulum and ultimately results in muscle contraction. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group",calmodulin binding,"Cell membrane, sarcolemma, T-tubule",inhibitor,DrugBank,drugbank_id
BE0009738,Voltage-gated sodium channel alpha subunit,target,P35498,SCN1A,Humans,"Pore-forming subunit of Nav1.1, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.",voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009793,Kainate receptors,target,P39086,GRIK1,Humans,"Ionotropic glutamate receptor that functions as a cation-permeable ligand-gated ion channel, gated by L-glutamate and the glutamatergic agonist kainic acid. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and en",glutamate-gated calcium ion channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003625,Carbonic anhydrase 3,target,P07451,CA3,Humans,Reversible hydration of carbon dioxide,carbonate dehydratase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0008718,Voltage-dependent R-type calcium channel,target,Q15878,CACNA1E,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells (PubMed:30343943). They are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1E gives rise to R-type calcium currents. R-type calcium channels belong to the 'high-voltage activated' (HVA) group and are blocked by nickel. They are however insensit",calcium ion binding,Membrane,antagonist,DrugBank,drugbank_id
BE0004907,5'-AMP-activated protein kinase,transporter,Q13131,PRKAA1,Humans,"Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism (PubMed:17307971, PubMed:17712357, PubMed:24563466, PubMed:37821951). In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation (PubMed:17307971, PubMed:17712357). AMPK acts",[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,Cytoplasm,inducer,DrugBank,drugbank_id
BE0003577,Penicillin binding protein 2a,target,C1KC03,mecA,Staphylococcus aureus,,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0000588,Penicillin-binding protein 1A,target,P02918,mrcA,Escherichia coli (strain K12),Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid intermediates. The enzyme has a penicillin-insensitive transglycosylase N-terminal domain (formation of linear glycan strands) and a penicillin-sensitive transpeptidase C-terminal domain (cross-linking of the peptide subunits).,penicillin binding,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0000488,Penicillin-binding protein 1B,target,P02919,mrcB,Escherichia coli (strain K12),Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid intermediates. The enzyme has a penicillin-insensitive transglycosylase N-terminal domain (formation of linear glycan strands) and a penicillin-sensitive transpeptidase C-terminal domain (cross-linking of the peptide subunits).,penicillin binding,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0002063,D-alanyl-D-alanine carboxypeptidase DacA,target,P0AEB2,dacA,Escherichia coli (strain K12),Removes C-terminal D-alanyl residues from sugar-peptide cell wall precursors.,beta-lactamase activity,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0003685,D-alanyl-D-alanine carboxypeptidase DacC,target,P08506,dacC,Escherichia coli (strain K12),Removes C-terminal D-alanyl residues from sugar-peptide cell wall precursors.,carboxypeptidase activity,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0002425,DNA topoisomerase 2-beta,target,Q02880,TOP2B,Humans,"Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand. Plays a role in B-cell differentiation",ATP binding,"Nucleus, nucleolus",inhibitor,DrugBank,drugbank_id
BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",target,P27815,PDE4A,Humans,"Hydrolyzes the second messenger 3',5'-cyclic AMP (cAMP), which is a key regulator of many important physiological processes","3',5'-cyclic-AMP phosphodiesterase activity","Cytoplasm, perinuclear region",inhibitor,DrugBank,drugbank_id
BE0009005,Protein RIC-3,target,Q7Z5B4,RIC3,Humans,"Molecular chaperone which facilitates proper subunit assembly and surface trafficking of alpha-7 (CHRNA7) and alpha-8 (CHRNA8) nicotinic acetylcholine receptors (PubMed:12821669, PubMed:15504725, PubMed:16120769, PubMed:18691158, PubMed:32204458). May also promote functional expression of homomeric serotoninergic 5-HT3 receptors, and of heteromeric acetylcholine receptors alpha-3/beta-2, alpha-3/beta-4, alpha-4/beta-2 and alpha-4/beta-4",acetylcholine receptor binding,Endoplasmic reticulum membrane,modulator,DrugBank,drugbank_id
BE0009002,Copine-1,target,Q99829,CPNE1,Humans,"Calcium-dependent phospholipid-binding protein that plays a role in calcium-mediated intracellular processes (PubMed:14674885). Involved in the TNF-alpha receptor signaling pathway in a calcium-dependent manner (PubMed:14674885). Exhibits calcium-dependent phospholipid binding properties (PubMed:19539605, PubMed:9430674). Plays a role in neuronal progenitor cell differentiation; induces neurite outgrowth via a AKT-dependent signaling cascade and calcium-independent manner (PubMed:23263657, PubMe",calcium ion binding,Nucleus,binder,DrugBank,drugbank_id
BE0004879,alpha1-acid glycoprotein,carrier,P02763,ORM1,Humans,Functions as a transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in the body. Appears to function in modulating the activity of the immune system during the acute-phase reaction,,Secreted,binder,DrugBank,drugbank_id
BE0000687,Thyroid hormone receptor alpha,target,P10827,THRA,Humans,"Nuclear hormone receptor that can act as a repressor or activator of transcription. High affinity receptor for thyroid hormones, including triiodothyronine and thyroxine",chromatin DNA binding,Nucleus,agonist,DrugBank,drugbank_id
BE0000315,Thyroid hormone receptor beta,target,P10828,THRB,Humans,"Nuclear hormone receptor that can act as a repressor or activator of transcription. High affinity receptor for thyroid hormones, including triiodothyronine and thyroxine",chromatin DNA binding,Nucleus,agonist,DrugBank,drugbank_id
BE0009045,Proliferating cell nuclear antigen,target,P12004,PCNA,Humans,"Auxiliary protein of DNA polymerase delta and epsilon, is involved in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand (PubMed:35585232). Induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities. Has to be loaded onto DNA in order to be able to stimulate APEX2. Plays a key role in DNA damage response (DDR) by being convenie",chromatin binding,Nucleus,antagonist,DrugBank,drugbank_id
BE0003653,Solute carrier organic anion transporter family member 4C1,transporter,Q6ZQN7,SLCO4C1,Humans,"Mediates the transport of organic anions such as steroids (estrone 3-sulfate, chenodeoxycholate, glycocholate) and thyroid hormones (3,3',5-triiodo-L-thyronine (T3), L-thyroxine (T4)), in the kidney (PubMed:14993604, PubMed:19129463, PubMed:20610891). Capable of transporting cAMP and pharmacological substances such as digoxin, ouabain and methotrexate (PubMed:14993604). Transport is independent of sodium, chloride ion, and ATP (PubMed:14993604). Transport activity is stimulated by an acidic extr",organic anion transmembrane transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0003656,Solute carrier organic anion transporter family member 4A1,transporter,Q96BD0,SLCO4A1,Humans,"Organic anion antiporter with apparent broad substrate specificity. Recognizes various substrates including thyroid hormones 3,3',5-triiodo-L-thyronine (T3), L-thyroxine (T4) and 3,3',5'-triiodo-L-thyronine (rT3), conjugated steroids such as estrone 3-sulfate and estradiol 17-beta glucuronide, bile acids such as taurocholate and prostanoids such as prostaglandin E2, likely operating in a tissue-specific manner (PubMed:10873595, PubMed:19129463, PubMed:30343886). May be involved in uptake of meta",organic anion transmembrane transporter activity,Cell membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0003603,A-type voltage-gated potassium channel KCND2,target,Q9NZV8,KCND2,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain. Mediates the major part of the dendritic A-type current I(SA) in brain neurons (By similarity). This current is activated at membrane potentials that are below the threshold for action potentials. It regulates neuronal excitability, prolongs the latency before the first spike in a series of action potentials, regulates the frequency of repetitive action potential firing",A-type (transient outward) potassium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003604,A-type voltage-gated potassium channel KCND3,target,Q9UK17,KCND3,Humans,"Pore-forming (alpha) subunit of voltage-gated A-type potassium channels that mediates transmembrane potassium transport in excitable membranes, in brain and heart (PubMed:10200233, PubMed:17187064, PubMed:21349352, PubMed:22457051, PubMed:23280837, PubMed:23280838, PubMed:34997220, PubMed:9843794). In cardiomyocytes, may generate the transient outward potassium current I(To) (By similarity). In neurons, may conduct the transient subthreshold somatodendritic A-type potassium current (ISA) (By sim",A-type (transient outward) potassium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003663,Alpha-1-acid glycoprotein 2,target,P19652,ORM2,Humans,Functions as a transport protein in the blood stream. Binds various hydrophobic ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability. Appears to function in modulating the activity of the immune system during the acute-phase reaction,,Secreted,binder,DrugBank,drugbank_id
BE0000177,Sodium channel protein type 10 subunit alpha,target,Q9Y5Y9,SCN10A,Humans,"Tetrodotoxin-resistant channel that mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. Plays a role in neuropathic pain mechanisms",transmembrane transporter binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001143,Sodium channel protein type 9 subunit alpha,target,Q15858,SCN9A,Humans,"Pore-forming subunit of Nav1.7, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.",voltage-gated sodium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000192,Sodium channel protein type 11 subunit alpha,target,Q9UI33,SCN11A,Humans,"Sodium channel mediating the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient (PubMed:10580103, PubMed:12384689, PubMed:24036948, PubMed:24776970, PubMed:25791876, PubMed:26645915). Involved in membrane depolarization during action potential in nocicepto",voltage-gated sodium channel activity,Cell membrane,blocker,DrugBank,drugbank_id
BE0002083,Sodium channel protein type 4 subunit alpha,target,P35499,SCN4A,Humans,"Pore-forming subunit of Nav1.4, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.",voltage-gated sodium channel activity,Cell membrane,,DrugBank,drugbank_id
BE0000776,Farnesyl pyrophosphate synthase,target,P14324,FDPS,Humans,"Key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (FPP), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. FPP also serves as substrate for protein farnesylation and geranylgeranylation. Catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product fa","(2E,6E)-farnesyl diphosphate synthase activity",Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004801,Hydroxylapatite,target,,,Humans,,,,antagonist,DrugBank,drugbank_id
BE0003570,Geranylgeranyl pyrophosphate synthase,target,O95749,GGPS1,Humans,"Catalyzes the trans-addition of the three molecules of IPP onto DMAPP to form geranylgeranyl pyrophosphate, an important precursor of carotenoids and geranylated proteins","(2E,6E)-farnesyl diphosphate synthase activity",Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001162,Caspase-3,target,P42574,CASP3,Humans,"Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:35338844, PubMed:35446120, PubMed:7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) p",aspartic-type endopeptidase activity,Cytoplasm,activator,DrugBank,drugbank_id
BE0009991,Caspase-9,target,P55211,CASP9,Humans,"Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates effector caspases caspase-3 (CASP3) or caspase-7 (CASP7). Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed:36758105, PubMed:36758106)",cysteine-type endopeptidase activity,,activator,DrugBank,drugbank_id
BE0000837,Maltase-glucoamylase,target,O43451,MGAM,Humans,"Alpha-(1,4) exo-glucosidase involved in breakdown of dietary starch oligosaccharides in small intestine. Cleaves the non-reducing alpha-(1,4)-linked glucose residue in linear dextrins with retention of anomeric center stereochemistry (PubMed:12547908, PubMed:18036614, PubMed:18356321, PubMed:22058037, PubMed:27480812). Mainly hydrolyzes short length oligomaltoses having two to seven glucose residues (PubMed:12547908, PubMed:18036614, PubMed:18356321, PubMed:22058037, PubMed:27480812). Can cleave","alpha-1,4-glucosidase activity",Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0001176,"Sucrase-isomaltase, intestinal",target,P14410,SI,Humans,"Plays an important role in the final stage of carbohydrate digestion. Isomaltase activity is specific for both alpha-1,4- and alpha-1,6-oligosaccharides","alpha-1,4-glucosidase activity",Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0002639,Pancreatic alpha-amylase,target,P04746,AMY2A,Humans,,alpha-amylase activity,"Secreted, extracellular space",inhibitor,DrugBank,drugbank_id
BE0000876,Lysosomal alpha-glucosidase,target,P10253,GAA,Humans,"Essential for the degradation of glycogen in lysosomes (PubMed:14695532, PubMed:18429042, PubMed:1856189, PubMed:7717400). Has highest activity on alpha-1,4-linked glycosidic linkages, but can also hydrolyze alpha-1,6-linked glucans (PubMed:29061980)","alpha-1,4-glucosidase activity",Lysosome,inhibitor,DrugBank,drugbank_id
BE0003652,Solute carrier family 22 member 10,transporter,Q63ZE4,SLC22A10,Humans,,transmembrane transporter activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0003667,Organic solute transporter subunit alpha,transporter,Q86UW1,SLC51A,Humans,"Essential component of the Ost-alpha/Ost-beta complex, a heterodimer that acts as the intestinal basolateral transporter responsible for bile acid export from enterocytes into portal blood (PubMed:16317684). Efficiently transports the major species of bile acids (taurocholate) (PubMed:16317684). Taurine conjugates are transported more efficiently across the basolateral membrane than glycine-conjugated bile acids (By similarity). Can also transport steroids such as estrone 3-sulfate and dehydroep",bile acid transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0003668,Organic solute transporter subunit beta,transporter,Q86UW2,SLC51B,Humans,"Essential component of the Ost-alpha/Ost-beta complex, a heterodimer that acts as the intestinal basolateral transporter responsible for bile acid export from enterocytes into portal blood (PubMed:16317684). Modulates SLC51A glycosylation, membrane trafficking and stability activities (PubMed:16317684). The Ost-alpha/Ost-beta complex efficiently transports the major species of bile acids (taurocholate) (PubMed:16317684). Taurine conjugates are transported more efficiently across the basolateral ",bile acid transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0003661,Solute carrier organic anion transporter family member 3A1,transporter,Q9UIG8,SLCO3A1,Humans,"Putative organic anion antiporter with apparent broad substrate specificity. Recognizes various substrates including thyroid hormone L-thyroxine, prostanoids such as prostaglandin E1 and E2, bile acids such as taurocholate, glycolate and glycochenodeoxycholate and peptide hormones such as L-arginine vasopressin, likely operating in a tissue-specific manner (PubMed:10873595, PubMed:14631946, PubMed:16971491, PubMed:19129463, PubMed:30063921). The transport mechanism, its electrogenicity and poten",organic anion transmembrane transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0000610,Prostaglandin F2-alpha receptor,target,P43088,PTGFR,Humans,Receptor for prostaglandin F2-alpha (PGF2-alpha). The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. Initiates luteolysis in the corpus luteum (By similarity). Isoforms 2 to 7 do not bind PGF2-alpha but are proposed to modulate signaling by participating in variant receptor complexes; heterodimers between isoform 1 and isoform 5 are proposed to be a receptor for prostamides including the synthetic analog bimatoprost,prostaglandin F receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000422,Annexin A1,target,P04083,ANXA1,Humans,"Plays important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity (PubMed:8425544). Plays a role in glucocorticoid-mediated down-regulation of the early phase of the inflammatory response (By similarity). Contributes to the adaptive immune response by enhancing signaling cascades that are triggered by T-cell activation, regulates differentiation and proliferation of activated T-cells (Pub",cadherin binding involved in cell-cell adhesion,Nucleus,agonist,DrugBank,drugbank_id
BE0001028,G protein-activated inward rectifier potassium channel 1,target,P48549,KCNJ3,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This potassium channel is controlled by G proteins (PubMed:8804710, ",G-protein activated inward rectifier potassium channel activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0000199,DNA ligase 1,target,P18858,LIG1,Humans,DNA ligase that seals nicks in double-stranded during DNA repair (PubMed:30395541). Also involved in DNA replication and DNA recombination,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000167,DNA ligase 3,target,P49916,LIG3,Humans,"Isoform 3 functions as a heterodimer with DNA-repair protein XRCC1 in the nucleus and can correct defective DNA strand-break repair and sister chromatid exchange following treatment with ionizing radiation and alkylating agents. Isoform 1 is targeted to mitochondria, where it functions as a DNA ligase in mitochondrial base-excision DNA repair (PubMed:10207110, PubMed:24674627)",ATP binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0004697,Bleomycin hydrolase,enzyme,Q13867,BLMH,Humans,"The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity",aminopeptidase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0010006,Glutathione S-transferases (Cytosolic),enzyme,P08263,GSTA1,Humans,"Glutathione S-transferase that catalyzes the nucleophilic attack of the sulfur atom of glutathione on the electrophilic groups of a wide range of exogenous and endogenous compounds (Probable). Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2) (PubMed:9084911). It also catalyzes the isomerization of D5-androstene-3,17-dione (AD) into D4-androstene-3,17-dione and may therefore play an important role in hormone biosynthesis (PubMed:11152",fatty acid binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,target,Q99928,GABRG3,Humans,"Gamma subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (By similarity). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride across the cell membr",GABA-A receptor activity,Postsynaptic cell membrane,modulator,DrugBank,drugbank_id
BE0003542,"Cytochrome P450 11B2, mitochondrial",enzyme,P19099,CYP11B2,Humans,"A cytochrome P450 monooxygenase that catalyzes the biosynthesis of aldosterone, the main mineralocorticoid in the human body responsible for salt and water homeostasis, thus involved in blood pressure regulation, arterial hypertension, and the development of heart failure (PubMed:11856349, PubMed:12530636, PubMed:1518866, PubMed:15356073, PubMed:1594605, PubMed:1775135, PubMed:22446688, PubMed:23322723, PubMed:9814482, PubMed:9814506). Catalyzes three sequential oxidative reactions of 11-deoxyco",corticosterone 18-monooxygenase activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0000324,Thymidylate synthase,target,P04818,TYMS,Humans,"Catalyzes the reductive methylation of 2'-deoxyuridine 5'-monophosphate (dUMP) to thymidine 5'-monophosphate (dTMP), using the cosubstrate, 5,10- methylenetetrahydrofolate (CH2H4folate) as a 1-carbon donor and reductant and contributes to the de novo mitochondrial thymidylate biosynthesis pathway",folic acid binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000021,Thymidylate synthase,target,P12461,TMP1,Yeast,,FMN binding,,inhibitor,DrugBank,drugbank_id
BE0000557,Progesterone receptor,target,P06401,PGR,Humans,"The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as a transcriptional activator or repressor",ATPase binding,Nucleus,agonist,DrugBank,drugbank_id
BE0004024,Lymphocyte antigen 96,target,Q9Y6Y9,LY96,Humans,"Binds bacterial lipopolysaccharide (LPS) (PubMed:17569869, PubMed:17803912). Cooperates with TLR4 in the innate immune response to bacterial lipopolysaccharide (LPS), and with TLR2 in the response to cell wall components from Gram-positive and Gram-negative bacteria (PubMed:11160242, PubMed:11593030). Enhances TLR4-dependent activation of NF-kappa-B (PubMed:10359581). Cells expressing both LY96 and TLR4, but not TLR4 alone, respond to LPS (PubMed:10359581)",coreceptor activity,"Secreted, extracellular space",activator,DrugBank,drugbank_id
BE0003681,UDP-glucuronosyltransferase 2B4,enzyme,P06133,UGT2B4,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:18719240, PubMed:23288867). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:18719240, PubMed:23288867). Catalyzes the glucuronidation of the endogenous estrogen hormones such ",glucuronosyltransferase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000064,Prostaglandin E2 receptor EP1 subtype,target,P34995,PTGER1,Humans,Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(q) proteins which activate a phosphatidylinositol-calcium second messenger system. May play a role as an important modulator of renal function. Implicated the smooth muscle contractile response to PGE2 in various tissues,D1 dopamine receptor binding,Cell membrane,other/unknown,DrugBank,drugbank_id
BE0000308,DNA polymerase catalytic subunit,target,P04293,,HHV-1,"Replicates viral genomic DNA. The replication complex is composed of six viral proteins: the DNA polymerase, processivity factor, primase, primase-associated factor, helicase, and ssDNA-binding protein. Additionally, the polymerase contains an intrinsic ribonuclease H (RNase H) activity that specifically degrades RNA/DNA heteroduplexes or duplex DNA substrates in the 5' to 3' direction. Therefore, it can catalyze the excision of the RNA primers that initiate the synthesis of Okazaki fragments at",3'-5'-DNA exonuclease activity,Host nucleus,inhibitor,DrugBank,drugbank_id
BE0000514,Thymidine kinase,target,P06478,TK,,Catalyzes the transfer of the gamma-phospho group of ATP to thymidine to generate dTMP in the salvage pathway of pyrimidine synthesis. The dTMP serves as a substrate for DNA polymerase during viral DNA replication. Allows the virus to be reactivated and to grow in non-proliferative cells lacking a high concentration of phosphorylated nucleic acid precursors.,ATP binding,,inducer,DrugBank,drugbank_id
BE0001260,"Thymidine kinase, cytosolic",target,P04183,TK1,Humans,Cell-cycle-regulated enzyme of importance in nucleotide metabolism (PubMed:9575153). Catalyzes the first enzymatic step in the salvage pathway converting thymidine into thymidine monophosphate (PubMed:22385435). Transcriptional regulation limits expression to the S phase of the cell cycle and transient expression coincides with the oscillation in the intracellular dTTP concentration (Probable). Also important for the activation of anticancer and antiviral nucleoside analog prodrugs such as 1-b-d,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000312,Protein P,target,P24024,P,HBV-D,"Multifunctional enzyme that converts the viral RNA genome into dsDNA in viral cytoplasmic capsids. This enzyme displays a DNA polymerase activity that can copy either DNA or RNA templates, and a ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-DNA heteroduplexes in a partially processive 3'- to 5'-endonucleasic mode. Neo-synthesized pregenomic RNA (pgRNA) are encapsidated together with the P protein, and reverse-transcribed inside the nucleocapsid. Initiation of reverse-trans",DNA binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0004477,"Adenylate kinase 2, mitochondrial",enzyme,P54819,AK2,Humans,Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. Adenylate kinase activity is critical for regulation of the phosphate utilization and the AMP de novo biosynthesis pathways. Plays a key role in hematopoiesis,adenylate kinase activity,Mitochondrion intermembrane space,substrate,DrugBank,drugbank_id
BE0004780,"Adenylate kinase 4, mitochondrial",enzyme,P27144,AK4,Humans,"Broad-specificity mitochondrial nucleoside phosphate kinase involved in cellular nucleotide homeostasis by catalyzing nucleoside-phosphate interconversions (PubMed:19073142, PubMed:19766732, PubMed:23416111, PubMed:24767988). Similar to other adenylate kinases, preferentially catalyzes the phosphorylation of the nucleoside monophosphate AMP with ATP as phosphate donor to produce ADP (PubMed:19766732). Phosphorylates only AMP when using GTP as phosphate donor (PubMed:19766732). In vitro, can also",adenylate kinase activity,Mitochondrion matrix,substrate,DrugBank,drugbank_id
BE0009626,Nucleoside diphosphokinase,enzyme,P15531,NME1,Humans,"Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Possesses nucleoside-diphosphate kinase, serine/threonine-specific protein kinase, geranyl and farnesyl pyrophosphate kinase, histidine protein kinase and 3'-5' exonuclease activities. Involved in cell proliferation, differentiation and development, signal transduction, G protein-couple",3'-5' exonuclease activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0009627,Creatine Kinases,enzyme,P12277,CKB,Humans,"Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate) (PubMed:8186255). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa (Probable). Acts as a key regulator of adaptive thermogenesis as part of the futile creatine cycle: localizes to the mitochondria of thermogenic fat cells and acts by mediating phosphorylation of cr",ATP binding,"Cytoplasm, cytosol",substrate|inducer,DrugBank,drugbank_id
BE0000103,"Peptidoglycan D,D-transpeptidase MrdA",target,P44469,mrdA,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),Catalyzes cross-linking of the peptidoglycan cell wall.,penicillin binding,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0003579,"Peptidoglycan D,D-transpeptidase MrdA",target,P0AD65,mrdA,Escherichia coli (strain K12),Catalyzes cross-linking of the peptidoglycan cell wall (PubMed:3009484). Responsible for the determination of the rod shape of the cell (PubMed:1103132). Is probably required for lateral peptidoglycan synthesis and maintenance of the correct diameter during lateral and centripetal growth (PubMed:12519203).,penicillin binding,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0000001,"Peptidoglycan D,D-transpeptidase FtsI",target,P45059,ftsI,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),Catalyzes cross-linking of the peptidoglycan cell wall at the division septum.,penicillin binding,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0000744,D-alanyl-D-alanine carboxypeptidase DacB,target,P24228,dacB,Escherichia coli (strain K12),Not involved in transpeptidation but exclusively catalyzes a DD-carboxypeptidase and DD-endopeptidase reaction.,carboxypeptidase activity,Periplasm,inhibitor,DrugBank,drugbank_id
BE0001148,Dipeptidase 1,enzyme,P16444,DPEP1,Humans,"Hydrolyzes a wide range of dipeptides including the conversion of leukotriene D4 to leukotriene E4 (PubMed:2303490, PubMed:31442408, PubMed:32325220, PubMed:6334084). Hydrolyzes cystinyl-bis-glycine (cys-bis-gly) formed during glutathione degradation (PubMed:32325220). Also possesses beta lactamase activity and can hydrolyze the beta-lactam antibiotic imipenem (PubMed:32325220, PubMed:6334084)",beta-lactamase activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0000412,Retinoic acid receptor RXR-alpha,target,P19793,RXRA,Humans,"Receptor for retinoic acid that acts as a transcription factor (PubMed:10874028, PubMed:11162439, PubMed:11915042, PubMed:37478846). Forms homo- or heterodimers with retinoic acid receptors (RARs) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes (PubMed:10195690, PubMed:11162439, PubMed:11915042, PubMed:16107141, PubMed:17761950, PubMed:18800767, PubMed:19167885, PubMed:28167758, PubM",DNA binding domain binding,Nucleus,agonist,DrugBank,drugbank_id
BE0000078,Retinoic acid receptor RXR-beta,target,P28702,RXRB,Humans,"Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE)",chromatin DNA binding,Nucleus,agonist,DrugBank,drugbank_id
BE0000707,Retinoic acid receptor RXR-gamma,target,P48443,RXRG,Humans,"Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid (By similarity)","DNA-binding transcription factor activity, RNA polymerase II-specific",Nucleus,agonist,DrugBank,drugbank_id
BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,target,Q02641,CACNB1,Humans,"Regulatory subunit of L-type calcium channels (PubMed:1309651, PubMed:15615847, PubMed:8107964). Regulates the activity of L-type calcium channels that contain CACNA1A as pore-forming subunit (By similarity). Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit and increases the presence of the channel complex at the cell membrane (PubMed:15615847). Required for functional expression L-type calcium channels that contain CACNA1D as pore-forming subunit (P",calcium channel regulator activity,"Cell membrane, sarcolemma",activator,DrugBank,drugbank_id
BE0000679,Voltage-dependent calcium channel gamma-1 subunit,target,Q06432,CACNG1,Humans,Regulatory subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Regulates channel inactivation kinetics,calcium channel regulator activity,"Cell membrane, sarcolemma",activator,DrugBank,drugbank_id
BE0000154,Potassium channel subfamily K member 1,target,O00180,KCNK1,Humans,"Ion channel that contributes to passive transmembrane potassium transport and to the regulation of the resting membrane potential in brain astrocytes, but also in kidney and in other tissues (PubMed:15820677, PubMed:21653227). Forms dimeric channels through which potassium ions pass in accordance with their electrochemical gradient. The channel is selective for K(+) ions at physiological potassium concentrations and at neutral pH, but becomes permeable to Na(+) at subphysiological K(+) levels an",identical protein binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000680,Potassium channel subfamily K member 6,target,Q9Y257,KCNK6,Humans,"K(+) channel that conducts outward rectifying currents at the membranes of the endolysosomal system (PubMed:10887187, PubMed:28381826). Active in lysosomes where it regulates lysosome numbers and size (PubMed:28381826). In macrophages, enables K(+) efflux coupled to ATP-induced NLRP3 inflammasome activation upon bacterial infection. Cooperates with ATP-gated P2RX7 channels to activate NLRP3 inflammasome, with P2RX7 conducting Ca(2+) and Na(+) influx that sets the membrane potential for K(+) effl",inward rectifier potassium channel activity,Late endosome membrane,inhibitor,DrugBank,drugbank_id
BE0000462,Voltage-gated inwardly rectifying potassium channel KCNH6,target,Q9H252,KCNH6,Humans,Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel. Characterized by unusual gating kinetics by producing relatively small outward currents during membrane depolarization and large inward currents during subsequent repolarization which reflect a rapid inactivation during depolarization and quick recovery from inactivation but slow deactivation (closing) during repolarization. Activates even more slowly than KCNH2,inward rectifier potassium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000699,Voltage-gated inwardly rectifying potassium channel KCNH7,target,Q9NS40,KCNH7,Humans,"Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel (PubMed:32723862). Exhibits faster activation and deactivation kinetics and slow inactivation at membrane potentials positive to 240 mV, resulting in the weakest inward rectification (PubMed:32723862)",heme binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000026,Tubulin beta-1 chain,target,Q9H4B7,TUBB1,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0003629,Carbonic anhydrase 7,target,P43166,CA7,Humans,Reversible hydration of carbon dioxide,carbonate dehydratase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000881,Histone deacetylase 9,target,Q9UKV0,HDAC9,Humans,"Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Represses MEF2-dependent transcription",DNA-binding transcription factor binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009446,Glycogen synthase kinase-3 alpha,target,P49840,GSK3A,Humans,"Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1 (PubMed:11749387, PubMed:17478001, PubMed:19366350). Requires primed phosphorylation of the majority of its substrates (PubMed:11749387, PubMed:17478001, PubMed:19366350). Contributes to insulin regulatio",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0000573,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",target,P45954,ACADSB,Humans,"Short and branched chain specific acyl-CoA dehydrogenase that catalyzes the removal of one hydrogen from C-2 and C-3 of the fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-CoA (PubMed:10832746, PubMed:11013134, PubMed:21430231, PubMed:7698750). Among the different mitochondrial acyl-CoA dehydrogenases, acts specifically on short and branched chain acyl-CoA derivatives such as (S)-2-methylbutyryl-CoA as well as short straight chain acyl-CoAs such as butyryl-CoA (PubMed:10832",acyl-CoA dehydrogenase activity,Mitochondrion matrix,inhibitor,DrugBank,drugbank_id
BE0000162,2-oxoglutarate dehydrogenase complex component E1,target,Q02218,OGDH,Humans,"2-oxoglutarate dehydrogenase (E1o) component of the 2-oxoglutarate dehydrogenase complex (OGDHC) (PubMed:24495017, PubMed:25210035, PubMed:28435050). Participates in the first step, rate limiting for the overall conversion of 2-oxoglutarate to succinyl-CoA and CO(2) catalyzed by the whole OGDHC (PubMed:24495017, PubMed:25210035, PubMed:28435050). Catalyzes the irreversible decarboxylation of 2-oxoglutarate (alpha-ketoglutarate) via the thiamine diphosphate (ThDP) cofactor and subsequent transfer",heat shock protein binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0008667,Histone deacetylase,target,Q13547,HDAC1,Humans,"Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:16762839, PubMed:17704056, PubMed:28497810). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed:16762839, PubMed:17704056). Histone deacetylases act via the formation of large multiprotein complexes (PubMed:16762839, PubMed:177040",core promoter sequence-specific DNA binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009012,Cyclin-dependent kinase inhibitor 1,target,P38936,CDKN1A,Humans,"Plays an important role in controlling cell cycle progression and DNA damage-induced G2 arrest (PubMed:9106657). Involved in p53/TP53 mediated inhibition of cellular proliferation in response to DNA damage. Also involved in p53-independent DNA damage-induced G2 arrest mediated by CREB3L1 in astrocytes and osteoblasts (By similarity). Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progressio",cyclin binding,Cytoplasm,regulator,DrugBank,drugbank_id
BE0001121,Hepatocyte growth factor,target,P14210,HGF,Humans,"Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types (PubMed:20624990). Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization (PubMed:15167892, PubMed:20977675). Activates MAPK signaling following TMPRSS13 cleavage and activation (PubMed:20977675)",chemoattractant activity,,inhibitor,DrugBank,drugbank_id
BE0009727,16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA,target,P9WJ63,tlyA,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),"Acts as a host evasion factor, that significantly contributes to the pathogenesis of M.tuberculosis by modulating adaptive immune responses by inhibiting host-protective Th1 and Th17 cytokine responses as well as autophagy (PubMed:25847237). Catalyzes the 2'-O-methylation at nucleotides C1409 in 16S rRNA and C1920 in 23S rRNA (PubMed:16857584, PubMed:20854656). Is likely involved in ribosomal biogenesis (PubMed:21443791). Also exhibits hemolytic activity in vitro, by binding with and oligomerizi",RNA binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002480,Prostaglandin E synthase 3,target,Q15185,PTGES3,Humans,"Cytosolic prostaglandin synthase that catalyzes the oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2) (PubMed:10922363). Molecular chaperone that localizes to genomic response elements in a hormone-dependent manner and disrupts receptor-mediated transcriptional activation, by promoting disassembly of transcriptional regulatory complexes (PubMed:11274138, PubMed:12077419). Facilitates HIF alpha proteins hydroxylation via interaction with EGLN1/PHD2, leading to recr",DNA polymerase binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000927,Sulfotransferase 1A1,enzyme,P50225,SULT1A1,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of a wide variety of acceptor molecules bearing a hydroxyl or an amine group. Sulfonation increases the water solubility of most compounds, and therefore their renal excretion, but it can also result in bioactivation to form active metabolites. Displays broad substrate specificity for small phenolic compounds. Plays an important role in the sulfonation of endogenous molecul",3'-phosphoadenosine 5'-phosphosulfate binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004767,Sulfotransferase 1A3,enzyme,P0DMM9,SULT1A3,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of phenolic monoamines (neurotransmitters such as dopamine, (R)-adrenaline/epinephrine, (R)-noradrenaline/norepinephrine and serotonin) and phenolic and catechol drugs (PubMed:8093002, PubMed:29524394, PubMed:14622112, PubMed:15358107). Catalyzes the sulfation of T4 (L-thyroxine/3,5,3',5'-tetraiodothyronine), T3 (3,5,3'-triiodothyronine), rT3 (3,3',5'-triiodothyronine) and ",amine sulfotransferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0002194,Fatty-acid amide hydrolase 1,enzyme,O00519,FAAH,Humans,"Catalyzes the hydrolysis of endogenous amidated lipids like the sleep-inducing lipid oleamide ((9Z)-octadecenamide), the endocannabinoid anandamide (N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine), as well as other fatty amides, to their corresponding fatty acids, thereby regulating the signaling functions of these molecules (PubMed:17015445, PubMed:19926788, PubMed:9122178). Hydrolyzes polyunsaturated substrate anandamide preferentially as compared to monounsaturated substrates (PubMed:1701544",amidase activity,Endomembrane system,substrate,DrugBank,drugbank_id
BE0000807,Glutathione S-transferase Mu 1,enzyme,P09488,GSTM1,Humans,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2) (PubMed:9084911). Participates in the formation of novel hepoxilin regioisomers (PubMed:21046276),enzyme binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004643,serine-type D-Ala-D-Ala carboxypeptidase,target,Q75Y35,pbp3,Streptococcus pneumoniae,Removes C-terminal D-alanyl residues from sugar-peptide cell wall precursors.,serine-type D-Ala-D-Ala carboxypeptidase activity,,inhibitor,DrugBank,drugbank_id
BE0003624,Penicillin-binding protein 2B,target,P0A3M6,penA,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),A transpeptidase that forms peptide cross-links between adjacent glycan strands in cell wall peptidoglycan (PG). Part of the elongasome machinery that synthesizes peripheral PG.,penicillin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004644,Penicillin-binding protein 2a,target,Q8DNB6,pbp2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),"Cell wall formation. Synthesis of cross-linked peptidoglycan (PG) from the lipid intermediates (By similarity). Binds dansylated lipid II and catalyzes the polymerization of glycan chains (PubMed:12867450, PubMed:22487093). Hydrolyzes S2d (N-benzoyl-D-alanylmercaptoacetic acid) molecule, a synthetic thiolester analog of cell wall stem peptide (PubMed:10217767, PubMed:22487093). Active against bocillin, a fluorescent penicillin. No transpeptidase activity with non-fluorescent lysine-containing li",acyltransferase activity,,inhibitor,DrugBank,drugbank_id
BE0004335,Penicillin-binding protein 1b,target,Q7CRA4,pbp1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),,acyltransferase activity,,inhibitor,DrugBank,drugbank_id
BE0000084,5-hydroxytryptamine receptor 4,target,Q13639,HTR4,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone and a mitogen (PubMed:10821780, PubMed:16102731, PubMed:35714614, PubMed:9603189). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors (PubMed:16102731, PubMed:35714614). HTR4 is coupled to G(s) G alpha proteins and mediates activation of adenylate ",G protein-coupled serotonin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0001012,Beta-3 adrenergic receptor,target,P13945,ADRB3,Humans,Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. Beta-3 is involved in the regulation of lipolysis and thermogenesis,beta-3 adrenergic receptor binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0001039,High affinity nerve growth factor receptor,target,P04629,NTRK1,Humans,"Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand (PubMed:1281417, PubMed:15488758, PubMed:17196528, PubMed:1849459, PubMed:1850821, PubMed:22649032, PubMed:27445338, PubMed:8325889). Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axon",ATP binding,Cell membrane,agonist|activator,DrugBank,drugbank_id
BE0003605,BDNF/NT-3 growth factors receptor,target,Q16620,NTRK2,Humans,"Receptor tyrosine kinase involved in the development and the maturation of the central and the peripheral nervous systems through regulation of neuron survival, proliferation, migration, differentiation, and synapse formation and plasticity (By similarity). Receptor for BDNF/brain-derived neurotrophic factor and NTF4/neurotrophin-4. Alternatively can also bind NTF3/neurotrophin-3 which is less efficient in activating the receptor but regulates neuron survival through NTRK2 (PubMed:15494731, PubM",ATP binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000897,Potassium voltage-gated channel subfamily KQT member 2,target,O43526,KCNQ2,Humans,"Pore-forming subunit of the voltage-gated potassium (Kv) M-channel which is responsible for the M-current, a key controller of neuronal excitability (PubMed:24277843, PubMed:28793216, PubMed:9836639). M-channel is composed of pore-forming subunits KCNQ2 and KCNQ3 assembled as heterotetramers (PubMed:10781098, PubMed:14534157, PubMed:32884139, PubMed:37857637, PubMed:9836639). The native M-current has a slowly activating and deactivating potassium conductance which plays a critical role in determ",ankyrin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000781,Potassium voltage-gated channel subfamily A member 1,target,Q09470,KCNA1,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and the central nervous system, but also in the kidney (PubMed:19903818, PubMed:8845167). Contributes to the regulation of the membrane potential and nerve signaling, and prevents neuronal hyperexcitability (PubMed:17156368). Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alte",delayed rectifier potassium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000112,Histamine H2 receptor,target,P25021,HRH2,Humans,"The H2 subclass of histamine receptors mediates gastric acid secretion. Also appears to regulate gastrointestinal motility and intestinal secretion. Possible role in regulating cell growth and differentiation. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase and, through a separate G protein-dependent mechanism, the phosphoinositide/protein kinase (PKC) signaling pathway (By similarity)",histamine receptor activity,Cell membrane,blocker,DrugBank,drugbank_id
BE0000146,Histamine H4 receptor,target,Q9H3N8,HRH4,Humans,The H4 subclass of histamine receptors could mediate the histamine signals in peripheral tissues. Displays a significant level of constitutive activity (spontaneous activity in the absence of agonist),histamine receptor activity,Cell membrane,binder,DrugBank,drugbank_id
BE0000156,Sigma non-opioid intracellular receptor 1,target,Q99720,SIGMAR1,Humans,Functions in lipid transport from the endoplasmic reticulum and is involved in a wide array of cellular functions probably through regulation of the biogenesis of lipid microdomains at the plasma membrane. Involved in the regulation of different receptors it plays a role in BDNF signaling and EGF signaling. Also regulates ion channels like the potassium channel and could modulate neurotransmitter release. Plays a role in calcium signaling through modulation together with ANK2 of the ITP3R-depend,G protein-coupled opioid receptor activity,Nucleus inner membrane,agonist,DrugBank,drugbank_id
BE0002398,Potassium voltage-gated channel subfamily KQT member 3,target,O43525,KCNQ3,Humans,"Pore-forming subunit of the voltage-gated potassium (Kv) M-channel which is responsible for the M-current, a key controller of neuronal excitability (PubMed:16319223, PubMed:27564677, PubMed:28793216, PubMed:9872318). M-channel is composed of pore-forming subunits KCNQ2 and KCNQ3 assembled as heterotetramers (PubMed:14534157, PubMed:16319223, PubMed:27564677, PubMed:9872318). The native M-current has a slowly activating and deactivating potassium conductance which plays a critical role in determ",calmodulin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004882,5-hydroxytryptamine receptor 2C,target,P08909,Htr2c,Rat,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including ergot alkaloid derivatives, 1-2,5,-dimethoxy-4-iodophenyl-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G protei","1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding",Cell membrane,antagonist,DrugBank,drugbank_id
BE0004890,Muscarinic acetylcholine receptor,target,P11229,CHRM1,Humans,"The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover",G protein-coupled acetylcholine receptor activity,Cell membrane,ligand,DrugBank,drugbank_id
BE0009629,HERG human cardiac K+ channel,target,Q12809,KCNH2,Humans,"Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel (PubMed:10219239, PubMed:10753933, PubMed:10790218, PubMed:10837251, PubMed:11997281, PubMed:12063277, PubMed:18559421, PubMed:22314138, PubMed:22359612, PubMed:26363003, PubMed:27916661, PubMed:9230439, PubMed:9351446, PubMed:9765245). Channel properties are modulated by cAMP and subunit assembly (PubMed:10837251). Characterized by unusual gating kinetics by producing relatively small outward currents during mem",delayed rectifier potassium channel activity,Cell membrane,blocker,DrugBank,drugbank_id
BE0009343,UDP-glucuronosyltransferase 2B10,enzyme,P36537,UGT2B10,Humans,UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds,UDP-glycosyltransferase activity,Microsome membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0002193,Thymidine phosphorylase,enzyme,P19971,TYMP,Humans,"May have a role in maintaining the integrity of the blood vessels. Has growth promoting activity on endothelial cells, angiogenic activity in vivo and chemotactic activity on endothelial cells in vitro","1,4-alpha-oligoglucan phosphorylase activity",,substrate,DrugBank,drugbank_id
BE0000556,Atrial natriuretic peptide receptor 1,target,P16066,NPR1,Humans,"Receptor for the atrial natriuretic peptide NPPA/ANP and the brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones playing a key role in cardiovascular homeostasis (PubMed:39543315). Plays an essential role in the regulation of endothelial cell senescence and vascular aging (PubMed:36016499). Upon activation by ANP or BNP, stimulates the production of cyclic guanosine monophosphate (cGMP) that promotes vascular tone and volume homeostasis by activation of protein kinase cGMP-de",ATP binding,Membrane,agonist,DrugBank,drugbank_id
BE0010029,Guanylate cyclase soluble subunit beta-1,target,Q02153,GUCY1B1,Humans,Mediates responses to nitric oxide (NO) by catalyzing the biosynthesis of the signaling molecule cGMP,adenylate cyclase activity,Cytoplasm,modulator,DrugBank,drugbank_id
BE0009594,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR2",target,Q14571,ITPR2,Humans,"Inositol 1,4,5-trisphosphate-gated calcium channel that upon inositol 1,4,5-trisphosphate binding transports calcium from the endoplasmic reticulum lumen to cytoplasm. Exists in two states; a long-lived closed state where the channel is essentially 'parked' with only very rare visits to an open state and that ligands facilitate the transition from the 'parked' state into a 'drive' mode represented by periods of bursting activity (By similarity)",ATP binding,Endoplasmic reticulum membrane,antagonist,DrugBank,drugbank_id
BE0009595,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR3",target,Q14573,ITPR3,Humans,"Inositol 1,4,5-trisphosphate-gated calcium channel that, upon 1D-myo-inositol 1,4,5-trisphosphate binding, transports calcium from the endoplasmic reticulum lumen to cytoplasm, thus releasing the intracellular calcium and therefore participates in cellular calcium ion homeostasis (PubMed:32949214, PubMed:37898605, PubMed:8081734, PubMed:8288584). 1D-myo-inositol 1,4,5-trisphosphate binds to the ligand-free channel without altering its global conformation, yielding the low-energy resting state, t",ATP binding,Endoplasmic reticulum membrane,antagonist,DrugBank,drugbank_id
BE0010061,Guanylate cyclase soluble subunit alpha-1,target,Q02108,GUCY1A1,Humans,,GTP binding,Cytoplasm,modulator,DrugBank,drugbank_id
BE0004522,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1",target,Q14643,ITPR1,Humans,"Inositol 1,4,5-trisphosphate-gated calcium channel that, upon inositol 1,4,5-trisphosphate binding, mediates calcium release from the endoplasmic reticulum (ER) (PubMed:10620513, PubMed:27108797). Undergoes conformational changes upon ligand binding, suggesting structural flexibility that allows the channel to switch from a closed state, capable of interacting with its ligands such as 1,4,5-trisphosphate and calcium, to an open state, capable of transferring calcium ions across the ER membrane (",ATP binding,Endoplasmic reticulum membrane,antagonist,DrugBank,drugbank_id
BE0001640,"Phospholipase A2, membrane associated",target,P14555,PLA2G2A,Humans,"Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids with implications in host antimicrobial defense, inflammatory response and tissue regeneration (PubMed:10455175, PubMed:10681567, PubMed:2925633). Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity) with preference for phosphatidylethanolamines and phosphatidylglycerols over phosphatidylcholines (PubMed:10455175, PubMed:10681567). Co",calcium ion binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0010085,Human Cyclooxygenases,target,P23219,PTGS1,Humans,"Dual cyclooxygenase and peroxidase that plays an important role in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate, AA, C20:4(n-6)), with a particular role in the inflammatory response. The cyclooxygenase activity oxygenates AA to the hydroperoxy endoperoxide prostaglandin G2 (PGG2), and the peroxidase activity reduces PGG2 to the hydroxy endoperoxide prostaglandin H2 (PGH2), the precursor of all 2-series prost",heme binding,Microsome membrane,inhibitor,DrugBank,drugbank_id
BE0009434,"Interferon-induced, double-stranded RNA-activated protein kinase",target,P19525,EIF2AK2,Humans,"IFN-induced dsRNA-dependent serine/threonine-protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) and plays a key role in the innate immune response to viral infection (PubMed:18835251, PubMed:19189853, PubMed:19507191, PubMed:21072047, PubMed:21123651, PubMed:22381929, PubMed:22948139, PubMed:23229543). Inhibits viral replication via the integrated stress response (ISR): EIF2S1/eIF-2-alpha phosphorylation in response to viral in",ATP binding,Cytoplasm,inducer,DrugBank,drugbank_id
BE0003560,Prostaglandin reductase 2,target,Q8N8N7,PTGR2,Humans,"Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-keto-PGE1, 15-keto-PGE2, 15-keto-PGE1-alpha and 15-keto-PGE2-alpha with highest activity towards 15-keto-PGE2 (PubMed:19000823). Overexpression represses transcriptional activity of PPARG and inhibits adipocyte differentiation (By similarity)",15-oxoprostaglandin 13-oxidase [NAD(P)+] activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000962,Lactoylglutathione lyase,target,Q04760,GLO1,Humans,"Catalyzes the conversion of hemimercaptal, formed from methylglyoxal and glutathione, to S-lactoylglutathione (PubMed:20454679, PubMed:23122816, PubMed:9705294). Involved in the regulation of TNF-induced transcriptional activity of NF-kappa-B (PubMed:19199007). Required for normal osteoclastogenesis (By similarity)",lactoylglutathione lyase activity,,inhibitor,DrugBank,drugbank_id
BE0003561,Prostaglandin D2 receptor 2,target,Q9Y5Y4,PTGDR2,Humans,"Receptor for prostaglandin D2 (PGD2). Coupled to the G(i)-protein. Receptor activation may result in pertussis toxin-sensitive decreases in cAMP levels and Ca(2+) mobilization. PI3K signaling is also implicated in mediating PTGDR2 effects. PGD2 induced receptor internalization. CRTH2 internalization can be regulated by diverse kinases such as, PKC, PKA, GRK2, GPRK5/GRK5 and GRK6. Receptor activation is responsible, at least in part, in immune regulation and allergic/inflammation responses",G protein-coupled receptor activity,Cell membrane,other/unknown,DrugBank,drugbank_id
BE0000592,Aldo-keto reductase family 1 member C3,target,P42330,AKR1C3,Humans,"Cytosolic aldo-keto reductase that catalyzes the NADH and NADPH-dependent reduction of ketosteroids to hydroxysteroids. Acts as a NAD(P)(H)-dependent 3-, 17- and 20-ketosteroid reductase on the steroid nucleus and side chain and regulates the metabolism of androgens, estrogens and progesterone (PubMed:10622721, PubMed:11165022, PubMed:7650035, PubMed:9415401, PubMed:9927279). Displays the ability to catalyze both oxidation and reduction in vitro, but most probably acts as a reductase in vivo sin",15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003640,ATP-binding cassette sub-family C member 6,transporter,O95255,ABCC6,Humans,"ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Mediates ATP-dependent transport of glutathione conjugates such as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS) (in vitro), and an anionic cyclopentapeptide endothelin antagonist, BQ-123 (PubMed:11880368, PubMed:12414644). May contribute to regulate the transport of organic compounds in testes across the blood-testis-barrier (Probable",ABC-type glutathione S-conjugate transporter activity,Basal cell membrane,inhibitor,DrugBank,drugbank_id
BE0000591,Probable arabinosyltransferase C,target,P9WNL5,embC,Mycobacterium tuberculosis,Arabinosyl transferase responsible for the polymerization of arabinose into the arabinan of arabinogalactan.,arabinosyltransferase activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000122,Probable arabinosyltransferase B,target,P9WNL7,embB,Mycobacterium tuberculosis,Arabinosyl transferase responsible for the polymerization of arabinose into the arabinan of arabinogalactan.,arabinosyltransferase activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000034,Probable arabinosyltransferase A,target,P9WNL9,embA,Mycobacterium tuberculosis,Arabinosyl transferase responsible for the polymerization of arabinose into the arabinan of arabinogalactan.,arabinosyltransferase activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003887,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",target,Q16134,ETFDH,Humans,Accepts electrons from ETF and reduces ubiquinone,"4 iron, 4 sulfur cluster binding",Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0000254,5'-AMP-activated protein kinase subunit beta-1,target,Q9Y478,PRKAB1,Humans,"Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of ",protein kinase binding,,inducer|activator,DrugBank,drugbank_id
BE0000208,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",target,P21695,GPD1,Humans,Has glycerol-3-phosphate dehydrogenase activity,glycerol-3-phosphate dehydrogenase (NAD+) activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004775,Equilibrative nucleoside transporter 4,transporter,Q7RTT9,SLC29A4,Humans,"Electrogenic voltage-dependent transporter that mediates the transport of a variety of endogenous bioactive amines, cationic xenobiotics and drugs (PubMed:15448143, PubMed:16099839, PubMed:16873718, PubMed:17018840, PubMed:17121826, PubMed:20592246, PubMed:20858707, PubMed:22396231, PubMed:31537831). Utilizes the physiologic inside-negative membrane potential as a driving force to facilitate cellular uptake of organic cations (PubMed:15448143, PubMed:20592246, PubMed:22396231). Functions as a Na",efflux transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000311,5-hydroxytryptamine receptor 3A,target,P46098,HTR3A,Humans,"Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons",excitatory extracellular ligand-gated monoatomic ion channel activity,Postsynaptic cell membrane,antagonist,DrugBank,drugbank_id
BE0004958,5-hydroxytryptamine receptor 1,target,P08908,HTR1A,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:37935376, PubMed:37935377, PubMed:8138923, PubMed:8393041). Also functions as a receptor for various drugs and psychoactive substances (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:38552625, PubMed:8138923, PubMed:8393041). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the acti",G protein-coupled serotonin receptor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002386,Serine/threonine-protein kinase mTOR,target,P42345,MTOR,Humans,"Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals (PubMed:12087098, PubMed:12150925, PubMed:12150926, PubMed:12231510, PubMed:12718876, PubMed:14651849, PubMed:15268862, PubMed:15467718, PubMed:15545625, PubMed:15718470, PubMed:18497260, PubMed:18762023, PubMed:18925875, PubMed:20516213, PubMed:20537536, PubMed:21659604, PubMed:23429703, PubMed:23429704, PubMed:257",ATP binding,Lysosome membrane,potentiator,DrugBank,drugbank_id
BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,P62942,FKBP1A,Humans,"Keeps in an inactive conformation TGFBR1, the TGF-beta type I serine/threonine kinase receptor, preventing TGF-beta receptor activation in absence of ligand. Recruits SMAD7 to ACVR1B which prevents the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. May modulate the RYR1 calcium channel activity. PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides",activin receptor binding,"Cytoplasm, cytosol",potentiator,DrugBank,drugbank_id
BE0003721,Aryl hydrocarbon receptor,target,P35869,AHR,Humans,"Ligand-activated transcription factor that enables cells to adapt to changing conditions by sensing compounds from the environment, diet, microbiome and cellular metabolism, and which plays important roles in development, immunity and cancer (PubMed:23275542, PubMed:30373764, PubMed:32818467, PubMed:7961644). Upon ligand binding, translocates into the nucleus, where it heterodimerizes with ARNT and induces transcription by binding to xenobiotic response elements (XRE) (PubMed:23275542, PubMed:30",cis-regulatory region sequence-specific DNA binding,Cytoplasm,agonist,DrugBank,drugbank_id
BE0009744,Probable fatty acid synthase Fas (Fatty acid synthetase),target,P95029,fas,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),,enoyl-[acyl-carrier-protein] reductase (NADH) activity,,inhibitor,DrugBank,drugbank_id
BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],target,P9WGR1,inhA,Mycobacterium tuberculosis,"Enoyl-ACP reductase of the type II fatty acid syntase (FAS-II) system, which is involved in the biosynthesis of mycolic acids, a major component of mycobacterial cell walls (PubMed:25227413). Catalyzes the NADH-dependent reduction of the double bond of 2-trans-enoyl-[acyl-carrier protein], an essential step in the fatty acid elongation cycle of the FAS-II pathway (PubMed:7599116). Shows preference for long-chain fatty acyl thioester substrates (>C16), and can also use 2-trans-enoyl-CoAs as alter",enoyl-[acyl-carrier-protein] reductase (NADH) activity,,inhibitor,DrugBank,drugbank_id
BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,target,O43497,CACNA1G,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1G gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group and are strongly blocked by mibefradil. A particularity of this type of c",high voltage-gated calcium channel activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0000077,Hypoxanthine-guanine phosphoribosyltransferase,enzyme,P00492,HPRT1,Humans,"Converts guanine to guanosine monophosphate, and hypoxanthine to inosine monophosphate. Transfers the 5-phosphoribosyl group from 5-phosphoribosylpyrophosphate onto the purine. Plays a central role in the generation of purine nucleotides through the purine salvage pathway",guanine phosphoribosyltransferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000790,Penicillin-binding protein 3,target,P42971,pbpC,Bacillus subtilis (strain 168),"Penicillin-binding proteins (PBPs) function in the late steps of murein biosynthesis (Probable). Probably required for both cortical and vegetative peptidoglycan synthesis (Probable). Although not usually required for cell division, in the absence of PBP 2B (pbpB) it becomes essential. Confers resistance to oxacillin and cephalexin (PubMed:28792086).",penicillin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001444,Beta-lactamase,target,P05193,ampC,Citrobacter freundii,This protein is a serine beta-lactamase with a substrate specificity for cephalosporins.,beta-lactamase activity,Periplasm,potentiator,DrugBank,drugbank_id
BE0001755,Beta-lactamase Toho-1,target,Q47066,bla,Escherichia coli,Has strong cefotaxime-hydrolyzing activity.,beta-lactamase activity,Cytoplasmic,substrate,DrugBank,drugbank_id
BE0000553,Calcium-activated potassium channel subunit alpha-1,target,Q12791,KCNMA1,Humans,"Potassium channel activated by both membrane depolarization or increase in cytosolic Ca(2+) that mediates export of K(+) (PubMed:14523450, PubMed:29330545, PubMed:31152168). It is also activated by the concentration of cytosolic Mg(2+). Its activation dampens the excitatory events that elevate the cytosolic Ca(2+) concentration and/or depolarize the cell membrane. It therefore contributes to repolarization of the membrane potential. Plays a key role in controlling excitability in a number of sys",actin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004805,Fe(II)-protoporphyrin IX,target,,,Plasmodium falciparum,,,,binder,DrugBank,drugbank_id
BE0009993,80S ribosomal subunit,target,,,Plasmodium falciparum,,,,binder,DrugBank,drugbank_id
BE0002360,dihydropteroate synthase,target,Q27738,,Plasmodium falciparum,,dihydropteroate synthase activity,,inhibitor,DrugBank,drugbank_id
BE0000143,Tubulin beta chain,target,P07437,TUBB,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",antagonist|inhibitor,DrugBank,drugbank_id
BE0000923,Mitogen-activated protein kinase 1,target,P28482,MAPK1,Humans,"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, c",ATP binding,"Cytoplasm, cytoskeleton, spindle",activator,DrugBank,drugbank_id
BE0000246,Apoptosis regulator Bcl-2,target,P10415,BCL2,Humans,"Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells (PubMed:1508712, PubMed:8183370). Regulates cell death by controlling the mitochondrial membrane permeability (PubMed:11368354). Appears to function in a feedback loop system with caspases (PubMed:11368354). Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (PubMed:11368354). ",BH3 domain binding,Mitochondrion outer membrane,downregulator,DrugBank,drugbank_id
BE0003475,Microtubule-associated protein 4,target,P27816,MAP4,Humans,Non-neuronal microtubule-associated protein. Promotes microtubule assembly,microtubule binding,"Cytoplasm, cytoskeleton",modulator,DrugBank,drugbank_id
BE0004669,"1,3-beta-glucan synthase component FKS1",target,A2QLK4,fksA,Aspergillus niger (strain CBS 513.88 / FGSC A1513),"Catalytic subunit of the 1,3-beta-glucan synthase. Synthesizes 1,3-beta-glucan, a major structural component of the fungal cell wall. Involved in cell wall synthesis, maintenance and remodeling (By similarity).","1,3-beta-D-glucan synthase activity",Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0010066,"1,3-beta-glucan synthase component GSC2",target,P40989,GSC2,Baker's yeast,"Alternate catalytic subunit of the 1,3-beta-glucan synthase (GS) complex. Synthesizes 1,3-beta-glucan, a major structural component of the yeast cell wall. Required for spore wall assembly. Negative regulation of activity by SMK1 is important for spore wall deposition. Activity is positively regulated by RHO1.","1,3-beta-D-glucan synthase activity",Membrane,inhibitor,DrugBank,drugbank_id
BE0000666,Neuron-specific vesicular protein calcyon,target,Q9NYX4,CALY,Humans,Interacts with clathrin light chain A and stimulates clathrin self-assembly and clathrin-mediated endocytosis,clathrin light chain binding,Cytoplasmic vesicle membrane,unknown,DrugBank,drugbank_id
BE0002344,Gamma-aminobutyric acid receptor subunit beta-1,target,P18505,GABRB1,Humans,"Beta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:10449790, PubMed:16412217, PubMed:26950270). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain one or two GABA active binding sites located at the alpha and beta subunit interfaces, depending on subunit composition (By similarity). When activated b",G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential,Postsynaptic cell membrane,antagonist,DrugBank,drugbank_id
BE0003593,Gamma-aminobutyric acid receptor subunit gamma-1,target,Q8N1C3,GABRG1,Humans,"Gamma subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:10449790). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the c",GABA receptor binding,Postsynaptic cell membrane,antagonist,DrugBank,drugbank_id
BE0009737,Pepsin A-5,target,P0DJD9,PGA5,Humans,"Shows particularly broad specificity; although bonds involving phenylalanine and leucine are preferred, many others are also cleaved to some extent",aspartic-type endopeptidase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0001015,Fibroblast growth factor 2,target,P09038,FGF2,Humans,"Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4 (PubMed:8663044). Also acts as an integrin ligand which is required for FGF2 signaling (PubMed:28302677). Binds to integrin ITGAV:ITGB3 (PubMed:28302677). Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration (PubMed:28302677, PubMed:8663044). Functions as a potent mitogen in vitro (PubMed:1721615, PubMed:3732516, PubMed:3964259). Can induce angiogenesis (PubMed:23469107, PubMed:283026",chemoattractant activity,Secreted,agonist|inducer,DrugBank,drugbank_id
BE0000953,Pro-epidermal growth factor,target,P01133,EGF,Humans,EGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR and activation of the magnesium channel TRPM6. Can induce neurite outgrowth in motoneurons of the pond snail Lymnaea stagnalis in vitro (PubMed:10964941),calcium ion binding,Membrane,inducer,DrugBank,drugbank_id
BE0009672,Fibrinogen,target,P02671,FGA,Humans,"Cleaved by the protease thrombin to yield monomers which, together with fibrinogen beta (FGB) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using an",extracellular matrix structural constituent,Secreted,binder,DrugBank,drugbank_id
BE0003848,Nuclear receptor subfamily 1 group I member 3,target,Q14994,NR1I3,Humans,Binds and transactivates the retinoic acid response elements that control expression of the retinoic acid receptor beta 2 and alcohol dehydrogenase 3 genes. Transactivates both the phenobarbital responsive element module of the human CYP2B6 gene and the CYP3A4 xenobiotic response element,"DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,ligand,DrugBank,drugbank_id
BE0001052,Cytochrome P450,enzyme,Q14097,CYP2B,Humans,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.",arachidonic acid epoxygenase activity,,inducer,DrugBank,drugbank_id
BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,target,P18405,SRD5A1,Humans,Converts testosterone into 5-alpha-dihydrotestosterone and progesterone or corticosterone into their corresponding 5-alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology,3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity,Microsome membrane,inhibitor,DrugBank,drugbank_id
BE0003665,"POU domain, class 5, transcription factor 1",transporter,Q01860,POU5F1,Humans,"Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3'). Forms a trimeric complex with SOX2 or SOX15 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206. Critical for early embryogenesis and for embryonic stem cell pluripotency",DNA binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000343,DNA polymerase catalytic subunit,target,P08546,UL54,HHV-5,"Replicates viral genomic DNA in the late phase of lytic infection, producing long concatemeric DNA. The replication complex is composed of six viral proteins: the DNA polymerase, processivity factor, primase, primase-associated factor, helicase, and ssDNA-binding protein (By similarity).",3'-5'-DNA exonuclease activity,Host nucleus,inhibitor,DrugBank,drugbank_id
BE0005582,5HT3 serotonin receptor,target,Q9UE69,,Humans,,,,antagonist,DrugBank,drugbank_id
BE0003431,Protein kinase C epsilon type,target,Q02156,PRKCE,Humans,"Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. Mediates cell adhesion to the extracellular matrix via integrin-dependent signaling, by m",14-3-3 protein binding,Cytoplasm,stimulator,DrugBank,drugbank_id
BE0002201,"Peptide deformylase, mitochondrial",target,Q9HBH1,PDF,Humans,Removes the formyl group from the N-terminal Met of newly synthesized proteins,metal ion binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0000475,Prostacyclin receptor,target,P43119,PTGIR,Humans,Receptor for prostacyclin (prostaglandin I2 or PGI2). The activity of this receptor is mediated by G(s) proteins which activate adenylate cyclase,guanyl-nucleotide exchange factor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000368,Prostaglandin E2 receptor EP2 subtype,target,P43116,PTGER2,Humans,Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. The subsequent raise in intracellular cAMP is responsible for the relaxing effect of this receptor on smooth muscle,prostaglandin E receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000296,Prostaglandin D2 receptor,target,Q13258,PTGDR,Humans,"Receptor for prostaglandin D2 (PGD2). The activity of this receptor is mainly mediated by G(s) proteins that stimulate adenylate cyclase, resulting in an elevation of intracellular cAMP. A mobilization of calcium is also observed, but without formation of inositol 1,4,5-trisphosphate (By similarity). Involved in PLA2G3-dependent maturation of mast cells. PLA2G3 is secreted by immature mast cells and acts on nearby fibroblasts upstream to PTDGS to synthesize PGD2, which in turn promotes mast cell",prostaglandin D receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0004809,Bile acids,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,target,Q9P0X4,CACNA1I,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This channel gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group and are strongly blocked by nickel and mibefradil. A particularity of this type o",voltage-gated calcium channel activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,target,Q00975,CACNA1B,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This alpha-1B subunit gives rise to N-type calcium currents. N-type calcium channels belong to the 'high-voltage activated' (HVA) group. They are involved in pain signaling (PubMed:25296916). Calcium channel",amyloid-beta binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0003563,Voltage-dependent calcium channel subunit alpha-2/delta-3,target,Q8IZS8,CACNA2D3,Humans,"The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. Acts as a regulatory subunit for P/Q-type calcium channel (CACNA1A), N-type (CACNA1B), L-type (CACNA1C OR CACNA1D) but not T-type (CACNA1G) (By similarity)",metal ion binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0000973,Sphingomyelin phosphodiesterase,target,P17405,SMPD1,Humans,"Converts sphingomyelin to ceramide (PubMed:12563314, PubMed:1840600, PubMed:18815062, PubMed:25339683, PubMed:25920558, PubMed:27659707, PubMed:33163980). Exists as two enzymatic forms that arise from alternative trafficking of a single protein precursor, one that is targeted to the endolysosomal compartment, whereas the other is released extracellularly (PubMed:20807762, PubMed:21098024, PubMed:9660788). However, in response to various forms of stress, lysosomal exocytosis may represent a major",acid sphingomyelin phosphodiesterase activity,Lysosome,inhibitor,DrugBank,drugbank_id
BE0000497,Epithelial sodium channel subunit gamma,target,P51170,SCNN1G,Humans,"This is one of the three pore-forming subunits of the heterotrimeric epithelial sodium channel (ENaC), a critical regulator of sodium balance and fluid homeostasis (PubMed:30251954, PubMed:32729833, PubMed:7550319, PubMed:7762608, PubMed:9792722). ENaC operates in epithelial tissues, where it mediates the electrodiffusion of sodium ions from extracellular fluid through the apical membrane of cells, with water following osmotically (PubMed:24124190). It plays a key role in maintaining sodium home",ligand-gated sodium channel activity,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0000190,Epithelial sodium channel subunit alpha,target,P37088,SCNN1A,Humans,"This is one of the three pore-forming subunits of the heterotrimeric epithelial sodium channel (ENaC), a critical regulator of sodium balance and fluid homeostasis (PubMed:30251954, PubMed:32729833, PubMed:8023962, PubMed:8278374, PubMed:9792722). ENaC operates in epithelial tissues, where it mediates the electrodiffusion of sodium ions from extracellular fluid through the apical membrane of cells, with water following osmotically (PubMed:24124190, PubMed:28710092, PubMed:8278374). It plays a ke",ligand-gated sodium channel activity,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0000024,Epithelial sodium channel subunit beta,target,P51168,SCNN1B,Humans,"This is one of the three pore-forming subunits of the heterotrimeric epithelial sodium channel (ENaC), a critical regulator of sodium balance and fluid homeostasis (PubMed:30251954, PubMed:32729833, PubMed:7762608, PubMed:9792722). ENaC operates in epithelial tissues, where it mediates the electrodiffusion of sodium ions from extracellular fluid through the apical membrane of cells, with water following osmotically (PubMed:24124190). It plays a key role in maintaining sodium homeostasis through ",ligand-gated sodium channel activity,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0000495,Epithelial sodium channel subunit delta,target,P51172,SCNN1D,Humans,"Potential alternative pore-forming subunit of the epithelial sodium channel (ENaC), capable of replacing the alpha/SCNN1A subunit, creating a more active channel with distinct properties (PubMed:16423824, PubMed:19520916, PubMed:22505667). ENaC functions in epithelial tissues, where it facilitates the electrodiffusion of sodium ions from the extracellular fluid through the apical membrane of cells, with water following osmotically, regulating sodium balance and fluid homeostasis (PubMed:16423824",ligand-gated sodium channel activity,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0000507,Thyroid peroxidase,target,P07202,TPO,Humans,Iodination and coupling of the hormonogenic tyrosines in thyroglobulin to yield the thyroid hormones T(3) and T(4),calcium ion binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,target,P05023,ATP1A1,Humans,"This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients (PubMed:29499166, PubMed:30388404). Could also be part of an osmosensory signaling pathway that senses body-fluid sodium levels and controls salt intake behavior as well as voluntary ",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0005026,Sodium/potassium-transporting ATPase subunit beta-3,target,P54709,ATP1B3,Humans,"This is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of Na(+) and K(+) ions across the plasma membrane. The exact function of the beta-3 subunit is not known",ATPase activator activity,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0005018,Sodium/potassium-transporting ATPase subunit beta-2,target,P14415,ATP1B2,Humans,"This is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of Na(+) and K(+) ions across the plasma membrane. The exact function of the beta-2 subunit is not known",ATPase activator activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,target,P05026,ATP1B1,Humans,"This is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of Na(+) and K(+) ions across the plasma membrane. The beta subunit regulates, through assembly of alpha/beta heterodimers, the number of sodium pumps transported to the plasma membrane (PubMed:19694409). Plays a role in innate immunity by enhancing virus-triggered induction of interferons (IFNs) and interferon stimulated genes (ISGs). Mechanistically, enhances the ubiquitina",ATPase activator activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,target,P13637,ATP1A3,Humans,"This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients",amyloid-beta binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,target,P50993,ATP1A2,Humans,"This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium, providing the energy for active transport of various nutrients",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,target,O60840,CACNA1F,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1F gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkyla",high voltage-gated calcium channel activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,target,P54284,CACNB3,Humans,Regulatory subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:8119293). Increases CACNA1B peak calcium current and shifts the voltage dependencies of channel activation and inactivation (By similarity). Increases CACNA1C peak calcium current and shifts the voltage dependencies of channel activation and inactivation (By similarity),calcium channel regulator activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,target,O00305,CACNB4,Humans,"The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting",protein kinase binding,,inhibitor,DrugBank,drugbank_id
BE0000668,Mineralocorticoid receptor,target,P08235,NR3C2,Humans,Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels,DNA-binding transcription factor activity,Cytoplasm,antagonist,DrugBank,drugbank_id
BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,target,P18507,GABRG2,Humans,"Gamma subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:16412217, PubMed:23909897, PubMed:2538761, PubMed:25489750, PubMed:27864268, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit in",benzodiazepine receptor activity,Postsynaptic cell membrane,modulator,DrugBank,drugbank_id
BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",target,P05093,CYP17A1,Humans,"A cytochrome P450 monooxygenase involved in corticoid and androgen biosynthesis (PubMed:22266943, PubMed:25301938, PubMed:27339894, PubMed:9452426). Catalyzes 17-alpha hydroxylation of C21 steroids, which is common for both pathways. A second oxidative step, required only for androgen synthesis, involves an acyl-carbon cleavage. The 17-alpha hydroxy intermediates, as part of adrenal glucocorticoids biosynthesis pathway, are precursors of cortisol (Probable) (PubMed:25301938, PubMed:9452426). Hyd",heme binding,Endoplasmic reticulum membrane,substrate|inhibitor,DrugBank,drugbank_id
BE0002449,Telomerase reverse transcriptase,target,O14746,TERT,Humans,"Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. Active in progenitor and cancer cells. Inactive, or very low activity, in normal somatic cells. Catalytic component of the teleromerase holoenzyme complex whose main activity is the elongation of telomeres by acting as a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Catalyzes the RNA-de",DNA binding,"Nucleus, nucleolus",inhibitor,DrugBank,drugbank_id
BE0000634,Serine/threonine-protein kinase B-raf,target,P15056,BRAF,Humans,"Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus (Probable). Phosphorylates MAP2K1, and thereby activates the MAP kinase signal transduction pathway (PubMed:21441910, PubMed:29433126). Phosphorylates PFKFB2 (PubMed:36402789). May play a role in the postsynaptic responses of hippocampal neurons (PubMed:1508179)",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000036,RAF proto-oncogene serine/threonine-protein kinase,target,P04049,RAF1,Humans,"Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and",adenylate cyclase activator activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000023,Vascular endothelial growth factor receptor 3,target,P35916,FLT4,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhance",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000369,Vascular endothelial growth factor receptor 2,target,P35968,KDR,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. Promotes proliferation, survival, migration and differentiation of endothelial cells. Promotes reorganization of the actin cytoskeleton. Isoforms lacking a transmembrane domain, such as isoform 2 and isoform 3, may function as decoy receptors for VEGFA, VEGFC and/or VEGFD. Isof",ATP binding,Cell junction,inhibitor,DrugBank,drugbank_id
BE0000029,Vascular endothelial growth factor receptor 1,target,P17948,FLT1,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. Acts as a positive regulator of postnatal retinal hyaloid vessel regression (By similarity). May play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothe",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000147,Receptor-type tyrosine-protein kinase FLT3,target,P36888,FLT3,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Promotes phosphorylation of SHC1 and AKT1, and activation of the downstream effector MTOR. Promotes activation of RAS signaling and phosphorylation of downstream kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation of FES, FER, PTPN6/SHP, PTPN11/SHP-2, PLCG1, and STAT5A and/or ",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0000205,Platelet-derived growth factor receptor beta,target,P09619,PDGFRB,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for homodimeric PDGFB and PDGFD and for heterodimers formed by PDGFA and PDGFB, and plays an essential role in the regulation of embryonic development, cell proliferation, survival, differentiation, chemotaxis and migration. Plays an essential role in blood vessel development by promoting proliferation, migration and recruitment of pericytes and smooth muscle cells to endothelial cells. Plays a role in the migration of vascular smooth ",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000453,Mast/stem cell growth factor receptor Kit,target,P10721,KIT,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulator",ATP binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,target,P07949,RET,Humans,"Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation in response to glia cell line-derived growth family factors (GDNF, NRTN, ARTN, PSPN and GDF15) (PubMed:20064382, PubMed:20616503, PubMed:20702524, PubMed:21357690, PubMed:21454698, PubMed:24560924, PubMed:28846097, PubMed:28846099, PubMed:28953886, PubMed:31118272). In contrast to most receptor tyrosine kinases, RET requires not onl",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004770,RalA-binding protein 1,transporter,Q15311,RALBP1,Humans,"Multifunctional protein that functions as a downstream effector of RALA and RALB (PubMed:7673236). As a GTPase-activating protein/GAP can inactivate CDC42 and RAC1 by stimulating their GTPase activity (PubMed:7673236). As part of the Ral signaling pathway, may also regulate ligand-dependent EGF and insulin receptors-mediated endocytosis (PubMed:10910768, PubMed:12775724). During mitosis, may act as a scaffold protein in the phosphorylation of EPSIN/EPN1 by the mitotic kinase cyclin B-CDK1, preve",ABC-type glutathione S-conjugate transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0010210,Tubulin beta chain,target,Q5UBX3,,Trichophyton rubrum,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin.",GTP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004660,"Keratin, type I cytoskeletal 12",target,Q99456,KRT12,Humans,"Involved in corneal epithelium organization, integrity and corneal keratin expression",structural molecule activity,,other/unknown,DrugBank,drugbank_id
BE0000280,Antithrombin-III,target,P01008,SERPINC1,Humans,"Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade (PubMed:15140129, PubMed:15853774). AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa (PubMed:15140129). Its inhibitory activity is greatly enhanced in the presence of heparin",heparin binding,"Secreted, extracellular space",potentiator,DrugBank,drugbank_id
BE0000775,Heparin cofactor 2,target,P05546,SERPIND1,Humans,"Thrombin inhibitor activated by the glycosaminoglycans, heparin or dermatan sulfate. In the presence of the latter, HC-II becomes the predominant thrombin inhibitor in place of antithrombin III (AT-III). Also inhibits chymotrypsin, but in a glycosaminoglycan-independent manner",endopeptidase inhibitor activity,,agonist,DrugBank,drugbank_id
BE0004764,Cytochrome P450 2B1,enzyme,P00176,Cyp2b1,Rat,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.",arachidonic acid epoxygenase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000804,Isoleucine--tRNA ligase,target,P41972,ileS,Staphylococcus aureus,"Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS can inadvertently accommodate and process structurally similar amino acids such as valine, to avoid such errors it has two additional distinct tRNA(Ile)-dependent editing activities. One activity is designated as 'pretransfer' editing and involves the hydrolysis of activated Val-AMP. The other activity is designated 'posttransfer' editing and involves deacylation of mischarged Val-tRNA(Ile) (By similarity).",aminoacyl-tRNA editing activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003074,Carbonyl reductase [NADPH] 1,enzyme,P16152,CBR1,Humans,"NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol (PubMed:15799708, PubMed:17344335, PubMed:17912391, PubMed:18449627, PubMed:18826943, PubMed:1921984, PubMed:7005231). Can convert prostaglandin E to prosta",15-hydroxyprostaglandin dehydrogenase (NADP+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004290,Penicillin-binding protein 1A,target,Q8DR59,pbpA,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),Cell wall formation.,penicillin binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0003618,MecA PBP2' (penicillin binding protein 2'),target,Q53707,mecA,Staphylococcus aureus,,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0010245,Estrogen receptor,target,P03372,ESR1,Humans,"Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand bindin",14-3-3 protein binding,Nucleus,agonist,DrugBank,drugbank_id
BE0004740,Carboxylesterase,enzyme,Q6LAP9,CES1A1a,Humans,,hydrolase activity,,substrate,DrugBank,drugbank_id
BE0000269,Adenylate cyclase type 1,target,Q08828,ADCY1,Humans,Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. Mediates responses to increased cellular Ca(2+)/calmodulin levels (By similarity). May be involved in regulatory processes in the central nervous system. May play a role in memory and learning. Plays a role in the regulation of the circadian rhythm of daytime contrast sensitivity probably by modulating the rhythmic synthesis of cyclic AMP in the retina (By similarity),adenylate cyclase activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0004258,O-GlcNAcase BT_4395,target,Q89ZI2,,Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / NCTC 10582 / E50 / VPI-5482),Can hydrolyze the glycosidic link of O-GlcNAcylated proteins. Can use p-nitrophenyl-beta-GlcNAc and 4-methylumbelliferone-GlcNAc as substrates (in vitro).,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,,antagonist,DrugBank,drugbank_id
BE0001045,"Solute carrier family 2, facilitated glucose transporter member 2",target,P11168,SLC2A2,Humans,"Facilitative hexose transporter that mediates the transport of glucose, fructose and galactose (PubMed:16186102, PubMed:23396969, PubMed:28083649, PubMed:8027028, PubMed:8457197). Likely mediates the bidirectional transfer of glucose across the plasma membrane of hepatocytes and is responsible for uptake of glucose by the beta cells; may comprise part of the glucose-sensing mechanism of the beta cell (PubMed:8027028). May also participate with the Na(+)/glucose cotransporter in the transcellular",D-glucose transmembrane transporter activity,Cell membrane,ligand,DrugBank,drugbank_id
BE0005827,Protein O-GlcNAcase,target,O60502,OGA,Humans,"Cleaves GlcNAc but not GalNAc from O-glycosylated proteins (PubMed:11148210, PubMed:11788610, PubMed:20673219, PubMed:22365600, PubMed:24088714, PubMed:28939839, PubMed:37962578). Deglycosylates a large and diverse number of proteins, such as CRYAB, ELK1, GSDMD, LMNB1 and TAB1 (PubMed:28939839, PubMed:37962578). Can use p-nitrophenyl-beta-GlcNAc and 4-methylumbelliferone-GlcNAc as substrates but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro) (PubMed:20673219). Does not bi",[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0003686,Penicillin-binding protein 1A,target,Q07806,mrcA,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid intermediates. The enzyme has a penicillin-insensitive transglycosylase N-terminal domain (formation of linear glycan strands) and a penicillin-sensitive transpeptidase C-terminal domain (cross-linking of the peptide subunits).,penicillin binding,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0003687,Penicillin-binding protein 1B,target,Q9X6W0,ponB,Pseudomonas aeruginosa,Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid intermediates. The enzyme has a penicillin-insensitive transglycosylase N-terminal domain (formation of linear glycan strands) and a penicillin-sensitive transpeptidase C-terminal domain (cross-linking of the peptide subunits).,penicillin binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0004705,Sodium/nucleoside cotransporter 1,transporter,O00337,SLC28A1,Humans,"Sodium and pyrimidine nucleoside symporter of the plasma membrane that imports uridine, thymidine and cytidine into cells by coupling their transport to the transmembrane sodium electrochemical gradient. Also transports adenosine, an atypical substrate transported with high apparent affinity, but low maximum velocity. Therefore, exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (PubMed:10455109, PubMed:14701834, PubMed:15194733, PubMed:21795683,",azole transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0004706,Equilibrative nucleoside transporter 2,transporter,Q14542,SLC29A2,Humans,"Bidirectional uniporter involved in the facilitative transport of nucleosides and nucleobases, and contributes to maintaining their cellular homeostasis (PubMed:10722669, PubMed:12527552, PubMed:12590919, PubMed:16214850, PubMed:21795683, PubMed:9396714, PubMed:9478986). Functions as a Na(+)-independent, passive transporter (PubMed:9478986). Involved in the transport of nucleosides such as inosine, adenosine, uridine, thymidine, cytidine and guanosine (PubMed:10722669, PubMed:12527552, PubMed:12",adenine transmembrane transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0003578,Guanylate cyclase soluble subunit alpha-2,target,P33402,GUCY1A2,Humans,Has guanylyl cyclase on binding to the beta-1 subunit,GTP binding,Cytoplasm,inducer,DrugBank,drugbank_id
BE0004778,Metallothionein-1A,target,P04731,MT1A,Humans,Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids,metal ion binding,,disruptor,DrugBank,drugbank_id
BE0000133,"Aldehyde dehydrogenase, mitochondrial",enzyme,P05091,ALDH2,Humans,"Required for clearance of cellular formaldehyde, a cytotoxic and carcinogenic metabolite that induces DNA damage",aldehyde dehydrogenase (NAD+) activity,Mitochondrion matrix,inhibitor,DrugBank,drugbank_id
BE0000419,Solute carrier family 12 member 3,target,P55017,SLC12A3,Humans,"Electroneutral sodium and chloride ion cotransporter, which acts as a key mediator of sodium and chloride reabsorption in kidney distal convoluted tubules (PubMed:18270262, PubMed:21613606, PubMed:22009145, PubMed:36351028, PubMed:36792826). Also acts as a receptor for the pro-inflammatory cytokine IL18, thereby contributing to IL18-induced cytokine production, including IFNG, IL6, IL18 and CCL2 (By similarity). May act either independently of IL18R1, or in a complex with IL18R1 (By similarity)",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000987,Thiopurine S-methyltransferase,enzyme,P51580,TPMT,Humans,"Catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine (also called mercaptopurine, 6-MP or its brand name Purinethol) and 6-thioguanine (also called tioguanine or 6-TG) using S-adenosyl-L-methionine as the methyl donor (PubMed:18484748, PubMed:657528). TPMT activity modulates the cytotoxic effects of thiopurine prodrugs. A natural substrate for this enzyme has yet to be identified",S-adenosyl-L-methionine binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002010,Dihydrofolate reductase,target,P0ABQ4,folA,Escherichia coli (strain K12),"Key enzyme in folate metabolism. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis.",dihydrofolate reductase activity,,inhibitor,DrugBank,drugbank_id
BE0000637,UMP-CMP kinase,target,P30085,CMPK1,Humans,Catalyzes the phosphorylation of pyrimidine nucleoside monophosphates at the expense of ATP. Plays an important role in de novo pyrimidine nucleotide biosynthesis. Has preference for UMP and CMP as phosphate acceptors. Also displays broad nucleoside diphosphate kinase activity,(d)CMP kinase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0004639,"Thymidine kinase 2, mitochondrial",enzyme,O00142,TK2,Humans,"Phosphorylates thymidine, deoxycytidine, and deoxyuridine in the mitochondrial matrix (PubMed:11687801, PubMed:9989599). In non-replicating cells, where cytosolic dNTP synthesis is down-regulated, mtDNA synthesis depends solely on TK2 and DGUOK (PubMed:9989599). Widely used as target of antiviral and chemotherapeutic agents (PubMed:9989599)",ATP binding,Mitochondrion,substrate,DrugBank,drugbank_id
BE0003106,Nucleoside diphosphate kinase A,enzyme,P15531,NME1,Humans,"Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Possesses nucleoside-diphosphate kinase, serine/threonine-specific protein kinase, geranyl and farnesyl pyrophosphate kinase, histidine protein kinase and 3'-5' exonuclease activities. Involved in cell proliferation, differentiation and development, signal transduction, G protein-couple",3'-5' exonuclease activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0002443,Cytidine deaminase,enzyme,P32320,CDA,Humans,This enzyme scavenges exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis,cytidine deaminase activity,,substrate,DrugBank,drugbank_id
BE0009677,Reverse transcriptase,target,Q3MS49,rt,HBV,,RNA-directed DNA polymerase activity,,inhibitor,DrugBank,drugbank_id
BE0004650,Large ribosomal subunit protein uL16,target,P0ADY7,rplP,Escherichia coli (strain K12),"This protein binds directly to 23S ribosomal RNA and is located at the A site of the peptidyltransferase center. It contacts the A and P site tRNAs (PubMed:8524654). It has an essential role in subunit assembly, which is not well understood (PubMed:3298242).",rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0001544,Dr hemagglutinin structural subunit,target,P24093,draA,Escherichia coli,Hemagglutinins of uropathogenic E.coli mediate adherence to the upper urinary tract. These adhesins bind to the Dr blood group antigen and also agglutinate human erythrocytes in the presence of D-mannose (mannose-resistant hemagglutination (MRHA)).,,Fimbrium,antagonist,DrugBank,drugbank_id
BE0000929,Complement decay-accelerating factor,target,P08174,CD55,Humans,"This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade (PubMed:7525274). Inhibits complem",lipid binding,Cell membrane,other,DrugBank,drugbank_id
BE0001542,Chloramphenicol acetyltransferase 3,enzyme,P00484,cat3,Escherichia coli,This enzyme is an effector of chloramphenicol resistance in bacteria.,chloramphenicol O-acetyltransferase activity,,substrate,DrugBank,drugbank_id
BE0001320,Chloramphenicol acetyltransferase,enzyme,P26841,cat,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),This enzyme is an effector of chloramphenicol (Cm) resistance in bacteria. Acetylates Cm but not 1-acetoxy-Cm.,chloramphenicol O-acetyltransferase activity,,substrate,DrugBank,drugbank_id
BE0001493,Chloramphenicol 3-O phosphotransferase,enzyme,Q56148,,Streptomyces venezuelae (strain ATCC 10712 / CBS 650.69 / DSM 40230 / JCM 4526 / NBRC 13096 / PD 04745),Inactivates chloramphenicol by catalyzing the transfer of the gamma-phosphate of ATP to the antibiotic's C-3' hydroxyl group.,ATP binding,,substrate,DrugBank,drugbank_id
BE0003474,Microtubule-associated protein tau,target,P10636,MAPT,Humans,"Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isofo",actin binding,"Cytoplasm, cytosol",binder,DrugBank,drugbank_id
BE0004799,16S ribosomal RNA,target,,,Enteric bacteria and other eubacteria,,,,inhibitor,DrugBank,drugbank_id
BE0000279,Small ribosomal subunit protein uS12,target,P0A7S3,rpsL,Escherichia coli (strain K12),With S4 and S5 plays an important role in translational accuracy.,misfolded RNA binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0000127,Small ribosomal subunit protein uS9,target,P0A7X3,rpsI,Escherichia coli (strain K12),The C-terminal tail plays a role in the affinity of the 30S P site for different tRNAs. Mutations that decrease this affinity are suppressed in the 70S ribosome.,RNA binding,,inhibitor,DrugBank,drugbank_id
BE0001349,D-alanyl-D-alanine carboxypeptidase,target,P15555,,Streptomyces sp. (strain R61),"Catalyzes distinct carboxypeptidation and transpeptidation reactions during the last stages of wall peptidoglycan synthesis. Mistaking a beta-lactam antibiotic molecule for a normal substrate (i.e. a D-alanyl-D-alanine-terminated peptide), it becomes immobilized in the form of a long-lived, serine-ester-linked acyl enzyme and thus behave as penicillin-binding protein (PBP).",serine-type D-Ala-D-Ala carboxypeptidase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0001358,Beta-lactamase,target,P00811,ampC,Escherichia coli (strain K12),"Class C beta-lactamase which confers resistance to penicillins and cephalosporins (PubMed:12323371, PubMed:17956081, PubMed:33199391, PubMed:6998377). Has benzylpenicillin- and cephaloridine-hydrolyzing activity (PubMed:3264154, PubMed:3264155, PubMed:6998377). Has weak cefuroxime, cefotaxime, cefoxitin and oxacillin-hydrolyzing activities (PubMed:3264154, PubMed:3264155).",beta-lactamase activity,Periplasm,potentiator,DrugBank,drugbank_id
BE0005191,Voltage-gated delayed rectifier potassium channel KCNH1,target,O95259,KCNH1,Humans,"Pore-forming (alpha) subunit of a voltage-gated delayed rectifier potassium channel that mediates outward-rectifying potassium currents which, on depolarization, reaches a steady-state level and do not inactivate (PubMed:10880439, PubMed:11943152, PubMed:22732247, PubMed:25420144, PubMed:25556795, PubMed:25915598, PubMed:27005320, PubMed:27325704, PubMed:27618660, PubMed:30149017, PubMed:9738473). The activation kinetics depend on the prepulse potential and external divalent cation concentration",calmodulin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0010065,Apolipoproteins,carrier,P02647,APOA1,Humans,"Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility",amyloid-beta binding,Secreted,binder,DrugBank,drugbank_id
BE0000329,11-beta-hydroxysteroid dehydrogenase 1,enzyme,P28845,HSD11B1,Humans,"Controls the reversible conversion of biologically active glucocorticoids such as cortisone to cortisol, and 11-dehydrocorticosterone to corticosterone in the presence of NADP(H) (PubMed:10497248, PubMed:12460758, PubMed:14973125, PubMed:15152005, PubMed:15280030, PubMed:17593962, PubMed:21453287, PubMed:27927697, PubMed:30902677). Participates in the corticosteroid receptor-mediated anti-inflammatory response, as well as metabolic and homeostatic processes (PubMed:10497248, PubMed:12414862, Pub",11-beta-hydroxysteroid dehydrogenase (NADP+) activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000126,Aldo-keto reductase family 1 member C1,enzyme,Q04828,AKR1C1,Humans,"Cytosolic aldo-keto reductase that catalyzes the NADH and NADPH-dependent reduction of ketosteroids to hydroxysteroids (PubMed:19218247). Most probably acts as a reductase in vivo since the oxidase activity measured in vitro is inhibited by physiological concentrations of NADPH (PubMed:14672942). Displays a broad positional specificity acting on positions 3, 17 and 20 of steroids and regulates the metabolism of hormones like estrogens and androgens (PubMed:10998348). May also reduce conjugated s","17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase [NAD(P)+] activity","Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0000622,Aldo-keto reductase family 1 member C2,enzyme,P52895,AKR1C2,Humans,"Cytosolic aldo-keto reductase that catalyzes the NADH and NADPH-dependent reduction of ketosteroids to hydroxysteroids (PubMed:19218247). Most probably acts as a reductase in vivo since the oxidase activity measured in vitro is inhibited by physiological concentrations of NADPH (PubMed:14672942). Displays a broad positional specificity acting on positions 3, 17 and 20 of steroids and regulates the metabolism of hormones like estrogens and androgens (PubMed:10998348). Works in concert with the 5-",aldose reductase (NADPH) activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0000438,Aldo-keto reductase family 1 member C4,enzyme,P17516,AKR1C4,Humans,"Cytosolic aldo-keto reductase that catalyzes the NADH and NADPH-dependent reduction of ketosteroids to hydroxysteroids. Liver specific enzyme that acts as an NAD(P)(H)-dependent 3-, 17- and 20-ketosteroid reductase on the steroid nucleus and side chain (PubMed:10634139, PubMed:10998348, PubMed:11158055, PubMed:14672942, PubMed:1530633, PubMed:19218247, PubMed:7650035). Displays the ability to catalyze both oxidation and reduction in vitro, but most probably acts as a reductase in vivo since the ","5-alpha-androstane-3-beta,17-beta-diol dehydrogenase (NADP+) activity","Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0000866,Platelet glycoprotein IX,target,P14770,GP9,Humans,The GPIb-V-IX complex functions as the vWF receptor and mediates vWF-dependent platelet adhesion to blood vessels. The adhesion of platelets to injured vascular surfaces in the arterial circulation is a critical initiating event in hemostasis. GP-IX may provide for membrane insertion and orientation of GP-Ib,,Membrane,other,DrugBank,drugbank_id
BE0000061,Cannabinoid receptor 1,target,P21554,CNR1,Humans,"G-protein coupled receptor for endogenous cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2-arachidonoylglycerol (2-AG), as well as phytocannabinoids, such as delta(9)-tetrahydrocannabinol (THC) (PubMed:15620723, PubMed:27768894, PubMed:27851727). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves r",cannabinoid receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000095,Cannabinoid receptor 2,target,P34972,CNR2,Humans,"Heterotrimeric G protein-coupled receptor for endocannabinoid 2-arachidonoylglycerol mediating inhibition of adenylate cyclase. May function in inflammatory response, nociceptive transmission and bone homeostasis",cannabinoid receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000705,Cysteinyl leukotriene receptor 1,target,Q9Y271,CYSLTR1,Humans,"Receptor for cysteinyl leukotrienes mediating bronchoconstriction of individuals with and without asthma. Stimulation by LTD4 results in the contraction and proliferation of smooth muscle, edema, eosinophil migration and damage to the mucus layer in the lung. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTD4 >> LTE4 = LTC4 >> LTB4",cysteinyl leukotriene receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004552,Cyclin-dependent kinases regulatory subunit 1,target,P61024,CKS1B,Humans,Binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function,cyclin-dependent protein serine/threonine kinase activator activity,,inhibitor,DrugBank,drugbank_id
BE0004881,5-hydroxytryptamine 2 receptor,target,P28223,HTR2A,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:1330647, PubMed:18703043, PubMed:19057895, PubMed:21645528, PubMed:22300836, PubMed:35084960, PubMed:38552625). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD) (PubMed:28129538, PubMed:35084960). Ligand binding causes a conformation change that triggers signaling via guanine nuc","1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding",Cell membrane,binder,DrugBank,drugbank_id
BE0027477,Calmodulin,target,P0DP23,CALM1,Humans,"Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269, PubMed:35568036). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269, PubMed:35568036). Among the",adenylate cyclase activator activity,"Cytoplasm, cytoskeleton, spindle",inhibitor,DrugBank,drugbank_id
BE0004755,Protein cereblon,target,Q96SW2,CRBN,Humans,"Substrate recognition component of a DCX (DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as MEIS2, ILF2 or GLUL (PubMed:26990986, PubMed:33009960). Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8 (PubMed:20223979, PubMed:24328678, PubMed:25043012, PubMed:25108355). Maintains presynaptic glutamate release and consequen",metal ion binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003517,Tumor necrosis factor ligand superfamily member 11,target,O14788,TNFSF11,Humans,Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy (PubMed:22664871). Induces osteoclastogenesis by ,cytokine activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003403,Cadherin-5,target,P33151,CDH5,Humans,Cadherins are calcium-dependent cell adhesion proteins (By similarity). They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types (PubMed:21269602). This cadherin may play a important role in endothelial cell biology through control of the cohesion and organization of the intercellular junctions (By similarity). It associates with alpha-catenin forming a link to the cytoskeleton (PubMed:108612,beta-catenin binding,"Cell junction, adherens junction",antagonist,DrugBank,drugbank_id
BE0008982,Serpin B9,target,P50453,SERPINB9,Humans,Granzyme B inhibitor,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,Cytoplasm,binder,DrugBank,drugbank_id
BE0008981,Trefoil factor 1,target,P04155,TFF1,Humans,Stabilizer of the mucous gel overlying the gastrointestinal mucosa that provides a physical barrier against various noxious agents. May inhibit the growth of calcium oxalate crystals in urine,growth factor activity,Secreted,binder,DrugBank,drugbank_id
BE0003462,Signal transducer and activator of transcription 3,target,P40763,STAT3,Humans,"Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors (PubMed:10688651, PubMed:12359225, PubMed:12873986, PubMed:15194700, PubMed:15653507, PubMed:16285960, PubMed:17344214, PubMed:18242580, PubMed:18782771, PubMed:22306293, PubMed:23084476, PubMed:28262505, PubMed:32929201, PubMed:38404237). Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene (PubMed:15653507, Pu",CCR5 chemokine receptor binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0010959,Cadherin-11,target,P55287,CDH11,Humans,Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. Required for proper focal adhesion assembly (PubMed:33811546). Involved in the regulation of cell migration (PubMed:33811546),beta-catenin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001193,3-phosphoinositide-dependent protein kinase 1,target,O15530,PDPK1,Humans,"Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases (PubMed:10226025, PubMed:10480933, PubMed:10995762, PubMed:12167717, PubMed:14585963, PubMed:14604990, PubMed:16207722, PubMed:16251192, PubMed:17327236, PubMed:17371830, PubMed:18835241, PubMed:9094314, PubMed:9368760, PubMed:9445476, PubMed:9445477, PubMed:9707564, PubMed:9768361). Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosom",3-phosphoinositide-dependent protein kinase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004950,DNA topoisomerase 1,target,Q06AK7,topA,Staphylococcus aureus,"Releases the supercoiling and torsional tension of DNA, which is introduced during the DNA replication and transcription, by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand the",DNA binding,,inhibitor,DrugBank,drugbank_id
BE0004698,Neutral alpha-glucosidase AB,target,Q14697,GANAB,Humans,"Catalytic subunit of glucosidase II that cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the Glc(2)Man(9)GlcNAc(2) oligosaccharide precursor of immature glycoproteins (PubMed:10929008). Required for PKD1/Polycystin-1 and PKD2/Polycystin-2 maturation and localization to the cell surface and cilia (PubMed:27259053)",alpha-glucosidase activity,Endoplasmic reticulum,antagonist,DrugBank,drugbank_id
BE0004699,Neutral alpha-glucosidase C,target,Q8TET4,GANC,Humans,Has alpha-glucosidase activity,"alpha-1,4-glucosidase activity",,antagonist,DrugBank,drugbank_id
BE0008388,Beta-lactamase,target,B2ZTR6,,Acinetobacter baumannii,,beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0003478,Melanin-concentrating hormone receptor 1,target,Q99705,MCHR1,Humans,"Receptor for melanin-concentrating hormone, coupled to both G proteins that inhibit adenylyl cyclase and G proteins that activate phosphoinositide hydrolysis",G protein-coupled receptor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009758,UDP-glucuronosyltransferases (UGTs),enzyme,P22309,UGT1A1,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:12181437, PubMed:15472229, PubMed:18004206, PubMed:18004212, PubMed:18719240, PubMed:19830808, PubMed:23288867, PubMed:15231852, PubMed:21422672, PubMed:38211441). Essential for the elimination and detoxification of drugs, xenobiot",enzyme binding,Endoplasmic reticulum membrane,inducer,DrugBank,drugbank_id
BE0004826,D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan,target,,,Gram-positive Bacteria,,,,ligand,DrugBank,drugbank_id
BE0009144,Histamine H1 receptor,carrier,P70174,Hrh1,Mouse,"In peripheral tissues, the H1 subclass of histamine receptors mediates the contraction of smooth muscles, increase in capillary permeability due to contraction of terminal venules, and catecholamine release from adrenal medulla, as well as mediating neurotransmission in the central nervous system. Involved in circadian rhythm of locomotor activity and exploratory behavior. Also involved in responsiveness to pertussis toxin through its control of susceptibility to histamine hypersensitivity and e",calcium ion transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0001088,Tissue-type plasminogen activator,target,P00750,PLAT,Humans,"Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events. During oocyte activation, plays a role in cortical granule reaction in the zona reaction, which contributes to the block to polyspermy (By similarity)",phosphoprotein binding,"Secreted, extracellular space",antagonist,DrugBank,drugbank_id
BE0001283,Apolipoprotein(a),target,P08519,LPA,Humans,Apo(a) is the main constituent of lipoprotein(a) (Lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1. Lp(a) may be a ligand for megalin/Gp 330,apolipoprotein binding,,other,DrugBank,drugbank_id
BE0004896,Membrane-associated progesterone receptor component 1,target,O00264,PGRMC1,Humans,"Component of a progesterone-binding protein complex (PubMed:28396637). Binds progesterone (PubMed:25675345). Has many reported cellular functions (heme homeostasis, interaction with CYPs). Required for the maintenance of uterine histoarchitecture and normal female reproductive lifespan (By similarity). Intracellular heme chaperone. Regulates heme synthesis via interactions with FECH and acts as a heme donor for at least some hemoproteins (PubMed:27599036). Forms a ternary complex with TMEM97 rec",amyloid-beta binding,Microsome membrane,binder,DrugBank,drugbank_id
BE0004904,NADPH oxidase,target,P13498,CYBA,Humans,"Subunit of NADPH oxidase complexes that is required for the NADPH oxidase activity that generates, in various cell types, superoxide from molecular oxygen utilizing NADPH as an electron donor (PubMed:15824103, PubMed:17140397, PubMed:38355798). Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:38355798). In the activated complex, electrons are first transferred from NADPH to flavin ade",electron transfer activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003680,UDP-glucuronosyltransferase 2B17,enzyme,O75795,UGT2B17,Humans,"UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:16595710, PubMed:18719240, PubMed:19022937, PubMed:23288867, PubMed:8798464). Catalyzes the glucuronidation of endogenous steroid hormones such as androgens (epitestosterone, androsterone) and estrogens (estradiol, epiestradiol) (P",glucuronosyltransferase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0008954,DNA-3-methyladenine glycosylase,target,P29372,MPG,Humans,"Hydrolysis of the deoxyribose N-glycosidic bond to excise 3-methyladenine, and 7-methylguanine from the damaged DNA polymer formed by alkylation lesions",alkylbase DNA N-glycosylase activity,Cytoplasm,blocker,DrugBank,drugbank_id
BE0000910,Alpha-2-macroglobulin,target,P01023,A2M,Humans,"Is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. The entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). Following cleavage ",calcium-dependent protein binding,Secreted,binder,DrugBank,drugbank_id
BE0000510,Serotransferrin,target,P02787,TF,Humans,"Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate. It is responsible for the transport of iron from sites of absorption and heme degradation to those of storage and utilization. Serum transferrin may also have a further role in stimulating cell proliferation",enzyme binding,Secreted,binder,DrugBank,drugbank_id
BE0002833,Copper transport protein ATOX1,target,O00244,ATOX1,Humans,Binds and deliver cytosolic copper to the copper ATPase proteins. May be important in cellular antioxidant defense,ATPase binding,,binder,DrugBank,drugbank_id
BE0004429,Arylamine N-acetyltransferase,enzyme,P9WJI5,nat,Mycobacterium tuberculosis,"Catalyzes the transfer of the acetyl group from acetyl coenzyme A to the free amino group of arylamines and hydrazines (PubMed:18795795). Is able to utilize not only acetyl-CoA, but also n-propionyl-CoA and acetoacetyl-CoA as acyl donors, although at a lower rate (PubMed:19014350). As acetyl-CoA and propionyl-CoA are products of cholesterol catabolism and the nat gene is likely present in the same operon than genes involved in cholesterol degradation, this enzyme could have a role in the utiliza",arylamine N-acetyltransferase activity,,inhibitor,DrugBank,drugbank_id
BE0000818,Glutathione S-transferase theta-1,enzyme,P30711,GSTT1,Humans,"Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Acts on 1,2-epoxy-3-(4-nitrophenoxy)propane, phenethylisothiocyanate 4-nitrobenzyl chloride and 4-nitrophenethyl bromide. Displays glutathione peroxidase activity with cumene hydroperoxide",glutathione peroxidase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004779,Metallothionein-2,enzyme,P02795,MT2A,Humans,Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids,metal ion binding,,substrate,DrugBank,drugbank_id
BE0003649,High affinity copper uptake protein 1,transporter,O15431,SLC31A1,Humans,"Uniporter that mediates the transport of copper(1+) from the extracellular space to the cytoplasm, across the plasma membrane (PubMed:11734551, PubMed:16135512, PubMed:17525160, PubMed:19740744, PubMed:20451502, PubMed:20569931, PubMed:23658018) and delivers directly copper(1+) to specific chaperone such as ATOX1, via a copper(1+)- mediated transient interaction between the C-terminal domain and a copper(1+) chaperone, thus controlling intracellular copper(1+) levels (PubMed:11734551, PubMed:161",copper ion binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0003662,Protein SLC31A2,transporter,O15432,SLC31A2,Humans,"Does not function as a copper(1+) importer in vivo (By similarity). However, in vitro functions as a low-affinity copper(1+) importer (PubMed:17617060, PubMed:17944601). Regulator of SLC31A1 which facilitates the cleavage of the SLC31A1 ecto-domain or which stabilizes the truncated form of SLC31A1 (Truncated CTR1 form), thereby drives the SLC31A1 truncated form-dependent endosomal copper export and modulates the copper and cisplatin accumulation via SLC31A1 (By similarity)",copper ion transmembrane transporter activity,Membrane,substrate,DrugBank,drugbank_id
BE0003664,Copper-transporting ATPase 2,transporter,P35670,ATP7B,Humans,"Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload",ATP binding,"Golgi apparatus, trans-Golgi network membrane",substrate,DrugBank,drugbank_id
BE0003666,Copper-transporting ATPase 1,transporter,Q04656,ATP7A,Humans,"ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to ",ATP binding,"Golgi apparatus, trans-Golgi network membrane",substrate,DrugBank,drugbank_id
BE0004789,Tubulin beta chain,target,F1L7U3,,Pig roundworm,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin.",GTP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001340,Tubulin alpha-1A chain,target,Q71U36,TUBA1A,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0001367,Tubulin beta-4B chain,target,P68371,TUBB4B,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",double-stranded RNA binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0001487,Fumarate reductase (cytochrome),target,P83223,fccA,Shewanella oneidensis (strain MR-1),"Flavocytochrome that catalyzes the reduction of fumarate to succinate (PubMed:12196158, PubMed:12899636, PubMed:22458729). Is essential for fumarate respiration during anaerobic growth, acting as the terminal reductase (By similarity). Receives electrons from the membrane-bound tetraheme c-type cytochrome CymA (PubMed:12196158, PubMed:12899636, PubMed:19837833, PubMed:22458729). Under ferric iron-reducing conditions, can be part of an electron transport chain to ferric iron, by accepting electro",FMN binding,Periplasm,inhibitor,DrugBank,drugbank_id
BE0000663,Retinoic acid receptor alpha,target,P10276,RARA,Humans,"Receptor for retinoic acid (PubMed:16417524, PubMed:19850744, PubMed:20215566, PubMed:21152046, PubMed:37478846). Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes (PubMed:21152046, PubMed:28167758, PubMed:37478846). The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR",alpha-actinin binding,Nucleus,agonist,DrugBank,drugbank_id
BE0000206,Retinoic acid receptor beta,target,P10826,RARB,Humans,"Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence or presence of hormone ligand, acts mainly as an activator of gene expression due to weak binding to corepressors (PubMe",DNA binding,Nucleus,agonist,DrugBank,drugbank_id
BE0000144,Retinoic acid receptor gamma,target,P13631,RARG,Humans,"Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, acts mainly as an activator of gene expression due to weak binding to corepressors. Required for limb bud dev",chromatin binding,Nucleus,agonist,DrugBank,drugbank_id
BE0000970,Insulin-like growth factor-binding protein 3,target,P17936,IGFBP3,Humans,"Multifunctional protein that plays a critical role in regulating the availability of IGFs such as IGF1 and IGF2 to their receptors and thereby regulates IGF-mediated cellular processes including proliferation, differentiation, and apoptosis in a cell-type specific manner (PubMed:10874028, PubMed:19556345). Also exhibits IGF-independent antiproliferative and apoptotic effects mediated by its receptor TMEM219/IGFBP-3R (PubMed:20353938). Inhibits the positive effect of humanin on insulin sensitivit",fibronectin binding,Secreted,,DrugBank,drugbank_id
BE0008996,Pregnancy-specific beta-1-glycoprotein 5,target,Q15238,PSG5,Humans,,,Secreted,,DrugBank,drugbank_id
BE0009043,Cytochrome P450 26C1,target,Q6V0L0,CYP26C1,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of retinoates (RAs), the active metabolites of vitamin A, and critical signaling molecules in animals (PubMed:14532297). RAs exist as at least four different isomers: all-trans-RA (atRA), 9-cis-RA, 13-cis-RA, and 9,13-dicis-RA, where atRA is considered to be the biologically active isomer, although 9-cis-RA and 13-cis-RA also have activity (Probable). Catalyzes the oxidation of atRA primarily at C-4 (PubMed:14532297). Oxidation of atRA l",heme binding,Membrane,,DrugBank,drugbank_id
BE0000782,Cellular retinoic acid-binding protein 2,carrier,P29373,CRABP2,Humans,Transports retinoic acid to the nucleus. Regulates the access of retinoic acid to the nuclear retinoic acid receptors,cyclin binding,Cytoplasm,agonist,DrugBank,drugbank_id
BE0000508,Cellular retinoic acid-binding protein 1,carrier,P29762,CRABP1,Humans,Cytosolic CRABPs may regulate the access of retinoic acid to the nuclear retinoic acid receptors,fatty acid binding,Cytoplasm,agonist,DrugBank,drugbank_id
BE0001046,Elastin,target,P15502,ELN,Humans,"Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle (By similarity)",extracellular matrix binding,"Secreted, extracellular space, extracellular matrix",other/unknown,DrugBank,drugbank_id
BE0003621,"Probable peptidoglycan D,D-transpeptidase PenA",target,P08149,penA,Neisseria gonorrhoeae,Catalyzes cross-linking of the peptidoglycan cell wall at the division septum.,penicillin binding,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0003622,"Peptidoglycan D,D-transpeptidase FtsI",target,Q60FT7,pbp3,Haemophilus influenzae,Catalyzes cross-linking of the peptidoglycan cell wall at the division septum.,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0009685,Peptidoglycan transpeptidase,target,,,,,,,inhibitor,DrugBank,drugbank_id
BE0003317,Ribonuclease pancreatic,target,P07998,RNASE1,Humans,Endonuclease that catalyzes the cleavage of RNA on the 3' side of pyrimidine nucleotides. Acts on single-stranded and double-stranded RNA,lyase activity,Secreted,,DrugBank,drugbank_id
BE0004524,Disks large homolog 4,target,P78352,DLG4,Humans,Postsynaptic scaffolding protein that plays a critical role in synaptogenesis and synaptic plasticity by providing a platform for the postsynaptic clustering of crucial synaptic proteins. Interacts with the cytoplasmic tail of NMDA receptor subunits and shaker-type potassium channels. Required for synaptic plasticity associated with NMDA receptor signaling. Overexpression or depletion of DLG4 changes the ratio of excitatory to inhibitory synapses in hippocampal neurons. May reduce the amplitude ,acetylcholine receptor binding,Cell membrane,,DrugBank,drugbank_id
BE0001248,Endolysin,target,P00720,E,Enterobacteria phage T4,"Endolysin with lysozyme activity that degrades host peptidoglycans and participates with the holin and spanin proteins in the sequential events which lead to the programmed host cell lysis releasing the mature viral particles. Once the holin has permeabilized the host cell membrane, the endolysin can reach the periplasm and break down the peptidoglycan layer.",lysozyme activity,Host cytoplasm,,DrugBank,drugbank_id
BE0000567,Guanidinoacetate N-methyltransferase,target,Q14353,GAMT,Humans,"Converts guanidinoacetate to creatine, using S-adenosylmethionine as the methyl donor (PubMed:24415674, PubMed:26003046, PubMed:26319512). Important in nervous system development (PubMed:24415674)",guanidinoacetate N-methyltransferase activity,,,DrugBank,drugbank_id
BE0002994,Arginase,target,P53608,rocF,Bacillus caldovelox,Controls arginine catabolism.,arginase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0008382,DNA gyrase subunit A,target,P0AES4,gyrA,Escherichia coli (strain K12),"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to maintain chromosomes in an underwound state (PubMed:12051842, PubMed:18642932, PubMed:186775, PubMed:19060136, PubMed:19965760, PubMed:20356737, PubMed:22457353, PubMed:23294697, PubMed:3031051, PubMed:7811004, PubMed:9148951). This makes better substrates for topoisomerase IV (ParC and ParE) which is the main enzyme that unlinks newly replicated chromosomes in E.coli (PubMed",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0008383,DNA topoisomerase 4 subunit A,target,P0C1U9,parC,Staphylococcus aureus,Topoisomerase IV is essential for chromosome segregation. It relaxes supercoiled DNA. Performs the decatenation events required during the replication of a circular DNA molecule.,ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0008386,DNA topoisomerase 4 subunit B,target,Q59192,parE,Bacillus subtilis (strain 168),Topoisomerase IV is essential for chromosome segregation. It relaxes supercoiled DNA. Performs the decatenation events required during the replication of a circular DNA molecule.,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0008387,DNA gyrase subunit A,target,P05653,gyrA,Bacillus subtilis (strain 168),"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to modulate DNA topology and maintain chromosomes in an underwound state. Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Also able to catalyze the interconversion of other topological isomers of dsDNA rings, including catenanes and knotted rings. Type II topoisomerases break an",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0008392,Multidrug resistance protein MdtK,target,C3T8E2,mdtK,Escherichia coli,Multidrug efflux pump that functions probably as a Na(+)/drug antiporter.,antiporter activity,Cell inner membrane,substrate,DrugBank,drugbank_id
BE0008384,Gyrase A,target,B4YQT9,,Mycobacterium tuberculosis,,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0004897,Sigma receptor,target,O00264,PGRMC1,Humans,"Component of a progesterone-binding protein complex (PubMed:28396637). Binds progesterone (PubMed:25675345). Has many reported cellular functions (heme homeostasis, interaction with CYPs). Required for the maintenance of uterine histoarchitecture and normal female reproductive lifespan (By similarity). Intracellular heme chaperone. Regulates heme synthesis via interactions with FECH and acts as a heme donor for at least some hemoproteins (PubMed:27599036). Forms a ternary complex with TMEM97 rec",amyloid-beta binding,Microsome membrane,binder,DrugBank,drugbank_id
BE0001391,Tubulin alpha-4A chain,target,P68366,TUBA4A,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],target,Q12882,DPYD,Humans,Involved in pyrimidine base degradation (PubMed:1512248). Catalyzes the reduction of uracil and thymine (PubMed:1512248). Also involved the degradation of the chemotherapeutic drug 5-fluorouracil (PubMed:1512248),"4 iron, 4 sulfur cluster binding",Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002456,Uridine phosphorylase 1,enzyme,Q16831,UPP1,Humans,Catalyzes the reversible phosphorylytic cleavage of uridine to uracil and ribose-1-phosphate which can then be utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis (PubMed:7488099). Shows broad substrate specificity and can also accept deoxyuridine and other analogous compounds (Probable),deoxyuridine phosphorylase activity,,substrate,DrugBank,drugbank_id
BE0002457,Uridine phosphorylase 2,enzyme,O95045,UPP2,Humans,"Catalyzes the reversible phosphorylytic cleavage of uridine to uracil and ribose-1-phosphate which can then be utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis (PubMed:12849978, PubMed:21855639). Shows broad substrate specificity and can also accept deoxyuridine and other analogous compounds (PubMed:12849978)",deoxyuridine phosphorylase activity,,substrate,DrugBank,drugbank_id
BE0004473,Uridine 5'-monophosphate synthase,enzyme,P11172,UMPS,Humans,"Bifunctional enzyme catalyzing the last two steps of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase (OPRT), which converts orotate to orotidine-5'-monophosphate (OMP), and orotidine-5'-monophosphate decarboxylase (ODC), the terminal enzymatic reaction that decarboxylates OMP to uridine monophosphate (UMP)",identical protein binding,,substrate,DrugBank,drugbank_id
BE0000374,Amidophosphoribosyltransferase,enzyme,Q06203,PPAT,Humans,Catalyzes the formation of phosphoribosylamine from phosphoribosylpyrophosphate (PRPP) and glutamine,"4 iron, 4 sulfur cluster binding",,substrate,DrugBank,drugbank_id
BE0000474,Thioredoxin reductase,target,P66010,trxB,Staphylococcus aureus (strain Mu50 / ATCC 700699),,thioredoxin-disulfide reductase (NADPH) activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009587,Polyprenal reductase,target,Q9H8P0,SRD5A3,Humans,"Plays a key role in early steps of protein N-linked glycosylation by being involved in the conversion of polyprenol into dolichol (PubMed:20637498, PubMed:38821050). Acts as a polyprenal reductase that mediates the reduction of polyprenal into dolichal in a NADP-dependent mechanism (PubMed:38821050). Dolichols are required for the synthesis of dolichol-linked monosaccharides and the oligosaccharide precursor used for N-glycosylation (PubMed:20637498, PubMed:38821050). Also able to convert testos",3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0003610,Aldo-keto reductase family 1 member D1,target,P51857,AKR1D1,Humans,"Catalyzes the stereospecific NADPH-dependent reduction of the C4-C5 double bond of bile acid intermediates and steroid hormones carrying a delta(4)-3-one structure to yield an A/B cis-ring junction. This cis-configuration is crucial for bile acid biosynthesis and plays important roles in steroid metabolism. Capable of reducing a broad range of delta-(4)-3-ketosteroids from C18 (such as, 17beta-hydroxyestr-4-en-3-one) to C27 (such as, 7alpha-hydroxycholest-4-en-3-one)",aldo-keto reductase (NADPH) activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000585,3-oxo-5-alpha-steroid 4-dehydrogenase 2,target,P31213,SRD5A2,Humans,Converts testosterone (T) into 5-alpha-dihydrotestosterone (DHT) and progesterone or corticosterone into their corresponding 5-alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology,3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity,Microsome membrane,inhibitor,DrugBank,drugbank_id
BE0000252,Tyrosinase,target,P14679,TYR,Humans,"This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds. Catalyzes the initial and rate limiting step in the cascade of reactions leading to melanin production from tyrosine (By similarity). In addition to hydroxylating tyrosine to DOPA (3,4-dihydroxyphenylalanine), also catalyzes the oxidation of DOPA to DOPA-quinone, and possibly the oxidation of DHI (5,6-dihydroxyindole) to indole-5,6 quinone (PubMed:28661582)",copper ion binding,Melanosome membrane,inhibitor,DrugBank,drugbank_id
BE0000498,DNA polymerase I,target,P00582,polA,Escherichia coli (strain K12),"In addition to polymerase activity, this DNA polymerase exhibits 3'-5' and 5'-3' exonuclease activity. It is able to utilize nicked circular duplex DNA as a template and can unwind the parental DNA strand from its template.",3'-5' exonuclease activity,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0009854,Type I iodothyronine deiodinase,target,P49895,DIO1,Humans,"Plays a crucial role in the metabolism of thyroid hormones (TH) and has specific roles in TH activation and inactivation by deiodination (PubMed:12586771, PubMed:32718224, PubMed:18821722). Catalyzes the deiodination of L-thyroxine (T4) to 3,5,3'-triiodothyronine (T3), 3,3',5'-triiodothyronine (rT3) to 3,3'-diiodothyronine (3,3'-T2) and 3',5'-diiodothyronine (3',5'-T2) to 3'-monoiodothyronine (3'-T1) via outer-ring deiodination (ORD) (PubMed:32718224, PubMed:18821722, PubMed:12586771, PubMed:183",selenium binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009609,Voltage-dependent R-type calcium channel subunit alpha-1E,target,Q15878,CACNA1E,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells (PubMed:30343943). They are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1E gives rise to R-type calcium currents. R-type calcium channels belong to the 'high-voltage activated' (HVA) group and are blocked by nickel. They are however insensit",calcium ion binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0004661,Acetylcholine receptor subunit alpha,target,P02708,CHRNA1,Humans,"Upon acetylcholine binding, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane",acetylcholine binding,Postsynaptic cell membrane,inhibitor,DrugBank,drugbank_id
BE0000057,Neuraminidase,target,P06818,NA,Influenza A virus (strain A/Bangkok/1/1979 H3N2),"Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates. Cleaves off the terminal sialic acids on the glycosylated HA during virus budding to facilitate virus release. Additionally helps virus spread through the circulation by further removing sialic acids from the cell surface. These cleavages prevent self-aggregation and ensure the efficient spread of the progeny virus from cell to cell. Otherwise, infection would be limited to one round of replication. D",exo-alpha-(2->3)-sialidase activity,Virion membrane,inhibitor,DrugBank,drugbank_id
BE0003527,Neuraminidase,target,P27907,NA,Influenza B virus (strain B/Beijing/1/1987),"Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates. Cleaves off the terminal sialic acids on the glycosylated HA during virus budding to facilitate virus release. Additionally helps virus spread through the circulation by further removing sialic acids from the cell surface. These cleavages prevent self-aggregation and ensure the efficient spread of the progeny virus from cell to cell. Otherwise, infection would be limited to one round of replication. D",exo-alpha-(2->3)-sialidase activity,Virion membrane,inhibitor,DrugBank,drugbank_id
BE0000043,Endothelin receptor type B,target,P24530,EDNRB,Humans,"Non-specific receptor for endothelin 1, 2, and 3. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system",endothelin receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000521,Endothelin-1 receptor,target,P25101,EDNRA,Humans,Receptor for endothelin-1. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of binding affinities for ET-A is: ET1 > ET2 >> ET3,endothelin receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003709,Small ribosomal subunit protein uS13,target,P0A7S9,rpsM,Escherichia coli (strain K12),"Located at the top of the head of the 30S subunit, it contacts several helices of the 16S rRNA.",rRNA binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0003708,Small ribosomal subunit protein uS14,target,P0AG59,rpsN,Escherichia coli (strain K12),"Binds 16S rRNA, required for the assembly of 30S particles and may also be responsible for determining the conformation of the 16S rRNA at the A site.",rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0003710,Small ribosomal subunit protein uS19,target,P0A7U3,rpsS,Escherichia coli (strain K12),"In the E.coli 70S ribosome in the initiation state (PubMed:12809609) it has been modeled to contact the 23S rRNA of the 50S subunit forming part of bridge B1a; this bridge is broken in the model with bound EF-G. The 23S rRNA contact site in bridge B1a is modeled to differ in different ribosomal states (PubMed:12859903), contacting alternately S13 or S19. In the 3.5 angstroms resolved ribosome structures (PubMed:16272117) the contacts between L5, S13 and S19 bridge B1b are different, confirming t",rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0003582,Potassium channel subfamily K member 3,target,O14649,KCNK3,Humans,"K(+) channel that conducts voltage-dependent outward rectifying currents upon membrane depolarization. Voltage sensing is coupled to K(+) electrochemical gradient in an 'ion flux gating' mode where outward but not inward ion flow opens the gate (PubMed:23169818, PubMed:26919430, PubMed:32499642, PubMed:36195757, PubMed:9312005). Changes ion selectivity and becomes permeable to Na(+) ions in response to extracellular acidification. Protonation of the pH sensor His-98 stabilizes C-type inactivatio",metal ion binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003583,Potassium channel subfamily K member 9,target,Q9NPC2,KCNK9,Humans,"K(+) channel that conducts voltage-dependent outward rectifying currents upon membrane depolarization. Voltage sensing is coupled to K(+) electrochemical gradient in an 'ion flux gating' mode where outward but not inward ion flow opens the gate (PubMed:11042359, PubMed:11431495, PubMed:26919430, PubMed:38630723). Changes ion selectivity and becomes permeable to Na(+) ions in response to extracellular acidification. Protonation of the pH sensor His-98 stabilizes C-type inactivation conformation l",identical protein binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009965,Carbonic anhydrase,target,P00915,CA1,Humans,"Catalyzes the reversible hydration of carbon dioxide (PubMed:10550681, PubMed:16506782, PubMed:16686544, PubMed:16807956, PubMed:17127057, PubMed:17314045, PubMed:17407288, PubMed:18618712, PubMed:19186056, PubMed:19206230). Can hydrate cyanamide to urea (PubMed:10550681)",arylesterase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001653,Carbonic anhydrase 12,target,O43570,CA12,Humans,Reversible hydration of carbon dioxide,carbonate dehydratase activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",enzyme,P52209,PGD,Humans,"Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH",carbohydrate binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0010185,Carboxypeptidase G2,enzyme,P06621,cpg2,Pseudomonas sp. (strain RS-16),Catalyzes the hydrolysis of reduced and non-reduced folates to pteroates and L-glutamate. This enzyme has a broad specificity.,carboxypeptidase activity,,substrate,DrugBank,drugbank_id
BE0003711,Tubulin delta chain,target,Q9UJT1,TUBD1,Humans,Acts as a positive regulator of hedgehog signaling and regulates ciliary function,GTP binding,Nucleus,binder,DrugBank,drugbank_id
BE0003713,Tubulin gamma-1 chain,target,P23258,TUBG1,Humans,"Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (PubMed:38305685, PubMed:38609661, PubMed:39321809). Gamma-tubulin is a key component of the gamma-tubulin ring complex (gTuRC) which mediates microtubule nucleation (PubMed:38305685, PubMed:38609661, PubMed:39321809). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplicati",GTP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",binder,DrugBank,drugbank_id
BE0003712,Tubulin epsilon chain,target,Q9UJT0,TUBE1,Humans,,GTP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",binder,DrugBank,drugbank_id
BE0003400,Tubulin beta-2A chain,target,Q13885,TUBB2A,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0001040,Transcription factor Jun,target,P05412,JUN,Humans,"Transcription factor that recognizes and binds to the AP-1 consensus motif 5'-TGA[GC]TCA-3' (PubMed:10995748, PubMed:22083952). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription complex, thereby enhancing its DNA binding activity to the AP-1 consensus sequence 5'-TGA[GC]TCA-3' and enhancing its transcriptional activity (By similarity). Together with FOSB, plays a role in activation-induced cell death of T cells by binding to the AP-1 promoter site of FASLG/CD95L, and ",cAMP response element binding,Nucleus,other/unknown,DrugBank,drugbank_id
BE0001002,Amine oxidase [copper-containing] 3,target,Q16853,AOC3,Humans,"Catalyzes the oxidative deamination of primary amines to the corresponding aldehydes with the concomitant production of hydrogen peroxide and ammonia (PubMed:19588076, PubMed:24304424, PubMed:9653080). Has a preference for the primary monoamines methylamine and benzylamine (PubMed:19588076, PubMed:9653080). Could also act on 2-phenylethylamine but much less efficiently (PubMed:19588076). At endothelial cells surface can also function as a cell adhesion protein that participates in lymphocyte ext",calcium ion binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000458,Thymidine kinase,target,Q9QNF7,TK,HHV-1,Catalyzes the transfer of the gamma-phospho group of ATP to thymidine to generate dTMP in the salvage pathway of pyrimidine synthesis. The dTMP serves as a substrate for DNA polymerase during viral DNA replication. Allows the virus to be reactivated and to grow in non-proliferative cells lacking a high concentration of phosphorylated nucleic acid precursors.,ATP binding,,substrate,DrugBank,drugbank_id
BE0002351,Guanylate kinase,enzyme,Q16774,GUK1,Humans,"Catalyzes the phosphorylation of GMP to GDP. Essential enzyme for recycling GMP and indirectly, cyclic GMP (cGMP) (PubMed:31201273). Involved in the cGMP metabolism in photoreceptors (By similarity). It may also have a role in the survival and growth progression of some tumors (PubMed:31201273). In addition to its physiological role, GUK1 is essential for converting prodrugs used for the treatment of cancers and viral infections into their pharmacologically active metabolites, most notably acycl",ATP binding,Photoreceptor inner segment,substrate,DrugBank,drugbank_id
BE0000423,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),transporter,Q9UN76,SLC6A14,Humans,"Amino acid transporter that plays an important role in the absorption of amino acids in the intestinal tract. Mediates the uptake of a broad range of neutral and cationic amino acids (with the exception of proline) in a Na(+)/Cl(-)-dependent manner (PubMed:10446133). Transports non-alpha-amino acids such as beta-alanine with low affinity, and has a higher affinity for dipolar and cationic amino acids such as leucine and lysine (PubMed:18599538). Can also transport carnitine, butirylcarnitine and",(R)-carnitine transmembrane transporter activity,Membrane,,DrugBank,drugbank_id
BE0004840,Penicillin-binding protein,target,P0AEB2,dacA,Gram positive and gram negative bacteria,Removes C-terminal D-alanyl residues from sugar-peptide cell wall precursors.,beta-lactamase activity,Cell inner membrane,inhibitor,DrugBank,drugbank_id
BE0000116,Evolved beta-galactosidase subunit alpha,target,P06864,ebgA,Escherichia coli (strain K12),The wild-type enzyme is an ineffective lactase. Two classes of point mutations dramatically improve activity of the enzyme.,beta-galactosidase activity,Cytoplasmic,other,DrugBank,drugbank_id
BE0017721,"Carnitine O-palmitoyltransferase 1, muscle isoform",target,Q92523,CPT1B,Humans,"Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion",carnitine O-palmitoyltransferase activity,Mitochondrion outer membrane,activator,DrugBank,drugbank_id
BE0000406,"Carnitine O-palmitoyltransferase 1, liver isoform",target,P50416,CPT1A,Humans,"Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion (PubMed:11350182, PubMed:14517221, PubMed:16651524, PubMed:9691089). Also possesses a lysine succinyltransferase activity that can regulate enzymatic activity of substrate proteins such as ENO1 and metabolism independent of its classical carnitine O-palmitoyltransferase ac",carnitine O-palmitoyltransferase activity,Mitochondrion outer membrane,activator,DrugBank,drugbank_id
BE0000496,Carnitine O-acetyltransferase,target,P43155,CRAT,Humans,"Catalyzes the reversible transfer of acyl groups from carnitine to coenzyme A (CoA) and regulates the acyl-CoA/CoA ratio. Also plays a crucial role in the transport of fatty acids for beta-oxidation (PubMed:15099582, PubMed:29395073). Responsible for the synthesis of short- and branched-chain acylcarnitines (PubMed:23485643). Active towards some branched-chain amino acid oxidation pathway (BCAAO) intermediates (PubMed:23485643). Trans-2-enoyl-CoAs and 2-methylacyl-CoAs are poor substrates (PubMe",acyl-CoA oxidase activity,Endoplasmic reticulum,,DrugBank,drugbank_id
BE0000097,Mitochondrial basic amino acids transporter,target,Q8N8R3,SLC25A29,Humans,"Mitochondrial transporter of arginine, lysine, homoarginine, methylarginine and, to a much lesser extent, ornithine and histidine (PubMed:19287344, PubMed:24652292). Does not transport carnitine nor acylcarnitines (PubMed:24652292). Functions by both counter-exchange and uniport mechanisms (PubMed:24652292). Plays a physiological role in the import of basic amino acids into mitochondria for mitochondrial protein synthesis and amino acid degradation (PubMed:19287344, PubMed:24652292)",basic amino acid transmembrane transporter activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0000579,Mitochondrial carnitine/acylcarnitine carrier protein,target,O43772,SLC25A20,Humans,"Mediates the electroneutral exchange of acylcarnitines (O-acyl-(R)-carnitine or L-acylcarnitine) of different acyl chain lengths (ranging from O-acetyl-(R)-carnitine to long-chain O-acyl-(R)-carnitines) with free carnitine ((R)-carnitine or L-carnitine) across the mitochondrial inner membrane, via a ping-pong mechanism (Probable) (PubMed:12892634, PubMed:18307102). Key player in the mitochondrial oxidation pathway, it translocates the fatty acids in the form of acylcarnitines into the mitochondr",carnitine,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0000373,Peroxisomal carnitine O-octanoyltransferase,target,Q9UKG9,CROT,Humans,"Beta-oxidation of fatty acids. The highest activity concerns the C6 to C10 chain length substrate. Converts the end product of pristanic acid beta oxidation, 4,8-dimethylnonanoyl-CoA, to its corresponding carnitine ester",carnitine O-octanoyltransferase activity,Peroxisome,,DrugBank,drugbank_id
BE0000179,"Carnitine O-palmitoyltransferase 2, mitochondrial",target,P23786,CPT2,Humans,"Involved in the intramitochondrial synthesis of acylcarnitines from accumulated acyl-CoA metabolites (PubMed:20538056, PubMed:24780397). Reconverts acylcarnitines back into the respective acyl-CoA esters that can then undergo beta-oxidation, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion. Active with medium (C8-C12) and long-chain (C14-C18) acyl-CoA esters (PubMed:20538056)",acyltransferase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003669,Solute carrier family 22 member 16,transporter,Q86VW1,SLC22A16,Humans,"Facilitative organic cation transporter that mediates the transport of carnitine as well as the polyamine spermidine (PubMed:12089149, PubMed:20037140). Mediates the partially Na(+)-dependent bidirectional transport of carnitine (PubMed:12089149). May mediate L-carnitine secretion from testis epididymal epithelium into the lumen which is involved in the maturation of spermatozoa (PubMed:12089149)",amine transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000353,Acid-sensing ion channel 1,transporter,P78348,ASIC1,Humans,"Forms voltage-independent, pH-gated trimeric sodium channels that act as postsynaptic excitatory receptors in the nervous system, playing a crucial role in regulating synaptic plasticity, learning, and memory (PubMed:21036899, PubMed:32915133, PubMed:34319232). Upon extracellular pH drop this channel elicits transient, fast activating, and completely desensitizing inward currents (PubMed:21036899). Displays high selectivity for sodium ions but can also permit the permeation of other cations (Pub",ligand-gated sodium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001170,Annexin A2,target,P07355,ANXA2,Humans,"Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. Inhibits PCSK9-enhanced LDLR degradation, probably reduces PCSK9 protein levels via a translational mechanism but also competes with LDLR for binding with PCSK9 (PubMed:18799458, PubMed:22848640, PubMed:24808179). Binds to endosomes damaged by phagocytosis of particulate wear debris and participa",cadherin binding involved in cell-cell adhesion,"Secreted, extracellular space, extracellular matrix, basement membrane",inducer,DrugBank,drugbank_id
BE0003201,Annexin A3,target,P12429,ANXA3,Humans,"Inhibitor of phospholipase A2, also possesses anti-coagulant properties. Also cleaves the cyclic bond of inositol 1,2-cyclic phosphate to form inositol 1-phosphate",calcium ion binding,,inducer,DrugBank,drugbank_id
BE0008969,Annexin A4,target,P09525,ANXA4,Humans,Calcium/phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis,calcium ion binding,Zymogen granule membrane,inducer,DrugBank,drugbank_id
BE0004149,Annexin A5,target,P08758,ANXA5,Humans,"This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade",calcium ion binding,,inducer,DrugBank,drugbank_id
BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,target,P28472,GABRB3,Humans,"Beta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:18514161, PubMed:22243422, PubMed:22303015, PubMed:24909990, PubMed:26950270, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMe",GABA-A receptor activity,Postsynaptic cell membrane,agonist,DrugBank,drugbank_id
BE0000351,Diamine oxidase [copper-containing],target,P19801,AOC1,Humans,"Catalyzes the oxidative deamination of primary amines to the corresponding aldehydes with the concomitant production of hydrogen peroxide and ammonia (PubMed:12072962, PubMed:19764817, PubMed:239684, PubMed:8144586). Its preferred substrates are the diamines histamine and 1-methylhistamine and it could therefore play a role in allergic and immune responses (PubMed:12072962). Has a broad specificity for diamines and can also act on cadaverine and putrescine, two products of amino acid catabolism ",calcium ion binding,"Secreted, extracellular space",inhibitor,DrugBank,drugbank_id
BE0000678,Acid-sensing ion channel 2,target,Q16515,ASIC2,Humans,"Forms pH-gated trimeric sodium channels that act as postsynaptic excitatory sensors in the nervous system (PubMed:10842183, PubMed:23034652, PubMed:8626462, PubMed:8631835). Upon extracellular acidification, these channels generate rapid, transient inward currents that fully desensitize (PubMed:10842183). Highly selective for sodium, they are permeable to other cations (PubMed:8626462, PubMed:8631835). By forming heterotrimeric channels with ASIC1, could contribute to synaptic plasticity, learni",ligand-gated sodium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000752,Sodium/hydrogen exchanger 1,target,P19634,SLC9A1,Humans,"Electroneutral Na(+) /H(+) antiporter that extrudes Na(+) in exchange for external protons driven by the inward sodium ion chemical gradient, protecting cells from acidification that occurs from metabolism (PubMed:11350981, PubMed:11532004, PubMed:14680478, PubMed:15035633, PubMed:15677483, PubMed:17073455, PubMed:17493937, PubMed:22020933, PubMed:27650500, PubMed:32130622, PubMed:7110335, PubMed:7603840). Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry (By similar",calcium-dependent protein binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004667,Diamine oxidase [copper-containing],enzyme,Q9TRC7,AOC1,Pig,"Catalyzes the oxidative deamination of primary amines to the corresponding aldehydes with the concomitant production of hydrogen peroxide and ammonia (PubMed:1457410, PubMed:8144586). Its preferred substrates in vitro are the diamines histamine and 1-methylhistamine and it could therefore play a role in allergic and immune responses (By similarity). Has a broad specificity for diamines and can also act on cadaverine and putrescine, two products of amino acid catabolism (PubMed:8144586). It could",copper ion binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0027480,Glutamate-gated chloride channel subunit beta,target,Q17328,glc-2,Caenorhabditis elegans,"Glutamate-gated chloride channel subunit; channel properties depend on the subunit composition. Glutamate binding triggers a rapidly reversible current in heteromeric channels formed by glc-1 and glc-2, while the anti-helmintic drug ivermectin and other avermectins trigger a permanently open channel configuration. Channels containing only glc-2 are activated by glutamate, but not by ivermectin (in vitro). The heteromeric channel formed by glc-1 and glc-2 is also activated by ibotenate, and it is",extracellularly glutamate-gated chloride channel activity,Postsynaptic cell membrane,binder,DrugBank,drugbank_id
BE0027481,Glutamate-gated chloride channel alpha,target,G5EBR3,glc-1,Caenorhabditis elegans,"Glutamate-gated chloride channel subunit; channel properties depend on the subunit composition. Glutamate binding triggers a rapidly reversible current in heteromeric channels formed by glc-1 and glc-2, while the anti-helmintic drug ivermectin and other avermectins trigger a permanently open channel configuration. Channels containing only glc-1 are activated by ivermectin, but not by glutamate alone (in vitro). The heteromeric channel formed by glc-1 and glc-2 is also activated by ibotenate, and",extracellularly glutamate-gated chloride channel activity,Postsynaptic cell membrane,binder,DrugBank,drugbank_id
BE0009555,Glutamate-gated chloride channel,target,Q25634,GluClX,Onchocerca volvulus,,chloride channel activity,,activator,DrugBank,drugbank_id
BE0000059,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,enzyme,P26439,HSD3B2,Humans,"3-beta-HSD is a bifunctional enzyme, that catalyzes the oxidative conversion of Delta(5)-ene-3-beta-hydroxy steroid, and the oxidative conversion of ketosteroids. The 3-beta-HSD enzymatic system plays a crucial role in the biosynthesis of all classes of hormonal steroids",3-beta-hydroxy-Delta5-steroid dehydrogenase (NAD+) activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0004760,Cytochrome P450 3A1,enzyme,P04800,Cyp3a1,Rat,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.",aromatase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0000747,Aldo-keto reductase family 1 member B1,target,P15121,AKR1B1,Humans,"Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols. Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosacharides, bile acids and xenobiotics substrates. Key enzyme in the polyol pathway, catalyzes reduction of glucose to sorbitol during hyperglycemia (PubMed:1936586). Reduces steroids and their derivatives and prostaglandins. Displays low enzymatic activity towa",aldose reductase (NADPH) activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001062,Mitogen-activated protein kinase 3,target,P27361,MAPK3,Humans,"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:34497368). MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcripti",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004353,Aldo-keto reductase family 1 member B10,target,O60218,AKR1B10,Humans,"Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols (PubMed:12732097, PubMed:18087047, PubMed:19013440, PubMed:19563777, PubMed:9565553). Displays strong enzymatic activity toward all-trans-retinal, 9-cis-retinal, and 13-cis-retinal (PubMed:12732097, PubMed:18087047). Plays a critical role in detoxifying dietary and lipid-derived unsaturated carbonyls, such as crotonaldehyde, 4-hydroxynonenal, trans-2-hexenal, trans-2,4-hexad",alcohol dehydrogenase (NADP+) activity,Lysosome,inhibitor,DrugBank,drugbank_id
BE0000229,Sodium/potassium-transporting ATPase subunit gamma,target,P54710,FXYD2,Humans,May be involved in forming the receptor site for cardiac glycoside binding or may modulate the transport function of the sodium ATPase,ATPase activator activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0009094,Secreted frizzled-related protein 4,target,Q6FHJ7,SFRP4,Humans,Soluble frizzled-related proteins (sFRPS) function as modulators of Wnt signaling through direct interaction with Wnts. They have a role in regulating cell growth and differentiation in specific cell types (By similarity). SFRP4 plays a role in bone morphogenesis. May also act as a regulator of adult uterine morphology and function. May also increase apoptosis during ovulation possibly through modulation of FZ1/FZ4/WNT4 signaling (By similarity). Has phosphaturic effects by specifically inhibiti,Wnt-protein binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0015068,Atypical chemokine receptor 1,target,Q16570,ACKR1,Humans,"Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Has a promiscuous chemokine-binding profile, interacting with inflammatory chemokines of both the CXC and the CC subfamilies",C-C chemokine binding,Early endosome,modulator,DrugBank,drugbank_id
BE0001171,Toll-like receptor 9,target,Q9NR96,TLR9,Humans,"Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR9 is a nucleotide-sensing TLR which is activated by unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides (PubMed:14716310). Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:11564765, PubMed:17932028). Controls lymphocyte response",interleukin-1 receptor binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0002659,Glutathione S-transferase,target,Q8ILQ7,GST,Plasmodium falciparum,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. May also function as a storage protein or ligandin for parasitotoxic ferriprotoporphyrin IX (hemin).,glutathione transferase activity,,inhibitor,DrugBank,drugbank_id
BE0003428,High mobility group protein B1,target,P09429,HMGB1,Humans,"Multifunctional redox sensitive protein with various roles in different cellular compartments. In the nucleus is one of the major chromatin-associated non-histone proteins and acts as a DNA chaperone involved in replication, transcription, chromatin remodeling, V(D)J recombination, DNA repair and genome stability (PubMed:33147444). Proposed to be an universal biosensor for nucleic acids. Promotes host inflammatory response to sterile and infectious signals and is involved in the coordination and",bubble DNA binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000982,Angiotensin-converting enzyme 2,target,Q9BYF1,ACE2,Humans,"Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis (PubMed:27217402). Converts angiotensin I to angiotensin 1-9, a nine-amino acid peptide with anti-hypertrophic effects in cardiomyocytes, and angiotensin II to angiotensin 1-7, which then acts as a beneficial vasodilator and anti-proliferation agent, counterbalancing the actions of the vasoconstrictor",carboxypeptidase activity,Secreted,modulator,DrugBank,drugbank_id
BE0010121,Nuclear factor erythroid 2-related factor 2,target,Q16236,NFE2L2,Humans,"Transcription factor that plays a key role in the response to oxidative stress: binds to antioxidant response (ARE) elements present in the promoter region of many cytoprotective genes, such as phase 2 detoxifying enzymes, and promotes their expression, thereby neutralizing reactive electrophiles (PubMed:11035812, PubMed:19489739, PubMed:29018201, PubMed:31398338). In normal conditions, ubiquitinated and degraded in the cytoplasm by the BCR(KEAP1) complex (PubMed:11035812, PubMed:15601839, PubMe",DNA binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0000466,Catalase-peroxidase,target,P9WIE5,katG,Mycobacterium tuberculosis,"Bifunctional enzyme with both catalase and broad-spectrum peroxidase activity, oxidizing various electron donors including NADP(H) (PubMed:18178143, PubMed:9006925). Protects M.tuberculosis against toxic reactive oxygen species (ROS) including hydrogen peroxide as well as organic peroxides and thus contributes to its survival within host macrophages by countering the phagocyte oxidative burst (PubMed:15165233, PubMed:8658136). Also displays efficient peroxynitritase activity, which may help the ",catalase activity,,other/unknown,DrugBank,drugbank_id
BE0002436,Histamine N-methyltransferase,target,P50135,HNMT,Humans,Inactivates histamine by N-methylation. Plays an important role in degrading histamine and in regulating the airway response to histamine,histamine N-methyltransferase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000461,DNA-directed RNA polymerase subunit alpha,target,P0A7Z4,rpoA,Escherichia coli (strain K12),DNA-dependent RNA polymerase (RNAP) catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. This subunit plays an important role in subunit assembly since its dimerization is the first step in the sequential assembly of subunits to form the holoenzyme.,DNA binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0000257,DNA-directed RNA polymerase subunit beta,target,P0A8V2,rpoB,Escherichia coli (strain K12),DNA-dependent RNA polymerase (RNAP) catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates.,DNA binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0003707,DNA-directed RNA polymerase subunit beta',target,P0A8T7,rpoC,Escherichia coli (strain K12),DNA-dependent RNA polymerase (RNAP) catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates.,DNA binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0001120,Heat shock protein HSP 90-alpha,target,P07900,HSP90AA1,Humans,"Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognit",ATP binding,Nucleus,other/unknown,DrugBank,drugbank_id
BE0001165,Endoplasmin,target,P14625,HSP90B1,Humans,"ATP-dependent chaperone involved in the processing of proteins in the endoplasmic reticulum, regulating their transport (PubMed:23572575, PubMed:39509507). Together with MESD, acts as a modulator of the Wnt pathway by promoting the folding of LRP6, a coreceptor of the canonical Wnt pathway (PubMed:23572575, PubMed:39509507). When associated with CNPY3, required for proper folding of Toll-like receptors (PubMed:11584270). Promotes folding and trafficking of TLR4 to the cell surface (PubMed:115842",ATP binding,Endoplasmic reticulum lumen,other/unknown,DrugBank,drugbank_id
BE0000266,Neprilysin,target,P08473,MME,Humans,"Thermolysin-like specificity, but is almost confined on acting on polypeptides of up to 30 amino acids (PubMed:15283675, PubMed:6208535, PubMed:6349683, PubMed:8168535). Biologically important in the destruction of opioid peptides such as Met- and Leu-enkephalins by cleavage of a Gly-Phe bond (PubMed:17101991, PubMed:6349683). Catalyzes cleavage of bradykinin, substance P and neurotensin peptides (PubMed:6208535). Able to cleave angiotensin-1, angiotensin-2 and angiotensin 1-9 (PubMed:15283675, ",cardiolipin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004743,Breakpoint cluster region protein,target,P11274,BCR,Humans,"Protein with a unique structure having two opposing regulatory activities toward small GTP-binding proteins. The C-terminus is a GTPase-activating protein (GAP) domain which stimulates GTP hydrolysis by RAC1, RAC2 and CDC42. Accelerates the intrinsic rate of GTP hydrolysis of RAC1 or CDC42, leading to down-regulation of the active GTP-bound form (PubMed:17116687, PubMed:1903516, PubMed:7479768). The central Dbl homology (DH) domain functions as guanine nucleotide exchange factor (GEF) that modul",ATP binding,Postsynaptic density,inhibitor,DrugBank,drugbank_id
BE0000852,Platelet-derived growth factor receptor alpha,target,P16234,PDGFRA,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal dev",ATP binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000014,Tyrosine-protein kinase ABL1,target,P00519,ABL1,Humans,"Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENA",actin filament binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0000853,Macrophage colony-stimulating factor 1 receptor,target,P07333,CSF1R,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for CSF1 and IL34 and plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of pro-inflammatory chemokines in response to IL34 and CSF1, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast ",ATP binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0001124,Epithelial discoidin domain-containing receptor 1,target,Q08345,DDR1,Humans,"Tyrosine kinase that functions as a cell surface receptor for fibrillar collagen and regulates cell attachment to the extracellular matrix, remodeling of the extracellular matrix, cell migration, differentiation, survival and cell proliferation. Collagen binding triggers a signaling pathway that involves SRC and leads to the activation of MAP kinases. Regulates remodeling of the extracellular matrix by up-regulation of the matrix metalloproteinases MMP2, MMP7 and MMP9, and thereby facilitates ce",ATP binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004741,Discoidin domain-containing receptor 2,target,Q16832,DDR2,Humans,"Tyrosine kinase involved in the regulation of tissues remodeling (PubMed:30449416). It functions as a cell surface receptor for fibrillar collagen and regulates cell differentiation, remodeling of the extracellular matrix, cell migration and cell proliferation. Required for normal bone development. Regulates osteoblast differentiation and chondrocyte maturation via a signaling pathway that involves MAP kinases and leads to the activation of the transcription factor RUNX2. Regulates remodeling of",ATP binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003511,Induced myeloid leukemia cell differentiation protein Mcl-1,target,Q07820,MCL1,Humans,"Involved in the regulation of apoptosis versus cell survival, and in the maintenance of viability but not of proliferation. Mediates its effects by interactions with a number of other regulators of apoptosis. Isoform 1 inhibits apoptosis. Isoform 2 promotes apoptosis",BH3 domain binding,Membrane,other/unknown,DrugBank,drugbank_id
BE0003671,Phospholipid-transporting ATPase ABCA3,transporter,Q99758,ABCA3,Humans,"Catalyzes the ATP-dependent transport of phospholipids such as phosphatidylcholine and phosphoglycerol from the cytoplasm into the lumen side of lamellar bodies, in turn participates in the lamellar bodies biogenesis and homeostasis of pulmonary surfactant (PubMed:16959783, PubMed:17574245, PubMed:27177387, PubMed:28887056, PubMed:31473345). Transports preferentially phosphatidylcholine containing short acyl chains (PubMed:27177387). In addition plays a role as an efflux transporter of miltefosi",ABC-type xenobiotic transporter activity,"Endosome, multivesicular body membrane",substrate,DrugBank,drugbank_id
BE0003565,"Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",target,P54750,PDE1A,Humans,"Calcium/calmodulin-dependent cyclic nucleotide phosphodiesterase with a dual specificity for the second messengers cGMP and cAMP, which are key regulators of many important physiological processes. Has a higher efficiency with cGMP compared to cAMP",calmodulin binding,,inhibitor,DrugBank,drugbank_id
BE0003323,"Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",target,Q01064,PDE1B,Humans,"Cyclic nucleotide phosphodiesterase with a dual specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (PubMed:15260978, PubMed:8855339, PubMed:9419816). Has a preference for cGMP as a substrate (PubMed:9419816)","3',5'-cyclic-AMP phosphodiesterase activity","Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0003550,Cytochrome P450 3A43,enzyme,Q9HB55,CYP3A43,Humans,Exhibits low testosterone 6-beta-hydroxylase activity,estrogen 16-alpha-hydroxylase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0004829,C55-isoprenyl pyrophosphate,target,,,Gram positive and gram negative bacteria,,,,antagonist,DrugBank,drugbank_id
BE0009705,Bacitracin transport ATP-binding protein BcrA,transporter,P42332,bcrA,Bacillus licheniformis,Part of the binding-protein-dependent transport system for bacitracin that confer resistance to this antibiotic. Probably responsible for energy coupling to the transport system (By similarity).,ATP binding,,substrate,DrugBank,drugbank_id
BE0009706,Bacitracin transport permease protein BCRB,transporter,P42333,bcrB,Bacillus licheniformis,Part of the binding-protein-dependent transport system for bacitracin that confer resistance to this antibiotic; probably responsible for the translocation of the substrate across the membrane.,,Cell membrane,substrate,DrugBank,drugbank_id
BE0009707,Bacitracin transport permease protein BcrC,transporter,P42334,bcrC,Bacillus licheniformis,Part of the binding-protein-dependent transport system for bacitracin that confer resistance to this antibiotic; probably responsible for the translocation of the substrate across the membrane.,sphingosine-1-phosphate phosphatase activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000836,Hydroxycarboxylic acid receptor 3,target,P49019,HCAR3,Humans,Receptor for 3-OH-octanoid acid mediates a negative feedback regulation of adipocyte lipolysis to counteract prolipolytic influences under conditions of physiological or pathological increases in beta-oxidation rates. Acts as a low affinity receptor for nicotinic acid. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet,G protein-coupled receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000526,Nicotinate-nucleotide pyrophosphorylase [carboxylating],target,Q15274,QPRT,Humans,Involved in the catabolism of quinolinic acid (QA),identical protein binding,,binder,DrugBank,drugbank_id
BE0000783,Nicotinamide N-methyltransferase,target,P40261,NNMT,Humans,"Catalyzes the N-methylation of nicotinamide using the universal methyl donor S-adenosyl-L-methionine to form N1-methylnicotinamide and S-adenosyl-L-homocysteine, a predominant nicotinamide/vitamin B3 clearance pathway (PubMed:21823666, PubMed:23455543, PubMed:8182091). Plays a central role in regulating cellular methylation potential, by consuming S-adenosyl-L-methionine and limiting its availability for other methyltransferases. Actively mediates genome-wide epigenetic and transcriptional chang",nicotinamide N-methyltransferase activity,Cytoplasm,binder,DrugBank,drugbank_id
BE0008719,Diacylglycerol O-acyltransferase 2,target,Q96PD7,DGAT2,Humans,"Essential acyltransferase that catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for synthesis and storage of intracellular triglycerides (PubMed:27184406). Probably plays a central role in cytosolic lipid accumulation. In liver, is primarily responsible for incorporating endogenously synthesized fatty acids into triglycerides (By similarity). Also functions as an acyl-CoA retinol acyltransferase (ARAT) ",2-acylglycerol O-acyltransferase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0004708,Sodium-coupled monocarboxylate transporter 1,transporter,Q8N695,SLC5A8,Humans,"Acts as an electrogenic sodium (Na(+)) and chloride (Cl-)-dependent sodium-coupled solute transporter, including transport of monocarboxylates (short-chain fatty acids including L-lactate, D-lactate, pyruvate, acetate, propionate, valerate and butyrate), mocarboxylate drugs (nicotinate, benzoate, salicylate and 5-aminosalicylate) and ketone bodies (beta-D-hydroxybutyrate, acetoacetate and alpha-ketoisocaproate), with a Na(+):substrate stoichiometry of between 4:1 and 2:1 (PubMed:14966140, PubMed",iodide channel activity,Apical cell membrane,,DrugBank,drugbank_id
BE0000449,Monocarboxylate transporter 4,transporter,O15427,SLC16A3,Humans,"Proton-dependent transporter of monocarboxylates such as L-lactate and pyruvate (PubMed:11101640, PubMed:23935841, PubMed:31719150). Plays a predominant role in L-lactate efflux from highly glycolytic cells (By similarity)",lactate,Cell membrane,,DrugBank,drugbank_id
BE0000980,Tyrosine-protein phosphatase non-receptor type 4,target,P29074,PTPN4,Humans,"Phosphatase that plays a role in immunity, learning, synaptic plasticity or cell homeostasis (PubMed:25825441, PubMed:27246854). Regulates neuronal cell homeostasis by protecting neurons against apoptosis (PubMed:20086240). Negatively regulates TLR4-induced interferon beta production by dephosphorylating adapter TICAM2 and inhibiting subsequent TRAM-TRIF interaction (PubMed:25825441). Also dephosphorylates the immunoreceptor tyrosine-based activation motifs/ITAMs of the TCR zeta subunit and ther",cytoskeletal protein binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003567,Receptor-type tyrosine-protein phosphatase S,target,Q13332,PTPRS,Humans,"Cell surface receptor that binds to glycosaminoglycans, including chondroitin sulfate proteoglycans and heparan sulfate proteoglycan (PubMed:21454754). Binding to chondroitin sulfate and heparan sulfate proteoglycans has opposite effects on PTPRS oligomerization and regulation of neurite outgrowth. Contributes to the inhibition of neurite and axonal outgrowth by chondroitin sulfate proteoglycans, also after nerve transection. Plays a role in stimulating neurite outgrowth in response to the hepar",chondroitin sulfate binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003568,Receptor-type tyrosine-protein phosphatase epsilon,target,P23469,PTPRE,Humans,Isoform 1 plays a critical role in signaling transduction pathways and phosphoprotein network topology in red blood cells. May play a role in osteoclast formation and function (By similarity),identical protein binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003569,V-type proton ATPase catalytic subunit A,target,P38606,ATP6V1A,Humans,"Catalytic subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:8463241). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:32001091). In aerobic conditions, invol",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004657,Dihydropteroate synthase type-1,target,P0C002,sul1,Escherichia coli,"Catalyzes the condensation of para-aminobenzoate (pABA) with 6-hydroxymethyl-7,8-dihydropterin diphosphate (DHPt-PP) to form 7,8-dihydropteroate (H2Pte), the immediate precursor of folate derivatives (By similarity). It is implicated in resistance to sulfonamide. The type II enzyme is stable whereas type I DHPS loses its activity rapidly.",dihydropteroate synthase activity,,inhibitor,DrugBank,drugbank_id
BE0004658,Folic acid synthesis protein FOL1,target,P53848,FOL1,Baker's yeast,Catalyzes three sequential steps of tetrahydrofolate biosynthesis.,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity,Mitochondrion membrane,inhibitor,DrugBank,drugbank_id
BE0000239,Lipoprotein lipase,target,P06858,LPL,Humans,"Key enzyme in triglyceride metabolism. Catalyzes the hydrolysis of triglycerides from circulating chylomicrons and very low density lipoproteins (VLDL), and thereby plays an important role in lipid clearance from the blood stream, lipid utilization and storage (PubMed:11342582, PubMed:27578112, PubMed:8675619). Although it has both phospholipase and triglyceride lipase activities it is primarily a triglyceride lipase with low but detectable phospholipase activity (PubMed:12032167, PubMed:7592706",apolipoprotein binding,Cell membrane,activator,DrugBank,drugbank_id
BE0001262,Adenylate kinase isoenzyme 1,enzyme,P00568,AK1,Humans,"Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Also displays broad nucleoside diphosphate kinase activity. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism (By similarity) (PubMed:21080915, PubMed:23416111, PubMed:2542324). Also catalyzes at a very low rate the synthesis of thiamine triphosphate (ThTP) from thiamine diphosphate (ThDP) and ADP (By similarity)",adenylate kinase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0003281,Nucleoside diphosphate kinase B,enzyme,P22392,NME2,Humans,"Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate (By similarity). Negatively regulates Rho activity by interacting with AKAP13/LBC (PubMed:15249197). Acts as a transcriptional activator of the MYC gene; binds DNA non-specifically (PubMed:19435876, PubMed:8392752). Binds to both single-stranded guanine- and cytosine-rich strands within ",ATP binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0003540,Adenosine kinase,enzyme,P55263,ADK,Humans,Catalyzes the phosphorylation of the purine nucleoside adenosine at the 5' position in an ATP-dependent manner. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides,adenosine kinase activity,Nucleus,substrate,DrugBank,drugbank_id
BE0010035,Equilibrative nucleoside transporter 3,transporter,Q9BZD2,SLC29A3,Humans,"Uniporter that mediates the facilitative transport of nucleoside across lysosomal and mitochondrial membranes (PubMed:15701636, PubMed:19164483, PubMed:20595384, PubMed:28729424). Functions as a non-electrogenic Na(+)-independent transporter (PubMed:15701636, PubMed:19164483, PubMed:28729424). Substrate transport is pH-dependent and enhanced under acidic condition, probably reflecting the location of the transporter in acidic intracellular compartments (PubMed:15701636, PubMed:19164483, PubMed:2",cytidine transmembrane transporter activity,Lysosome membrane,substrate,DrugBank,drugbank_id
BE0004781,Sodium/nucleoside cotransporter 2,transporter,O43868,SLC28A2,Humans,"Sodium-dependent and purine-selective transporter (PubMed:10087507, PubMed:9435697). Exhibits the transport characteristics of the nucleoside transport system cif or N1 subtype (N1/cif) (selective for purine nucleosides and uridine) (PubMed:10087507, PubMed:21795683, PubMed:9435697). Plays a critical role in specific uptake and salvage of purine nucleosides in kidney and other tissues (PubMed:9435697). May contribute to regulate the transport of organic compounds in testes across the blood-testi",azole transmembrane transporter activity,Membrane,substrate,DrugBank,drugbank_id
BE0001095,Gap junction alpha-1 protein,transporter,P17302,GJA1,Humans,"Gap junction protein that acts as a regulator of bladder capacity. A gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph. Negative regulator of bladder functional capacity: acts by enhancing intercellular electrical and chemical transmission, th",alpha-tubulin binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0004712,Cocaine esterase,enzyme,O00748,CES2,Humans,"Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs (PubMed:9169443). Shows high catalytic efficiency for hydrolysis of cocaine, 4-methylumbelliferyl acetate, heroin and 6-monoacetylmorphine (PubMed:9169443). Hydrolyzes aspirin, substrates with large alcohol group and small acyl group and endogenous lipids such as triacylglycerol (PubMed:28677105). Converts monoacylglycerides to free fatty acids and glycerol. Hydrolyzes of 2-arachidonoylglycerol and pr",carboxylesterase activity,Endoplasmic reticulum lumen,inhibitor,DrugBank,drugbank_id
BE0000882,Trifunctional purine biosynthetic protein adenosine-3,target,P22102,GART,Humans,Trifunctional enzyme that catalyzes three distinct reactions as part of the 'de novo' inosine monophosphate biosynthetic pathway,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0000242,"Adrenodoxin, mitochondrial",target,P10109,FDX1,Humans,"Essential for the synthesis of various steroid hormones (PubMed:20547883, PubMed:21636783). Participates in the reduction of mitochondrial cytochrome P450 for steroidogenesis (PubMed:20547883, PubMed:21636783). Transfers electrons from adrenodoxin reductase to CYP11A1, a cytochrome P450 that catalyzes cholesterol side-chain cleavage (PubMed:20547883, PubMed:21636783). Does not form a ternary complex with adrenodoxin reductase and CYP11A1 but shuttles between the two enzymes to transfer electrons","2 iron, 2 sulfur cluster binding",Mitochondrion matrix,unknown,DrugBank,drugbank_id
BE0002353,"3',5'-cyclic-AMP phosphodiesterase 4C",target,Q08493,PDE4C,Humans,"Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes","3',5'-cyclic-AMP phosphodiesterase activity","Cell projection, cilium",inhibitor,DrugBank,drugbank_id
BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",target,Q08499,PDE4D,Humans,"Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes","3',5'-cyclic-AMP phosphodiesterase activity",Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0009756,Corneal esterases,enzyme,,,Humans,,,,substrate,DrugBank,drugbank_id
BE0003655,Solute carrier organic anion transporter family member 2A1,transporter,Q92959,SLCO2A1,Humans,"Mediates the transport of prostaglandins (PGs, mainly PGE2, PGE1, PGE3, PGF2alpha, PGD2, PGH2) and thromboxanes (thromboxane B2) across the cell membrane (PubMed:11997326, PubMed:26692285, PubMed:8787677). PGs and thromboxanes play fundamental roles in diverse functions such as intraocular pressure, gastric acid secretion, renal salt and water transport, vascular tone, and fever (PubMed:15044627). Plays a role in the clearance of PGs from the circulation through cellular uptake, which allows cyt",lipid transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0001192,Metabotropic glutamate receptor 5,target,P41594,GRM5,Humans,G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system and generates a calcium-activated chloride current. Plays an important role in the regulation of synaptic plasticity and the modulation of the neural network activity,A2A adenosine receptor binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,target,O00555,CACNA1A,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1A gives rise to P and/or Q-type calcium currents. P/Q-type calcium channels belong to the 'high-voltage activated' (HVA) group and are specifically blocked by the spider omega-agatoxin-IVA",amyloid-beta binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000472,Putative gonadotropin-releasing hormone II receptor,target,Q96P88,GNRHR2,Humans,Putative receptor for gonadotropin releasing hormone II (GnRH II) which is most probably non-functional,gonadotropin-releasing hormone receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0009591,ATP-sensitive inward rectifier potassium channel 10,target,P78508,KCNJ10,Humans,"May be responsible for potassium buffering action of glial cells in the brain (By similarity). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:8995301). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:8995301). The inward rectification is mainly d",ATP binding,Membrane,blocker,DrugBank,drugbank_id
BE0010000,Muscle nicotinic acetylcholine receptor,target,A9X444,,Humans,,extracellular ligand-gated monoatomic ion channel activity,,allosteric modulator,DrugBank,drugbank_id
BE0004895,Protein kinase C,target,P17252,PRKCA,Humans,"Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004877,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",target,Q15125,EBP,Humans,Isomerase that catalyzes the conversion of Delta(8)-sterols to their corresponding Delta(7)-isomers a catalytic step in the postlanosterol biosynthesis of cholesterol,C-8 sterol isomerase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0003790,Mitogen-activated protein kinase 8,target,P45983,MAPK8,Humans,"Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway (PubMed:28943315). In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates",ATP binding,Cytoplasm,modulator,DrugBank,drugbank_id
BE0000886,Sulfotransferase 2A1,enzyme,Q06520,SULT2A1,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands. Mediates the sulfation of a wide range of steroids and sterols, including pregnenolone, androsterone, DHEA, bile acids, cholesterol and as well many xenobiotics that contain alcohol and phenol functional groups (PubMed:14573603, PubMed:18042734, PubMed:19589875, PubMed:21187059, PubMed:2268288, PubMed:29671343, PubMed:7678",3'-phosphoadenosine 5'-phosphosulfate binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000951,Sulfotransferase 1E1,enzyme,P49888,SULT1E1,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of estradiol and estrone (PubMed:11006110, PubMed:11884392, PubMed:7779757). Is a key enzyme in estrogen homeostasis, the sulfation of estrogens leads to their inactivation. Also sulfates dehydroepiandrosterone (DHEA), pregnenolone, (24S)-hydroxycholesterol and xenobiotic compounds like ethinylestradiol, equalenin, diethyl stilbesterol and 1-naphthol at significantly lower ",aryl sulfotransferase activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0004782,Solute carrier family 22 member 12,transporter,Q96S37,SLC22A12,Humans,"Electroneutral antiporter that translocates urate across the apical membrane of proximal tubular cells in exchange for monovalent organic or inorganic anions (PubMed:12024214, PubMed:22194875, PubMed:35144162, PubMed:35462902). Involved in renal reabsorption of urate and helps maintaining blood levels of uric acid (PubMed:12024214, PubMed:22194875). Mediates urate uptake by an exchange with organic anions such as (S)-lactate and nicotinate, and inorganic anion Cl(-) (PubMed:12024214). Other inor",PDZ domain binding,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0004783,"Solute carrier family 2, facilitated glucose transporter member 9",transporter,Q9NRM0,SLC2A9,Humans,"High-capacity urate transporter, which may play a role in the urate reabsorption by proximal tubules (PubMed:18327257, PubMed:18701466, PubMed:22647630, PubMed:28083649, PubMed:36749388). May have a residual high-affinity, low-capacity glucose and fructose transporter activity (PubMed:18327257, PubMed:18701466, PubMed:18842065). Transports urate at rates 45- to 60-fold faster than glucose (PubMed:18842065). Does not transport galactose (PubMed:28083649). May mediate small uptake of adenine but n",carbohydrate,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004833,Bacterial outer membrane,target,,,Bacteria,,,,incorporation into and destabilization,DrugBank,drugbank_id
BE0000689,Fibroblast growth factor 1,target,P05230,FGF1,Humans,"Plays an important role in the regulation of cell survival, cell division, angiogenesis, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Acts as a ligand for FGFR1 and integrins. Binds to FGFR1 in the presence of heparin leading to FGFR1 dimerization and activation via sequential autophosphorylation on tyrosine residues which act as docking sites for interacting proteins, leading to the activation of several signaling cascades. Binds to integrin ITGAV:ITGB3. Its ",fibroblast growth factor receptor binding,Secreted,antagonist,DrugBank,drugbank_id
BE0000326,Fibroblast growth factor 4,target,P08620,FGF4,Humans,"Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal limb and cardiac valve development during embryogenesis. May play a role in embryonic molar tooth bud development via inducing the expression of MSX1, MSX2 and MSX1-mediated expression of SDC1 in dental mesenchyme cells (By similarity)",fibroblast growth factor receptor binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0000131,11-beta-hydroxysteroid dehydrogenase type 2,enzyme,P80365,HSD11B2,Humans,"Catalyzes the conversion of biologically active 11beta-hydroxyglucocorticoids (11beta-hydroxysteroid) such as cortisol, to inactive 11-ketoglucocorticoids (11-oxosteroid) such as cortisone, in the presence of NAD(+) (PubMed:10497248, PubMed:12788846, PubMed:17314322, PubMed:22796344, PubMed:27927697, PubMed:30902677, PubMed:33387577, PubMed:7859916, PubMed:8538347). Functions as a dehydrogenase (oxidase), thereby decreasing the concentration of active glucocorticoids, thus protecting the nonsele",11-beta-hydroxysteroid dehydrogenase (NAD+) activity,Microsome,substrate,DrugBank,drugbank_id
BE0000761,Inosine-5'-monophosphate dehydrogenase 1,target,P20839,IMPDH1,Humans,"Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors",DNA binding,Cytoplasm,inhibitor|inducer,DrugBank,drugbank_id
BE0000722,Inosine-5'-monophosphate dehydrogenase 2,target,P12268,IMPDH2,Humans,"Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth (PubMed:7763314, PubMed:7903306). Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism (PubMed:14766016). It may also have a role in the development of malignancy and the growth progress",DNA binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004520,6-pyruvoyl tetrahydrobiopterin synthase,target,Q03393,PTS,Humans,"Involved in the biosynthesis of tetrahydrobiopterin, an essential cofactor of aromatic amino acid hydroxylases. Catalyzes the transformation of 7,8-dihydroneopterin triphosphate into 6-pyruvoyl tetrahydropterin",6-pyruvoyltetrahydropterin synthase activity,,inhibitor,DrugBank,drugbank_id
BE0009693,Carboxylic ester hydrolase,enzyme,Q6IPK9,CES2,Humans,,carboxylic ester hydrolase activity,,substrate,DrugBank,drugbank_id
BE0003837,Immunoglobulin kappa variable 2-30,target,P06310,IGKV2-30,Humans,"V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition (PubMed:24600447). Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secr",antigen binding,Secreted,other,DrugBank,drugbank_id
BE0004771,Carbonyl reductase [NADPH] 3,enzyme,O75828,CBR3,Humans,"Catalyzes the NADPH-dependent reduction of carbonyl compounds to their corresponding alcohols (PubMed:18493841). Has low NADPH-dependent oxidoreductase activity. Acts on several orthoquinones, acts as well on non-quinone compounds, such as isatin or on the anticancer drug oracin (PubMed:15537833, PubMed:18493841, PubMed:19841672). Best substrates for CBR3 is 1,2- naphthoquinone, hence could play a role in protection against cytotoxicity of exogenous quinones (PubMed:19841672). Exerts activity to",3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0005562,G-protein coupled receptor 35,target,Q9HC97,GPR35,Humans,"G-protein coupled receptor that binds to several ligands including the tryptophan metabolite kynurenic acid (KYNA), lysophosphatidic acid (LPA) or 5-hydroxyindoleacetic acid (5-HIAA) with high affinity, leading to rapid and transient activation of numerous intracellular signaling pathways (PubMed:16754668, PubMed:20361937, PubMed:35148838). Plays a role in neutrophil recruitment to sites of inflammation and bacterial clearance through the major serotonin metabolite 5-HIAA that acts as a physiolo",C-X-C chemokine receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0003580,Nischarin,target,Q9Y2I1,NISCH,Humans,"Acts either as the functional imidazoline-1 receptor (I1R) candidate or as a membrane-associated mediator of the I1R signaling. Binds numerous imidazoline ligands that induces initiation of cell-signaling cascades triggering to cell survival, growth and migration. Its activation by the agonist rilmenidine induces an increase in phosphorylation of mitogen-activated protein kinases MAPK1 and MAPK3 in rostral ventrolateral medulla (RVLM) neurons that exhibited rilmenidine-evoked hypotension (By sim",identical protein binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0002361,Probable pyruvate-flavodoxin oxidoreductase,target,P52647,ydbK,Escherichia coli (strain K12),Oxidoreductase required for the transfer of electrons from pyruvate to flavodoxin.,"4 iron, 4 sulfur cluster binding",,potentiator,DrugBank,drugbank_id
BE0000621,Oxygen-insensitive NADPH nitroreductase,target,P17117,nfsA,Escherichia coli (strain K12),Catalyzes the reduction of nitroaromatic compounds using NADPH. Has a broad electron acceptor specificity. Reduces nitrofurazone by a ping-pong bi-bi mechanism possibly to generate a two-electron transfer product. Major oxygen-insensitive nitroreductase in E.coli.,chromate reductase activity,,potentiator,DrugBank,drugbank_id
BE0000158,Small ribosomal subunit protein uS10,target,P0A7R5,rpsJ,Escherichia coli (strain K12),"Involved in the binding of tRNA to the ribosomes (PubMed:6759118). Part of the processive rRNA transcription and antitermination complex (rrnTAC). The complex forms an RNA-chaperone ring around the RNA exit tunnel of RNA polymerase (RNAP). It supports rapid transcription and antitermination of rRNA operons, cotranscriptional rRNA folding, and annealing of distal rRNA regions to allow correct ribosome biogenesis (PubMed:32871103). In complex with NusB is involved in the regulation of ribosomal RN",structural constituent of ribosome,,inhibitor,DrugBank,drugbank_id
BE0000555,Protein P,target,Q05486,P,HBV-F,"Multifunctional enzyme that converts the viral RNA genome into dsDNA in viral cytoplasmic capsids. This enzyme displays a DNA polymerase activity that can copy either DNA or RNA templates, and a ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-DNA heteroduplexes in a partially processive 3'- to 5'-endonucleasic mode. Neo-synthesized pregenomic RNA (pgRNA) are encapsidated together with the P protein, and reverse-transcribed inside the nucleocapsid. Initiation of reverse-trans",DNA binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0004454,Phosphoglycerate kinase 1,enzyme,P00558,PGK1,Humans,"Catalyzes one of the two ATP producing reactions in the glycolytic pathway via the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate (PubMed:30323285, PubMed:7391028). Both L- and D- forms of purine and pyrimidine nucleotides can be used as substrates, but the activity is much lower on pyrimidines (PubMed:18463139). In addition to its role as a glycolytic enzyme, it seems that PGK1 acts as a polymerase alpha cofactor protein (primer recognition protein) (PubMed:2324090). Acts",ADP binding,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0004773,Ethanolamine-phosphate cytidylyltransferase,enzyme,Q99447,PCYT2,Humans,"Ethanolamine-phosphate cytidylyltransferase that catalyzes the second step in the synthesis of phosphatidylethanolamine (PE) from ethanolamine via the CDP-ethanolamine pathway (PubMed:31637422, PubMed:9083101). Phosphatidylethanolamine is a dominant inner-leaflet phospholipid in cell membranes, where it plays a role in membrane function by structurally stabilizing membrane-anchored proteins, and participates in important cellular processes such as cell division, cell fusion, blood coagulation, a",ethanolamine-phosphate cytidylyltransferase activity,,substrate,DrugBank,drugbank_id
BE0004774,"5'(3')-deoxyribonucleotidase, cytosolic type",enzyme,Q8TCD5,NT5C,Humans,"Dephosphorylates the 5' and 2'(3')-phosphates of deoxyribonucleotides, with a preference for dUMP and dTMP, intermediate activity towards dGMP, and low activity towards dCMP and dAMP",5'-nucleotidase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0008389,Penicillin-binding protein 2,target,D6R448,mecA,Staphylococcus aureus,,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0009673,Sulfotransferase 1A2,enzyme,P50226,SULT1A2,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of catecholamines, phenolic drugs and neurotransmitters. Is also responsible for the sulfonation and activation of minoxidil. Mediates the metabolic activation of carcinogenic N-hydroxyarylamines to DNA binding products and could so participate as modulating factor of cancer risk",aryl sulfotransferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0002561,Sulfotransferase 1B1,enzyme,O43704,SULT1B1,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of dopamine, small phenols such as 1-naphthol and p-nitrophenol and thyroid hormones, including 3,3'-diiodothyronine, triidothyronine (T3) and reverse triiodothyronine (rT3) (PubMed:28084139, PubMed:9443824, PubMed:9463486). May play a role in gut microbiota-host metabolic interaction. O-sulfonates 4-ethylphenol (4-EP), a dietary tyrosine-derived metabolite produced by gut ",aryl sulfotransferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000099,Cysteinyl leukotriene receptor 2,target,Q9NS75,CYSLTR2,Humans,"Receptor for cysteinyl leukotrienes. The response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. Stimulation by BAY u9773, a partial agonist, induces specific contractions of pulmonary veins and might also have an indirect role in the relaxation of the pulmonary vascular endothelium. The rank order of affinities for the leukotrienes is LTC4 = LTD4 >> LTE4",cysteinyl leukotriene receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000995,fMet-Leu-Phe receptor,target,P21462,FPR1,Humans,"High affinity receptor for N-formyl-methionyl peptides (fMLP), which are powerful neutrophil chemotactic factors (PubMed:10514456, PubMed:15153520, PubMed:2161213, PubMed:2176894). Binding of fMLP to the receptor stimulates intracellular calcium mobilization and superoxide anion release (PubMed:15153520, PubMed:15210802, PubMed:1712023, PubMed:2161213). This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system (PubMed:10514456, PubMed:1712023",complement receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004887,3-oxo-5-alpha-steroid 4-dehydrogenase,enzyme,P18405,SRD5A1,Humans,Converts testosterone into 5-alpha-dihydrotestosterone and progesterone or corticosterone into their corresponding 5-alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology,3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity,Microsome membrane,substrate,DrugBank,drugbank_id
BE0000599,ADP/ATP translocase 1,target,P12235,SLC25A4,Humans,"ADP:ATP antiporter that mediates import of ADP into the mitochondrial matrix for ATP synthesis, and export of ATP out to fuel the cell (PubMed:21586654, PubMed:27693233). Cycles between the cytoplasmic-open state (c-state) and the matrix-open state (m-state): operates by the alternating access mechanism with a single substrate-binding site intermittently exposed to either the cytosolic (c-state) or matrix (m-state) side of the inner mitochondrial membrane (By similarity). In addition to its ADP:",adenine transmembrane transporter activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0000709,ADP/ATP translocase 2,target,P05141,SLC25A5,Humans,"ADP:ATP antiporter that mediates import of ADP into the mitochondrial matrix for ATP synthesis, and export of ATP out to fuel the cell (By similarity). Cycles between the cytoplasmic-open state (c-state) and the matrix-open state (m-state): operates by the alternating access mechanism with a single substrate-binding site intermittently exposed to either the cytosolic (c-state) or matrix (m-state) side of the inner mitochondrial membrane (By similarity). In addition to its ADP:ATP antiporter acti",adenine nucleotide transmembrane transporter activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0000624,ADP/ATP translocase 3,target,P12236,SLC25A6,Humans,"ADP:ATP antiporter that mediates import of ADP into the mitochondrial matrix for ATP synthesis, and export of ATP out to fuel the cell (By similarity). Cycles between the cytoplasmic-open state (c-state) and the matrix-open state (m-state): operates by the alternating access mechanism with a single substrate-binding site intermittently exposed to either the cytosolic (c-state) or matrix (m-state) side of the inner mitochondrial membrane (By similarity). In addition to its ADP:ATP antiporter acti",ATP,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0004906,Calcium-activated potassium channel,target,Q12791,KCNMA1,Humans,"Potassium channel activated by both membrane depolarization or increase in cytosolic Ca(2+) that mediates export of K(+) (PubMed:14523450, PubMed:29330545, PubMed:31152168). It is also activated by the concentration of cytosolic Mg(2+). Its activation dampens the excitatory events that elevate the cytosolic Ca(2+) concentration and/or depolarize the cell membrane. It therefore contributes to repolarization of the membrane potential. Plays a key role in controlling excitability in a number of sys",actin binding,Cell membrane,blocker,DrugBank,drugbank_id
BE0009743,60 kDa lysophospholipase,target,Q86U10,ASPG,Humans,"Exhibits lysophospholipase, transacylase, PAF acetylhydrolase and asparaginase activities (By similarity). Can catalyze three types of transacylation reactions: (1) acyl transfer from 1-acyl-sn-glycero-3-phosphocholine (1-acyl-GPC) to the sn-1(3) positions of glycerol and 2-acylglycerol (sn-1 to -1(3) transfer), (2) acyl transfer from 1-acyl-GPC to the sn-2 positions of 1-acyl-GPC, 1-acyl-sn-glycero-3-phosphoethanolamine (1-acyl-GPE), and other lysophospholipids (sn-1 to -2 transfer) and (3) acy",1-alkyl-2-acetylglycerophosphocholine esterase activity,,inhibitor,DrugBank,drugbank_id
BE0000892,DNA (cytosine-5)-methyltransferase 1,target,P26358,DNMT1,Humans,"Methylates CpG residues. Preferentially methylates hemimethylated DNA. Associates with DNA replication sites in S phase maintaining the methylation pattern in the newly synthesized strand, that is essential for epigenetic inheritance. Associates with chromatin during G2 and M phases to maintain DNA methylation independently of replication. It is responsible for maintaining methylation patterns established in development. DNA methylation is coordinated with methylation of histones. Mediates trans",DNA (cytosine-5-)-methyltransferase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009880,DNA (cytosine-5)-methyltransferase 3A,target,Q9Y6K1,DNMT3A,Humans,"Required for genome-wide de novo methylation and is essential for the establishment of DNA methylation patterns during development (PubMed:12138111, PubMed:16357870, PubMed:30478443). DNA methylation is coordinated with methylation of histones (PubMed:12138111, PubMed:16357870, PubMed:30478443). It modifies DNA in a non-processive manner and also methylates non-CpG sites (PubMed:12138111, PubMed:16357870, PubMed:30478443). May preferentially methylate DNA linker between 2 nucleosomal cores and i",chromatin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000155,Toll-like receptor 7,target,Q9NYK1,TLR7,Humans,"Endosomal receptor that plays a key role in innate and adaptive immunity (PubMed:14976261, PubMed:32433612). Controls host immune response against pathogens through recognition of uridine-containing single strand RNAs (ssRNAs) of viral origin or guanosine analogs (PubMed:12738885, PubMed:27742543, PubMed:31608988, PubMed:32706371, PubMed:35477763). Upon binding to agonists, undergoes dimerization that brings TIR domains from the two molecules into direct contact, leading to the recruitment of TI",double-stranded RNA binding,Endoplasmic reticulum membrane,agonist,DrugBank,drugbank_id
BE0003518,Toll-like receptor 8,target,Q9NR97,TLR8,Humans,"Endosomal receptor that plays a key role in innate and adaptive immunity (PubMed:25297876, PubMed:32433612). Controls host immune response against pathogens through recognition of RNA degradation products specific to microorganisms that are initially processed by RNASET2 (PubMed:31778653). Recognizes GU-rich single-stranded RNA (GU-rich RNA) derived from SARS-CoV-2, SARS-CoV-1 and HIV-1 viruses (PubMed:33718825). Upon binding to agonists, undergoes dimerization that brings TIR domains from the t",DNA binding,Endosome membrane,agonist,DrugBank,drugbank_id
BE0000548,Fumarate reductase flavoprotein subunit,target,P00363,frdA,Escherichia coli (strain K12),"Two distinct, membrane-bound, FAD-containing enzymes are responsible for the catalysis of fumarate and succinate interconversion; fumarate reductase is used during anaerobic growth, and succinate dehydrogenase is used during aerobic growth. The QFR enzyme complex binds 2 quinones in or near the membrane; 1 near the [3Fe-4S] cluster (QP is proximal to the [3Fe-4S] cluster, on the cytoplasmic side of the membrane) while QD (the distal cluster) is on the other side of the membrane. It is not clear ",electron transfer activity,,inhibitor,DrugBank,drugbank_id
BE0003736,Tryptase alpha/beta-1,target,Q15661,TPSAB1,Humans,"Tryptase is the major neutral protease present in mast cells and is secreted upon the coupled activation-degranulation response of this cell type. May play a role in innate immunity. Isoform 2 cleaves large substrates, such as fibronectin, more efficiently than isoform 1, but seems less efficient toward small substrates (PubMed:18854315)",identical protein binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0002517,tRNA (cytosine(38)-C(5))-methyltransferase,target,O14717,TRDMT1,Humans,Specifically methylates cytosine 38 in the anticodon loop of tRNA(Asp) (PubMed:16424344). Has higher activity on tRNA(Asp) modified with queuosine at position 34 (PubMed:30093495),RNA binding,Cytoplasm,other,DrugBank,drugbank_id
BE0002615,Mannitol dehydrogenase,enzyme,O08355,mtlD,Pseudomonas fluorescens,,mannitol 2-dehydrogenase activity,,substrate,DrugBank,drugbank_id
BE0004807,Iron,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0004818,Aluminum,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0003392,Amyloid-beta precursor protein,target,P05067,APP,Humans,"Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed:25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptos",DNA binding,Cell membrane,downregulator,DrugBank,drugbank_id
BE0000484,"ATP synthase F(1) complex subunit delta, mitochondrial",target,P30049,ATP5F1D,Humans,"Subunit delta, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable) (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk r","proton-transporting ATP synthase activity, rotational mechanism",Mitochondrion,unknown,DrugBank,drugbank_id
BE0000503,NADH-ubiquinone oxidoreductase chain 1,enzyme,P03886,MT-ND1,Humans,"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:1959619). Essential for the catalytic activity and assembly of complex I (PubMed:1959619, PubMed:26929434)",NADH dehydrogenase (ubiquinone) activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0000653,Retinoic acid receptor responder protein 1,target,P49788,RARRES1,Humans,"Inhibitor of the cytoplasmic carboxypeptidase AGBL2, may regulate the alpha-tubulin tyrosination cycle",metalloendopeptidase inhibitor activity,Membrane,agonist,DrugBank,drugbank_id
BE0000554,Aldehyde dehydrogenase 1A1,target,P00352,ALDH1A1,Humans,"Cytosolic dehydrogenase that catalyzes the irreversible oxidation of a wide range of aldehydes to their corresponding carboxylic acid (PubMed:12941160, PubMed:15623782, PubMed:17175089, PubMed:19296407, PubMed:25450233, PubMed:26373694). Functions downstream of retinol dehydrogenases and catalyzes the oxidation of retinaldehyde into retinoic acid, the second step in the oxidation of retinol/vitamin A into retinoic acid (By similarity). This pathway is crucial to control the levels of retinol and",3-deoxyglucosone dehydrogenase activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0000513,Retinal dehydrogenase 2,target,O94788,ALDH1A2,Humans,"Catalyzes the NAD-dependent oxidation of aldehyde substrates, such as all-trans-retinal and all-trans-13,14-dihydroretinal, to their corresponding carboxylic acids, all-trans-retinoate and all-trans-13,14-dihydroretinoate, respectively (PubMed:29240402, PubMed:33565183). Retinoate signaling is critical for the transcriptional control of many genes, for instance it is crucial for initiation of meiosis in both male and female (Probable) (PubMed:33565183). Recognizes retinal as substrate, both in i",3-chloroallyl aldehyde dehydrogenase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000697,Retinoic acid-induced protein 3,target,Q8NFJ5,GPRC5A,Humans,Orphan receptor. Could be involved in modulating differentiation and maintaining homeostasis of epithelial cells. This retinoic acid-inducible GPCR provide evidence for a possible interaction between retinoid and G-protein signaling pathways. Functions as a negative modulator of EGFR signaling (By similarity). May act as a lung tumor suppressor (PubMed:18000218),cadherin binding,Cell membrane,regulator,DrugBank,drugbank_id
BE0005828,Lipocalin-1,target,P31025,LCN1,Humans,"Could play a role in taste reception. Could be necessary for the concentration and delivery of sapid molecules in the gustatory system. Can bind various ligands, with chemical structures ranging from lipids and retinoids to the macrocyclic antibiotic rifampicin and even to microbial siderophores. Exhibits an extremely wide ligand pocket",chloride ion binding,Secreted,binder,DrugBank,drugbank_id
BE0005829,Odorant-binding protein 2a,target,Q9NY56,OBP2A,Humans,"Binds and transports small hydrophobic volatile molecules with a higher affinity for aldehydes and large fatty acids, including undecanal, palmitic acid, efficient aldehydes, benzenic aldehydes, heterocyclic aldehydes and aliphatic acids",odorant binding,Secreted,binder,DrugBank,drugbank_id
BE0000314,Retinol-binding protein 4,target,P02753,RBP4,Humans,"Retinol-binding protein that mediates retinol transport in blood plasma (PubMed:5541771). Delivers retinol from the liver stores to the peripheral tissues (Probable). Transfers the bound all-trans retinol to STRA6, that then facilitates retinol transport across the cell membrane (PubMed:22665496)",molecular carrier activity,Secreted,binder,DrugBank,drugbank_id
BE0004284,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",target,Q16654,PDK4,Humans,"Kinase that plays a key role in regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvate dehydrogenase activity, and thereby regulates metabolite flux through the tricarboxylic acid cycle, down-regulates aerobic respiration and inhibits the formation of acetyl-coenzyme A from pyruvate. Inhibition of pyruvate dehydrogenase decreases glucose utilization and increases fat metabolism in response",ATP binding,Mitochondrion matrix,upregulator,DrugBank,drugbank_id
BE0002477,Carcinoembryonic antigen,target,Q14081,,Humans,,,,downregulator,DrugBank,drugbank_id
BE0003480,Cytochrome P450 26A1,enzyme,O43174,CYP26A1,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of retinoates (RAs), the active metabolites of vitamin A, and critical signaling molecules in animals (PubMed:22020119, PubMed:9228017, PubMed:9716180). RAs exist as at least four different isomers: all-trans-RA (atRA), 9-cis-RA, 13-cis-RA, and 9,13-dicis-RA, where atRA is considered to be the biologically active isomer, although 9-cis-RA and 13-cis-RA also have activity (Probable). Catalyzes the hydroxylation of atRA primarily at C-4 an",all-trans retinoic acid 18-hydroxylase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0004653,Small ribosomal subunit protein uS7,target,P02359,rpsG,Escherichia coli (strain K12),"One of the primary rRNA binding proteins, it binds directly to 16S rRNA where it nucleates assembly of the head domain of the 30S subunit (PubMed:2461734). Is located at the subunit interface close to the decoding center, where it has been shown to contact mRNA (PubMed:10606263). Has been shown to contact tRNA in both the P and E sites; it probably blocks exit of the E site tRNA (PubMed:8524654).",mRNA binding,,inhibitor,DrugBank,drugbank_id
BE0004651,Small ribosomal subunit protein uS3,target,P0A7V3,rpsC,Escherichia coli (strain K12),"Binds the lower part of the 30S subunit head. Binds mRNA in the 70S ribosome, positioning it for translation (By similarity).",mRNA binding,,inhibitor,DrugBank,drugbank_id
BE0004652,Small ribosomal subunit protein uS8,target,P0A7W7,rpsH,Escherichia coli (strain K12),"One of the primary rRNA binding proteins, it binds directly to 16S rRNA central domain where it helps coordinate assembly of the platform of the 30S subunit.",rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0001105,Major prion protein,target,P04156,PRNP,Humans,Its primary physiological function is unclear. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May promote myelin homeostasis through acting as an agonist for ADGRG6 receptor. May play a role in iron uptake and iron homeostasis. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (By similarity). Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also ,amyloid-beta binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001274,Beta-lactamase OXA-10,enzyme,P14489,OXA-10,Pseudomonas aeruginosa,Hydrolyzes both carbenicillin and oxacillin.,beta-lactamase activity,Cytoplasmic,substrate,DrugBank,drugbank_id
BE0000047,Solute carrier family 12 member 5,target,Q9H2X9,SLC12A5,Humans,"Mediates electroneutral potassium-chloride cotransport in mature neurons and is required for neuronal Cl(-) homeostasis (PubMed:12106695). As major extruder of intracellular chloride, it establishes the low neuronal Cl(-) levels required for chloride influx after binding of GABA-A and glycine to their receptors, with subsequent hyperpolarization and neuronal inhibition (By similarity). Involved in the regulation of dendritic spine formation and maturation (PubMed:24668262)",ammonium channel activity,Cell membrane,,DrugBank,drugbank_id
BE0000140,Solute carrier family 12 member 6,target,Q9UHW9,SLC12A6,Humans,"Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:10600773, PubMed:11551954, PubMed:16048901, PubMed:18566107, PubMed:19665974, PubMed:21628467, PubMed:27485015). May contribute to cell volume homeostasis in single cells (PubMed:16048901, PubMed:27485015)",metal ion binding,Cell membrane,,DrugBank,drugbank_id
BE0000276,Solute carrier family 12 member 7,target,Q9Y666,SLC12A7,Humans,Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:10913127). May mediate K(+) uptake into Deiters' cells in the cochlea and contribute to K(+) recycling in the inner ear. Important for the survival of cochlear outer and inner hair cells and the maintenance of the organ of Corti. May be required for basolateral Cl(-) extrusion in the kidney and contribute to renal acidification (By similarity),potassium,Cell membrane,,DrugBank,drugbank_id
BE0000601,Solute carrier family 12 member 4,target,Q9UP95,SLC12A4,Humans,"Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:35759661). May contribute to cell volume homeostasis in single cells (PubMed:10913127, PubMed:34031912). May be involved in the regulation of basolateral Cl(-) exit in NaCl absorbing epithelia (By similarity)",ATP binding,Cell membrane,,DrugBank,drugbank_id
BE0000091,"DNA topoisomerase I, mitochondrial",target,Q969P6,TOP1MT,Humans,"Releases the supercoiling and torsional tension of DNA introduced during duplication of mitochondrial DNA by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free DNA strand then rotates around",DNA binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0000971,DNA topoisomerase 1,target,P11387,TOP1,Humans,"Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free DNA strand then rotates a",ATP binding,"Nucleus, nucleolus",inhibitor,DrugBank,drugbank_id
BE0010086,Human Carboxylesterases,enzyme,O00748,CES2,Humans,"Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs (PubMed:9169443). Shows high catalytic efficiency for hydrolysis of cocaine, 4-methylumbelliferyl acetate, heroin and 6-monoacetylmorphine (PubMed:9169443). Hydrolyzes aspirin, substrates with large alcohol group and small acyl group and endogenous lipids such as triacylglycerol (PubMed:28677105). Converts monoacylglycerides to free fatty acids and glycerol. Hydrolyzes of 2-arachidonoylglycerol and pr",carboxylesterase activity,Endoplasmic reticulum lumen,substrate,DrugBank,drugbank_id
BE0009711,Bacterial beta-lactamase enzymes,target,,,,,,,inhibitor,DrugBank,drugbank_id
BE0000302,Beta-lactamase,target,P00807,blaZ,Staphylococcus aureus,,beta-lactamase activity,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0004754,Sodium/glucose cotransporter 1,transporter,P13866,SLC5A1,Humans,"Electrogenic Na(+)-coupled sugar symporter that actively transports D-glucose or D-galactose at the plasma membrane, with a Na(+) to sugar coupling ratio of 2:1. Transporter activity is driven by a transmembrane Na(+) electrochemical gradient set by the Na(+)/K(+) pump (PubMed:20980548, PubMed:34880492, PubMed:35077764, PubMed:8563765, PubMed:37217492). Has a primary role in the transport of dietary monosaccharides from enterocytes to blood. Responsible for the absorption of D-glucose or D-galac",alpha-glucoside transmembrane transporter activity,Apical cell membrane,inducer,DrugBank,drugbank_id
BE0002375,Prostaglandin E2 receptor EP3 subtype,target,P43115,PTGER3,Humans,"Receptor for prostaglandin E2 (PGE2) (PubMed:7883006, PubMed:7981210, PubMed:8117308, PubMed:8135729, PubMed:8307176). The activity of this receptor can couple to both the inhibition of adenylate cyclase mediated by G(i) proteins, and to an elevation of intracellular calcium (PubMed:7883006, PubMed:7981210, PubMed:8117308, PubMed:8135729). Required for normal development of fever in response to pyrinogens, including IL1B, prostaglandin E2 and bacterial lipopolysaccharide (LPS). Required for norm",prostaglandin E receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0003522,Prostaglandin E2 receptor EP4 subtype,target,P35408,PTGER4,Humans,"Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. Has a relaxing effect on smooth muscle. May play an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function",prostaglandin E receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000759,Thromboxane A2 receptor,target,P21731,TBXA2R,Humans,"Receptor for thromboxane A2 (TXA2), a potent stimulator of platelet aggregation. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. In the kidney, the binding of TXA2 to glomerular TP receptors causes intense vasoconstriction. Activates phospholipase C",guanyl-nucleotide exchange factor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0000552,15-hydroxyprostaglandin dehydrogenase [NAD(+)],enzyme,P15428,HPGD,Humans,"Catalyzes the NAD-dependent dehydrogenation (oxidation) of a broad array of hydroxylated polyunsaturated fatty acids (mainly eicosanoids and docosanoids, including prostaglandins, lipoxins and resolvins), yielding their corresponding keto (oxo) metabolites (PubMed:10837478, PubMed:16757471, PubMed:16828555, PubMed:21916491, PubMed:25586183, PubMed:8086429). Decreases the levels of the pro-proliferative prostaglandins such as prostaglandin E2 (whose activity is increased in cancer because of an i",15-hydroxyprostaglandin dehydrogenase (NAD+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000743,Large ribosomal subunit protein uL10,target,P0A7J6,rplJ,Shigella flexneri,Protein L10 is also a translational repressor protein. It controls the translation of the rplJL-rpoBC operon by binding to its mRNA (By similarity).,large ribosomal subunit rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0027584,Aerobic bacterial DNA,target,,,,,,,inhibitor,DrugBank,drugbank_id
BE0000799,DNA gyrase subunit B,target,P0AES6,gyrB,Escherichia coli (strain K12),"DNA gyrase negatively supercoils closed circular double-stranded DNA in an ATP-dependent manner to maintain chromosomes in an underwound state (PubMed:12051842, PubMed:12051843, PubMed:1323022, PubMed:18642932, PubMed:186775, PubMed:19060136, PubMed:19965760, PubMed:20356737, PubMed:20675723, PubMed:22457353, PubMed:23294697, PubMed:23352267, PubMed:24386374, PubMed:25202966, PubMed:25849408, PubMed:3031051, PubMed:7811004, PubMed:8248233, PubMed:8621650, PubMed:9657678). This makes better subst",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002173,Glutamate decarboxylase 2,target,Q9UGI5,GAD65,Humans,Catalyzes the production of GABA.,glutamate decarboxylase activity,,inhibitor,DrugBank,drugbank_id
BE0003446,G-protein coupled estrogen receptor 1,target,Q99527,GPER1,Humans,"G-protein coupled estrogen receptor that binds to 17-beta-estradiol (E2) with high affinity, leading to rapid and transient activation of numerous intracellular signaling pathways. Stimulates cAMP production, calcium mobilization and tyrosine kinase Src inducing the release of heparin-bound epidermal growth factor (HB-EGF) and subsequent transactivation of the epidermal growth factor receptor (EGFR), activating downstream signaling pathways such as PI3K/Akt and ERK/MAPK. Mediates pleiotropic fun",chromatin binding,Nucleus,binder,DrugBank,drugbank_id
BE0009014,ATP synthase F(0) complex subunit a,target,P00846,MT-ATP6,Humans,"Subunit a, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the F(1",proton channel activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0009015,Beclin-1,target,Q14457,BECN1,Humans,"Plays a central role in autophagy (PubMed:18570871, PubMed:21358617, PubMed:23184933, PubMed:23974797, PubMed:25484083, PubMed:28445460, PubMed:37776275). Acts as a core subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of deg",GTPase binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0003591,"Fatty acid-binding protein, intestinal",carrier,P12104,FABP2,Humans,"FABPs are thought to play a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters. FABP2 is probably involved in triglyceride-rich lipoprotein synthesis. Binds saturated long-chain fatty acids with a high affinity, but binds with a lower affinity to unsaturated long-chain fatty acids. FABP2 may also help maintain energy homeostasis by functioning as a lipid sensor",fatty acid binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0000633,DNA polymerase catalytic subunit,target,P09252,,HHV-3,"Replicates viral genomic DNA. The replication complex is composed of six viral proteins: the DNA polymerase, processivity factor, primase, primase-associated factor, helicase, and ssDNA-binding protein. Additionally, the polymerase contains an intrinsic ribonuclease H (RNase H) activity that specifically degrades RNA/DNA heteroduplexes or duplex DNA substrates in the 5' to 3' direction. Therefore, it can catalyze the excision of the RNA primers that initiate the synthesis of Okazaki fragments at",3'-5'-DNA exonuclease activity,Host nucleus,inhibitor,DrugBank,drugbank_id
BE0009686,Pyruvate Kinases,enzyme,P30613,PKLR,Humans,"Pyruvate kinase that catalyzes the conversion of phosphoenolpyruvate to pyruvate with the synthesis of ATP, and which plays a key role in glycolysis",ATP binding,,substrate,DrugBank,drugbank_id
BE0009688,Phosphoglycerate Kinases,enzyme,P00558,PGK1,Humans,"Catalyzes one of the two ATP producing reactions in the glycolytic pathway via the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate (PubMed:30323285, PubMed:7391028). Both L- and D- forms of purine and pyrimidine nucleotides can be used as substrates, but the activity is much lower on pyrimidines (PubMed:18463139). In addition to its role as a glycolytic enzyme, it seems that PGK1 acts as a polymerase alpha cofactor protein (primer recognition protein) (PubMed:2324090). Acts",ADP binding,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0009689,Succinyl-CoA Synthetases,enzyme,Q9P2R7,SUCLA2,Humans,"ATP-specific succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of ATP and thus represents the only step of substrate-level phosphorylation in the TCA (PubMed:15877282, PubMed:34492704). The beta subunit provides nucleotide specificity of the enzyme and binds the substrate succinate, while the binding sites for coenzyme A and phosphate are found in the alpha subunit (By similarity)",ATP binding,Mitochondrion,substrate,DrugBank,drugbank_id
BE0009690,Phosphoenolpyruvate Carboxykinases,enzyme,Q16822,PCK2,Humans,"Mitochondrial phosphoenolpyruvate carboxykinase that catalyzes the conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle (PubMed:28955899). Can play an active role in glyceroneogenesis and gluconeogenesis (PubMed:28955899)",GTP binding,Mitochondrion,substrate,DrugBank,drugbank_id
BE0009692,Adenylosuccinate Synthetases,enzyme,Q8N142,ADSS1,Humans,"Component of the purine nucleotide cycle (PNC), which interconverts IMP and AMP to regulate the nucleotide levels in various tissues, and which contributes to glycolysis and ammoniagenesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP",actin filament binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000683,Pancreatic triacylglycerol lipase,target,P16233,PNLIP,Humans,"Plays an important role in fat metabolism. It preferentially splits the esters of long-chain fatty acids at positions 1 and 3, producing mainly 2-monoacylglycerol and free fatty acids, and shows considerably higher activity against insoluble emulsified substrates than against soluble ones","all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity",Secreted,inhibitor,DrugBank,drugbank_id
BE0004038,Peptostreptococcal albumin-binding protein,target,Q51911,pab,Peptostreptococcus magnus,Binds serum albumin.,,Secreted,binder,DrugBank,drugbank_id
BE0009808,Transient receptor potential cation channel subfamily M member 3,transporter,Q9HCF6,TRPM3,Humans,"Constitutively active, non-selective divalent cation-conducting channel that is permeable to Ca(2+), Mn(2+), and Mg(2+), with a high permeability for Ca(2+). However, can be enhanced by increasing temperature and by ligands, including the endogenous neurosteroid pregnenolone sulfate and sphingosine-1 and suppressed by intracellular Mg(2+) (PubMed:12672799, PubMed:12672827, PubMed:32343227). Implicated in a variety of cellular processes, including insulin/peptide secretion, vascular constriction ",calcium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000069,"Acetyl-CoA acetyltransferase, mitochondrial",target,P24752,ACAT1,Humans,"This is one of the enzymes that catalyzes the last step of the mitochondrial beta-oxidation pathway, an aerobic process breaking down fatty acids into acetyl-CoA (PubMed:1715688, PubMed:7728148, PubMed:9744475). Using free coenzyme A/CoA, catalyzes the thiolytic cleavage of medium- to long-chain 3-oxoacyl-CoAs into acetyl-CoA and a fatty acyl-CoA shortened by two carbon atoms (PubMed:1715688, PubMed:7728148, PubMed:9744475). The activity of the enzyme is reversible and it can also catalyze the c",acetyl-CoA C-acetyltransferase activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0010782,Proto-oncogene c-Rel,target,Q04864,REL,Humans,"Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA ","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,activator,DrugBank,drugbank_id
BE0013795,Transcription factor RelB,target,Q01201,RELB,Humans,"NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences ","DNA-binding transcription factor activity, RNA polymerase II-specific",Nucleus,activator,DrugBank,drugbank_id
BE0005551,Transcription factor p65,target,Q04206,RELA,Humans,"NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric RELA-NFKB",actinin binding,Nucleus,activator,DrugBank,drugbank_id
BE0001086,Nuclear factor NF-kappa-B p105 subunit,target,P19838,NFKB1,Humans,"NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p5",actinin binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002387,Nuclear factor NF-kappa-B p100 subunit,target,Q00653,NFKB2,Humans,"NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B ","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,inhibitor,DrugBank,drugbank_id
BE0001601,NH(3)-dependent NAD(+) synthetase,target,P08164,nadE,Bacillus subtilis (strain 168),Catalyzes the ATP-dependent amidation of deamido-NAD to form NAD. Uses ammonia as a nitrogen source.,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009788,Phosphodiesterase enzymes,target,,,Humans,,,,inhibitor,DrugBank,drugbank_id
BE0000672,Potassium voltage-gated channel subfamily KQT member 1,target,P51787,KCNQ1,Humans,"Pore-forming subunit of the voltage-gated potassium (Kv) channel involved in the regulation of cardiomyocyte excitability and important in normal development and functions of myocardium, inner ear, stomach and colon (PubMed:10646604, PubMed:25441029). Associates with KCNE beta subunits that modulates current kinetics (PubMed:10646604, PubMed:11101505, PubMed:19687231, PubMed:8900283, PubMed:9108097, PubMed:9312006). Induces a voltage-dependent current by rapidly activating and slowly deactivatin",calmodulin binding,Cell membrane,blocker,DrugBank,drugbank_id
BE0010007,Erythrocyte,carrier,,,Humans,,,,binder,DrugBank,drugbank_id
BE0000681,RNA-directed RNA polymerase L,target,P26676,L,HPIV-2,"RNA-directed RNA polymerase that catalyzes the transcription of viral mRNAs, their capping and polyadenylation. The template is composed of the viral RNA tightly encapsidated by the nucleoprotein (N). The viral polymerase binds to the genomic RNA at the 3' leader promoter, and transcribes subsequently all viral mRNAs with a decreasing efficiency. The first gene is the most transcribed, and the last the least transcribed. The viral phosphoprotein acts as a processivity factor. Capping is concommi",ATP binding,Virion,antagonist,DrugBank,drugbank_id
BE0001261,Genome polyprotein,target,P12823,,DENV-2,"Capsid protein C
    Plays a role in virus budding by binding to the cell membrane and gathering the viral RNA into a nucleocapsid that forms the core of a mature virus particle. During virus entry, may induce genome penetration into the host cytoplasm after hemifusion induced by the surface proteins. Can migrate to the cell nucleus where it modulates host functions. Overcomes the anti-viral effects of host EXOC1 by sequestering and degrading the latter through the proteasome degradation pathway",ATP binding,Virion,inhibitor,DrugBank,drugbank_id
BE0000282,RNA-directed RNA polymerase catalytic subunit,target,P16502,PB1,Influenza A virus (strain A/Beijing/11/1956 H1N1),"RNA-dependent RNA polymerase which is responsible for replication and transcription of virus RNA segments. The transcription of viral mRNAs occurs by a unique mechanism called cap-snatching. 5' methylated caps of cellular mRNAs are cleaved after 10-13 nucleotides by PA. In turn, these short capped RNAs are used as primers by PB1 for transcription of viral mRNAs. During virus replication, PB1 initiates RNA synthesis and copy vRNA into complementary RNA (cRNA) which in turn serves as a template fo",nucleotide binding,Host nucleus,inhibitor,DrugBank,drugbank_id
BE0000261,Cytosolic purine 5'-nucleotidase,enzyme,P49902,NT5C2,Humans,"Broad specificity cytosolic 5'-nucleotidase that catalyzes the dephosphorylation of 6-hydroxypurine nucleoside 5'-monophosphates (PubMed:10092873, PubMed:12907246, PubMed:1659319, PubMed:9371705). In addition, possesses a phosphotransferase activity by which it can transfer a phosphate from a donor nucleoside monophosphate to an acceptor nucleoside, preferably inosine, deoxyinosine and guanosine (PubMed:1659319, PubMed:9371705). Has the highest activities for IMP and GMP followed by dIMP, dGMP a",5'-nucleotidase activity,"Cytoplasm, cytosol",modulator,DrugBank,drugbank_id
BE0000117,Prostacyclin synthase,target,Q16647,PTGIS,Humans,"Catalyzes the biosynthesis and metabolism of eicosanoids. Catalyzes the isomerization of prostaglandin H2 to prostacyclin (= prostaglandin I2), a potent mediator of vasodilation and inhibitor of platelet aggregation (PubMed:12372404, PubMed:15115769, PubMed:18032380, PubMed:25623425). Additionally, displays dehydratase activity, toward hydroperoxyeicosatetraenoates (HPETEs), especially toward (15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate (15(S)-HPETE) (PubMed:17459323)",heme binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009848,Human vesicular glutamate transporters,transporter,,,Humans,,,,modulator,DrugBank,drugbank_id
BE0000798,DNA topoisomerase 4 subunit A,target,P0AFI2,parC,Escherichia coli (strain K12),"Topoisomerase IV is essential for chromosome segregation; it is the principal protein responsible for decatenating newly replicated chromosomes (PubMed:9334322). It relaxes supercoiled DNA (PubMed:12269820, PubMed:16023670, PubMed:21300644). MukB stimulates the relaxation activity of topoisomerase IV and also has a modest effect on decatenation (PubMed:20921377).",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000880,Aquaporin-1,target,P29972,AQP1,Humans,"Forms a water channel that facilitates the transport of water across cell membranes, playing a crucial role in water homeostasis in various tissues (PubMed:1373524, PubMed:23219802). Could also be permeable to small solutes including hydrogen peroxide, glycerol and gases such as amonnia (NH3), nitric oxide (NO) and carbon dioxide (CO2) (PubMed:16682607, PubMed:17012249, PubMed:19273840, PubMed:33028705, PubMed:8584435). Recruited to the ankyrin-1 complex, a multiprotein complex of the erythrocyt",ammonium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003558,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",target,Q9HCR9,PDE11A,Humans,"Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides cAMP and cGMP (PubMed:10725373, PubMed:10906126, PubMed:11050148, PubMed:16330539). Catalyzes the hydrolysis of both cAMP and cGMP to 5'-AMP and 5'-GMP, respectively (PubMed:10725373, PubMed:10906126, PubMed:11050148)","3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity","Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0000600,Aldehyde dehydrogenase family 3 member A2,target,P51648,ALDH3A2,Humans,"Catalyzes the oxidation of medium and long chain aliphatic aldehydes to fatty acids. Active on a variety of saturated and unsaturated aliphatic aldehydes between 6 and 24 carbons in length (PubMed:18035827, PubMed:18182499, PubMed:22633490, PubMed:25047030, PubMed:9133646, PubMed:9662422). Responsible for conversion of the sphingosine 1-phosphate (S1P) degradation product hexadecenal to hexadecenoic acid (PubMed:22633490)",3-chloroallyl aldehyde dehydrogenase activity,Microsome membrane,inhibitor,DrugBank,drugbank_id
BE0001186,Transient receptor potential cation channel subfamily M member 8,target,Q7Z2W7,TRPM8,Humans,"Non-selective ion channel permeable to monovalent and divalent cations, including Na(+), K(+), and Ca(2+), with higher permeability for Ca(2+). Activated by multiple factors, such as temperature, voltage, pressure, and changes in osmolality. Activated by cool temperatures (<23-28 degrees Celsius) and by chemical ligands evoking a sensation of coolness, such as menthol and icilin therefore plays a central role in the detection of environmental cold temperatures (PubMed:15306801, PubMed:15852009, ",calcium channel activity,Cell membrane,inducer,DrugBank,drugbank_id
BE0001122,Transient receptor potential cation channel subfamily A member 1,target,O75762,TRPA1,Humans,"Ligand-activated Ca(2+)-permeable, nonselective cation channel involved in pain detection and possibly also in cold perception, oxygen concentration perception, cough, itch, and inner ear function (PubMed:17259981, PubMed:21195050, PubMed:21873995, PubMed:23199233, PubMed:25389312, PubMed:33152265). Has a relatively high Ca(2+) selectivity, with a preference for divalent over monovalent cations (Ca(2+) > Ba(2+) > Mg(2+) > NH4(+) > Li(+) > K(+)), the influx of cation into the cytoplasm leads to m",calcium channel activity,Cell membrane,inhibitor|inducer,DrugBank,drugbank_id
BE0003416,Transient receptor potential cation channel subfamily V member 3,target,Q8NET8,TRPV3,Humans,"Non-selective calcium permeant cation channel (PubMed:12077604, PubMed:12077606, PubMed:26818531, PubMed:37648856, PubMed:38691614). It is activated by innocuous (warm) temperatures and shows an increased response at noxious temperatures greater than 39 degrees Celsius (PubMed:12077604, PubMed:12077606). Activation exhibits an outward rectification (PubMed:12077604). The channel pore can dilate to provide permeability to larger cations (PubMed:37648856). May associate with TRPV1 and may modulate",calcium channel activity,Cell membrane,inducer,DrugBank,drugbank_id
BE0000468,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,P0A749,murA,Escherichia coli (strain K12),"Cell wall formation (PubMed:1512209). Adds enolpyruvyl to UDP-N-acetylglucosamine (PubMed:1512209, PubMed:20392080). Target for the antibiotic fosfomycin.",UDP-N-acetylglucosamine 1-carboxyvinyltransferase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0008706,Calmodulin-3,target,P0DP25,CALM3,Humans,"Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:31454269). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:31454269, PubMed:35568036). Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases, such as myosin light-chain kinases and calmodulin-dependent ",adenylate cyclase activator activity,"Cytoplasm, cytoskeleton, spindle",inhibitor,DrugBank,drugbank_id
BE0008705,Calmodulin-2,target,P0DP24,CALM2,Humans,"Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:26969752, PubMed:27165696). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:26969752, PubMed:27165696, PubMed:35568036). Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases, such as myosin light-chain",adenylate cyclase activator activity,"Cytoplasm, cytoskeleton, spindle",inhibitor,DrugBank,drugbank_id
BE0012563,Calmodulin-1,target,P0DP23,CALM1,Humans,"Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269, PubMed:35568036). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269, PubMed:35568036). Among the",adenylate cyclase activator activity,"Cytoplasm, cytoskeleton, spindle",inhibitor,DrugBank,drugbank_id
BE0001024,"Troponin C, slow skeletal and cardiac muscles",target,P63316,TNNC1,Humans,"Troponin is the central regulatory protein of striated muscle contraction. Tn consists of three components: Tn-I which is the inhibitor of actomyosin ATPase, Tn-T which contains the binding site for tropomyosin and Tn-C. The binding of calcium to Tn-C abolishes the inhibitory action of Tn on actin filaments",actin filament binding,,allosteric modulator,DrugBank,drugbank_id
BE0004350,Protein S100-A4,target,P26447,S100A4,Humans,"Calcium-binding protein that plays a role in various cellular processes including motility, angiogenesis, cell differentiation, apoptosis, and autophagy (PubMed:16707441, PubMed:23752197, PubMed:30713770). Increases cell motility and invasiveness by interacting with non-muscle myosin heavy chain (NMMHC) IIA/MYH9 (PubMed:16707441). Mechanistically, promotes filament depolymerization and increases the amount of soluble myosin-IIA, resulting in the formation of stable protrusions facilitating chemo",actin binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0000947,Pro-opiomelanocortin,target,P01189,POMC,Humans,Stimulates the adrenal glands to release cortisol,G protein-coupled receptor binding,Secreted,modulator,DrugBank,drugbank_id
BE0008670,"Sulfonylurea receptor 1, Kir6.2",target,Q09428,ABCC8,Humans,"Regulator subunit of pancreatic ATP-sensitive potassium channel (KATP), playing a major role in the regulation of insulin release. In pancreatic cells, it forms KATP channels with KCNJ11; KCNJ11 forms the channel pore while ABCC8 is required for activation and regulation",ABC-type transporter activity,Cell membrane,blocker,DrugBank,drugbank_id
BE0004952,Tumor necrosis factor-inducible gene 6 protein,target,P98066,TNFAIP6,Humans,"Major regulator of extracellular matrix organization during tissue remodeling (PubMed:15917224, PubMed:18042364, PubMed:26823460). Catalyzes the transfer of a heavy chain (HC) from inter-alpha-inhibitor (I-alpha-I) complex to hyaluronan. Cleaves the ester bond between the C-terminus of the HC and GalNAc residue of the chondroitin sulfate chain in I-alpha-I complex followed by transesterification of the HC to hyaluronan. In the process, potentiates the antiprotease function of I-alpha-I complex t",calcium ion binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0001051,Interleukin-1 beta,target,P01584,IL1B,Humans,"Potent pro-inflammatory cytokine (PubMed:10653850, PubMed:12794819, PubMed:28331908, PubMed:3920526). Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production (PubMed:3920526). Promotes Th17 differentiation of T-cells. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T-helper 1 (",cytokine activity,"Cytoplasm, cytosol",inhibitor|inducer,DrugBank,drugbank_id
BE0004903,Nuclear factor NF-kappa-B,target,Q00653,NFKB2,Humans,"NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B ","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,inhibitor,DrugBank,drugbank_id
BE0004716,Potassium voltage-gated channel subfamily A member 3,target,P22001,KCNA3,Humans,"Mediates the voltage-dependent potassium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a potassium-selective channel through which potassium ions may pass in accordance with their electrochemical gradient",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000716,DNA polymerase alpha subunit B,target,Q14181,POLA2,Humans,"Accessory subunit of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which plays an essential role in the initiation of DNA synthesis (PubMed:9705292). During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, an accessory subunit POLA2 and two primase subunits, the catalytic subunit PRIM1 and the regulatory subunit PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 ",DNA binding,Nucleus,other/unknown,DrugBank,drugbank_id
BE0004878,"Nuclear factor of activated T-cells, cytoplasmic 1",target,O95644,NFATC1,Humans,"Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells (PubMed:10358178). Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function (By si","DNA-binding transcription activator activity, RNA polymerase II-specific",Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004924,activator protein 1,target,P18846,ATF1,Humans,"This protein binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters. Binds to the Tax-responsive element (TRE) of HTLV-I. Mediates PKA-induced stimulation of CRE-reporter genes. Represses the expression of FTH1 and other antioxidant detoxification genes. Triggers cell proliferation and transformation","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,inhibitor,DrugBank,drugbank_id
BE0000050,Delta-aminolevulinic acid dehydratase,target,P13716,ALAD,Humans,"Catalyzes an early step in the biosynthesis of tetrapyrroles. Binds two molecules of 5-aminolevulinate per subunit, each at a distinct site, and catalyzes their condensation to form porphobilinogen",catalytic activity,"Cytoplasm, cytosol",inducer,DrugBank,drugbank_id
BE0013344,Protoporphyrinogen oxidase,target,P50336,PPOX,Humans,Catalyzes the 6-electron oxidation of protoporphyrinogen-IX to form protoporphyrin-IX,flavin adenine dinucleotide binding,Mitochondrion inner membrane,modulator,DrugBank,drugbank_id
BE0004670,Squalene epoxidase ERG1,target,Q92206,ERG1,Yeast,"Squalene epoxidase; part of the third module of ergosterol biosynthesis pathway that includes the late steps of the pathway (PubMed:15845783, PubMed:3877503, PubMed:6378256, PubMed:9161422). Erg1 catalyzes the epoxidation of squalene into 2,3-epoxysqualene (PubMed:15845783, PubMed:3877503, PubMed:6378256, PubMed:9161422). The third module or late pathway involves the ergosterol synthesis itself through consecutive reactions that mainly occur in the endoplasmic reticulum (ER) membrane. Firstly, t",flavin adenine dinucleotide binding,Microsome membrane,inhibitor,DrugBank,drugbank_id
BE0000577,Squalene monooxygenase,target,Q14534,SQLE,Humans,"Catalyzes the stereospecific oxidation of squalene to (S)-2,3-epoxysqualene, and is considered to be a rate-limiting enzyme in steroid biosynthesis",FAD binding,Microsome membrane,inhibitor,DrugBank,drugbank_id
BE0009791,ABC multidrug transporter MDR2,transporter,A0A059JJ46,MDR2,Trichophyton interdigitale (strain MR816),"Pleiotropic ABC efflux transporter that may be involved in the modulation susceptibility to a wide range of unrelated cytotoxic compounds, including terbinafine, 4-nitroquinoline N-oxide, and ethidium bromide (PubMed:16849730). May play a role in pathogenicity (PubMed:19141731).",ABC-type transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0004825,Copper,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0004827,Cystine,target,,,Humans,,,,cleavage,DrugBank,drugbank_id
BE0003670,Cholesterol transporter ABCA5,transporter,Q8WWZ7,ABCA5,Humans,Cholesterol efflux transporter in macrophages that is responsible for APOAI/high-density lipoproteins (HDL) formation at the plasma membrane under high cholesterol levels and participates in reverse cholesterol transport (PubMed:25125465). May play a role in the processing of autolysosomes (By similarity),ABC-type transporter activity,Golgi apparatus membrane,substrate,DrugBank,drugbank_id
BE0004905,ATP-sensitive potassium channel,target,P48048,KCNJ1,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This channel is activated by internal ATP and can be blocked by exte",ATP binding,Cell membrane,activator,DrugBank,drugbank_id
BE0010002,Calcium transporting ATPases,target,P98194,ATP2C1,Humans,"ATP-driven pump that supplies the Golgi apparatus with Ca(2+) and Mn(2+) ions, both essential cofactors for processing and trafficking of newly synthesized proteins in the secretory pathway (PubMed:12707275, PubMed:16192278, PubMed:20439740, PubMed:21187401, PubMed:30923126). Within a catalytic cycle, acquires Ca(2+) or Mn(2+) ions on the cytoplasmic side of the membrane and delivers them to the lumenal side. The transfer of ions across the membrane is coupled to ATP hydrolysis and is associated",ATP binding,"Golgi apparatus, trans-Golgi network membrane",inhibitor,DrugBank,drugbank_id
BE0009492,"Myosin light chain kinase, smooth muscle",target,Q15746,MYLK,Humans,"Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activity. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscl",actin binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009765,Sulfotransferase 1C4,target,O75897,SULT1C4,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of phenolic compounds. Can also sulfonate estrogenic compounds, however, the dietary flavonoids (phytoestrogen) and environmental estrogens, like bisphenol A are better substrates than 17beta-estradiol (E2) (PubMed:17425406, PubMed:26948952, PubMed:28222028, PubMed:9852044). Mediates the sulfation of doxorubicin and its analog epirubicin, two antitumor anthracyclines (PubMe",aryl sulfotransferase activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0009567,Sulfotransferase,enzyme,P50225,SULT1A1,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of a wide variety of acceptor molecules bearing a hydroxyl or an amine group. Sulfonation increases the water solubility of most compounds, and therefore their renal excretion, but it can also result in bioactivation to form active metabolites. Displays broad substrate specificity for small phenolic compounds. Plays an important role in the sulfonation of endogenous molecul",3'-phosphoadenosine 5'-phosphosulfate binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004761,Cytochrome P450 3A2,enzyme,P05183,Cyp3a2,Rat,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.","1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity",Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0001195,Cystic fibrosis transmembrane conductance regulator,target,P13569,CFTR,Humans,"Epithelial ion channel that plays an important role in the regulation of epithelial ion and water transport and fluid homeostasis (PubMed:26823428). Mediates the transport of chloride ions across the cell membrane (PubMed:10792060, PubMed:11524016, PubMed:11707463, PubMed:12519745, PubMed:12529365, PubMed:12588899, PubMed:12727866, PubMed:15010471, PubMed:17036051, PubMed:1712898, PubMed:17182731, PubMed:19398555, PubMed:19621064, PubMed:22178883, PubMed:25330774, PubMed:26846474, PubMed:2808770",14-3-3 protein binding,Apical cell membrane,antagonist,DrugBank,drugbank_id
BE0009583,5-hydroxytryptamine receptor 3B,target,O95264,HTR3B,Humans,"Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons",excitatory extracellular ligand-gated monoatomic ion channel activity,Postsynaptic cell membrane,antagonist,DrugBank,drugbank_id
BE0000120,Dihydropteroate synthase type-1,target,Q49184,sulI,Mycobacterium fortuitum,"Catalyzes the condensation of para-aminobenzoate (pABA) with 6-hydroxymethyl-7,8-dihydropterin diphosphate (DHPt-PP) to form 7,8-dihydropteroate (H2Pte), the immediate precursor of folate derivatives (By similarity). Implicated in resistance to sulfonamide (PubMed:2163027).",dihydropteroate synthase activity,,inhibitor,DrugBank,drugbank_id
BE0000629,Hemoglobin subunit beta,target,P68871,HBB,Humans,Involved in oxygen transport from the lung to the various peripheral tissues,heme binding,,activator,DrugBank,drugbank_id
BE0000130,Hemoglobin subunit alpha,target,P69905,HBA1,Humans,Involved in oxygen transport from the lung to the various peripheral tissues,heme binding,,activator,DrugBank,drugbank_id
BE0000399,Ferritin heavy chain,target,P02794,FTH1,Humans,"Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Has ferroxidase activity (PubMed:9003196). Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation (PubMed:9003196). Also plays a role in delivery of iron to cells (By similarity). Mediates iron uptake in capsule cells of the developing kidney (By similarity). Delivery to lysosomes is mediated by the cargo receptor NCOA4 for autophagic degradation and release of iron (PubM",ferric iron binding,Cytoplasm,other,DrugBank,drugbank_id
BE0000085,Ferritin light chain,target,P02792,FTL,Humans,"Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity). Delivery to lysosomes by the cargo receptor NCOA4 for autophagic degradation and release or iron (PubMed:24695223)",ferric iron binding,"Cytoplasmic vesicle, autophagosome",other,DrugBank,drugbank_id
BE0000015,High affinity immunoglobulin epsilon receptor subunit alpha,target,P12319,FCER1A,Humans,"High-affinity receptor for immunoglobulin epsilon/IgE. Mediates IgE effector functions in myeloid cells. Upon IgE binding and antigen/allergen cross-linking initiates signaling pathways that lead to myeloid cell activation and differentiation. On mast cells, basophils and eosinophils stimulates the secretion of vasoactive amines, lipid mediators and cytokines that contribute to inflammatory response, tissue remodeling and cytotoxicity against microbes. Triggers the immediate hypersensitivity res",high-affinity IgE receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0001030,G protein-activated inward rectifier potassium channel 2,target,P48051,KCNJ6,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This potassium channel may be involved in the regulation of insulin ",G-protein activated inward rectifier potassium channel activity,Membrane,,DrugBank,drugbank_id
BE0001114,Vascular cell adhesion protein 1,target,P19320,VCAM1,Humans,"Cell adhesion glycoprotein predominantly expressed on the surface of endothelial cells that plays an important role in immune surveillance and inflammation (PubMed:31310649). Acts as a major regulator of leukocyte adhesion to the endothelium through interaction with different types of integrins (PubMed:10209034). During inflammatory responses, binds ligands on the surface of activated endothelial cells to initiate the activation of calcium channels and the plasma membrane-associated small GTPase",cell adhesion mediator activity,Cell membrane,,DrugBank,drugbank_id
BE0002218,G protein-activated inward rectifier potassium channel 4,target,P48544,KCNJ5,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by external barium. This potassium channel is control",G-protein activated inward rectifier potassium channel activity,Membrane,,DrugBank,drugbank_id
BE0003595,Gamma-aminobutyric acid receptor subunit epsilon,target,P78334,GABRE,Humans,"Epsilon subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:16412217, PubMed:9882711). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interfaces (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride ani",GABA-A receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0003596,Gamma-aminobutyric acid receptor subunit pi,target,O00591,GABRP,Humans,"Pi subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA) (PubMed:10462548). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interfaces (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMe",GABA-A receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0003597,Gamma-aminobutyric acid receptor subunit theta,target,Q9UN88,GABRQ,Humans,"Theta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:10449790, PubMed:16412217). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interfaces (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride anio",GABA-A receptor activity,Postsynaptic cell membrane,,DrugBank,drugbank_id
BE0003599,Gamma-aminobutyric acid receptor subunit delta,target,O14764,GABRD,Humans,"Delta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:35355020). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:35355020). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the",chloride channel activity,Cell membrane,,DrugBank,drugbank_id
BE0009586,5-hydroxytryptamine receptor 3E,target,A5X5Y0,HTR3E,Humans,"Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons",excitatory extracellular ligand-gated monoatomic ion channel activity,Postsynaptic cell membrane,,DrugBank,drugbank_id
BE0009585,5-hydroxytryptamine receptor 3D,target,Q70Z44,HTR3D,Humans,"Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons",excitatory extracellular ligand-gated monoatomic ion channel activity,Postsynaptic cell membrane,,DrugBank,drugbank_id
BE0009584,5-hydroxytryptamine receptor 3C,target,Q8WXA8,HTR3C,Humans,"Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons",excitatory extracellular ligand-gated monoatomic ion channel activity,Postsynaptic cell membrane,,DrugBank,drugbank_id
BE0005108,Voltage-dependent calcium channel gamma-2 subunit,target,Q9Y698,CACNG2,Humans,"Regulates the trafficking and gating properties of AMPA-selective glutamate receptors (AMPARs). Promotes their targeting to the cell membrane and synapses and modulates their gating properties by slowing their rates of activation, deactivation and desensitization. Does not show subunit-specific AMPA receptor regulation and regulates all AMPAR subunits. Thought to stabilize the calcium channel in an inactivated (closed) state",channel regulator activity,Membrane,,DrugBank,drugbank_id
BE0005190,G protein-activated inward rectifier potassium channel 3,target,Q92806,KCNJ9,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium, This receptor is controlled by G proteins. Unable to produce channel",G-protein activated inward rectifier potassium channel activity,Membrane,,DrugBank,drugbank_id
BE0008999,Neural cell adhesion molecule L1,target,P32004,L1CAM,Humans,"Neural cell adhesion molecule involved in the dynamics of cell adhesion and in the generation of transmembrane signals at tyrosine kinase receptors. During brain development, critical in multiple processes, including neuronal migration, axonal growth and fasciculation, and synaptogenesis. In the mature brain, plays a role in the dynamics of neuronal structure and function, including synaptic plasticity",axon guidance receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0000522,All-trans-retinol dehydrogenase [NAD(+)] ADH7,target,P40394,ADH7,Humans,"Catalyzes the NAD-dependent oxidation of all-trans-retinol, alcohol, and omega-hydroxy fatty acids and their derivatives (PubMed:15369820, PubMed:16787387, PubMed:9600267). Oxidizes preferentially all trans-retinol, all-trans-4-hydroxyretinol, 9-cis-retinol, 2-hexenol, and long chain omega-hydroxy fatty acids such as juniperic acid (PubMed:15369820, PubMed:16787387, PubMed:9600267). In vitro can also catalyze the NADH-dependent reduction of all-trans-retinal and aldehydes and their derivatives (",alcohol dehydrogenase (NAD+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000227,Alcohol dehydrogenase 1A,enzyme,P07327,ADH1A,Humans,Alcohol dehydrogenase (PubMed:2738060). Oxidizes primary as well as secondary alcohols. Ethanol is a very poor substrate (PubMed:2738060),alcohol dehydrogenase (NAD+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000400,All-trans-retinol dehydrogenase [NAD(+)] ADH1B,enzyme,P00325,ADH1B,Humans,"Catalyzes the NAD-dependent oxidation of all-trans-retinol and its derivatives such as all-trans-4-hydroxyretinol and may participate in retinoid metabolism (PubMed:15369820, PubMed:16787387). In vitro can also catalyze the NADH-dependent reduction of all-trans-retinal and its derivatives such as all-trans-4-oxoretinal (PubMed:15369820, PubMed:16787387). Catalyzes in the oxidative direction with higher efficiency (PubMed:16787387). Has the same affinity for all-trans-4-hydroxyretinol and all-tra",alcohol dehydrogenase (NAD+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000465,Alcohol dehydrogenase 1C,enzyme,P00326,ADH1C,Humans,Alcohol dehydrogenase. Exhibits high activity for ethanol oxidation and plays a major role in ethanol catabolism,alcohol dehydrogenase (NAD+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000009,Alcohol dehydrogenase class-3,enzyme,P11766,ADH5,Humans,"Catalyzes the oxidation of long-chain primary alcohols and the oxidation of S-(hydroxymethyl) glutathione (PubMed:8460164). Also oxidizes long chain omega-hydroxy fatty acids, such as 20-HETE, producing both the intermediate aldehyde, 20-oxoarachidonate and the end product, a dicarboxylic acid, (5Z,8Z,11Z,14Z)-eicosatetraenedioate (PubMed:16081420). Class-III ADH is remarkably ineffective in oxidizing ethanol (PubMed:8460164). Required for clearance of cellular formaldehyde, a cytotoxic and carc",alcohol dehydrogenase (NAD+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000360,All-trans-retinol dehydrogenase [NAD(+)] ADH4,enzyme,P08319,ADH4,Humans,"Catalyzes the NAD-dependent oxidation of either all-trans-retinol or 9-cis-retinol (PubMed:17279314). Also oxidizes long chain omega-hydroxy fatty acids, such as 20-HETE, producing both the intermediate aldehyde, 20-oxoarachidonate and the end product, a dicarboxylic acid, (5Z,8Z,11Z,14Z)-eicosatetraenedioate (PubMed:16081420). Also catalyzes the reduction of benzoquinones (PubMed:10514444)",alcohol dehydrogenase (NAD+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0003545,Alcohol dehydrogenase 6,enzyme,P28332,ADH6,Humans,Alcohol dehydrogenase (PubMed:1755855). Catalyzes the NAD-dependent oxidation of primary alcohols to the corresponding aldehydes (PubMed:1755855). Oxidizes secondary alcohols to the corresponding ketones (By similarity),alcohol dehydrogenase (NAD+) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004352,Aldo-keto reductase family 1 member A1,enzyme,P14550,AKR1A1,Humans,"Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols (PubMed:10510318, PubMed:30538128). Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosaccharides and bile acids, with a preference for negatively charged substrates, such as glucuronate and succinic semialdehyde (PubMed:10510318, PubMed:30538128). Functions as a detoxifiying enzyme by reducing a range of toxic ",aldo-keto reductase (NADPH) activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0009011,Lymphoid enhancer-binding factor 1,target,Q9UJU2,LEF1,Humans,"Transcription factor that binds DNA in a sequence-specific manner (PubMed:2010090). Participates in the Wnt signaling pathway (By similarity). Activates transcription of target genes in the presence of CTNNB1 and EP300 (By similarity). PIAG antagonizes both Wnt-dependent and Wnt-independent activation by LEF1 (By similarity). TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1 (PubMed:11266540). Regulates T-cell receptor alpha enhancer function (PubMed:19653274). Requir",armadillo repeat domain binding,Nucleus,,DrugBank,drugbank_id
BE0000249,Sodium- and chloride-dependent GABA transporter 1,target,P30531,SLC6A1,Humans,"Mediates transport of gamma-aminobutyric acid (GABA) together with sodium and chloride and is responsible for the reuptake of GABA from the synapse (PubMed:30132828). The translocation of GABA, however, may also occur in the reverse direction leading to the release of GABA (By similarity). The direction and magnitude of GABA transport is a consequence of the prevailing thermodynamic conditions, determined by membrane potential and the intracellular and extracellular concentrations of Na(+), Cl(-",gamma-aminobutyric acid transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003636,Sodium channel regulatory subunit beta-2,target,O60939,SCN2B,Humans,"Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes (PubMed:19808477, PubMed:23559163, PubMed:26894959, PubMed:30765605, PubMed:30765606, PubMed:35277491, PubMed:36823201). Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they all",sodium channel regulator activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003637,Sodium channel regulatory subunit beta-3,target,Q9NY72,SCN3B,Humans,"Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provoke",sodium channel inhibitor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003638,Sodium channel regulatory subunit beta-4,target,Q8IWT1,SCN4B,Humans,"Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provoke",sodium channel regulator activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003626,"Carbonic anhydrase 5A, mitochondrial",target,P35218,CA5A,Humans,"Mitochondrial carbonic anhydrase that catalyzes the reversible conversion of carbon dioxide to bicarbonate/HCO3 (PubMed:24530203, PubMed:8356065). Mitochondria are impermeable to HCO3, and thus this intramitochondrial carbonic anhydrase is pivotal in providing HCO3 for multiple mitochondrial enzymes that catalyze the formation of essential metabolites of intermediary metabolism in the urea and Krebs cycles (PubMed:24530203)",carbonate dehydratase activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0003627,"Carbonic anhydrase 5B, mitochondrial",target,Q9Y2D0,CA5B,Humans,Mitochondrial carbonic anhydrase that catalyzes the reversible conversion of carbon dioxide to bicarbonate/HCO3,carbonate dehydratase activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0003630,Carbonic anhydrase-related protein,target,P35219,CA8,Humans,Does not have a carbonic anhydrase catalytic activity,carbonate dehydratase activity,,inhibitor,DrugBank,drugbank_id
BE0003631,Carbonic anhydrase-related protein 10,target,Q9NS85,CA10,Humans,Does not have a catalytic activity,carbonate dehydratase activity,,inhibitor,DrugBank,drugbank_id
BE0003632,Carbonic anhydrase-related protein 11,target,O75493,CA11,Humans,Does not have a catalytic activity,hydro-lyase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0003633,Carbonic anhydrase 13,target,Q8N1Q1,CA13,Humans,Reversible hydration of carbon dioxide,carbonate dehydratase activity,,inhibitor,DrugBank,drugbank_id
BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,target,Q13131,PRKAA1,Humans,"Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism (PubMed:17307971, PubMed:17712357, PubMed:24563466, PubMed:37821951). In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation (PubMed:17307971, PubMed:17712357). AMPK acts",[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,Cytoplasm,activator,DrugBank,drugbank_id
BE0009988,5'-AMP-activated protein kinase subunit gamma-1,target,P54619,PRKAG1,Humans,"AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism (PubMed:21680840, PubMed:24563466). In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation (PubMed:21680840, PubMed:24563466). AMPK acts via direct phosphorylation ",ADP binding,,activator,DrugBank,drugbank_id
BE0002441,ATP-sensitive inward rectifier potassium channel 8,target,Q15842,KCNJ8,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:20558321, PubMed:21836131, PubMed:24700710, PubMed:28842488). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:20558321, PubMed:21836131, PubMed:24700710, PubMed:28842488). The inward rectification is",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0000630,Matrix protein 2,target,P21430,M,Influenza A virus (strain A/Ann Arbor/6/1960 H2N2),"Forms a proton-selective ion channel that is necessary for the efficient release of the viral genome during virus entry. After attaching to the cell surface, the virion enters the cell by endocytosis. Acidification of the endosome triggers M2 ion channel activity. The influx of protons into virion interior is believed to disrupt interactions between the viral ribonucleoprotein (RNP), matrix protein 1 (M1), and lipid bilayers, thereby freeing the viral genome from interaction with viral proteins ",monoatomic ion channel activity,Virion membrane,inhibitor,DrugBank,drugbank_id
BE0004435,Oxygen-insensitive NADPH nitroreductase,target,O25608,rdxA,Helicobacter pylori (strain ATCC 700392 / 26695),"Reduction of a variety of nitroaromatic compounds using NADPH as source of reducing equivalents; two electrons are transferred (By similarity). Capable of reducing metronidazole; inactive RdxA renders the bacterium resistant to this compound. The reduction of metronidazole generates hydroxylamine, a potent mutagen and bactericide.",oxidoreductase activity,,potentiator,DrugBank,drugbank_id
BE0009695,Anaerobic bacterial DNA,target,,,,,,,inhibitor,DrugBank,drugbank_id
BE0009696,Protozoal DNA,target,,,,,,,inhibitor,DrugBank,drugbank_id
BE0002378,Nociceptin receptor,target,P41146,OPRL1,Humans,G-protein coupled opioid receptor that functions as a receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead,G protein-coupled receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0003688,Penicillin-binding protein 2,target,Q70KI2,pbpA,Bacteroides fragilis,,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0002442,Toll-like receptor 4,target,O00206,TLR4,Humans,"Transmembrane receptor that functions as a pattern recognition receptor recognizing pathogen- and damage-associated molecular patterns (PAMPs and DAMPs) to induce innate immune responses via downstream signaling pathways (PubMed:10835634, PubMed:15809303, PubMed:16622205, PubMed:17292937, PubMed:17478729, PubMed:20037584, PubMed:20711192, PubMed:23880187, PubMed:27022195, PubMed:29038465, PubMed:17803912). At the plasma membrane, cooperates with LY96 to mediate the innate immune response to bact",amyloid-beta binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003380,Cellular tumor antigen p53,target,P04637,TP53,Humans,"Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apop",14-3-3 protein binding,Cytoplasm,inducer,DrugBank,drugbank_id
BE0004876,Ribosomal protein S6 kinase alpha-3,target,P51812,RPS6KA3,Humans,"Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:16213824, PubMed:16223362, PubMed:17360704, PubMed:9770464). In f",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0003469,NF-kappa-B inhibitor alpha,target,P25963,NFKBIA,Humans,"Inhibits the activity of dimeric NF-kappa-B/REL complexes by trapping REL (RELA/p65 and NFKB1/p50) dimers in the cytoplasm by masking their nuclear localization signals (PubMed:1493333, PubMed:36651806, PubMed:7479976). On cellular stimulation by immune and pro-inflammatory responses, becomes phosphorylated promoting ubiquitination and degradation, enabling the dimeric RELA to translocate to the nucleus and activate transcription (PubMed:7479976, PubMed:7628694, PubMed:7796813, PubMed:7878466)",enzyme binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000444,Caspase-1,target,P29466,CASP1,Humans,"Thiol protease involved in a variety of inflammatory processes by proteolytically cleaving other proteins, such as the precursors of the inflammatory cytokines interleukin-1 beta (IL1B) and interleukin 18 (IL18) as well as the pyroptosis inducer Gasdermin-D (GSDMD), into active mature peptides (PubMed:15326478, PubMed:15498465, PubMed:1574116, PubMed:26375003, PubMed:32051255, PubMed:37993714, PubMed:7876192, PubMed:9334240). Plays a key role in cell immunity as an inflammatory response initiato",CARD domain binding,Cytoplasm,inhibitor|downregulator,DrugBank,drugbank_id
BE0001027,G1/S-specific cyclin-D1,target,P24385,CCND1,Humans,"Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed:1827756, PubMed:1833066, PubMed:19412162, PubMed:33854235, PubMed:8114739, PubMed:8302605). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression",cyclin-dependent protein serine/threonine kinase activator activity,Nucleus,downregulator,DrugBank,drugbank_id
BE0004689,Myc proto-oncogene protein,target,P01106,MYC,Humans,"Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed:24940000, PubMed:25956029). Activates the transcription of growth-related genes (PubMed:24940000, PubMed:25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed:24940000, PubMed:25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF",core promoter sequence-specific DNA binding,"Nucleus, nucleoplasm",downregulator,DrugBank,drugbank_id
BE0009669,Cyclin A,target,,,,,,,downregulator,DrugBank,drugbank_id
BE0001944,Dihydrofolate reductase,target,P9WNX1,folA,Mycobacterium tuberculosis,"Key enzyme in folate metabolism. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis.",dihydrofolate reductase activity,,,DrugBank,drugbank_id
BE0009795,20-ketosteroid reductase (20-hydroxysteroid dehydrogenase),enzyme,Q04828,AKR1C1,Humans and other mammals,"Cytosolic aldo-keto reductase that catalyzes the NADH and NADPH-dependent reduction of ketosteroids to hydroxysteroids (PubMed:19218247). Most probably acts as a reductase in vivo since the oxidase activity measured in vitro is inhibited by physiological concentrations of NADPH (PubMed:14672942). Displays a broad positional specificity acting on positions 3, 17 and 20 of steroids and regulates the metabolism of hormones like estrogens and androgens (PubMed:10998348). May also reduce conjugated s","17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase [NAD(P)+] activity","Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0009796,11beta-hydroxysteroid dehydrogenase,enzyme,P28845,HSD11B1,Humans and other mammals,"Controls the reversible conversion of biologically active glucocorticoids such as cortisone to cortisol, and 11-dehydrocorticosterone to corticosterone in the presence of NADP(H) (PubMed:10497248, PubMed:12460758, PubMed:14973125, PubMed:15152005, PubMed:15280030, PubMed:17593962, PubMed:21453287, PubMed:27927697, PubMed:30902677). Participates in the corticosteroid receptor-mediated anti-inflammatory response, as well as metabolic and homeostatic processes (PubMed:10497248, PubMed:12414862, Pub",11-beta-hydroxysteroid dehydrogenase (NADP+) activity,Endoplasmic reticulum membrane,,DrugBank,drugbank_id
BE0000865,Phenylethanolamine N-methyltransferase,enzyme,P11086,PNMT,Humans,"Catalyzes the transmethylation of nonepinephrine (noradrenaline) to form epinephrine (adrenaline), using S-adenosyl-L-methionine as the methyl donor (PubMed:20496117). Other substrates include phenylethanolamine and octopamine (PubMed:16277617, PubMed:16363801, PubMed:8812853). Also methylates normetanephrine (By similarity)",phenylethanolamine N-methyltransferase activity,,substrate,DrugBank,drugbank_id
BE0004951,DNA topoisomerase 2,target,P11388,TOP2A,Humans,"Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand (PubMed:17567603, PubMed:18790802, PubMed:22013166, PubMed:22323612). May play a role in regulating the period length of BMAL1 transcriptional oscillation (By similarity)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001117,Leukotriene C4 synthase,target,Q16873,LTC4S,Humans,"Catalyzes the conjugation of leukotriene A4 with reduced glutathione (GSH) to form leukotriene C4 with high specificity (PubMed:23409838, PubMed:27365393, PubMed:27791009, PubMed:7937884, PubMed:9153254). Can also catalyze the transfer of a glutathionyl group from glutathione (GSH) to 13(S),14(S)-epoxy-docosahexaenoic acid to form maresin conjugate in tissue regeneration 1 (MCTR1), a bioactive lipid mediator that possess potent anti-inflammatory and proresolving actions (PubMed:27791009)",enzyme activator activity,Nucleus outer membrane,inhibitor,DrugBank,drugbank_id
BE0000105,Sterol O-acyltransferase 1,target,P35610,SOAT1,Humans,"Catalyzes the formation of fatty acid-cholesterol esters, which are less soluble in membranes than cholesterol (PubMed:16154994, PubMed:16647063, PubMed:32433613, PubMed:32433614, PubMed:32944968, PubMed:9020103). Plays a role in lipoprotein assembly and dietary cholesterol absorption (PubMed:16154994, PubMed:9020103). Preferentially utilizes oleoyl-CoA ((9Z)-octadecenoyl-CoA) as a substrate: shows a higher activity towards an acyl-CoA substrate with a double bond at the delta-9 position (9Z) th",cholesterol binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0001078,Aminopeptidase N,target,P15144,ANPEP,Humans,"Broad specificity aminopeptidase which plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases. Also involved in the processing of various peptides including peptide hormones, such as angiotensin III and IV, neuropeptides, and chemokines. May also be involved the cleavage of peptides bound to major histocompatibility complex class II molecules of antigen presenting cells. May have a role in angiogenesis and promote cholesterol cry",alanyl aminopeptidase activity,Cell membrane,other,DrugBank,drugbank_id
BE0004808,Lead,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0004812,Manganese cation,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,Q9Y233,PDE10A,Humans,"Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides (PubMed:10373451, PubMed:10393245, PubMed:16330539, PubMed:17389385, PubMed:27058447). Can hydrolyze both cAMP and cGMP, but has higher affinity for cAMP and is more efficient with cAMP as substrate (PubMed:10373451, PubMed:10393245, PubMed:17389385, PubMed:27058447). May play a critical role in regulating cAMP and cGMP levels in the striatum, a region of the brain that contributes to the cont","3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity","Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0009008,Calcipressin-1,target,P53805,RCAN1,Humans,Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A (PubMed:12809556). Could play a role during central nervous system development (By similarity),calcium-dependent protein serine/threonine phosphatase regulator activity,,inhibitor,DrugBank,drugbank_id
BE0000327,Melatonin receptor type 1B,target,P49286,MTNR1B,Humans,High affinity receptor for melatonin. Likely to mediate the reproductive and circadian actions of melatonin. The activity of this receptor is mediated by pertussis toxin sensitive G proteins that inhibit adenylate cyclase activity,G protein-coupled receptor activity,Cell membrane,multitarget,DrugBank,drugbank_id
BE0000515,Melatonin receptor type 1A,target,P48039,MTNR1A,Humans,"High affinity receptor for melatonin. Likely to mediate the reproductive and circadian actions of melatonin. The activity of this receptor is mediated by pertussis toxin sensitive G proteins that inhibit adenylate cyclase activity. Possibly involved in sleep induction, by melatonin activation of the potassium channel KCNMA1/BK and the dissociation of G-beta and G-gamma subunits, thereby decreasing synaptic transmission (By similarity)",G protein-coupled receptor activity,Cell membrane,multitarget,DrugBank,drugbank_id
BE0000113,DNA polymerase beta,target,P06746,POLB,Humans,"Repair polymerase that plays a key role in base-excision repair (PubMed:10556592, PubMed:9207062, PubMed:9572863). During this process, the damaged base is excised by specific DNA glycosylases, the DNA backbone is nicked at the abasic site by an apurinic/apyrimidic (AP) endonuclease, and POLB removes 5'-deoxyribose-phosphate from the preincised AP site acting as a 5'-deoxyribose-phosphate lyase (5'-dRP lyase); through its DNA polymerase activity, it adds one nucleotide to the 3' end of the arisi",5'-deoxyribose-5-phosphate lyase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0004700,Deoxycytidylate deaminase,enzyme,P32321,DCTD,Humans,"Catalyzes the deamination of dCMP to dUMP, providing the nucleoside monophosphate substrate for the thymidylate synthase/TYMS (PubMed:7685356). Also, part of a nucleotide salvage pathway that eliminates epigenetically modified 5-hydroxymethyl-dCMP (hmdCMP) in a two-step process entailing deamination to cytotoxic 5-hydroxymethyl-dUMP (hmdUMP), followed by its hydrolysis into 5-hydroxymethyluracil (hmU) and 2-deoxy-D-ribose 5-phosphate (deoxyribosephosphate) (PubMed:33833118). Catalyzes the first ",5-hydroxymethyl-dUMP N-hydrolase activity,,substrate,DrugBank,drugbank_id
BE0001109,Ras-related C3 botulinum toxin substrate 1,target,P63000,RAC1,Humans,"Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization, neurons adhesion, migration and differentiation, and growth-factor induced formation of membrane ruffles (PubMed:1643658, PubMed:22843693, PubMed:23512198, PubMed:28886345). Rac1 p21/rho GDI heterodimer is t",enzyme binding,Cell membrane,modulator,DrugBank,drugbank_id
BE0009809,Nucleotide triphosphate diphosphatase NUDT15,enzyme,Q9NV35,NUDT15,Humans,"May catalyze the hydrolysis of nucleoside triphosphates including dGTP, dTTP, dCTP, their oxidized forms like 8-oxo-dGTP and the prodrug thiopurine derivatives 6-thio-dGTP and 6-thio-GTP (PubMed:26238318). Could also catalyze the hydrolysis of some nucleoside diphosphate derivatives (PubMed:22556419, PubMed:26238318). Hydrolyzes oxidized nucleosides triphosphates like 8-oxo-dGTP in vitro, but the specificity and efficiency towards these substrates are low. Therefore, the potential in vivo saniti","8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity",,substrate,DrugBank,drugbank_id
BE0002281,Glutathione S-transferase A1,enzyme,P08263,GSTA1,Humans,"Glutathione S-transferase that catalyzes the nucleophilic attack of the sulfur atom of glutathione on the electrophilic groups of a wide range of exogenous and endogenous compounds (Probable). Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2) (PubMed:9084911). It also catalyzes the isomerization of D5-androstene-3,17-dione (AD) into D4-androstene-3,17-dione and may therefore play an important role in hormone biosynthesis (PubMed:11152",fatty acid binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004443,Inosine triphosphate pyrophosphatase,enzyme,Q9BY32,ITPA,Humans,"Pyrophosphatase that hydrolyzes the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP) as well as 2'-deoxy-N-6-hydroxylaminopurine triphosphate (dHAPTP) and xanthosine 5'-triphosphate (XTP) to their respective monophosphate derivatives. The enzyme does not distinguish between the deoxy- and ribose forms. Probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal",dITP diphosphatase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0009810,Equilibrative nucleobase transporter 1,transporter,Q8NBI5,SLC43A3,Humans,"Sodium-independent purine-selective nucleobase transporter which mediates the equilibrative transport of extracellular purine nucleobases such as adenine, guanine and hypoxanthine (PubMed:26455426, PubMed:32339528). May regulate fatty acid (FA) transport in adipocytes, acting as a positive regulator of FA efflux and as a negative regulator of FA uptake (By similarity)",adenine transmembrane transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0000907,"Peroxiredoxin-5, mitochondrial",target,P30044,PRDX5,Humans,"Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events",antioxidant activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0002400,Potassium voltage-gated channel subfamily KQT member 5,target,Q9NR82,KCNQ5,Humans,"Pore-forming subunit of the voltage-gated potassium (Kv) channel broadly expressed in brain and involved in the regulation of neuronal excitability (PubMed:10787416, PubMed:10816588, PubMed:11159685, PubMed:28669405). Associates with KCNQ3/Kv7.3 pore-forming subunit to form a potassium channel which contributes to M-type current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons (PubMed:108165",voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,Cell membrane,activator,DrugBank,drugbank_id
BE0005819,Nucleolar and coiled-body phosphoprotein 1,target,Q14978,NOLC1,Humans,"Nucleolar protein that acts as a regulator of RNA polymerase I by connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification (PubMed:10567578, PubMed:26399832). Required for neural crest specification: following monoubiquitination by the BCR(KBTBD8) complex, associates with TCOF1 and acts as a platform to connect RNA polymerase I with enzymes responsible for ribosomal processing and modification, leading to remodel the translational program of differentiating ",ATP binding,"Nucleus, nucleolus",inhibitor,DrugBank,drugbank_id
BE0000729,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",enzyme,O75306,NDUFS2,Humans,"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:22036843, PubMed:28031252, PubMed:30922174). Essential for the catalytic activity of complex I (PubMed:22036843, PubMed:30922174). Essential for the assembly of complex I (By similarity). Redox-sensitive, critical component of the oxygen-sensing pathway in the pulmonary vasculature w","4 iron, 4 sulfur cluster binding",Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000191,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",enzyme,O75489,NDUFS3,Humans,"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:14729820, PubMed:30140060). Essential for the catalytic activity and assembly of complex I (PubMed:14729820, PubMed:24028823, PubMed:30140060)",electron transfer activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0000307,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",enzyme,O75251,NDUFS7,Humans,"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:17275378). Essential for the catalytic activity of complex I (PubMed:17275378)","4 iron, 4 sulfur cluster binding",Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0003673,Mitochondrial potassium channel ATP-binding subunit,transporter,Q9NUT2,ABCB8,Humans,"ATP-binding subunit of the mitochondrial ATP-gated potassium channel (mitoK(ATP)) (PubMed:31435016). Together with pore-forming subunit CCDC51/MITOK of the mitoK(ATP) channel, mediates ATP-dependent potassium currents across the mitochondrial inner membrane (PubMed:31435016). An increase in ATP intracellular levels closes the channel, inhibiting K(+) transport, whereas a decrease in ATP levels enhances K(+) uptake in the mitochondrial matrix (PubMed:31435016). Plays a role in mitochondrial iron ",ABC-type transporter activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0004008,Urease subunit alpha,enzyme,P41020,ureC,Bacillus pasteurii,,nickel cation binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004691,Urea transporter 2,transporter,Q15849,SLC14A2,Humans,Mediates the transport of urea driven by a concentration gradient across the cell membrane of the renal inner medullary collecting duct which is critical to the urinary concentrating mechanism,cell adhesion molecule binding,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0004692,Urea transporter 1,transporter,Q13336,SLC14A1,Humans,"Mediates the transport of urea driven by a concentration gradient across the cell membrane of erythrocytes (PubMed:10514515, PubMed:7797558, PubMed:7989337, PubMed:8997401). Also mediates the transport of urea across the cell membrane of the renal inner medullary collecting duct which is critical to the urinary concentrating mechanism (By similarity). Facilitates water transport in erythrocytes (By similarity)",urea channel activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000875,Lanosterol 14-alpha demethylase,target,Q16850,CYP51A1,Humans,"Sterol 14alpha-demethylase that plays a critical role in the cholesterol biosynthesis pathway, being cholesterol the major sterol component in mammalian membranes as well as a precursor for bile acid and steroid hormone synthesis (PubMed:20149798, PubMed:8619637, PubMed:9559662). Cytochrome P450 monooxygenase that catalyzes the three-step oxidative removal of the 14alpha-methyl group (C-32) of sterols such as lanosterol (lanosta-8,24-dien-3beta-ol) and 24,25-dihydrolanosterol (DHL) in the form o",heme binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0002290,Microsomal glutathione S-transferase 2,enzyme,Q99735,MGST2,Humans,"Catalyzes several different glutathione-dependent reactions (PubMed:23409838, PubMed:26066610, PubMed:26656251, PubMed:8703034, PubMed:9278457). Catalyzes the glutathione-dependent reduction of lipid hydroperoxides, such as 5-HPETE (PubMed:23409838, PubMed:9278457). Has glutathione transferase activity, toward xenobiotic electrophiles, such as 1-chloro-2, 4-dinitrobenzene (CDNB) (PubMed:23409838, PubMed:8703034). Also catalyzes the conjugation of leukotriene A4 with reduced glutathione to form l",enzyme activator activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0003552,C-X-C chemokine receptor type 1,target,P25024,CXCR1,Humans,"Receptor to interleukin-8, which is a powerful neutrophils chemotactic factor (PubMed:1840701). Binding of IL-8 to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system (PubMed:8662698)",C-C chemokine binding,Cell membrane,other,DrugBank,drugbank_id
BE0001246,Camphor 5-monooxygenase,target,P00183,camC,Pseudomonas putida,Involved in a camphor oxidation system.,camphor 5-monooxygenase activity,Cytoplasm,other/unknown,DrugBank,drugbank_id
BE0000638,NADPH azoreductase,enzyme,Q9FAW5,azr,Bacillus sp. (strain OY1-2),"Catalyzes the reductive cleavage of azo bond in aromatic azo compounds to the corresponding amines. Requires NADPH as an electron donor for its activity. Compounds with paired naphthalene groups coupled with the azo group are good substrates, with the following preference order: Rocceline > Sumifix Black B > Solar Orange.",azobenzene reductase activity,,substrate,DrugBank,drugbank_id
BE0004923,Mitochondrial ATP-sensitive potassium channel,target,Q14654,KCNJ11,Humans,"Inward rectifier potassium channel that forms the pore of ATP-sensitive potassium channels (KATP), regulating potassium permeability as a function of cytoplasmic ATP and ADP concentrations in many different cells (PubMed:29286281, PubMed:34815345). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is",ankyrin binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0009748,Transient receptor potential cation channel subfamily M member 4,target,Q8TD43,TRPM4,Humans,"Calcium-activated selective cation channel that mediates membrane depolarization (PubMed:12015988, PubMed:12842017, PubMed:29211723, PubMed:30528822). While it is activated by increase in intracellular Ca(2+), it is impermeable to it (PubMed:12015988). Mediates transport of monovalent cations (Na(+) > K(+) > Cs(+) > Li(+)), leading to depolarize the membrane (PubMed:12015988). It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, e",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000058,Matrix metalloproteinase-9,target,P14780,MMP9,Humans,"Matrix metalloproteinase that plays an essential role in local proteolysis of the extracellular matrix and in leukocyte migration (PubMed:12879005, PubMed:1480034, PubMed:2551898). Could play a role in bone osteoclastic resorption (By similarity). Cleaves KiSS1 at a Gly-|-Leu bond (PubMed:12879005). Cleaves NINJ1 to generate the Secreted ninjurin-1 form (PubMed:32883094). Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragment",collagen binding,"Secreted, extracellular space, extracellular matrix",inhibitor,DrugBank,drugbank_id
BE0001009,Cytochrome c,target,P99999,CYCS,Humans,"Electron carrier protein. The oxidized form of the cytochrome c heme group can accept an electron from the heme group of the cytochrome c1 subunit of cytochrome reductase. Cytochrome c then transfers this electron to the cytochrome oxidase complex, the final protein carrier in the mitochondrial electron-transport chain",electron transfer activity,Mitochondrion intermembrane space,negative modulator,DrugBank,drugbank_id
BE0009853,Mitogen-activated Protein Kinases,target,P28482,MAPK1,Humans,"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, c",ATP binding,"Cytoplasm, cytoskeleton, spindle",inhibitor,DrugBank,drugbank_id
BE0001570,Outer membrane porin F,transporter,P02931,ompF,Escherichia coli (strain K12),Forms pores that allow passive diffusion of small molecules across the outer membrane.,colicin transmembrane transporter activity,Cell outer membrane,substrate,DrugBank,drugbank_id
BE0009852,Outer membrane porin C,transporter,P06996,ompC,Escherichia coli (strain K12),Forms pores that allow passive diffusion of small molecules across the outer membrane.,identical protein binding,Cell outer membrane,substrate,DrugBank,drugbank_id
BE0004727,Cytochrome P450 4F2,enzyme,P78329,CYP4F2,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, eicosanoids and vitamins (PubMed:10660572, PubMed:10833273, PubMed:11997390, PubMed:17341693, PubMed:18574070, PubMed:18577768). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). Catalyzes predomi",20-aldehyde-leukotriene B4 20-monooxygenase activity,Microsome membrane,substrate,DrugBank,drugbank_id
BE0010058,UbiA prenyltransferase domain-containing protein 1,enzyme,Q9Y5Z9,UBIAD1,Humans,"Prenyltransferase that mediates the formation of menaquinone-4 (MK-4) and coenzyme Q10 (PubMed:20953171, PubMed:23374346). MK-4 is a vitamin K2 isoform present at high concentrations in the brain, kidney and pancreas, and is required for endothelial cell development (PubMed:20953171). Mediates the conversion of phylloquinone (PK) into MK-4, probably by cleaving the side chain of phylloquinone (PK) to release 2-methyl-1,4-naphthoquinone (menadione; K3) and then prenylating it with geranylgeranyl ",antioxidant activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0003566,"Troponin C, skeletal muscle",target,P02585,TNNC2,Humans,"Troponin is the central regulatory protein of striated muscle contraction. Tn consists of three components: Tn-I which is the inhibitor of actomyosin ATPase, Tn-T which contains the binding site for tropomyosin and Tn-C. The binding of calcium to Tn-C abolishes the inhibitory action of Tn on actin filaments",calcium ion binding,,other,DrugBank,drugbank_id
BE0000690,Lanosterol 14-alpha demethylase,target,P50859,ERG11,,"Sterol 14alpha-demethylase that plays a critical role in the third module of ergosterol biosynthesis pathway, being ergosterol the major sterol component in fungal membranes that participates in a variety of functions (By similarity). The third module or late pathway involves the ergosterol synthesis itself through consecutive reactions that mainly occur in the endoplasmic reticulum (ER) membrane (By similarity). In filamentous fungi, during the initial step of this module, lanosterol (lanosta-8",heme binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0004873,Steroid 21-hydroxylase,target,P08686,CYP21A2,Humans,"A cytochrome P450 monooxygenase that plays a major role in adrenal steroidogenesis. Catalyzes the hydroxylation at C-21 of progesterone and 17alpha-hydroxyprogesterone to respectively form 11-deoxycorticosterone and 11-deoxycortisol, intermediate metabolites in the biosynthetic pathway of mineralocorticoids and glucocorticoids (PubMed:10602386, PubMed:16984992, PubMed:22014889, PubMed:25855791, PubMed:27721825). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, a",17-hydroxyprogesterone 21-hydroxylase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0004729,Cytochrome P450 4F12,enzyme,Q9HCS2,CYP4F12,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of endogenous polyunsaturated fatty acids (PUFAs). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). Catalyzes the hydroxylation of carbon hydrogen bonds, with preference for omega-2 position. Metabolizes (5Z,8Z,11Z,14Z)-eicosatetraenoic acid (arachidon",alkane 1-monooxygenase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009016,Taste receptor type 2 member 16,target,Q9NYV7,TAS2R16,Humans,Gustducin-coupled receptor implicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract. Signals through PLCB2 and the calcium-regulated cation channel TRPM5,bitter taste receptor activity,Cell membrane,inhibitory allosteric modulator,DrugBank,drugbank_id
BE0003719,Pannexin-1,target,Q96RD7,PANX1,Humans,"Ion channel involved in a variety of physiological functions such as blood pressure regulation, apoptotic cell clearance and oogenesis (PubMed:15304325, PubMed:16908669, PubMed:20829356, PubMed:20944749, PubMed:30918116). Forms anion-selective channels with relatively low conductance and an order of permeabilities: nitrate>iodide>chlroride>>aspartate=glutamate=gluconate (By similarity). Can release ATP upon activation through phosphorylation or cleavage at C-terminus (PubMed:32238926). May play ",actin filament binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000440,Monocarboxylate transporter 2,transporter,O60669,SLC16A7,Humans,"Proton-coupled monocarboxylate symporter. Catalyzes the rapid transport across the plasma membrane of monocarboxylates such as L-lactate, pyruvate and ketone bodies, acetoacetate, beta-hydroxybutyrate and acetate (PubMed:32415067, PubMed:9786900). Dimerization is functionally required and both subunits work cooperatively in transporting substrate (PubMed:32415067)",identical protein binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004941,Inosine-5'-monophosphate dehydrogenase,target,P20839,IMPDH1,Humans,"Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors",DNA binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000801,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,P0A953,fabB,Escherichia coli (strain K12),"Involved in the type II fatty acid elongation cycle. Catalyzes the elongation of a wide range of acyl-ACP by the addition of two carbons from malonyl-ACP to an acyl acceptor (PubMed:19679654, PubMed:22017312, PubMed:8910376, PubMed:9013860). Can also use unsaturated fatty acids (PubMed:19679654, PubMed:3076377, PubMed:8910376). Catalyzes a key reaction in unsaturated fatty acid (UFA) synthesis, the elongation of the cis-3-decenoyl-ACP produced by FabA (PubMed:19679654). Can use acyl chains from ",3-oxoacyl-[acyl-carrier-protein] synthase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000800,3-oxoacyl-[acyl-carrier-protein] synthase 2,target,P0AAI5,fabF,Escherichia coli (strain K12),"Involved in the type II fatty acid elongation cycle (PubMed:6988423, PubMed:9013860). Catalyzes the elongation of a wide range of acyl-ACP by the addition of two carbons from malonyl-ACP to an acyl acceptor (PubMed:22017312, PubMed:9013860). Can efficiently catalyze the conversion of palmitoleoyl-ACP (cis-hexadec-9-enoyl-ACP) to cis-vaccenoyl-ACP (cis-octadec-11-enoyl-ACP), an essential step in the thermal regulation of fatty acid composition (PubMed:6988423, PubMed:9013860). Can use acyl chains",3-oxoacyl-[acyl-carrier-protein] synthase activity,,inhibitor,DrugBank,drugbank_id
BE0000558,Beta-ketoacyl-[acyl-carrier-protein] synthase III,target,P0A6R0,fabH,Escherichia coli (strain K12),Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Has some substrate specificity for acetyl-CoA. Its substrate specificity determines the biosynthesis of straight-chain of fatty acid,3-oxoacyl-[acyl-carrier-protein] synthase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000959,Fatty acid synthase,target,P49327,FASN,Humans,Fatty acid synthetase is a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This multifunctional protein contains 7 catalytic activities and a site for the binding of the prosthetic group 4'-phosphopantetheine of the acyl carrier protein ([ACP]) domain,(3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009742,Matrix metalloproteinase-25,target,Q9NPA2,MMP25,Humans,May activate progelatinase A,metalloendopeptidase activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004709,Asc-type amino acid transporter 1,transporter,Q9NS82,SLC7A10,Humans,"Associates with SLC3A2/4F2hc to form a functional heterodimeric complex that translocates small neutral L- and D-amino acids across the plasma membrane. Preferentially mediates exchange transport, but can also operate via facilitated diffusion (By similarity) (PubMed:10863037). Acts as a major transporter for glycine, L- and D-serine in the central nervous system. At the spinal cord and brainstem regulates glycine metabolism and glycinergic inhibitory neurotransmission by providing for glycine d",L-amino acid transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0003724,DNA gyrase subunit A,target,P72524,gyrA,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to modulate DNA topology and maintain chromosomes in an underwound state. Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Also able to catalyze the interconversion of other topological isomers of dsDNA rings, including catenanes and knotted rings. Type II topoisomerases break an",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003725,DNA gyrase subunit B,target,P0A4L9,gyrB,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to modulate DNA topology and maintain chromosomes in an underwound state. Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Also able to catalyze the interconversion of other topological isomers of dsDNA rings, including catenanes and knotted rings. Type II topoisomerases break an",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003726,DNA topoisomerase 4 subunit A,target,P72525,parC,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),"Topoisomerase IV is essential for chromosome segregation. It relaxes supercoiled DNA (PubMed:17375187, PubMed:20596531). Performs the decatenation events required during the replication of a circular DNA molecule.",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003727,DNA topoisomerase 4 subunit B,target,Q59961,parE,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Topoisomerase IV is essential for chromosome segregation. It relaxes supercoiled DNA. Performs the decatenation events required during the replication of a circular DNA molecule.,ATP binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0010989,DNA-directed RNA polymerase subunit beta,target,P9WGY9,rpoB,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates.,DNA binding,,inhibitor,DrugBank,drugbank_id
BE0000765,Chloride channel protein 2,target,P51788,CLCN2,Humans,"Voltage-gated and osmosensitive chloride channel. Forms a homodimeric channel where each subunit has its own ion conduction pathway. Conducts double-barreled currents controlled by two types of gates, two fast glutamate gates that control each subunit independently and a slow common gate that opens and shuts off both subunits simultaneously. Displays inward rectification currents activated upon membrane hyperpolarization and extracellular hypotonicity (PubMed:16155254, PubMed:17567819, PubMed:19",chloride channel regulator activity,Cell membrane,inducer,DrugBank,drugbank_id
BE0004659,Protein smoothened,target,Q99835,SMO,Humans,"G protein-coupled receptor which associates with the patched protein (PTCH) to transduce hedgehog protein signaling. Binding of sonic hedgehog (SHH) to its receptor patched prevents inhibition of smoothened (SMO) by patched. When active, SMO binds to and sequesters protein kinase A catalytic subunit PRKACA at the cell membrane, preventing PRKACA-mediated phosphorylation of GLI transcription factors which releases the GLI proteins from PRKACA-mediated inhibition and allows for transcriptional act",cAMP-dependent protein kinase inhibitor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0009376,Dopamine receptor,target,P21728,DRD1,Humans,Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase,arrestin family protein binding,Cell membrane,antagonist|agonist,DrugBank,drugbank_id
BE0004862,Serotonin Receptors,target,P08908,HTR1A,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:37935376, PubMed:37935377, PubMed:8138923, PubMed:8393041). Also functions as a receptor for various drugs and psychoactive substances (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:38552625, PubMed:8138923, PubMed:8393041). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the acti",G protein-coupled serotonin receptor activity,Cell membrane,antagonist|agonist,DrugBank,drugbank_id
BE0000961,Interleukin-8,target,P10145,CXCL8,Humans,"Chemotactic factor that mediates inflammatory response by attracting neutrophils, basophils, and T-cells to clear pathogens and protect the host from infection (PubMed:18692776, PubMed:7636208). Also plays an important role in neutrophil activation (PubMed:2145175, PubMed:9623510). Released in response to an inflammatory stimulus, exerts its effect by binding to the G-protein-coupled receptors CXCR1 and CXCR2, primarily found in neutrophils, monocytes and endothelial cells (PubMed:1840701, PubMe",chemokine activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0001025,Platelet glycoprotein Ib alpha chain,target,P07359,GP1BA,Humans,"GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium",thrombin-activated receptor activity,Membrane,inducer,DrugBank,drugbank_id
BE0003756,Protein S100-A7,target,P31151,S100A7,Humans,,calcium ion binding,Cytoplasm,inducer,DrugBank,drugbank_id
BE0009569,Alpha-methylacyl-CoA racemase,enzyme,D6RB81,AMACR,Humans,,catalytic activity,,substrate,DrugBank,drugbank_id
BE0003723,Penicillin-binding protein 1C,target,P76577,pbpC,Escherichia coli (strain K12),Cell wall formation. The enzyme has a penicillin-insensitive transglycosylase N-terminal domain (formation of linear glycan strands) and a transpeptidase C-terminal domain which may not be functional.,carboxypeptidase activity,Cell inner membrane,binder,DrugBank,drugbank_id
BE0004654,Penicillin-binding protein 3,target,A0A0H2XJ39,pbp3,Staphylococcus aureus (strain USA300),,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0003894,Beta-lactamase TEM,enzyme,P62593,bla,Escherichia coli,"TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins. TEM-3 and TEM-4 are capable of hydrolyzing cefotaxime and ceftazidime. TEM-5 is capable of hydrolyzing ceftazidime. TEM-6 is capable of hydrolyzing ceftazidime and aztreonam. TEM-8/CAZ-2, TEM-16/CAZ-7 and TEM-24/CAZ-6 are markedly active against ceftazidime. IRT-4 shows resistance to beta-lacta",beta-lactamase activity,Cytoplasmic,substrate,DrugBank,drugbank_id
BE0004851,Schistosome calcium ion (Ca2+) channels,target,,,Schistosoma,,,,other/unknown,DrugBank,drugbank_id
BE0001167,Hematopoietic prostaglandin D synthase,target,O60760,HPGDS,Humans,"Bifunctional enzyme which catalyzes both the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation, and the conjugation of glutathione with a wide range of aryl halides and organic isothiocyanates. Also exhibits low glutathione-peroxidase activity towards cumene hydroperoxide",calcium ion binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009851,Penicillin binding protein,target,Q8L103,PBP1,Helicobacter pylori,,carboxypeptidase activity,,inhibitor,DrugBank,drugbank_id
BE0001426,Metallo-beta-lactamase type 2,enzyme,P04190,blm,Bacillus cereus,"Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring. Active on cephalosporin and penicillin.",beta-lactamase activity,Cytoplasmic,substrate,DrugBank,drugbank_id
BE0000981,Interleukin-12 subunit beta,target,P29460,IL12B,Humans,"Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC",cytokine activity,Secreted,modulator,DrugBank,drugbank_id
BE0003554,Nuclear receptor ROR-beta,target,Q92753,RORB,Humans,"Nuclear receptor that binds DNA as a monomer to ROR response elements (RORE) containing a single core motif half-site 5'-AGGTCA-3' preceded by a short A-T-rich sequence. Considered to have intrinsic transcriptional activity, have some natural ligands such as all-trans retinoic acid (ATRA) and other retinoids which act as inverse agonists repressing the transcriptional activity. Required for normal postnatal development of rod and cone photoreceptor cells. Modulates rod photoreceptors differentia","DNA-binding transcription activator activity, RNA polymerase II-specific","Nucleus, nucleoplasm",agonist,DrugBank,drugbank_id
BE0003555,Eosinophil peroxidase,target,P11678,EPX,Humans,Mediates tyrosine nitration of secondary granule proteins in mature resting eosinophils. Shows significant inhibitory activity towards Mycobacterium tuberculosis H37Rv by inducing bacterial fragmentation and lysis,heme binding,Cytoplasmic granule,inhibitor,DrugBank,drugbank_id
BE0003553,Acetylserotonin O-methyltransferase,enzyme,P46597,ASMT,Humans,"Catalyzes the transfer of a methyl group onto N-acetylserotonin, producing melatonin (N-acetyl-5-methoxytryptamine)",acetylserotonin O-methyltransferase activity,,substrate,DrugBank,drugbank_id
BE0009827,P2 Purinoceptors,target,Q99677,LPAR4,,"Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. Transduces a signal by increasing the intracellular calcium ions and by stimulating adenylyl cyclase activity. The rank order of potency for agonists of this receptor is 1-oleoyl- > 1-stearoyl- > 1-palmitoyl- > 1-myristoyl- > 1-alkyl- > 1-alkenyl-LPA",lysophosphatidic acid binding,Cell membrane,modulator,DrugBank,drugbank_id
BE0000854,Dipeptidyl peptidase 4,target,P27487,DPP4,Humans,"Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation (PubMed:10900005, PubMed:10951221, PubMed:11772392, PubMed:17287217). Acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC (PubMed:10900005, PubMed:10951221, PubMed:11772392, PubMed:14691230). Its binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent man",aminopeptidase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0003620,Gastric triacylglycerol lipase,target,P07098,LIPF,Humans,"Catalyzes the hydrolysis of triacylglycerols to yield free fatty acids, diacylglycerol, monoacylglycerol, and glycerol (PubMed:10358049, PubMed:2243091). Shows a preferential hydrolysis at the sn-3 position of triacylglycerol (PubMed:2243091)",lipid binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0002459,"Keratin, type II cytoskeletal 7",target,P08729,KRT7,Humans,Blocks interferon-dependent interphase and stimulates DNA synthesis in cells. Involved in the translational regulation of the human papillomavirus type 16 E7 mRNA (HPV16 E7),structural constituent of skin epidermis,Cytoplasm,other/unknown,DrugBank,drugbank_id
BE0003471,Interleukin-5 receptor subunit alpha,target,Q01344,IL5RA,Humans,"Cell surface receptor that plays an important role in the survival, differentiation, and chemotaxis of eosinophils (PubMed:9378992). Acts by forming a heterodimeric receptor with CSF2RB subunit and subsequently binding to interleukin-5 (PubMed:1495999, PubMed:22528658). In unstimulated conditions, interacts constitutively with JAK2. Heterodimeric receptor activation leads to JAK2 stimulation and subsequent activation of the JAK-STAT pathway (PubMed:9516124)",cytokine binding,Membrane,downregulator,DrugBank,drugbank_id
BE0002439,Mucin-16,target,Q8WXI7,MUC16,Humans,"Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces",,Cell membrane,downregulator,DrugBank,drugbank_id
BE0000232,Microsomal triglyceride transfer protein large subunit,target,P55157,MTTP,Humans,"Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid between phospholipid surfaces (PubMed:15897609, PubMed:16478722, PubMed:22236406, PubMed:23475612, PubMed:25108285, PubMed:26224785, PubMed:8876250, PubMed:8939939). Required for the assembly and secretion of plasma lipoproteins that contain apolipoprotein B (PubMed:16478722, PubMed:23475612, PubMed:26224785, PubMed:8876250, PubMed:8939939). May be involved in regulating cholesteryl ester biosynthesis in cells that prod",apolipoprotein binding,Endoplasmic reticulum,antagonist,DrugBank,drugbank_id
BE0012021,Diacylglycerol O-acyltransferase 1,target,O75907,DGAT1,Humans,"Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates (PubMed:16214399, PubMed:18768481, PubMed:28420705, PubMed:32433610, PubMed:32433611, PubMed:9756920). Highly expressed in epithelial cells of the small intestine and its activity is essential for the absorption of dietary fats (PubMed:18768481). In liver, plays a role in esterifying exogenous fatty acids to glycerol, and is required to synthesize fat for storage (",2-acylglycerol O-acyltransferase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0004608,Sterol O-acyltransferase 2,target,O75908,SOAT2,Humans,"Catalyzes the formation of fatty acid-cholesterol esters, which are less soluble in membranes than cholesterol (PubMed:11294643, PubMed:16647063). Plays a role in lipoprotein assembly and dietary cholesterol absorption (PubMed:11294643). Utilizes oleoyl-CoA ((9Z)-octadecenoyl-CoA) and linolenoyl-CoA ((9Z,12Z,15Z)-octadecatrienoyl-CoA) as substrates (PubMed:11294643). May provide cholesteryl esters for lipoprotein secretion from hepatocytes and intestinal mucosa (PubMed:11294643)",acyltransferase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,Q02127,DHODH,Humans,Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. Required for UMP biosynthesis via de novo pathway,dihydroorotase activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0000871,Protein-tyrosine kinase 2-beta,target,Q14289,PTK2B,Humans,"Non-receptor protein-tyrosine kinase that regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading and bone remodeling. Plays a role in the regulation of the humoral immune response, and is required for normal levels of marginal B-cells in the spleen and normal migration of splenic B-cells. Required for normal macrophage polarization and migration towards sites of inflammation. Regulates cytoskeleton rearrangement and cell spreading in T-cells, a",ATP binding,Cytoplasm,antagonist,DrugBank,drugbank_id
BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,Q08210,,Plasmodium falciparum (isolate 3D7),Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.,dihydroorotate dehydrogenase (quinone) activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0001077,85/88 kDa calcium-independent phospholipase A2,target,O60733,PLA2G6,Humans,"Calcium-independent phospholipase involved in phospholipid remodeling with implications in cellular membrane homeostasis, mitochondrial integrity and signal transduction. Hydrolyzes the ester bond of the fatty acyl group attached at sn-1 or sn-2 position of phospholipids (phospholipase A1 and A2 activity respectively), producing lysophospholipids that are used in deacylation-reacylation cycles (PubMed:10092647, PubMed:10336645, PubMed:20886109, PubMed:9417066). Hydrolyzes both saturated and unsa",1-alkyl-2-acetylglycerophosphocholine esterase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001081,Inactive phospholipase C-like protein 1,target,Q15111,PLCL1,Humans,"Involved in an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol. Component in the phospho-dependent endocytosis process of GABA A receptor (By similarity). Regulates the turnover of receptors and thus contributes to the maintenance of GABA-mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as an inhibitor of PPP1C","phosphatidylinositol-4,5-bisphosphate phospholipase C activity",Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000464,Neurotensin receptor type 2,target,O95665,NTSR2,Humans,Receptor for the tridecapeptide neurotensin. It is associated with G proteins that activate a phosphatidylinositol-calcium second messenger system,G protein-coupled neurotensin receptor activity,Cell membrane,partial antagonist,DrugBank,drugbank_id
BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,target,P14060,HSD3B1,Humans,"A bifunctional enzyme responsible for the oxidation and isomerization of 3beta-hydroxy-Delta(5)-steroid precursors to 3-oxo-Delta(4)-steroids, an essential step in steroid hormone biosynthesis. Specifically catalyzes the conversion of pregnenolone to progesterone, 17alpha-hydroxypregnenolone to 17alpha-hydroxyprogesterone, dehydroepiandrosterone (DHEA) to 4-androstenedione, and androstenediol to testosterone. Additionally, catalyzes the interconversion between 3beta-hydroxy and 3-oxo-5alpha-andr",3-beta-hydroxy-Delta5-steroid dehydrogenase (NAD+) activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0001159,P-selectin,target,P16109,SELP,Humans,Ca(2+)-dependent receptor for myeloid cells that binds to carbohydrates on neutrophils and monocytes. Mediates the interaction of activated endothelial cells or platelets with leukocytes. The ligand recognized is sialyl-Lewis X. Mediates rapid rolling of leukocyte rolling over vascular surfaces during the initial steps in inflammation through interaction with SELPLG. Mediates cell-cell interactions and cell adhesion via the interaction with integrin alpha-IIb/beta3 (ITGA2B:ITGB3) and integrin al,calcium ion binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001203,Fibroblast growth factor receptor 4,target,P22455,FGFR4,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to th",ATP binding,Cell membrane,,DrugBank,drugbank_id
BE0005820,Fibroblast growth factor 19,target,O95750,FGF19,Humans,"Involved in the suppression of bile acid biosynthesis through down-regulation of CYP7A1 expression, following positive regulation of the JNK and ERK1/2 cascades. Stimulates glucose uptake in adipocytes. Activity requires the presence of KLB and FGFR4",fibroblast growth factor receptor binding,Secreted,activator,DrugBank,drugbank_id
BE0001064,Heparanase,enzyme,Q9Y251,HPSE,Humans,"Endoglycosidase that cleaves heparan sulfate proteoglycans (HSPGs) into heparan sulfate side chains and core proteoglycans. Participates in extracellular matrix (ECM) degradation and remodeling. Selectively cleaves the linkage between a glucuronic acid unit and an N-sulfo glucosamine unit carrying either a 3-O-sulfo or a 6-O-sulfo group. Can also cleave the linkage between a glucuronic acid unit and an N-sulfo glucosamine unit carrying a 2-O-sulfo group, but not linkages between a glucuronic aci",beta-glucuronidase activity,Lysosome membrane,substrate,DrugBank,drugbank_id
BE0008716,Voltage-dependent T-type calcium channel,target,O43497,CACNA1G,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1G gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group and are strongly blocked by mibefradil. A particularity of this type of c",high voltage-gated calcium channel activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0004428,Cytochrome b,target,Q02768,MT-CYB,Plasmodium falciparum,Component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex) that is part of the mitochondrial respiratory chain. The b-c1 complex mediates electron transfer from ubiquinol to cytochrome c. Contributes to the generation of a proton gradient across the mitochondrial membrane that is then used for ATP synthesis.,metal ion binding,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0009811,Thyroid hormone receptor,target,P10827,THRA,Humans and other mammals,"Nuclear hormone receptor that can act as a repressor or activator of transcription. High affinity receptor for thyroid hormones, including triiodothyronine and thyroxine",chromatin DNA binding,Nucleus,antagonist|binder,DrugBank,drugbank_id
BE0009812,Peroxisome proliferator-activated receptor gamma coactivator 1-beta,target,Q86YN6,PPARGC1B,Humans,"Plays a role of stimulator of transcription factors and nuclear receptors activities. Activates transcriptional activity of estrogen receptor alpha, nuclear respiratory factor 1 (NRF1) and glucocorticoid receptor in the presence of glucocorticoids. May play a role in constitutive non-adrenergic-mediated mitochondrial biogenesis as suggested by increased basal oxygen consumption and mitochondrial number when overexpressed. May be involved in fat oxidation and non-oxidative glucose metabolism and ",AF-2 domain binding,Nucleus,agonist,DrugBank,drugbank_id
BE0010209,Mitochondrial ATP synthase F1 domain,target,P25705,ATP5F1A,Humans,"Subunit alpha, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the",ADP binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0009676,Sodium-dependent dopamine transporter,transporter,Q61327,Slc6a3,Mouse,"Mediates sodium- and chloride-dependent transport of dopamine (PubMed:10375632, PubMed:12606774). Also mediates sodium- and chloride-dependent transport of norepinephrine (also known as noradrenaline) (By similarity). Regulator of light-dependent retinal hyaloid vessel regression, downstream of OPN5 signaling (PubMed:30936473).",amine binding,Cell membrane,binder,DrugBank,drugbank_id
BE0009675,Synaptic vesicular amine transporter,transporter,Q8BRU6,Slc18a2,Mouse,"Electrogenic antiporter that exchanges one cationic monoamine with two intravesicular protons across the membrane of secretory and synaptic vesicles. Uses the electrochemical proton gradient established by the V-type proton-pump ATPase to accumulate high concentrations of monoamines inside the vesicles prior to their release via exocytosis. Transports a variety of catecholamines such as dopamine, adrenaline and noradrenaline, histamine, and indolamines such as serotonin (By similarity) (PubMed:1",amine transmembrane transporter activity,Cytoplasmic vesicle membrane,binder,DrugBank,drugbank_id
BE0008669,Adenosine triphosphate (ATP),target,,,Humans,,,,inhibitor,DrugBank,drugbank_id
BE0009940,Tyrosine-protein phosphatase non-receptor type 12,target,Q05209,PTPN12,Humans,"Dephosphorylates a range of proteins, and thereby regulates cellular signaling cascades (PubMed:18559503). Dephosphorylates cellular tyrosine kinases, such as ERBB2 and PTK2B/PYK2, and thereby regulates signaling via ERBB2 and PTK2B/PYK2 (PubMed:17329398, PubMed:27134172). Selectively dephosphorylates ERBB2 phosphorylated at 'Tyr-1112', 'Tyr-1196', and/or 'Tyr-1248' (PubMed:27134172)",non-membrane spanning protein tyrosine phosphatase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009941,Tyrosine-protein phosphatase non-receptor type 6,target,P29350,PTPN6,Humans,"Tyrosine phosphatase enzyme that plays important roles in controlling immune signaling pathways and fundamental physiological processes such as hematopoiesis (PubMed:14739280, PubMed:29925997). Dephosphorylates and negatively regulate several receptor tyrosine kinases (RTKs) such as EGFR, PDGFR and FGFR, thereby modulating their signaling activities (PubMed:21258366, PubMed:9733788). When recruited to immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing receptors such as immunoglobul",cell adhesion molecule binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009961,V-ATPase Subunits,target,Q93050,ATP6V0A1,Humans,"Subunit of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that transports protons across cellular membranes. V-ATPase is responsible for the acidification of various organelles, such as lysosomes, endosomes, the trans-Golgi network, and secretory granules, including synaptic vesicles (PubMed:33065002, PubMed:33833240, PubMed:34909687). In certain cell types, can be exported to ",ATPase binding,"Cytoplasmic vesicle, clathrin-coated vesicle membrane",inhibitor,DrugBank,drugbank_id
BE0000173,NADH dehydrogenase [ubiquinone] 1 subunit C2,target,O95298,NDUFC2,Humans,"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis but required for the complex assembly. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone",NADH dehydrogenase (ubiquinone) activity,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0000979,Natriuretic peptides B,target,P16860,NPPB,Humans,"Cardiac hormone that plays a key role in mediating cardio-renal homeostasis (PubMed:1672777, PubMed:17372040, PubMed:1914098, PubMed:9458824). May also function as a paracrine antifibrotic factor in the heart (By similarity). Acts by specifically binding and stimulating NPR1 to produce cGMP, which in turn activates effector proteins that drive various biological responses (PubMed:1672777, PubMed:17349887, PubMed:17372040, PubMed:21098034, PubMed:25339504, PubMed:9458824). Involved in regulating ",diuretic hormone activity,Secreted,other,DrugBank,drugbank_id
BE0001074,E-selectin,target,P16581,SELE,Humans,Cell-surface glycoprotein having a role in immunoadhesion. Mediates in the adhesion of blood neutrophils in cytokine-activated endothelium through interaction with SELPLG/PSGL1. May have a role in capillary morphogenesis,metal ion binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002374,Hypoxia-inducible factor 1-alpha,target,Q16665,HIF1A,Humans,"Functions as a master transcriptional regulator of the adaptive response to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:18658046, PubMed:20624928, PubMed:22009797, PubMed:30125331, PubMed:9887100). Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delive",cis-regulatory region sequence-specific DNA binding,Cytoplasm,modulator,DrugBank,drugbank_id
BE0005187,Inward rectifier potassium channel 4,target,P48050,KCNJ4,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium and cesium",inward rectifier potassium channel activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009710,Inward rectifier potassium channel 2,target,P63252,KCNJ2,Humans,"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:36149965, PubMed:7590287, PubMed:9490857). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:7590287, PubMed:7696590). The inward rectification is mainly due to the blockage of outward current by inter",identical protein binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003195,Arylsulfatase A,enzyme,P15289,ARSA,Humans,Hydrolyzes cerebroside sulfate,arylsulfatase activity,Endoplasmic reticulum,substrate,DrugBank,drugbank_id
BE0000896,"Alkaline phosphatase, germ cell type",target,P10696,ALPG,Humans,Alkaline phosphatase that can hydrolyze various phosphate compounds,alkaline phosphatase activity,Cell membrane,inducer,DrugBank,drugbank_id
BE0001868,Penicillin-binding protein 2X,target,P59676,pbpX,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),A transpeptidase that forms peptide cross-links between adjacent glycan strands in cell wall peptidoglycan (PG). Part of the divisome machinery that synthesizes the septal cross wall. Beta-lactams inactivate the PBPs by acylating an essential serine residue in the active site of these proteins.,penicillin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003395,Penicillin-binding protein 1A,target,Q04707,ponA,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Cell wall formation.,penicillin binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0002392,Penicillin-binding protein 2x,target,P14677,pbpX,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),A transpeptidase that forms peptide cross-links between adjacent glycan strands in cell wall peptidoglycan (PG). Part of the divisome machinery that synthesizes the septal cross wall. Beta-lactams inactivate the PBPs by acylating an essential serine residue in the active site of these proteins.,penicillin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000142,Penicillin-binding protein 2B,target,P0A3M5,penA,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),A transpeptidase that forms peptide cross-links between adjacent glycan strands in cell wall peptidoglycan (PG). Part of the elongasome machinery that synthesizes peripheral PG.,penicillin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009972,Plasma membrane calcium-transporting ATPase,target,P20020,ATP2B1,Humans,Catalyzes the hydrolysis of ATP coupled with the transport of calcium from the cytoplasm to the extracellular space thereby maintaining intracellular calcium homeostasis (PubMed:35358416). Plays a role in blood pressure regulation through regulation of intracellular calcium concentration and nitric oxide production leading to regulation of vascular smooth muscle cells vasoconstriction. Positively regulates bone mineralization through absorption of calcium from the intestine. Plays dual roles in ,ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001200,Rhodopsin,target,P08100,RHO,Humans,"Photoreceptor required for image-forming vision at low light intensity (PubMed:7846071, PubMed:8107847). Required for photoreceptor cell viability after birth (PubMed:12566452, PubMed:2215617). Light-induced isomerization of the chromophore 11-cis-retinal to all-trans-retinal triggers a conformational change that activates signaling via G-proteins (PubMed:26200343, PubMed:28524165, PubMed:28753425, PubMed:8107847). Subsequent receptor phosphorylation mediates displacement of the bound G-protein ",11-cis retinal binding,Membrane,other,DrugBank,drugbank_id
BE0001080,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,target,P59768,GNG2,Humans,"Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems (PubMed:29925951, PubMed:33762731, PubMed:34239069, PubMed:35610220, PubMed:35714614, PubMed:35835867, PubMed:36087581, PubMed:36989299, PubMed:37327704, PubMed:37935376, PubMed:37935377, PubMed:37963465, PubMed:38168118, PubMed:38552625). The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector inte",G-protein beta-subunit binding,Cell membrane,other/unknown,DrugBank,drugbank_id
BE0000948,Neuropeptide S receptor,target,Q6W5P4,NPSR1,Humans,G-protein coupled receptor for neuropeptide S (NPS) (PubMed:16790440). Promotes mobilization of intracellular Ca(2+) stores (PubMed:16790440). Inhibits cell growth in response to NPS binding (PubMed:15947423). Involved in pathogenesis of asthma and other IgE-mediated diseases,neuropeptide receptor activity,Cell membrane,other/unknown,DrugBank,drugbank_id
BE0000885,Protein S100-A13,target,Q99584,S100A13,Humans,"Plays a role in the export of proteins that lack a signal peptide and are secreted by an alternative pathway. Binds two calcium ions per subunit. Binds one copper ion. Binding of one copper ion does not interfere with calcium binding. Required for the copper-dependent stress-induced export of IL1A and FGF1. The calcium-free protein binds to lipid vesicles containing phosphatidylserine, but not to vesicles containing phosphatidylcholine (By similarity)",calcium ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0010965,Lanosterol 14-alpha demethylase,target,P14263,ERG11,Candida tropicalis,"Sterol 14alpha-demethylase that plays a critical role in the third module of ergosterol biosynthesis pathway, being ergosterol the major sterol component in fungal membranes that participates in a variety of functions (By similarity). The third module or late pathway involves the ergosterol synthesis itself through consecutive reactions that mainly occur in the endoplasmic reticulum (ER) membrane (By similarity). In filamentous fungi, during the initial step of this module, lanosterol (lanosta-8",heme binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0000428,RAC-alpha serine/threonine-protein kinase,target,P31749,AKT1,Humans,"AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMe",14-3-3 protein binding,Cytoplasm,inducer,DrugBank,drugbank_id
BE0005808,Protein PML,target,P29590,PML,Humans,"Functions via its association with PML-nuclear bodies (PML-NBs) in a wide range of important cellular processes, including tumor suppression, transcriptional regulation, apoptosis, senescence, DNA damage response, and viral defense mechanisms. Acts as the scaffold of PML-NBs allowing other proteins to shuttle in and out, a process which is regulated by SUMO-mediated modifications and interactions. Inhibits EIF4E-mediated mRNA nuclear export by reducing EIF4E affinity for the 5' 7-methylguanosine",cobalt ion binding,Nucleus,degradation,DrugBank,drugbank_id
BE0002566,Aminoglycoside 2'-N-acetyltransferase,enzyme,P9WQG9,aac,Mycobacterium tuberculosis,"May catalyze the coenzyme A-dependent acetylation of the 2' hydroxyl or amino group of a broad spectrum of aminoglycosides and confer resistance to aminoglycosides (By similarity). In vitro assays show no significant increase of resistance to aminoglycosides, possibly due to low expression in a heterologous system (PubMed:9159528).",aminoglycoside 2'-N-acetyltransferase activity,,substrate,DrugBank,drugbank_id
BE0003547,Aminoglycoside nucleotidyltransferase (4'),enzyme,P05057,knt,Staphylococcus aureus,Inactivates the antibiotic kanamycin by catalyzing the transfer of a nucleotidyl group from nucleoside triphosphates such as ATP to the 4'-hydroxyl group of the aminoglycoside.,nucleotidyltransferase activity,,substrate,DrugBank,drugbank_id
BE0003548,Aminoglycoside 3'-phosphotransferase,enzyme,P00551,aphA1,Escherichia coli,"Resistance to kanamycin and structurally-related aminoglycosides, including amikacin.",ATP binding,,substrate,DrugBank,drugbank_id
BE0009850,Large ribosomal subunit protein uL1,target,Q2G0P0,rplA,Staphylococcus aureus (strain NCTC 8325),"Binds directly to 23S rRNA. The L1 stalk is quite mobile in the ribosome, and is involved in E site tRNA release.",rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0005295,Ryanodine receptor 2,target,Q92736,RYR2,Humans,"Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) cytosolic levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required fo",calcium channel activity,Sarcoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0001100,Microtubule-associated protein 2,target,P11137,MAP2,Humans,The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules,calmodulin binding,"Cytoplasm, cytoskeleton",antagonist,DrugBank,drugbank_id
BE0001169,Microtubule-associated protein 1A,target,P78559,MAP1A,Humans,Structural protein involved in the filamentous cross-bridging between microtubules and other skeletal elements,actin binding,"Cytoplasm, cytoskeleton",antagonist,DrugBank,drugbank_id
BE0000642,72 kDa type IV collagenase,target,P08253,MMP2,Humans,"Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidat",endopeptidase activity,"Secreted, extracellular space, extracellular matrix",inhibitor,DrugBank,drugbank_id
BE0001680,Leukotriene A-4 hydrolase,target,P09960,LTA4H,Humans,"Bifunctional zinc metalloenzyme that comprises both epoxide hydrolase (EH) and aminopeptidase activities. Acts as an epoxide hydrolase to catalyze the conversion of LTA4 to the pro-inflammatory mediator leukotriene B4 (LTB4) (PubMed:11917124, PubMed:12207002, PubMed:15078870, PubMed:18804029, PubMed:1897988, PubMed:1975494, PubMed:2244921). Also has aminopeptidase activity, with high affinity for N-terminal arginines of various synthetic tripeptides (PubMed:18804029, PubMed:20813919). In additio",aminopeptidase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000186,DNA-directed RNA polymerase subunit beta',target,P9WGY7,rpoC,Mycobacterium tuberculosis,DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates.,DNA binding,,inhibitor,DrugBank,drugbank_id
BE0000993,Synaptic vesicle glycoprotein 2A,target,Q7L0J3,SV2A,Humans,"Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles (By similarity)",protein kinase binding,Presynapse,agonist,DrugBank,drugbank_id
BE0009712,"POU domain, class 2, transcription factor 1",transporter,P14859,POU2F1,Humans,"Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3') and activates the promoters of the genes for some small nuclear RNAs (snRNA) and of genes such as those for histone H2B and immunoglobulins. Modulates transcription transactivation by NR3C1, AR and PGR",DNA binding,Nucleus,substrate,DrugBank,drugbank_id
BE0004865,"POU domain, class 2, transcription factor 2",transporter,P09086,POU2F2,Humans,"Transcription factor that specifically binds to the octamer motif (5'-ATTTGCAT-3') (PubMed:2904654, PubMed:7859290). Regulates IL6 expression in B cells with POU2AF1 (By similarity). Regulates transcription in a number of tissues in addition to activating immunoglobulin gene expression (PubMed:2901913, PubMed:2904654). Modulates transcription transactivation by NR3C1, AR and PGR (PubMed:10480874)",DNA-binding transcription factor activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004003,Stathmin-4,target,Q9H169,STMN4,Humans,Exhibits microtubule-destabilizing activity,tubulin binding,Golgi apparatus,antagonist,DrugBank,drugbank_id
BE0001893,Thromboxane-A synthase,target,P24557,TBXAS1,Humans,"Catalyzes the conversion of prostaglandin H2 (PGH2) to thromboxane A2 (TXA2), a potent inducer of blood vessel constriction and platelet aggregation (PubMed:11097184, PubMed:11297515, PubMed:22735388, PubMed:24009185, PubMed:8436233, PubMed:9873013). Also cleaves PGH2 to 12-hydroxy-heptadecatrienoicacid (12-HHT) and malondialdehyde, which is known to act as a mediator of DNA damage. 12-HHT and malondialdehyde are formed stoichiometrically in the same amounts as TXA2 (PubMed:11297515, PubMed:2273",12-hydroxyheptadecatrienoic acid synthase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0001207,Catalase,target,P04040,CAT,Humans,"Catalyzes the degradation of hydrogen peroxide (H(2)O(2)) generated by peroxisomal oxidases to water and oxygen, thereby protecting cells from the toxic effects of hydrogen peroxide (PubMed:7882369). Promotes growth of cells including T-cells, B-cells, myeloid leukemia cells, melanoma cells, mastocytoma cells and normal and transformed fibroblast cells (PubMed:7882369)",aminoacylase activity,Peroxisome matrix,inhibitor,DrugBank,drugbank_id
BE0009674,Solute carrier family 12 member 5,transporter,Q91V14,Slc12a5,Mouse,"Mediates electroneutral potassium-chloride cotransport in mature neurons and is required for neuronal Cl(-) homeostasis (By similarity). As major extruder of intracellular chloride, it establishes the low neuronal Cl(-) levels required for chloride influx after binding of GABA-A and glycine to their receptors, with subsequent hyperpolarization and neuronal inhibition (By similarity). Involved in the regulation of dendritic spine formation and maturation (By similarity).",ammonium transmembrane transporter activity,Cell projection,modulator,DrugBank,drugbank_id
BE0001694,Plasmepsin II,target,P46925,PMII,Plasmodium falciparum,"During the asexual blood stage, participates in initial cleavage of native host hemoglobin (Hb) resulting in Hb denaturation (PubMed:11782538, PubMed:15574427, PubMed:8844673). May cleave preferentially denatured hemoglobin that has been cleaved by PMI (PubMed:8844673). Digestion of host Hb is an essential step which provides the parasite with amino acids for protein synthesis, and regulates osmolarity (Probable).",aspartic-type endopeptidase activity,Vacuole,inhibitor,DrugBank,drugbank_id
BE0004957,5-hydroxytryptamine receptor 2,target,P28223,HTR2A,Humans,"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:1330647, PubMed:18703043, PubMed:19057895, PubMed:21645528, PubMed:22300836, PubMed:35084960, PubMed:38552625). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD) (PubMed:28129538, PubMed:35084960). Ligand binding causes a conformation change that triggers signaling via guanine nuc","1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding",Cell membrane,antagonist,DrugBank,drugbank_id
BE0000074,Nuclear receptor subfamily 0 group B member 1,target,P51843,NR0B1,Humans,"Nuclear receptor that lacks a DNA-binding domain and acts as a corepressor that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions (PubMed:12482977, PubMed:32433991). Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis (PubMed:7990953, PubMed:8675564). May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)",AF-2 domain binding,Nucleus,stimulator,DrugBank,drugbank_id
BE0009966,Mitochondrial potassium channel,target,Q96ER9,CCDC51,Humans,"Pore-forming subunit of the mitochondrial ATP-gated potassium channel (mitoK(ATP)) (PubMed:31435016). Together with ATP-binding subunit ABCB8/MITOSUR of the mitoK(ATP) channel, mediates ATP-dependent K(+) currents across the mitochondrial inner membrane (PubMed:31435016). An increase in ATP intracellular levels closes the channel, inhibiting K(+) transport, whereas a decrease in ATP levels enhances K(+) uptake in the mitochondrial matrix. May contribute to the homeostatic control of cellular met",mitochondrial ATP-gated potassium channel activity,Mitochondrion inner membrane,activator,DrugBank,drugbank_id
BE0000968,Histamine H3 receptor,target,Q9Y5N1,HRH3,Humans,The H3 subclass of histamine receptors could mediate the histamine signals in CNS and peripheral nervous system. Signals through the inhibition of adenylate cyclase and displays high constitutive activity (spontaneous activity in the absence of agonist). Agonist stimulation of isoform 3 neither modified adenylate cyclase activity nor induced intracellular calcium mobilization,histamine receptor activity,Cell membrane,ligand,DrugBank,drugbank_id
BE0005055,Sodium-dependent phosphate transporter 1,transporter,Q8WUM9,SLC20A1,Humans,"Sodium-phosphate symporter which preferentially transports the monovalent form of phosphate with a stoichiometry of two sodium ions per phosphate ion (PubMed:11009570, PubMed:16790504, PubMed:17494632, PubMed:19726692, PubMed:7929240, PubMed:8041748). May play a role in extracellular matrix and cartilage calcification as well as in vascular calcification (PubMed:11009570). Essential for cell proliferation but this function is independent of its phosphate transporter activity (PubMed:19726692)",high-affinity phosphate,Cell membrane,upregulator,DrugBank,drugbank_id
BE0010055,Sodium/Potassium Transporting ATPase,transporter,P05023,ATP1A1,Humans,"This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients (PubMed:29499166, PubMed:30388404). Could also be part of an osmosensory signaling pathway that senses body-fluid sodium levels and controls salt intake behavior as well as voluntary ",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000838,Proto-oncogene tyrosine-protein kinase Src,target,P12931,SRC,Humans,"Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors (PubMed:34234773). Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosi",ATP binding,Cell membrane,inhibitor|multitarget,DrugBank,drugbank_id
BE0000841,Ephrin type-A receptor 2,target,P29317,EPHA2,Humans,"Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation ",ATP binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000842,Tyrosine-protein kinase Lck,target,P06239,LCK,Humans,Non-receptor tyrosine-protein kinase that plays an essential role in the selection and maturation of developing T-cells in the thymus and in the function of mature T-cells. Plays a key role in T-cell antigen receptor (TCR)-linked signal transduction pathways. Constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules,ATP binding,Cell membrane,inhibitor|multitarget,DrugBank,drugbank_id
BE0000840,Tyrosine-protein kinase Yes,target,P07947,YES1,Humans,"Non-receptor protein tyrosine kinase that is involved in the regulation of cell growth and survival, apoptosis, cell-cell adhesion, cytoskeleton remodeling, and differentiation. Stimulation by receptor tyrosine kinases (RTKs) including EGFR, PDGFR, CSF1R and FGFR leads to recruitment of YES1 to the phosphorylated receptor, and activation and phosphorylation of downstream substrates. Upon EGFR activation, promotes the phosphorylation of PARD3 to favor epithelial tight junction assembly. Participa",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000839,Tyrosine-protein kinase Fyn,target,P06241,FYN,Humans,"Non-receptor tyrosine-protein kinase that plays a role in many biological processes including regulation of cell growth and survival, cell adhesion, integrin-mediated signaling, cytoskeletal remodeling, cell motility, immune response and axon guidance (PubMed:11536198, PubMed:15489916, PubMed:15557120, PubMed:16387660, PubMed:20100835, PubMed:7568038, PubMed:7822789). Inactive FYN is phosphorylated on its C-terminal tail within the catalytic domain (PubMed:15489916). Following activation by PKA,",alpha-tubulin binding,Cytoplasm,inhibitor|multitarget,DrugBank,drugbank_id
BE0000891,Signal transducer and activator of transcription 5B,target,P51692,STAT5B,Humans,Carries out a dual function: signal transduction and activation of transcription (PubMed:29844444). Mediates cellular responses to the cytokine KITLG/SCF and other growth factors. Binds to the GAS element and activates PRL-induced transcription. Positively regulates hematopoietic/erythroid differentiation,chromatin binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000435,Tyrosine-protein kinase ABL2,target,P42684,ABL2,Humans,"Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates ",actin filament binding,"Cytoplasm, cytoskeleton",multitarget,DrugBank,drugbank_id
BE0001284,Tyrosine-protein kinase BTK,target,Q06187,BTK,Humans,"Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling (PubMed:19290921). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (PubMed:19290921). After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members (P",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0008998,Nuclear receptor subfamily 4 group A member 3,target,Q92570,NR4A3,Humans,"Transcriptional activator that binds to regulatory elements in promoter regions in a cell- and response element (target)-specific manner. Induces gene expression by binding as monomers to the NR4A1 response element (NBRE) 5'-AAAAGGTCA-3' site and as homodimers to the Nur response element (NurRE) site in the promoter of their regulated target genes (By similarity). Plays a role in the regulation of proliferation, survival and differentiation of many different cell types and also in metabolism and",cAMP response element binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0001356,Tyrosine-protein kinase CSK,target,P41240,CSK,Humans,"Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN, CSK or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0005587,Ephrin type-A receptor 5,target,P54756,EPHA5,Humans,"Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 most probably constitutes the cognate/functional ligand for EPHA5. Functions as an",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002453,Ephrin type-B receptor 4,target,P54760,EPHB4,Humans,"Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Together with its cognate ligand/functional ligand EFNB2 it is involved in the regulation of cell adhesion and migration, an",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0005539,Tyrosine-protein kinase Fgr,target,P09769,FGR,Humans,"Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors devoid of kinase activity and contributes to the regulation of immune responses, including neutrophil, monocyte, macrophage and mast cell functions, cytoskeleton remodeling in response to extracellular stimuli, phagocytosis, cell adhesion and migration. Promotes mast cell degranulation, release of inflammatory cytokines and IgE-mediated anaphylaxis. Acts downstream of receptors that bind the Fc region of immu",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004742,Tyrosine-protein kinase FRK,target,P42685,FRK,Humans,"Non-receptor tyrosine-protein kinase that negatively regulates cell proliferation. Positively regulates PTEN protein stability through phosphorylation of PTEN on 'Tyr-336', which in turn prevents its ubiquitination and degradation, possibly by reducing its binding to NEDD4. May function as a tumor suppressor",ATP binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0003775,Heat shock cognate 71 kDa protein,target,P11142,HSPA8,Humans,"Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, chaperone-mediated autophagy, activation of proteolysis of misfolded proteins, formation and dissociation of protein complexes, and antigen presentation. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targetin",ATP binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0004315,Tyrosine-protein kinase Lyn,target,P07948,LYN,Humans,"Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down-regulation an",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0005595,Mitogen-activated protein kinase kinase kinase 20,target,Q9NYL2,MAP3K20,Humans,"Stress-activated component of a protein kinase signal transduction cascade that promotes programmed cell death in response to various stress, such as ribosomal stress, osmotic shock and ionizing radiation (PubMed:10924358, PubMed:11836244, PubMed:12220515, PubMed:14521931, PubMed:15350844, PubMed:15737997, PubMed:18331592, PubMed:20559024, PubMed:26999302, PubMed:32289254, PubMed:32610081, PubMed:35857590). Acts by catalyzing phosphorylation of MAP kinase kinases, leading to activation of the JN",ATP binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0001019,Mitogen-activated protein kinase 14,target,Q16539,MAPK14,Humans,"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each",ATP binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0000843,Large ribosomal subunit protein uL3,target,Q9A1X4,rplC,Streptococcus pyogenes serotype M1,"One of the primary rRNA binding proteins, it binds directly near the 3'-end of the 23S rRNA, where it nucleates assembly of the 50S subunit.",rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0011325,Eukaryotic elongation factor 2 kinase,target,O00418,EEF2K,Humans,"Threonine kinase that regulates protein synthesis by controlling the rate of peptide chain elongation. Upon activation by a variety of upstream kinases including AMPK or TRPM7, phosphorylates the elongation factor EEF2 at a single site, renders it unable to bind ribosomes and thus inactive. In turn, the rate of protein synthesis is reduced",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0003109,Antigen peptide transporter 1,transporter,Q03518,TAP1,Humans,"ABC transporter associated with antigen processing. In complex with TAP2 mediates unidirectional translocation of peptide antigens from cytosol to endoplasmic reticulum (ER) for loading onto MHC class I (MHCI) molecules (PubMed:25377891, PubMed:25656091). Uses the chemical energy of ATP to export peptides against the concentration gradient (PubMed:25377891). During the transport cycle alternates between 'inward-facing' state with peptide binding site facing the cytosol to 'outward-facing' state ",ABC-type peptide antigen transporter activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0010009,DNA (cytosine-5)-methyltransferase 3B,target,Q9UBC3,DNMT3B,Humans,Required for genome-wide de novo methylation and is essential for the establishment of DNA methylation patterns during development. DNA methylation is coordinated with methylation of histones. May preferentially methylates nucleosomal DNA within the nucleosome core region. May function as transcriptional co-repressor by associating with CBX4 and independently of DNA methylation. Seems to be involved in gene silencing (By similarity). In association with DNMT1 and via the recruitment of CTCFL/BOR,DNA (cytosine-5-)-methyltransferase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000915,Hepatocyte growth factor receptor,target,P08581,MET,Humans,"Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, ",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0010179,Adenylate cyclase,target,Q08828,ADCY1,Humans,Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. Mediates responses to increased cellular Ca(2+)/calmodulin levels (By similarity). May be involved in regulatory processes in the central nervous system. May play a role in memory and learning. Plays a role in the regulation of the circadian rhythm of daytime contrast sensitivity probably by modulating the rhythmic synthesis of cyclic AMP in the retina (By similarity),adenylate cyclase activity,Membrane,activator,DrugBank,drugbank_id
BE0003418,Insulin-like growth factor 1,target,P05019,IGF1,Humans,"The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake",growth factor activity,Secreted,gene replacement,DrugBank,drugbank_id
BE0003623,Cation-independent mannose-6-phosphate receptor,target,P11717,IGF2R,Humans,"Mediates the transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes (PubMed:18817523, PubMed:2963003). Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelysosomal compartment where the low pH mediates the dissociation of the complex (PubMed:18817523, PubMed:2963003). The receptor is then recycled back t",D-mannose binding,Golgi apparatus membrane,agonist,DrugBank,drugbank_id
BE0009058,Insulin-like growth factor-binding protein complex acid labile subunit,carrier,P35858,IGFALS,Humans,"Involved in protein-protein interactions that result in protein complexes, receptor-ligand binding or cell adhesion",insulin-like growth factor binding,"Secreted, extracellular space",carrier,DrugBank,drugbank_id
BE0009658,Insulin-like growth factor-binding protein 1,carrier,P08833,IGFBP1,Humans,"Multifunctional protein that plays a critical role in regulating the availability of IGFs such as IGF1 and IGF2 to their receptors and thereby regulates IGF-mediated cellular processes including cell migration, proliferation, differentiation or apoptosis in a cell-type specific manner (PubMed:11397844, PubMed:15972819). Also plays a positive role in cell migration by interacting with integrin ITGA5:ITGB1 through its RGD motif (PubMed:7504269). Mechanistically, binding to integrins leads to activ",insulin-like growth factor binding,Secreted,carrier,DrugBank,drugbank_id
BE0009659,Insulin-like growth factor-binding protein 2,carrier,P18065,IGFBP2,Humans,"Multifunctional protein that plays a critical role in regulating the availability of IGFs such as IGF1 and IGF2 to their receptors and thereby regulates IGF-mediated cellular processes including proliferation, differentiation, and apoptosis in a cell-type specific manner (PubMed:18563800, PubMed:38796567). Functions coordinately with receptor protein tyrosine phosphatase beta/PTPRB and the IGF1 receptor to regulate IGF1-mediated signaling by stimulating the phosphorylation of PTEN leading to its",insulin-like growth factor I binding,Secreted,carrier,DrugBank,drugbank_id
BE0009660,Insulin-like growth factor-binding protein 4,carrier,P22692,IGFBP4,Humans,IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors,insulin-like growth factor I binding,Secreted,carrier,DrugBank,drugbank_id
BE0009661,Insulin-like growth factor-binding protein 5,carrier,P24593,IGFBP5,Humans,"Multifunctional protein that plays a critical role in regulating the availability of IGFs to their receptors and thereby regulates IGF-mediated cellular processes including proliferation, differentiation, and apoptosis in a cell-type specific manner (PubMed:18930415, PubMed:7683690). Increases the cell proliferation of osteoblasts, intestinal smooth muscle cells and neuroblastoma cells. Enhances adhesion and survival of epithelial cells but decreases adhesion of mesenchymal cells (By similarity)",fibronectin binding,Secreted,carrier,DrugBank,drugbank_id
BE0009662,Insulin-like growth factor-binding protein 6,carrier,P24592,IGFBP6,Humans,IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Activates the MAPK signaling pathway and induces cell migration (PubMed:24003225),fibronectin binding,Secreted,carrier,DrugBank,drugbank_id
BE0000859,Receptor activity-modifying protein 1,target,O60894,RAMP1,Humans,"Accessory protein that interacts with and modulates the function of G-protein coupled receptors including calcitonin gene-related peptide type 1 receptor (CALCRL) and calcitonin receptor (CALCR) (PubMed:33602864, PubMed:9620797, PubMed:35324283, PubMed:38603770). Required for the transport of CALCRL to the plasma membrane (PubMed:9620797). Together with CALCRL, form the receptor complex for the calcitonin gene-related peptides CGRP1/CALCA and CGRP2/CALCB (PubMed:33602864, PubMed:9620797). Togeth",amylin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0000860,Receptor activity-modifying protein 2,target,O60895,RAMP2,Humans,"Accessory protein that interacts with and modulates the function of G-protein coupled receptors including calcitonin gene-related peptide type 1 receptor (CALCRL) and calcitonin receptor (CALCR) (PubMed:9620797). Required for the transport of CALCRL to the plasma membrane (PubMed:9620797). Together with CALCRL, form a receptor complex for adrenomedullin/ADM (PubMed:22102369, PubMed:32296767, PubMed:9620797). Together with CALCR, act as a receptor complex for calcitonin/CT/CALC (PubMed:35324283).",adrenomedullin binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0000861,Receptor activity-modifying protein 3,target,O60896,RAMP3,Humans,"Accessory protein that interacts with and modulates the function of G-protein coupled receptors including calcitonin gene-related peptide type 1 receptor (CALCRL), calcitonin receptor (CALCR) and G-protein coupled estrogen receptor 1 (GPER1) (PubMed:23674134, PubMed:9620797). Required for the transport of CALCRL and GPER1 receptors to the plasma membrane (PubMed:23674134, PubMed:9620797). Plays a role in cardioprotection by reducing cardiac hypertrophy and perivascular fibrosis in a GPER1-depend",adrenomedullin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0010216,DNA primase small subunit,target,P49642,PRIM1,Humans,"Catalytic subunit of the DNA primase complex and component of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex - primosome/replisome) which play an essential role in the initiation of DNA synthesis (PubMed:17893144, PubMed:24043831, PubMed:25550159, PubMed:26975377, PubMed:31479243, PubMed:33060134, PubMed:9268648, PubMed:9705292). During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, an accessory su",DNA-directed RNA polymerase activity,,inhibitor,DrugBank,drugbank_id
BE0000847,T-lymphocyte activation antigen CD80,target,P33681,CD80,Humans,"Costimulatory molecule that belongs to the immunoglobulin superfamily that plays an important role in T-lymphocyte activation (PubMed:38467718). Acts as the primary auxiliary signal augmenting the MHC/TCR signal in naive T-cells together with the CD28 receptor which is constitutively expressed on the cell surface of T-cells (PubMed:12196291). In turn, activates different signaling pathways such as NF-kappa-B or MAPK leading to the production of different cytokines (PubMed:10438913). In addition,",coreceptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000848,Adrenocorticotropic hormone receptor,target,Q01718,MC2R,Humans,"Hormone receptor primarily expressed in adrenal cortex that plays a key role in regulating adrenocortical function (PubMed:36588120). Upon corticotropin (ACTH) binding, facilitates the release of adrenal glucocorticoids, including cortisol and corticosterone. In addition, MC2R is required for fetal and neonatal adrenal gland development (By similarity). Mechanistically, activates adenylate cyclase (cAMP), the MAPK cascade as well as the cAMP-dependent protein kinase A pathway leading to steroido",corticotropin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0001026,Corticoliberin,target,P06850,CRH,Humans,"Hormone regulating the release of corticotropin from pituitary gland (By similarity). Induces NLRP6 in intestinal epithelial cells, hence may influence gut microbiota profile (By similarity)",corticotropin-releasing hormone activity,Secreted,agonist,DrugBank,drugbank_id
BE0000944,Interferon gamma,target,P01579,IFNG,Humans,"Type II interferon produced by immune cells such as T-cells and NK cells that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation (PubMed:16914093, PubMed:8666937). Primarily signals through the JAK-STAT pathway after interaction with its receptor IFNGR1 to affect gene regulation (PubMed:8349687). Upon IFNG binding, IFNGR1 intracellular domain opens out to allow association of downstream signaling compone",cytokine activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0003720,Large ribosomal subunit protein uL4,target,P44345,rplD,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),"One of the primary rRNA binding proteins, this protein initially binds near the 5'-end of the 23S rRNA. It is important during the early stages of 50S assembly. It makes multiple contacts with different domains of the 23S rRNA in the assembled 50S subunit and ribosome (By similarity).",rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0003486,Interleukin-15,target,P40933,IL15,Humans,"Cytokine that plays a major role in the development of inflammatory and protective immune responses to microbial invaders and parasites by modulating immune cells of both the innate and adaptive immune systems (PubMed:15123770). Stimulates the proliferation of natural killer cells, T-cells and B-cells and promotes the secretion of several cytokines (PubMed:8178155, PubMed:9326248). In monocytes, induces the production of IL8 and monocyte chemotactic protein 1/CCL2, two chemokines that attract ne",cytokine activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0004430,D-alanyl-D-alanine endopeptidase,target,P0AFI5,pbpG,Escherichia coli (strain K12),Cell wall formation. May play a specialized role in remodeling the cell wall. Specifically hydrolyzes the DD-diaminopimelate-alanine bonds in high-molecular-mass murein sacculi.,endopeptidase activity,Periplasm,inhibitor,DrugBank,drugbank_id
BE0001482,Beta-lactamase,enzyme,P00808,penP,Bacillus licheniformis,,beta-lactamase activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0004816,Potassium,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0003426,Type-2 angiotensin II receptor,target,P50052,AGTR2,Humans,"Receptor for angiotensin II, a vasoconstricting peptide (PubMed:28379944, PubMed:29967536, PubMed:31899086, PubMed:8185599). Signals primarily via a non-canonical G-protein- and beta-arrestin independent pathways (PubMed:28379944). Cooperates with MTUS1 to inhibit ERK2 activation and cell proliferation (PubMed:15123706)",angiotensin type II receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0001065,Glycogen synthase kinase-3 beta,target,P49841,GSK3B,Humans,"Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1 (PubMed:11430833, PubMed:12554650, PubMed:14690523, PubMed:16484495, PubMed:1846781, PubMed:20937854, PubMed:9072970). Requires primed phosphorylat",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001152,Inositol monophosphatase 1,target,P29218,IMPA1,Humans,"Phosphatase involved in the dephosphorylation of myo-inositol monophosphates to generate myo-inositol (PubMed:17068342, PubMed:8718889, PubMed:9462881). Is also able to dephosphorylate scyllo-inositol-phosphate, myo-inositol 1,4-diphosphate, scyllo-inositol-1,3-diphosphate and scyllo-inositol-1,4-diphosphate (PubMed:17068342). Also dephosphorylates in vitro other sugar-phosphates including D-galactose-1-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosph",fructose-1-phosphatase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000983,Inositol monophosphatase 2,target,O14732,IMPA2,Humans,"Phosphatase that can use myo-inositol monophosphates, myo-inositol 1,4-diphosphate, scyllo-inositol-1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate and 2'-AMP as substrates in vitro (PubMed:17068342). It is likely that IMPA2 has an as yet unidentified in vivo substrate(s) (PubMed:17068342). Has been implicated as the pharmacological target for lithium (Li(+)) action in brain (PubMed:17068342)",glucose-1-phosphatase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002464,Large ribosomal subunit protein uL22,target,P61177,rplV,Escherichia coli O157:H7,"This protein binds specifically to 23S rRNA; its binding is stimulated by other ribosomal proteins, e.g. L4, L17, and L20. It is important during the early stages of 50S assembly. It makes multiple contacts with different domains of the 23S rRNA in the assembled 50S subunit and ribosome (By similarity).",rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0001091,Kallikrein-1,target,P06870,KLK1,Humans,Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin,serine-type endopeptidase activity,,inhibitor,DrugBank,drugbank_id
BE0004593,"Spectrin beta chain, non-erythrocytic 1",target,Q01082,SPTBN1,Humans,"Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane. Plays a critical role in central nervous system development and function",actin binding,"Cytoplasm, cytoskeleton",agonist,DrugBank,drugbank_id
BE0001177,Protein S100-B,target,P04271,S100B,Humans,"Small zinc- and- and calcium-binding protein that is highly expressed in astrocytes and constitutes one of the most abundant soluble proteins in brain (PubMed:20950652, PubMed:6487634). Weakly binds calcium but binds zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer (PubMed:20950652, PubMed:6487634). Physiological concentrations of potassium ion antagonize the binding of both divalent cations, especially affecting high-affinity calcium-binding",calcium ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0000904,Calpastatin,target,P20810,CAST,Humans,Specific inhibition of calpain (calcium-dependent cysteine protease). Plays a key role in postmortem tenderization of meat and have been proposed to be involved in muscle protein degradation in living tissue,cadherin binding,,,DrugBank,drugbank_id
BE0000899,Cartilage oligomeric matrix protein,target,P49747,COMP,Humans,"Plays a role in the structural integrity of cartilage via its interaction with other extracellular matrix proteins such as the collagens and fibronectin. Can mediate the interaction of chondrocytes with the cartilage extracellular matrix through interaction with cell surface integrin receptors (PubMed:16051604, PubMed:16542502). Could play a role in the pathogenesis of osteoarthritis (PubMed:16542502). Potent suppressor of apoptosis in both primary chondrocytes and transformed cells. Suppresses ",BMP binding,"Secreted, extracellular space, extracellular matrix",,DrugBank,drugbank_id
BE0004314,"Alkaline phosphatase, placental type",target,P05187,ALPP,Humans,Alkaline phosphatase that can hydrolyze various phosphate compounds,alkaline phosphatase activity,Cell membrane,,DrugBank,drugbank_id
BE0008955,Protein S100-A8,target,P05109,S100A8,Humans,"S100A8 is a calcium- and zinc-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response. It can induce neutrophil chemotaxis and adhesion. Predominantly found as calprotectin (S100A8/A9) which has a wide plethora of intra- and extracellular functions. The intracellular functions include: facilitating leukocyte arachidonic acid trafficking and metabolism, modulation of the tubulin-dependent cytoskeleton during migration of phagocytes and activati",arachidonate binding,Secreted,,DrugBank,drugbank_id
BE0008993,Protein S100-A9,target,P06702,S100A9,Humans,"S100A9 is a calcium- and zinc-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response (PubMed:12626582, PubMed:15331440, PubMed:16258195, PubMed:19122197, PubMed:20103766, PubMed:21325622, PubMed:8423249). It can induce neutrophil chemotaxis, adhesion, can increase the bactericidal activity of neutrophils by promoting phagocytosis via activation of SYK, PI3K/AKT, and ERK1/2 and can induce degranulation of neutrophils by a MAPK-dependent mechan",antioxidant activity,Secreted,,DrugBank,drugbank_id
BE0003602,Protein S100-A2,target,P29034,S100A2,Humans,"May function as calcium sensor and modulator, contributing to cellular calcium signaling. May function by interacting with other proteins, such as TPR-containing proteins, and indirectly play a role in many physiological processes. May also play a role in suppressing tumor cell growth",calcium ion binding,,,DrugBank,drugbank_id
BE0001140,Ceruloplasmin,target,P00450,CP,Humans,"Multifunctional blue, copper-binding (6-7 atoms per molecule) glycoprotein. It has ferroxidase activity oxidizing Fe(2+) to Fe(3+) without releasing radical oxygen species. It is involved in iron transport across the cell membrane (PubMed:16150804). Copper ions provide a large number of enzymatic activites. Oxidizes highly toxic ferrous ions to the ferric state for further incorporation onto apo-transferrins, catalyzes Cu(+) oxidation and promotes the oxidation of biogenic amines such as norepin",copper ion binding,Secreted,,DrugBank,drugbank_id
BE0009000,Bone morphogenetic protein 4,target,P12644,BMP4,Humans,"Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including neurogenesis, vascular development, angiogenesis and osteogenesis (PubMed:31363885). Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction (By similarity). Initiates the canonical BMP signaling cascade by associating with type I receptor BMPR1A and type II receptor BMPR2 (PubMed:25868050, PubMed:800600",BMP receptor binding,"Secreted, extracellular space, extracellular matrix",,DrugBank,drugbank_id
BE0005813,Matrix Gla protein,target,P08493,MGP,Humans,Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation,calcium ion binding,Secreted,,DrugBank,drugbank_id
BE0005814,Protocadherin-19,target,Q8TAB3,PCDH19,Humans,Calcium-dependent cell-adhesion protein,calcium ion binding,Cell membrane,,DrugBank,drugbank_id
BE0005812,Programmed cell death protein 6,target,O75340,PDCD6,Humans,"Calcium sensor that plays a key role in processes such as endoplasmic reticulum (ER)-Golgi vesicular transport, endosomal biogenesis or membrane repair. Acts as an adapter that bridges unrelated proteins or stabilizes weak protein-protein complexes in response to calcium: calcium-binding triggers exposure of apolar surface, promoting interaction with different sets of proteins thanks to 3 different hydrophobic pockets, leading to translocation to membranes (PubMed:20691033, PubMed:25667979). Inv",calcium ion binding,Endoplasmic reticulum membrane,,DrugBank,drugbank_id
BE0004849,Hydrogen ions,target,,,,,,,neutralizer,DrugBank,drugbank_id
BE0004675,Electrogenic sodium bicarbonate cotransporter 1,transporter,Q9Y6R1,SLC4A4,Humans,Electrogenic sodium/bicarbonate cotransporter with a Na(+):HCO3(-) stoichiometry varying from 1:2 to 1:3. May regulate bicarbonate influx/efflux at the basolateral membrane of cells and regulate intracellular pH,identical protein binding,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0004676,Sodium bicarbonate cotransporter 3,transporter,Q9Y6M7,SLC4A7,Humans,"Electroneutral sodium- and bicarbonate-dependent cotransporter with a Na(+):HCO3(-) 1:1 stoichiometry (PubMed:10347222, PubMed:12403779, PubMed:14578046, PubMed:14736710). Mediates the sodium-dependent bicarbonate transport important for pH recovery after acid load as well as for regulation of steady-state pH in the duodenum and vascular smooth muscle cells (By similarity). Plays a key role in macrophage acidification, mediating bicarbonate import into the cytoplasm which is crucial for net acid",monoatomic anion transmembrane transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0004680,Electroneutral sodium bicarbonate exchanger 1,transporter,Q2Y0W8,SLC4A8,Humans,Mediates electroneutral sodium- and carbonate-dependent chloride-HCO3(-) exchange with a Na(+):HCO3(-) stoichiometry of 2:1 (PubMed:18577713). Plays a major role in pH regulation in neurons (By similarity). Mediates sodium reabsorption in the renal cortical collecting ducts (By similarity),bicarbonate transmembrane transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0004677,Electrogenic sodium bicarbonate cotransporter 4,transporter,Q9BY07,SLC4A5,Humans,"Mediates sodium- and bicarbonate-dependent electrogenic sodium bicarbonate cotransport, with a Na(+):HCO3(-) stoichiometry varying from 1:2 to 1:3",monoatomic anion transmembrane transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0004683,Sodium-driven chloride bicarbonate exchanger,transporter,Q6U841,SLC4A10,Humans,"Sodium/bicarbonate cotransporter which plays an important role in regulating intracellular pH (PubMed:18319254). Has been shown to act as a sodium/bicarbonate cotransporter in exchange for intracellular chloride (By similarity). Has also been shown to act as a sodium/biocarbonate cotransporter which does not couple net influx of bicarbonate to net efflux of chloride, with the observed chloride efflux being due to chloride self-exchange (PubMed:18319254). Controls neuronal pH and may contribute t","sodium,bicarbonate",Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0000918,Interleukin-6,target,P05231,IL6,Humans,"Cytokine with a wide variety of biological functions in immunity, tissue regeneration, and metabolism. Binds to IL6R, then the complex associates to the signaling subunit IL6ST/gp130 to trigger the intracellular IL6-signaling pathway (Probable). The interaction with the membrane-bound IL6R and IL6ST stimulates 'classic signaling', whereas the binding of IL6 and soluble IL6R to IL6ST stimulates 'trans-signaling'. Alternatively, 'cluster signaling' occurs when membrane-bound IL6:IL6R complexes on ",cytokine activity,Secreted,antagonist,DrugBank,drugbank_id
BE0001047,C-C motif chemokine 2,target,P13500,CCL2,Humans,"Acts as a ligand for C-C chemokine receptor CCR2 (PubMed:10529171, PubMed:10587439, PubMed:9837883). Signals through binding and activation of CCR2 and induces a strong chemotactic response and mobilization of intracellular calcium ions (PubMed:10587439, PubMed:9837883). Exhibits a chemotactic activity for monocytes and basophils but not neutrophils or eosinophils (PubMed:8195247, PubMed:8627182, PubMed:9792674). May be involved in the recruitment of monocytes into the arterial wall during the d",CCR chemokine receptor binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0001094,Beta-nerve growth factor,target,P01138,NGF,Humans,"Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems (PubMed:14976160, PubMed:20978020). Extracellular ligand for the NTRK1 and NGFR receptors, activates cellular signaling cascades to regulate neuronal proliferation, differentiation and survival (Probable) (PubMed:20978020). The immature NGF precursor (proNGF) functions as a ligand for the heterodimeric receptor formed by SORCS2 and NGFR, and activates cellular signaling cascades th",growth factor activity,Secreted,stimulator,DrugBank,drugbank_id
BE0001208,Interleukin-5,target,P05113,IL5,Humans,"Homodimeric cytokine expressed predominantly by T-lymphocytes and NK cells that plays an important role in the survival, differentiation, and chemotaxis of eosinophils (PubMed:2653458, PubMed:9010276). Also acts on activated and resting B-cells to induce immunoglobulin production, growth, and differentiation (By similarity). Mechanistically, exerts its biological effects through a receptor composed of IL5RA subunit and the cytokine receptor common subunit beta/CSF2RB (PubMed:1495999, PubMed:2252",cytokine activity,Secreted,antagonist,DrugBank,drugbank_id
BE0000908,Eosinophil cationic protein,target,P12724,RNASE3,Humans,"Cytotoxin and helminthotoxin with low-efficiency ribonuclease activity. Possesses a wide variety of biological activities. Exhibits antibacterial activity, including cytoplasmic membrane depolarization of preferentially Gram-negative, but also Gram-positive strains. Promotes E.coli outer membrane detachment, alteration of the overall cell shape and partial loss of cell content",endonuclease activity,Secreted,other/unknown,DrugBank,drugbank_id
BE0001034,Mucin-2,target,Q02817,MUC2,Humans,"Coats the epithelia of the intestines and other mucus membrane-containing organs to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces (PubMed:17058067, PubMed:19432394, PubMed:33031746). Major constituent of the colon mucus, which is mainly formed by large polymeric networks of MUC2 secreted by goblet cells that cover the exposed surfaces of intestine (PubMed:19432394, PubMed:33031746). MUC2 networks form hydrogels that guard the underlying epi",cupric ion binding,Secreted,other/unknown,DrugBank,drugbank_id
BE0004647,"Peptidoglycan D,D-transpeptidase FtsI",target,Q51504,pbpB,Pseudomonas aeruginosa,Catalyzes cross-linking of the peptidoglycan cell wall at the division septum.,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0004648,"Peptidoglycan D,D-transpeptidase MrdA",target,Q9X6V3,pbpA,Pseudomonas aeruginosa,Catalyzes cross-linking of the peptidoglycan cell wall.,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0003676,Small ribosomal subunit protein uS10,target,Q5SHN7,rpsJ,Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579),Involved in the binding of tRNA to the ribosomes (By similarity). Part of the top of the 30S subunit head.,rRNA binding,,inhibitor,DrugBank,drugbank_id
BE0002402,Small ribosomal subunit protein uS2,target,P08865,RPSA,Humans,Required for the assembly and/or stability of the 40S ribosomal subunit. Required for the processing of the 20S rRNA-precursor to mature 18S rRNA in a late step of the maturation of 40S ribosomal subunits. Also functions as a cell surface receptor for laminin. Plays a role in cell adhesion to the basement membrane and in the consequent activation of signaling transduction pathways. May play a role in cell fate determination and tissue morphogenesis. Acts as a PPP1R16B-dependent substrate of PPP1,DNA binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003823,Ribosomal protein uL16-like,target,Q96L21,RPL10L,Humans,"Testis-specific component of the ribosome, which is required for the transition from prophase to metaphase in male meiosis I (By similarity). Compensates for the inactivated X-linked RPL10 paralog during spermatogenesis (PubMed:12490704). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:25901680, PubMed:32669547). The male germ cell-specific ribosome displays a ribosomal polypeptide exit tunnel of distinct size and c",structural constituent of ribosome,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001534,Methionine aminopeptidase 2,target,P50579,METAP2,Humans,"Cotranslationally removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val). The catalytic activity of human METAP2 toward Met-Val peptides is consistently two orders of magnitude higher than that of METAP1, suggesting that it is responsible for processing proteins containing N-terminal Met-Val and Met-Thr sequences in vivo",aminopeptidase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004811,Magnesium cation,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0009963,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",target,P27815,PDE4A,Humans,"Hydrolyzes the second messenger 3',5'-cyclic AMP (cAMP), which is a key regulator of many important physiological processes","3',5'-cyclic-AMP phosphodiesterase activity","Cytoplasm, perinuclear region",inhibitor,DrugBank,drugbank_id
BE0001223,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B",target,Q13370,PDE3B,Humans,"Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological process (PubMed:14592490, PubMed:21393242). Regulates angiogenesis by inhibiting the cAMP-dependent guanine nucleotide exchange factor RAPGEF3 and downstream phosphatidylinositol 3-kinase gamma-mediated signaling (PubMed:21393242). Controls cardiac contractility by reducing cAMP concentration in cardiocytes (By similarity)","3',5'-cyclic-AMP phosphodiesterase activity",Membrane,inhibitor,DrugBank,drugbank_id
BE0014016,Hormone-sensitive lipase,target,Q05469,LIPE,Humans,"Lipase with broad substrate specificity, catalyzing the hydrolysis of triacylglycerols (TAGs), diacylglycerols (DAGs), monoacylglycerols (MAGs), cholesteryl esters and retinyl esters (PubMed:15716583, PubMed:15955102, PubMed:19800417, PubMed:8812477). Shows a preferential hydrolysis of DAGs over TAGs and MAGs and preferentially hydrolyzes the fatty acid (FA) esters at the sn-3 position of the glycerol backbone in DAGs (PubMed:19800417). Preferentially hydrolyzes FA esters at the sn-1 and sn-2 po","all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity",Cell membrane,inhibitor,DrugBank,drugbank_id
BE0010059,Alpha globin,carrier,V9H1D9,,Humans,Involved in oxygen transport from the lung to the various peripheral tissues.,haptoglobin binding,,binder,DrugBank,drugbank_id
BE0009708,Group A nerve fibers,target,,,Rat,,,,inhibitor,DrugBank,drugbank_id
BE0010194,GABA(B) Receptor,target,Q9UBS5,GABBR1,,"Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2 (PubMed:15617512, PubMed:18165688, PubMed:22660477, PubMed:24305054, PubMed:36103875, PubMed:9872316, PubMed:9872744). Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins (PubMed:18165688). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity",extracellular matrix protein binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0004841,"Solute carrier family 52, riboflavin transporter, member 2",target,Q9HAB3,SLC52A2,Humans,"Plasma membrane transporter mediating the uptake by cells of the water soluble vitamin B2/riboflavin that plays a key role in biochemical oxidation-reduction reactions of the carbohydrate, lipid, and amino acid metabolism (PubMed:20463145, PubMed:22864630, PubMed:23243084, PubMed:24253200, PubMed:27702554). Humans are unable to synthesize vitamin B2/riboflavin and must obtain it via intestinal absorption (PubMed:20463145). May also act as a receptor for 4-hydroxybutyrate (Probable)",4-hydroxybutyrate receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0001063,E3 ubiquitin-protein ligase TRIM13,target,O60858,TRIM13,Humans,Endoplasmic reticulum (ER) membrane anchored E3 ligase involved in the retrotranslocation and turnover of membrane and secretory proteins from the ER through a set of processes named ER-associated degradation (ERAD). This process acts on misfolded proteins as well as in the regulated degradation of correctly folded proteins. Enhances ionizing radiation-induced p53/TP53 stability and apoptosis via ubiquitinating MDM2 and AKT1 and decreasing AKT1 kinase activity through MDM2 and AKT1 proteasomal d,transcription coactivator activity,Endoplasmic reticulum membrane,agonist,DrugBank,drugbank_id
BE0000194,17-beta-hydroxysteroid dehydrogenase type 1,target,P14061,HSD17B1,Humans,"Favors the reduction of estrogens and androgens. Converts estrone (E1) to a more potent estrogen, 17beta-estradiol (E2) (PubMed:8994190). Also has 20-alpha-HSD activity. Uses preferentially NADH",17-beta-hydroxysteroid dehydrogenase (NADP+) activity,Cytoplasm,inducer,DrugBank,drugbank_id
BE0001638,6-deoxyerythronolide B hydroxylase,target,Q00441,eryF,Saccharopolyspora erythraea (strain NRRL 23338),Catalyzes the conversion of 6-deoxyerythronolide B (6-DEB) to erythronolide B (EB) by the insertion of an oxygen at the 6S position of 6-DEB. Requires the participation of a ferredoxin and a ferredoxin reductase for the transfer of electrons from NADPH to the monooxygenase.,cholest-4-en-3-one 26-monooxygenase activity,Cytoplasm,inducer,DrugBank,drugbank_id
BE0000129,Gamma-aminobutyric acid receptor subunit rho-1,target,P24046,GABRR1,Humans,"Rho subunit of the pentameric ligand-gated chloride channels responsible for mediating the effects of gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the brain (PubMed:37659407). Rho-containing GABA-gated chloride channels are a subclass of GABA(A) receptors (GABAARs) entirely composed of rho subunits, where GABA molecules bind at the rho intersubunit interfaces (PubMed:37659407). When activated by GABA, rho-GABAARs selectively allow the flow of chloride anions across th",GABA-A receptor activity,Postsynaptic cell membrane,potentiator,DrugBank,drugbank_id
BE0003598,Gamma-aminobutyric acid receptor subunit rho-2,target,P28476,GABRR2,Humans,"Rho subunit of the pentameric ligand-gated chloride channels responsible for mediating the effects of gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the brain (By similarity). Rho-containing GABA-gated chloride channels are a subclass of GABA(A) receptors (GABAARs) entirely composed of rho subunits, where GABA molecules bind at the rho intersubunit interfaces (By similarity). When activated by GABA, rho-GABAARs selectively allow the flow of chloride anions across the ce",GABA-A receptor activity,Postsynaptic cell membrane,potentiator,DrugBank,drugbank_id
BE0003619,Gamma-aminobutyric acid receptor subunit rho-3,target,A8MPY1,GABRR3,Humans,"Rho subunit of the pentameric ligand-gated chloride channels responsible for mediating the effects of gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the brain (By similarity). Rho-containing GABA-gated chloride channels are a subclass of GABA(A) receptors (GABAARs) entirely composed of rho subunits, where GABA molecules bind at the rho intersubunit interfaces (By similarity). When activated by GABA, rho-GABAARs selectively allow the flow of chloride anions across the ce",GABA-A receptor activity,Postsynaptic cell membrane,potentiator,DrugBank,drugbank_id
BE0001222,Primary amine oxidase,enzyme,P46883,tynA,Escherichia coli (strain K12),The enzyme prefers aromatic over aliphatic amines.,aliphatic amine oxidase activity,Periplasm,substrate,DrugBank,drugbank_id
BE0000741,Biliverdin reductase A,target,P53004,BLVRA,Humans,"Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IXalpha, to bilirubin with the concomitant oxidation of a NADH or NADPH cofactor (PubMed:10858451, PubMed:7929092, PubMed:8424666, PubMed:8631357). Does not reduce bilirubin IXbeta (PubMed:10858451). Uses the reactants NADH or NADPH depending on the pH; NADH is used at the acidic pH range (6-6.9) and NADPH at the alkaline range (8.5-8.7) (PubMed:7929092, PubMed:8424666, PubMed:8631357). NADPH, however, is the probable reactant",biliberdin reductase (NAD+) activity,"Cytoplasm, cytosol",activator,DrugBank,drugbank_id
BE0001777,Bile acid receptor,target,Q96RI1,NR1H4,Humans,"Ligand-activated transcription factor. Receptor for bile acids (BAs) such as chenodeoxycholic acid (CDCA), lithocholic acid, deoxycholic acid (DCA) and allocholic acid (ACA). Plays a essential role in BA homeostasis through the regulation of genes involved in BA synthesis, conjugation and enterohepatic circulation. Also regulates lipid and glucose homeostasis and is involved innate immune response (PubMed:10334992, PubMed:10334993, PubMed:21383957, PubMed:22820415). The FXR-RXR heterodimer binds",bile acid binding,Nucleus,partial agonist,DrugBank,drugbank_id
BE0010211,Chloride anion exchanger,transporter,P40879,SLC26A3,Humans,"Mediates chloride-bicarbonate exchange with a chloride bicarbonate stoichiometry of 2:1 in the intestinal epithelia (PubMed:16606687, PubMed:19321737, PubMed:22159084, PubMed:22627094). Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation (By similarity)",bicarbonate transmembrane transporter activity,Apical cell membrane,upregulator,DrugBank,drugbank_id
BE0008725,Transferrin receptor protein 1,target,P02786,TFRC,Humans,"Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes (PubMed:26214738). Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the h",double-stranded RNA binding,Cell membrane,,DrugBank,drugbank_id
BE0001608,Histone deacetylase 8,target,Q9BY41,HDAC8,Humans,"Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:10748112, PubMed:10922473, PubMed:10926844, PubMed:14701748, PubMed:28497810). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed:10748112, PubMed:10922473, PubMed:10926844, PubMed:14701748). Histone deacetylases act via the forma",DNA-binding transcription factor binding,Nucleus,cofactor,DrugBank,drugbank_id
BE0008990,Alpha-hemoglobin-stabilizing protein,target,Q9NZD4,AHSP,Humans,Acts as a chaperone to prevent the harmful aggregation of alpha-hemoglobin during normal erythroid cell development. Specifically protects free alpha-hemoglobin from precipitation. It is predicted to modulate pathological states of alpha-hemoglobin excess such as beta-thalassemia,hemoglobin binding,Cytoplasm,,DrugBank,drugbank_id
BE0008991,"Frataxin, mitochondrial",target,Q16595,FXN,Humans,"Functions as an activator of persulfide transfer to the scaffoding protein ISCU as component of the core iron-sulfur cluster (ISC) assembly complex and participates to the [2Fe-2S] cluster assembly (PubMed:12785837, PubMed:24971490). Accelerates sulfur transfer from NFS1 persulfide intermediate to ISCU and to small thiols such as L-cysteine and glutathione leading to persulfuration of these thiols and ultimately sulfide release (PubMed:24971490). Binds ferrous ion and is released from FXN upon t","2 iron, 2 sulfur cluster binding",Mitochondrion,,DrugBank,drugbank_id
BE0009013,Flap endonuclease 1,target,P39748,FEN1,Humans,"Structure-specific nuclease with 5'-flap endonuclease and 5'-3' exonuclease activities involved in DNA replication and repair. During DNA replication, cleaves the 5'-overhanging flap structure that is generated by displacement synthesis when DNA polymerase encounters the 5'-end of a downstream Okazaki fragment. It enters the flap from the 5'-end and then tracks to cleave the flap base, leaving a nick for ligation. Also involved in the long patch base excision repair (LP-BER) pathway, by cleaving",5'-3' exonuclease activity,"Nucleus, nucleolus",,DrugBank,drugbank_id
BE0003175,Endonuclease 8-like 1,target,Q96FI4,NEIL1,Humans,"Involved in base excision repair of DNA damaged by oxidation or by mutagenic agents. Acts as a DNA glycosylase that recognizes and removes damaged bases. Has a preference for oxidized pyrimidines, such as thymine glycol, formamidopyrimidine (Fapy) and 5-hydroxyuracil. Has marginal activity towards 8-oxoguanine. Has AP (apurinic/apyrimidinic) lyase activity and introduces nicks in the DNA strand. Cleaves the DNA backbone by beta-delta elimination to generate a single-strand break at the site of t",class I DNA-(apurinic or apyrimidinic site) endonuclease activity,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",,DrugBank,drugbank_id
BE0005817,Endonuclease 8-like 2,target,Q969S2,NEIL2,Humans,"Involved in base excision repair of DNA damaged by oxidation or by mutagenic agents. Has DNA glycosylase activity towards 5-hydroxyuracil and other oxidized derivatives of cytosine with a preference for mismatched double-stranded DNA (DNA bubbles). Has low or no DNA glycosylase activity towards thymine glycol, 2-hydroxyadenine, hypoxanthine and 8-oxoguanine. Has AP (apurinic/apyrimidinic) lyase activity and introduces nicks in the DNA strand. Cleaves the DNA backbone by beta-delta elimination to",class I DNA-(apurinic or apyrimidinic site) endonuclease activity,Nucleus,,DrugBank,drugbank_id
BE0001145,Methylated-DNA--protein-cysteine methyltransferase,target,P16455,MGMT,Humans,Involved in the cellular defense against the biological effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT) in DNA. Repairs the methylated nucleobase in DNA by stoichiometrically transferring the methyl group to a cysteine residue in the enzyme. This is a suicide reaction: the enzyme is irreversibly inactivated,DNA binding,Nucleus,,DrugBank,drugbank_id
BE0001683,Fructose-bisphosphate aldolase A,target,P04075,ALDOA,Humans,"Catalyzes the reversible conversion of beta-D-fructose 1,6-bisphosphate (FBP) into two triose phosphate and plays a key role in glycolysis and gluconeogenesis (PubMed:14766013). In addition, may also function as scaffolding protein (By similarity)",actin binding,"Cytoplasm, myofibril, sarcomere, I band",,DrugBank,drugbank_id
BE0004528,Elongation factor 1-alpha 1,target,P68104,EEF1A1,Humans,"Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis (PubMed:26593721, PubMed:26651998, PubMed:36123449, PubMed:36264623, PubMed:36638793). Base pairing between the mRNA codon and the aa-tRNA anticodon promotes GTP hydrolysis, releasing the aa-tRNA from EEF1A1 and allowing its accommodation into the ribosome (PubMed:26593721, PubMed:26651998, PubMed:36123449, PubMed:36264623,",GTP binding,Cytoplasm,,DrugBank,drugbank_id
BE0005807,Alpha-enolase,target,P06733,ENO1,Humans,"Glycolytic enzyme the catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate (PubMed:1369209, PubMed:29775581). In addition to glycolysis, involved in various processes such as growth control, hypoxia tolerance and allergic responses (PubMed:10802057, PubMed:12666133, PubMed:2005901, PubMed:29775581). May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell",cadherin binding,Cytoplasm,,DrugBank,drugbank_id
BE0000720,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",target,O14556,GAPDHS,Humans,May play an important role in regulating the switch between different pathways for energy production during spermiogenesis and in the spermatozoon. Required for sperm motility and male fertility (By similarity),glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,Cytoplasm,,DrugBank,drugbank_id
BE0002467,Protein disulfide-isomerase,target,P07237,P4HB,Humans,"This multifunctional protein catalyzes the formation, breakage and rearrangement of disulfide bonds. At the cell surface, seems to act as a reductase that cleaves disulfide bonds of proteins attached to the cell. May therefore cause structural modifications of exofacial proteins. Inside the cell, seems to form/rearrange disulfide bonds of nascent proteins. At high concentrations and following phosphorylation by FAM20C, functions as a chaperone that inhibits aggregation of misfolded proteins (Pub",actin binding,Endoplasmic reticulum,,DrugBank,drugbank_id
BE0008980,Protein disulfide-isomerase A3,target,P30101,PDIA3,Humans,"Protein disulfide isomerase that catalyzes the formation, isomerization, and reduction or oxidation of disulfide bonds in client proteins and functions as a protein folding chaperone (PubMed:11825568, PubMed:16193070, PubMed:27897272, PubMed:36104323, PubMed:7487104). Core component of the major histocompatibility complex class I (MHC I) peptide loading complex where it functions as an essential folding chaperone for TAPBP. Through TAPBP, assists the dynamic assembly of the MHC I complex with hi",cysteine-type endopeptidase activity,Endoplasmic reticulum,,DrugBank,drugbank_id
BE0005844,Peroxiredoxin-1,target,Q06830,PRDX1,Humans,"Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2) (PubMed:9497357). Reduces an intramolecular disulfide bond in G",cadherin binding,Cytoplasm,,DrugBank,drugbank_id
BE0004590,Phosphoserine phosphatase,target,P78330,PSPH,Humans,"Catalyzes the last irreversible step in the biosynthesis of L-serine from carbohydrates, the dephosphorylation of O-phospho-L-serine to L-serine (PubMed:12213811, PubMed:14673469, PubMed:15291819, PubMed:25080166, PubMed:9222972). L-serine can then be used in protein synthesis, to produce other amino acids, in nucleotide metabolism or in glutathione synthesis, or can be racemized to D-serine, a neuromodulator (PubMed:14673469). May also act on O-phospho-D-serine (Probable)",identical protein binding,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0003844,Triosephosphate isomerase,target,P60174,TPI1,Humans,Triosephosphate isomerase is an extremely efficient metabolic enzyme that catalyzes the interconversion between dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde-3-phosphate (G3P) in glycolysis and gluconeogenesis,methylglyoxal synthase activity,Cytoplasm,,DrugBank,drugbank_id
BE0004542,"Elongation factor Tu, mitochondrial",target,P49411,TUFM,Humans,"GTP hydrolase that promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. Also plays a role in the regulation of autophagy and innate immunity. Recruits ATG5-ATG12 and NLRX1 at mitochondria and serves as a checkpoint of the RIGI-MAVS pathway. In turn, inhibits RLR-mediated type I interferon while promoting autophagy",GTP binding,Mitochondrion,,DrugBank,drugbank_id
BE0000125,Interleukin-3,target,P08700,IL3,Humans,"Cytokine secreted predominantly by activated T-lymphocytes as well as mast cells and osteoblastic cells that controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells (PubMed:2556442). Also stimulates mature basophils, eosinophils, and monocytes to become functionally activated (PubMed:10779277, PubMed:32889153). In addition, plays an important role in neural cell proliferation and survival (PubMed:23226269). Participates as well in bone homeosta",cytokine activity,Secreted,,DrugBank,drugbank_id
BE0005815,Copper chaperone for superoxide dismutase,target,O14618,CCS,Humans,Delivers copper to copper zinc superoxide dismutase (SOD1),cadherin binding,Cytoplasm,,DrugBank,drugbank_id
BE0002365,Histone deacetylase 1,target,Q13547,HDAC1,Humans,"Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:16762839, PubMed:17704056, PubMed:28497810). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed:16762839, PubMed:17704056). Histone deacetylases act via the formation of large multiprotein complexes (PubMed:16762839, PubMed:177040",core promoter sequence-specific DNA binding,Nucleus,cofactor,DrugBank,drugbank_id
BE0003523,Histone deacetylase 4,target,P56524,HDAC4,Humans,"Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation via its interaction with the myocyte enhancer factors such as MEF2A, MEF2C and MEF2D. Involved in the MTA1",DNA-binding transcription activator activity,Nucleus,cofactor,DrugBank,drugbank_id
BE0005833,Semenogelin-1,target,P04279,SEMG1,Humans,Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA,zinc ion binding,Secreted,,DrugBank,drugbank_id
BE0005834,Apoptosis regulatory protein Siva,target,O15304,SIVA1,Humans,Induces CD27-mediated apoptosis. Inhibits BCL2L1 isoform Bcl-x(L) anti-apoptotic activity. Inhibits activation of NF-kappa-B and promotes T-cell receptor-mediated apoptosis,CD27 receptor binding,Cytoplasm,,DrugBank,drugbank_id
BE0001003,E3 ubiquitin-protein ligase Mdm2,target,Q00987,MDM2,Humans,"E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome (PubMed:29681526). Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its",5S rRNA binding,"Nucleus, nucleoplasm",,DrugBank,drugbank_id
BE0005835,Utrophin,target,P46939,UTRN,Humans,May play a role in anchoring the cytoskeleton to the plasma membrane,actin binding,Postsynaptic cell membrane,,DrugBank,drugbank_id
BE0000187,Aspartoacylase,target,P45381,ASPA,Humans,Catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids,aspartoacylase activity,Cytoplasm,cofactor,DrugBank,drugbank_id
BE0008994,Tumor protein p73,target,O15350,TP73,Humans,"Participates in the apoptotic response to DNA damage. Isoforms containing the transactivation domain are pro-apoptotic, isoforms lacking the domain are anti-apoptotic and block the function of p53 and transactivating p73 isoforms. May be a tumor suppressor protein. Is an activator of FOXJ1 expression (By similarity). It is an essential factor for the positive regulation of lung ciliated cell differentiation (PubMed:34077761)","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,cofactor,DrugBank,drugbank_id
BE0005770,Metallothionein-3,target,P25713,MT3,Humans,Binds heavy metals. Contains three zinc and three copper atoms per polypeptide chain and only a negligible amount of cadmium. Inhibits survival and neurite formation of cortical neurons in vitro,antioxidant activity,,,DrugBank,drugbank_id
BE0005538,DAN domain family member 5,target,Q8N907,DAND5,Humans,"Antagonist of the extracellular signaling protein NODAL, which is required for correct left-right patterning during embryonic development (By similarity). Antagonist of BMP and TGF-beta signaling (PubMed:33587337). Independently of its role in left-right axis establishment, plays a role during heart development, possibly through the regulation of TGF-beta/Nodal signaling pathway (By similarity). Displays anti-angiogenic activity by inhibiting endothelial sprouting, migration, and proliferation. ",morphogen activity,Secreted,cofactor,DrugBank,drugbank_id
BE0009047,Alpha-1B-glycoprotein,target,P04217,A1BG,Humans,,,Secreted,,DrugBank,drugbank_id
BE0001060,Angiotensinogen,target,P01019,AGT,Humans,"Essential component of the renin-angiotensin system (RAS), a potent regulator of blood pressure, body fluid and electrolyte homeostasis",growth factor activity,Secreted,,DrugBank,drugbank_id
BE0009048,Alpha-2-HS-glycoprotein,target,P02765,AHSG,Humans,"Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Shows affinity for calcium and barium ions",cysteine-type endopeptidase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0001213,Serum amyloid P-component,target,P02743,APCS,Humans,Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells. May also function as a calcium-dependent lectin,calcium ion binding,Secreted,,DrugBank,drugbank_id
BE0003449,Apolipoprotein A-I,target,P02647,APOA1,Humans,"Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility",amyloid-beta binding,Secreted,,DrugBank,drugbank_id
BE0000922,Apolipoprotein A-II,target,P02652,APOA2,Humans,"May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism",apolipoprotein receptor binding,Secreted,,DrugBank,drugbank_id
BE0009049,Apolipoprotein A-IV,target,P06727,APOA4,Humans,May have a role in chylomicrons and VLDL secretion and catabolism. Required for efficient activation of lipoprotein lipase by ApoC-II; potent activator of LCAT. Apoa-IV is a major component of HDL and chylomicrons,antioxidant activity,Secreted,,DrugBank,drugbank_id
BE0005852,Apolipoprotein B receptor,target,Q0VD83,APOBR,Humans,"Macrophage receptor that binds to the apolipoprotein B48 (APOB) of dietary triglyceride (TG)-rich lipoproteins (TRL) or to a like domain of APOB in hypertriglyceridemic very low density lipoprotein (HTG-VLDL). Binds and internalizes TRL when out of the context of the macrophage. May provide essential lipids to reticuloendothelial cells. Could also be involved in foam cell formation with elevated TRL and remnant lipoprotein (RLP). Mediates the rapid high-affinity uptake of chylomicrons (CM), HTG-",very-low-density lipoprotein particle receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0001119,Apolipoprotein E,target,P02649,APOE,Humans,"APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids (PubMed:14754908, PubMed:1911868, PubMed:6860692). APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance (PubMed:14754908, PubMed:1911868, PubMed:1917954, PubMed:23620513, PubMed:2762297, PubMed:6860692, PubMed:9395455). Apolipoproteins are amphipathic mole",amyloid-beta binding,Secreted,,DrugBank,drugbank_id
BE0009069,Apolipoprotein L1,target,O14791,APOL1,Humans,May play a role in lipid exchange and transport throughout the body. May participate in reverse cholesterol transport from peripheral cells to the liver,chloride channel activity,Secreted,,DrugBank,drugbank_id
BE0001529,Complement C1s subcomponent,target,P09871,C1S,Humans,"Component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:11445589, PubMed:16169853, PubMed:417728, PubMed:467643, PubMed:6271784, PubMed:6282646, PubMed:6319179, PubMed:70787, PubMed:9422791). C1S is activated following association of the C1 complex with immunoglobulins (IgG or IgM) compl",calcium ion binding,Secreted,,DrugBank,drugbank_id
BE0009050,C4b-binding protein alpha chain,target,P04003,C4BPA,Humans,"Controls the classical pathway of complement activation. It binds as a cofactor to C3b/C4b inactivator (C3bINA), which then hydrolyzes the complement fragment C4b. It also accelerates the degradation of the C4bC2a complex (C3 convertase) by dissociating the complement fragment C2a. Alpha chain binds C4b. It also interacts with anticoagulant protein S and with serum amyloid P component",RNA binding,Secreted,,DrugBank,drugbank_id
BE0009070,C4b-binding protein beta chain,target,P20851,C4BPB,Humans,"Controls the classical pathway of complement activation. It binds as a cofactor to C3b/C4b inactivator (C3bINA), which then hydrolyzes the complement fragment C4b. It also accelerates the degradation of the C4bC2a complex (C3 convertase) by dissociating the complement fragment C2a. It also interacts with anticoagulant protein S and with serum amyloid P component. The beta chain binds protein S",,Secreted,,DrugBank,drugbank_id
BE0009071,Lys-63-specific deubiquitinase BRCC36,target,P46736,BRCC3,Humans,"Metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains (PubMed:19214193, PubMed:20656690, PubMed:24075985, PubMed:26344097). Does not have activity toward 'Lys-48'-linked polyubiquitin chains (PubMed:19214193, PubMed:20656690, PubMed:24075985, PubMed:26344097). Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damag",cysteine-type deubiquitinase activity,Nucleus,,DrugBank,drugbank_id
BE0009072,Complement component C8 alpha chain,target,P07357,C8A,Humans,"Component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade, which inserts into a target cell membrane and forms a pore, leading to target cell membrane rupture and cell lysis (PubMed:17872444, PubMed:22832194, PubMed:26841837, PubMed:27052168, PubMed:30552328, PubMed:7440581). The MAC is initiated by proteolytic cleavage of C5 into complement C5b in response to the classical, alternative, lectin and GZMK complement pathways (PubMed:17872444, PubMed",complement binding,Secreted,,DrugBank,drugbank_id
BE0009051,Complement component C8 beta chain,target,P07358,C8B,Humans,"Component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade, which inserts into a target cell membrane and forms a pore, leading to target cell membrane rupture and cell lysis (PubMed:22832194, PubMed:26841837, PubMed:27052168, PubMed:30552328, PubMed:7440581). The MAC is initiated by proteolytic cleavage of C5 into complement C5b in response to the classical, alternative, lectin and GZMK complement pathways (PubMed:30552328, PubMed:7440581). The co",protein-containing complex binding,Secreted,,DrugBank,drugbank_id
BE0003266,Complement component C8 gamma chain,target,P07360,C8G,Humans,"Component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade, which inserts into a target cell membrane and forms a pore, leading to target cell membrane rupture and cell lysis (PubMed:26841837, PubMed:27052168, PubMed:30552328). The MAC is initiated by proteolytic cleavage of C5 into complement C5b in response to the classical, alternative, lectin and GZMK complement pathways (PubMed:30552328). The complement pathways consist in a cascade of protein",retinol binding,Secreted,,DrugBank,drugbank_id
BE0001701,Complement factor B,target,P00751,CFB,Humans,"Precursor of the catalytic component of the C3 and C5 convertase complexes of the alternative pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:3638964, PubMed:624565, PubMed:6554279, PubMed:6919543, PubMed:9748277). The alternative complement pathway acts as an amplification loop that enhances other complement pathways (classical, lectin and GZMK) by promoting formation ",complement binding,Secreted,,DrugBank,drugbank_id
BE0009053,Complement factor H,target,P08603,CFH,Humans,"Glycoprotein that plays an essential role in maintaining a well-balanced immune response by modulating complement activation. Acts as a soluble inhibitor of complement, where its binding to self markers such as glycan structures prevents complement activation and amplification on cell surfaces (PubMed:21285368, PubMed:21317894, PubMed:25402769). Accelerates the decay of the complement alternative pathway (AP) C3 convertase C3bBb, thus preventing local formation of more C3b, the central player of",complement component C3b binding,Secreted,,DrugBank,drugbank_id
BE0009054,Complement factor I,target,P05156,CFI,Humans,"Trypsin-like serine protease that plays an essential role in regulating the immune response by controlling all complement pathways. Inhibits these pathways by cleaving three peptide bonds in the alpha-chain of C3b and two bonds in the alpha-chain of C4b thereby inactivating these proteins (PubMed:17320177, PubMed:7360115). Essential cofactors for these reactions include factor H and C4BP in the fluid phase and membrane cofactor protein/CD46 and CR1 on cell surfaces (PubMed:12055245, PubMed:21418",metal ion binding,"Secreted, extracellular space",,DrugBank,drugbank_id
BE0009055,Clusterin,target,P10909,CLU,Humans,"Functions as extracellular chaperone that prevents aggregation of non native proteins (PubMed:11123922, PubMed:19535339). Prevents stress-induced aggregation of blood plasma proteins (PubMed:11123922, PubMed:12176985, PubMed:17260971, PubMed:19996109). Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro) (PubMed:12047389, PubMed:17407782, PubMed:17412999). Does not require ATP (PubMed:11123922). Maintains partially unfolded pro",amyloid-beta binding,Secreted,,DrugBank,drugbank_id
BE0003503,Carboxypeptidase N catalytic chain,target,P15169,CPN1,Humans,Protects the body from potent vasoactive and inflammatory peptides containing C-terminal Arg or Lys (such as kinins or anaphylatoxins) which are released into the circulation,metallocarboxypeptidase activity,"Secreted, extracellular space",,DrugBank,drugbank_id
BE0003504,Carboxypeptidase N subunit 2,target,P22792,CPN2,Humans,The 83 kDa subunit binds and stabilizes the catalytic subunit at 37 degrees Celsius and keeps it in circulation. Under some circumstances it may be an allosteric modifier of the catalytic subunit,enzyme regulator activity,Secreted,,DrugBank,drugbank_id
BE0009073,Dermcidin,target,P81605,DCD,Humans,"Found in sweat, has an antimicrobial activity during early bacterial colonization (PubMed:11694882, PubMed:23426625). The secreted peptide assembles into homohexameric complexes that can associate with and also insert into pathogen membranes (PubMed:23426625). Once inserted in bacteria membranes forms anion channels probably altering the transmembrane potential essential for bacterial survival (PubMed:23426625). Highly effective against E.coli, E.faecalis, S.aureus and C.albicans (PubMed:1169488",lipid binding,Secreted,,DrugBank,drugbank_id
BE0009074,Desmoplakin,target,P15924,DSP,Humans,Major high molecular weight protein of desmosomes. Regulates profibrotic gene expression in cardiomyocytes via activation of the MAPK14/p38 MAPK signaling cascade and increase in TGFB1 protein abundance (By similarity),cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,"Cell junction, desmosome",,DrugBank,drugbank_id
BE0004672,Coagulation factor XII,target,P00748,F12,Humans,"Factor XII is a serum glycoprotein that participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then trypsin cleaves it to beta-factor XIIa. Alpha-factor XIIa activates factor XI to factor XIa (PubMed:2019570, PubMed:21304106, PubMed:8427954)",calcium ion binding,Secreted,,DrugBank,drugbank_id
BE0009075,Coagulation factor XIII B chain,target,P05160,F13B,Humans,"The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin",,Secreted,,DrugBank,drugbank_id
BE0009076,Ficolin-3,target,O75636,FCN3,Humans,"May function in innate immunity through activation of the lectin complement pathway. Calcium-dependent and GlcNAc-binding lectin. Has affinity with GalNAc, GlcNAc, D-fucose, as mono/oligosaccharide and lipopolysaccharides from S.typhimurium and S.minnesota",antigen binding,Secreted,,DrugBank,drugbank_id
BE0001180,Fibronectin,target,P02751,FN1,Humans,"Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin (PubMed:3024962, PubMed:3593230, PubMed:3900070, PubMed:7989369). Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape (PubMed:3024962, PubMed:3593230, PubMed:3900070, PubMed:7989369). Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast minera",collagen binding,"Secreted, extracellular space, extracellular matrix",,DrugBank,drugbank_id
BE0004161,Gelsolin,target,P06396,GSN,Humans,"Calcium-regulated, actin-modulating protein that binds to the plus (or barbed) ends of actin monomers or filaments, preventing monomer exchange (end-blocking or capping). It can promote the assembly of monomers into filaments (nucleation) as well as sever filaments already formed (PubMed:19666512). Plays a role in ciliogenesis (PubMed:20393563)",actin binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0009057,Haptoglobin-related protein,target,P00739,HPR,Humans,"Primate-specific plasma protein associated with apolipoprotein L-I (apoL-I)-containing high-density lipoprotein (HDL). This HDL particle, termed trypanosome lytic factor-1 (TLF-1), mediates human innate immune protection against many species of African trypanosomes. Binds hemoglobin with high affinity and may contribute to the clearance of cell-free hemoglobin to allow hepatic recycling of heme iron",hemoglobin binding,Secreted,,DrugBank,drugbank_id
BE0009077,Hornerin,target,Q86YZ3,HRNR,Humans,Component of the epidermal cornified cell envelopes,calcium ion binding,Cytoplasmic granule,,DrugBank,drugbank_id
BE0005097,Immunoglobulin heavy constant alpha 1,target,P01876,IGHA1,Humans,"Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which resu",antigen binding,Secreted,,DrugBank,drugbank_id
BE0005098,Immunoglobulin heavy constant mu,target,P01871,IGHM,Humans,"Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which resu",antigen binding,Secreted,,DrugBank,drugbank_id
BE0009078,Immunoglobulin kappa variable 1-17,target,P01599,IGKV1-17,Humans,"V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition (PubMed:24600447). Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secr",antigen binding,Secreted,,DrugBank,drugbank_id
BE0000616,Immunoglobulin kappa variable 3-20,target,P01619,IGKV3-20,Humans,"V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition (PubMed:24600447). Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secr",antigen binding,Secreted,,DrugBank,drugbank_id
BE0009079,Immunoglobulin lambda variable 3-21,target,P80748,IGLV3-21,Humans,"V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition (PubMed:24600447). Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secr",antigen binding,Secreted,,DrugBank,drugbank_id
BE0009080,Inter-alpha-trypsin inhibitor heavy chain H1,target,P19827,ITIH1,Humans,"May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes",calcium ion binding,Secreted,,DrugBank,drugbank_id
BE0009060,Inter-alpha-trypsin inhibitor heavy chain H2,target,P19823,ITIH2,Humans,"May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes",endopeptidase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0009081,Inter-alpha-trypsin inhibitor heavy chain H3,target,Q06033,ITIH3,Humans,"May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes",endopeptidase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0009082,Inter-alpha-trypsin inhibitor heavy chain H4,target,Q14624,ITIH4,Humans,Type II acute-phase protein (APP) involved in inflammatory responses to trauma. May also play a role in liver development or regeneration,endopeptidase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0009083,Immunoglobulin J chain,target,P01591,JCHAIN,Humans,"Serves to link two monomer units of either IgM or IgA. In the case of IgM, the J chain-joined dimer is a nucleating unit for the IgM pentamer, and in the case of IgA it induces dimers and/or larger polymers. It also helps to bind these immunoglobulins to secretory component",antigen binding,Secreted,,DrugBank,drugbank_id
BE0009084,Junction plakoglobin,target,P14923,JUP,Humans,Common junctional plaque protein. The membrane-associated plaques are architectural elements in an important strategic position to influence the arrangement and function of both the cytoskeleton and the cells within the tissue. The presence of plakoglobin in both the desmosomes and in the intermediate junctions suggests that it plays a central role in the structure and function of submembranous plaques. Acts as a substrate for VE-PTP and is required by it to stimulate VE-cadherin function in end,alpha-catenin binding,"Cell junction, adherens junction",,DrugBank,drugbank_id
BE0002440,Plasma kallikrein,target,P03952,KLKB1,Humans,"Participates in the surface-dependent activation of blood coagulation. Activates, in a reciprocal reaction, coagulation factor XII/F12 after binding to negatively charged surfaces. Releases bradykinin from HMW kininogen and may also play a role in the renin-angiotensin system by converting prorenin into renin",serine-type endopeptidase activity,Secreted,,DrugBank,drugbank_id
BE0001017,Kininogen-1,target,P01042,KNG1,Humans,Kininogens are inhibitors of thiol proteases. HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes. LMW-kininogen inhibits the aggregation of thrombocytes. LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting,cysteine-type endopeptidase inhibitor activity,"Secreted, extracellular space",,DrugBank,drugbank_id
BE0009061,"Keratin, type II cytoskeletal 1",target,P04264,KRT1,Humans,May regulate the activity of kinases such as PKC and SRC via binding to integrin beta-1 (ITB1) and the receptor of activated protein C kinase 1 (RACK1). In complex with C1QBP is a high affinity receptor for kininogen-1/HMWK,carbohydrate binding,Cell membrane,,DrugBank,drugbank_id
BE0009062,"Keratin, type I cytoskeletal 10",target,P13645,KRT10,Humans,Plays a role in the establishment of the epidermal barrier on plantar skin (By similarity). Involved in the maintenance of cell layer development and keratin filament bundles in suprabasal cells of the epithelium (By similarity),protein heterodimerization activity,"Secreted, extracellular space",,DrugBank,drugbank_id
BE0009085,"Keratin, type I cytoskeletal 14",target,P02533,KRT14,Humans,The nonhelical tail domain is involved in promoting KRT5-KRT14 filaments to self-organize into large bundles and enhances the mechanical properties involved in resilience of keratin intermediate filaments in vitro,keratin filament binding,Cytoplasm,,DrugBank,drugbank_id
BE0009086,"Keratin, type I cytoskeletal 16",target,P08779,KRT16,Humans,Epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance,structural constituent of cytoskeleton,,,DrugBank,drugbank_id
BE0009063,"Keratin, type II cytoskeletal 2 epidermal",target,P35908,KRT2,Humans,"Probably contributes to terminal cornification (PubMed:1380918). Associated with keratinocyte activation, proliferation and keratinization (PubMed:12598329). Required for maintenance of corneocytes and keratin filaments in suprabasal keratinocytes in the epidermis of the ear, potentially via moderation of expression and localization of keratins and their partner proteins (By similarity). Plays a role in the establishment of the epidermal barrier on plantar skin (By similarity)",cytoskeletal protein binding,Cytoplasm,,DrugBank,drugbank_id
BE0009087,"Keratin, type II cytoskeletal 5",target,P13647,KRT5,Humans,"Required for the formation of keratin intermediate filaments in the basal epidermis and maintenance of the skin barrier in response to mechanical stress (By similarity). Regulates the recruitment of Langerhans cells to the epidermis, potentially by modulation of the abundance of macrophage chemotactic cytokines, macrophage inflammatory cytokines and CTNND1 localization in keratinocytes (By similarity)",scaffold protein binding,Cytoplasm,,DrugBank,drugbank_id
BE0009088,"Keratin, type II cytoskeletal 6A",target,P02538,KRT6A,Humans,"Epidermis-specific type I keratin involved in wound healing. Involved in the activation of follicular keratinocytes after wounding, while it does not play a major role in keratinocyte proliferation or migration. Participates in the regulation of epithelial migration by inhibiting the activity of SRC during wound repair",structural constituent of cytoskeleton,,,DrugBank,drugbank_id
BE0009064,"Keratin, type I cytoskeletal 9",target,P35527,KRT9,Humans,May serve an important special function either in the mature palmar and plantar skin tissue or in the morphogenetic program of the formation of these tissues. Plays a role in keratin filament assembly,structural constituent of cytoskeleton,,,DrugBank,drugbank_id
BE0004613,N-acetylmuramoyl-L-alanine amidase,target,Q96PD5,PGLYRP2,Humans,May play a scavenger role by digesting biologically active peptidoglycan (PGN) into biologically inactive fragments. Has no direct bacteriolytic activity,N-acetylmuramoyl-L-alanine amidase activity,Secreted,,DrugBank,drugbank_id
BE0009089,Pregnancy zone protein,target,P20742,PZP,Humans,"Is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. The entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). Following cleavage ",endopeptidase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0005533,Selenoprotein P,target,P49908,SELENOP,Humans,Might be responsible for some of the extracellular antioxidant defense properties of selenium or might be involved in the transport of selenium. May supply selenium to tissues such as brain and testis,selenium binding,Secreted,,DrugBank,drugbank_id
BE0009090,Alpha-1-antichymotrypsin,target,P01011,SERPINA3,Humans,"Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2",DNA binding,Secreted,,DrugBank,drugbank_id
BE0009067,Kallistatin,target,P29622,SERPINA4,Humans,"Inhibits human amidolytic and kininogenase activities of tissue kallikrein. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and generation of a small C-terminal fragment of the inhibitor due to cleavage at the reactive site by tissue kallikrein",serine-type endopeptidase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0009092,Amyloid beta precursor like protein 1,target,P51693,APLP1,Humans,"May play a role in postsynaptic function. The C-terminal gamma-secretase processed fragment, ALID1, activates transcription activation through APBB1 (Fe65) binding (By similarity). Couples to JIP signal transduction through C-terminal binding. May interact with cellular G-protein signaling pathways. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I",alpha-2A adrenergic receptor binding,Cell membrane,cofactor,DrugBank,drugbank_id
BE0009093,Amyloid beta precursor like protein 2,target,Q06481,APLP2,Humans,"May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5'-GTCACATG-3'(CDEI box). Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts (By similarity)",DNA binding,Cell membrane,cofactor,DrugBank,drugbank_id
BE0008485,Penicillin-binding protein 4,target,P72355,pbp4,Staphylococcus aureus,Removes C-terminal D-alanyl residues from sugar-peptide cell wall precursors.,beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0003189,Beta-lactamase,target,P52664,blaB,Proteus vulgaris,Hydrolyzes broad-spectrum beta-lactam antibiotics. Active against cephalosporins such as cefuroxime and cefotaxime.,beta-lactamase activity,Cytoplasmic,activator,DrugBank,drugbank_id
BE0002015,Beta-lactamase SHV-1,enzyme,P0AD63,bla,Escherichia coli,,beta-lactamase activity,Cytoplasmic,substrate,DrugBank,drugbank_id
BE0002831,Beta-lactamase CTX-M,enzyme,Q939N4,,Escherichia coli,,beta-lactamase activity,,substrate,DrugBank,drugbank_id
BE0009747,Beta-lactamase,enzyme,Q93LQ9,KPC-2,Klebsiella pneumoniae,,beta-lactamase activity,,substrate,DrugBank,drugbank_id
BE0001568,Beta-lactamase TEM,target,P62594,bla,Salmonella typhi,"TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins.",beta-lactamase activity,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0009681,Beta-lactamase Ohio-1,target,P18251,,Enterobacter cloacae,,beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0000997,Atrial natriuretic peptide receptor 2,target,P20594,NPR2,Humans,Receptor for the C-type natriuretic peptide NPPC/CNP hormone. Has guanylate cyclase activity upon binding of its ligand. May play a role in the regulation of skeletal growth,ATP binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0001224,Uridine phosphorylase,target,P12758,udp,Escherichia coli (strain K12),Catalyzes the reversible phosphorylytic cleavage of uridine to uracil and ribose-1-phosphate (PubMed:16751). Shows weak activity towards deoxyuridine and thymidine (PubMed:16751). The produced molecules are then utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis (Probable).,ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0003728,Nuclear receptor coactivator 1,target,Q15788,NCOA1,Humans,"Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Involved in the coactivation of different nuclear receptors, such as for steroids (PGR, GR and ER), retinoids (RXRs), thyroid hormone (TRs) and prostanoids (PPARs). Also involved in coactivation mediated by STAT3, STAT5A, STAT5B and STAT6 transcription factors. Displays histone acetyltransferase activity toward H3 and H4; the relevance of such activity ",chromatin binding,Nucleus,,DrugBank,drugbank_id
BE0009369,Cytochrome P450 1A1,enzyme,P00185,Cyp1a1,Rat,"A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of hydroxy",arachidonic acid monooxygenase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001226,Major NAD(P)H-flavin oxidoreductase,target,P46072,,Vibrio fischeri,"Involved in bioluminescence. It is a good supplier of reduced flavin mononucleotide (FMNH2) to the bioluminescence reaction. Major FMN reductase. It is capable of using both NADH and NADPH as electron donors. As electron acceptor, FMN is the most effective, FAD is considerably effective, and riboflavin is the least effective.",oxidoreductase activity,,,DrugBank,drugbank_id
BE0001238,Streptogramin A acetyltransferase,target,P50870,vatD,Enterococcus faecium,"Inactivates the A compounds of streptogramin antibiotics by acetylation, thus providing resistance to these antibiotics.",acyltransferase activity,,,DrugBank,drugbank_id
BE0001089,Glucose-6-phosphate 1-dehydrogenase,target,P11413,G6PD,Humans,"Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. The main function of this enzyme is to provide reducing power (NADPH) and pentose phosphates for fatty acid and nucleic acid synthesis",D-glucose binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0001264,Sulfotransferase 2B1,enzyme,O00204,SULT2B1,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation. Responsible for the sulfation of cholesterol (PubMed:12145317, PubMed:19589875). Catalyzes sulfation of the 3beta-hydroxyl groups of steroids, such as, pregnenolone and dehydroepiandrosterone (DHEA) (PubMed:12145317, PubMed:16855051, PubMed:21855633, PubMed:9799594). Preferentially sulfonates cholesterol, while it also has significant activity with pregnenolone and DHEA (P",cholesterol binding,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0001230,Cholesterol oxidase,enzyme,P22637,choB,Brevibacterium sterolicum,"Catalyzes the oxidation and isomerization of cholesterol to cholestenone (4-cholesten-3-one), which is an initial step in the cholesterol degradation process.",cholesterol oxidase activity,Secreted,substrate,DrugBank,drugbank_id
BE0027486,Bacterial 50S ribosomal protein,target,,,Gram positive bacteria,,,,inhibitor,DrugBank,drugbank_id
BE0001294,Pantothenate kinase,target,P0A6I3,coaA,Escherichia coli (strain K12),,ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0001345,"Glucan 1,3-beta-glucosidase",target,P29717,XOG1,Yeast,"Major glucan 1,3-beta-glucosidase required for cell wall integrity. Beta-glucanases participate in the metabolism of beta-glucan, the main structural component of the cell wall. Can also function biosynthetically as a transglycosylase. Functions to deliver glucan from the cell to the extracellular matrix. Does not appear to impact cell wall glucan content of biofilm cells, nor is it necessary for filamentation or biofilm formation. Involved in cell-substrate and cell-cell adhesion. Adhesion to h",cell adhesion molecule binding,Secreted,,DrugBank,drugbank_id
BE0002565,Glycerol dehydratase,target,Q8GEZ8,dhaB1,Clostridium butyricum,,lyase activity,,,DrugBank,drugbank_id
BE0001408,Tubulin beta-4A chain,target,P04350,TUBB4A,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",calcium ion binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0001415,Tubulin beta-3 chain,target,Q13509,TUBB3,Humans,"Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (PubMed:34996871, PubMed:38305685, PubMed:38609661). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms (PubMed:34996871, PubMed:38305685, PubMed:38609661). Below the cap, alpha-beta tubulin heterodimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin (PubMed:34996871, PubMed:38609661). TUBB3 plays a cr",GTP binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0001388,Tubulin alpha-1C chain,target,Q9BQE3,TUBA1C,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0001359,Tubulin alpha-8 chain,target,Q9NY65,TUBA8,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0001275,Tubulin alpha-1B chain,target,P68363,TUBA1B,Humans,"Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (PubMed:38305685, PubMed:34996871, PubMed:38609661). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms (PubMed:38305685, PubMed:34996871, PubMed:38609661). Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin (PubMed:34996871, PubMed:38609661)",double-stranded RNA binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0027478,Tubulin alpha 3C/D chain,target,P0DPH7,TUBA3C,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0000916,"Glycogen phosphorylase, muscle form",target,P11217,PYGM,Humans,"Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis",glycogen phosphorylase activity,,inhibitor,DrugBank,drugbank_id
BE0001456,Type II methyltransferase M.RsrI,target,P14751,rsrIM,Rhodobacter sphaeroides,"A beta subtype methylase, recognizes the double-stranded sequence 5'-GAATTC-3', methylates A-3 on both strands, and protects the DNA from cleavage by the RsrI endonuclease.",DNA binding,Cytoplasmic,,DrugBank,drugbank_id
BE0002526,Aclacinomycin 10-hydroxylase RdmB,target,Q54527,rdmB,Streptomyces purpurascens,"Involved in the biosynthesis of the anthracycline aclacinomycin which is an aromatic polyketide antibiotic that exhibits high cytotoxicity and is widely applied in the chemotherapy of a variety of cancers. In vivo and in vitro, RdmB catalyzes the removal of the carboxylic group from the C-10 position of 15-demethoxyaclacinomycin T coupled to hydroxylation at the same C-10 position. It could also catalyze the removal of the carboxylic group at the C-10 position of 15-demethoxy-epsilon-rhodomycin ",carboxy-lyase activity,,,DrugBank,drugbank_id
BE0002516,rRNA adenine N-6-methyltransferase,target,P13956,ermC',Bacillus subtilis,"This protein produces a dimethylation of the adenine residue at position 2085 in 23S rRNA, resulting in reduced affinity between ribosomes and macrolide-lincosamide-streptogramin B antibiotics.",23S rRNA (adenine(2085)-N(6))-dimethyltransferase activity,,,DrugBank,drugbank_id
BE0002531,Type II methyltransferase M.TaqI,target,P14385,taqIM,Thermus aquaticus,"A gamma subtype methylase that recognizes the double-stranded sequence 5'-TCGA-3', methylates A-4 on both strands and protects the DNA from cleavage by the TaqI endonuclease.",DNA binding,Cytoplasmic,,DrugBank,drugbank_id
BE0003382,Serine/threonine-protein kinase Chk1,target,O14757,CHEK1,Humans,"Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA (PubMed:11535615, PubMed:12399544, PubMed:12446774, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15650047, PubMed:15665856, PubMed:32357935). May also negatively regulate cell cycle progression during unperturbed cell cycles (PubMed:11535615, PubMed:12399544, PubMed:12446774, PubMed:14559997, PubMed:149",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0002535,Peptide deformylase,target,P68826,def,Staphylococcus aureus,Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity).,metal ion binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,target,P20035,LACZ,Plasmodium falciparum (isolate FCR-3 / Gambia),"Catalyzes the transfer of a ribosyl phosphate group from 5-phosphoribose 1-diphosphate to the N(9) of hypoxanthine, guanine or xanthine, leading to IMP, GMP and XMP, respectively. Plays a central role in the generation of purine nucleotides through the purine salvage pathway.",guanine phosphoribosyltransferase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001368,2-oxo-tetronate isomerase,target,Q46891,otnI,Escherichia coli (strain K12),Catalyzes the isomerization of 2-oxo-tetronate to 3-oxo-tetronate.,hydroxypyruvate isomerase activity,,,DrugBank,drugbank_id
BE0001285,Delta-aminolevulinic acid dehydratase,target,Q59643,hemB,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),"Catalyzes an early step in the biosynthesis of tetrapyrroles. Binds two molecules of 5-aminolevulinate per subunit, each at a distinct site, and catalyzes their condensation to form porphobilinogen (By similarity).",porphobilinogen synthase activity,,,DrugBank,drugbank_id
BE0001381,3-phosphoshikimate 1-carboxyvinyltransferase,target,P0A6D3,aroA,Escherichia coli (strain K12),Catalyzes the transfer of the enolpyruvyl moiety of phosphoenolpyruvate (PEP) to the 5-hydroxyl of shikimate-3-phosphate (S3P) to produce enolpyruvyl shikimate-3-phosphate and inorganic phosphate.,3-phosphoshikimate 1-carboxyvinyltransferase activity,Cytoplasm,,DrugBank,drugbank_id
BE0001397,Subtilisin Carlsberg,target,P00780,subC,Bacillus licheniformis,"Subtilisin is an extracellular alkaline serine protease, it catalyzes the hydrolysis of proteins and peptide amides (PubMed:11109488, Ref.4). Shows high specificity for aromatic and hydrophobic amino acids in the P1 substrate position (PubMed:11109488). May play an important role in the degradation of feather keratin (PubMed:11109488).",metal ion binding,Secreted,,DrugBank,drugbank_id
BE0001475,Peptide deformylase,target,P0A6K3,def,Escherichia coli (strain K12),Removes the formyl group from the N-terminal Met of newly synthesized proteins (PubMed:7896716). Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions.,ferrous iron binding,Cytoplasmic,,DrugBank,drugbank_id
BE0000597,Aminodeoxychorismate synthase component 1,target,P05041,pabB,Escherichia coli (strain K12),"Part of a heterodimeric complex that catalyzes the two-step biosynthesis of 4-amino-4-deoxychorismate (ADC), a precursor of p-aminobenzoate (PABA) and tetrahydrofolate. In the first step, a glutamine amidotransferase (PabA) generates ammonia as a substrate that, along with chorismate, is used in the second step, catalyzed by aminodeoxychorismate synthase (PabB) to produce ADC. PabB, in the absence of PabA, can catalyze the formation of ADC in the presence of exogenous ammonia.",4-amino-4-deoxychorismate synthase activity,,,DrugBank,drugbank_id
BE0001525,Dihydroorotate dehydrogenase (quinone),target,P0A7E1,pyrD,Escherichia coli (strain K12),Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.,dihydroorotate dehydrogenase (quinone) activity,Cell membrane,,DrugBank,drugbank_id
BE0001613,(S)-2-haloacid dehalogenase,target,Q60099,dhlB,Xanthobacter autotrophicus,"Catalyzes the hydrolytic dehalogenation of small (S)-2-haloalkanoic acids to yield the corresponding (R)-2-hydroxyalkanoic acids (PubMed:1744048). Acts on acids of short chain lengths, C(2) to C(4), with inversion of configuration at C-2 (PubMed:1744048). Active with 2-halogenated carboxylic acids and converts only the S-isomer (or L-isomer) of 2-chloropropionic acid with inversion of configuration to produce R-lactate (or D-isomer) (PubMed:1744048).",(S)-2-haloacid dehalogenase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0001778,Beta-lactamase OXA-2,target,P0A1V8,bla,Salmonella typhimurium,This is an oxacillin-hydrolyzing beta-lactamase.,beta-lactamase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0001988,Catalase,target,P42321,katA,Proteus mirabilis,Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide.,catalase activity,Cytoplasm,,DrugBank,drugbank_id
BE0001792,Signal recognition particle protein,target,O07347,ffh,Thermus aquaticus,Involved in targeting and insertion of nascent membrane proteins into the cytoplasmic membrane. Binds to the hydrophobic signal sequence of the ribosome-nascent chain (RNC) as it emerges from the ribosomes. The SRP-RNC complex is then targeted to the cytoplasmic membrane where it interacts with the SRP receptor FtsY.,7S RNA binding,Cytoplasm,,DrugBank,drugbank_id
BE0001668,Streptavidin,target,P22629,,Streptomyces avidinii,The biological function of streptavidin is not known. Forms a strong non-covalent specific complex with biotin (one molecule of biotin per subunit of streptavidin).,biotin binding,Secreted,,DrugBank,drugbank_id
BE0001905,Methylglyoxal synthase,target,P0A733,mgsA,Shigella flexneri,Catalyzes the formation of methylglyoxal from dihydroxyacetone phosphate.,methylglyoxal synthase activity,Cytoplasm,,DrugBank,drugbank_id
BE0002624,C-terminal-binding protein 1,target,Q13363,CTBP1,Humans,Corepressor targeting diverse transcription regulators such as GLIS2 or BCL6. Has dehydrogenase activity. Involved in controlling the equilibrium between tubular and stacked structures in the Golgi complex. Functions in brown adipose tissue (BAT) differentiation,chromatin binding,Cytoplasm,,DrugBank,drugbank_id
BE0001966,6-phosphogluconolactonase,target,Q9X0N8,pgl,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate.,6-phosphogluconolactonase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0002640,Citrate lyase subunit beta-like protein,target,P9WPE1,citE,Mycobacterium tuberculosis,May play a role in fatty acid biosynthesis.,lyase activity,,,DrugBank,drugbank_id
BE0002641,Peripheral plasma membrane protein CASK,target,O14936,CASK,Humans,"Multidomain scaffolding Mg(2+)-independent protein kinase that catalyzes the phosphotransfer from ATP to proteins such as NRXN1, and plays a role in synaptic transmembrane protein anchoring and ion channel trafficking (PubMed:18423203). Contributes to neural development and regulation of gene expression via interaction with the transcription factor TBR1. Binds to cell-surface proteins, including amyloid precursor protein, neurexins and syndecans. May mediate a link between the extracellular matr",ATP binding,Nucleus,,DrugBank,drugbank_id
BE0002642,Guanylate kinase,target,P9WKE9,gmk,Mycobacterium tuberculosis,"Essential for recycling GMP and indirectly, cGMP.",adenylate kinase activity,Cytoplasm,,DrugBank,drugbank_id
BE0002643,Probable butyrate kinase 2,target,Q9X278,buk2,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),,acetate kinase activity,Cytoplasm,,DrugBank,drugbank_id
BE0004623,Gamma-glutamylaminecyclotransferase,target,Q9BVM4,GGACT,Humans,Contributes to degradation of proteins cross-linked by transglutaminases by degrading the cross-link between a lysine and a glutamic acid residue. Catalyzes the formation of 5-oxo-L-proline from L-gamma-glutamyl-L-epsilon-lysine. Inactive with L-gamma-glutamyl-alpha-amino acid substrates such as L-gamma-glutamyl-L-alpha-cysteine and L-gamma-glutamyl-L-alpha-alanine,gamma-glutamylaminecyclotransferase activity,,,DrugBank,drugbank_id
BE0004470,Parvalbumin alpha,target,P20472,PVALB,Humans,"In muscle, parvalbumin is thought to be involved in relaxation after contraction (By similarity). It binds two calcium ions (PubMed:15122922, PubMed:39584689)",calcium ion binding,,,DrugBank,drugbank_id
BE0004569,Acylphosphatase-2,target,P14621,ACYP2,Humans,Its physiological role is not yet clear,acylphosphatase activity,,,DrugBank,drugbank_id
BE0002644,ABM domain-containing protein,target,Q81C15,,Bacillus cereus (strain ATCC 14579 / DSM 31),,oxidoreductase activity,,,DrugBank,drugbank_id
BE0002645,Arginine N-succinyltransferase subunit alpha,target,P80357,astA,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),Catalyzes the transfer of succinyl-CoA to arginine to produce N(2)-succinylarginine. Also acts on L-ornithine.,arginine N-succinyltransferase activity,,,DrugBank,drugbank_id
BE0002646,Putative mannose-6-phosphate isomerase YvyI,target,P39841,yvyI,Bacillus subtilis (strain 168),,mannose-6-phosphate isomerase activity,,,DrugBank,drugbank_id
BE0002647,"Oligopeptide ABC transporter, periplasmic oligopeptide-binding protein",target,Q9X0V0,,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),,metal ion binding,,,DrugBank,drugbank_id
BE0002648,Probable phosphatase YcdX,target,P75914,ycdX,Escherichia coli (strain K12),Hydrolyzes p-nitrophenyl phosphate (pNPP) in vitro. Involved in the swarming motility process.,identical protein binding,Cytoplasmic,,DrugBank,drugbank_id
BE0002650,Oxalate decarboxylase OxdC,target,O34714,oxdC,Bacillus subtilis (strain 168),"Converts oxalate to formate and CO(2) in an O(2)-dependent reaction. Can also catalyze minor side reactions: oxalate oxidation to produce H(2)O(2), and oxalate-dependent, H(2)O(2)-independent dye oxidations.",metal ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0002651,Putative ketoacyl reductase,target,P16544,actIII,Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145),,oxidoreductase activity,,,DrugBank,drugbank_id
BE0002652,Gephyrin,target,Q9NQX3,GPHN,Humans,"Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Acts as a major instructive molecule at inhibitory synapses, where it also clusters GABA type A receptors (PubMed:25025157, PubMed:26613940)",ATP binding,Postsynaptic cell membrane,,DrugBank,drugbank_id
BE0002653,Glyoxalase family protein,target,Q81F54,,Bacillus cereus (strain ATCC 14579 / DSM 31),,methylmalonyl-CoA epimerase activity,,,DrugBank,drugbank_id
BE0002654,Cytohesin-2,target,Q99418,CYTH2,Humans,"Acts as a guanine-nucleotide exchange factor (GEF). Promotes guanine-nucleotide exchange on ARF1, ARF3 and ARF6. Activates ARF factors through replacement of GDP with GTP (By similarity). The cell membrane form, in association with ARL4 proteins, recruits ARF6 to the plasma membrane (PubMed:17398095). Involved in neurite growth (By similarity)",guanyl-nucleotide exchange factor activity,Cell membrane,,DrugBank,drugbank_id
BE0002655,Glutaconyl-CoA decarboxylase subunit alpha,target,Q06700,gcdA,Acidaminococcus fermentans (strain ATCC 25085 / DSM 20731 / VR4),Decarboxylase subunit of the primary sodium pump glutaconyl-CoA decarboxylase (GCD).,glutaconyl-CoA decarboxylase activity,,,DrugBank,drugbank_id
BE0002656,"Transcriptional regulator, IclR family",target,Q9WXS0,,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),,DNA binding,Cytoplasmic,,DrugBank,drugbank_id
BE0002657,Catalase,target,P77872,katA,Helicobacter pylori (strain ATCC 700392 / 26695),Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide.,catalase activity,Cytoplasm,,DrugBank,drugbank_id
BE0002658,Sensory rhodopsin transducer,target,Q9X0F9,,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),,metal ion binding,,,DrugBank,drugbank_id
BE0002488,Hypoxanthine phosphoribosyltransferase,target,Q27796,HGPRTase,Trypanosoma cruzi,,guanine phosphoribosyltransferase activity,Cytoplasm (By similarity),,DrugBank,drugbank_id
BE0002660,Glutaminase 1,target,O31465,glsA1,Bacillus subtilis (strain 168),,glutaminase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0002661,Glutaminase 1,target,P77454,glsA1,Escherichia coli (strain K12),,glutaminase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0002662,Molybdopterin synthase catalytic subunit,target,P30749,moaE,Escherichia coli (strain K12),Converts molybdopterin precursor Z to molybdopterin. This requires the incorporation of two sulfur atoms into precursor Z to generate a dithiolene group. The sulfur is provided by MoaD.,molybdopterin synthase activity,,,DrugBank,drugbank_id
BE0002663,"Aminotransferase, putative",target,Q9X0L5,,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),,pyridoxal phosphate binding,,,DrugBank,drugbank_id
BE0002664,Fe(3+) ABC transporter substrate-binding protein,target,Q9Z4N6,fbpA,Pasteurella haemolytica,,metal ion binding,,,DrugBank,drugbank_id
BE0002665,DNA gyrase subunit B,target,Q5SHZ4,gyrB,Thermus thermophilus,"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner (PubMed:11850422, PubMed:23804759). It probably also catalyzes the interconversion of other topological isomers of double-stranded DNA rings, including catenanes (PubMed:11850422). Relaxes negatively supercoiled DNA in an ATP-independent manner (PubMed:11850422, PubMed:23804759). At comparable concentrations T.thermophilus gyrase does not introduce as many negative supercoils in",ATP binding,Cytoplasmic,,DrugBank,drugbank_id
BE0027485,Phenazine biosynthesis protein PhzD,target,P0DPB9,phzD1,Pseudomonas aeruginosa,"Involved in the biosynthesis of the antibiotic phenazine, a nitrogen-containing heterocyclic molecule. PhzD1 (operon phzA1B1C1E1F1G1) has a role in the biosynthesis of the phenazine during planktonic growth (PubMed:23129634). Catalyzes the hydrolysis of the vinyl ether functional group of 2-amino-2-deoxyisochorismate (ADIC), yielding pyruvate and trans-2,3-dihydro-3-hydroxyanthranilic acid (DHHA) (PubMed:12741825, PubMed:23129634). Also able to act on isochorismate, chorismate and 4-amino-4-deox",isochorismatase activity,,,DrugBank,drugbank_id
BE0001402,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,P07617,OPG102,VACV,"Displays methyltransferase, positive regulation of the poly(A) polymerase and transcription elongation activities. Involved in the modification of both mRNA ends and in intermediate and late gene positive transcription elongation. At the mRNAs 5' end, methylates the ribose 2' OH group of the first transcribed nucleotide, thereby producing a 2'-O-methylpurine cap. At the 3' end, functions as a processivity factor which stimulates the activity of the viral poly(A) polymerase OPG063 that creates mR",mRNA (nucleoside-2'-O-)-methyltransferase activity,Virion,,DrugBank,drugbank_id
BE0001433,Nitric oxide synthase oxygenase,target,O34453,nos,Bacillus subtilis (strain 168),Catalyzes the production of nitric oxide.,heme binding,,,DrugBank,drugbank_id
BE0001438,Thymidylate synthase,target,P0A884,thyA,Escherichia coli (strain K12),"Catalyzes the reductive methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP) while utilizing 5,10-methylenetetrahydrofolate (mTHF) as the methyl donor and reductant in the reaction, yielding dihydrofolate (DHF) as a by-product (PubMed:2223754, PubMed:3286637, PubMed:9826509). This enzymatic reaction provides an intracellular de novo source of dTMP, an essential precursor for DNA biosynthesis. This protein also binds to its mRNA thus repressing its o",magnesium ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0003355,Metallo-beta-lactamase L1 type 3,target,P52700,,Pseudomonas maltophilia,"Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring.",beta-lactamase activity,Periplasm,,DrugBank,drugbank_id
BE0004195,Metallo-beta-lactamase type 2,target,P26918,cphA,Aeromonas hydrophila,"Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring (PubMed:15588826, PubMed:17307979, PubMed:1856163, PubMed:19651913, PubMed:2327760). It is able to hydrolyze penicillin and imipenem, but is much less active against cephalothin, cefotaxime, meropenem and ceftazidime (PubMed:1856163, PubMed:2327760).",beta-lactamase activity,Periplasm,,DrugBank,drugbank_id
BE0004196,"Organic hydroperoxide resistance protein, putative",target,Q9KKU4,,Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961),,metal ion binding,,,DrugBank,drugbank_id
BE0002693,FEZ-1 protein,target,Q9K578,blaFEZ-1,Fluoribacter gormanii,,beta-lactamase activity,,,DrugBank,drugbank_id
BE0002694,Metallo-beta-lactamase type 2,target,O08498,blaB1,Chryseobacterium meningosepticum,"Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring.",beta-lactamase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0002700,Adenylosuccinate synthetase,target,Q9U8D3,Adss,Plasmodium falciparum,Plays an important role in the salvage pathway for purine nucleotide biosynthesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP (By similarity).,adenylosuccinate synthase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001441,Adenylosuccinate synthetase,target,P0A7D4,purA,Escherichia coli (strain K12),Plays an important role in the de novo pathway of purine nucleotide biosynthesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP.,adenylosuccinate synthase activity,Cytoplasm,,DrugBank,drugbank_id
BE0002231,Adenylosuccinate synthetase isozyme 1,target,Q8N142,ADSS1,Humans,"Component of the purine nucleotide cycle (PNC), which interconverts IMP and AMP to regulate the nucleotide levels in various tissues, and which contributes to glycolysis and ammoniagenesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP",actin filament binding,Cytoplasm,,DrugBank,drugbank_id
BE0001999,7alpha-hydroxysteroid dehydrogenase,target,P0AET8,hdhA,Escherichia coli (strain K12),"7alpha-hydroxysteroid dehydrogenase involved in the metabolism of bile acids. Catalyzes the NAD(+)-dependent oxidation of the 7alpha-hydroxy group of 7alpha-hydroxysteroids, such as the major human bile acids cholate and chenodeoxycholate, to the corresponding 7-oxosteroids. To a lesser extent, can also act on taurochenodeoxycholate, taurocholate and glycocholate (PubMed:2007545). Can also use glycochenodeoxycholate as substrate (PubMed:8672472). Is not able to use NADP(+) instead of NAD(+) as t",chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity,,,DrugBank,drugbank_id
BE0001556,Purine nucleoside phosphorylase 2,target,P45563,xapA,Escherichia coli (strain K12),"The purine nucleoside phosphorylases catalyze the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate. This protein can degrade all purine nucleosides including xanthosine, inosine and guanosine, but cannot cleave adenosine, deoxyadenosine or hypoxanthine arabinoside. Has a preference for the neutral over the monoanionic form of xanthosine.",guanosine phosphorylase activity,,,DrugBank,drugbank_id
BE0002009,Xanthine-guanine phosphoribosyltransferase,target,P0A9M5,gpt,Escherichia coli (strain K12),"Purine salvage pathway enzyme that catalyzes the transfer of the ribosyl-5-phosphate group from 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) to the N9 position of the 6-oxopurines guanine and xanthine to form the corresponding ribonucleotides GMP (guanosine 5'-monophosphate) and XMP (xanthosine 5'-monophosphate), with the release of PPi. To a lesser extent, also acts on hypoxanthine (PubMed:3886014, PubMed:9100006). Does not ribophosphorylate adenine (PubMed:3886014).",guanine phosphoribosyltransferase activity,Cell inner membrane,,DrugBank,drugbank_id
BE0001483,Nitric oxide synthase oxygenase,target,P0A094,nos,Staphylococcus aureus (strain MW2),Catalyzes the production of nitric oxide.,heme binding,,,DrugBank,drugbank_id
BE0001500,"Glucan 1,4-alpha-maltotetraohydrolase",target,P13507,amyP,Pseudomonas stutzeri,,alpha-amylase activity,Secreted,,DrugBank,drugbank_id
BE0001427,Neopullulanase 2,target,Q08751,tvaII,Thermoactinomyces vulgaris,"Hydrolyzes pullulan efficiently but only a small amount of starch. Endohydrolysis of 1,4-alpha-glucosidic linkages in pullulan to form panose. Cleaves also (1-6)-alpha-glucosidic linkages to form maltotriose.",metal ion binding,Cytoplasmic,,DrugBank,drugbank_id
BE0001432,Ganglioside GM2 activator,target,P17900,GM2A,Humans,"The large binding pocket can accommodate several single chain phospholipids and fatty acids, GM2A also exhibits some calcium-independent phospholipase activity (By similarity). Binds gangliosides and stimulates ganglioside GM2 degradation. It stimulates only the breakdown of ganglioside GM2 and glycolipid GA2 by beta-hexosaminidase A. It extracts single GM2 molecules from membranes and presents them in soluble form to beta-hexosaminidase A for cleavage of N-acetyl-D-galactosamine and conversion ",beta-N-acetylgalactosaminidase activity,Lysosome,,DrugBank,drugbank_id
BE0001554,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase,target,P19992,,Streptomyces exfoliatus,,"androstan-3-alpha,17-beta-diol dehydrogenase activity",,,DrugBank,drugbank_id
BE0001434,Methyl-accepting chemotaxis protein II,target,P02941,tar,Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720),"Receptor for the attractant L-aspartate and related amino and dicarboxylic acids. Tar mediates taxis away from the repellents cobalt and nickel. Unlike in E.coli tar, it does not mediate maltose taxis.",transmembrane signaling receptor activity,Cell inner membrane,,DrugBank,drugbank_id
BE0001055,GTP cyclohydrolase 1,target,P30793,GCH1,Humans,"Positively regulates nitric oxide synthesis in umbilical vein endothelial cells (HUVECs). May be involved in dopamine synthesis. May modify pain sensitivity and persistence. Isoform GCH-1 is the functional enzyme, the potential function of the enzymatically inactive isoforms remains unknown",GTP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002734,Purine nucleoside phosphorylase,target,Q9X1T2,,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),"The purine nucleoside phosphorylases catalyze the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate.",purine-nucleoside phosphorylase activity,,,DrugBank,drugbank_id
BE0001898,Heat shock protein HSP 90-beta,target,P08238,HSP90AB1,Humans,"Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:16478",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0001289,Dihydroneopterin aldolase,target,P56740,folB,Staphylococcus aureus,"Catalyzes the conversion of 7,8-dihydroneopterin to 6-hydroxymethyl-7,8-dihydropterin. Can also catalyze the epimerization of carbon 2' of dihydroneopterin to dihydromonapterin.",dihydroneopterin aldolase activity,,,DrugBank,drugbank_id
BE0004631,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,target,Q9UL51,HCN2,Humans,"Hyperpolarization-activated ion channel that is permeable to sodium and potassium ions. Displays lower selectivity for K(+) over Na(+) ions (PubMed:10228147, PubMed:22006928). Contributes to the native pacemaker currents in heart (If) and in neurons (Ih) (PubMed:10228147, PubMed:10524219). Can also transport ammonium in the distal nephron (By similarity). Involved in the initiation of neuropathic pain in sensory neurons (By similarity)",cAMP binding,Cell membrane,,DrugBank,drugbank_id
BE0003425,cAMP-dependent protein kinase type I-alpha regulatory subunit,target,P10644,PRKAR1A,Humans,Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells,cAMP binding,Cell membrane,,DrugBank,drugbank_id
BE0004497,cAMP-dependent protein kinase type II-beta regulatory subunit,target,P31323,PRKAR2B,Humans,"Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. Type II regulatory chains mediate membrane association by binding to anchoring proteins, including the MAP2 kinase",cAMP binding,Cytoplasm,,DrugBank,drugbank_id
BE0002013,DNA-binding transcriptional dual regulator CRP,target,P0ACJ8,crp,Escherichia coli (strain K12),"A global transcription regulator, which plays a major role in carbon catabolite repression (CCR) as well as other processes. Binds cyclic AMP (cAMP) which allosterically activates DNA binding (to consensus sequence 5'-AAATGTGATCTAGATCACATTT-3') to directly regulate the transcription of about 300 genes in about 200 operons and indirectly regulate the expression of about half the genome. There are 3 classes of CRP promoters; class I promoters have a single CRP-binding site upstream of the RNA poly",cAMP binding,Cytoplasmic,,DrugBank,drugbank_id
BE0002794,Adenylate cyclase,target,P94182,cyaB2,Anabaena sp.,,adenylate cyclase activity,,,DrugBank,drugbank_id
BE0002795,Cyclic nucleotide-gated potassium channel mll3241,target,Q98GN8,,Rhizobium loti (strain MAFF303099),Cyclic nucleotide-regulated potassium channel activated by cAMP.,cAMP binding,Cell membrane,,DrugBank,drugbank_id
BE0002367,Histone deacetylase 3,target,O15379,HDAC3,Humans,"Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates (PubMed:21030595, PubMed:21444723, PubMed:23911289, PubMed:25301942, PubMed:28167758, PubMed:28497810, PubMed:32404892, PubMed:22230954). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed:23911289).",chromatin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0002368,Protein deacetylase HDAC6,target,Q9UBN7,HDAC6,Humans,"Deacetylates a wide range of non-histone substrates (PubMed:12024216, PubMed:18606987, PubMed:20308065, PubMed:24882211, PubMed:26246421, PubMed:30538141, PubMed:31857589, PubMed:30770470, PubMed:38534334, PubMed:39567688). Plays a central role in microtubule-dependent cell motility by mediating deacetylation of tubulin (PubMed:12024216, PubMed:20308065, PubMed:26246421). Required for cilia disassembly via deacetylation of alpha-tubulin (PubMed:17604723, PubMed:26246421). Alpha-tubulin deacetyla",actin binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004106,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,P62617,ispF,Escherichia coli (strain K12),"Involved in the biosynthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), two major building blocks of isoprenoid compounds. Catalyzes the conversion of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) to 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP) with a corresponding release of cytidine 5-monophosphate (CMP). Also converts 4-diphosphocytidyl-2-C-methyl-D-erythritol into 2-C-methyl-D-erythritol 3,4-cyclophosphate and CMP.","2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity",,,DrugBank,drugbank_id
BE0004037,Prenyltransferase,target,Q4R2T2,,Streptomyces sp. (strain CL190),,metal ion binding,,,DrugBank,drugbank_id
BE0004093,"(2Z,6E)-farnesyl diphosphate synthase",target,P9WFF5,,Mycobacterium tuberculosis,"Catalyzes the condensation of only one isopentenyl pyrophosphate (IPP) unit in the cis configuration to E-geranyl diphosphate (E-GPP) generating the 15 carbon product (2Z,6E)-farnesyl diphosphate (Z-FPP or EZ-FPP). Z-FPP is the precursor of decaprenyl diphosphate, which has a central role in the biosynthesis of the mycobacterial cell wall.",magnesium ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0004107,Decaprenyl diphosphate synthase,target,P9WFF7,uppS,Mycobacterium tuberculosis,"Catalyzes the sequential condensation of isopentenyl diphosphate (IPP) in the cis configuration with (2Z,6E)-farnesyl diphosphate (Z-FPP or EZ-FPP) generating the 50 carbon product trans,polycis-decaprenyl diphosphate. When (2E,6E)-farnesyl diphosphate (E-FPP or EE-FPP) is used in vitro, both primary products decaprenyl diphosphate and (2E,6E,10E)-geranylgeranyl diphosphate (EEE-GGPP) are synthesized. M.tuberculosis does not synthesize (2E,6E,10Z)-geranylgeranyl diphosphate (EEZ-GGPP) and heptap",all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity,Cell membrane,,DrugBank,drugbank_id
BE0001303,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,P62619,ispF,Shigella flexneri,"Involved in the biosynthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), two major building blocks of isoprenoid compounds. Catalyzes the conversion of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) to 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP) with a corresponding release of cytidine 5-monophosphate (CMP).","2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity",,,DrugBank,drugbank_id
BE0001748,Bifunctional enzyme IspD/IspF,target,Q9PM68,ispDF,Campylobacter jejuni subsp. jejuni serotype O:2 (strain NCTC 11168),"Bifunctional enzyme that catalyzes the formation of 4-diphosphocytidyl-2-C-methyl-D-erythritol from CTP and 2-C-methyl-D-erythritol 4-phosphate (MEP) (IspD), and catalyzes the conversion of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) to 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP) with a corresponding release of cytidine 5-monophosphate (CMP) (IspF).","2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity",,,DrugBank,drugbank_id
BE0003732,Adenylate cyclase type 2,target,Q08462,ADCY2,Humans,Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling (PubMed:15385642). Down-stream signaling cascades mediate changes in gene expression patterns and lead to increased IL6 production. Functions in signaling cascades downstream of the muscarinic acetylcholine receptors (By similarity),adenylate cyclase activity,Membrane,,DrugBank,drugbank_id
BE0003731,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,target,P63092,GNAS,Humans,"Guanine nucleotide-binding proteins (G proteins) function as transducers in numerous signaling pathways controlled by G protein-coupled receptors (GPCRs) (PubMed:12391161, PubMed:17110384, PubMed:21488135, PubMed:26206488, PubMed:8702665, PubMed:10200251). The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state (PubMed:12391161, PubMed:17110384, PubMed:10200251). Signaling by an activated GPCR promotes GDP re",adenylate cyclase activator activity,Cell membrane,,DrugBank,drugbank_id
BE0003733,Adenylate cyclase type 5,target,O95622,ADCY5,Humans,"Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling (PubMed:15385642, PubMed:24700542, PubMed:26206488). Mediates signaling downstream of ADRB1 (PubMed:24700542). Regulates the increase of free cytosolic Ca(2+) in response to increased blood glucose levels and contributes to the regulation of Ca(2+)-dependent insulin secretion (PubMed:24740569)",adenylate cyclase activity,Cell membrane,,DrugBank,drugbank_id
BE0004367,CREB-binding protein,target,Q92793,CREBBP,Humans,"Acetylates histones, giving a specific tag for transcriptional activation (PubMed:21131905, PubMed:24616510). Mediates acetylation of histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively) (PubMed:21131905). Also acetylates non-histone proteins, like DDX21, FBL, IRF2, MAFG, NCOA3, POLR1E/PAF53 and FOXO1 (PubMed:10490106, PubMed:11154691, PubMed:12738767, PubMed:12929931, PubMed:24207024, PubMed:28790157, PubMed:30540930, PubMed:35675826, PubMed:9707565). Binds specifically to ph",acetyltransferase activity,Cytoplasm,activator,DrugBank,drugbank_id
BE0009668,Extracellular signal-regulated kinase (ERK),target,P28482,MAPK1,Humans,"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, c",ATP binding,"Cytoplasm, cytoskeleton, spindle",activator,DrugBank,drugbank_id
BE0001033,"Ferrochelatase, mitochondrial",target,P22830,FECH,Humans,Catalyzes the ferrous insertion into protoporphyrin IX and participates in the terminal step in the heme biosynthetic pathway,"2 iron, 2 sulfur cluster binding",Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0001967,Gastrotropin,target,P51161,FABP6,Humans,Binds to bile acids and is involved in enterohepatic bile acid metabolism. Required for efficient apical to basolateral transport of conjugated bile acids in ileal enterocytes (By similarity). In vitro binds to bile acids in the order: deoxycholic acid > cholic acid > chenodeoxycholic acid and respective BA conjugation modifies affinities in the order taurine-conjugated > glycine-conjugated > unconjugated bile acids. Stimulates gastric acid and pepsinogen secretion (By similarity),fatty acid binding,Cytoplasm,,DrugBank,drugbank_id
BE0003986,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",target,P13073,COX4I1,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0000335,Cytochrome c oxidase subunit 1,target,P00395,MT-CO1,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003385,Cytochrome c oxidase subunit 2,target,P00403,MT-CO2,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",copper ion binding,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003987,Cytochrome c oxidase subunit 3,target,P00414,MT-CO3,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003988,"Cytochrome c oxidase subunit 5A, mitochondrial",target,P20674,COX5A,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003989,"Cytochrome c oxidase subunit 5B, mitochondrial",target,P10606,COX5B,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003990,Cytochrome c oxidase subunit 6C,target,P09669,COX6C,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003991,"Cytochrome c oxidase subunit 7B, mitochondrial",target,P24311,COX7B,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003992,"Cytochrome c oxidase subunit 7C, mitochondrial",target,P15954,COX7C,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003993,"Cytochrome c oxidase subunit 8A, mitochondrial",target,P10176,COX8A,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003994,"Cytochrome c oxidase subunit 6A2, mitochondrial",target,Q02221,COX6A2,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",enzyme regulator activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003995,Cytochrome c oxidase subunit 6B1,target,P14854,COX6B1,Humans,"Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003996,"Cytochrome c oxidase subunit 7A1, mitochondrial",target,P24310,COX7A1,Humans,"Component of the mitochondrial respiratory complex IV (CIV, also named cytochrome c oxidase complex), the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation (By similarity). The CIV complex is the component of the respiratory chain that catalyzes the reduction of oxygen to water (By similarity). Acts as an assembly factor that specifically drives the homodimerization of CIV complexes, mediating the formation of mitochondrial respiratory supercomplexe",cytochrome-c oxidase activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0001392,Bile salt hydrolase/transferase,target,P54965,cbh,Clostridium perfringens (strain 13 / Type A),"Possesses dual functions in bile acid metabolism (PubMed:38326608). Acts as a bile salt hydrolase that catalyzes the deconjugation of glycine- and taurine-linked bile salts, which occurs naturally in the intestines of humans, releasing amino acid residues and deconjugated bile salts (bile acids). Can hydrolyze the amide bond in major human conjugated bile salts, such as glycocholate (GCA), taurocholate (TCA) and taurodeoxycholate (TDCA) (PubMed:7618863, PubMed:15823032, PubMed:38326608). Shows a",chenodeoxycholoyltaurine hydrolase activity,,,DrugBank,drugbank_id
BE0005788,G-protein coupled bile acid receptor 1,target,Q8TDU6,GPBAR1,Humans,"Receptor for bile acid. Bile acid-binding induces its internalization, activation of extracellular signal-regulated kinase and intracellular cAMP production. May be involved in the suppression of macrophage functions by bile acids",G protein-coupled bile acid receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0003998,"Fatty acid-binding protein, liver",carrier,P07148,FABP1,Humans,"Plays a role in lipoprotein-mediated cholesterol uptake in hepatocytes (PubMed:25732850). Binds cholesterol (PubMed:25732850). Binds free fatty acids and their coenzyme A derivatives, bilirubin, and some other small molecules in the cytoplasm. May be involved in intracellular lipid transport (By similarity)",antioxidant activity,Cytoplasm,,DrugBank,drugbank_id
BE0001796,Elongation factor G,target,P13551,fusA,Thermus thermophilus,"Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome.",GDP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001800,Chloramphenicol acetyltransferase,target,P62580,cat,Salmonella typhi,This enzyme is an effector of chloramphenicol resistance in bacteria.,chloramphenicol O-acetyltransferase activity,,inhibitor,DrugBank,drugbank_id
BE0002461,NAD-dependent protein deacetylase sirtuin-1,target,Q96EB6,SIRT1,Humans,"NAD-dependent protein deacetylase that links transcriptional regulation directly to intracellular energetics and participates in the coordination of several separated cellular functions such as cell cycle, response to DNA damage, metabolism, apoptosis and autophagy (PubMed:11672523, PubMed:12006491, PubMed:14976264, PubMed:14980222, PubMed:15126506, PubMed:15152190, PubMed:15205477, PubMed:15469825, PubMed:15692560, PubMed:16079181, PubMed:16166628, PubMed:16892051, PubMed:16998810, PubMed:17283",bHLH transcription factor binding,"Nucleus, PML body",inhibitor,DrugBank,drugbank_id
BE0001209,Casein kinase II subunit alpha,target,P68400,CSNK2A1,Humans,"Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed:11239457, PubMed:11704824, PubMed:16193064, PubMed:18411307, PubMed:18583988, PubMed:18678890, PubMed:19188443, PubMed:20545769, PubMed:20625391, PubMed:22017874, PubMed:22406621, PubMed:24962073, PubMed:30898438, PubMed:31439799). Regulates numerous cellular processes, such as",ATP binding,Nucleus,,DrugBank,drugbank_id
BE0000309,Polyunsaturated fatty acid lipoxygenase ALOX15,target,P16050,ALOX15,Humans,"Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators (PubMed:17052953, PubMed:1944593, PubMed:24282679, PubMed:25293588, PubMed:32404334, PubMed:8334154). It inserts peroxyl groups at C12 or C15 of arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) producing both 12-hydroperoxyeicosatetraenoate/12-HPETE and 15-hydroperoxyeicosatetraenoate/15-HPETE (PubMed:17052953, ",arachidonate 12(S)-lipoxygenase activity,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0008985,Phosphatidylinositol 4-kinase type 2-beta,target,Q8TCG2,PI4K2B,Humans,"Together with PI4K2A and the type III PI4Ks (PIK4CA and PIK4CB) it contributes to the overall PI4-kinase activity of the cell (PubMed:11923287, PubMed:12324459). This contribution may be especially significant in plasma membrane, endosomal and Golgi compartments (PubMed:11923287, PubMed:12324459). The phosphorylation of phosphatidylinositol (PI) to PI4P is the first committed step in the generation of phosphatidylinositol 4,5-bisphosphate (PIP2), a precursor of the second messenger inositol 1,4,",1-phosphatidylinositol 4-kinase activity,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0008988,Integrin alpha-5,target,P08648,ITGA5,Humans,"Integrin alpha-5/beta-1 (ITGA5:ITGB1) is a receptor for fibronectin and fibrinogen. It recognizes the sequence R-G-D in its ligands. ITGA5:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887, PubMed",calcium ion binding,Cell membrane,,DrugBank,drugbank_id
BE0000878,Alpha-synuclein,target,P37840,SNCA,Humans,"Neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release (PubMed:20798282, PubMed:26442590, PubMed:28288128, PubMed:30404828). Participates as a monomer in synaptic vesicle exocytosis by enhancing vesicle priming, fusion and dilation of exocytotic fusion pores (PubMed:28288128, PubMed:30404828). Mechanistically, acts by increasing local Ca(2+) release from microdomains which is essential for the enha",actin binding,Cytoplasm,,DrugBank,drugbank_id
BE0005467,C-type lectin domain family 14 member A,target,Q86T13,CLEC14A,Humans,,carbohydrate binding,Membrane,,DrugBank,drugbank_id
BE0009095,Far upstream element-binding protein 2,target,Q92945,KHSRP,Humans,Binds to the dendritic targeting element and may play a role in mRNA trafficking (By similarity). Part of a ternary complex that binds to the downstream control sequence (DCS) of the pre-mRNA. Mediates exon inclusion in transcripts that are subject to tissue-specific alternative splicing. May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their ,DNA binding,Nucleus,,DrugBank,drugbank_id
BE0000230,"Tyrosine--tRNA ligase, cytoplasmic",target,P54577,YARS1,Humans,"Tyrosine--tRNA ligase that catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr) (Probable) (PubMed:25533949). Also acts as a positive regulator of poly-ADP-ribosylation in the nucleus, independently of its tyrosine--tRNA ligase activity (PubMed:25533949). Activity is switched upon resveratrol-binding: resveratrol strongly inhibits the tyrosine--tRNA ligase activity and pr",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004710,Sodium-dependent organic anion transporter,transporter,Q3KNW5,SLC10A6,Humans,"Transports sulfoconjugated steroid hormones from the extracellular compartment into the cytosol in a sodium-dependent manner without hydrolysis (PubMed:17491011, PubMed:23667501, PubMed:24717977, PubMed:28951227). Steroid sulfate hormones are commonly considered to be biologically inactive metabolites, that may be activated by steroid sulfatases into free steroids (PubMed:23667501, PubMed:24717977). May play an important role by delivering sulfoconjugated steroids to specific target cells in rep",bile acid,Membrane,,DrugBank,drugbank_id
BE0001897,Esterase,target,P22266,estA,Streptomyces scabies,,triglyceride lipase activity,Secreted,,DrugBank,drugbank_id
BE0001447,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,target,P36873,PPP1CC,Humans,"Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets (PubMed:17936702, PubMed:25012651). Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Dephosphorylates RPS6KB1 (PubMed:17936702). Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an import",lamin binding,Cytoplasm,,DrugBank,drugbank_id
BE0001575,1-deoxy-D-xylulose 5-phosphate reductoisomerase,target,P45568,dxr,Escherichia coli (strain K12),Catalyzes the NADPH-dependent rearrangement and reduction of 1-deoxy-D-xylulose-5-phosphate (DXP) to 2-C-methyl-D-erythritol 4-phosphate (MEP).,1-deoxy-D-xylulose-5-phosphate reductoisomerase activity,,,DrugBank,drugbank_id
BE0001830,Tryptophan--tRNA ligase 2,target,Q9RVD6,trpS2,Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422),"Catalyzes the formation of 5'adenyl-Trp and tRNA(Trp) but with 5-fold less activity than TrpRS. Increases the solubility of the nitric oxide synthase oxygenase (nos), as well as its affinity for substrate L-arginine and its nitric-oxide synthase activity. The complex between trpS2 and nos catalyzes the regioselective nitration of tryptophan at the 4-position.",ATP binding,,,DrugBank,drugbank_id
BE0001655,Regulatory protein BlaR1,target,P18357,blaR1,Staphylococcus aureus,"Integral membrane protein involved in sensing of the presence of beta-lactam antibiotics and transduction of the information to the cytoplasm. Mechanistically, activation of the signal transducer involves acylation of a serine in the C-terminal sensor domain upon binding of the beta-lactam antibiotic (PubMed:12591921, PubMed:15506754). In turn, a conformational change occurs and the signal is transmitted from the cell surface to the cytoplasm. There, the zinc protease domain is activated and ini",penicillin binding,Cell membrane,,DrugBank,drugbank_id
BE0001904,Beta-lactam-inducible penicillin-binding protein,target,P07944,pbp,Staphylococcus aureus,,penicillin binding,Cell membrane,,DrugBank,drugbank_id
BE0001864,Elongation factor Tu,target,Q83JC4,tufA,Shigella flexneri,This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis.,GTP binding,Cytoplasm,,DrugBank,drugbank_id
BE0009166,Elongation factor 1-alpha,target,Q00080,MEF-1,Plasmodium falciparum (isolate K1 / Thailand),This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis.,GTP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002011,Purine nucleoside phosphorylase DeoD-type,target,P0ABP8,deoD,Escherichia coli (strain K12),"Catalyzes the reversible phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate (PubMed:11786017, PubMed:21672603, PubMed:235429, PubMed:30337572). Acts on 6-amino and 6-oxopurines including deoxyinosine, deoxyguanosine, deoxyadenosine, adenosine, guanosine, and inosine (PubMed:11786017, PubMed:21672603, PubMed:235429, PubMed:30337572). Does not act on xanthosine (Probable). ",guanosine phosphorylase activity,,,DrugBank,drugbank_id
BE0003783,Thermolysin,target,P00800,npr,Bacillus thermoproteolyticus,Extracellular zinc metalloprotease.,metal ion binding,Secreted,,DrugBank,drugbank_id
BE0001753,Serine hydroxymethyltransferase,target,Q5KUI2,glyA,Geobacillus kaustophilus (strain HTA426),"Catalyzes the reversible interconversion of serine and glycine with tetrahydrofolate (THF) serving as the one-carbon carrier. This reaction serves as the major source of one-carbon groups required for the biosynthesis of purines, thymidylate, methionine, and other important biomolecules. Also exhibits THF-independent aldolase activity toward beta-hydroxyamino acids, producing glycine and aldehydes, via a retro-aldol mechanism.",cobalt ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0001692,Aminomethyltransferase,target,Q9WY54,gcvT,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),The glycine cleavage system catalyzes the degradation of glycine.,aminomethyltransferase activity,,,DrugBank,drugbank_id
BE0001788,Bifunctional polymyxin resistance protein ArnA,target,P77398,arnA,Escherichia coli (strain K12),Bifunctional enzyme that catalyzes the oxidative decarboxylation of UDP-glucuronic acid (UDP-GlcUA) to UDP-4-keto-arabinose (UDP-Ara4O) and the addition of a formyl group to UDP-4-amino-4-deoxy-L-arabinose (UDP-L-Ara4N) to form UDP-L-4-formamido-arabinose (UDP-L-Ara4FN). The modified arabinose is attached to lipid A and is required for resistance to polymyxin and cationic antimicrobial peptides.,identical protein binding,,,DrugBank,drugbank_id
BE0002961,Dimethylglycine oxidase,target,Q9AGP8,dmg,Arthrobacter globiformis,"Catalyzes the oxidative demethylation of N,N-dimethylglycine to yield sarcosine, formaldehyde and hydrogen peroxide. The oxidation of dimethylglycine is coupled to the synthesis of 5,10-methylenetetrahydrofolate through an unusual substrate channeling mechanism. This channeling occurs by nonbiased diffusion of the iminium intermediate through a large solvent cavity connecting active site 1 (N-terminus) and active site 2 (C-terminus). The synthesis of 5,10-methylenetetrahydrofolate (at active sit",dimethylglycine oxidase activity,,,DrugBank,drugbank_id
BE0003762,cAMP-dependent protein kinase inhibitor alpha,target,P61925,PKIA,Humans,"Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains",cAMP-dependent protein kinase inhibitor activity,,,DrugBank,drugbank_id
BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,target,P17612,PRKACA,Humans,"Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:188",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0004371,Alpha-amylase G-6,target,Q9KFR4,,Bacillus halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125),,starch binding,Cytoplasmic,,DrugBank,drugbank_id
BE0004372,Nickel-binding periplasmic protein,target,P33590,nikA,Escherichia coli (strain K12),"Involved in a nickel transport system, probably represents the nickel binder.",heme binding,Periplasm,,DrugBank,drugbank_id
BE0004373,Iodotyrosine deiodinase 1,target,Q6PHW0,IYD,Humans,"Catalyzes the dehalogenation of halotyrosines such as 3-bromo-L-tyrosine, 3-chloro-L-tyrosine, 3-iodo-L-tyrosine and 3,5-diiodo-L-tyrosine (PubMed:15289438, PubMed:18434651, PubMed:25395621, PubMed:28157283). During thyroid hormone biosynthesis, facilitates iodide salvage by catalysing the oxidative NADPH-dependent deiodination of the halogenated by-products of thyroid hormone production, monoiodotyrosine (L-MIT) and diiodotyrosine (L-DIT) (PubMed:15289438, PubMed:18434651). The scavanged iodide",FMN binding,Cell membrane,,DrugBank,drugbank_id
BE0004582,Uridine-cytidine kinase-like 1,target,Q9NWZ5,UCKL1,Humans,May contribute to UTP accumulation needed for blast transformation and proliferation,ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0001918,Uracil-DNA glycosylase,target,P10186,,HHV-1,"Excises uracil residues from the DNA which can arise as a result of misincorporation of dUMP residues by DNA polymerase or deamination of cytosines. Therefore may reduce deleterious uracil incorporation into the viral genome, particularly in terminally differentiated cells which lack DNA repair enzymes.",uracil DNA N-glycosylase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0001925,Uracil-DNA glycosylase,target,Q8X444,ung,Escherichia coli O157:H7,Excises uracil residues from the DNA which can arise as a result of misincorporation of dUMP residues by DNA polymerase or due to deamination of cytosine.,uracil DNA N-glycosylase activity,Cytoplasm,,DrugBank,drugbank_id
BE0002034,Ribosomal small subunit pseudouridine synthase A,target,P0AA43,rsuA,Escherichia coli (strain K12),Responsible for synthesis of pseudouridine from uracil-516 in 16S ribosomal RNA.,16S rRNA pseudouridine(516) synthase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0003080,Type-4 uracil-DNA glycosylase,target,Q5SKC5,udg,Thermus thermophilus,"Removes uracil bases that are present in DNA as a result of either deamination of cytosine or misincorporation of dUMP instead of dTMP. Can remove uracil from double-stranded DNA containing either a U/G, U/A, U/C or U/T base pair as well as from single-stranded DNA (PubMed:12000829, PubMed:14556741). Specifically recognizes uracil that is flipped out from double-stranded DNA (PubMed:14556741).","4 iron, 4 sulfur cluster binding",,,DrugBank,drugbank_id
BE0003081,Pyrimidine-nucleoside phosphorylase,target,P77836,pdp,Geobacillus stearothermophilus,"Catalyzes phosphorolysis of the pyrimidine nucleosides uridine, thymidine and 2'-deoxyuridine with the formation of the corresponding pyrimidine base and ribose-1-phosphate.","1,4-alpha-oligoglucan phosphorylase activity",,,DrugBank,drugbank_id
BE0001395,Bacterial leucyl aminopeptidase,target,Q01693,,Vibrio proteolyticus,,aminopeptidase activity,Secreted,,DrugBank,drugbank_id
BE0001928,Aspartate carbamoyltransferase catalytic subunit,target,P0A789,pyrB,Shigella flexneri,"Catalyzes the condensation of carbamoyl phosphate and aspartate to form carbamoyl aspartate and inorganic phosphate, the committed step in the de novo pyrimidine nucleotide biosynthesis pathway.",amino acid binding,,,DrugBank,drugbank_id
BE0002227,Multifunctional protein CAD,target,P27708,CAD,Humans,"Multifunctional protein that encodes the first 3 enzymatic activities of the de novo pyrimidine pathway: carbamoylphosphate synthetase (CPSase; EC 6.3.5.5), aspartate transcarbamylase (ATCase; EC 2.1.3.2) and dihydroorotase (DHOase; EC 3.5.2.3). The CPSase-function is accomplished in 2 steps, by a glutamine-dependent amidotransferase activity (GATase) that binds and cleaves glutamine to produce ammonia, followed by an ammonium-dependent carbamoyl phosphate synthetase, which reacts with the ammon",aspartate binding,Cytoplasm,,DrugBank,drugbank_id
BE0004096,HTH-type transcriptional regulator TtgR,target,Q9AIU0,ttgR,Pseudomonas putida (strain DOT-T1E),Represses expression from the ttgABC operon promoter and its own expression. Binds to a promoter region between the divergently transcribed ttgR and ttgABC genes/operons; in the presence of chloramphenicol or tetracycline this binding no longer occurs and ttgR and ttgABC are derepressed. This suggests that TtgR binds these antibiotics.,DNA-binding transcription repressor activity,Cytoplasmic,,DrugBank,drugbank_id
BE0009091,KAT8 regulatory NSL complex subunit 3,target,Q9P2N6,KANSL3,Humans,"Non-catalytic component of the NSL histone acetyltransferase complex, a multiprotein complex that mediates histone H4 acetylation at 'Lys-5'- and 'Lys-8' (H4K5ac and H4K8ac) at transcription start sites and promotes transcription initiation (PubMed:20018852, PubMed:33657400). The NSL complex also acts as a regulator of gene expression in mitochondria (PubMed:27768893). Within the NSL complex, KANSL3 is required to promote KAT8 association with mitochondrial DNA (PubMed:27768893). Required for tr",,Nucleus,,DrugBank,drugbank_id
BE0002207,Cyclin-dependent kinase 9,target,P50750,CDK9,Humans,"Protein kinase involved in the regulation of transcription (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094, PubMed:29335245). Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-",7SK snRNA binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0002150,"Glycogen phosphorylase, brain form",target,P11216,PYGB,Humans,"Glycogen phosphorylase that regulates glycogen mobilization (PubMed:27402852). Phosphorylase is an important allosteric enzyme in carbohydrate metabolism (PubMed:3346228). Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates (PubMed:3346228). However, all known phosphorylases share catalytic and structural properties (PubMed:3346228)",glycogen phosphorylase activity,,,DrugBank,drugbank_id
BE0000007,"Glycogen phosphorylase, liver form",target,P06737,PYGL,Humans,"Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis",AMP binding,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0001913,Cyclin-dependent kinase 7,target,P50613,CDK7,Humans,"Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription (PubMed:9852112, PubMed:19136461, PubMed:26257281, PubMed:28768201). Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and fo",ATP binding,Nucleus,,DrugBank,drugbank_id
BE0000890,Cyclin-dependent kinase 5,target,Q00535,CDK5,Humans,"Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Phosphorylates SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, hun",acetylcholine receptor activator activity,Cytoplasm,,DrugBank,drugbank_id
BE0001082,Cyclin-dependent kinase 1,target,P06493,CDK1,Humans,"Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition via association with multiple interphase cyclins (PubMed:16407259, PubMed:16933150, PubMed:17459720, PubMed:18356527, PubMed:19509060, PubMed:19917720, PubMed:20171170, PubMed:20935635, PubMed:20937773, PubMed:21063390, PubMed:2188730, PubMed:23355470, PubMed:2344612, PubMed:23601106, PubMed:23602554, PubMed:25556658, PubMed:26829474, PubMed:27814491,",ATP binding,Nucleus,,DrugBank,drugbank_id
BE0002212,Cyclin-dependent kinase 6,target,Q00534,CDK6,Humans,"Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition. Phosphorylates pRB/RB1 and NPM1. Interacts with D-type G1 cyclins during interphase at G1 to form a pRB/RB1 kinase and controls the entrance into the cell cycle. Involved in initiation and maintenance of cell cycle exit during cell differentiation; prevents cell proliferation and negatively regulates cell differentiation, but is required for the proliferation of specific cell ",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0002216,Cyclin-dependent kinase 4,target,P11802,CDK4,Humans,Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are ma,ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0002224,Cyclin-dependent kinase 8,target,P49336,CDK8,Humans,"Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional pre-initiation complex with RNA polymerase II and the general transcript",ATP binding,Nucleus,,DrugBank,drugbank_id
BE0001072,Cyclin-dependent kinase 2,target,P24941,CDK2,Humans,"Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis (PubMed:10499802, PubMed:10884347, PubMed:10995386, PubMed:10995387, PubMed:11051553, PubMed:11113184, PubMed:12944431, PubMed:15800615, PubMed:17495531, PubMed:19966300, PubMed:20935635, PubMed:21262353, PubMed:21596315, PubMed:28216226, PubMed:28666995). Phosphorylates CABLES1, CTNNB1, CDK2AP2, ERCC6, NBN, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2 (PubMed",ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",inhibitor,DrugBank,drugbank_id
BE0001236,Steroid Delta-isomerase,target,P07445,ksi,Pseudomonas putida,,steroid delta-isomerase activity,,,DrugBank,drugbank_id
BE0001607,Steroid Delta-isomerase,target,P00947,ksi,Comamonas testosteroni,,steroid delta-isomerase activity,,,DrugBank,drugbank_id
BE0001217,Aspartate aminotransferase,target,P00509,aspC,Escherichia coli (strain K12),,identical protein binding,Cytoplasm,,DrugBank,drugbank_id
BE0002016,Branched-chain-amino-acid aminotransferase,target,P0AB80,ilvE,Escherichia coli (strain K12),"Acts on leucine, isoleucine and valine.",branched-chain-amino-acid transaminase activity,,,DrugBank,drugbank_id
BE0003129,Glutamate decarboxylase alpha,target,P69908,gadA,Escherichia coli (strain K12),"Converts glutamate to gamma-aminobutyrate (GABA), consuming one intracellular proton in the reaction. The gad system helps to maintain a near-neutral intracellular pH when cells are exposed to extremely acidic conditions. The ability to survive transit through the acidic conditions of the stomach is essential for successful colonization of the mammalian host by commensal and pathogenic bacteria.",glutamate decarboxylase activity,,,DrugBank,drugbank_id
BE0001953,Gentamicin 3-N-acetyltransferase,target,P23181,aacC1,Pseudomonas aeruginosa,Responsible for gentamicin resistance and has a limited substrate range.,aminoglycoside 3-N-acetyltransferase activity,,,DrugBank,drugbank_id
BE0002032,Spermidine/putrescine-binding periplasmic protein,target,P0AFK9,potD,Escherichia coli (strain K12),Required for the activity of the bacterial periplasmic transport system of putrescine and spermidine. Polyamine binding protein.,putrescine binding,Periplasm,,DrugBank,drugbank_id
BE0002397,Furin,target,P09958,FURIN,Humans,"Ubiquitous endoprotease within constitutive secretory pathways capable of cleavage at the RX(K/R)R consensus motif (PubMed:11799113, PubMed:1629222, PubMed:1713771, PubMed:2251280, PubMed:24666235, PubMed:25974265, PubMed:7592877, PubMed:7690548, PubMed:9130696). Mediates processing of TGFB1, an essential step in TGF-beta-1 activation (PubMed:7737999). Converts through proteolytic cleavage the non-functional Brain natriuretic factor prohormone into its active hormone BNP(1-32) (PubMed:20489134, ",endopeptidase activator activity,"Golgi apparatus, trans-Golgi network membrane",,DrugBank,drugbank_id
BE0001854,Glycolipid transfer protein,target,Q9NZD2,GLTP,Humans,Accelerates the intermembrane transfer of various glycolipids. Catalyzes the transfer of various glycosphingolipids between membranes but does not catalyze the transfer of phospholipids. May be involved in the intracellular translocation of glucosylceramides,ceramide 1-phosphate binding,Cytoplasm,,DrugBank,drugbank_id
BE0004039,Octanoyltransferase,target,P9WK83,lipB,Mycobacterium tuberculosis,Catalyzes the transfer of endogenously produced octanoic acid from octanoyl-acyl-carrier-protein onto the lipoyl domains of lipoate-dependent enzymes. Lipoyl-ACP can also act as a substrate although octanoyl-ACP is likely to be the physiological substrate.,lipoyl(octanoyl) transferase activity,Cytoplasm,,DrugBank,drugbank_id
BE0004040,LmbE family N-acetylglucosaminyl deacetylase,target,Q6ZZJ1,tcp14,Actinoplanes teichomyceticus,,acyltransferase activity,,,DrugBank,drugbank_id
BE0002677,Aminoglycoside N(6')-acetyltransferase type 1,target,Q9R381,,Salmonella enteritidis,"Catalyzes the transfer of an acetyl group from acetyl-CoA to the 6'-amino group of aminoglycoside molecules conferring resistance to antibiotics containing the purpurosamine ring including amikacin, tobramycin, dibekacin and ribostamycin. Able to acetylate eukaryotic histone proteins.",aminoglycoside 6'-N-acetyltransferase activity,,,DrugBank,drugbank_id
BE0002929,PpcA,target,Q8GGK7,ppcA,Geobacter sulfurreducens,,electron transfer activity,,,DrugBank,drugbank_id
BE0004053,Elongation factor-like GTPase 1,target,Q7Z2Z2,EFL1,Humans,"GTPase involved in the biogenesis of the 60S ribosomal subunit and translational activation of ribosomes. Together with SBDS, triggers the GTP-dependent release of EIF6 from 60S pre-ribosomes in the cytoplasm, thereby activating ribosomes for translation competence by allowing 80S ribosome assembly and facilitating EIF6 recycling to the nucleus, where it is required for 60S rRNA processing and nuclear export",GTP binding,,,DrugBank,drugbank_id
BE0004054,Lactaldehyde dehydrogenase,target,P25553,aldA,Escherichia coli (strain K12),"Catalyzes the irreversible oxidation of L-lactaldehyde to L-lactate (PubMed:27671251, PubMed:3298215, PubMed:3308886, PubMed:6345530). Also shows high activity with glycolaldehyde and L-glyceraldehyde (PubMed:16731973, PubMed:31850327, PubMed:3275622, PubMed:3308886, PubMed:6345530). Has weaker activity with various aldehydes such as methylglyoxal, propionaldehyde or benzaldehyde (PubMed:16731973, PubMed:3308886). Involved in the degradation of lactaldehyde produced during metabolism of L-fucose",glycolaldehyde dehydrogenase activity,,,DrugBank,drugbank_id
BE0004056,Cytochrome c oxidase subunit 2,target,Q03736,ctaC,Rhodobacter sphaeroides,Subunits I and II form the functional core of the enzyme complex. Electrons originating in cytochrome c are transferred via heme a and Cu(A) to the binuclear center formed by heme a3 and Cu(B).,copper ion binding,Cell membrane,,DrugBank,drugbank_id
BE0001817,Multidrug efflux pump subunit AcrB,target,P31224,acrB,Escherichia coli (strain K12),AcrA-AcrB-AcrZ-TolC is a drug efflux protein complex with broad substrate specificity that uses the proton motive force to export substrates.,efflux transmembrane transporter activity,Cell inner membrane,,DrugBank,drugbank_id
BE0004055,Cytochrome c oxidase subunit 1,target,P33517,ctaD,Rhodobacter sphaeroides,Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Subunits 1-3 form the functional core of the enzyme complex. Co I is the catalytic subunit of the enzyme. Electrons originating in cytochrome c are transferred via the copper A center of subunit 2 and heme a of subunit 1 to the bimetallic center formed by heme a3 and copper B. This cytochrome c oxidase shows proton pump activity across the membrane in addition to the electron transfer.,cytochrome-c oxidase activity,Cell membrane,,DrugBank,drugbank_id
BE0005540,Sterol regulatory element-binding protein 1,target,P36956,SREBF1,Humans,"Precursor of the transcription factor form (Processed sterol regulatory element-binding protein 1), which is embedded in the endoplasmic reticulum membrane (PubMed:32322062). Low sterol concentrations promote processing of this form, releasing the transcription factor form that translocates into the nucleus and activates transcription of genes involved in cholesterol biosynthesis and lipid homeostasis (By similarity)",chromatin binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0000065,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",target,P10515,DLAT,Humans,"As part of the pyruvate dehydrogenase complex, catalyzes the transfers of an acetyl group to a lipoic acid moiety (Probable). The pyruvate dehydrogenase complex, catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links cytoplasmic glycolysis and the mitochondrial tricarboxylic acid (TCA) cycle (Probable)",dihydrolipoyllysine-residue acetyltransferase activity,Mitochondrion matrix,,DrugBank,drugbank_id
BE0004330,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",target,Q15120,PDK3,Humans,"Inhibits pyruvate dehydrogenase activity by phosphorylation of the E1 subunit PDHA1, and thereby regulates glucose metabolism and aerobic respiration. Can also phosphorylate PDHA2. Decreases glucose utilization and increases fat metabolism in response to prolonged fasting, and as adaptation to a high-fat diet. Plays a role in glucose homeostasis and in maintaining normal blood glucose levels in function of nutrient levels and under starvation. Plays a role in the generation of reactive oxygen sp",ATP binding,Mitochondrion matrix,,DrugBank,drugbank_id
BE0004331,Virulence sensor histidine kinase PhoQ,target,P0DM80,phoQ,Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720),"Member of the two-component regulatory system PhoP/PhoQ which regulates the expression of genes involved in virulence, adaptation to acidic and low Mg(2+) environments and resistance to host defense antimicrobial peptides. Essential for intramacrophage survival of S.typhimurium. In low periplasmic Mg(2+), PhoQ functions as a membrane-associated protein kinase that undergoes autophosphorylation and subsequently transfers the phosphate to PhoP, resulting in the expression of PhoP-activated genes (",ATP binding,Cell inner membrane,,DrugBank,drugbank_id
BE0001710,Ras-related protein Rab-9A,target,P51151,RAB9A,Humans,"The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (By similarity). RAB9A is involved in the transport of proteins between the endosomes and the trans-Golgi network (TGN) (",G protein activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001413,Cocaine esterase,target,Q9L9D7,cocE,Rhodococcus sp. (strain MB1 Bresler),"Hydrolyzes cocaine to benzoate and ecgonine methyl ester, endowing the bacteria with the ability to utilize cocaine as a sole source of carbon and energy for growth, as this bacterium lives in the rhizosphere of coca plants. Also efficiently hydrolyzes cocaethylene, a more potent cocaine metabolite that has been observed in patients who concurrently abuse cocaine and alcohol. Is able to prevent cocaine-induced convulsions and lethality in rat.",carboxylic ester hydrolase activity,Cytoplasm,product of,DrugBank,drugbank_id
BE0004141,D-amino-acid oxidase,target,P14920,DAO,Humans,"Catalyzes the oxidative deamination of D-amino acids with broad substrate specificity (PubMed:16616139, PubMed:17088322, PubMed:17303072, PubMed:18544534, PubMed:20368421, PubMed:20567862, PubMed:20603179, PubMed:22203986, PubMed:23219954, PubMed:23391306, PubMed:25030849, PubMed:25701391, PubMed:29274788, PubMed:29326945, PubMed:30938755, PubMed:31799256, PubMed:32730563, PubMed:33484270, PubMed:34041270, PubMed:37558109, PubMed:38035964). Required to catabolize D-amino acids synthesized endoge",D-amino-acid dehydrogenase activity,Peroxisome matrix,,DrugBank,drugbank_id
BE0001976,"Chlorocatechol 1,2-dioxygenase",target,O67987,clcA,Rhodococcus opacus,,"catechol 1,2-dioxygenase activity",,substrate,DrugBank,drugbank_id
BE0002742,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",target,P96965,cumD,Pseudomonas fluorescens,,hydrolase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0003176,Non-heme chloroperoxidase,target,O31168,cpo,Streptomyces aureofaciens,,chloride peroxidase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0003031,Oxygen-insensitive NAD(P)H nitroreductase,target,Q01234,nfsB,Enterobacter cloacae,Reduction of a variety of nitroaromatic compounds using NADH (and to lesser extent NADPH) as source of reducing equivalents; two electrons are transferred.,oxidoreductase activity,,,DrugBank,drugbank_id
BE0003177,"Hydroxyquinol 1,2-dioxygenase",target,Q5PXQ6,chqB,Nocardioides simplex,Catalyzes the ortho-cleavage of the aromatic ring of hydroxyquinol.,"4-hydroxycatechol 1,2-dioxygenase activity",,,DrugBank,drugbank_id
BE0003178,Replication protein,target,Q52546,repA,Pseudomonas syringae,,DNA-directed DNA polymerase activity,,,DrugBank,drugbank_id
BE0001268,HTH-type transcriptional regulator QacR,target,P0A0N5,qacR,Staphylococcus haemolyticus,"Transcriptional repressor of qacA. Binds to IR1, an unusually long 28 bp operator, which is located downstream from the qacA promoter and overlaps its transcription start site. QacR is induced from its IR1 site by binding to one of many structurally dissimilar cationic lipophilic compounds, which are also substrates of QacA (By similarity).",DNA binding,Cytoplasmic,,DrugBank,drugbank_id
BE0001116,Stromelysin-1,target,P08254,MMP3,Humans,"Metalloproteinase with a rather broad substrate specificity that can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates different molecules including growth factors, plasminogen or other matrix metalloproteinases such as MMP9 (PubMed:11029580, PubMed:1371271). Once released into the extracellular matrix (ECM), the inactive pro-enzyme is activated by the plasmin cascade signaling pathway (PubMed:2383557). Also act",endopeptidase activity,"Secreted, extracellular space, extracellular matrix",modulator,DrugBank,drugbank_id
BE0003872,Disintegrin and metalloproteinase domain-containing protein 28,target,Q9UKQ2,ADAM28,Humans,"May play a role in the adhesive and proteolytic events that occur during lymphocyte emigration or may function in ectodomain shedding of lymphocyte surface target proteins, such as FASL and CD40L. May be involved in sperm maturation",immunoglobulin receptor binding,Cell membrane,,DrugBank,drugbank_id
BE0003730,A disintegrin and metalloproteinase with thrombospondin motifs 5,target,Q9UNA0,ADAMTS5,Humans,"Metalloproteinase that plays an important role in connective tissue organization, development, inflammation and cell migration. Extracellular matrix (ECM) degrading enzyme that show proteolytic activity toward the hyalectan group of chondroitin sulfate proteoglycans (CSPGs) including ACAN, VCAN, BCAN and NCAN (PubMed:16133547, PubMed:18992360). Cleavage within the hyalectans occurs at Glu-Xaa recognition motifs. Plays a role in embryonic development, including limb and cardiac morphogenesis, and",endopeptidase activity,"Secreted, extracellular space, extracellular matrix",,DrugBank,drugbank_id
BE0001182,Neutrophil collagenase,target,P22894,MMP8,Humans,"Can degrade fibrillar type I, II, and III collagens",endopeptidase activity,Cytoplasmic granule,,DrugBank,drugbank_id
BE0001637,Matrix metalloproteinase-16,target,P51512,MMP16,Humans,"Endopeptidase that degrades various components of the extracellular matrix, such as collagen type III and fibronectin. Activates progelatinase A. Involved in the matrix remodeling of blood vessels. Isoform short cleaves fibronectin and also collagen type III, but at lower rate. It has no effect on type I, II, IV and V collagen. However, upon interaction with CSPG4, it may be involved in degradation and invasion of type I collagen by melanoma cells",enzyme activator activity,Cell membrane,,DrugBank,drugbank_id
BE0001833,Deacetoxycephalosporin C synthase,target,P18548,cefE,Streptomyces clavuligerus (strain ATCC 27064 / DSM 738 / JCM 4710 / NBRC 13307 / NCIMB 12785 / NRRL 3585 / VKM Ac-602),Catalyzes the step from penicillin N to deacetoxy-cephalosporin C.,deacetoxycephalosporin-C synthase activity,,,DrugBank,drugbank_id
BE0001735,Elongation factor Tu-B,target,P60339,tufB,Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579),This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis.,GTP binding,Cytoplasm,,DrugBank,drugbank_id
BE0001517,Farnesyl diphosphate synthase,target,P22939,ispA,Escherichia coli (strain K12),,dimethylallyltranstransferase activity,Cytoplasm,modulator,DrugBank,drugbank_id
BE0001865,"Limonene-1,2-epoxide hydrolase",target,Q9ZAG3,limA,Rhodococcus erythropolis,"Catalyzes the conversion of limonene-1,2-epoxide to limonene-1,2-diol. Can use both the (-) and (+) isomers of limonene-1,2-epoxide as substrates and also has some activity with 1-methylcyclohexene oxide, cyclohexene oxide and indene oxide as substrates.","limonene-1,2-epoxide hydrolase activity",,,DrugBank,drugbank_id
BE0001156,E3 ubiquitin-protein ligase XIAP,target,P98170,XIAP,Humans,"Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, copper homeostasis, mitogenic kinase signaling, cell proliferation, as well as cell invasion and metastasis (PubMed:11257230, PubMed:11257231, PubMed:11447297, PubMed:12121969, PubMed:12620238, PubMed:17560374, PubMed:17967870, PubMed:19473982, PubMed:20154138, PubMed:22103349, PubMed:9230442). Acts as a direct caspase inhibitor (PubMed:11257230, PubMed:11257231, PubM",cysteine-type endopeptidase inhibitor activity,Cytoplasm,antagonist|inhibitor,DrugBank,drugbank_id
BE0005300,Cyclic nucleotide-gated channel alpha-1,target,P29973,CNGA1,Humans,"Pore-forming subunit of the rod cyclic nucleotide-gated channel. Mediates rod photoresponses at dim light converting transient changes in intracellular cGMP levels into electrical signals. In the dark, cGMP levels are high and keep the channel open enabling a steady inward current carried by Na(+) and Ca(2+) ions that leads to membrane depolarization and neurotransmitter release from synaptic terminals. Upon photon absorption cGMP levels decline leading to channel closure and membrane hyperpolar",calcium channel activity,Cell membrane,blocker,DrugBank,drugbank_id
BE0004427,Small conductance calcium-activated potassium channel protein 3,target,Q9UGI6,KCNN3,Humans,"Small conductance calcium-activated potassium channel that mediates the voltage-independent transmembrane transfer of potassium across the cell membrane through a constitutive interaction with calmodulin which binds the intracellular calcium allowing its opening (PubMed:12808432, PubMed:20562108, PubMed:31155282, PubMed:36502918). The current is characterized by a voltage-independent activation, an intracellular calcium concentration increase-dependent activation and a single-channel conductance",calmodulin binding,Cell membrane,blocker,DrugBank,drugbank_id
BE0004426,Small conductance calcium-activated potassium channel protein 2,target,Q9H2S1,KCNN2,Humans,"Small conductance calcium-activated potassium channel that mediates the voltage-independent transmembrane transfer of potassium across the cell membrane through a constitutive interaction with calmodulin which binds the intracellular calcium allowing its opening (PubMed:10991935, PubMed:33242881, PubMed:9287325). The current is characterized by a voltage-independent activation, an intracellular calcium concentration increase-dependent activation and a single-channel conductance of about 3 picosi",alpha-actinin binding,Membrane,blocker,DrugBank,drugbank_id
BE0004425,Small conductance calcium-activated potassium channel protein 1,target,Q92952,KCNN1,Humans,"Small conductance calcium-activated potassium channel that mediates the voltage-independent transmembrane transfer of potassium across the cell membrane through a constitutive interaction with calmodulin which binds the intracellular calcium allowing its opening (PubMed:17142458, PubMed:8781233, PubMed:9287325). The current is characterized by a voltage-independent activation, an intracellular calcium concentration increase-dependent activation and a single-channel conductance of about 3 picosie",calcium-activated potassium channel activity,Membrane,blocker,DrugBank,drugbank_id
BE0014924,Cyclic nucleotide-gated channel alpha-2,target,Q16280,CNGA2,Humans,"Pore-forming subunit of the olfactory cyclic nucleotide-gated channel. Operates in the cilia of olfactory sensory neurons where chemical stimulation of the odorant is converted to an electrical signal. Mediates odorant-induced cAMP-dependent Ca(2+) influx triggering neuron depolarization. The rise of intracellular Ca(2+) levels potentiates the olfactory response by activating Ca(2+)-dependent Cl(-) channels, but it also serves as a negative feedback signal to desensitize the channel for rapid ad",calcium channel activity,"Cell projection, cilium membrane",blocker,DrugBank,drugbank_id
BE0003959,HTH-type transcriptional regulator QacR,target,P0A0N4,qacR,Staphylococcus aureus,"Transcriptional repressor of qacA. Binds to IR1, an unusually long 28 bp operator, which is located downstream from the qacA promoter and overlaps its transcription start site. QacR is induced from its IR1 site by binding to one of many structurally dissimilar cationic lipophilic compounds, which are also substrates of QacA.",DNA binding,Cytoplasmic,regulator,DrugBank,drugbank_id
BE0010192,Response regulator RamR,target,Q7AKE4,ramR,Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145),"A transcription factor required for aerial hyphae formation on rich medium (PubMed:12100547, PubMed:12453210). Activates transcription of ramC. Might be part of a two-component regulatory system (PubMed:12453210). Binds the promoter of ramC (PubMed:12100547, PubMed:12453210). Non-phosphorylated protein cooperatively binds multiple sites in the ramC promoter. Has not been seen to autophosphorylate using the small molecule phosphodonors phosphoramidate, acetyl phosphate or carbamoyl phosphate (Pub",DNA binding,,regulator,DrugBank,drugbank_id
BE0010193,L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase,target,A5U4F6,mshC,Mycobacterium tuberculosis (strain ATCC 25177 / H37Ra),Catalyzes the ATP-dependent condensation of GlcN-Ins and L-cysteine to form L-Cys-GlcN-Ins.,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0016122,Lysophosphatidylcholine acyltransferase 2,target,Q7L5N7,LPCAT2,Humans,"Exhibits both acyltransferase and acetyltransferase activities (PubMed:17182612, PubMed:20363836, PubMed:21498505). Catalyzes the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (PubMed:21498505). Catalyzes the conversion 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 ",1-acylglycerol-3-phosphate O-acyltransferase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0017259,Lysophosphatidylcholine acyltransferase 1,target,Q8NF37,LPCAT1,Humans,"Exhibits acyltransferase activity (PubMed:18156367, PubMed:21498505). Exhibits acetyltransferase activity (By similarity). Activity is calcium-independent (By similarity). Catalyzes the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (PubMed:18156367, PubMed:21498505). Catalyzes the conversion 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3-phospha",1-acylglycerol-3-phosphate O-acyltransferase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,P48736,PIK3CG,Humans,"Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Links G-protein coupled receptor activation to PIP3 production. Involved in immune, inflammatory and allergic response",1-phosphatidylinositol-3-kinase activity,Cytoplasm,,DrugBank,drugbank_id
BE0004151,UDP-glucuronosyltransferase 3A1,target,Q6NUS8,UGT3A1,Humans,UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds (By similarity),glucuronosyltransferase activity,Membrane,,DrugBank,drugbank_id
BE0003840,"ATP synthase F(1) complex subunit alpha, mitochondrial",target,P25705,ATP5F1A,Humans,"Subunit alpha, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the",ADP binding,Mitochondrion,,DrugBank,drugbank_id
BE0003841,"ATP synthase F(1) complex subunit beta, mitochondrial",target,P06576,ATP5F1B,Humans,"Catalytic subunit beta, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable) (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a centra",angiostatin binding,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0003842,"ATP synthase F(1) complex subunit gamma, mitochondrial",target,P36542,ATP5F1C,Humans,"Subunit gamma, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating ins","proton-transporting ATP synthase activity, rotational mechanism",Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0001277,Serine/threonine-protein kinase pim-1,target,P11309,PIM1,Humans,"Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis (PubMed:15528381, PubMed:1825810, PubMed:31548394). Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3) (PubMed:18593906). Phosphorylation of MYC leads to an increase of MYC protei",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0004327,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial",target,Q6NVY1,HIBCH,Humans,"Hydrolyzes 3-hydroxyisobutyryl-CoA (HIBYL-CoA), a saline catabolite. Has high activity toward isobutyryl-CoA. Could be an isobutyryl-CoA dehydrogenase that functions in valine catabolism. Also hydrolyzes 3-hydroxypropanoyl-CoA",3-hydroxyisobutyryl-CoA hydrolase activity,Mitochondrion,,DrugBank,drugbank_id
BE0003757,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,Q5G940,fabZ,Helicobacter pylori,Involved in unsaturated fatty acids biosynthesis. Catalyzes the dehydration of short chain beta-hydroxyacyl-ACPs and long chain saturated and unsaturated beta-hydroxyacyl-ACPs.,(3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,Cytoplasm,,DrugBank,drugbank_id
BE0004328,Serine/threonine-protein kinase 17B,target,O94768,STK17B,Humans,Phosphorylates myosin light chains (By similarity). Acts as a positive regulator of apoptosis,ATP binding,Nucleus,,DrugBank,drugbank_id
BE0004966,"Actin, cytoplasmic 1",target,P60709,ACTB,Humans,"Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:25255767, PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damage",ATP binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0005435,Casein kinase II subunit beta,target,P67870,CSNK2B,Humans,"Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed:11239457, PubMed:16818610). Participates in Wnt signaling (By similarity)",chromatin binding,Nucleus,,DrugBank,drugbank_id
BE0009017,Eukaryotic translation initiation factor 3 subunit F,target,O00303,EIF3F,Humans,"Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. T",cysteine-type deubiquitinase activity,Cytoplasm,,DrugBank,drugbank_id
BE0009018,Heat shock-related 70 kDa protein 2,target,P54652,HSPA2,Humans,"Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is",ATP binding,"Cytoplasm, cytoskeleton, spindle",,DrugBank,drugbank_id
BE0009019,RuvB-like 2,target,Q9Y230,RUVBL2,Humans,"Possesses single-stranded DNA-stimulated ATPase and ATP-dependent DNA helicase (5' to 3') activity; hexamerization is thought to be critical for ATP hydrolysis and adjacent subunits in the ring-like structure contribute to the ATPase activity (PubMed:10428817, PubMed:17157868, PubMed:33205750). Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A (PubMed:14966270). Thi",ADP binding,Nucleus matrix,,DrugBank,drugbank_id
BE0009020,Splicing factor 3B subunit 3,target,Q15393,SF3B3,Humans,"Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:10490618, PubMed:10882114, PubMed:12234937, PubMed:27720643, PubMed:28781166, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleoph",protein-containing complex binding,Nucleus,,DrugBank,drugbank_id
BE0004573,Ubiquitin-like modifier-activating enzyme 1,target,P22314,UBA1,Humans,"Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system (PubMed:1447181, PubMed:1606621, PubMed:33108101). Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP (PubMed:1447181). Essential for the formation of radiation-induced foci, timely DNA repair and for respon",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0005461,CCAAT/enhancer-binding protein beta,target,P17676,CEBPB,Humans,"Important transcription factor regulating the expression of genes involved in immune and inflammatory responses (PubMed:12048245, PubMed:1741402, PubMed:18647749, PubMed:9374525). Also plays a significant role in adipogenesis, as well as in the gluconeogenic pathway, liver regeneration, and hematopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Its functional capacity is governed by protein interactions and post-translational protein modifications. During early embryogenesis, pl",chromatin DNA binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0001424,Tyrosine-protein kinase HCK,target,P08631,HCK,Humans,"Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for IFNG, IL2, IL6 and IL8, ",ATP binding,Lysosome,,DrugBank,drugbank_id
BE0001616,Oxygen-insensitive NAD(P)H nitroreductase,target,P38489,nfsB,Escherichia coli (strain K12),"Reduction of a variety of nitroaromatic compounds using NADH (and to lesser extent NADPH) as source of reducing equivalents; two electrons are transferred. Capable of reducing nitrofurazone, quinones and the anti-tumor agent CB1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). The reduction of CB1954 results in the generation of cytotoxic species.","6,7-dihydropteridine reductase activity",,,DrugBank,drugbank_id
BE0009973,Metallo-beta-lactamase type 2,target,C7C422,blaNDM-1,Klebsiella pneumoniae,"Confers resistance to the different beta-lactams antibiotics (penicillin, cephalosporin and carbapenem) via the hydrolysis of the beta-lactam ring. Does not confer resistance to the polymixin colistin or the fluoroquinolone ciprofloxacin.",beta-lactamase activity,Periplasm,inhibitor,DrugBank,drugbank_id
BE0001524,Isocitrate dehydrogenase [NADP],target,P39126,icd,Bacillus subtilis (strain 168),,isocitrate dehydrogenase (NADP+) activity,,substrate|inhibitor,DrugBank,drugbank_id
BE0009159,Transient receptor potential cation channel subfamily V member 4,target,Q9HBA0,TRPV4,Humans,"Non-selective calcium permeant cation channel involved in osmotic sensitivity and mechanosensitivity (PubMed:16293632, PubMed:18695040, PubMed:18826956, PubMed:22526352, PubMed:23136043, PubMed:29899501). Activation by exposure to hypotonicity within the physiological range exhibits an outward rectification (PubMed:18695040, PubMed:18826956, PubMed:29899501). Also activated by heat, low pH, citrate and phorbol esters (PubMed:16293632, PubMed:18695040, PubMed:18826956, PubMed:20037586, PubMed:219",actin binding,Cell membrane,activator,DrugBank,drugbank_id
BE0004459,"Citrate synthase, mitochondrial",target,O75390,CS,Humans,Key enzyme of the Krebs tricarboxylic acid cycle which catalyzes the synthesis of citrate from acetyl coenzyme A and oxaloacetate,citrate (Si)-synthase activity,Mitochondrion matrix,,DrugBank,drugbank_id
BE0001914,Fumarate hydratase class II,target,P05042,fumC,Escherichia coli (strain K12),"Involved in the TCA cycle. FumC seems to be a backup enzyme for FumA under conditions of iron limitation and oxidative stress (PubMed:7592392). Catalyzes the stereospecific interconversion of fumarate to L-malate (PubMed:1917897, PubMed:3282546).",fumarate hydratase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004566,L-amino-acid oxidase,target,Q96RQ9,IL4I1,Humans,"Secreted L-amino-acid oxidase that acts as a key immunoregulator (PubMed:17356132, PubMed:32818467, PubMed:32866000). Has preference for L-aromatic amino acids: converts phenylalanine (Phe), tyrosine (Tyr) and tryptophan (Trp) to phenylpyruvic acid (PP), hydroxyphenylpyruvic acid (HPP), and indole-3-pyruvic acid (I3P), respectively (PubMed:17356132, PubMed:32818467, PubMed:32866000). Also has weak L-arginine oxidase activity (PubMed:26673964). Acts as a negative regulator of anti-tumor immunity ",L-amino-acid oxidase activity,Secreted,,DrugBank,drugbank_id
BE0004551,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,target,Q9GZU7,CTDSP1,Humans,"Preferentially catalyzes the dephosphorylation of 'Ser-5' within the tandem 7 residue repeats in the C-terminal domain (CTD) of the largest RNA polymerase II subunit POLR2A. Negatively regulates RNA polymerase II transcription, possibly by controlling the transition from initiation/capping to processive transcript elongation. Recruited by REST to neuronal genes that contain RE-1 elements, leading to neuronal gene silencing in non-neuronal cells",metal ion binding,Nucleus,,DrugBank,drugbank_id
BE0002930,Cytochrome c peroxidase,target,P83787,,Marinobacter hydrocarbonoclasticus,,cytochrome-c peroxidase activity,,,DrugBank,drugbank_id
BE0004625,Hepatocyte growth factor-regulated tyrosine kinase substrate,target,O14964,HGS,Humans,"Involved in intracellular signal transduction mediated by cytokines and growth factors. When associated with STAM, it suppresses DNA signaling upon stimulation by IL-2 and GM-CSF. Could be a direct effector of PI3-kinase in vesicular pathway via early endosomes and may regulate trafficking to early and late endosomes by recruiting clathrin. May concentrate ubiquitinated receptors within clathrin-coated regions. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs",phosphatidylinositol binding,Cytoplasm,,DrugBank,drugbank_id
BE0003253,Invasin,target,P11922,,Yersinia pseudotuberculosis serotype I (strain IP32953),Invasin is a protein that allows enteric bacteria to penetrate cultured mammalian cells. The entry of invasin in the cell is mediated by binding several beta-1 chain integrins.,,Cell surface,,DrugBank,drugbank_id
BE0002953,Intron-associated endonuclease 1,target,P13299,ITEVIR,Enterobacteria phage T4,This endonuclease is specific to the thymidylate synthase (td) gene splice junction and is involved in intron homing.,DNA binding,Cytoplasmic,,DrugBank,drugbank_id
BE0003254,Short tail fiber protein gp12,target,P10930,12,Enterobacteria phage T4,"Structural component of the short tail fiber. Adhesion protein that binds irreversibly to the lipopolysaccharides component (LPS) on the cell surface of Escherichia coli B strains during virus attachment. After at least three long tail fibers have bound, short tail fibers extend and bind irreversibly to the core region of the host cell LPS.",metal ion binding,Virion,,DrugBank,drugbank_id
BE0000780,"Malate dehydrogenase, mitochondrial",target,P40926,MDH2,Humans,,identical protein binding,Mitochondrion matrix,,DrugBank,drugbank_id
BE0003255,N5-carboxyaminoimidazole ribonucleotide mutase,target,Q2QJL3,purE,Acetobacter aceti,Catalyzes the conversion of N5-carboxyaminoimidazole ribonucleotide (N5-CAIR) to 4-carboxy-5-aminoimidazole ribonucleotide (CAIR).,5-(carboxyamino)imidazole ribonucleotide mutase activity,,,DrugBank,drugbank_id
BE0003256,Large ribosomal subunit protein uL4,target,P38516,rplD,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),"One of the primary rRNA binding proteins, this protein initially binds near the 5'-end of the 23S rRNA. It is important during the early stages of 50S assembly. It makes multiple contacts with different domains of the 23S rRNA in the assembled 50S subunit and ribosome (By similarity).",DNA binding,,,DrugBank,drugbank_id
BE0003257,Carboxypeptidase B,target,P15086,CPB1,Humans,,carboxypeptidase activity,Secreted,,DrugBank,drugbank_id
BE0003258,Hexon protein,target,P03277,L3,HAdV-2,"Major capsid protein that self-associates to form 240 hexon trimers, each in the shape of a hexagon, building most of the pseudo T=25 capsid. Assembled into trimeric units with the help of the chaperone shutoff protein. Transported by pre-protein VI to the nucleus where it associates with other structural proteins to form an empty capsid. Might be involved, through its interaction with host dyneins, in the intracellular microtubule-dependent transport of incoming viral capsid to the nucleus.",structural molecule activity,Virion,,DrugBank,drugbank_id
BE0002551,Riboflavin biosynthesis protein,target,Q9WZW1,,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),,ATP binding,,,DrugBank,drugbank_id
BE0003259,Beta-fructosidase,target,O33833,bfrA,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),"Hydrolysis of sucrose, raffinose, inulin and levan. Specific for the fructose moiety and the beta-anomeric configuration of the glycosidic linkages of its substrates. The enzyme released fructose from sucrose and raffinose, and the fructose polymer inulin is hydrolyzed quantitatively in an exo-type fashion.",beta-fructofuranosidase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0003260,Stringent starvation protein A,target,A0A5P8YJZ1,pog,Yersinia pestis,,,,,DrugBank,drugbank_id
BE0002685,Citrate synthase,target,Q9LCX9,cit,Thermus thermophilus,,citrate (Si)-synthase activity,,,DrugBank,drugbank_id
BE0003261,RNA 3'-terminal phosphate cyclase,target,P46849,rtcA,Escherichia coli (strain K12),"Catalyzes the conversion of 3'-phosphate to a 2',3'-cyclic phosphodiester at the end of RNA. The mechanism of action of the enzyme occurs in 3 steps: (A) adenylation of the enzyme by ATP; (B) transfer of adenylate to an RNA-N3'P to produce RNA-N3'PP5'A; (C) and attack of the adjacent 2'-hydroxyl on the 3'-phosphorus in the diester linkage to produce the cyclic end product. Likely functions in some aspects of cellular RNA processing.",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0004434,U6 snRNA-associated Sm-like protein LSm6,target,P62312,LSM6,Humans,"Plays a role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex) (PubMed:28781166). The heptameric LSM2-8 complex binds specifically to the 3'-terminal U-tract of U6 snRNA (PubMed:10523320). Component of LSm protein complexes, which are involved in RNA processing and may function in a chaperone-like manner, facilitating the efficient association of RNA processing fac",protein heterodimerization activity,Cytoplasm,,DrugBank,drugbank_id
BE0003262,Pleckstrin homology domain-containing family A member 1,target,Q9HB21,PLEKHA1,Humans,"Binds specifically to phosphatidylinositol 3,4-diphosphate (PtdIns3,4P2), but not to other phosphoinositides. May recruit other proteins to the plasma membrane",PDZ domain binding,Cytoplasm,,DrugBank,drugbank_id
BE0003263,Fe(3+)-binding periplasmic protein,target,P21408,fbpA,Serratia marcescens,Part of the ABC transporter complex FbpABC (TC 3.A.1.10.1) involved in Fe(3+) ions import. This protein specifically binds Fe(3+) and is involved in its transmembrane transport (By similarity).,metal ion binding,Periplasm,,DrugBank,drugbank_id
BE0003264,Signal recognition particle receptor FtsY,target,Q9WZ40,ftsY,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),Involved in targeting and insertion of nascent membrane proteins into the cytoplasmic membrane. Acts as a receptor for the complex formed by the signal recognition particle (SRP) and the ribosome-nascent chain (RNC).,ATP hydrolysis activity,Cell inner membrane,,DrugBank,drugbank_id
BE0002611,Nicotinate-nucleotide adenylyltransferase,target,P0A753,nadD,Shigella flexneri,Catalyzes the reversible adenylation of nicotinate mononucleotide (NaMN) to nicotinic acid adenine dinucleotide (NaAD).,ATP binding,,,DrugBank,drugbank_id
BE0003265,Transcription antitermination protein NusB,target,Q9X286,nusB,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),Involved in transcription antitermination. Required for transcription of ribosomal RNA (rRNA) genes. Binds specifically to the boxA antiterminator sequence of the ribosomal RNA (rrn) operons.,RNA binding,Cytoplasmic,,DrugBank,drugbank_id
BE0003267,Ribonucleoside-diphosphate reductase subunit beta,target,Q9CBQ2,nrdF,Mycobacterium leprae (strain TN),Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides (By similarity).,metal ion binding,,,DrugBank,drugbank_id
BE0002555,Glutamine synthetase 1,target,P9WN39,glnA1,Mycobacterium tuberculosis,"Involved in nitrogen metabolism via ammonium assimilation. Catalyzes the ATP-dependent biosynthesis of glutamine from glutamate and ammonia (PubMed:12819079, PubMed:7937767). Also able to use GTP (PubMed:7937767). D-glutamate is a poor substrate, and DL-glutamate shows about 50% of the standard specific activity (PubMed:7937767). Also plays a key role in controlling the ammonia levels within infected host cells and so contributes to the pathogens capacity to inhibit phagosome acidification and p",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0002690,2-methylcitrate synthase,target,O34002,gltA,Antarctic bacterium DS2-3R,Involved in the catabolism of short chain fatty acids (SCFA) via the tricarboxylic acid (TCA)(acetyl degradation route) and via the 2-methylcitrate cycle I (propionate degradation route). Catalyzes the Claisen condensation of propionyl-CoA and oxaloacetate (OAA) to yield 2-methylcitrate (2-MC) and CoA. Also catalyzes the condensation of oxaloacetate with acetyl-CoA but with a lower specificity.,2-methylcitrate synthase activity,,,DrugBank,drugbank_id
BE0003121,"9,11-endoperoxide prostaglandin H2 reductase",target,Q9GV41,,Trypanosoma brucei brucei,"Catalyzes the NADP-dependent formation of prostaglandin F2-alpha from prostaglandin H2. Has also aldo/ketoreductase activity towards the synthetic substrates 9,10-phenanthrenequinone and p-nitrobenzaldehyde.",aldo-keto reductase (NADPH) activity,Cytoplasm,,DrugBank,drugbank_id
BE0002493,Glucose-1-phosphate thymidylyltransferase,target,Q9HU22,rmlA,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),"Catalyzes the formation of dTDP-glucose, from dTTP and glucose 1-phosphate, as well as its pyrophosphorolysis.",glucose-1-phosphate thymidylyltransferase activity,,,DrugBank,drugbank_id
BE0002757,Purine nucleoside phosphorylase YfiH,target,P33644,yfiH,Escherichia coli (strain K12),"Purine nucleoside enzyme that catalyzes the phosphorolysis of adenosine and inosine nucleosides, yielding D-ribose 1-phosphate and the respective free bases, adenine and hypoxanthine (PubMed:31978345). Also catalyzes the phosphorolysis of S-methyl-5'-thioadenosine into adenine and S-methyl-5-thio-alpha-D-ribose 1-phosphate (PubMed:31978345). Also has adenosine deaminase activity (PubMed:31978345). May also act as a polyphenol oxidase: able to oxidize syringaldazine and 2,2'-azino-bis(3-ethylbenz",2'-deoxyadenosine deaminase activity,,,DrugBank,drugbank_id
BE0003268,Ribose-5-phosphate isomerase A,target,P44725,rpiA,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate.,ribose-5-phosphate isomerase activity,,,DrugBank,drugbank_id
BE0002545,GMP synthase [glutamine-hydrolyzing],target,P04079,guaA,Escherichia coli (strain K12),Catalyzes the synthesis of GMP from XMP.,ATP binding,,,DrugBank,drugbank_id
BE0003269,SAR-endolysin,target,Q37875,17,Enterobacteria phage P1,"Signal-arrest-release (SAR) endolysin with lysozyme activity that degrades host peptidoglycans and participates with the pinholin and spanin proteins in the sequential events which lead to programmed host cell lysis releasing the mature viral particles. Once the pinholin has permeabilized the host cell membrane, the SAR-endolysin is released into the periplasm where it breaks down the peptidoglycan layer.",lysozyme activity,Cytoplasmic,,DrugBank,drugbank_id
BE0003270,Glycerol uptake operon antiterminator-related protein,target,Q9X1F0,,Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099),,"transcription antitermination factor activity, RNA binding",,,DrugBank,drugbank_id
BE0003271,"3-carboxy-cis,cis-muconate cycloisomerase",target,P32427,pcaB,Pseudomonas putida,Catalyzes an anti cycloisomerization.,"3-carboxy-cis,cis-muconate cycloisomerase activity",Cytoplasm,,DrugBank,drugbank_id
BE0003272,Pyruvate decarboxylase,target,P06672,pdc,Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4),,magnesium ion binding,,,DrugBank,drugbank_id
BE0003525,Histone deacetylase 7,target,Q8WUI4,HDAC7,Humans,"Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (By similarity). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (By similarity). Histone deacetylases act via the formation of large multiprotein complexes (By similarity). Involved in muscle maturation by repressing transcription of myocyte enhancer factors su",14-3-3 protein binding,Nucleus,,DrugBank,drugbank_id
BE0002796,Acetoin utilization protein AcuC,target,O67135,acuC1,Aquifex aeolicus (strain VF5),,histone deacetylase activity,Cytoplasmic,,DrugBank,drugbank_id
BE0003460,Caspase-8,target,Q14790,CASP8,Humans,"Thiol protease that plays a key role in programmed cell death by acting as a molecular switch for apoptosis, necroptosis and pyroptosis, and is required to prevent tissue damage during embryonic development and adulthood (PubMed:23516580, PubMed:35338844, PubMed:35446120, PubMed:8681376, PubMed:8681377, PubMed:8962078, PubMed:9006941, PubMed:9184224). Initiator protease that induces extrinsic apoptosis by mediating cleavage and activation of effector caspases responsible for FAS/CD95-mediated an",cysteine-type endopeptidase activity,Cytoplasm,activator,DrugBank,drugbank_id
BE0010100,Prostaglandin E2 Receptors,target,P34995,PTGER1,Humans,Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(q) proteins which activate a phosphatidylinositol-calcium second messenger system. May play a role as an important modulator of renal function. Implicated the smooth muscle contractile response to PGE2 in various tissues,D1 dopamine receptor binding,Cell membrane,regulator,DrugBank,drugbank_id
BE0004529,Trypsin-2,target,P07478,PRSS2,Humans,"In the ileum, may be involved in defensin processing, including DEFA5",calcium ion binding,"Secreted, extracellular space",,DrugBank,drugbank_id
BE0001852,Kinesin-like protein KIF11,target,P52732,KIF11,Humans,"Motor protein required for establishing a bipolar spindle and thus contributing to chromosome congression during mitosis (PubMed:19001501, PubMed:37728657). Required in non-mitotic cells for transport of secretory proteins from the Golgi complex to the cell surface (PubMed:23857769)",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0004523,Bile salt-activated lipase,target,P19835,CEL,Humans,"Catalyzes the hydrolysis of a wide range of substrates including cholesteryl esters, phospholipids, lysophospholipids, di- and tri-acylglycerols, and fatty acid esters of hydroxy fatty acids (FAHFAs) (PubMed:10220579, PubMed:27509211, PubMed:27650499, PubMed:8471055). Preferentially hydrolyzes FAHFAs with the ester bond further away from the carboxylate. Unsaturated FAHFAs are hydrolyzed more quickly than saturated FAHFAs (By similarity). Has an essential role in the complete digestion of dietar",acetylesterase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0000656,"Troponin I, cardiac muscle",target,P19429,TNNI3,Humans,"Troponin I is the inhibitory subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity",actin binding,,,DrugBank,drugbank_id
BE0002014,Thioesterase 1/protease 1/lysophospholipase L1,target,P0ADA1,tesA,Escherichia coli (strain K12),"TesA is a multifunctional esterase that can act as a thioesterase, lysophospholipase and protease (PubMed:10423542, PubMed:1864840, PubMed:238979, PubMed:4554913, PubMed:4945109, PubMed:791643, PubMed:8098033, PubMed:8132479, PubMed:8432696, PubMed:9070299). TesA functions as a thioesterase specific for fatty acyl thioesters of greater than ten carbons, with highest activity on palmitoyl-CoA, cis-vaccenoyl-CoA and palmitoleoyl-CoA (PubMed:10423542, PubMed:4554913, PubMed:8098033, PubMed:8132479,",arylesterase activity,Periplasm,,DrugBank,drugbank_id
BE0009096,C-type lectin domain family 4 member E,target,Q9ULY5,CLEC4E,Humans,"Calcium-dependent lectin that acts as a pattern recognition receptor (PRR) of the innate immune system: recognizes damage-associated molecular patterns (DAMPs) of abnormal self and pathogen-associated molecular patterns (PAMPs) of bacteria and fungi (PubMed:18509109, PubMed:23602766). The PAMPs notably include mycobacterial trehalose 6,6'-dimycolate (TDM), a cell wall glycolipid with potent adjuvant immunomodulatory functions (PubMed:23602766, PubMed:24101491). Interacts with signaling adapter F",calcium ion binding,Cell membrane,ligand,DrugBank,drugbank_id
BE0004545,Nuclear receptor ROR-alpha,target,P35398,RORA,Humans,"Nuclear receptor that binds DNA as a monomer to ROR response elements (RORE) containing a single core motif half-site 5'-AGGTCA-3' preceded by a short A-T-rich sequence. Key regulator of embryonic development, cellular differentiation, immunity, circadian rhythm as well as lipid, steroid, xenobiotics and glucose metabolism. Considered to have intrinsic transcriptional activity, have some natural ligands like oxysterols that act as agonists (25-hydroxycholesterol) or inverse agonists (7-oxygenate",beta-catenin binding,Nucleus,,DrugBank,drugbank_id
BE0002376,Chloride channel protein ClC-Ka,target,P51800,CLCNKA,Humans,"Anion-selective channel permeable to small monovalent anions with ion selectivity for chloride > bromide > nitrate > iodide (PubMed:11734858, PubMed:12111250). Forms a homodimeric channel where each subunit has its own ion conduction pathway. May conduct double-barreled currents controlled by two types of gates, two fast gates that control each subunit independently and a slow common gate that opens and shuts off both subunits simultaneously (PubMed:11734858, PubMed:12111250, PubMed:18310267, Pu",chloride channel activity,Basolateral cell membrane,inducer,DrugBank,drugbank_id
BE0001566,14 kDa fatty acid-binding protein,target,P29498,,Blood fluke,"May play a role in the transport of fatty acids. Binds various fatty acids, such as arachidonic, oleic, palmitic and linolenic acid (in vitro).",fatty acid binding,Cytoplasm,,DrugBank,drugbank_id
BE0001194,"Fatty acid-binding protein, adipocyte",carrier,P15090,FABP4,Humans,Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid. Delivers long-chain fatty acids and retinoic acid to their cognate receptors in the nucleus,fatty acid binding,Cytoplasm,,DrugBank,drugbank_id
BE0003330,Glutaminyl-peptide cyclotransferase,target,Q16769,QPCT,Humans,"Responsible for the biosynthesis of pyroglutamyl peptides. Has a bias against acidic and tryptophan residues adjacent to the N-terminal glutaminyl residue and a lack of importance of chain length after the second residue. Also catalyzes N-terminal pyroglutamate formation. In vitro, catalyzes pyroglutamate formation of N-terminally truncated form of APP amyloid-beta peptides [Glu-3]-amyloid-beta. May be involved in the N-terminal pyroglutamate formation of several amyloid-related plaque-forming p",glutaminyl-peptide cyclotransferase activity,Secreted,,DrugBank,drugbank_id
BE0003805,Immunoglobulin heavy constant gamma 2,target,P01859,IGHG2,Humans,"Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which resu",antigen binding,Secreted,,DrugBank,drugbank_id
BE0003836,Immunoglobulin kappa constant,target,P01834,IGKC,Humans,"Constant region of immunoglobulin light chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which resu",antigen binding,Secreted,,DrugBank,drugbank_id
BE0004094,Mevalonate kinase,target,Q03426,MVK,Humans,"Catalyzes the phosphorylation of mevalonate to mevalonate 5-phosphate, a key step in isoprenoid and cholesterol biosynthesis (PubMed:11278915, PubMed:18302342, PubMed:9325256, PubMed:9392419)",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0003866,"4,4'-diapophytoene synthase",target,A9JQL9,crtM,Staphylococcus aureus,"Involved in the biosynthesis of the yellow-orange carotenoid staphyloxanthin, which plays a role in the virulence via its protective function against oxidative stress. Catalyzes the head-to-head condensation of two molecules of farnesyl diphosphate (FPP) into the colorless C(30) carotenoid 4,4'-diapophytoene (dehydrosqualene).",15-cis-phytoene synthase activity,,,DrugBank,drugbank_id
BE0003350,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",target,P60472,ispU,Escherichia coli (strain K12),"Generates ditrans,octacis-undecaprenyl pyrophosphate (UPP) from isopentenyl pyrophosphate (IPP) and farnesyl diphosphate (FPP). UPP is the precursor of glycosyl carrier lipid in the biosynthesis of bacterial cell wall polysaccharide components such as peptidoglycan and lipopolysaccharide.","di-trans,poly-cis-undecaprenyl-diphosphate synthase activity",,,DrugBank,drugbank_id
BE0001016,Rho-associated protein kinase 1,target,Q13464,ROCK1,Humans,"Protein kinase which is a key regulator of the actin cytoskeleton and cell polarity (PubMed:10436159, PubMed:10652353, PubMed:11018042, PubMed:11283607, PubMed:17158456, PubMed:18573880, PubMed:19131646, PubMed:8617235, PubMed:9722579). Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, TPPP, PFN1 and PPP1R12A (P",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001005,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,P31930,UQCRC1,Humans,"Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular ",metal ion binding,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0000994,Lactotransferrin,target,P02788,LTF,Humans,"Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate",cysteine-type endopeptidase inhibitor activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0010497,Tumor necrosis factor ligand superfamily member 10,target,P50591,TNFSF10,Humans,"Cytokine that binds to TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and possibly also to TNFRSF11B/OPG (PubMed:10549288, PubMed:26457518). Induces apoptosis. Its activity may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and TNFRSF11B/OPG that cannot induce apoptosis",cytokine activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0002401,P2Y purinoceptor 2,target,P41231,P2RY2,Humans,Receptor for ATP and UTP coupled to G-proteins that activate a phosphatidylinositol-calcium second messenger system. The affinity range is UTP = ATP > ATP-gamma-S >> 2-methylthio-ATP = ADP,A1 adenosine receptor binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",target,Q9NXA8,SIRT5,Humans,"NAD-dependent lysine demalonylase, desuccinylase and deglutarylase that specifically removes malonyl, succinyl and glutaryl groups on target proteins (PubMed:21908771, PubMed:22076378, PubMed:24703693, PubMed:29180469). Activates CPS1 and contributes to the regulation of blood ammonia levels during prolonged fasting: acts by mediating desuccinylation and deglutarylation of CPS1, thereby increasing CPS1 activity in response to elevated NAD levels during fasting (PubMed:22076378, PubMed:24703693).","histone deacetylase activity, NAD-dependent",Mitochondrion matrix,inhibitor,DrugBank,drugbank_id
BE0001457,Complement control protein C3,target,P68638,,VACV,Serves to protect the virus against complement attack by inhibiting both classical and alternative pathways of complement activation. Binds C3b and C4b.,complement binding,Virion membrane,,DrugBank,drugbank_id
BE0004946,"Myosin light chain kinase 2, skeletal/cardiac muscle",target,Q9H1R3,MYLK2,Humans,Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N-terminus of a myosin light chain,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000911,C-C chemokine receptor type 5,target,P51681,CCR5,Humans,"Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. Participates in T-lymphocyte migration to the infection site by acting as a chemotactic receptor (PubMed:30713770)",actin binding,Cell membrane,antagonist|inhibitor,DrugBank,drugbank_id
BE0008983,Prostate-specific antigen,target,P07288,KLK3,Humans,Hydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum,endopeptidase activity,Secreted,,DrugBank,drugbank_id
BE0004717,Potassium voltage-gated channel subfamily A member 5,target,P22460,KCNA5,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane. Can form functional homotetrameric channels and heterotetrameric channels that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5, and ",alpha-actinin binding,Cell membrane,blocker,DrugBank,drugbank_id
BE0000402,Cholecystokinin receptor type A,target,P32238,CCKAR,Humans,"Receptor for cholecystokinin. Mediates pancreatic growth and enzyme secretion, smooth muscle contraction of the gall bladder and stomach. Has a 1000-fold higher affinity for CCK rather than for gastrin. It modulates feeding and dopamine-induced behavior in the central and peripheral nervous system. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system",cholecystokinin receptor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001158,Gastrin/cholecystokinin type B receptor,target,P32239,CCKBR,Humans,"Receptor for gastrin and cholecystokinin. The CCK-B receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system",1-phosphatidylinositol-3-kinase regulator activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004749,Large ribosomal subunit protein uL2,target,P20276,rpl2,Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809),"One of the primary rRNA binding proteins. Required for association of the 30S and 50S subunits to form the 70S ribosome, for tRNA binding and peptide bond formation. It has been suggested to have peptidyltransferase activity; this is somewhat controversial. Makes several contacts with the 16S rRNA in the 70S ribosome (By similarity).",rRNA binding,,antagonist,DrugBank,drugbank_id
BE0003833,Large ribosomal subunit protein uL3,target,P39023,RPL3,Humans,"Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:32669547, PubMed:35674491). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:32669547)",RNA binding,"Nucleus, nucleolus",antagonist,DrugBank,drugbank_id
BE0010249,Platelet-derived growth factor receptor,target,P16234,PDGFRA,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal dev",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0027487,Discoidin domain receptor,target,Q16832,DDR2,Humans,"Tyrosine kinase involved in the regulation of tissues remodeling (PubMed:30449416). It functions as a cell surface receptor for fibrillar collagen and regulates cell differentiation, remodeling of the extracellular matrix, cell migration and cell proliferation. Required for normal bone development. Regulates osteoblast differentiation and chondrocyte maturation via a signaling pathway that involves MAP kinases and leads to the activation of the transcription factor RUNX2. Regulates remodeling of",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002371,Neuromedin-K receptor,target,P29371,TACR3,Humans,This is a receptor for the tachykinin neuropeptide neuromedin-K (neurokinin B). It is associated with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinity of this receptor to tachykinins is: neuromedin-K > substance K > substance P,tachykinin receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003641,Phosphatidylcholine translocator ABCB4,target,P21439,ABCB4,Humans,Energy-dependent phospholipid efflux translocator that acts as a positive regulator of biliary lipid secretion. Functions as a floppase that translocates specifically phosphatidylcholine (PC) from the inner to the outer leaflet of the canalicular membrane bilayer into the canaliculi of hepatocytes. Translocation of PC makes the biliary phospholipids available for extraction into the canaliculi lumen by bile salt mixed micelles and therefore protects the biliary tree from the detergent activity o,ABC-type transporter activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0004382,Mediator of RNA polymerase II transcription subunit 1,target,Q15648,MED1,Humans,"Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcriptio",chromatin binding,Nucleus,,DrugBank,drugbank_id
BE0002147,Somatostatin receptor type 5,target,P35346,SSTR5,Humans,Receptor for somatostatin 28 and to a lesser extent for somatostatin-14. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. Increases cell growth inhibition activity of SSTR2 following heterodimerization,neuropeptide binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0002129,Neuropilin-1,target,O14786,NRP1,Humans,"Cell-surface receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. Mediates the chemorepulsant activity of semaphorins (PubMed:10688880, PubMed:9288753, PubMed:9529250). Recognizes a C-end rule (CendR) motif R/KXXR/K on its ligands which causes cellular internalization and vascular leakage (PubMed:19805273). It binds to semaphorin 3A, the PLGF-2 isoform of PGF, the VEGF165",coreceptor activity,Secreted,other/unknown,DrugBank,drugbank_id
BE0002426,Atrial natriuretic peptide receptor 3,target,P17342,NPR3,Humans,"Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for NPPA, NPPB and NPPC, regulating their local concentrations and effects. Acts as a regulator of osteoblast differentiation and bone growth by binding to its ligand osteocrin, thereby preventing binding between NPR3/NPR-C and natriuretic peptides, leading to increase ",chloride ion binding,Cell membrane,,DrugBank,drugbank_id
BE0009912,Peptidoglycan precursors,target,,,Gram negative and gram positive bacteria,,,,binder,DrugBank,drugbank_id
BE0009913,Bacterial cell wall peptide bridging segments,target,,,Staphylococcus aureus,,,,inhibitor,DrugBank,drugbank_id
BE0009914,Pentaglycyl bridging segment,target,,,Staphylococcus aureus,,,,disruptor,DrugBank,drugbank_id
BE0002391,MecA,target,Q7DHH4,mecA,Staphylococcus aureus,,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0002399,Potassium voltage-gated channel subfamily KQT member 4,target,P56696,KCNQ4,Humans,"Pore-forming subunit of the voltage-gated potassium (Kv) channel involved in the regulation of sensory cells excitability in the cochlea (PubMed:10025409, PubMed:34767770). KCNQ4/Kv7.4 channel is composed of 4 pore-forming subunits assembled as tetramers (PubMed:34767770). Promotes the outflow of potassium ions in the repolarization phase of action potential which plays a role in regulating membrane potential of excitable cells (PubMed:10025409, PubMed:11245603, PubMed:34767770). The channel con",potassium channel activity,Basal cell membrane,,DrugBank,drugbank_id
BE0000489,Potassium voltage-gated channel subfamily E member 1,target,P15382,KCNE1,Humans,"Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. KCNE1 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:19219384, PubMed:20533308, PubMed:9230439). Alters the gating of the delayed rectifier Kv channel containing KCNB1 alpha subunit (PubMed:19219384). Associates with KCNQ1/KVLQT1 alpha subunit",delayed rectifier potassium channel activity,Cell membrane,,DrugBank,drugbank_id
BE0000183,B-cell receptor CD22,target,P20273,CD22,Humans,"Most highly expressed siglec (sialic acid-binding immunoglobulin-like lectin) on B-cells that plays a role in various aspects of B-cell biology including differentiation, antigen presentation, and trafficking to bone marrow (PubMed:34330755, PubMed:8627166). Binds to alpha 2,6-linked sialic acid residues of surface molecules such as CD22 itself, CD45 and IgM in a cis configuration. Can also bind to ligands on other cells as an adhesion molecule in a trans configuration (PubMed:20172905). Acts as",carbohydrate binding,Cell membrane,antibody|regulator,DrugBank,drugbank_id
BE0002372,Protein farnesyltransferase subunit beta,target,P49356,FNTB,Humans,Essential subunit of the farnesyltransferase complex. Catalyzes the transfer of a farnesyl moiety from farnesyl diphosphate to a cysteine at the fourth position from the C-terminus of several proteins having the C-terminal sequence Cys-aliphatic-aliphatic-X,acetyltransferase activator activity,,modulator,DrugBank,drugbank_id
BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,P49354,FNTA,Humans,Essential subunit of both the farnesyltransferase and the geranylgeranyltransferase complex. Contributes to the transfer of a farnesyl or geranylgeranyl moiety from farnesyl or geranylgeranyl diphosphate to a cysteine at the fourth position from the C-terminus of several proteins having the C-terminal sequence Cys-aliphatic-aliphatic-X. May positively regulate neuromuscular junction development downstream of MUSK via its function in RAC1 prenylation and activation,acetyltransferase activator activity,,modulator,DrugBank,drugbank_id
BE0004538,Palmitoyl-protein thioesterase 1,target,P50897,PPT1,Humans,"Has thioesterase activity against fatty acid thioesters with 14 -18 carbons, including palmitoyl-CoA, S-palmitoyl-N-acetylcysteamine, and palmitoylated proteins (PubMed:12855696, PubMed:26731412, PubMed:8816748). In contrast to PPT2, PPT1 can hydrolyze palmitoylated proteins and palmitoylcysteine (PubMed:12855696)",long-chain fatty acyl-CoA hydrolase activity,Lysosome,modulator,DrugBank,drugbank_id
BE0010196,Elongation factor 1-alpha 2,target,Q05639,EEF1A2,Humans,"Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis. Base pairing between the mRNA codon and the aa-tRNA anticodon promotes GTP hydrolysis, releasing the aa-tRNA from EEF1A1 and allowing its accommodation into the ribosome (By similarity). The growing protein chain is subsequently transferred from the P-site peptidyl tRNA to the A-site aa-tRNA, extending it by one amino acid",GTP binding,Endoplasmic reticulum membrane,,DrugBank,drugbank_id
BE0009794,Dystrophin,target,P11532,DMD,Humans,Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission,actin binding,"Cell membrane, sarcolemma",modulator,DrugBank,drugbank_id
BE0002422,Alpha-galactosidase A,target,P06280,GLA,Humans,Catalyzes the hydrolysis of glycosphingolipids and participates in their degradation in the lysosome,alpha-galactosidase activity,Lysosome,stabilization,DrugBank,drugbank_id
BE0003508,Parathyroid hormone/parathyroid hormone-related peptide receptor,target,Q03431,PTH1R,Humans,"G-protein-coupled receptor for parathyroid hormone (PTH) and for parathyroid hormone-related peptide (PTHLH) (PubMed:10913300, PubMed:18375760, PubMed:19674967, PubMed:27160269, PubMed:30975883, PubMed:35932760, PubMed:8397094). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase (cAMP) (PubMed:30975883, PubMed:35932760). PTH1R is coupled to G(s) G al",G protein-coupled peptide receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0004224,Cell adhesion molecule CEACAM5,target,P06731,CEACAM5,Humans,"Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression (PubMed:10864933, PubMed:10910050, PubMed:2803308). Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed:2803308). Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells (PubMed:10910050)",GPI anchor binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003411,Platelet-derived growth factor D,target,Q9GZP0,PDGFD,Humans,"Growth factor that plays an essential role in the regulation of embryonic development, cell proliferation, cell migration, survival and chemotaxis. Potent mitogen for cells of mesenchymal origin. Plays an important role in wound healing. Induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Can initiate events that lead to a mesangial proliferative glomerulonephritis, including influx of monocytes and macrophages and production of extra",growth factor activity,Secreted,,DrugBank,drugbank_id
BE0002521,Cyclopropane mycolic acid synthase 3,target,P9WPB3,pcaA,Mycobacterium tuberculosis,"Involved in the phagosome maturation block (PMB). Catalyzes the conversion of a double bond to a cyclopropane ring at the proximal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. It can use cis, cis 11,14-eicosadienoic acid and linoelaidic acid as substrate. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence.",cyclopropane-fatty-acyl-phospholipid synthase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001211,Cyclopropane mycolic acid synthase 2,target,P9WPB5,cmaA2,Mycobacterium tuberculosis,"Catalyzes the formation of trans cyclopropanated ketomycolate or methoxymycolate through the conversion of a double bond to a cyclopropane ring at the proximal position of an oxygenated mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. In the absence of MmaA2, CmaA2 has a non-specific cis-cyclopropanating activity and is able to catalyze the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid. Cyclopropanated mycol",cyclopropane-fatty-acyl-phospholipid synthase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003738,Cyclopropane mycolic acid synthase 1,target,P9WPB7,cmaA1,Mycobacterium tuberculosis,"Catalyzes the conversion of a double bond to a cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence.",cyclopropane-fatty-acyl-phospholipid synthase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009715,Uncharacterized MFS-type transporter EfpA,target,P9WJY5,efpA,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),,transmembrane transporter activity,Cell membrane,other/unknown,DrugBank,drugbank_id
BE0009714,Nucleoid-associated protein Lsr2,target,P9WIP7,lsr2,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),"DNA-bridging protein that has both architectural and regulatory roles (PubMed:18187505). Influences the organization of chromatin and gene expression by binding non-specifically to DNA, with a preference for AT-rich sequences, and bridging distant DNA segments (PubMed:20133735). Binds in the minor groove of AT-rich DNA (PubMed:21673140). Represses expression of multiple genes involved in a broad range of cellular processes, including major virulence factors or antibiotic-induced genes, such as i",acyltransferase activity,Cytoplasm,other/unknown,DrugBank,drugbank_id
BE0009325,Deazaflavin-dependent nitroreductase,enzyme,P9WP15,ddn,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),"Involved in a F420-dependent anti-oxidant mechanism that protects M.tuberculosis against oxidative stress and bactericidal agents. Catalyzes the F420H(2)-dependent two-electron reduction of quinones to dihydroquinones, thereby preventing the formation of cytotoxic semiquinones obtained by the one-electron reduction pathway (PubMed:23240649). In vitro, catalyzes the reduction of both benzoquinone and naphthoquinone analogs; since menaquinone is the sole quinone electron carrier in the respiratory",coenzyme F420 binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0003795,Prostaglandin reductase 1,enzyme,Q14914,PTGR1,Humans,"NAD(P)H-dependent oxidoreductase involved in metabolic inactivation of pro- and anti-inflammatory eicosanoids: prostaglandins (PG), leukotrienes (LT) and lipoxins (LX) (PubMed:25619643). Catalyzes with high efficiency the reduction of the 13,14 double bond of 15-oxoPGs, including 15-oxo-PGE1, 15-oxo-PGE2, 15-oxo-PGF1-alpha and 15-oxo-PGF2-alpha (PubMed:25619643). Catalyzes with lower efficiency the oxidation of the hydroxyl group at C12 of LTB4 and its derivatives, converting them into biologica",13-lipoxin reductase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0002389,Rhesus blood group D antigen,target,A6PZ59,RHD,Humans,,ammonium transmembrane transporter activity,,,DrugBank,drugbank_id
BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,target,Q02750,MAP2K1,Humans,"Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of ",ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",inhibitor,DrugBank,drugbank_id
BE0011001,MHC class II protein complex,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0000334,Urease subunit alpha,target,P18314,ureC,Enterobacter aerogenes,,nickel cation binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002423,NADPH oxidase organizer 1,target,Q8NFA2,NOXO1,Humans,"Constitutively potentiates the superoxide-generating activity of NOX1 and NOX3 and is required for the biogenesis of otoconia/otolith, which are crystalline structures of the inner ear involved in the perception of gravity. Isoform 3 is more potent than isoform 1 in activating NOX3. Together with NOXA1, may also substitute to NCF1/p47phox and NCF2/p67phox in supporting the phagocyte NOX2/gp91phox superoxide-generating activity",enzyme binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0002427,HBsAg,target,Q69600,S gene,HBV,,,Virion membrane,,DrugBank,drugbank_id
BE0004731,Protein-tyrosine kinase 6,target,Q13882,PTK6,Humans,"Non-receptor tyrosine-protein kinase implicated in the regulation of a variety of signaling pathways that control the differentiation and maintenance of normal epithelia, as well as tumor growth. Function seems to be context dependent and differ depending on cell type, as well as its intracellular localization. A number of potential nuclear and cytoplasmic substrates have been identified. These include the RNA-binding proteins: KHDRBS1/SAM68, KHDRBS2/SLM1, KHDRBS3/SLM2 and SFPQ/PSF; transcriptio",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003379,Angiopoietin-1 receptor,target,Q02763,TEK,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for ANGPT1, ANGPT2 and ANGPT4 and regulates angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Has anti-inflammatory effects by preventing the leakage of pro-inflammatory plasma proteins and leukocytes from blood vessels. Required for normal angiogenesis and heart development during embryogenesis. Required",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001313,Uric acid degradation bifunctional protein,target,Q45697,uao,Bacillus sp. (strain TB-90),"Catalyzes two steps in the degradation of uric acid, i.e. the oxidation of uric acid to 5-hydroxyisourate (HIU) and the stereoselective decarboxylation of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline (OHCU) to (S)-allantoin (By similarity).",2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity,,,DrugBank,drugbank_id
BE0003440,Thrombopoietin receptor,target,P40238,MPL,Humans,"Receptor for thrombopoietin that regulates hematopoietic stem cell renewal, megakaryocyte differentiation, and platelet formation. Upon activation by THPO, induces rapid tyrosine phosphorylation and activation of JAK2, providing docking sites for many signaling proteins such as STAT5, SHIP/INPP5D, GRB2, SOS1 and PI3K (PubMed:15899890, PubMed:37633268). In turn, These signaling cascades lead to the proliferation, survival, and differentiation of megakaryocytes, ultimately leading to increased pla",thrombopoietin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0004747,Protective antigen,target,P13423,pagA,Bacillus anthracis,"Protective antigen constitutes one of the three proteins composing the anthrax toxin; it mediates attachment to host cells and translocation of edema factor (EF) and lethal factor (LF) into the host cytoplasm (PubMed:11700562, PubMed:14507921, PubMed:15243628, PubMed:15326297). PA associated with LF forms the lethal toxin (LeTx) and causes death when injected; PA associated with EF forms the edema toxin (EdTx) and produces edema (PubMed:1651334). PA induces immunity to infection with anthrax (Pu",identical protein binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0003387,C-C chemokine receptor type 2,target,P41597,CCR2,Humans,"Key functional receptor for CCL2 but can also bind CCL7, and CCL12 (PubMed:23408426, PubMed:38157855, PubMed:8048929, PubMed:8146186). Also transduces signaling mediated by CCL13 (PubMed:38157855). Its binding with CCL2 on monocytes and macrophages mediates chemotaxis and migration induction through the activation of the PI3K cascade, the small G protein Rac and lamellipodium protrusion (PubMed:38157855). Also acts as a receptor for the beta-defensin DEFB106A/DEFB106B (PubMed:23938203). Regulate",C-C chemokine binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003371,Metalloproteinase inhibitor 3,target,P35625,TIMP3,Humans,"Mediates a variety of processes including matrix regulation and turnover, inflammation, and angiogenesis, through reversible inhibition of zinc protease superfamily enzymes, primarily matrix metalloproteinases (MMPs). Regulates extracellular matrix (ECM) remodeling through inhibition of matrix metalloproteinases (MMP) including MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, MMP-14 and MMP-15. Additionally, modulates the processing of amyloid precursor protein (APP) and apolipoprotein E receptor ApoE",metal ion binding,"Secreted, extracellular space, extracellular matrix",,DrugBank,drugbank_id
BE0002482,GM-CSF receptor alpha subunit,target,Q16498,CSF2RA,Humans,,,,,DrugBank,drugbank_id
BE0004772,Receptor tyrosine-protein kinase erbB-4,target,Q15303,ERBB4,Humans,"Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins and EGF family members and regulates development of the heart, the central nervous system and the mammary gland, gene transcription, cell proliferation, differentiation, migration and apoptosis. Required for normal cardiac muscle differentiation during embryonic development, and for postnatal cardiomyocyte proliferation. Required for normal development of the embryonic central nervous system, especially",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003388,"Thioredoxin reductase 2, mitochondrial",target,Q9NNW7,TXNRD2,Humans,Involved in the control of reactive oxygen species levels and the regulation of mitochondrial redox homeostasis (PubMed:24601690). Maintains thioredoxin in a reduced state. May play a role in redox-regulated cell signaling,flavin adenine dinucleotide binding,Mitochondrion,,DrugBank,drugbank_id
BE0003415,Interleukin-23 subunit alpha,target,Q9NPF7,IL23A,Humans,"Associates with IL12B to form the pro-inflammatory cytokine IL-23 that plays different roles in innate and adaptive immunity (PubMed:11114383). Released by antigen-presenting cells such as dendritic cells or macrophages, binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R to activate JAK2 and TYK2 which then phosphorylate the receptor to form a docking site leading to the phosphorylation of STAT3 and STAT4 (PubMed:29287995, PubMed:32474165, PubMed:33606986). This process lead",cytokine activity,Secreted,,DrugBank,drugbank_id
BE0004701,Genome polyprotein,target,B0B3C9,NS3/4A,Hepatitis C Virus,,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0003427,Genome polyprotein,target,P26664,,,"Mature core protein
    Packages viral RNA to form a viral nucleocapsid, and promotes virion budding (Probable). Participates in the viral particle production as a result of its interaction with the non-structural protein 5A (By similarity). Binds RNA and may function as a RNA chaperone to induce the RNA structural rearrangements taking place during virus replication (By similarity). Modulates viral translation initiation by interacting with viral IRES and 40S ribosomal subunit (By similarity). ",ATP binding,Host endoplasmic reticulum membrane,modulator,DrugBank,drugbank_id
BE0004845,mRNA of ApoB-100,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0009908,Apolipoprotein B-100,target,P04114,APOB,Humans,"Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor",cholesterol transfer activity,Cytoplasm,other/unknown,DrugBank,drugbank_id
BE0003341,Aspartate carbamoyltransferase catalytic subunit,target,P0A786,pyrB,Escherichia coli (strain K12),"Catalyzes the condensation of carbamoyl phosphate and aspartate to form carbamoyl aspartate and inorganic phosphate, the committed step in the de novo pyrimidine nucleotide biosynthesis pathway.",amino acid binding,,,DrugBank,drugbank_id
BE0002228,Adenylosuccinate synthetase isozyme 2,target,P30520,ADSS2,Humans,Plays an important role in the de novo pathway and in the salvage pathway of purine nucleotide biosynthesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP,adenylosuccinate synthase activity,Cytoplasm,,DrugBank,drugbank_id
BE0009549,Interleukin-1 receptor type 2,target,P27930,IL1R2,Humans,"Non-signaling receptor for IL1A, IL1B and IL1RN. Reduces IL1B activities. Serves as a decoy receptor by competitive binding to IL1B and preventing its binding to IL1R1. Also modulates cellular response through non-signaling association with IL1RAP after binding to IL1B. IL1R2 (membrane and secreted forms) preferentially binds IL1B and poorly IL1A and IL1RN. The secreted IL1R2 recruits secreted IL1RAP with high affinity; this complex formation may be the dominant mechanism for neutralization of I",interleukin-1 binding,Secreted,antagonist,DrugBank,drugbank_id
BE0003479,Tumor necrosis factor receptor superfamily member 8,target,P28908,TNFRSF8,Humans,Receptor for TNFSF8/CD30L (PubMed:8391931). May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B (PubMed:8999898),protease binding,Cell membrane,antibody|regulator,DrugBank,drugbank_id
BE0010183,Cytochrome P450 7A1,enzyme,P22680,CYP7A1,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of endogenous cholesterol and its oxygenated derivatives (oxysterols) (PubMed:11013305, PubMed:12077124, PubMed:19965590, PubMed:21813643, PubMed:2384150). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:11013305, PubMed:12077124, PubMed:199655",24S-hydroxycholesterol 7-alpha-hydroxylase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009697,Phosphodiesterase isozyme 4,target,Q86V67,PDE4,Humans,,"3',5'-cyclic-AMP phosphodiesterase activity",,inhibitor,DrugBank,drugbank_id
BE0008663,Interleukin-23,target,P29460,IL12B,Humans,"Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC",cytokine activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0012862,Interleukin-12 subunit alpha,target,P29459,IL12A,Humans,"Heterodimerizes with IL12B to form the IL-12 cytokine or with EBI3/IL27B to form the IL-35 cytokine (PubMed:8605935, PubMed:8943050). IL-12 is primarily produced by professional antigen-presenting cells (APCs) such as B-cells and dendritic cells (DCs) as well as macrophages and granulocytes and regulates T-cell and natural killer-cell responses, induces the production of interferon-gamma (IFN-gamma), favors the differentiation of T-helper 1 (Th1) cells and is an important link between innate res",cytokine activity,Secreted,other/unknown,DrugBank,drugbank_id
BE0003481,Transforming growth factor beta-2 proprotein,target,P61812,TGFB2,Humans,"Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains, which constitute the regulatory and active subunit of TGF-beta-2, respectively",amyloid-beta binding,"Secreted, extracellular space, extracellular matrix",,DrugBank,drugbank_id
BE0003381,Serine/threonine-protein kinase Chk2,target,O96017,CHEK2,Humans,"Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T] (PubMed:37943659). Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, in",ATP binding,Nucleus,modulator,DrugBank,drugbank_id
BE0003422,Far upstream element-binding protein 1,target,Q96AE4,FUBP1,Humans,Regulates MYC expression by binding to a single-stranded far-upstream element (FUSE) upstream of the MYC promoter. May act both as activator and repressor of transcription,mRNA binding,Nucleus,,DrugBank,drugbank_id
BE0003399,Free fatty acid receptor 4,target,Q5NUL3,FFAR4,Humans,"G-protein-coupled receptor for long-chain fatty acids (LCFAs) with a major role in adipogenesis, energy metabolism and inflammation. Signals via G-protein and beta-arrestin pathways (PubMed:22282525, PubMed:22343897, PubMed:24742677, PubMed:24817122, PubMed:27852822). LCFAs sensing initiates activation of phosphoinositidase C-linked G proteins GNAQ and GNA11 (G(q)/G(11)), inducing a variety of cellular responses via second messenger pathways such as intracellular calcium mobilization, modulation",arrestin family protein binding,Cell membrane,,DrugBank,drugbank_id
BE0004703,Parathyroid hormone 2 receptor,target,P49190,PTH2R,Humans,This is a specific receptor for parathyroid hormone. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. PTH2R may be responsible for PTH effects in a number of physiological systems. It may play a significant role in pancreatic function. PTH2R presence in neurons indicates that it may function as a neurotransmitter receptor (By similarity),G protein-coupled peptide receptor activity,Cell membrane,activator,DrugBank,drugbank_id
BE0004857,Glycine receptor (alpha-1/beta),target,P23415,GLRA1,Humans,"Subunit of heteromeric glycine-gated chloride channels (PubMed:14551753, PubMed:23994010, PubMed:25730860, PubMed:37821459). Plays an important role in the down-regulation of neuronal excitability (PubMed:8298642, PubMed:9009272). Contributes to the generation of inhibitory postsynaptic currents (PubMed:25445488). Channel activity is potentiated by ethanol (PubMed:25973519). Potentiation of channel activity by intoxicating levels of ethanol contribute to the sedative effects of ethanol (By simil",extracellularly glycine-gated chloride channel activity,Postsynaptic cell membrane,binding,DrugBank,drugbank_id
BE0003435,Growth/differentiation factor 8,target,O14793,MSTN,Humans,Acts specifically as a negative regulator of skeletal muscle growth,cytokine activity,Secreted,,DrugBank,drugbank_id
BE0003436,Programmed cell death protein 1,target,Q15116,PDCD1,Humans,"Inhibitory receptor on antigen activated T-cells that plays a critical role in induction and maintenance of immune tolerance to self (PubMed:21276005, PubMed:37208329). Delivers inhibitory signals upon binding to ligands CD274/PDCD1L1 and CD273/PDCD1LG2 (PubMed:21276005). Following T-cell receptor (TCR) engagement, PDCD1 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation (By similarity). Suppresses T-cell activation through the recruitment of PTPN11/SHP-",signaling receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0002133,Fibroblast growth factor receptor 3,target,P22607,FGFR3,Humans,"Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferat",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003473,Transmembrane glycoprotein NMB,target,Q14956,GPNMB,Humans,Could be a melanogenic enzyme,chemoattractant activity,Cell membrane,binder,DrugBank,drugbank_id
BE0009802,Aldo-keto reductase family,enzyme,Q96JD6,AKR1E2,Humans,"Catalyzes the NADPH-dependent reduction of 1,5-anhydro-D-fructose (AF) to 1,5-anhydro-D-glucitol (By similarity). Has low NADPH-dependent reductase activity towards 9,10-phenanthrenequinone (in vitro) (PubMed:12604216, PubMed:15118078)","1,5-anhydro-D-fructose reductase activity",Cytoplasm,substrate,DrugBank,drugbank_id
BE0000934,C-X-C motif chemokine 10,target,P02778,CXCL10,Humans,"Pro-inflammatory cytokine that is involved in a wide variety of processes such as chemotaxis, differentiation, and activation of peripheral immune cells, regulation of cell growth, apoptosis and modulation of angiostatic effects (PubMed:11157474, PubMed:22652417, PubMed:7540647). Plays thereby an important role during viral infections by stimulating the activation and migration of immune cells to the infected sites (By similarity). Mechanistically, binding of CXCL10 to the CXCR3 receptor activat",cAMP-dependent protein kinase regulator activity,Secreted,,DrugBank,drugbank_id
BE0004839,NAPQI (N-acetyl-p-benzoquinone imine),target,,,Humans,,,,reducer,DrugBank,drugbank_id
BE0000481,Aminoacylase-1,target,Q03154,ACY1,Humans,Catalyzes the hydrolysis of N-acetylated amino acids to acetate and free amino acids,aminoacylase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0009339,Free radicals,target,,,Humans,,,,antagonist,DrugBank,drugbank_id
BE0005802,G-protein coupled receptor 55,target,Q9Y2T6,GPR55,Humans,"G-protein coupled receptor that binds to several ligands including 2-arachidonoyl lysophosphatidylinositol or lysophosphatidylglucoside with high affinity, leading to rapid and transient activation of numerous intracellular signaling pathways (PubMed:36142844, PubMed:36523570, PubMed:37544935). Induces the Ca(2+) release from intracellular stores via ERK, the heterotrimeric G protein GNA13 and RHOA leading to morphological changes including cell rounding and stress fiber formation (PubMed:361428",cannabinoid receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0003465,Low affinity immunoglobulin epsilon Fc receptor,target,P06734,FCER2,Humans,"Low-affinity receptor for immunoglobulin E (IgE) and CR2/CD21. Has essential roles in the regulation of IgE production and in the differentiation of B cells. On B cells, initiates IgE-dependent antigen uptake and presentation to T cells (PubMed:2167225). On macrophages, upon IgE binding and antigen cross-linking induces intracellular killing of parasites through activation of L-Arginine-nitric oxide pathway (PubMed:7544003)",carbohydrate binding,Cell membrane,antibody|regulator,DrugBank,drugbank_id
BE0000887,Cytotoxic T-lymphocyte protein 4,target,P16410,CTLA4,Humans,"Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28",,Cell membrane,inhibitor|antibody,DrugBank,drugbank_id
BE0003512,Casein kinase I isoform epsilon,target,P49674,CSNK1E,Humans,"Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates (Probable). Participates in Wnt signaling (PubMed:12556519, PubMed:23413191). Phosphorylates DVL1 (PubMed:12556519). Phosphorylates DVL2 (PubMed:23413191). Phosphorylates NEDD9/HEF1 (By similarity). Central component of the circadian clock (PubMed:16790549). In balance with PP1, determines the circadian period length, through the regulation of the speed and rhythmicity of P",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0003513,B2 bradykinin receptor,target,P30411,BDKRB2,Humans,Receptor for bradykinin. It is associated with G proteins that activate a phosphatidylinositol-calcium second messenger system,bradykinin receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0009857,Hyaluronic acid,target,,,Humans and other mammals,,,,modulator|metabolizer,DrugBank,drugbank_id
BE0005806,Dihydropyrimidinase-related protein 2,target,Q16555,DPYSL2,Humans,"Plays a role in neuronal development and polarity, as well as in axon growth and guidance, neuronal growth cone collapse and cell migration. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. May play a role in endocytosis",dihydropyrimidinase activity,"Cytoplasm, cytosol",modulator,DrugBank,drugbank_id
BE0003484,Serine/threonine protein kinase UL97,target,P16788,UL97,HHV-5,"Serine/threonine protein kinase that plays important roles in several processes including nuclear viral egress, viral replication or regulation of host cell cycle progression (PubMed:25339763, PubMed:31291580, PubMed:31548682). Participates in the acquisition of tegument during virion morphogenesis in the nucleus. Phosphorylates the viral nuclear egress complex (NEC) subunits UL50 and UL53 (PubMed:25339763). Redistributes the host nuclear lamina by phosphorylating cellular Lamins-A/C. Plays a ro",ATP binding,Virion,inhibitor,DrugBank,drugbank_id
BE0002103,Laminin subunit alpha-5,target,O15230,LAMA5,Humans,"Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Plays a role in the regulation of skeletogenesis, through a mechanism that involves integrin-mediated signaling and PTK2B/PYK2 (PubMed:33242826)",cell adhesion mediator activity,"Secreted, extracellular space, extracellular matrix, basement membrane",,DrugBank,drugbank_id
BE0002104,Tetranectin,target,P05452,CLEC3B,Humans,Tetranectin binds to plasminogen and to isolated kringle 4. May be involved in the packaging of molecules destined for exocytosis. Plays a role in retinal function (PubMed:35331648),calcium ion binding,Secreted,,DrugBank,drugbank_id
BE0002105,"Keratin, type II cytoskeletal 8",target,P05787,KRT8,Humans,"Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle",scaffold protein binding,Cytoplasm,,DrugBank,drugbank_id
BE0002106,Laminin subunit beta-1,target,P07942,LAMB1,Humans,"Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Involved in the organization of the laminar architecture of cerebral cortex. It is probably required for the integrity of the basement membrane/glia limitans that serves as an anchor point for the endfeet of radial glial cells and as a physical barrier to migrating neur",enzyme binding,"Secreted, extracellular space, extracellular matrix, basement membrane",,DrugBank,drugbank_id
BE0002107,Laminin subunit gamma-1,target,P11047,LAMC1,Humans,"Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components",extracellular matrix structural constituent,"Secreted, extracellular space, extracellular matrix, basement membrane",,DrugBank,drugbank_id
BE0002108,Laminin subunit alpha-1,target,P25391,LAMA1,Humans,"Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components",extracellular matrix structural constituent,"Secreted, extracellular space, extracellular matrix, basement membrane",,DrugBank,drugbank_id
BE0002111,Laminin subunit alpha-3,target,Q16787,LAMA3,Humans,"Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components",signaling receptor binding,"Secreted, extracellular space, extracellular matrix, basement membrane",,DrugBank,drugbank_id
BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",target,O00408,PDE2A,Humans,"cGMP-activated cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (PubMed:15938621, PubMed:29392776, PubMed:9210593). Has a higher efficiency with cGMP compared to cAMP (PubMed:15938621). Plays a role in cell growth and migration (PubMed:24705027)","3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity",Cell membrane,,DrugBank,drugbank_id
BE0009964,Caspase-4,target,P49662,CASP4,Humans,"Inflammatory caspase that acts as the effector of the non-canonical inflammasome by mediating lipopolysaccharide (LPS)-induced pyroptosis (PubMed:25119034, PubMed:26375003, PubMed:32109412, PubMed:34671164, PubMed:37001519, PubMed:37993712, PubMed:37993714). Also indirectly activates the NLRP3 and NLRP6 inflammasomes (PubMed:23516580, PubMed:26375003, PubMed:32109412, PubMed:7797510). Acts as a thiol protease that cleaves a tetrapeptide after an Asp residue at position P1: catalyzes cleavage of ",CARD domain binding,"Cytoplasm, cytosol",activator,DrugBank,drugbank_id
BE0001826,Caspase-7,target,P55210,CASP7,Humans,"Thiol protease involved in different programmed cell death processes, such as apoptosis, pyroptosis or granzyme-mediated programmed cell death, by proteolytically cleaving target proteins (PubMed:11257230, PubMed:11257231, PubMed:11701129, PubMed:15314233, PubMed:16916640, PubMed:17646170, PubMed:18723680, PubMed:19581639, PubMed:8521391, PubMed:8567622, PubMed:8576161, PubMed:9070923). Has a marked preference for Asp-Glu-Val-Asp (DEVD) consensus sequences, with some plasticity for alternate non",aspartic-type endopeptidase activity,"Cytoplasm, cytosol",activator,DrugBank,drugbank_id
BE0001108,Hexokinase-1,target,P19367,HK1,Humans,"Catalyzes the phosphorylation of various hexoses, such as D-glucose, D-glucosamine, D-fructose, D-mannose and 2-deoxy-D-glucose, to hexose 6-phosphate (D-glucose 6-phosphate, D-glucosamine 6-phosphate, D-fructose 6-phosphate, D-mannose 6-phosphate and 2-deoxy-D-glucose 6-phosphate, respectively) (PubMed:1637300, PubMed:25316723, PubMed:27374331). Does not phosphorylate N-acetyl-D-glucosamine (PubMed:27374331). Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to ",ATP binding,Mitochondrion outer membrane,,DrugBank,drugbank_id
BE0002859,Interleukin-6 receptor subunit alpha,target,P08887,IL6R,Humans,"Part of the receptor for interleukin 6. Binds to IL6 with low affinity, but does not transduce a signal (PubMed:28265003). Signal activation necessitate an association with IL6ST. Activation leads to the regulation of the immune response, acute-phase reactions and hematopoiesis (PubMed:30995492, PubMed:31235509). The interaction with membrane-bound IL6R and IL6ST stimulates 'classic signaling', the restricted expression of the IL6R limits classic IL6 signaling to only a few tissues such as the l",ciliary neurotrophic factor binding,Cell membrane,inhibitor|antibody,DrugBank,drugbank_id
BE0010013,Interleukin-6 receptor subunit beta,target,P40189,IL6ST,Humans,"Signal-transducing molecule (PubMed:2261637). The receptor systems for IL6, LIF, OSM, CNTF, IL11, CTF1 and BSF3 can utilize IL6ST for initiating signal transmission. Binding of IL6 to IL6R induces IL6ST homodimerization and formation of a high-affinity receptor complex, which activates the intracellular JAK-MAPK and JAK-STAT3 signaling pathways (PubMed:19915009, PubMed:2261637, PubMed:23294003). That causes phosphorylation of IL6ST tyrosine residues which in turn activates STAT3 (PubMed:19915009",ciliary neurotrophic factor receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0003309,Parathyroid hormone,target,P01270,PTH,Humans,"Parathyroid hormone elevates calcium level by dissolving the salts in bone and preventing their renal excretion (PubMed:11604398, PubMed:35932760). Acts by binding to its receptor, PTH1R, activating G protein-coupled receptor signaling (PubMed:18375760, PubMed:35932760). Stimulates [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblastic cells (PubMed:21076856)",hormone activity,Secreted,modulator,DrugBank,drugbank_id
BE0004004,NS3 protease,target,Q91RS4,,Hepatitis C Virus,,metal ion binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0004753,Sodium/glucose cotransporter 2,target,P31639,SLC5A2,Humans,"Electrogenic Na(+)-coupled sugar symporter that actively transports D-glucose at the plasma membrane, with a Na(+) to sugar coupling ratio of 1:1 (PubMed:20980548, PubMed:28592437, PubMed:34880493, PubMed:37217492, PubMed:38057552). Transporter activity is driven by a transmembrane Na(+) electrochemical gradient set by the Na(+)/K(+) pump (PubMed:20980548, PubMed:28592437, PubMed:34880493). Unlike SLC5A1/SGLT1, requires the auxiliary protein PDZK1IP1/MAP17 for full transporter activity (PubMed:3",alpha-glucoside transmembrane transporter activity,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0003492,SLAM family member 7,target,Q9NQ25,SLAMF7,Humans,"Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Isoform 1 mediates NK cell activat",identical protein binding,Membrane,modulator,DrugBank,drugbank_id
BE0003494,Endoglin,target,P17813,ENG,Humans,"Vascular endothelium glycoprotein that plays an important role in the regulation of angiogenesis (PubMed:21737454, PubMed:23300529). Required for normal structure and integrity of adult vasculature (PubMed:7894484). Regulates the migration of vascular endothelial cells (PubMed:17540773). Required for normal extraembryonic angiogenesis and for embryonic heart development (By similarity). May regulate endothelial cell shape changes in response to blood flow, which drive vascular remodeling and est",activin binding,Cell membrane,,DrugBank,drugbank_id
BE0003495,Platelet-derived growth factor subunit B,target,P01127,PDGFB,Humans,"Growth factor that plays an essential role in the regulation of embryonic development, cell proliferation, cell migration, survival and chemotaxis. Potent mitogen for cells of mesenchymal origin (PubMed:26599395). Required for normal proliferation and recruitment of pericytes and vascular smooth muscle cells in the central nervous system, skin, lung, heart and placenta. Required for normal blood vessel development, and for normal development of kidney glomeruli. Plays an important role in wound ",chemoattractant activity,Secreted,,DrugBank,drugbank_id
BE0003496,B-lymphocyte antigen CD19,target,P15391,CD19,Humans,"Functions as a coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes (PubMed:29523808). Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens (PubMed:1373518, PubMed:16672701, PubMed:2463100). Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores (PubMed:12387743, PubMed:16672701, PubMed:9317126, PubMed:9382888). Is not requ",,Cell membrane,,DrugBank,drugbank_id
BE0001196,Tumor necrosis factor receptor superfamily member 5,target,P25942,CD40,Humans,"Receptor for TNFSF5/CD40LG (PubMed:31331973). Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion (By similarity)",antigen binding,Cell membrane,,DrugBank,drugbank_id
BE0004734,Interleukin-1 alpha,target,P01583,IL1A,Humans,"Cytokine constitutively present intracellularly in nearly all resting non-hematopoietic cells that plays an important role in inflammation and bridges the innate and adaptive immune systems (PubMed:26439902). After binding to its receptor IL1R1 together with its accessory protein IL1RAP, forms the high affinity interleukin-1 receptor complex (PubMed:17507369, PubMed:2950091). Signaling involves the recruitment of adapter molecules such as MYD88, IRAK1 or IRAK4 (PubMed:17507369). In turn, mediate",copper ion binding,Nucleus,binder,DrugBank,drugbank_id
BE0004735,Interleukin-1 receptor antagonist protein,target,P18510,IL1RN,Humans,Anti-inflammatory antagonist of interleukin-1 family of proinflammatory cytokines such as interleukin-1beta/IL1B and interleukin-1alpha/IL1A. Protects from immune dysregulation and uncontrolled systemic inflammation triggered by IL1 for a range of innate stimulatory agents such as pathogens,cytokine activity,Secreted,binder,DrugBank,drugbank_id
BE0008658,Corticotropin-releasing factor receptor 1,target,P34998,CRHR1,Humans,"G-protein coupled receptor for CRH (corticotropin-releasing factor) and UCN (urocortin). Has high affinity for CRH and UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels. Inhibits the activity of the calcium channel CACNA1H. Required for normal embryonic development of the adre",corticotrophin-releasing factor receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0001594,Gag-Pol polyprotein,target,P04585,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate HXB2),"Gag-Pol polyprotein
    Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi). Gag-Pol polyprotein may regulate its own translation, by the binding genomic RNA in the 5'-UTR. At low concentration, the polyprotein would promote transla",aspartic-type endopeptidase activity,Host cell membrane,modulator,DrugBank,drugbank_id
BE0000966,Collagenase 3,target,P45452,MMP13,Humans,"Plays a role in the degradation of extracellular matrix proteins including fibrillar collagen, fibronectin, TNC and ACAN. Cleaves triple helical collagens, including type I, type II and type III collagen, but has the highest activity with soluble type II collagen. Can also degrade collagen type IV, type XIV and type X. May also function by activating or degrading key regulatory proteins, such as TGFB1 and CCN2. Plays a role in wound healing, tissue remodeling, cartilage degradation, bone develop",calcium ion binding,"Secreted, extracellular space, extracellular matrix",,DrugBank,drugbank_id
BE0003090,Focal adhesion kinase 1,target,Q05397,PTK2,Humans,"Non-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuron",actin binding,"Cell junction, focal adhesion",,DrugBank,drugbank_id
BE0010246,Platelet-derived growth factor subunit A,target,P04085,PDGFA,Humans,"Growth factor that plays an essential role in the regulation of embryonic development, cell proliferation, cell migration, survival and chemotaxis. Potent mitogen for cells of mesenchymal origin. Required for normal lung alveolar septum formation during embryogenesis, normal development of the gastrointestinal tract, normal development of Leydig cells and spermatogenesis. Required for normal oligodendrocyte development and normal myelination in the spinal cord and cerebellum. Plays an important ",collagen binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0010102,Vascular endothelial growth factor D,target,O43915,VEGFD,Humans,"Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors",chemoattractant activity,Secreted,modulator,DrugBank,drugbank_id
BE0010101,Vascular endothelial growth factor C,target,P49767,VEGFC,Humans,"Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates KDR/VEGFR2 and FLT4/VEGFR3 receptors",chemoattractant activity,Secreted,modulator,DrugBank,drugbank_id
BE0004736,Vascular endothelial growth factor B,target,P49765,VEGFB,Humans,Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis,chemoattractant activity,Secreted,modulator,DrugBank,drugbank_id
BE0009757,Sodium/hydrogen exchanger 3,target,P48764,SLC9A3,Humans,"Plasma membrane Na(+)/H(+) antiporter (PubMed:18829453, PubMed:26358773, PubMed:35613257). Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry, playing a key role in salt and fluid absorption and pH homeostasis (By similarity). Major apical Na(+)/H(+) exchanger in kidney and intestine playing an important role in renal and intestine Na(+) absorption and blood pressure regulation (PubMed:24622516, PubMed:26358773)",identical protein binding,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0003507,Prolyl endopeptidase FAP,target,Q12884,FAP,Humans,"Cell surface glycoprotein serine protease that participates in extracellular matrix degradation and involved in many cellular processes including tissue remodeling, fibrosis, wound healing, inflammation and tumor growth. Both plasma membrane and soluble forms exhibit post-proline cleaving endopeptidase activity, with a marked preference for Ala/Ser-Gly-Pro-Ser/Asn/Ala consensus sequences, on substrate such as alpha-2-antiplasmin SERPINF2 and SPRY2 (PubMed:14751930, PubMed:16223769, PubMed:164102",dipeptidyl-peptidase activity,Cell surface,,DrugBank,drugbank_id
BE0001113,CD44 antigen,target,P16070,CD44,Humans,"Cell-surface receptor that plays a role in cell-cell interactions, cell adhesion and migration, helping them to sense and respond to changes in the tissue microenvironment (PubMed:16541107, PubMed:19703720, PubMed:22726066). Participates thereby in a wide variety of cellular functions including the activation, recirculation and homing of T-lymphocytes, hematopoiesis, inflammation and response to bacterial infection (PubMed:7528188). Engages, through its ectodomain, extracellular matrix component",collagen binding,Cell membrane,,DrugBank,drugbank_id
BE0003501,Mucin-1,target,P15941,MUC1,Humans,The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack,p53 binding,Apical cell membrane,,DrugBank,drugbank_id
BE0001341,Tyrosine-protein kinase ITK/TSK,target,Q08881,ITK,Humans,"Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of ITK to the cell membrane, in the vicinity of the stimulated TCR receptor, where it is phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation and full activat",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004714,SH2B adapter protein 3,target,Q9UQQ2,SH2B3,Humans,"Links T-cell receptor activation signal to phospholipase C-gamma-1, GRB2 and phosphatidylinositol 3-kinase",protein tyrosine kinase binding,,inhibitor,DrugBank,drugbank_id
BE0009588,Protein kinase C gamma type,target,P05129,PRKCG,Humans,"Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003433,Tumor necrosis factor receptor superfamily member 10B,target,O14763,TNFRSF10B,Humans,Receptor for the cytotoxic ligand TNFSF10/TRAIL (PubMed:10549288). The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B. Essential for ER stress-induced apoptosis,signaling receptor activity,Membrane,,DrugBank,drugbank_id
BE0002446,Epithelial cell adhesion molecule,target,P16422,EPCAM,Humans,"May act as a physical homophilic interaction molecule between intestinal epithelial cells (IECs) and intraepithelial lymphocytes (IELs) at the mucosal epithelium for providing immunological barrier as a first line of defense against mucosal infection. Plays a role in embryonic stem cells proliferation and differentiation. Up-regulates the expression of FABP5, MYC and cyclins A and E",cadherin binding involved in cell-cell adhesion,Lateral cell membrane,ligand,DrugBank,drugbank_id
BE0009560,"Ferredoxin--NADP reductase, apicoplast",enzyme,C6KT68,FNR,Plasmodium falciparum (isolate 3D7),May play a role in the terminal step of the DOXP/MEP pathway for isoprenoid precursor biosynthesis.,electron transfer activity,Plastid,substrate,DrugBank,drugbank_id
BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,target,P36507,MAP2K2,Humans,Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126),ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004745,Mitogen-activated protein kinase kinase kinase 2,target,Q9Y2U5,MAP3K2,Humans,Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004384,Calcium/calmodulin-dependent protein kinase type II subunit gamma,target,Q13555,CAMK2G,Humans,"Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in sarcoplasmic reticulum Ca(2+) transport in skeletal muscle and may function in dendritic spine and synapse formation and neuronal plasticity (PubMed:16690701). In slow-twitch muscles, is involved in regulation of sarcoplasmic reticulum (SR) Ca(2+) transport and in fast-twitch muscle participates in the control of Ca(2+) release from the SR through ph",ATP binding,Sarcoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009385,Tyrosine-protein kinase Tec,target,P42680,TEC,Humans,"Non-receptor tyrosine kinase that contributes to signaling from many receptors and participates as a signal transducer in multiple downstream pathways, including regulation of the actin cytoskeleton. Plays a redundant role to ITK in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. Required for TCR-dependent IL2 gene induction. Phosphorylates DOK1, one CD28-specific substrate, and contributes",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004041,STE20-like serine/threonine-protein kinase,target,Q9H2G2,SLK,Humans,Mediates apoptosis and actin stress fiber dissolution,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004715,Potassium voltage-gated channel subfamily A member 2,target,P16389,KCNA2,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and the central nervous system, but also in the cardiovascular system. Prevents aberrant action potential firing and regulates neuronal output. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage differen",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004502,Potassium voltage-gated channel subfamily A member 4,target,P22459,KCNA4,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane (PubMed:19912772, PubMed:8495559). Can form functional homotetrameric channels and heterotetrameric channels that contain variable proportions o",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004718,Potassium voltage-gated channel subfamily A member 6,target,P17658,KCNA6,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient (PubMed:14575698, PubMed:2347305). The channel alternates between opened and closed conformations in response to the voltage difference across the membrane (PubMed:14575698, PubMed:2347305). Can form functional homotetrameric channels and heterotetrameric channels t",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004719,Potassium voltage-gated channel subfamily A member 7,target,Q96RP8,KCNA7,Humans,"Mediates the voltage-dependent potassium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a potassium-selective channel through which potassium ions may pass in accordance with their electrochemical gradient (By similarity)",delayed rectifier potassium channel activity,Membrane,antagonist,DrugBank,drugbank_id
BE0004720,Potassium voltage-gated channel subfamily A member 10,target,Q16322,KCNA10,Humans,"Voltage-gated potassium ion channel that mediates K(+) permeability of excitable membranes. When opened in response to the voltage difference across the membrane, KCNA10 channel selectively allows the flow of potassium ions across the membrane down their electrochemical gradient",delayed rectifier potassium channel activity,Membrane,antagonist,DrugBank,drugbank_id
BE0004721,Potassium voltage-gated channel subfamily B member 1,target,Q14721,KCNB1,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain, but also in the pancreas and cardiovascular system. Contributes to the regulation of the action potential (AP) repolarization, duration and frequency of repetitive AP firing in neurons, muscle cells and endocrine cells and plays a role in homeostatic attenuation of electrical excitability throughout the brain (PubMed:23161216). Plays also a role in the regulation of exo",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004722,Potassium voltage-gated channel subfamily B member 2,target,Q92953,KCNB2,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and smooth muscle cells. Channels open or close in response to the voltage difference across the membrane, letting potassium ions pass in accordance with their electrochemical gradient. Homotetrameric channels mediate a delayed-rectifier voltage-dependent outward potassium current that display rapid activation and slow inactivation in response to membrane depolarization.",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004723,Voltage-gated potassium channel KCNC1,target,P48547,KCNC1,Humans,"Voltage-gated potassium channel that opens in response to the voltage difference across the membrane and through which potassium ions pass in accordance with their electrochemical gradient (PubMed:25401298, PubMed:35840580). The mechanism is time-dependent and inactivation is slow (By similarity). Plays an important role in the rapid repolarization of fast-firing brain neurons (By similarity). Can form functional homotetrameric channels and heterotetrameric channels that contain variable proport",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004724,Voltage-gated potassium channel KCNC2,target,Q96PR1,KCNC2,Humans,"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain. Contributes to the regulation of the fast action potential repolarization and in sustained high-frequency firing in neurons of the central nervous system. Homotetramer channels mediate delayed-rectifier voltage-dependent potassium currents that activate rapidly at high-threshold voltages and inactivate slowly. Forms tetrameric channels through which potassium ions pass ",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004725,Voltage-gated potassium channel KCNC3,target,Q14003,KCNC3,Humans,"Voltage-gated potassium channel that plays an important role in the rapid repolarization of fast-firing brain neurons. The channel opens in response to the voltage difference across the membrane, forming a potassium-selective channel through which potassium ions pass in accordance with their electrochemical gradient. The channel displays rapid activation and inactivation kinetics (PubMed:10712820, PubMed:16501573, PubMed:19953606, PubMed:21479265, PubMed:22289912, PubMed:23734863, PubMed:2575679",delayed rectifier potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0004726,A-type voltage-gated potassium channel KCND1,target,Q9NSA2,KCND1,Humans,"A-type voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes in the brain (PubMed:15454437). Mediates A-type current I(SA) in suprachiasmatic nucleus (SCN) neurons. Exhibits a low-threshold A-type current with a hyperpolarized steady-state inactivation midpoint and the recovery process was steeply voltage-dependent, with recovery being markedly faster at more negative potentials. May regulates repetitive firing rates in the suprachiasmatic nucleus",A-type (transient outward) potassium channel activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0002222,Substance-K receptor,target,P21452,TACR2,Humans,This is a receptor for the tachykinin neuropeptide substance K (neurokinin A). It is associated with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinity of this receptor to tachykinins is: substance K > neuromedin-K > substance P,substance K receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0003529,Somatostatin receptor type 3,target,P32745,SSTR3,Humans,Receptor for somatostatin-14 and -28. This receptor is coupled via pertussis toxin sensitive G proteins to inhibition of adenylyl cyclase,G protein-coupled receptor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000452,Somatostatin receptor type 1,target,P30872,SSTR1,Humans,Receptor for somatostatin with higher affinity for somatostatin-14 than -28. This receptor is coupled via pertussis toxin sensitive G proteins to inhibition of adenylyl cyclase. In addition it stimulates phosphotyrosine phosphatase and Na(+)/H(+) exchanger via pertussis toxin insensitive G proteins,neuropeptide binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003417,Cathepsin K,target,P43235,CTSK,Humans,Thiol protease involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an important role in extracellular matrix degradation. Involved in the release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen (PubMed:11082042),collagen binding,Lysosome,inhibitor,DrugBank,drugbank_id
BE0010325,T-cell-specific surface glycoprotein CD28,target,P10747,CD28,Humans,"Receptor that plays a role in T-cell activation, proliferation, survival and the maintenance of immune homeostasis (PubMed:1650475, PubMed:7568038). Functions not only as an amplifier of TCR signals but delivers unique signals that control intracellular biochemical events that alter the gene expression program of T-cells (PubMed:24665965). Stimulation upon engagement of its cognate ligands CD80 or CD86 increases proliferation and expression of various cytokines in particular IL2 production in bo",coreceptor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0010525,C-X-C motif chemokine 2,target,P19875,CXCL2,Humans,"Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity",chemokine activity,Secreted,modulator,DrugBank,drugbank_id
BE0001102,Prostatic acid phosphatase,target,P15309,ACP3,Humans,"A non-specific tyrosine phosphatase that dephosphorylates a diverse number of substrates under acidic conditions (pH 4-6) including alkyl, aryl, and acyl orthophosphate monoesters and phosphorylated proteins (PubMed:10506173, PubMed:15280042, PubMed:20498373, PubMed:9584846). Has lipid phosphatase activity and inactivates lysophosphatidic acid in seminal plasma (PubMed:10506173, PubMed:15280042)",5'-nucleotidase activity,Secreted,other,DrugBank,drugbank_id
BE0003531,Chymotrypsinogen B,target,P17538,CTRB1,Humans,,serine-type endopeptidase activity,"Secreted, extracellular space",,DrugBank,drugbank_id
BE0001197,Steryl-sulfatase,enzyme,P08842,STS,Humans,"Catalyzes the conversion of sulfated steroid precursors, such as dehydroepiandrosterone sulfate (DHEA-S) and estrone sulfate to the free steroid",arylsulfatase activity,"Cytoplasmic vesicle, secretory vesicle, microneme membrane",inhibitor,DrugBank,drugbank_id
BE0004824,Tyrosine,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0009719,Glucocorticoid binding proteins,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0008953,COUP transcription factor 1,target,P10589,NR2F1,Humans,"Coup (chicken ovalbumin upstream promoter) transcription factor binds to the ovalbumin promoter and, in conjunction with another protein (S300-II) stimulates initiation of transcription. Binds to both direct repeats and palindromes of the 5'-AGGTCA-3' motif. Represses transcriptional activity of LHCG",DNA-binding transcription factor activity,Nucleus,,DrugBank,drugbank_id
BE0000845,Betaine--homocysteine S-methyltransferase 1,target,Q93088,BHMT,Humans,"Involved in the regulation of homocysteine metabolism. Converts betaine and homocysteine to dimethylglycine and methionine, respectively. This reaction is also required for the irreversible oxidation of choline",betaine-homocysteine S-methyltransferase activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0002330,"Proline dehydrogenase 1, mitochondrial",enzyme,O43272,PRODH,Humans,Converts proline to delta-1-pyrroline-5-carboxylate,FAD binding,Mitochondrion matrix,inhibitor,DrugBank,drugbank_id
BE0004777,Sodium- and chloride-dependent betaine transporter,transporter,P48065,SLC6A12,Humans,"Transporter that mediates cellular uptake of betaine and GABA in a sodium- and chloride-dependent process (PubMed:7589472). May have a role in regulation of GABAergic transmission in the brain through the reuptake of GABA into presynaptic terminals, as well as in osmotic regulation. Probably also involved in renal and hepatic osmotic regulation (By similarity)",amino acid transmembrane transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0004020,Very low-density lipoprotein receptor,carrier,P98155,VLDLR,Humans,"Multifunctional cell surface receptor that binds VLDL and transports it into cells by endocytosis and therefore plays an important role in energy metabolism. Also binds to a wide range of other molecules including Reelin/RELN or apolipoprotein E/APOE-containing ligands as well as clusterin/CLU (PubMed:24381170, PubMed:30873003). In the off-state of the pathway, forms homooligomers or heterooligomers with LRP8 (PubMed:30873003). Upon binding to ligands, homooligomers are rearranged to higher orde",apolipoprotein binding,Cell membrane,binder,DrugBank,drugbank_id
BE0010226,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,carrier,Q8IV16,GPIHBP1,Humans,"Mediates the transport of lipoprotein lipase LPL from the basolateral to the apical surface of endothelial cells in capillaries (By similarity). Anchors LPL on the surface of endothelial cells in the lumen of blood capillaries (By similarity). Protects LPL against loss of activity, and against ANGPTL4-mediated unfolding (PubMed:27929370, PubMed:29899144). Thereby, plays an important role in lipolytic processing of chylomicrons by LPL, triglyceride metabolism and lipid homeostasis (PubMed:1930457",chylomicron binding,Apical cell membrane,binder,DrugBank,drugbank_id
BE0009007,Prohibitin-2,target,Q99623,PHB2,Humans,"Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors and sex steroid hormones in the nucleus",amide binding,Mitochondrion inner membrane,modulator,DrugBank,drugbank_id
BE0004813,Arsenic,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0004802,Cadmium,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0004814,Mercury,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0004453,"Superoxide dismutase [Mn], mitochondrial",enzyme,P04179,SOD2,Humans,Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems,DNA binding,Mitochondrion matrix,activator,DrugBank,drugbank_id
BE0008685,Natural resistance-associated macrophage protein 2,transporter,P49281,SLC11A2,Humans,"Proton-coupled metal ion symporter operating with a proton to metal ion stoichiometry of 1:1 (PubMed:17109629, PubMed:17293870, PubMed:22736759, PubMed:25326704, PubMed:25491917). Selectively transports various divalent metal cations, in decreasing affinity: Cd(2+) > Fe(2+) > Co(2+), Mn(2+) >> Zn(2+), Ni(2+), VO(2+) (PubMed:17109629, PubMed:17293870, PubMed:22736759, PubMed:25326704, PubMed:25491917). Essential for maintenance of iron homeostasis by modulating intestinal absorption of dietary Fe",cadmium ion binding,Early endosome membrane,substrate,DrugBank,drugbank_id
BE0009682,Melanocortin receptor 4,target,P32245,MC4R,Humans,"Hormone receptor that acts as a key component of the leptin-melanocortin pathway at the intersection of homeostatic maintenance of energetic state (PubMed:32327598, PubMed:33858992). Plays a role in regulating food intake: activation by a stimulating hormone such as anorexigenic alpha-melanocyte stimulating hormone (alpha-MSH) inhibits appetite, whereas binding to a natural antagonist like Agouti-related protein/AGRP promotes appetite. G-protein-coupled receptor that activates conventional Galph",melanocortin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0004855,Gag-Pol polyprotein,target,Q7ZJM1,pol,Human immunodeficiency virus 1,,DNA binding,,inhibitor,DrugBank,drugbank_id
BE0001389,Aromatic-amino-acid aminotransferase,target,P95468,tyrB,Paracoccus denitrificans,Shows activities toward both dicarboxylic and aromatic substrates.,identical protein binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0001150,Stromal cell-derived factor 1,target,P48061,CXCL12,Humans,"Chemoattractant active on T-lymphocytes and monocytes but not neutrophils. Activates the C-X-C chemokine receptor CXCR4 to induce a rapid and transient rise in the level of intracellular calcium ions and chemotaxis. SDF-1-beta(3-72) and SDF-1-alpha(3-67) show a reduced chemotactic activity. Binding to cell surface proteoglycans seems to inhibit formation of SDF-1-alpha(3-67) and thus to preserve activity on local sites. Also binds to atypical chemokine receptor ACKR3, which activates the beta-ar",chemokine activity,Secreted,binder,DrugBank,drugbank_id
BE0004687,A disintegrin and metalloproteinase with thrombospondin motifs 4,enzyme,O75173,ADAMTS4,Humans,"Cleaves aggrecan, a cartilage proteoglycan, at the '392-Glu-|-Ala-393' site and may be involved in its turnover (PubMed:10356395, PubMed:10827174). Also cleaves COMP (PubMed:39672391). May play an important role in the destruction of aggrecan in arthritic diseases. Could be a critical factor in the exacerbation of neurodegeneration in Alzheimer disease",metalloendopeptidase activity,"Secreted, extracellular space, extracellular matrix",inhibitor,DrugBank,drugbank_id
BE0003785,Arylsulfate sulfotransferase AssT,target,A0A0H2Z368,assT,Escherichia coli O1:K1 / APEC,Catalyzes the transfer of sulfuryl groups between phenolic compounds.,aryl sulfotransferase activity,Periplasm,,DrugBank,drugbank_id
BE0003798,Poly [ADP-ribose] polymerase 2,target,Q9UGN5,PARP2,Humans,"Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair (PubMed:10364231, PubMed:25043379, PubMed:27471034, PubMed:30104678, PubMed:32028527, PubMed:32939087, PubMed:34108479, PubMed:34486521, PubMed:34874266). Mediates glutamate, aspartate or serine ADP-ribosylation of proteins: the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of target residues and further ADP-ribosyl groups are transferred to the 2'-position",chromatin binding,Nucleus,,DrugBank,drugbank_id
BE0003814,ADP-ribosylation factor 1,target,P84077,ARF1,Humans,"Small GTPase involved in protein trafficking between different compartments (PubMed:8253837). Modulates vesicle budding and uncoating within the Golgi complex (PubMed:8253837). In its GTP-bound form, triggers the recruitment of coatomer proteins to the Golgi membrane (PubMed:8253837). The hydrolysis of ARF1-bound GTP, which is mediated by ARFGAPs proteins, is required for dissociation of coat proteins from Golgi membranes and vesicles (PubMed:8253837). The GTP-bound form interacts with PICK1 to ",GTP binding,Golgi apparatus membrane,,DrugBank,drugbank_id
BE0003824,Large ribosomal subunit protein uL13,target,P40429,RPL13A,Humans,"Associated with ribosomes but is not required for canonical ribosome function and has extra-ribosomal functions (PubMed:14567916, PubMed:17218275, PubMed:23636399, PubMed:32669547). Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes (PubMed:23071094). Upon interferon-gamma activation and subsequent phosphorylation dissociates from the ribosome and assembl",mRNA binding,Cytoplasm,,DrugBank,drugbank_id
BE0003825,Large ribosomal subunit protein uL14,target,P62829,RPL23,Humans,Component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell,large ribosomal subunit rRNA binding,Cytoplasm,,DrugBank,drugbank_id
BE0003826,Large ribosomal subunit protein eL15,target,P61313,RPL15,Humans,Component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell,cadherin binding,Cytoplasm,,DrugBank,drugbank_id
BE0003827,Large ribosomal subunit protein eL19,target,P84098,RPL19,Humans,"Component of the large ribosomal subunit (PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:32669547)",RNA binding,Cytoplasm,,DrugBank,drugbank_id
BE0003828,Large ribosomal subunit protein uL23,target,P62750,RPL23A,Humans,"Component of the large ribosomal subunit (PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:32669547). Binds a specific region on the 26S rRNA (PubMed:23636399, PubMed:32669547). May promote p53/TP53 degradation possibly through the stimulation of MDM2-mediated TP53 polyubiquitination (PubMed:26203195)",cadherin binding,Cytoplasm,,DrugBank,drugbank_id
BE0003829,Probable ribosome biogenesis protein RLP24,target,Q9UHA3,RSL24D1,Humans,Involved in the biogenesis of the 60S ribosomal subunit. Ensures the docking of GTPBP4/NOG1 to pre-60S particles (By similarity),structural constituent of ribosome,"Nucleus, nucleolus",,DrugBank,drugbank_id
BE0003830,Ribosomal protein uL24-like,target,Q9UNX3,RPL26L1,Humans,,RNA binding,,,DrugBank,drugbank_id
BE0003831,Large ribosomal subunit protein uL2,target,P62917,RPL8,Humans,Component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell,RNA binding,Cytoplasm,,DrugBank,drugbank_id
BE0003832,Large ribosomal subunit protein eL37,target,P61927,RPL37,Humans,"Component of the large ribosomal subunit (PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:32669547)",MDM2/MDM4 family protein binding,Cytoplasm,,DrugBank,drugbank_id
BE0003834,Large ribosomal subunit protein uL5,target,P62913,RPL11,Humans,"Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:19191325, PubMed:32669547). The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules (PubMed:19191325, PubMed:32669547). The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds",5S rRNA binding,"Nucleus, nucleolus",,DrugBank,drugbank_id
BE0003835,NHP2-like protein 1,target,P55769,SNU13,Humans,"Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). Involved in pre-mRNA splicing as component of th",ATPase binding,Nucleus,,DrugBank,drugbank_id
BE0002135,Procathepsin L,target,P07711,CTSL,Humans,"Thiol protease important for the overall degradation of proteins in lysosomes (Probable). Plays a critical for normal cellular functions such as general protein turnover, antigen processing and bone remodeling. Involved in the solubilization of cross-linked TG/thyroglobulin and in the subsequent release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen (By similarity). In neuroendocrine chromaffin cells secretory vesicles, catalyzes the pr",collagen binding,Lysosome,,DrugBank,drugbank_id
BE0003963,CHRNA7-FAM7A fusion protein,target,Q494W8,CHRFAM7A,Humans,,acetylcholine-gated monoatomic cation-selective channel activity,Membrane,,DrugBank,drugbank_id
BE0003007,"Endo-1,4-beta-xylanase Y",target,P51584,xynY,Clostridium thermocellum,,"endo-1,4-beta-xylanase activity",Cytoplasmic,,DrugBank,drugbank_id
BE0004078,"Endo-1,4-beta-xylanase Z",target,P10478,xynZ,Clostridium thermocellum (strain ATCC 27405 / DSM 1237),,carbohydrate binding,Cytoplasmic,,DrugBank,drugbank_id
BE0004079,Est1e,target,D2YW37,,Butyrivibrio proteoclasticus,,,,,DrugBank,drugbank_id
BE0003784,O-methyltransferase,target,Q55813,,Synechocystis sp. (strain PCC 6803 / Kazusa),,metal ion binding,,,DrugBank,drugbank_id
BE0002444,Squalene synthase,target,P37268,FDFT1,Humans,"Catalyzes the condensation of 2 farnesyl pyrophosphate (FPP) moieties to form squalene. Proceeds in two distinct steps. In the first half-reaction, two molecules of FPP react to form the stable presqualene diphosphate intermediate (PSQPP), with concomitant release of a proton and a molecule of inorganic diphosphate. In the second half-reaction, PSQPP undergoes heterolysis, isomerization, and reduction with NADPH or NADH to form squalene. It is the first committed enzyme of the sterol biosynthesi",metal ion binding,Endoplasmic reticulum membrane,modulator,DrugBank,drugbank_id
BE0004071,GTPase KRas,target,P01116,KRAS,Humans,"Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed:20949621, PubMed:39809765). Plays an important role in the regulation of cell proliferation (PubMed:22711838, PubMed:23698361). Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner (PubMed:24623306)",G protein activity,Cell membrane,,DrugBank,drugbank_id
BE0004091,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,Q8EBR3,ispF,Shewanella oneidensis (strain MR-1),"Involved in the biosynthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), two major building blocks of isoprenoid compounds. Catalyzes the conversion of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) to 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP) with a corresponding release of cytidine 5-monophosphate (CMP).","2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity",,,DrugBank,drugbank_id
BE0004092,Lantibiotic nisin-Z,target,P29559,nisZ,Lactococcus lactis subsp. lactis,"Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.",signaling receptor binding,,,DrugBank,drugbank_id
BE0004072,Geranylgeranyl transferase type-2 subunit alpha,target,Q92696,RABGGTA,Humans,"Catalyzes the transfer of a geranylgeranyl moiety from geranylgeranyl diphosphate to both cysteines of Rab proteins with the C-terminal sequence -XXCC, -XCXC and -CCXX, such as RAB1A, RAB3A, RAB5A and RAB7A",Rab geranylgeranyltransferase activity,,,DrugBank,drugbank_id
BE0004073,Geranylgeranyl transferase type-2 subunit beta,target,P53611,RABGGTB,Humans,"Catalyzes the transfer of a geranylgeranyl moiety from geranylgeranyl diphosphate to both cysteines of Rab proteins with the C-terminal sequence -XXCC, -XCXC and -CCXX, such as RAB1A, RAB3A, RAB5A and RAB7A",Rab geranylgeranyltransferase activity,,,DrugBank,drugbank_id
BE0001142,Geranylgeranyl transferase type-1 subunit beta,target,P53609,PGGT1B,Humans,"Catalyzes the transfer of a geranyl-geranyl moiety from geranyl-geranyl pyrophosphate to a cysteine at the fourth position from the C-terminus of proteins having the C-terminal sequence Cys-aliphatic-aliphatic-X. Known substrates include RAC1, RAC2, RAP1A and RAP1B",CAAX-protein geranylgeranyltransferase activity,,,DrugBank,drugbank_id
BE0000706,"High affinity 3',5'-cyclic-AMP phosphodiesterase 7A",target,Q13946,PDE7A,Humans,"Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes (PubMed:19350606, PubMed:8389765, PubMed:9195912). May have a role in muscle signal transduction (PubMed:9195912)","3',5'-cyclic-AMP phosphodiesterase activity","Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0003134,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",target,O76083,PDE9A,Humans,"Specifically hydrolyzes the second messenger cGMP, which is a key regulator of many important physiological processes. Highly specific: compared to other members of the cyclic nucleotide phosphodiesterase family, has the highest affinity and selectivity for cGMP (PubMed:18757755, PubMed:21483814, PubMed:9624146). Specifically regulates natriuretic-peptide-dependent cGMP signaling in heart, acting as a regulator of cardiac hypertrophy in myocytes and muscle. Does not regulate nitric oxide-depende","3',5'-cyclic-AMP phosphodiesterase activity","Cell projection, ruffle membrane",,DrugBank,drugbank_id
BE0003717,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",target,O60658,PDE8A,Humans,"Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes (PubMed:18983167). May be involved in maintaining basal levels of the cyclic nucleotide and/or in the cAMP regulation of germ cell development (PubMed:18983167). Binding to RAF1 reduces RAF1 'Ser-259' inhibitory-phosphorylation and stimulates RAF1-dependent EGF-activated ERK-signaling (PubMed:23509299). Protects against cell death induced by hydrogen peroxide and staurosporine (PubMed:2350929","3',5'-cyclic-AMP phosphodiesterase activity",,,DrugBank,drugbank_id
BE0003745,Serine/threonine-protein kinase PLK1,target,P53350,PLK1,Humans,"Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis (PubMed:11202906, PubMed:12207013, PubMed:12447691, PubMed:12524548, PubMed:12738781, PubMed:12852856, PubMed:12939256, PubMed:14532005, PubMe",anaphase-promoting complex binding,Nucleus,,DrugBank,drugbank_id
BE0000955,Phosphatidylinositol 3-kinase regulatory subunit alpha,target,P27986,PIK3R1,Humans,"Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed:17626883, PubMed:19805105, PubMed:75",1-phosphatidylinositol-3-kinase regulator activity,,,DrugBank,drugbank_id
BE0004191,Rho-associated protein kinase 2,target,O75116,ROCK2,Humans,"Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0004193,Transcriptional regulator,target,Q8NMG3,,Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / LMG 3730 / NCIMB 10025),,DNA binding,Cytoplasmic,,DrugBank,drugbank_id
BE0004322,Leucyl/phenylalanyl-tRNA--protein transferase,target,P0A8P1,aat,Escherichia coli (strain K12),"Functions in the N-end rule pathway of protein degradation where it conjugates Leu, Phe and, less efficiently, Met from aminoacyl-tRNAs to the N-termini of proteins containing an N-terminal arginine or lysine.",aminoacyltransferase activity,Cytoplasm,,DrugBank,drugbank_id
BE0004080,Neocarzinostatin,target,P0A3R9,ncsA,Streptomyces carzinostaticus,NCS has antibiotic activity (for Gram-positive bacteria) and antitumor activity (for certain mouse tumors). NCS binds non-covalently to a chromophore which is the cytotoxic and mutagenic component of the antibiotic. The chromophore binds to DNA as a weak intercalator and causes single- and double-strand breaks.,DNA binding,Cytoplasmic,,DrugBank,drugbank_id
BE0001126,Protein c-Fos,target,P01100,FOS,Humans,"Nuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor. In the heterodimer, FOS and JUN/AP-1 basic regions each seems to interact with symmetrical DNA half sites. On TGF-beta activation, forms a multimeric SMAD3/SMAD4/JUN/FOS complex at the AP1/SMAD-binding site to regulate TGF-beta-mediated signaling. Has a critical function in regulating the development of cells destined to form and maintain the skeleton. It is thought to have an imp","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,inducer,DrugBank,drugbank_id
BE0004750,ATP-binding cassette sub-family G member 5,transporter,Q9H222,ABCG5,Humans,"ABCG5 and ABCG8 form an obligate heterodimer that mediates Mg(2+)- and ATP-dependent sterol transport across the cell membrane (PubMed:27144356). Plays an essential role in the selective transport of dietary plant sterols and cholesterol in and out of the enterocytes and in the selective sterol excretion by the liver into bile (PubMed:11099417, PubMed:11138003, PubMed:15054092, PubMed:27144356). Required for normal sterol homeostasis (PubMed:11099417, PubMed:11138003, PubMed:15054092). The heter",ABC-type transporter activity,Cell membrane,downregulator,DrugBank,drugbank_id
BE0004751,ATP-binding cassette sub-family G member 8,transporter,Q9H221,ABCG8,Humans,"ABCG5 and ABCG8 form an obligate heterodimer that mediates Mg(2+)- and ATP-dependent sterol transport across the cell membrane. Plays an essential role in the selective transport of the dietary cholesterol in and out of the enterocytes and in the selective sterol excretion by the liver into bile (PubMed:11099417, PubMed:11452359, PubMed:15054092, PubMed:27144356). Required for normal sterol homeostasis (PubMed:11099417, PubMed:11452359, PubMed:15054092). The heterodimer with ABCG5 has ATPase act",ABC-type transporter activity,Cell membrane,downregulator,DrugBank,drugbank_id
BE0004768,Acid-sensing ion channel 3,target,Q9UHC3,ASIC3,Humans,"Forms pH-gated heterotrimeric sodium channels that act as postsynaptic excitatory receptors in the nervous system (PubMed:10842183, PubMed:11587714, PubMed:9744806, PubMed:9886053). Upon extracellular acidification, these channels generate a biphasic current with a fast inactivating and a slow sustained phase (PubMed:10842183, PubMed:9744806, PubMed:9886053). ASIC3 is more sensitive to protons and gates between closed, open, and desensitized states faster than other ASICs (By similarity). Displa",enterobactin transmembrane transporter activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0004769,Y+L amino acid transporter 1,transporter,Q9UM01,SLC7A7,Humans,"Heterodimer with SLC3A2, that functions as an antiporter which operates as an efflux route by exporting cationic amino acids from inside the cells in exchange with neutral amino acids plus sodium ions and may participate in nitric oxide synthesis via the transport of L-arginine (PubMed:10080182, PubMed:10655553, PubMed:14603368, PubMed:15756301, PubMed:15776427, PubMed:17329401, PubMed:9829974, PubMed:9878049). Also mediates arginine transport in non-polarized cells, such as monocytes, and is es",basic amino acid transmembrane transporter activity,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0001316,Tyrosine-protein kinase SYK,target,P43405,SYK,Humans,"Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR). Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development (PubMed:12387735, PubMed:33782605). Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 doma",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0012549,Heat shock 70 kDa protein 1B,target,P0DMV9,HSPA1B,Humans,"Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0010433,Heat shock 70 kDa protein 1A,target,P0DMV8,HSPA1A,Humans,"Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000359,ALK tyrosine kinase receptor,target,Q9UM73,ALK,Humans,"Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system (PubMed:11121404, PubMed:11387242, PubMed:16317043, PubMed:17274988, PubMed:30061385, PubMed:34646012, PubMed:34819673). Also acts as a key thinness protein involved in the resistance to weight gain: in hypothalamic neurons, controls energy expenditure acting as a nega",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009534,Proto-oncogene tyrosine-protein kinase ROS,target,P08922,ROS1,Humans,"Receptor tyrosine kinase (RTK) that plays a role in epithelial cell differentiation and regionalization of the proximal epididymal epithelium. NELL2 is an endogenous ligand for ROS1. Upon endogenous stimulation by NELL2, ROS1 activates the intracellular signaling pathway and triggers epididymal epithelial differentiation and subsequent sperm maturation (By similarity). May activate several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009490,Macrophage-stimulating protein receptor,target,Q04912,MST1R,Humans,"Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to MST1 ligand. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces autophosphorylation of RON on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1 or the adapter GAB1. Recruitment o",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0002432,Sphingosine 1-phosphate receptor 5,target,Q9H228,S1PR5,Humans,Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P). S1P is a bioactive lysophospholipid that elicits diverse physiological effect on most types of cells and tissues. Is coupled to both the G(i/0)alpha and G(12) subclass of heteromeric G-proteins (By similarity). May play a regulatory role in the transformation of radial glial cells into astrocytes and may affect proliferative activity of these cells,G protein-coupled receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0008652,Sphingosine 1-phosphate receptor 1,target,P21453,S1PR1,Humans,"G-protein coupled receptor for the bioactive lysosphingolipid sphingosine 1-phosphate (S1P) that seems to be coupled to the G(i) subclass of heteromeric G proteins. Signaling leads to the activation of RAC1, SRC, PTK2/FAK1 and MAP kinases. Plays an important role in cell migration, probably via its role in the reorganization of the actin cytoskeleton and the formation of lamellipodia in response to stimuli that increase the activity of the sphingosine kinase SPHK1. Required for normal chemotaxis",G protein-coupled receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0009881,Sphingosine 1-phosphate receptor 3,target,Q99500,S1PR3,Humans,"Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P). S1P is a bioactive lysophospholipid that elicits diverse physiological effect on most types of cells and tissues. When expressed in rat HTC4 hepatoma cells, is capable of mediating S1P-induced cell proliferation and suppression of apoptosis",G protein-coupled receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0004728,Sphingosine kinase 1,target,Q9NYA1,SPHK1,Humans,"Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro-sphingosine and to a lesser extent sphinganine, but not other lipids, such as D,L-threo-dihydrosphingosine, N,N-dimethylsphingosine, diacylglycerol, ceramide, or phosphatidylinositol (PubMed:11923095, PubMed:20577214, PubMed:23602659, PubMed:24929359, PubMed:29662056). In contrast to proapoptotic SPHK2, has a negative effect on ",acetyltransferase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009882,Sphingosine 1-phosphate receptor 4,target,O95977,S1PR4,Humans,Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P). S1P is a bioactive lysophospholipid that elicits diverse physiological effect on most types of cells and tissues. May be involved in cell migration processes that are specific for lymphocytes,G protein-coupled receptor activity,Cell membrane,modulator,DrugBank,drugbank_id
BE0000625,Growth hormone-releasing hormone receptor,target,Q02643,GHRHR,Humans,"Receptor for GRF, coupled to G proteins which activate adenylyl cyclase. Stimulates somatotroph cell growth, growth hormone gene transcription and growth hormone secretion",G protein-coupled peptide receptor activity,Cell membrane,binder,DrugBank,drugbank_id
BE0004732,RNA polymerase sigma factor SigA,target,Q18BX5,sigA1,Clostridium difficile (strain 630),Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. This sigma factor is the primary sigma factor during exponential growth.,DNA binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009412,Tyrosine-protein kinase receptor UFO,target,P30530,AXL,Humans,"Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding growth factor GAS6 and which is thus regulating many physiological processes including cell survival, cell proliferation, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of AXL. Following activation by ligand, AXL binds and induces tyrosine phosphorylation of PI3-kinase subunits PIK3R1, PIK3R2 and PIK3R3; but also GRB2, PLCG1,",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009404,Tyrosine-protein kinase receptor TYRO3,target,Q06418,TYRO3,Humans,"Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including TULP1 or GAS6. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of TYRO3 on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with PIK3R1 and thereby enhan",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004271,Tyrosine-protein kinase Mer,target,Q12866,MERTK,Humans,"Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by l",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0002408,Tyrosine-protein kinase JAK2,target,O60674,JAK2,Humans,"Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin receptor (MPL/TPOR); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and",acetylcholine receptor binding,Endomembrane system,inhibitor,DrugBank,drugbank_id
BE0004145,Tyrosine-protein kinase JAK1,target,P23458,JAK1,Humans,"Tyrosine kinase of the non-receptor type, involved in the IFN-alpha/beta/gamma signal pathway (PubMed:16239216, PubMed:28111307, PubMed:32750333, PubMed:7615558, PubMed:8232552). Kinase partner for the interleukin (IL)-2 receptor (PubMed:11909529) as well as interleukin (IL)-10 receptor (PubMed:12133952). Kinase partner for the type I interferon receptor IFNAR2 (PubMed:16239216, PubMed:28111307, PubMed:32750333, PubMed:7615558, PubMed:8232552). In response to interferon-binding to IFNAR1-IFNAR2 ",ATP binding,Endomembrane system,inhibitor,DrugBank,drugbank_id
BE0003493,Tyrosine-protein kinase JAK3,target,P52333,JAK3,Humans,"Non-receptor tyrosine kinase involved in various processes such as cell growth, development, or differentiation. Mediates essential signaling events in both innate and adaptive immunity and plays a crucial role in hematopoiesis during T-cells development. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors sharing the common subunit gamma such as IL2R, IL4R, IL7R, IL9R, IL15R and IL21R. Following ligand binding to cell surface receptors, phosph",ATP binding,Endomembrane system,inhibitor,DrugBank,drugbank_id
BE0004146,Non-receptor tyrosine-protein kinase TYK2,target,P29597,TYK2,Humans,"Tyrosine kinase of the non-receptor type involved in numerous cytokines and interferons signaling, which regulates cell growth, development, cell migration, innate and adaptive immunity (PubMed:10542297, PubMed:10995743, PubMed:7657660, PubMed:7813427, PubMed:8232552). Plays both structural and catalytic roles in numerous interleukins and interferons (IFN-alpha/beta) signaling (PubMed:10542297). Associates with heterodimeric cytokine receptor complexes and activates STAT family members including",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0000999,Tumor necrosis factor ligand superfamily member 13B,target,Q9Y275,TNFSF13B,Humans,"Cytokine that binds to TNFRSF13B/TACI and TNFRSF17/BCMA. TNFSF13/APRIL binds to the same 2 receptors. Together, they form a 2 ligands -2 receptors pathway involved in the stimulation of B- and T-cell function and the regulation of humoral immunity. A third B-cell specific BAFF-receptor (BAFFR/BR3) promotes the survival of mature B-cells and the B-cell response",cytokine activity,Cell membrane,blocker,DrugBank,drugbank_id
BE0004739,Proteasome subunit beta type-8,target,P28062,PSMB8,Humans,"The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB5 by PSMB8 increases the capacity of the immunoproteasome to cleave model peptides after hydrophobic and basic residues. Involved i",endopeptidase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004737,Proteasome subunit beta type-9,target,P28065,PSMB9,Humans,"The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH (PubMed:33727065, PubMed:34819510). The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB6 by PSMB9 increases the capacity of the immunoproteasome to cleave model peptides after hydroph",endopeptidase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002349,Proteasome subunit beta type-2,target,P49721,PSMB2,Humans,"Non-catalytic component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or d",,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004738,Proteasome subunit beta type-10,target,P40306,PSMB10,Humans,"The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides",endopeptidase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003502,Guanylyl cyclase C,target,P25092,GUCY2C,Humans,"Guanylyl cyclase that catalyzes synthesis of cyclic GMP (cGMP) from GTP (PubMed:11950846, PubMed:1718270, PubMed:22436048, PubMed:22521417, PubMed:23269669). Receptor for the E.coli heat-stable enterotoxin; E.coli enterotoxin markedly stimulates the accumulation of cGMP in mammalian cells expressing GUCY2C (PubMed:1680854, PubMed:1718270). Also activated by the endogenous peptides guanylin and uroguanylin (PubMed:8381596)",ATP binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0003390,Mitogen-activated protein kinase 11,target,Q15759,MAPK11,Humans,"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors (PubMed:12452429, PubMed:20626350, PubMed:35857590). Accordingly, p38 MAPKs phosphorylate a broad",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004748,ATP synthase subunit c,target,P9WPS1,atpE,Mycobacterium tuberculosis,"F(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation.",lipid binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004756,Kelch-like ECH-associated protein 1,target,Q14145,KEAP1,Humans,"Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that regulates the response to oxidative stress by targeting NFE2L2/NRF2 for ubiquitination (PubMed:14585973, PubMed:15379550, PubMed:15572695, PubMed:15601839, PubMed:15983046, PubMed:37339955). KEAP1 acts as a key sensor of oxidative and electrophilic stress: in normal conditions, the BCR(KEAP1) complex mediates ubiquitination and degradation of NFE2L2/NRF2, a transcription factor regulating expression of many cyto",disordered domain specific binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0004757,Serine/threonine-protein kinase SIK1,target,P57059,SIK1,Humans,"Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis regulation, muscle growth and differentiation and tumor suppression. Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, CRTC1/TORC1. Inhibits CREB activity by phosphorylating and inhibiting activity of TORCs, the CREB-specific coactivators, like CRTC2/TORC2 and CRTC3/TORC3 in response to cAMP signaling (PubMed:29211348). Acts as a tumor suppressor and plays a key role in p53/TP53",14-3-3 protein binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004758,Serine/threonine-protein kinase Nek11,target,Q8NG66,NEK11,Humans,Protein kinase which plays an important role in the G2/M checkpoint response to DNA damage. Controls degradation of CDC25A by directly phosphorylating it on residues whose phosphorylation is required for BTRC-mediated polyubiquitination and degradation,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0004759,LIM domain kinase 1,target,P53667,LIMK1,Humans,"Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways (PubMed:10436159, PubMed:11832213, PubMed:12807904, PubMed:15660133, PubMed:16230460, PubMed:18028908, PubMed:22328514, PubMed:23633677). Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop (PubMed:10436159). LIMK1 subsequently p",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0013774,Retinal guanylyl cyclase 1,target,Q02846,GUCY2D,Humans,"Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. Plays an essential role in phototransduction, by mediating cGMP replenishment (PubMed:15123990, PubMed:21928830, PubMed:26100624, PubMed:30319355, PubMed:9600905). May also participate in the trafficking of membrane-asociated proteins to the photoreceptor outer segment membrane (By similarity)",ATP binding,Photoreceptor outer segment membrane,modulator,DrugBank,drugbank_id
BE0002403,RNA-directed RNA polymerase,target,O39930,NS5b,Hepatitis C Virus,,ATP hydrolysis activity,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0008657,Lysosomal protective protein,enzyme,P10619,CTSA,Humans,"Protective protein appears to be essential for both the activity of beta-galactosidase and neuraminidase, it associates with these enzymes and exerts a protective function necessary for their stability and activity. This protein is also a carboxypeptidase and can deamidate tachykinins",carboxypeptidase activity,Lysosome,substrate,DrugBank,drugbank_id
BE0001473,Adenosine 5'-monophosphoramidase HINT1,enzyme,P49773,HINT1,Humans,"Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monophosphoramidate (AMP-NH2) to yield AMP and NH2 (PubMed:15703176, PubMed:16835243, PubMed:17217311, PubMed:17337452, PubMed:22329685, PubMed:23614568, PubMed:28691797, PubMed:29787766, PubMed:31990367). Hydrolyzes adenosine 5'monophosphomorpholidate (AMP-morpholidate) and guanosine 5'monophosphomorpholidate (GMP-morpholidate) (PubMed:15703176, Pu",adenosine 5'-monophosphoramidase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0000088,Pyruvate kinase PKM,target,P14618,PKM,Humans,"Catalyzes the final rate-limiting step of glycolysis by mediating the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP (PubMed:15996096, PubMed:1854723, PubMed:20847263). The ratio between the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production (PubMed:15996096, PubMed:1854723, PubMed:20847263). The transition between the 2 forms contribu",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003758,Chymotrypsin-like elastase family member 1,target,Q9UNI1,CELA1,Humans,Serine proteases that hydrolyze many proteins in addition to elastin,metal ion binding,Secreted,inhibitor,DrugBank,drugbank_id
BE0009664,Aquaporin-3,target,Q92482,AQP3,Humans,"Aquaglyceroporins form homotetrameric transmembrane channels, with each monomer independently mediating glycerol and water transport across the plasma membrane along their osmotic gradient (PubMed:12239222, PubMed:30420639). Could also be permeable to urea (By similarity). Also participates in cell permeability to H2O2 and H2O2-mediated signaling (PubMed:20724658). In skin, transports glycerol to the epidermis and stratum corneum, where it maintains hydration, elasticity, and supports lipid bios",glycerol channel activity,Cell membrane,negative modulator,DrugBank,drugbank_id
BE0008651,Nonstructural protein 5A,target,Q5L478,NS5A,Hepatitis C Virus,,cysteine-type endopeptidase activity,,inhibitor,DrugBank,drugbank_id
BE0005863,Interleukin-17A,target,Q16552,IL17A,Humans,"Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (PubMed:24120361). Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metallopro",cytokine activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0003414,Integrin beta-7,target,P26010,ITGB7,Humans,"Integrin ITGA4/ITGB7 (alpha-4/beta-7) (Peyer patches-specific homing receptor LPAM-1) is an adhesion molecule that mediates lymphocyte migration and homing to gut-associated lymphoid tissue (GALT) (Probable). Integrin ITGA4/ITGB7 interacts with the cell surface adhesion molecules MADCAM1 which is normally expressed by the vascular endothelium of the gastrointestinal tract (PubMed:10837471, PubMed:14608374). Also interacts with VCAM1 and fibronectin, an extracellular matrix component (Probable). ",cell adhesion molecule binding,Cell membrane,antibody,DrugBank,drugbank_id
BE0005864,Orexin/Hypocretin receptor type 1,target,O43613,HCRTR1,Humans,"Moderately selective excitatory receptor for orexin-A and, with a lower affinity, for orexin-B neuropeptide (PubMed:26950369, PubMed:9491897). Triggers an increase in cytoplasmic Ca(2+) levels in response to orexin-A binding (PubMed:26950369, PubMed:9491897)",G protein-coupled receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0005865,Orexin receptor type 2,target,O43614,HCRTR2,Humans,"Nonselective, high-affinity receptor for both orexin-A and orexin-B neuropeptides (PubMed:26950369, PubMed:9491897). Triggers an increase in cytoplasmic Ca(2+) levels in response to orexin-A binding (PubMed:26950369, PubMed:9491897)",neuropeptide receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0000477,Ceramide glucosyltransferase,target,Q16739,UGCG,Humans,"Participates in the initial step of the glucosylceramide-based glycosphingolipid/GSL synthetic pathway at the cytosolic surface of the Golgi (PubMed:1532799, PubMed:8643456). Catalyzes the transfer of glucose from UDP-glucose to ceramide to produce glucosylceramide/GlcCer (such as beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine) (PubMed:1532799, PubMed:8643456). GlcCer is the core component of glycosphingolipids/GSLs, amphipathic molecules consisting of a ceramide lipid moiety embedded in the oute",ceramide glucosyltransferase activity,Golgi apparatus membrane,inhibitor,DrugBank,drugbank_id
BE0003376,Leptin receptor,target,P48357,LEPR,Humans,"Receptor for hormone LEP/leptin (Probable) (PubMed:22405007). On ligand binding, mediates LEP central and peripheral effects through the activation of different signaling pathways such as JAK2/STAT3 and MAPK cascade/FOS. In the hypothalamus, LEP acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitar",cytokine binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0027701,Delta(14)-sterol reductase ERG24,target,P32462,ERG24,Baker's yeast,"Delta(14)-sterol reductase; part of the third module of ergosterol biosynthesis pathway that includes the late steps of the pathway (PubMed:1418625, PubMed:8125337). ERG24 reduces the C14=C15 double bond of 4,4-dimethyl-cholesta-8,14,24-trienol to produce 4,4-dimethyl-cholesta-8,24-dienol (PubMed:1418625, PubMed:8125337). The third module or late pathway involves the ergosterol synthesis itself through consecutive reactions that mainly occur in the endoplasmic reticulum (ER) membrane. Firstly, t",Delta14-sterol reductase activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0027702,C-8 sterol isomerase ERG2,target,P32352,ERG2,Baker's yeast,"C-8 sterol isomerase; part of the third module of ergosterol biosynthesis pathway that includes the late steps of the pathway (Ref.5). ERG2 catalyzes the reaction which results in unsaturation at C-7 in the B ring of sterols and thus converts fecosterol to episterol (Ref.5). The third module or late pathway involves the ergosterol synthesis itself through consecutive reactions that mainly occur in the endoplasmic reticulum (ER) membrane. Firstly, the squalene synthase ERG9 catalyzes the condensa",C-8 sterol isomerase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009590,Sodium channel protein type 7 subunit alpha,target,Q01118,SCN7A,Humans,"Sodium leak channel functioning as an osmosensor regulating sodium ion levels in various tissues and organs. While most sodium channels are voltage-gated, SCN7A is not and lets sodium flow through membrane along its concentration gradient (PubMed:26537257, PubMed:35301303). In glial cells of the central nervous system, senses body-fluid sodium levels and controls salt intake behavior as well as voluntary water intake through activation of nearby neurons to maintain appropriate sodium levels in t",osmolarity-sensing monoatomic cation channel activity,Cell membrane,blocker,DrugBank,drugbank_id
BE0001430,Beta-lactamase,target,P05364,ampC,Enterobacter cloacae,This protein is a serine beta-lactamase with a substrate specificity for cephalosporins.,beta-lactamase activity,Periplasm,inhibitor,DrugBank,drugbank_id
BE0002029,Beta-lactamase SHV-2,target,P0A9Z7,bla,Escherichia coli,"This enzyme hydrolyzes cefotaxime, ceftazidime and other broad spectrum cephalosporins.",beta-lactamase activity,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0004185,Beta-lactamase SHV-1,target,P0AD64,bla,Klebsiella pneumoniae,"Broad-spectrum beta-lactamase which confers resistance to penicillins, as well as first- and third-generation cephalosporins (PubMed:10639363, PubMed:18955486, PubMed:19351161, PubMed:22908166, PubMed:23145056, PubMed:23252553). Has nitrocefin-hydrolyzing activity (PubMed:10231522, PubMed:19351161, PubMed:23252553). Inactive against the cephalosporins, cefotaxime and cefoxitin, and the carbapenem, meropenem (PubMed:10639363, PubMed:19351161).",beta-lactamase activity,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0008648,OXA-48 carbapenemase,target,A0A023W3H0,OXA-48,Klebsiella pneumoniae,,penicillin binding,,inhibitor,DrugBank,drugbank_id
BE0008649,Carbapenem-hydrolyzing beta-lactamase KPC-2,target,Q9F663,KPC-2,Klebsiella pneumoniae,"Hydrolyzes carbapenems, penicillins, cephalosporins and monobactams with varying efficiency.",beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0008650,Beta-lactamase,target,Q9EXV5,blaUOE-1,Escherichia coli,,beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0008647,Extended-spectrum beta-lactamase PER-1,target,P37321,PER-1,Pseudomonas aeruginosa,,beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0009153,G-protein coupled receptor 12,target,P47775,GPR12,Humans,Promotes neurite outgrowth and blocks myelin inhibition in neurons (By similarity). Receptor with constitutive G(s) signaling activity that stimulates cyclic AMP production,G protein-coupled receptor activity,Cell membrane,inverse agonist,DrugBank,drugbank_id
BE0009158,Transient receptor potential cation channel subfamily V member 2,target,Q9Y5S1,TRPV2,Humans,"Calcium-permeable, non-selective cation channel with an outward rectification. Seems to be regulated, at least in part, by IGF1, PDGF and neuropeptide head activator. May transduce physical stimuli in mast cells. Activated by temperatures higher than 52 degrees Celsius; is not activated by vanilloids and acidic pH",calcium channel activity,Cell membrane,activator,DrugBank,drugbank_id
BE0002468,Non-selective voltage-gated ion channel VDAC1,target,P21796,VDAC1,Humans,"Non-selective voltage-gated ion channel that mediates the transport of anions and cations through the mitochondrion outer membrane and plasma membrane (PubMed:10661876, PubMed:11845315, PubMed:18755977, PubMed:30061676, PubMed:8420959). The channel at the outer mitochondrial membrane allows diffusion of small hydrophilic molecules; in the plasma membrane it is involved in cell volume regulation and apoptosis (PubMed:10661876, PubMed:11845315, PubMed:18755977, PubMed:8420959). It adopts an open c",ATP binding,Mitochondrion outer membrane,inhibitor,DrugBank,drugbank_id
BE0000816,Glutathione peroxidase 1,target,P07203,GPX1,Humans,"Catalyzes the reduction of hydroperoxides in a glutathione-dependent manner thus regulating cellular redox homeostasis (PubMed:11115402, PubMed:36608588). Can reduce small soluble hydroperoxides such as H2O2, cumene hydroperoxide and tert-butyl hydroperoxide, as well as several fatty acid-derived hydroperoxides (PubMed:11115402, PubMed:36608588). In platelets catalyzes the reduction of 12-hydroperoxyeicosatetraenoic acid, the primary product of the arachidonate 12-lipoxygenase pathway (PubMed:11",glutathione peroxidase activity,Cytoplasm,stimulator,DrugBank,drugbank_id
BE0004584,Serotonin N-acetyltransferase,target,Q16613,AANAT,Humans,"Controls the night/day rhythm of melatonin production in the pineal gland. Catalyzes the N-acetylation of serotonin into N-acetylserotonin, the penultimate step in the synthesis of melatonin",14-3-3 protein binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009156,N-acylethanolamine-hydrolyzing acid amidase,target,Q02083,NAAA,Humans,"Degrades bioactive fatty acid amides to their corresponding acids, with the following preference: N-palmitoylethanolamine > N-myristoylethanolamine > N-lauroylethanolamine = N-stearoylethanolamine > N-arachidonoylethanolamine > N-oleoylethanolamine (PubMed:15655246, PubMed:17980170, PubMed:18793752, PubMed:22825852, PubMed:30301806). Also exhibits weak hydrolytic activity against the ceramides N-lauroylsphingosine and N-palmitoylsphingosine (PubMed:15655246)",DNA-binding transcription factor binding,Lysosome,inhibitor,DrugBank,drugbank_id
BE0014244,Corticotropin-releasing factor receptor 2,target,Q13324,CRHR2,Humans,"G-protein coupled receptor for CRH (corticotropin-releasing factor), UCN (urocortin), UCN2 and UCN3. Has high affinity for UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels",corticotrophin-releasing factor receptor activity,Cell membrane,ligand,DrugBank,drugbank_id
BE0010052,"3-ketoacyl-CoA thiolase, mitochondrial",target,P42765,ACAA2,Humans,"In the production of energy from fats, this is one of the enzymes that catalyzes the last step of the mitochondrial beta-oxidation pathway, an aerobic process breaking down fatty acids into acetyl-CoA (Probable). Using free coenzyme A/CoA, catalyzes the thiolytic cleavage of medium- to long-chain unbranched 3-oxoacyl-CoAs into acetyl-CoA and a fatty acyl-CoA shortened by two carbon atoms (Probable). Also catalyzes the condensation of two acetyl-CoA molecules into acetoacetyl-CoA and could be inv",acetyl-CoA C-acetyltransferase activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0008675,"Hydroxyacid-oxoacid transhydrogenase, mitochondrial",enzyme,Q8IWW8,ADHFE1,Humans,"Catalyzes the cofactor-independent reversible oxidation of gamma-hydroxybutyrate (GHB) to succinic semialdehyde (SSA) coupled to reduction of 2-ketoglutarate (2-KG) to D-2-hydroxyglutarate (D-2-HG). D,L-3-hydroxyisobutyrate and L-3-hydroxybutyrate (L-3-OHB) are also substrates for HOT with 10-fold lower activities",alcohol dehydrogenase (NAD+) activity,Mitochondrion,substrate,DrugBank,drugbank_id
BE0000008,"NAD(P) transhydrogenase, mitochondrial",enzyme,Q13423,NNT,Humans,The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane (By similarity). May play a role in reactive oxygen species (ROS) detoxification in the adrenal gland (PubMed:22634753),NAD binding,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0004049,Protein mono-ADP-ribosyltransferase PARP3,target,Q9Y6F1,PARP3,Humans,"Mono-ADP-ribosyltransferase that mediates mono-ADP-ribosylation of target proteins and plays a key role in the response to DNA damage (PubMed:16924674, PubMed:19354255, PubMed:20064938, PubMed:21211721, PubMed:21270334, PubMed:23742272, PubMed:24598253, PubMed:25043379, PubMed:28447610). Mediates mono-ADP-ribosylation of glutamate, aspartate or lysine residues on target proteins (PubMed:20064938, PubMed:25043379). In contrast to PARP1 and PARP2, it is not able to mediate poly-ADP-ribosylation (P",catalytic activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0008624,GD2 disialoganglioside,target,,,Humans,,,,inhibitor|binder,DrugBank,drugbank_id
BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,target,P04406,GAPDH,Humans,"Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively (PubMed:11724794, PubMed:3170585). Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate (PubMed:11724794, PubMed:3170585). Modulates the organization and assembly of the cytoskeleton (By similarity). ",aspartic-type endopeptidase inhibitor activity,"Cytoplasm, cytosol",cofactor,DrugBank,drugbank_id
BE0000011,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",target,P50213,IDH3A,Humans,"Catalytic subunit of the enzyme which catalyzes the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers",isocitrate dehydrogenase (NAD+) activity,Mitochondrion,cofactor,DrugBank,drugbank_id
BE0001786,Catalase,target,P29422,katA,Micrococcus luteus,Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide.,catalase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009441,Ephrin type-B receptor 1,target,P54762,EPHB1,Humans,"Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Cognate/functional ephrin ligands for this receptor include EFNB1, EFNB2 and EFNB3. During nervous system development, regul",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009273,Somatostatin receptor type 4,target,P31391,SSTR4,Humans,"Receptor for somatostatin-14. The activity of this receptor is mediated by G proteins which inhibits adenylyl cyclase. It is functionally coupled not only to inhibition of adenylate cyclase, but also to activation of both arachidonate release and mitogen-activated protein (MAP) kinase cascade. Mediates antiproliferative action of somatostatin in tumor cells",neuropeptide binding,Cell membrane,agonist,DrugBank,drugbank_id
BE0009855,Type II iodothyronine deiodinase,enzyme,Q92813,DIO2,Humans,"Plays a crucial role in the metabolism of thyroid hormones (TH) and has specific roles in TH activation and inactivation by deiodination (PubMed:12586771, PubMed:11108274, PubMed:10403186, PubMed:18821722). Catalyzes the deiodination of L-thyroxine (T4) to 3,5,3'-triiodothyronine (T3), 3,3',5'-triiodothyronine (rT3) to 3,3'-diiodothyronine (3,3'-T2) and 3',5'-diiodothyronine (3',5'-T2) to 3'-monoiodothyronine (3'-T1) via outer-ring deiodination (ORD) (PubMed:12586771, PubMed:11108274, PubMed:104",selenium binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0009333,Thyroxine 5-deiodinase,enzyme,P55073,DIO3,Humans,"Plays a crucial role in the metabolism of thyroid hormones (TH) and has specific roles in TH activation and inactivation by deiodination (PubMed:7593630, PubMed:12586771, PubMed:12746313, PubMed:18821722). Catalyzes the deiodination of L-thyroxine (T4) to 3,3',5'-triiodothyronine (rT3), 3,5,3'-triiodothyronine (T3) to 3,3'-diiodothyronine (3,3'-T2), 3,5-diiodothyronine (3,5-T2) to 3-monoiodothyronine (3-T1), rT3 to 3',5'-diiodothyronine (3',5'-T2) and 3,3'-T2 to 3'-monoiodothyronine (3'-T1) via ",thyroxine 5'-deiodinase activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0009763,Sulfotransferase 1C2,enzyme,O00338,SULT1C2,Humans,"Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) to catalyze the sulfate conjugation of phenolic compounds (PubMed:10481272, PubMed:10783263, PubMed:9852044). Does not transfer sulfate to steroids, dopamine, acetaminophen, or alpha-naphthol (PubMed:10481272, PubMed:9852044). Except in mitochondria, where it can add sulfate to cholesterol producing cholesterol sulfate, which alters mitochondrial membrane organization, and impacts protein complex mobility increasing state-III r",aryl sulfotransferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0008653,Pyrophosphate,target,,,,,,,ligand,DrugBank,drugbank_id
BE0004467,Myoglobin,target,P02144,MB,Humans,"Monomeric heme protein which primary function is to store oxygen and facilitate its diffusion within muscle tissues. Reversibly binds oxygen through a pentacoordinated heme iron and enables its timely and efficient release as needed during periods of heightened demand (PubMed:30918256, PubMed:34679218). Depending on the oxidative conditions of tissues and cells, and in addition to its ability to bind oxygen, it also has a nitrite reductase activity whereby it regulates the production of bioactiv",heme binding,"Cytoplasm, sarcoplasm",oxidizer,DrugBank,drugbank_id
BE0000425,L-lactate dehydrogenase A chain,target,P00338,LDHA,Humans,Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+),cadherin binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0000068,L-lactate dehydrogenase B chain,target,P07195,LDHB,Humans,Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+),identical protein binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0005793,P2X purinoceptor 4,target,Q99571,P2RX4,Humans,"ATP-gated nonselective transmembrane cation channel permeable to potassium, sodium and calcium (PubMed:9016352). CTP, but not GTP or UTP, functions as a weak affinity agonist for P2RX4 (By similarity). Activated by extracellularly released ATP, it plays multiple role in immunity and central nervous system physiology (PubMed:35165166). Plays a key role in initial steps of T-cell activation and Ca(2+) microdomain formation (By similarity). Also participates in basal T-cell activity without TCR/CD3",ATP binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0001684,Adenosylhomocysteinase,target,P23526,AHCY,Humans,Catalyzes the hydrolysis of S-adenosyl-L-homocysteine to form adenosine and homocysteine (PubMed:10933798). Binds copper ions (By similarity),adenosylhomocysteinase activity,Cytoplasm,allosteric modulator,DrugBank,drugbank_id
BE0005156,Histone H2B type 1-C/E/F/G/I,target,P62807,H2BC4,Humans,"Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling",DNA binding,Nucleus,,DrugBank,drugbank_id
BE0005131,Histone H1.4,target,P10412,H1-4,Humans,"Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Also acts as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity)",chromatin DNA binding,Nucleus,,DrugBank,drugbank_id
BE0005013,"Actin, cytoplasmic 2",target,P63261,ACTG1,Humans,Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. May play a role in the repair of noise-induced stereocilia gaps thereby maintains hearing sensitivity following loud noise damage (By similarity),ATP binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0008956,"60 kDa heat shock protein, mitochondrial",target,P10809,HSPD1,Humans,"Chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp10, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (PubMed:11422376, PubMed:1346131). The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In",apolipoprotein A-I binding,Mitochondrion matrix,,DrugBank,drugbank_id
BE0008957,Heat shock 70 kDa protein 13,target,P48723,HSPA13,Humans,Has peptide-independent ATPase activity,ATP binding,Microsome,,DrugBank,drugbank_id
BE0008958,Cell growth-regulating nucleolar protein,target,Q08288,Lyar,Mouse,"Plays a role in the maintenance of the appropriate processing of 47S/45S pre-rRNA to 32S/30S pre-rRNAs and their subsequent processing to produce 18S and 28S rRNAs (By similarity). Also acts at the level of transcription regulation. Along with PRMT5, binds embryonic globin promoter (By similarity). Represses the expression of embryonic globin Hbb-y gene (PubMed:25092918). In neuroblastoma cells, may also repress the expression of oxidative stress genes, including CHAC1, HMOX1, SLC7A11, ULBP1 and",DNA binding,Nucleus,,DrugBank,drugbank_id
BE0008959,Small ribosomal subunit protein uS5,target,P15880,RPS2,Humans,"Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules (PubMed:23636399). The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino a",cadherin binding,Cytoplasm,,DrugBank,drugbank_id
BE0009139,Serine/arginine-rich splicing factor 1,target,Q07955,SRSF1,Humans,"Plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-containing pre-mRNA. Binds to purine-rich RNA sequences, either the octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers, AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'-CG",DNA topoisomerase binding,Cytoplasm,,DrugBank,drugbank_id
BE0008960,Heterogeneous nuclear ribonucleoproteins A2/B1,target,P22626,HNRNPA2B1,Humans,"Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs (PubMed:19099192). Forms",DNA polymerase binding,Nucleus,,DrugBank,drugbank_id
BE0008961,Heterogeneous nuclear ribonucleoprotein H,target,P31943,HNRNPH1,Humans,"This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Mediates pre-mRNA alternative splicing regulation. Inhibits, together with CUGBP1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Binds to the IR RNA. Binds poly(RG)",identical protein binding,"Nucleus, nucleoplasm",,DrugBank,drugbank_id
BE0008962,Heterogeneous nuclear ribonucleoprotein H3,target,P31942,HNRNPH3,Humans,Involved in the splicing process and participates in early heat shock-induced splicing arrest. Due to their great structural variations the different isoforms may possess different functions in the splicing reaction,RNA binding,Nucleus,,DrugBank,drugbank_id
BE0008963,Cobalt-precorrin-5B C(1)-methyltransferase,target,P61987,cbiD,Treponema denticola (strain ATCC 35405 / CIP 103919 / DSM 14222),Catalyzes the methylation of C-1 in cobalt-precorrin-5B to form cobalt-precorrin-6A.,cobalt-precorrin-5B C1-methyltransferase activity,,,DrugBank,drugbank_id
BE0008964,Heterogeneous nuclear ribonucleoprotein L,target,P14866,HNRNPL,Humans,"Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion. Exhibits a binding preference for CA-rich elements (PubMed:11809897, PubMed:22570490, PubMed:24164894, PubMed:25623890, PubMed:26051023). Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and associated with most nascent transcripts (PubMed:2687284). Associates, together with APEX1, to the negative calcium responsive element (nCaRE) B2 of the APEX2 promot",mRNA binding,"Nucleus, nucleoplasm",,DrugBank,drugbank_id
BE0008965,"Splicing factor, proline- and glutamine-rich",target,P23246,SFPQ,Humans,"DNA- and RNA binding protein, involved in several nuclear processes. Essential pre-mRNA splicing factor required early in spliceosome formation and for splicing catalytic step II, probably as a heteromer with NONO. Binds to pre-mRNA in spliceosome C complex, and specifically binds to intronic polypyrimidine tracts. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45, a phosphorylated form is sequestered by THRAP3 from the pre-mRNA in resting T-cells; T-ce",chromatin binding,Nucleus speckle,,DrugBank,drugbank_id
BE0008966,Splicing factor 3A subunit 2,target,Q15428,SF3A2,Humans,"Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:10882114, PubMed:11533230, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:10882114",RNA binding,Nucleus,,DrugBank,drugbank_id
BE0008967,Small ribosomal subunit protein RACK1,target,P63244,RACK1,Humans,"Scaffolding protein involved in the recruitment, assembly and/or regulation of a variety of signaling molecules. Interacts with a wide variety of proteins and plays a role in many cellular processes. Component of the 40S ribosomal subunit involved in translational repression (PubMed:23636399). Involved in the initiation of the ribosome quality control (RQC), a pathway that takes place when a ribosome has stalled during translation, by promoting ubiquitination of a subset of 40S ribosomal subunit",BH3 domain binding,Cell membrane,,DrugBank,drugbank_id
BE0008968,Alpha-actinin-1,target,P12814,ACTN1,Humans,F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. Association with IGSF8 regulates the immune synapse formation and is required for efficient T-cell activation (PubMed:22689882),actin filament binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0000160,NADH-cytochrome b5 reductase 3,target,P00387,CYB5R3,Humans,Catalyzes the reduction of two molecules of cytochrome b5 using NADH as the electron donor,"cytochrome-b5 reductase activity, acting on NAD(P)H",Endoplasmic reticulum membrane,,DrugBank,drugbank_id
BE0000039,Transketolase,target,P29401,TKT,Humans,"Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate",calcium ion binding,,,DrugBank,drugbank_id
BE0001972,Peroxiredoxin-2,target,P32119,PRDX2,Humans,"Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2)",antioxidant activity,Cytoplasm,,DrugBank,drugbank_id
BE0004641,Peroxiredoxin-6,target,P30041,PRDX6,Humans,"Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively (PubMed:10893423, PubMed:9497358). Can reduce H(2)O(2) and short chain organic, fatty acid, and phospholipid hydroperoxides (PubMed:10893423). Also has phospholipase activity, can therefore either reduce the oxidized sn-2 fatty acyl group of phospholipids (peroxidase activity) or hydrolyze the sn-2 ester bond of phospholipids (phospholipase activity) (PubMed:",1-acylglycerophosphocholine O-acyltransferase activity,Cytoplasm,,DrugBank,drugbank_id
BE0008970,Stress-induced-phosphoprotein 1,target,P31948,STIP1,Humans,Acts as a co-chaperone for HSP90AA1 (PubMed:27353360). Mediates the association of the molecular chaperones HSPA8/HSC70 and HSP90 (By similarity),Hsp90 protein binding,Cytoplasm,,DrugBank,drugbank_id
BE0008972,Eukaryotic translation initiation factor 6,target,P56537,EIF6,Humans,"Binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit to form the 80S initiation complex in the cytoplasm (PubMed:10085284, PubMed:14654845, PubMed:21536732, PubMed:32669547). Behaves as a stimulatory translation initiation factor downstream insulin/growth factors. Is also involved in ribosome biogenesis. Associates with pre-60S subunits in the nucleus and is involved in its nuclear export. Cytoplasmic release of TIF6 from 60S subunits and nuclear relocal",ribosomal large subunit binding,Cytoplasm,,DrugBank,drugbank_id
BE0008973,Eukaryotic initiation factor 4A-I,target,P60842,EIF4A1,Humans,"ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome (PubMed:20156963). In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. As a result, promotes cell proliferation and growth (PubMed:20156963)",ATP binding,"Cytoplasm, perinuclear region",,DrugBank,drugbank_id
BE0001199,Glucose-6-phosphate isomerase,target,P06744,GPI,Humans,"In the cytoplasm, catalyzes the conversion of glucose-6-phosphate to fructose-6-phosphate, the second step in glycolysis, and the reverse reaction during gluconeogenesis (PubMed:28803808). Besides it's role as a glycolytic enzyme, also acts as a secreted cytokine: acts as an angiogenic factor (AMF) that stimulates endothelial cell motility (PubMed:11437381). Acts as a neurotrophic factor, neuroleukin, for spinal and sensory neurons (PubMed:11004567, PubMed:3352745). It is secreted by lectin-stim",carbohydrate derivative binding,Cytoplasm,,DrugBank,drugbank_id
BE0004174,Cofilin-1,target,P23528,CFL1,Humans,"Binds to F-actin and exhibits pH-sensitive F-actin depolymerizing activity (PubMed:11812157). In conjunction with the subcortical maternal complex (SCMC), plays an essential role for zygotes to progress beyond the first embryonic cell divisions via regulation of actin dynamics (PubMed:15580268). Required for the centralization of the mitotic spindle and symmetric division of zygotes (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization in epithelial cel",actin filament binding,Nucleus matrix,,DrugBank,drugbank_id
BE0008974,14-3-3 protein beta/alpha,target,P31946,YWHAB,Humans,"Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negative regulator of osteogenesis. Blocks the nuclear translocation of the phosphorylated form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on cyclin D1 expression resulting in bl",cadherin binding,Cytoplasm,,DrugBank,drugbank_id
BE0008975,Hepatoma-derived growth factor,target,P51858,HDGF,Humans,"Acts as a transcriptional repressor (PubMed:17974029). Has mitogenic activity for fibroblasts (PubMed:11751870, PubMed:26845719). Heparin-binding protein (PubMed:15491618)",actin binding,Nucleus,,DrugBank,drugbank_id
BE0005284,Chloride intracellular channel protein 1,target,O00299,CLIC1,Humans,"In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor. Reduces selenite and dehydroascorbate and may act as an antioxidant during oxidative stress response (PubMed:25581026, PubMed:37759794). Can insert into membranes and form voltage-dependent multi-ion conductive channels. Membrane insertion seems to be redox-regulated and may occur only under oxidizing conditions. Involved in regulation of the cell cycle",cadherin binding,Nucleus,,DrugBank,drugbank_id
BE0008976,Proteasome activator complex subunit 1,target,Q06323,PSME1,Humans,Implicated in immunoproteasome assembly and required for efficient antigen processing. The PA28 activator complex enhances the generation of class I binding peptides by altering the cleavage pattern of the proteasome,endopeptidase activator activity,,,DrugBank,drugbank_id
BE0001179,Phosphatidylethanolamine-binding protein 1,target,P30086,PEBP1,Humans,"Binds ATP, opioids and phosphatidylethanolamine. Has lower affinity for phosphatidylinositol and phosphatidylcholine. Serine protease inhibitor which inhibits thrombin, neuropsin and chymotrypsin but not trypsin, tissue type plasminogen activator and elastase (By similarity). Inhibits the kinase activity of RAF1 by inhibiting its activation and by dissociating the RAF1/MEK complex and acting as a competitive inhibitor of MEK phosphorylation",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0008977,Phosphoglycerate mutase 1,target,P18669,PGAM1,Humans,"Catalyzes the interconversion of 2-phosphoglycerate and 3-phosphoglyceratea crucial step in glycolysis, by using 2,3-bisphosphoglycerate (PubMed:23653202). Also catalyzes the interconversion of (2R)-2,3-bisphosphoglycerate and (2R)-3-phospho-glyceroyl phosphate (PubMed:23653202)",bisphosphoglycerate mutase activity,,,DrugBank,drugbank_id
BE0008978,Ran-specific GTPase-activating protein,target,P43487,RANBP1,Humans,Plays a role in RAN-dependent nucleocytoplasmic transport. Alleviates the TNPO1-dependent inhibition of RAN GTPase activity and mediates the dissociation of RAN from proteins involved in transport into the nucleus (By similarity). Induces a conformation change in the complex formed by XPO1 and RAN that triggers the release of the nuclear export signal of cargo proteins (PubMed:20485264). Promotes the disassembly of the complex formed by RAN and importin beta. Promotes dissociation of RAN from a ,cadherin binding,,,DrugBank,drugbank_id
BE0000645,UDP-glucose 6-dehydrogenase,target,O60701,UGDH,Humans,"Catalyzes the formation of UDP-alpha-D-glucuronate, a constituent of complex glycosaminoglycans (PubMed:21502315, PubMed:21961565, PubMed:22123821, PubMed:23106432, PubMed:25478983, PubMed:27966912, PubMed:30420606, PubMed:30457329). Required for the biosynthesis of chondroitin sulfate and heparan sulfate. Required for embryonic development via its role in the biosynthesis of glycosaminoglycans (By similarity). Required for proper brain and neuronal development (PubMed:32001716)",identical protein binding,,,DrugBank,drugbank_id
BE0003777,Beta-2-microglobulin,target,P61769,B2M,Humans,"Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. Exogenously applied M.tuberculosis EsxA or EsxA-EsxB (or EsxA expressed in host) binds B2M and decreases its export to the cell surface (total protein levels do not change), probably leading to defects in class I antigen presentation (PubMed:25356553)",identical protein binding,Secreted,,DrugBank,drugbank_id
BE0005818,"Protein SCO1 homolog, mitochondrial",target,O75880,SCO1,Humans,"Copper metallochaperone essential for the maturation of cytochrome c oxidase subunit II (MT-CO2/COX2). Not required for the synthesis of MT-CO2/COX2 but plays a crucial role in stabilizing MT-CO2/COX2 during its subsequent maturation. Involved in transporting copper to the Cu(A) site on MT-CO2/COX2 (PubMed:15229189, PubMed:15659396, PubMed:16735468, PubMed:17189203, PubMed:19336478). Plays an important role in the regulation of copper homeostasis by controlling the abundance and cell membrane lo",copper chaperone activity,Mitochondrion,,DrugBank,drugbank_id
BE0008989,Alternative prion protein,target,F7VJQ1,PRNP,Humans,,,Mitochondrion outer membrane,,DrugBank,drugbank_id
BE0008995,Huntingtin,target,P42858,HTT,Humans,May play a role in microtubule-mediated transport or vesicle function,beta-tubulin binding,Cytoplasm,,DrugBank,drugbank_id
BE0005816,Ferroxidase HEPHL1,target,Q6MZM0,HEPHL1,Humans,Is a copper-binding glycoprotein with ferroxidase activity. It oxidizes Fe(2+) to Fe(3+) without releasing radical oxygen species (PubMed:31125343). May be involved in the regulation of intracellular iron content (PubMed:31125343),copper ion binding,Membrane,cofactor,DrugBank,drugbank_id
BE0003394,Neurotrophic factor BDNF precursor form,target,P23560,BDNF,Humans,"Important signaling molecule that activates signaling cascades downstream of NTRK2 (PubMed:11152678). During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribu",growth factor activity,Secreted,cofactor,DrugBank,drugbank_id
BE0000992,Parkinson disease protein 7,target,Q99497,PARK7,Humans,"Multifunctional protein with controversial molecular function which plays an important role in cell protection against oxidative stress and cell death acting as oxidative stress sensor and redox-sensitive chaperone and protease (PubMed:12796482, PubMed:17015834, PubMed:18711745, PubMed:19229105, PubMed:20304780, PubMed:25416785, PubMed:26995087, PubMed:28993701). It is involved in neuroprotective mechanisms like the stabilization of NFE2L2 and PINK1 proteins, male fertility as a positive regulat",cadherin binding,Cell membrane,,DrugBank,drugbank_id
BE0000921,Islet amyloid polypeptide,target,P10997,IAPP,Humans,"Amylin/IAPP is a glucoregulatory peptide hormone that plays an important role in the regulation of energy homeostasis (PubMed:2690069). Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism. IAPP function is mediated by the CALCR-RAMPs (AMYRs) receptor complexes (By similarity). Amylin can also bind CALCR receptor in the absence of RAMPs, although it is more selective for AMYRs (By similarity)",amyloid-beta binding,Secreted,,DrugBank,drugbank_id
BE0009046,Tachykinin-3,target,Q9UHF0,TAC3,Humans,"Tachykinins are active peptides which excite neurons, evoke behavioral responses, are potent vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles (By similarity). Is a critical central regulator of gonadal function",signaling receptor binding,Secreted,,DrugBank,drugbank_id
BE0008979,Afamin,target,P43652,AFM,Humans,"Functions as a carrier for hydrophobic molecules in body fluids (Probable). Essential for the solubility and activity of lipidated Wnt family members, including WNT1, WNT2B, WNT3, WNT3A, WNT5A, WNT7A, WNT7B, WNT8, WNT9A, WNT9B, WNT10A and WNT10B (PubMed:26902720). Binds vitamin E (PubMed:12463752, PubMed:15952736). May transport vitamin E in body fluids under conditions where the lipoprotein system is not sufficient (PubMed:15952736). May be involved in the transport of vitamin E across the bloo",vitamin E binding,Secreted,,DrugBank,drugbank_id
BE0008879,Apolipoprotein C-II,target,P02655,APOC2,Humans,"Component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL) in plasma. Plays an important role in lipoprotein metabolism as an activator of lipoprotein lipase. Both proapolipoprotein C-II and apolipoprotein C-II can activate lipoprotein lipase. In normolipidemic individuals, it is mainly distributed in the HDL, whereas in hypertriglyceridemic individuals, predominantly found in the VLDL and LDL",lipase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0008880,Apolipoprotein C-III,target,P02656,APOC3,Humans,"Component of triglyceride-rich very low density lipoproteins (VLDL) and high density lipoproteins (HDL) in plasma (PubMed:18201179, PubMed:22510806). Plays a multifaceted role in triglyceride homeostasis (PubMed:18201179, PubMed:22510806). Intracellularly, promotes hepatic very low density lipoprotein 1 (VLDL1) assembly and secretion; extracellularly, attenuates hydrolysis and clearance of triglyceride-rich lipoproteins (TRLs) (PubMed:18201179, PubMed:22510806). Impairs the lipolysis of TRLs by ",cholesterol binding,Secreted,,DrugBank,drugbank_id
BE0005056,Apolipoprotein D,target,P05090,APOD,Humans,APOD occurs in the macromolecular complex with lecithin-cholesterol acyltransferase. It is probably involved in the transport and binding of bilin. Appears to be able to transport a variety of ligands in a number of different contexts,cholesterol binding,Secreted,,DrugBank,drugbank_id
BE0002854,Beta-2-glycoprotein 1,target,P02749,APOH,Humans,"Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells",heparin binding,Secreted,,DrugBank,drugbank_id
BE0002857,Zinc-alpha-2-glycoprotein,target,P25311,AZGP1,Humans,Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. May bind polyunsaturated fatty acids,protein transmembrane transporter activity,Secreted,,DrugBank,drugbank_id
BE0009052,Complement component C9,target,P02748,C9,Humans,"Pore-forming component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade, which inserts into a target cell membrane and forms a pore, leading to target cell membrane rupture and cell lysis (PubMed:22832194, PubMed:26841837, PubMed:26841934, PubMed:27052168, PubMed:30552328, PubMed:6177822, PubMed:9212048, PubMed:9634479). The MAC is initiated by proteolytic cleavage of C5 into complement C5b in response to the classical, alternative, lectin and GZMK",,Secreted,,DrugBank,drugbank_id
BE0004930,"Complement component 1 Q subcomponent-binding protein, mitochondrial",target,Q07021,C1QBP,Humans,"Multifunctional and multicompartmental protein involved in inflammation and infection processes, ribosome biogenesis, protein synthesis in mitochondria, regulation of apoptosis, transcriptional regulation and pre-mRNA splicing (PubMed:10022843, PubMed:10479529, PubMed:10722602, PubMed:11086025, PubMed:11859136, PubMed:15243141, PubMed:16140380, PubMed:16177118, PubMed:17881511, PubMed:18676636, PubMed:19004836, PubMed:19164550, PubMed:20810993, PubMed:21536856, PubMed:21544310, PubMed:22700724, ",adrenergic receptor binding,Mitochondrion matrix,,DrugBank,drugbank_id
BE0009056,Chromobox protein homolog 5,target,P45973,CBX5,Humans,"Component of heterochromatin that recognizes and binds histone H3 tails methylated at 'Lys-9' (H3K9me), leading to epigenetic repression. In contrast, it is excluded from chromatin when 'Tyr-41' of histone H3 is phosphorylated (H3Y41ph) (PubMed:19783980). May contribute to the association of heterochromatin with the inner nuclear membrane by interactions with the lamin-B receptor (LBR) (PubMed:19783980). Involved in the formation of kinetochore through interaction with the MIS12 complex subunit ",chromatin binding,Nucleus,,DrugBank,drugbank_id
BE0002815,Immunoglobulin heavy constant gamma 1,target,P01857,IGHG1,Humans,"Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which resu",antigen binding,Secreted,,DrugBank,drugbank_id
BE0005089,Immunoglobulin heavy constant gamma 4,target,P01861,IGHG4,Humans,"Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which resu",antigen binding,Secreted,,DrugBank,drugbank_id
BE0009059,Immunoglobulin lambda-like polypeptide 1,target,P15814,IGLL1,Humans,Critical for B-cell development,antigen binding,Endoplasmic reticulum,,DrugBank,drugbank_id
BE0009065,Leucine-rich alpha-2-glycoprotein,target,P02750,LRG1,Humans,,transforming growth factor beta binding,Secreted,,DrugBank,drugbank_id
BE0009066,Lumican,target,P51884,LUM,Humans,,collagen binding,"Secreted, extracellular space, extracellular matrix",,DrugBank,drugbank_id
BE0000946,Platelet basic protein,target,P02775,PPBP,Humans,"LA-PF4 stimulates DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by human synovial cells. NAP-2 is a ligand for CXCR1 and CXCR2, and NAP-2, NAP-2(73), NAP-2(74), NAP-2(1-66), and most potent NAP-2(1-63) are chemoattractants and activators for neutrophils. TC-1 and TC-2 are antibacterial proteins, in vitro releas",chemokine activity,Secreted,,DrugBank,drugbank_id
BE0009068,Pigment epithelium-derived factor,target,P36955,SERPINF1,Humans,"Neurotrophic protein; induces extensive neuronal differentiation in retinoblastoma cells. Potent inhibitor of angiogenesis. As it does not undergo the S (stressed) to R (relaxed) conformational transition characteristic of active serpins, it exhibits no serine protease inhibitory activity",serine-type endopeptidase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0001125,Alpha-2-antiplasmin,target,P08697,SERPINF2,Humans,"Serine protease inhibitor. The major targets of this inhibitor are plasmin and trypsin, but it also inactivates matriptase-3/TMPRSS7 and chymotrypsin",endopeptidase inhibitor activity,Secreted,,DrugBank,drugbank_id
BE0008684,Protein-lysine 6-oxidase,enzyme,P28300,LOX,Humans,Responsible for the post-translational oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin (PubMed:26838787). Regulator of Ras expression. May play a role in tumor suppression. Plays a role in the aortic wall architecture (By similarity),collagen binding,Secreted,cofactor,DrugBank,drugbank_id
BE0001181,Angiogenin,enzyme,P03950,ANG,Humans,"Secreted ribonuclease that can either promote or restrict cell proliferation of target cells, depending on the context (PubMed:12051708, PubMed:1400510, PubMed:19332886, PubMed:20129916, PubMed:21855800, PubMed:23047679, PubMed:23843625, PubMed:2424496, PubMed:2459697, PubMed:2730651, PubMed:27518564, PubMed:28176817, PubMed:29100074, PubMed:29748193, PubMed:3122207, PubMed:32510170, PubMed:38718836, PubMed:8159680, PubMed:8570639, PubMed:8622921, PubMed:9578571). Endocytosed in target cells via",actin binding,Secreted,cofactor,DrugBank,drugbank_id
BE0008686,Cytochrome c oxidase copper chaperone,carrier,Q14061,COX17,Humans,"Copper metallochaperone essential for the assembly of the mitochondrial respiratory chain complex IV (CIV), also known as cytochrome c oxidase. Binds two copper ions and delivers them to the metallochaperone SCO1 which transports the copper ions to the Cu(A) site on the cytochrome c oxidase subunit II (MT-CO2/COX2)",copper chaperone activity,Mitochondrion intermembrane space,binder,DrugBank,drugbank_id
BE0008687,Hephaestin,carrier,Q9BQS7,HEPH,Humans,"Plasma membrane ferroxidase that mediates the extracellular conversion of ferrous/Fe(2+) iron into its ferric/Fe(3+) form. Couples ferroportin which specifically exports ferrous/Fe(2+) iron from cells to transferrin that only binds and shuttles extracellular ferric/Fe(3+) iron throughout the body (PubMed:22961397, PubMed:37277838). By helping iron transfer from cells to blood mainly contributes to dietary iron absorption by the intestinal epithelium and more generally regulates iron levels in th",copper ion binding,Basolateral cell membrane,binder,DrugBank,drugbank_id
BE0008688,Metallothionein,carrier,Q14872,MTF1,Humans,Zinc-dependent transcriptional regulator of cellular adaption to conditions of exposure to heavy metals (PubMed:8065932). Binds to metal responsive elements (MRE) in promoters and activates the transcription of metallothionein genes like metallothionein-2/MT2A (PubMed:8065932). Also regulates the expression of metalloproteases in response to intracellular zinc and functions as a catabolic regulator of cartilages (By similarity),cis-regulatory region sequence-specific DNA binding,Nucleus,binder,DrugBank,drugbank_id
BE0011000,Beta amyloid plaque,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0008678,Mitochondrial 2-oxodicarboxylate carrier,transporter,Q9BQT8,SLC25A21,Humans,"Transports dicarboxylates across the inner membranes of mitochondria by a counter-exchange mechanism (PubMed:11083877). Can transport 2-oxoadipate (2-oxohexanedioate), 2-oxoglutarate, adipate (hexanedioate), glutarate, and to a lesser extent, pimelate (heptanedioate), 2-oxopimelate (2-oxoheptanedioate), 2-aminoadipate (2-aminohexanedioate), oxaloacetate, and citrate (PubMed:11083877). Plays a central role in catabolism of lysine, hydroxylysine, and tryptophan, by transporting common metabolite i",alpha-ketoglutarate transmembrane transporter activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0008677,Na(+)/citrate cotransporter,transporter,Q86YT5,SLC13A5,Humans,"High-affinity sodium/citrate cotransporter that mediates the entry of citrate into cells, which is a critical participant of biochemical pathways (PubMed:12445824, PubMed:12826022, PubMed:26324167, PubMed:26384929, PubMed:30054523, PubMed:33597751). May function in various metabolic processes in which citrate has a critical role such as energy production (Krebs cycle), fatty acid synthesis, cholesterol synthesis, glycolysis, and gluconeogenesis (PubMed:12826022). Transports citrate into the cell",citrate transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0008676,"Tricarboxylate transport protein, mitochondrial",transporter,P53007,SLC25A1,Humans,"Mitochondrial electroneutral antiporter that exports citrate from the mitochondria into the cytosol in exchange for malate (PubMed:26870663, PubMed:29031613, PubMed:29238895, PubMed:39881208). Also able to mediate the exchange of citrate for isocitrate, phosphoenolpyruvate, cis-aconitate and to a lesser extent trans-aconitate, maleate and succinate (PubMed:29031613). In the cytoplasm, citrate plays important roles in fatty acid and sterol synthesis, regulation of glycolysis, protein acetylation,",antiporter activity,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0004961,Hydroxyapatite,target,,,Humans,,,,ligand,DrugBank,drugbank_id
BE0008720,Amorphous calcium phosphate,target,,,Humans,,,,ligand,DrugBank,drugbank_id
BE0008655,Nonstructural protein 5b,target,P87764,NS5b,,,nucleotide binding,,inhibitor,DrugBank,drugbank_id
BE0001292,Cruzipain,target,P25779,,Trypanosoma cruzi,"Hydrolyzes chromogenic peptides at the carboxyl Arg or Lys; requires at least one more amino acid, preferably Arg, Phe, Val or Leu, between the terminal Arg or Lys and the amino-blocking group.",cysteine-type endopeptidase activity,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0009334,Macrophage mannose receptor 1,target,P22897,MRC1,Humans,Mediates the endocytosis of glycoproteins by macrophages. Binds both sulfated and non-sulfated polysaccharide chains,cargo receptor activity,Endosome membrane,ligand,DrugBank,drugbank_id
BE0000027,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",target,P56181,NDUFV3,Humans,"Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. May be the terminally assembled subunit of Complex I",NADH dehydrogenase (ubiquinone) activity,Mitochondrion inner membrane,cofactor,DrugBank,drugbank_id
BE0008642,Malaria protein EXP-1,target,P04926,EXP-1,Plasmodium falciparum,,,Parasitophorous vacuole membrane,inhibitor,DrugBank,drugbank_id
BE0003089,ATP-dependent Clp protease ATP-binding subunit ClpX,target,O25926,clpX,Helicobacter pylori (strain ATCC 700392 / 26695),ATP-dependent specificity component of the Clp protease. It directs the protease to specific substrates. Can perform chaperone functions in the absence of ClpP.,ATP binding,Cytoplasmic,antagonist,DrugBank,drugbank_id
BE0003490,Leukotriene B4 receptor 1,target,Q15722,LTB4R,Humans,"Receptor for extracellular ATP > UTP and ADP. The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. May be the cardiac P2Y receptor involved in the regulation of cardiac muscle contraction through modulation of L-type calcium currents. Is a receptor for leukotriene B4, a potent chemoattractant involved in inflammation and immune response",G protein-coupled peptide receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0009678,DNA polymerase,target,I6TLU5,,Human herpesvirus 2 (strain 186),"Replicates viral genomic DNA. The replication complex is composed of six viral proteins: the DNA polymerase, processivity factor, primase, primase-associated factor, helicase, and ssDNA-binding protein. Additionally, the polymerase contains an intrinsic ribonuclease H (RNase H) activity that specifically degrades RNA/DNA heteroduplexes or duplex DNA substrates in the 5' to 3' direction. Therefore, it can catalyze the excision of the RNA primers that initiate the synthesis of Okazaki fragments at",3'-5'-DNA exonuclease activity,,inhibitor,DrugBank,drugbank_id
BE0002486,Glial cell line-derived neurotrophic factor,target,P39905,GDNF,Humans,"Neurotrophic factor that enhances survival and morphological differentiation of dopaminergic neurons and increases their high-affinity dopamine uptake (PubMed:8493557). Acts by binding to its coreceptor, GFRA1, leading to autophosphorylation and activation of the RET receptor (PubMed:10829012, PubMed:25242331, PubMed:31535977). Involved in the development of the neural crest (PubMed:15242795)",chemoattractant activity involved in axon guidance,Secreted,,DrugBank,drugbank_id
BE0000972,Beta-glucuronidase,enzyme,P08236,GUSB,Humans,Plays an important role in the degradation of dermatan and keratan sulfates,beta-glucuronidase activity,Lysosome,substrate,DrugBank,drugbank_id
BE0000883,N-acetylgalactosamine-6-sulfatase,enzyme,P34059,GALNS,Humans,,arylsulfatase activity,Lysosome,substrate,DrugBank,drugbank_id
BE0009328,Iduronate 2-sulfatase,enzyme,P22304,IDS,Humans,Lysosomal enzyme involved in the degradation pathway of dermatan sulfate and heparan sulfate,calcium ion binding,Lysosome,substrate,DrugBank,drugbank_id
BE0009329,Alpha-L-iduronidase,enzyme,P35475,IDUA,Humans,,L-iduronidase activity,Lysosome,substrate,DrugBank,drugbank_id
BE0009330,Arylsulfatase B,enzyme,P15848,ARSB,Humans,"Removes sulfate groups from chondroitin-4-sulfate (C4S) and regulates its degradation (PubMed:19306108). Involved in the regulation of cell adhesion, cell migration and invasion in colonic epithelium (PubMed:19306108). In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity)",arylsulfatase activity,Lysosome,substrate,DrugBank,drugbank_id
BE0008643,Proprotein convertase subtilisin/kexin type 9,target,Q8NBP7,PCSK9,Humans,"Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments (PubMed:18039658). Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediat",apolipoprotein binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004122,Enolase-phosphatase E1,enzyme,Q9UHY7,ENOPH1,Humans,"Bifunctional enzyme that catalyzes the enolization of 2,3-diketo-5-methylthiopentyl-1-phosphate (DK-MTP-1-P) into the intermediate 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate (HK-MTPenyl-1-P), which is then dephosphorylated to form the acireductone 1,2-dihydroxy-3-keto-5-methylthiopentene (DHK-MTPene)",acireductone synthase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009702,Enolase,enzyme,B3WCW7,eno,Lactobacillus casei (strain BL23),Catalyzes the reversible conversion of 2-phosphoglycerate (2-PG) into phosphoenolpyruvate (PEP). It is essential for the degradation of carbohydrates via glycolysis.,magnesium ion binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009703,Enolase,enzyme,A3CMA7,eno,Streptococcus sanguinis (strain SK36),Catalyzes the reversible conversion of 2-phosphoglycerate (2-PG) into phosphoenolpyruvate (PEP). It is essential for the degradation of carbohydrates via glycolysis.,magnesium ion binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0027492,Enolase,enzyme,Q8DTS9,eno,Streptococcus mutans serotype c (strain ATCC 700610 / UA159),Catalyzes the reversible conversion of 2-phosphoglycerate (2-PG) into phosphoenolpyruvate (PEP). It is essential for the degradation of carbohydrates via glycolysis.,magnesium ion binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002247,Very long chain fatty acid elongase 4,enzyme,Q9GZR5,ELOVL4,Humans,Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that catalyzes the synthesis of very long chain saturated (VLC-SFA) and polyunsaturated (PUFA) fatty acids that are involved in multiple biological processes as precursors of membrane lipids and,fatty acid elongase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0004135,Peroxisomal acyl-coenzyme A oxidase 1,enzyme,Q15067,ACOX1,Humans,"Involved in the initial and rate-limiting step of peroxisomal beta-oxidation of straight-chain saturated and unsaturated very-long-chain fatty acids (PubMed:15060085, PubMed:17458872, PubMed:17603022, PubMed:32169171, PubMed:33234382, PubMed:7876265). Catalyzes the desaturation of fatty acyl-CoAs such as palmitoyl-CoA (hexadecanoyl-CoA) to 2-trans-enoyl-CoAs ((2E)-enoyl-CoAs) such as (2E)-hexadecenoyl-CoA, and donates electrons directly to molecular oxygen (O(2)), thereby producing hydrogen pero",acyl-CoA oxidase activity,Peroxisome,substrate,DrugBank,drugbank_id
BE0005459,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,target,P28907,CD38,Humans,"Synthesizes cyclic ADP-ribose (cADPR), a second messenger for glucose-induced insulin secretion (PubMed:7961800, PubMed:8253715). Synthesizes the Ca(2+) mobilizer nicotinate-adenine dinucleotide phosphate, NAADP(+), from 2'-phospho-cADPR and nicotinic acid, as well as from NADP(+) and nicotinic acid. At both pH 5.0 and pH 7.4 preferentially transforms 2'-phospho-cADPR into NAADP(+), while preferentially cleaving NADP(+) to cADPR and ADPRP rather than into NADDP(+) (PubMed:16690024). Has cADPR hy",identical protein binding,Cell surface,binder|downregulator,DrugBank,drugbank_id
BE0000906,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",enzyme,P35558,PCK1,Humans,"Cytosolic phosphoenolpyruvate carboxykinase that catalyzes the reversible decarboxylation and phosphorylation of oxaloacetate (OAA) and acts as the rate-limiting enzyme in gluconeogenesis (PubMed:24863970, PubMed:26971250, PubMed:28216384, PubMed:30193097). Regulates cataplerosis and anaplerosis, the processes that control the levels of metabolic intermediates in the citric acid cycle (PubMed:24863970, PubMed:26971250, PubMed:28216384, PubMed:30193097). At low glucose levels, it catalyzes the ca",carboxylic acid binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0001056,Hexokinase-4,enzyme,P35557,GCK,Humans,"Catalyzes the phosphorylation of hexose, such as D-glucose, D-fructose and D-mannose, to hexose 6-phosphate (D-glucose 6-phosphate, D-fructose 6-phosphate and D-mannose 6-phosphate, respectively) (PubMed:11916951, PubMed:15277402, PubMed:17082186, PubMed:18322640, PubMed:19146401, PubMed:25015100, PubMed:7742312, PubMed:8325892). Compared to other hexokinases, has a weak affinity for D-glucose, and is effective only when glucose is abundant (By similarity). Mainly expressed in pancreatic beta ce",ATP binding,Cytoplasm,substrate,DrugBank,drugbank_id
BE0001818,ATP-dependent 6-phosphofructokinase,enzyme,P00512,pfkA,Geobacillus stearothermophilus,"Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis.",6-phosphofructokinase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0005216,"Solute carrier family 2, facilitated glucose transporter member 5",transporter,P22732,SLC2A5,Humans,"Functions as a fructose transporter that has only low activity with other monosaccharides (PubMed:16186102, PubMed:17710649, PubMed:28083649, PubMed:29548810, PubMed:8333543). Can mediate the uptake of 2-deoxyglucose, but with low efficiency (PubMed:1695905). Essential for fructose uptake in the small intestine (By similarity). Plays a role in the regulation of salt uptake and blood pressure in response to dietary fructose (By similarity). Required for the development of high blood pressure in r",D-glucose transmembrane transporter activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,enzyme,O75874,IDH1,Humans,"Catalyzes the NADP(+)-dependent oxidative decarboxylation of isocitrate (D-threo-isocitrate) to 2-ketoglutarate (2-oxoglutarate), which is required by other enzymes such as the phytanoyl-CoA dioxygenase (PubMed:10521434, PubMed:19935646). Plays a critical role in the generation of NADPH, an important cofactor in many biosynthesis pathways (PubMed:10521434). May act as a corneal epithelial crystallin and may be involved in maintaining corneal epithelial transparency (By similarity)",cadherin binding,"Cytoplasm, cytosol",cofactor,DrugBank,drugbank_id
BE0000350,"Acetyl-coenzyme A synthetase, cytoplasmic",enzyme,Q9NR19,ACSS2,Humans,"Catalyzes the synthesis of acetyl-CoA from short-chain fatty acids (PubMed:10843999, PubMed:28003429, PubMed:28552616). Acetate is the preferred substrate (PubMed:10843999, PubMed:28003429). Can also utilize propionate with a much lower affinity (By similarity). Nuclear ACSS2 promotes glucose deprivation-induced lysosomal biogenesis and autophagy, tumor cell survival and brain tumorigenesis (PubMed:28552616). Glucose deprivation results in AMPK-mediated phosphorylation of ACSS2 leading to its tr",acetate-CoA ligase activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0010064,Guanylate cyclase,target,Q02108,GUCY1A1,Humans,,GTP binding,Cytoplasm,activator,DrugBank,drugbank_id
BE0009346,Sodium/iodide cotransporter,target,Q92911,SLC5A5,Humans,"Sodium:iodide symporter that mediates the transport of iodide into the thyroid gland (PubMed:12488351, PubMed:18372236, PubMed:18708479, PubMed:20797386, PubMed:31310151, PubMed:32084174, PubMed:8806637, PubMed:9329364). Can also mediate the transport of chlorate, thiocynate, nitrate and selenocynate (PubMed:12488351)",iodide transmembrane transporter activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0008659,Thyrotropin-releasing hormone receptor,target,P34981,TRHR,Humans,"Receptor for thyrotropin-releasing hormone (TRH). Upon ligand binding, this G-protein-coupled receptor triggers activation of the phosphatidylinositol (IP3)-calcium-protein kinase C (PKC) pathway",thyrotropin-releasing hormone receptor activity,Cell membrane,ligand,DrugBank,drugbank_id
BE0008680,Sodium-dependent phosphate transporter 2,transporter,Q08357,SLC20A2,Humans,"Sodium-phosphate symporter which preferentially transports the monovalent form of phosphate with a stoichiometry of two sodium ions per phosphate ion (PubMed:12205090, PubMed:15955065, PubMed:16790504, PubMed:17494632, PubMed:22327515, PubMed:28722801, PubMed:30704756). Plays a critical role in the determination of bone quality and strength by providing phosphate for bone mineralization (By similarity). Required to maintain normal cerebrospinal fluid phosphate levels (By similarity). Mediates ph",phosphate transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0008681,Sodium-dependent phosphate transport protein 2A,transporter,Q06495,SLC34A1,Humans,"Involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane (PubMed:12324554, PubMed:20335586, PubMed:26047794, PubMed:8327470). The cotransport has a Na(+):Pi stoichiometry of 3:1 and is electrogenic (By similarity)",identical protein binding,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0008682,Sodium-dependent phosphate transport protein 2B,transporter,O95436,SLC34A2,Humans,Involved in actively transporting phosphate into cells via Na(+) cotransport,phosphate ion binding,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0008683,Sodium-dependent phosphate transport protein 2C,transporter,Q8N130,SLC34A3,Humans,Involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane (PubMed:11880379). The cotransport has a Na(+):Pi stoichiometry of 2:1 and is electroneutral (By similarity),sodium,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0004496,Inositol-3-phosphate synthase 1,target,Q9NPH2,ISYNA1,Humans,"Key enzyme in myo-inositol biosynthesis pathway that catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol 1-phosphate in a NAD-dependent manner (PubMed:15024000, PubMed:23902760). Rate-limiting enzyme in the synthesis of all inositol-containing compounds (PubMed:15024000)",inositol-3-phosphate synthase activity,Cytoplasm,,DrugBank,drugbank_id
BE0003957,Glycodelin,target,P09466,PAEP,Humans,"Glycoprotein that regulates critical steps during fertilization and also has immunomonomodulatory effects. Four glycoforms, namely glycodelin-S, -A, -F and -C have been identified in reproductive tissues that differ in glycosylation and biological activity. Glycodelin-A has contraceptive and immunosuppressive activities (PubMed:7531163, PubMed:9918684). Glycodelin-C stimulates binding of spermatozoa to the zona pellucida (PubMed:17192260). Glycodelin-F inhibits spermatozoa-zona pellucida binding",small molecule binding,Secreted,,DrugBank,drugbank_id
BE0004619,Alpha-N-acetylgalactosaminidase,target,P17050,NAGA,Humans,Removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. Required for the breakdown of glycolipids,alpha-galactosidase activity,Lysosome,,DrugBank,drugbank_id
BE0003094,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,target,O43252,PAPSS1,Humans,"Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS: activated sulfate donor used by sulfotransferase). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate-",adenylylsulfate kinase activity,,,DrugBank,drugbank_id
BE0001565,DNA mismatch repair protein MutL,target,P23367,mutL,Escherichia coli (strain K12),"This protein is involved in the repair of mismatches in DNA. It is required for dam-dependent methyl-directed DNA mismatch repair. May act as a 'molecular matchmaker', a protein that promotes the formation of a stable complex between two or more DNA-binding proteins in an ATP-dependent manner without itself being part of the final effector complex. The ATPase activity of MutL is stimulated by DNA.",ATP binding,,,DrugBank,drugbank_id
BE0003206,Ribonucleoside-diphosphate reductase 1 subunit beta,target,P69924,nrdB,Escherichia coli (strain K12),Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. R2 contains the tyrosyl radical required for catalysis.,identical protein binding,,,DrugBank,drugbank_id
BE0000819,Maleylacetoacetate isomerase,target,O43708,GSTZ1,Humans,"Bifunctional enzyme showing minimal glutathione-conjugating activity with ethacrynic acid and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole and maleylacetoacetate isomerase activity. Also has low glutathione peroxidase activity with T-butyl and cumene hydroperoxides. Is able to catalyze the glutathione dependent oxygenation of dichloroacetic acid to glyoxylic acid",glutathione peroxidase activity,Cytoplasm,,DrugBank,drugbank_id
BE0010003,Aquaporin-7,transporter,O14520,AQP7,Humans,"Aquaglyceroporins form homotetrameric transmembrane channels, with each monomer independently mediating glycerol and water transport across the plasma membrane along their osmotic gradient (PubMed:11952783, PubMed:30420639, PubMed:30423801, PubMed:36737436, PubMed:9405233). Could also be permeable to urea (PubMed:9405233). Mediates the efflux of glycerol, formed upon triglyceride hydrolysis, to avoid its accumulation in adipocytes and to make it available to other tissues. In the kidney, mediate",glycerol channel activity,Cell membrane,,DrugBank,drugbank_id
BE0010004,Aquaporin-9,transporter,O43315,AQP9,Humans,"Aquaglyceroporins form homotetrameric transmembrane channels, with each monomer independently mediating glycerol and water transport across the plasma membrane along their osmotic gradient (PubMed:10564231, PubMed:30420639, PubMed:35054513, PubMed:9514918). AQP9 is the primary route for glycerol uptake in hepatocytes, supporting hepatic gluconeogenesis (By similarity). It exhibits broad specificity and may transport various small, non-charged solutes, including carbamides, polyols, purines, and ",channel activity,Cell membrane,,DrugBank,drugbank_id
BE0002037,Glycerol uptake facilitator protein,transporter,P0AER0,glpF,Escherichia coli (strain K12),"Mediates glycerol diffusion across the cytoplasmic membrane via a pore-type mechanism (PubMed:11039922, PubMed:11226336, PubMed:6998951, PubMed:7512955). Is highly permeable to glycerol, but less well permeated by water (PubMed:11226336). Does not transport ions (PubMed:7512955). It may also have limited permeability to various other substrates, including xylitol, erythritol, D-arabitol, L-arabitol, ribitol, D-galactitol, D-mannitol, D-sorbitol, urea, glycine, D/L-glyceraldehyde and the trivalen",glycerol channel activity,Cell inner membrane,,DrugBank,drugbank_id
BE0005126,Transient receptor potential cation channel subfamily M member 6,transporter,Q9BX84,TRPM6,Humans,"Bifunctional protein that combines an ion channel with an intrinsic kinase domain, enabling it to modulate cellular functions either by conducting ions through the pore or by phosphorylating downstream proteins via its kinase domain (PubMed:14576148, PubMed:16636202, PubMed:18258429, PubMed:18365021). Crucial for Mg(2+) homeostasis. Has an important role in epithelial Mg(2+) transport and in the active Mg(2+) absorption in the gut and kidney (PubMed:14576148). However, whether TRPM6 forms functi",ATP binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0008673,Solute carrier family 41 member 3,transporter,Q96GZ6,SLC41A3,Humans,Na(+)/Mg(2+) ion exchanger that acts as a predominant Mg(2+) efflux system at the mitochondrial inner membrane,magnesium,Mitochondrion inner membrane,substrate,DrugBank,drugbank_id
BE0008674,Metal transporter CNNM2,transporter,Q9H8M5,CNNM2,Humans,Divalent metal cation transporter. Mediates transport of divalent metal cations in an order of Mg(2+) > Co(2+) > Mn(2+) > Sr(2+) > Ba(2+) > Cu(2+) > Fe(2+) (By similarity),ATP binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0004455,Thiosulfate sulfurtransferase,enzyme,Q16762,TST,Humans,"Formation of iron-sulfur complexes, cyanide detoxification or modification of sulfur-containing enzymes. Other thiol compounds, besides cyanide, can act as sulfur ion acceptors. Also has weak mercaptopyruvate sulfurtransferase (MST) activity (By similarity). Together with MRPL18, acts as a mitochondrial import factor for the cytosolic 5S rRNA. Only the nascent unfolded cytoplasmic form is able to bind to the 5S rRNA",3-mercaptopyruvate sulfurtransferase activity,Mitochondrion matrix,substrate,DrugBank,drugbank_id
BE0010200,Thiosulfate:glutathione sulfurtransferase,enzyme,Q8NFU3,TSTD1,Humans,"Thiosulfate:glutathione sulfurtransferase (TST) required to produce S-sulfanylglutathione (GSS(-)), a central intermediate in hydrogen sulfide metabolism (PubMed:24981631). Provides the link between the first step in mammalian H(2)S metabolism performed by the sulfide:quinone oxidoreductase (SQOR) which catalyzes the conversion of H(2)S to thiosulfate, and the sulfur dioxygenase (SDO) which uses GSS(-) as substrate (PubMed:24981631). The thermodynamic coupling of the irreversible SDO and reversi",thiosulfate-thiol sulfurtransferase activity,"Cytoplasm, perinuclear region",substrate,DrugBank,drugbank_id
BE0010199,Solute carrier family 13 member 4,transporter,Q9UKG4,SLC13A4,Humans,Sodium:sulfate symporter that mediates sulfate reabsorption in the high endothelial venules (HEV),sodium,Membrane,binder,DrugBank,drugbank_id
BE0005217,"Solute carrier family 2, facilitated glucose transporter member 6",transporter,Q9UGQ3,SLC2A6,Humans,Probable sugar transporter that acts as a regulator of glycolysis in macrophages (Probable). Does not transport glucose (PubMed:30431159),D-glucose transmembrane transporter activity,Lysosome membrane,substrate,DrugBank,drugbank_id
BE0005218,"Solute carrier family 2, facilitated glucose transporter member 7",transporter,Q6PXP3,SLC2A7,Humans,"Probable sugar transporter (PubMed:28083649). Even if its physiological substrate is subject to discussion, it is able to transport glucose and fructose (PubMed:16186102, PubMed:28083649, PubMed:29548810). Does not transport galactose, 2-deoxy-d-glucose and xylose (PubMed:15033637)",D-glucose transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0005219,"Solute carrier family 2, facilitated glucose transporter member 8",transporter,Q9NY64,SLC2A8,Humans,"Insulin-regulated facilitative hexose transporter that mediates the transport of glucose and fructose (By similarity). Facilitates hepatic influx of dietary trehalose, which in turn inhibits glucose and fructose influx triggering a starvation signal and hepatic autophagy through activation of AMPK and ULK1 (PubMed:27922102). Also able to mediate the transport of dehydroascorbate",D-glucose binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0005220,"Solute carrier family 2, facilitated glucose transporter member 10",transporter,O95528,SLC2A10,Humans,Facilitative glucose transporter required for the development of the cardiovascular system,carbohydrate,Endomembrane system,substrate,DrugBank,drugbank_id
BE0005221,"Solute carrier family 2, facilitated glucose transporter member 11",transporter,Q9BYW1,SLC2A11,Humans,Facilitative glucose transporter,D-glucose transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0005222,"Solute carrier family 2, facilitated glucose transporter member 12",transporter,Q8TD20,SLC2A12,Humans,Insulin-independent facilitative glucose transporter,D-glucose transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000318,Secretin receptor,target,P47872,SCTR,Humans,"G protein-coupled receptor activated by secretin (SCT), which is involved in different processes such as regulation of the pH of the duodenal content, food intake and water homeostasis (PubMed:25332973, PubMed:32811827, PubMed:33008599, PubMed:7612008). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and activates cAMP-dependent pathway (PubMed:32811827, PubMed:33008599). Upon binding to secretin, regulates the pH of the du",G protein-coupled peptide receptor activity,Cell membrane,ligand,DrugBank,drugbank_id
BE0010366,Secretin,target,P09683,SCT,Humans,"Hormone involved in different processes, such as regulation of the pH of the duodenal content, food intake and water homeostasis (PubMed:25332973). Exerts its biological effects by binding to secretin receptor (SCTR), a G-protein coupled receptor expressed in the basolateral domain of several cells (PubMed:25332973, PubMed:33008599, PubMed:32811827). Acts as a key gastrointestinal hormone by regulating the pH of the duodenal content (By similarity). Secreted by S cells of the duodenum in the cry",digestive hormone activity,Secreted,binder,DrugBank,drugbank_id
BE0000317,3-hydroxyacyl-CoA dehydrogenase type-2,target,Q99714,HSD17B10,Humans,"Mitochondrial dehydrogenase involved in pathways of fatty acid, branched-chain amino acid and steroid metabolism (PubMed:10600649, PubMed:12917011, PubMed:18996107, PubMed:19706438, PubMed:20077426, PubMed:25925575, PubMed:26950678, PubMed:28888424, PubMed:9553139). Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid beta-oxidation, a major degradation pathway of fatty acids. Catalyzes the third step in the beta-oxidation cycle, namely the reversible conversion of (S)-3-hydro",17-beta-hydroxysteroid dehydrogenase (NAD+) activity,Mitochondrion,potentiator,DrugBank,drugbank_id
BE0004500,"Enoyl-CoA hydratase, mitochondrial",target,P30084,ECHS1,Humans,"Converts unsaturated trans-2-enoyl-CoA species ((2E)-enoyl-CoA) to the corresponding (3S)-3hydroxyacyl-CoA species through addition of a water molecule to the double bond (PubMed:25125611, PubMed:26251176). Catalyzes the hydration of medium- and short-chained fatty enoyl-CoA thioesters from 4 carbons long (C4) up to C16 (PubMed:26251176). Has high substrate specificity for crotonyl-CoA ((2E)-butenoyl-CoA) and moderate specificity for acryloyl-CoA, 3-methylcrotonyl-CoA (3-methyl-(2E)-butenoyl-CoA",3-hydroxypropionyl-CoA dehydratase activity,Mitochondrion matrix,potentiator,DrugBank,drugbank_id
BE0000377,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",target,Q16836,HADH,Humans,"Mitochondrial fatty acid beta-oxidation enzyme that catalyzes the third step of the beta-oxidation cycle for medium and short-chain 3-hydroxy fatty acyl-CoAs (C4 to C10) (PubMed:10231530, PubMed:11489939, PubMed:16725361). Plays a role in the control of insulin secretion by inhibiting the activation of glutamate dehydrogenase 1 (GLUD1), an enzyme that has an important role in regulating amino acid-induced insulin secretion (By similarity). Plays a role in the maintenance of normal spermatogenesi",3-hydroxyacyl-CoA dehydrogenase activity,Mitochondrion matrix,potentiator,DrugBank,drugbank_id
BE0000935,Phosphatidylcholine transfer protein,carrier,Q9UKL6,PCTP,Humans,Catalyzes the transfer of phosphatidylcholine between membranes. Binds a single lipid molecule,phosphatidylcholine binding,Cytoplasm,binder,DrugBank,drugbank_id
BE0009883,B-lymphocytes,target,,,,,,,inducer,DrugBank,drugbank_id
BE0002499,Pentaerythritol tetranitrate reductase,enzyme,P71278,onr,Enterobacter cloacae,,FMN binding,,substrate,DrugBank,drugbank_id
BE0000623,Tyrosine-protein phosphatase non-receptor type 1,target,P18031,PTPN1,Humans,Tyrosine-protein phosphatase which acts as a regulator of endoplasmic reticulum unfolded protein response. Mediates dephosphorylation of EIF2AK3/PERK; inactivating the protein kinase activity of EIF2AK3/PERK. May play an important role in CKII- and p60c-src-induced signal transduction cascades. May regulate the EFNA5-EPHA3 signaling pathway which modulates cell reorganization and cell-cell repulsion. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylat,cadherin binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0008691,Calcium and integrin-binding protein 1,target,Q99828,CIB1,Humans,"Calcium-binding protein that plays a role in the regulation of numerous cellular processes, such as cell differentiation, cell division, cell proliferation, cell migration, thrombosis, angiogenesis, cardiac hypertrophy and apoptosis. Involved in bone marrow megakaryocyte differentiation by negatively regulating thrombopoietin-mediated signaling pathway. Participates in the endomitotic cell cycle of megakaryocyte, a form of mitosis in which both karyokinesis and cytokinesis are interrupted. Plays",calcium ion binding,Membrane,ligand,DrugBank,drugbank_id
BE0008692,Sorcin,target,P30626,SRI,Humans,Calcium-binding protein that modulates excitation-contraction coupling in the heart. Contributes to calcium homeostasis in the heart sarcoplasmic reticulum. Modulates the activity of RYR2 calcium channels,calcium channel regulator activity,Cytoplasm,ligand,DrugBank,drugbank_id
BE0008693,Calcineurin B homologous protein 1,target,Q99653,CHP1,Humans,"Calcium-binding protein involved in different processes such as regulation of vesicular trafficking, plasma membrane Na(+)/H(+) exchanger and gene transcription. Involved in the constitutive exocytic membrane traffic. Mediates the association between microtubules and membrane-bound organelles of the endoplasmic reticulum and Golgi apparatus and is also required for the targeting and fusion of transcytotic vesicles (TCV) with the plasma membrane. Functions as an integral cofactor in cell pH regul",calcium ion binding,Nucleus,agonist,DrugBank,drugbank_id
BE0002145,SPARC,target,P09486,SPARC,Humans,"Appears to regulate cell growth through interactions with the extracellular matrix and cytokines. Binds calcium and copper, several types of collagen, albumin, thrombospondin, PDGF and cell membranes. There are two calcium binding sites; an acidic domain that binds 5 to 8 Ca(2+) with a low affinity and an EF-hand loop that binds a Ca(2+) ion with a high affinity",calcium ion binding,"Secreted, extracellular space, extracellular matrix, basement membrane",ligand,DrugBank,drugbank_id
BE0008694,Fibrillin-2,target,P35556,FBN2,Humans,"Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-2-containing microfibrils regulate the early process of elastic fiber assembly. Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively",calcium ion binding,Secreted,ligand,DrugBank,drugbank_id
BE0008695,Calsequestrin-2,target,O14958,CASQ2,Humans,"Calsequestrin is a high-capacity, moderate affinity, calcium-binding protein and thus acts as an internal calcium store in muscle. Calcium ions are bound by clusters of acidic residues at the protein surface, especially at the interface between subunits. Can bind around 60 Ca(2+) ions. Regulates the release of lumenal Ca(2+) via the calcium release channel RYR2; this plays an important role in triggering muscle contraction. Plays a role in excitation-contraction coupling in the heart and in regu",calcium ion binding,Sarcoplasmic reticulum lumen,ligand,DrugBank,drugbank_id
BE0005259,Regucalcin,target,Q15493,RGN,Humans,"Gluconolactonase with low activity towards other sugar lactones, including gulonolactone and galactonolactone. Can also hydrolyze diisopropyl phosphorofluoridate and phenylacetate (in vitro). Calcium-binding protein. Modulates Ca(2+) signaling, and Ca(2+)-dependent cellular processes and enzyme activities (By similarity)",calcium ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0008696,Peflin,target,Q9UBV8,PEF1,Humans,"Calcium-binding protein that acts as an adapter that bridges unrelated proteins or stabilizes weak protein-protein complexes in response to calcium. Together with PDCD6, acts as a calcium-dependent adapter for the BCR(KLHL12) complex, a complex involved in endoplasmic reticulum (ER)-Golgi transport by regulating the size of COPII coats (PubMed:27716508). In response to cytosolic calcium increase, the heterodimer formed with PDCD6 interacts with, and bridges together the BCR(KLHL12) complex and S",calcium ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0002950,Protein S100-A6,target,P06703,S100A6,Humans,"May function as calcium sensor and modulator, contributing to cellular calcium signaling. May function by interacting with other proteins, such as TPR-containing proteins, and indirectly play a role in many physiological processes such as the reorganization of the actin cytoskeleton and in cell motility. Binds 2 calcium ions. Calcium binding is cooperative",calcium ion binding,Nucleus envelope,ligand,DrugBank,drugbank_id
BE0008697,Translationally-controlled tumor protein,target,P13693,TPT1,Humans,"Involved in calcium binding and microtubule stabilization (PubMed:12167714, PubMed:15162379, PubMed:15958728). Acts as a negative regulator of TSC22D1-mediated apoptosis, via interaction with and destabilization of TSC22D1 protein (PubMed:18325344)",calcium ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0008698,Calcium and integrin-binding family member 2,target,O75838,CIB2,Humans,Calcium- and integrin-binding protein that plays a role in intracellular calcium homeostasis (By similarity). Acts as an auxiliary subunit of the sensory mechanoelectrical transduction (MET) channel in hair cells (By similarity). Essential for mechanoelectrical transduction (MET) currents in auditory hair cells and thereby required for hearing (By similarity). Regulates the function of hair cell mechanotransduction by controlling the distribution of transmembrane channel-like proteins TMC1 and T,calcium ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0008699,Calsequestrin-1,target,P31415,CASQ1,Humans,"Calsequestrin is a high-capacity, moderate affinity, calcium-binding protein and thus acts as an internal calcium store in muscle (PubMed:28895244). Calcium ions are bound by clusters of acidic residues at the protein surface, often at the interface between subunits. Can bind around 80 Ca(2+) ions (PubMed:28895244). Regulates the release of lumenal Ca(2+) via the calcium release channel RYR1; this plays an important role in triggering muscle contraction. Negatively regulates store-operated Ca(2+",calcium ion binding,Endoplasmic reticulum,ligand,DrugBank,drugbank_id
BE0008700,Nucleobindin-1,target,Q02818,NUCB1,Humans,Major calcium-binding protein of the Golgi which may have a role in calcium homeostasis (By similarity). Acts as a non-receptor guanine nucleotide exchange factor which binds to and activates alpha subunits of guanine nucleotide-binding proteins (G proteins) (By similarity),calcium ion binding,"Golgi apparatus, cis-Golgi network membrane",ligand,DrugBank,drugbank_id
BE0008701,Nucleobindin-2,target,P80303,NUCB2,Humans,Calcium-binding protein which may have a role in calcium homeostasis (By similarity). Acts as a non-receptor guanine nucleotide exchange factor which binds to and activates guanine nucleotide-binding protein (G-protein) alpha subunit GNAI3 (By similarity),calcium ion binding,Golgi apparatus,ligand,DrugBank,drugbank_id
BE0008702,Fibrillin-3,target,Q75N90,FBN3,Humans,"Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-containing microfibrils provide long-term force bearing structural support",calcium ion binding,"Secreted, extracellular space, extracellular matrix",ligand,DrugBank,drugbank_id
BE0008703,Grancalcin,target,P28676,GCA,Humans,Calcium-binding protein that may play a role in the adhesion of neutrophils to fibronectin. May play a role in the formation of focal adhesions,calcium ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0008704,Calcium-dependent secretion activator 1,target,Q9ULU8,CADPS,Humans,"Calcium-binding protein involved in exocytosis of vesicles filled with neurotransmitters and neuropeptides. Probably acts upstream of fusion in the biogenesis or maintenance of mature secretory vesicles. Regulates catecholamine loading of DCVs. May specifically mediate the Ca(2+)-dependent exocytosis of large dense-core vesicles (DCVs) and other dense-core vesicles by acting as a PtdIns(4,5)P2-binding protein that acts at prefusion step following ATP-dependent priming and participates in DCVs-me",lipid binding,Synapse,agonist,DrugBank,drugbank_id
BE0008707,Protein S100-A16,target,Q96FQ6,S100A16,Humans,"Calcium-binding protein. Binds one calcium ion per monomer (PubMed:17030513). Can promote differentiation of adipocytes (in vitro) (By similarity). Overexpression in preadipocytes increases their proliferation, enhances adipogenesis and reduces insulin-stimulated glucose uptake (By similarity)",calcium ion binding,"Nucleus, nucleolus",ligand,DrugBank,drugbank_id
BE0008708,Calretinin,target,P22676,CALB2,Humans,"Calcium-binding protein involved in calcium homeostasis and signal transduction. It plays a critical role in buffering intracellular calcium levels and modulating calcium-dependent signaling pathways (PubMed:2001709). Predominantly expressed in specific neuronal populations, influences synaptic plasticity and neuronal excitability, contributing to learning and memory (By similarity). During embryonic development, it facilitates neuronal differentiation and maturation (By similarity)",calcium ion binding,Synapse,ligand,DrugBank,drugbank_id
BE0008709,Calcyphosin,target,Q13938,CAPS,Humans,Calcium-binding protein. May play a role in cellular signaling events (Potential),calcium ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0008710,Calcium-dependent secretion activator 2,target,Q86UW7,CADPS2,Humans,Calcium-binding protein involved in exocytosis of vesicles filled with neurotransmitters and neuropeptides. Probably acts upstream of fusion in the biogenesis or maintenance of mature secretory vesicles. Regulates neurotrophin release from granule cells leading to regulate cell differentiation and survival during cerebellar development. May specifically mediate the Ca(2+)-dependent exocytosis of large dense-core vesicles (DCVs) and other dense-core vesicles (By similarity),lipid binding,Cytoplasmic vesicle membrane,agonist,DrugBank,drugbank_id
BE0008711,Calreticulin-3,target,Q96L12,CALR3,Humans,"During spermatogenesis, may act as a lectin-independent chaperone for specific client proteins such as ADAM3. Required for sperm fertility (By similarity). CALR3 capacity for calcium-binding may be absent or much lower than that of CALR",carbohydrate binding,Endoplasmic reticulum lumen,ligand,DrugBank,drugbank_id
BE0005274,Neurexin-1,target,Q9ULB1,NRXN1,Humans,"Cell surface protein involved in cell-cell-interactions, exocytosis of secretory granules and regulation of signal transmission. Function is isoform-specific. Alpha-type isoforms have a long N-terminus with six laminin G-like domains and play an important role in synaptic signal transmission. Alpha-type isoforms play a role in the regulation of calcium channel activity and Ca(2+)-triggered neurotransmitter release at synapses and at neuromuscular junctions. They play an important role in Ca(2+)-",acetylcholine receptor binding,Presynaptic cell membrane,agonist,DrugBank,drugbank_id
BE0004557,Neuronal calcium sensor 1,target,P62166,NCS1,Humans,"Neuronal calcium sensor, regulator of G protein-coupled receptor phosphorylation in a calcium dependent manner. Directly regulates GRK1 (RHOK), but not GRK2 to GRK5. Can substitute for calmodulin (By similarity). Stimulates PI4KB kinase activity (By similarity). Involved in long-term synaptic plasticity through its interaction with PICK1 (By similarity). May also play a role in neuron differentiation through inhibition of the activity of N-type voltage-gated calcium channel (By similarity)",calcium ion binding,Golgi apparatus,ligand,DrugBank,drugbank_id
BE0008690,Calbindin,carrier,P05937,CALB1,Humans,"Buffers cytosolic calcium. May stimulate a membrane Ca(2+)-ATPase and a 3',5'-cyclic nucleotide phosphodiesterase",calcium ion binding,,substrate,DrugBank,drugbank_id
BE0004083,Protein S100-G,carrier,P29377,S100G,Humans,,calcium ion binding,,substrate,DrugBank,drugbank_id
BE0005102,Transient receptor potential cation channel subfamily V member 6,transporter,Q9H1D0,TRPV6,Humans,"Calcium selective cation channel that mediates Ca(2+) uptake in various tissues, including the intestine (PubMed:11097838, PubMed:11248124, PubMed:11278579, PubMed:15184369, PubMed:23612980, PubMed:29258289). Important for normal Ca(2+) ion homeostasis in the body, including bone and skin (By similarity). The channel is activated by low internal calcium level, probably including intracellular calcium store depletion, and the current exhibits an inward rectification (PubMed:15184369). Inactivatio",calcium channel activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0005112,Transient receptor potential cation channel subfamily V member 5,transporter,Q9NQA5,TRPV5,Humans,"Constitutively active calcium selective cation channel thought to be involved in Ca(2+) reabsorption in kidney and intestine (PubMed:11549322, PubMed:18768590). Required for normal Ca(2+) reabsorption in the kidney distal convoluted tubules (By similarity). The channel is activated by low internal calcium level and the current exhibits an inward rectification (PubMed:11549322, PubMed:18768590). A Ca(2+)-dependent feedback regulation includes fast channel inactivation and slow current decay (By s",calcium channel activity,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0008712,Polycystin-2-like protein 1,transporter,Q9P0L9,PKD2L1,Humans,"Homotetrameric, non-selective cation channel that is permeable to sodium, potassium, magnesium and calcium (PubMed:10517637, PubMed:11959145, PubMed:25820328, PubMed:27754867, PubMed:29425510, PubMed:30004384). Also forms functionnal heteromeric channels with PKD1, PKD1L1 and PKD1L3 (PubMed:23212381, PubMed:24336289). Pore-forming subunit of a heterotetrameric, non-selective cation channel, formed by PKD1L2 and PKD1L3, that is permeable to sodium, potassium, magnesium and calcium and which may a",alpha-actinin binding,"Cell projection, cilium membrane",substrate,DrugBank,drugbank_id
BE0005296,Ryanodine receptor 3,transporter,Q15413,RYR3,Humans,"Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm in muscle and thereby plays a role in triggering muscle contraction (PubMed:12354756, PubMed:9395096). May regulate Ca(2+) release by other calcium channels. Calcium channel that mediates Ca(2+)-induced Ca(2+) release from the endoplasmic reticulum in non-muscle cells. Contributes to cellular calcium ion homeostasis (By similarity). Plays a role in cellular calcium s",calcium ion binding,Sarcoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0008713,Polycystin-1-like protein 3,transporter,Q7Z443,PKD1L3,Humans,"Pore-forming subunit of a heterotetrameric, non-selective cation channel that is permeable to Ca(2+) (PubMed:19464260, PubMed:23212381). Also shows permeability towards NA(1+), K(+) and Mg(2+) (PubMed:23212381). Heterotetrameric complex channel is activated by external low pH and Ca(2+), but opens only when the extracellular pH rises again and after the removal of acid stimulus (PubMed:19464260, PubMed:23212381). May act as a sour taste receptor in gustatory cells; however, its contribution to s",calcium channel activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0008714,Cation channel sperm-associated protein 1,transporter,Q8NEC5,CATSPER1,Humans,"Pore-forming subunit of the CatSper complex, a sperm-specific voltage-gated calcium channel that plays a central role in calcium-dependent physiological responses essential for successful fertilization, such as sperm hyperactivation, acrosome reaction and chemotaxis towards the oocyte",calcium-activated cation channel activity,"Cell projection, cilium, flagellum membrane",substrate,DrugBank,drugbank_id
BE0008717,Voltage-dependent P/Q-type calcium channel,transporter,O00555,CACNA1A,Humans,"Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1A gives rise to P and/or Q-type calcium currents. P/Q-type calcium channels belong to the 'high-voltage activated' (HVA) group and are specifically blocked by the spider omega-agatoxin-IVA",amyloid-beta binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0003753,Carboxypeptidase A1,enzyme,P15085,CPA1,Humans,"Carboxypeptidase that catalyzes the release of a C-terminal amino acid, but has little or no action with -Asp, -Glu, -Arg, -Lys or -Pro (PubMed:20385563, PubMed:8806703). Catalyzes the conversion of leukotriene C4 to leukotriene F4 via the hydrolysis of an amide bond (By similarity)",metallocarboxypeptidase activity,Secreted,substrate,DrugBank,drugbank_id
BE0004605,Selenocysteine lyase,enzyme,Q96I15,SCLY,Humans,Catalyzes the decomposition of L-selenocysteine to L-alanine and elemental selenium,amino acid binding,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0001173,Cytochrome b5,target,P00167,CYB5A,Humans,Cytochrome b5 is a membrane-bound hemoprotein functioning as an electron carrier for several membrane-bound oxygenases,enzyme binding,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0002091,Fibrinogen beta chain,target,P02675,FGB,Humans,"Cleaved by the protease thrombin to yield monomers which, together with fibrinogen alpha (FGA) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using a",extracellular matrix structural constituent,Secreted,cleavage,DrugBank,drugbank_id
BE0000004,Coagulation factor XIII A chain,target,P00488,F13A1,Humans,"Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin",metal ion binding,Cytoplasm,agonist,DrugBank,drugbank_id
BE0003407,Carboxypeptidase B2,target,Q96IY4,CPB2,Humans,Cleaves C-terminal arginine or lysine residues from biologically active peptides such as kinins or anaphylatoxins in the circulation thereby regulating their activities. Down-regulates fibrinolysis by removing C-terminal lysine residues from fibrin that has already been partially degraded by plasmin,metallocarboxypeptidase activity,Secreted,agonist,DrugBank,drugbank_id
BE0009375,Very long chain fatty acid elongase 5,enzyme,Q9NYP7,ELOVL5,Humans,Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6) acyl-CoA. May participate in the production of monounsaturated and of polyunsaturated VLCFAs of ,fatty acid elongase activity,Endoplasmic reticulum membrane,ligand,DrugBank,drugbank_id
BE0002246,Acyl-CoA 6-desaturase,enzyme,O95864,FADS2,Humans,"Involved in the biosynthesis of highly unsaturated fatty acids (HUFA) from the essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3) precursors, acting as a fatty acyl-coenzyme A (CoA) desaturase that introduces a cis double bond at carbon 6 of the fatty acyl chain. Catalyzes the first and rate limiting step in this pathway which is the desaturation of LA (18:2n-6) and ALA (18:3n-3) into gamma-linoleate (GLA) (18:3n-6) and stearidonate",acyl-CoA 6-desaturase activity,Endoplasmic reticulum membrane,ligand,DrugBank,drugbank_id
BE0009550,Prostaglandin G/H synthase 2,target,Q8SPQ9,PTGS2,Canis lupus familiaris,,enzyme binding,,inhibitor,DrugBank,drugbank_id
BE0003520,Interleukin-4,target,P05112,IL4,Humans,"Cytokine secreted primarily by mast cells, T-cells, eosinophils, and basophils that plays a role in regulating antibody production, hematopoiesis and inflammation, and the development of effector T-cell responses (PubMed:1993171, PubMed:3016727). Induces the expression of class II MHC molecules on resting B-cells. Enhances both secretion and cell surface expression of IgE and IgG1 (PubMed:1993171). Also regulates the expression of the low affinity Fc receptor for IgE (CD23) on both lymphocytes a",cytokine activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0001478,Genome polyprotein,target,P26663,,Hepatitis C virus genotype 1b (isolate BK),"Mature core protein
    Packages viral RNA to form a viral nucleocapsid, and promotes virion budding (Probable). Participates in the viral particle production as a result of its interaction with the non-structural protein 5A (By similarity). Binds RNA and may function as a RNA chaperone to induce the RNA structural rearrangements taking place during virus replication (Probable). Modulates viral translation initiation by interacting with viral IRES and 40S ribosomal subunit (By similarity). Affec",ATP binding,Host endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0001838,Serine hydroxymethyltransferase,target,P0A827,glyA,Shigella flexneri,"Catalyzes the reversible interconversion of serine and glycine with tetrahydrofolate (THF) serving as the one-carbon carrier. This reaction serves as the major source of one-carbon groups required for the biosynthesis of purines, thymidylate, methionine, and other important biomolecules. Also exhibits THF-independent aldolase activity toward beta-hydroxyamino acids, producing glycine and aldehydes, via a retro-aldol mechanism.",cobalt ion binding,Cytoplasm,,DrugBank,drugbank_id
BE0009755,Rabies Virus Proteins,target,P08667,G,Rabies virus (strain Pasteur vaccins / PV),"Attaches the virus to host cellular receptor, inducing endocytosis of the virion. In the endosome, the acidic pH induces conformational changes in the glycoprotein trimer, which trigger fusion between virus and cell membrane. There is convincing in vitro evidence that the muscular form of the nicotinic acetylcholine receptor (nAChR), the neuronal cell adhesion molecule (NCAM), and the p75 neurotrophin receptor (p75NTR) bind glycoprotein and thereby facilitate rabies virus entry into cells (By si",,Virion membrane,antibody,DrugBank,drugbank_id
BE0001411,Tetanus toxin,target,P04958,tetX,Clostridium tetani (strain Massachusetts / E88),"Tetanus toxin acts by inhibiting neurotransmitter release. It binds to peripheral neuronal synapses, is internalized and moves by retrograde transport up the axon into the spinal cord where it can move between postsynaptic and presynaptic neurons. It inhibits neurotransmitter release by acting as a zinc endopeptidase that catalyzes the hydrolysis of the '76-Gln-|-Phe-77' bond of synaptobrevin-2.",metalloendopeptidase activity,Cytoplasmic,blocker,DrugBank,drugbank_id
BE0010182,IgG receptor FcRn large subunit p51,target,P55899,FCGRT,Humans,"Cell surface receptor that transfers passive humoral immunity from the mother to the newborn. Binds to the Fc region of monomeric immunoglobulin gamma and mediates its selective uptake from milk (PubMed:10933786, PubMed:7964511). IgG in the milk is bound at the apical surface of the intestinal epithelium. The resultant FcRn-IgG complexes are transcytosed across the intestinal epithelium and IgG is released from FcRn into blood or tissue fluids. Throughout life, contributes to effective humoral i",beta-2-microglobulin binding,Cell membrane,ligand,DrugBank,drugbank_id
BE0000135,Alpha-aminoadipic semialdehyde dehydrogenase,target,P49419,ALDH7A1,Humans,"Multifunctional enzyme mediating important protective effects. Metabolizes betaine aldehyde to betaine, an important cellular osmolyte and methyl donor. Protects cells from oxidative stress by metabolizing a number of lipid peroxidation-derived aldehydes. Involved in lysine catabolism",aldehyde dehydrogenase (NAD+) activity,"Cytoplasm, cytosol",ligand,DrugBank,drugbank_id
BE0009022,"ATP synthase F(0) complex subunit g, mitochondrial",target,O75964,ATP5MG,Humans,"Subunit g, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside ",proton transmembrane transporter activity,Mitochondrion,ligand,DrugBank,drugbank_id
BE0009097,"ATP synthase peripheral stalk subunit OSCP, mitochondrial",target,P48047,ATP5PO,Humans,"Subunit OSCP, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating insi",ATP hydrolysis activity,Mitochondrion,ligand,DrugBank,drugbank_id
BE0004554,T-complex protein 1 subunit gamma,target,P49368,CCT3,Humans,"Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of actin, tubulin and other proteins upon ATP hydrolysis (PubMed:25467444, PubMed:36493755, PubMed:35449234, PubMed:37193829). The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance (PubMed:25467444). As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cil",ATP binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009098,Cysteine and glycine-rich protein 1,target,P21291,CSRP1,Humans,Could play a role in neuronal development,actinin binding,Nucleus,ligand,DrugBank,drugbank_id
BE0009099,Filamin-A,target,P21333,FLNA,Humans,"Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in cilio",actin filament binding,"Cytoplasm, cell cortex",ligand,DrugBank,drugbank_id
BE0005795,Alpha-ketoglutarate-dependent dioxygenase FTO,target,Q9C0B1,FTO,Humans,"RNA demethylase that mediates oxidative demethylation of different RNA species, such as mRNAs, tRNAs and snRNAs, and acts as a regulator of fat mass, adipogenesis and energy homeostasis (PubMed:22002720, PubMed:25452335, PubMed:26457839, PubMed:26458103, PubMed:28002401, PubMed:30197295). Specifically demethylates N(6)-methyladenosine (m6A) RNA, the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes (PubMed:22002720, PubMed:25452335, PubMed:26457839, PubMed:2645810",broad specificity oxidative DNA demethylase activity,Nucleus,ligand,DrugBank,drugbank_id
BE0009100,Heterogeneous nuclear ribonucleoprotein D0,target,Q14103,HNRNPD,Humans,Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Also binds to double- and single-stranded DNA sequences in a specific manner and functions a transcription factor. Each of the RNA-binding domains specifically can bind solely to a single-stranded non-monotonous 5'-UUAG-3' sequence and also weaker to the single-stranded 5'-TTAGGG-3' telomeric DNA repeat. Binds RNA oligonucleotides with 5'-UUAGGG-3' re,chromatin binding,Nucleus,ligand,DrugBank,drugbank_id
BE0009026,Heterogeneous nuclear ribonucleoprotein K,target,P61978,HNRNPK,Humans,"One of the major pre-mRNA-binding proteins. Binds tenaciously to poly(C) sequences. Likely to play a role in the nuclear metabolism of hnRNAs, particularly for pre-mRNAs that contain cytidine-rich sequences. Can also bind poly(C) single-stranded DNA. Plays an important role in p53/TP53 response to DNA damage, acting at the level of both transcription activation and repression. When sumoylated, acts as a transcriptional coactivator of p53/TP53, playing a role in p21/CDKN1A and 14-3-3 sigma/SFN in",cadherin binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009101,Heterochromatin protein 1-binding protein 3,target,Q5SSJ5,HP1BP3,Humans,"Component of heterochromatin that maintains heterochromatin integrity during G1/S progression and regulates the duration of G1 phase to critically influence cell proliferative capacity (PubMed:24830416). Mediates chromatin condensation during hypoxia, leading to increased tumor cell viability, radio-resistance, chemo-resistance and self-renewal (PubMed:25100860)",DNA binding,Nucleus,ligand,DrugBank,drugbank_id
BE0003432,Heat shock protein beta-1,target,P04792,HSPB1,Humans,"Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975). Plays a role in stress resistance and actin organization (PubMed:19166925). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742)",identical protein binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009102,Ras GTPase-activating-like protein IQGAP1,target,P46940,IQGAP1,Humans,Plays a crucial role in regulating the dynamics and assembly of the actin cytoskeleton. Recruited to the cell cortex by interaction with ILK which allows it to cooperate with its effector DIAPH1 to locally stabilize microtubules and allow stable insertion of caveolae into the plasma membrane (By similarity). Binds to activated CDC42 but does not stimulate its GTPase activity. Associates with calmodulin. May promote neurite outgrowth (PubMed:15695813). May play a possible role in cell cycle regul,actin filament binding,Cell membrane,ligand,DrugBank,drugbank_id
BE0004493,Galectin-1,target,P09382,LGALS1,Humans,"Lectin that binds beta-galactoside and a wide array of complex carbohydrates. Plays a role in regulating apoptosis, cell proliferation and cell differentiation. Inhibits CD45 protein phosphatase activity and therefore the dephosphorylation of Lyn kinase. Strong inducer of T-cell apoptosis. Plays a negative role in Th17 cell differentiation via activation of the receptor CD69 (PubMed:24752896)",lactose binding,"Secreted, extracellular space, extracellular matrix",ligand,DrugBank,drugbank_id
BE0000589,"Malate dehydrogenase, cytoplasmic",target,P40925,MDH1,Humans,"Catalyzes the reduction of aromatic alpha-keto acids in the presence of NADH (PubMed:2449162, PubMed:3052244). Plays essential roles in the malate-aspartate shuttle and the tricarboxylic acid cycle, important in mitochondrial NADH supply for oxidative phosphorylation (PubMed:31538237). Catalyzes the reduction of 2-oxoglutarate to 2-hydroxyglutarate, leading to elevated reactive oxygen species (ROS) (PubMed:34012073)",diiodophenylpyruvate reductase activity,"Cytoplasm, cytosol",ligand,DrugBank,drugbank_id
BE0003419,Puromycin-sensitive aminopeptidase,target,P55786,NPEPPS,Humans,Aminopeptidase with broad substrate specificity for several peptides. Involved in proteolytic events essential for cell growth and viability. May act as regulator of neuropeptide activity. Plays a role in the antigen-processing pathway for MHC class I molecules. Involved in the N-terminal trimming of cytotoxic T-cell epitope precursors. Digests the poly-Q peptides found in many cellular proteins. Digests tau from normal brain more efficiently than tau from Alzheimer disease brain,alanyl aminopeptidase activity,"Cytoplasm, cytosol",ligand,DrugBank,drugbank_id
BE0004118,Profilin-1,target,P07737,PFN1,Humans,"Binds to actin and affects the structure of the cytoskeleton. At high concentrations, profilin prevents the polymerization of actin, whereas it enhances it at low concentrations. By binding to PIP2, it inhibits the formation of IP3 and DG. Inhibits androgen receptor (AR) and HTT aggregation and binding of G-actin is essential for its inhibition of AR",actin binding,"Cytoplasm, cytoskeleton",ligand,DrugBank,drugbank_id
BE0009104,Large ribosomal subunit protein uL16,target,P27635,RPL10,Humans,Component of the large ribosomal subunit (PubMed:26290468). Plays a role in the formation of actively translating ribosomes (PubMed:26290468). May play a role in the embryonic brain development (PubMed:25316788),RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009105,Large ribosomal subunit protein eL14,target,P50914,RPL14,Humans,"Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:32669547)",cadherin binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009106,Large ribosomal subunit protein eL18,target,Q07020,RPL18,Humans,"Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688, PubMed:32669547)",RNA binding,"Cytoplasm, cytosol",ligand,DrugBank,drugbank_id
BE0009107,Large ribosomal subunit protein uL29,target,P42766,RPL35,Humans,"Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:32669547)",mRNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009108,Large ribosomal subunit protein uL4,target,P36578,RPL4,Humans,Component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell,RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009109,Small ribosomal subunit protein uS15,target,P62277,RPS13,Humans,"Component of the small ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and c",mRNA 5'-UTR binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009110,Small ribosomal subunit protein eS17,target,P08708,RPS17,Humans,"Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding,",RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009111,Small ribosomal subunit protein uS13,target,P62269,RPS18,Humans,Component of the small ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell,RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009112,Small ribosomal subunit protein eS19,target,P39019,RPS19,Humans,"Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Required for pre-rRNA processing and maturation of 40S ribosomal subunits (PubMed:16990592). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and riboso",fibroblast growth factor binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009113,Small ribosomal subunit protein eS28,target,P62857,RPS28,Humans,"Component of the small ribosomal subunit (PubMed:23636399, PubMed:25901680, PubMed:25957688). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:25901680, PubMed:25957688). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate wi",RNA binding,"Cytoplasm, cytosol",ligand,DrugBank,drugbank_id
BE0009114,Small ribosomal subunit protein uS7,target,P46782,RPS5,Humans,"Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding,",mRNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009115,Small ribosomal subunit protein eS6,target,P62753,RPS6,Humans,"Component of the 40S small ribosomal subunit (PubMed:23636399, PubMed:8706699). Plays an important role in controlling cell growth and proliferation through the selective translation of particular classes of mRNA (PubMed:17220279). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-",mRNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009116,Small ribosomal subunit protein eS8,target,P62241,RPS8,Humans,"Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding,",RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009117,Small ribosomal subunit protein uS4,target,P46781,RPS9,Humans,"Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding,",RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009118,Splicing factor 1,target,Q15637,SF1,Humans,Necessary for the ATP-dependent first step of spliceosome assembly. Binds to the intron branch point sequence (BPS) 5'-UACUAAC-3' of the pre-mRNA. May act as transcription repressor,identical protein binding,Nucleus,ligand,DrugBank,drugbank_id
BE0009119,Small nuclear ribonucleoprotein Sm D2,target,P62316,SNRPD2,Humans,"Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome (PubMed:11991638, PubMed:18984161, PubMed:19325628, PubMed:23333303, PubMed:25555158, PubMed:26912367, PubMed:28076346, PubMed:28502770, PubMed:28781166, PubMed:32494006). Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes (PubMed:11991638, PubMed:28076346, PubMed:28502770, PubMed",RNA binding,"Cytoplasm, cytosol",ligand,DrugBank,drugbank_id
BE0004503,Signal recognition particle 14 kDa protein,target,P37108,SRP14,Humans,"Component of the signal recognition particle (SRP) complex, a ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER) (PubMed:11089964). SRP9 together with SRP14 and the Alu portion of the SRP RNA, constitutes the elongation arrest domain of SRP (PubMed:11089964). The complex of SRP9 and SRP14 is required for SRP RNA binding (PubMed:11089964)",7S RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009120,Serine/arginine-rich splicing factor 4,target,Q08170,SRSF4,Humans,Plays a role in alternative splice site selection during pre-mRNA splicing. Represses the splicing of MAPT/Tau exon 10,RNA binding,Nucleus speckle,ligand,DrugBank,drugbank_id
BE0009160,Transgelin,target,Q01995,TAGLN,Humans,Actin cross-linking/gelling protein (By similarity). Involved in calcium interactions and contractile properties of the cell that may contribute to replicative senescence,actin binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009122,Transgelin-2,target,P37802,TAGLN2,Humans,,actin filament binding,,ligand,DrugBank,drugbank_id
BE0009037,Tropomyosin alpha-1 chain,target,P09493,TPM1,Humans,"Binds to actin filaments in muscle and non-muscle cells (PubMed:23170982). Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction (PubMed:23170982). Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments",actin binding,"Cytoplasm, cytoskeleton",ligand,DrugBank,drugbank_id
BE0004469,Vimentin,target,P08670,VIM,Humans,"Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally. Plays a role in cell directional movement, orientation, cell sheet organization and Golgi complex polarization at the cell migration front (By similarity). Protects SCRIB from proteasomal degradation and facilitates its localization to intermediate filaments in a cell conta",double-stranded RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009123,Zyxin,target,Q15942,ZYX,Humans,Adhesion plaque protein. Binds alpha-actinin and the CRP protein. Important for targeting TES and ENA/VASP family members to focal adhesions and for the formation of actin-rich structures. May be a component of a signal transduction pathway that mediates adhesion-stimulated changes in gene expression (By similarity),metal ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0003402,Tubulin beta-6 chain,target,Q9BUF5,TUBB6,Humans,"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin",GTP binding,"Cytoplasm, cytoskeleton",ligand,DrugBank,drugbank_id
BE0009161,Myosin-9,target,P35579,MYH9,Humans,"Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Required for cortical actin clearance prior to oocyte exocytosis (By similarity). Promotes cell motility in conjunction with S100A4 (PubMed:16707441). During cell spreading, plays an important role in cytoskeleton reorganization, focal contact formation (in the margins but not the central part of spreading cells), and lamellipodial retraction; this function is mechanic",actin binding,"Cytoplasm, cytoskeleton",ligand,DrugBank,drugbank_id
BE0009162,Probable ATP-dependent RNA helicase DDX5,target,P17844,DDX5,Humans,Involved in the alternative regulation of pre-mRNA splicing; its RNA helicase activity is necessary for increasing tau exon 10 inclusion and occurs in a RBM4-dependent manner. Binds to the tau pre-mRNA in the stem-loop region downstream of exon 10. The rate of ATP hydrolysis is highly stimulated by single-stranded RNA. Involved in transcriptional regulation; the function is independent of the RNA helicase activity. Transcriptional coactivator for androgen receptor AR but probably not ESR1. Syner,ATP binding,Nucleus,ligand,DrugBank,drugbank_id
BE0004598,Spliceosome RNA helicase DDX39B,target,Q13838,DDX39B,Humans,"Involved in nuclear export of spliced and unspliced mRNA (PubMed:15833825, PubMed:15998806, PubMed:17190602). Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA (PubMed:15833825, PubMed:15998806, PubMed:17190602). The TREX complex is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and ",ATP binding,Nucleus,ligand,DrugBank,drugbank_id
BE0009103,Nucleophosmin,target,P06748,NPM1,Humans,"Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stran",chromatin binding,"Nucleus, nucleolus",ligand,DrugBank,drugbank_id
BE0009163,Translationally-controlled tumor protein homolog,target,Q8I3Z5,TCTP,Plasmodium falciparum (isolate 3D7),Involved in calcium binding and microtubule stabilization.,calcium ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009164,P-type Ca(2+) transporter,target,Q5R2K6,serca,Plasmodium falciparum,,ATP binding,,antagonist,DrugBank,drugbank_id
BE0009165,Ornithine aminotransferase,target,Q6LFH8,OAT,Plasmodium falciparum (isolate 3D7),"The enzyme has a very narrow substrate specificity and can only catalyze the transamination of alpha-ketoglutarate with ornithine or N-acetylornithine and, to a lesser extent, of glutamate-5-semialdehyde with glutamate and alanine.",identical protein binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009167,Multidrug resistance protein 1,target,P13568,MDR1,Plasmodium falciparum (isolate FC27 / Papua New Guinea),Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.,ABC-type xenobiotic transporter activity,Membrane,ligand,DrugBank,drugbank_id
BE0009168,Elongation factor 2,target,Q8IKW5,,Plasmodium falciparum (isolate 3D7),,GTP binding,,ligand,DrugBank,drugbank_id
BE0009170,Actin-1,target,P86287,ACT1,Plasmodium falciparum (isolate HB3),"Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm (PubMed:15670824). Polymerizes into shorter and less stable actin filaments compared to ACT2/actin-2; this is thought to facilitate gliding motility and host cell invasion (PubMed:15670824). Has ATPase activity (By similarity). ATP hydrolysis leads to the formation of a stable intermediate ADP-inorganic phosphate (Pi) actin, which is followed by the release of Pi (By similar",ATP binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009171,Glyceraldehyde-3-phosphate dehydrogenase,target,Q8IKK7,,Plasmodium falciparum (isolate 3D7),,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,,ligand,DrugBank,drugbank_id
BE0009172,Fructose-bisphosphate aldolase,target,P14223,FBPA,Plasmodium falciparum,"Plays a key role in glycolysis by catalyzing the cleavage of fructose 1,6-bisphosphate into dihydroxyacetone phosphate and glyceraldehyde 3-phosphate (PubMed:2190085). Independently of its catalytic activity, connects the actin filaments, and thus the actomyosin motor, to cell surface adhesins of the thrombospondin-related anonymous protein (TRAP), the erythrocyte binding ligand (EBL) and reticulocyte binding homolog (RH) protein families; this interaction is probably involved in transducing the",actin binding,,ligand,DrugBank,drugbank_id
BE0009173,"Cell division cycle protein 48 homologue, putative",target,C6KT34,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009174,Heat shock protein 90,target,Q8IC05,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009175,RNA helicase,target,Q8IKF0,,Plasmodium falciparum (isolate 3D7),,3'-5' DNA/RNA helicase activity,,ligand,DrugBank,drugbank_id
BE0009176,Pyruvate kinase,target,C6KTA4,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0001448,L-lactate dehydrogenase,target,Q27743,,Plasmodium falciparum (isolate CDC / Honduras),,L-lactate dehydrogenase activity,,ligand,DrugBank,drugbank_id
BE0009177,Protein disulfide-isomerase,target,C0H4Y6,,Plasmodium falciparum (isolate 3D7),,protein disulfide isomerase activity,,ligand,DrugBank,drugbank_id
BE0009178,"Thioredoxin-related protein, putative",target,Q8IDH5,,Plasmodium falciparum (isolate 3D7),,protein disulfide isomerase activity,,ligand,DrugBank,drugbank_id
BE0009179,Spermidine synthase,target,Q8II73,,Plasmodium falciparum (isolate 3D7),,spermidine synthase activity,,ligand,DrugBank,drugbank_id
BE0009180,Probable ATP-dependent 6-phosphofructokinase,target,Q8I2Z8,,Plasmodium falciparum (isolate 3D7),"Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis.",6-phosphofructokinase activity,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009181,Glutamate dehydrogenase,target,Q8ILF7,,Plasmodium falciparum (isolate 3D7),,glutamate dehydrogenase (NADP+) activity,,ligand,DrugBank,drugbank_id
BE0009182,"Endoplasmin, putative",target,Q8I0V4,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009183,Enolase,target,Q8IJN7,ENO,Plasmodium falciparum (isolate 3D7),"Glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate (PubMed:19268421, PubMed:25787157). In addition to glycolysis, involved in various processes such as parasite development and invasion (By similarity). Plays an essential role during ookinete invasion of the mosquito vector midgut by mediating the interaction of the ookinete with the midgut epithelium and, further, by binding to mammalian host plasminogen in the blood meal, whose conversion to active pla",actin binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009184,40S ribosomal protein S3,target,Q8IKH8,,Plasmodium falciparum (isolate 3D7),,RNA binding,,ligand,DrugBank,drugbank_id
BE0009185,P-type sodium-transporting ATPase4,target,A0A143ZZK9,ATP4,Plasmodium falciparum (isolate 3D7),"Sodium-exporting ATPase (PubMed:23414762, PubMed:29986883, PubMed:31311978, PubMed:36180431). Required for the extrusion of Na(+) from the intraerythrocytic parasites to maintain a low cytosolic concentration of Na(+) (PubMed:23414762, PubMed:25322084, PubMed:25453091, PubMed:29555632, PubMed:36180431).",ABC-type sodium transporter activity,,ligand,DrugBank,drugbank_id
BE0009186,Tubulin alpha chain,target,P14642,,Plasmodium falciparum (isolate K1 / Thailand),"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin.",GTP binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009187,Knob-associated histidine-rich protein,target,P13817,,Plasmodium falciparum,KAHRP might mimick human histidine-rich glycoproteins to anchor host thrombospondin or a parasite analog in a binding complex with the endothelial cell receptor.,,Secreted,ligand,DrugBank,drugbank_id
BE0009188,S-adenosylmethionine synthase,target,Q7K6A4,,Plasmodium falciparum (isolate 3D7),Catalyzes the formation of S-adenosylmethionine from methionine and ATP.,ATP binding,,ligand,DrugBank,drugbank_id
BE0009189,H(+)-exporting diphosphatase,target,Q8IKR1,,Plasmodium falciparum (isolate 3D7),,diphosphate hydrolysis-driven proton transmembrane transporter activity,,ligand,DrugBank,drugbank_id
BE0009190,Large ribosomal subunit protein uL4,target,Q8I431,,Plasmodium falciparum (isolate 3D7),,RNA binding,,ligand,DrugBank,drugbank_id
BE0009191,Phosphoethanolamine N-methyltransferase,target,Q8IDQ9,PMT,Plasmodium falciparum (isolate 3D7),"Catalyzes N-methylation of phosphoethanolamine, phosphomonomethylethanolamine and phosphodimethylethanolamine, the three methylation steps required to convert phosphoethanolamine to phosphocholine (PubMed:15073329, PubMed:15664981, PubMed:18178564, PubMed:18694927, PubMed:22117061). Has no ethanolamine- or phosphatidylethanolamine-N-methyltransferase activity (PubMed:15073329, PubMed:15664981). Required for gametocyte development, maturation and transmission to mosquitoes and for oocyst formatio",phosphoethanolamine N-methyltransferase activity,,ligand,DrugBank,drugbank_id
BE0009192,Small ribosomal subunit protein eS1,target,O97313,RPS3A,Plasmodium falciparum (isolate 3D7),"Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (Probable). The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules (Probable). The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered",structural constituent of ribosome,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009193,Protein ARV,target,Q8IJT2,,Plasmodium falciparum (isolate 3D7),"Mediator of sterol homeostasis involved in sterol uptake, trafficking and distribution into membranes.",,,ligand,DrugBank,drugbank_id
BE0009194,60S ribosomal protein L3,target,Q8IJC6,,Plasmodium falciparum (isolate 3D7),,RNA binding,,ligand,DrugBank,drugbank_id
BE0009195,High molecular weight rhoptry protein 2,target,C0H571,RhopH2,Plasmodium falciparum (isolate 3D7),Participates in the formation of new permeability pathways in Plasmodium-infected erythrocytes enabling the uptake of nutrients from the blood plasma (PubMed:28252383). Required for maintaining invasion capacity of merozoites (PubMed:28252383). Required for parasite growth and proliferation (PubMed:28252383).,,,ligand,DrugBank,drugbank_id
BE0009196,Serine repeat antigen 5,target,T1RTG8,SERA5,Plasmodium falciparum,,cysteine-type peptidase activity,,ligand,DrugBank,drugbank_id
BE0009197,40S ribosomal protein S19,target,C0H5C2,,Plasmodium falciparum (isolate 3D7),,RNA binding,,ligand,DrugBank,drugbank_id
BE0009198,Glycophorin-binding protein 130,target,Q8I6U8,GBP130,Plasmodium falciparum (isolate 3D7),Involved in merozoite invasion of host erythrocytes.,,,ligand,DrugBank,drugbank_id
BE0009199,Calcium-transporting ATPase,target,Q08853,ATP6,Plasmodium falciparum (isolate K1 / Thailand),This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of the calcium.,ATP binding,Membrane,ligand,DrugBank,drugbank_id
BE0009200,V-type proton ATPase catalytic subunit A,target,Q76NM6,vapA,Plasmodium falciparum (isolate 3D7),"Catalytic subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (By similarity). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:10915784). During the trophozoite stage,",ATP binding,,ligand,DrugBank,drugbank_id
BE0009201,60S ribosomal protein L2,target,Q8I3T9,,Plasmodium falciparum (isolate 3D7),,RNA binding,,ligand,DrugBank,drugbank_id
BE0009202,Acyl-CoA synthetase,target,Q8I0X2,,Plasmodium falciparum (isolate 3D7),,ankyrin binding,,ligand,DrugBank,drugbank_id
BE0009203,Plasmepsin IV,target,Q8IM16,PMIV,Plasmodium falciparum (isolate 3D7),"During the asexual blood stage, catalyzes the cleavage of denatured host hemoglobin (Hb) (By similarity). Digestion of host Hb is an essential step which provides the parasite with amino acids for protein synthesis, and regulates osmolarity (Probable).",aspartic-type endopeptidase activity,,ligand,DrugBank,drugbank_id
BE0009204,Plasmepsin I,target,Q7KQM4,PMI,Plasmodium falciparum (isolate 3D7),"During the asexual blood stage, catalyzes the initial cleavage of native host hemoglobin (Hb) resulting in Hb denaturation; specifically cleaves between Phe-33 and Leu-34 of Hb alpha-chain. Digestion of host Hb is an essential step which provides the parasite with amino acids for protein synthesis, and regulates osmolarity.",aspartic-type endopeptidase activity,Vacuole,ligand,DrugBank,drugbank_id
BE0009205,Chloroquine resistance transporter,target,Q9N623,CRT,Plasmodium falciparum,"Nutrient transporter (PubMed:25733858, PubMed:32764664, PubMed:35867395). Substrate transport is pH-dependent (PubMed:25733858, PubMed:37454114). Can transport arginine, lysine, histidine, peptides, histamine and spermidine (PubMed:25733858, PubMed:32764664, PubMed:35867395). May modulate activity of endogenous transporters (PubMed:15258157). Involved in maintaining the osmotic homeostasis of the digestive vacuole (PubMed:26351679, PubMed:26420308, PubMed:35867395). Required for the asexual intr",xenobiotic transmembrane transporter activity,Vacuole membrane,ligand,DrugBank,drugbank_id
BE0009206,14-3-3 protein I,target,C0H4V6,14-3-3I,Plasmodium falciparum (isolate 3D7),"Adapter protein which binds to its partners, usually via a phosphoserine or phosphothreonine motif (PubMed:23308157, PubMed:32484216, PubMed:32817103). Binding generally results in the modulation of the activity and/or cellular localization of the binding partner (Probable). Via its interaction with CDPK1 and PKAr, involved in merozoite microneme secretion and thus in merozoite invasion of host erythrocytes (PubMed:32817103).",histone binding,,ligand,DrugBank,drugbank_id
BE0009207,"Isoleucine--tRNA ligase, putative",target,Q8I5G6,,Plasmodium falciparum (isolate 3D7),,aminoacyl-tRNA editing activity,,ligand,DrugBank,drugbank_id
BE0009208,Plasmodium RESA N-terminal domain-containing protein,target,C6S3C7,,Plasmodium falciparum (isolate 3D7),,,,ligand,DrugBank,drugbank_id
BE0009209,Tubulin beta chain,target,Q7KQL5,,Plasmodium falciparum (isolate 3D7),"Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers (PubMed:33633135). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin.",GTP binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009210,60S ribosomal protein L27,target,Q8IKM5,,Plasmodium falciparum (isolate 3D7),,structural constituent of ribosome,,ligand,DrugBank,drugbank_id
BE0009211,Translocation protein SEC62,target,Q8IL86,,Plasmodium falciparum (isolate 3D7),,,,ligand,DrugBank,drugbank_id
BE0009212,Autophagy-related protein 18,target,Q8IJR6,,Plasmodium falciparum (isolate 3D7),,"phosphatidylinositol-3,5-bisphosphate binding",,ligand,DrugBank,drugbank_id
BE0009213,Mature parasite-infected erythrocyte surface antigen,target,Q8I492,,Plasmodium falciparum (isolate 3D7),,,,ligand,DrugBank,drugbank_id
BE0009214,"Importin-7, putative",target,C0H4L1,,Plasmodium falciparum (isolate 3D7),,small GTPase binding,Nucleus,ligand,DrugBank,drugbank_id
BE0009740,Importin subunit alpha,target,Q8IAW0,,Plasmodium falciparum (isolate 3D7),,nuclear import signal receptor activity,,ligand,DrugBank,drugbank_id
BE0009216,Peptidyl-prolyl cis-trans isomerase,target,Q76NN7,,Plasmodium falciparum (isolate 3D7),PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides.,cyclosporin A binding,,ligand,DrugBank,drugbank_id
BE0009217,"DnaJ protein, putative",target,Q8IB72,,Plasmodium falciparum (isolate 3D7),,nucleic acid binding,,ligand,DrugBank,drugbank_id
BE0009218,Merozoite surface protein 1,target,P13827,MSP1,Plasmodium falciparum (isolate CDC / Honduras),"During the asexual blood stage, involved in merozoite egress from host erythrocytes possibly via its interaction with the host cytoskeleton protein spectrin resulting in the destabilization of the host cytoskeleton and thus leading to erythrocyte cell membrane rupture (By similarity). Involved in the binding to host erythrocytes and is required for host erythrocyte invasion (By similarity).",,Cell membrane,ligand,DrugBank,drugbank_id
BE0009219,Glutamate--tRNA ligase,target,Q8IDD3,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009220,T-complex protein 1 subunit eta,target,O77323,,Plasmodium falciparum (isolate 3D7),"Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. Known to play a role, in vitro, in the folding of actin and tubulin (By similarity).",ATP binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009221,"Chaperone, putative",target,C0H546,,Plasmodium falciparum (isolate 3D7),,ATPase activator activity,,ligand,DrugBank,drugbank_id
BE0009222,Rhoptry neck protein 3,target,Q8I4R5,,Plasmodium falciparum (isolate 3D7),,host cell surface binding,,ligand,DrugBank,drugbank_id
BE0009223,"40S ribosomal protein S5, putative",target,Q8IBN5,,Plasmodium falciparum (isolate 3D7),,mRNA binding,,ligand,DrugBank,drugbank_id
BE0009224,Skeleton-binding protein 1,target,Q8I487,,Plasmodium falciparum (isolate 3D7),,,,ligand,DrugBank,drugbank_id
BE0003172,Purine nucleoside phosphorylase,target,Q8I3X4,PNP,Plasmodium falciparum (isolate 3D7),"As part of the purine salvage pathway, catalyzes the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate (PubMed:14982926, PubMed:16131758, PubMed:18957439, PubMed:19575810, PubMed:24416224, PubMed:29440412). Preferentially acts on inosine and guanosine, and to a lesser extent on 2'-deoxyguanosine and guanosine (PubMed:14982926, PubMed:16131758, PubMed:19575810). Also cata",guanosine phosphorylase activity,,ligand,DrugBank,drugbank_id
BE0009225,Adenosylhomocysteinase,target,P50250,,Plasmodium falciparum (isolate 3D7),Adenosylhomocysteine is a competitive inhibitor of S-adenosyl-L-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylations via regulation of the intracellular concentration of adenosylhomocysteine.,adenosylhomocysteinase activity,,ligand,DrugBank,drugbank_id
BE0009226,Adenosine deaminase,target,Q8IJA9,ADA,Plasmodium falciparum (isolate 3D7),"Catalyzes the hydrolytic deamination of adenosine to produce inosine (PubMed:19728741, PubMed:31002765). Unlike mammalian adenosine deaminases, also catalyzes the deamination of 5'-methylthioadenosine (MTA), a by-product of polyamine biosynthesis, to produce 5'-methylthioinosine (MTI) (PubMed:19728741, PubMed:31002765). Plays an essential role in the purine salvage pathway which allows the parasite to use host cell purines for the synthesis of nucleic acids (Probable).",2'-deoxyadenosine deaminase activity,,ligand,DrugBank,drugbank_id
BE0009227,Methionine--tRNA ligase,target,Q8IJ60,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009228,carbamoyl-phosphate synthase (ammonia),target,Q8IEN3,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009230,Signal recognition particle receptor subunit beta,target,Q8I4W4,,Plasmodium falciparum (isolate 3D7),,GTP binding,,ligand,DrugBank,drugbank_id
BE0009231,"N-acetylgalactosaminide beta-1,3-galactosyltransferase",target,O77361,,Plasmodium falciparum (isolate 3D7),,glycosyltransferase activity,,ligand,DrugBank,drugbank_id
BE0009232,"Coatomer alpha subunit, putative",target,C6KSR5,,Plasmodium falciparum (isolate 3D7),,structural molecule activity,,ligand,DrugBank,drugbank_id
BE0009233,Hexokinase,target,Q02155,HK,Plasmodium falciparum,Catalyzes the phosphorylation of various hexoses to hexose 6-phosphate.,ATP binding,,ligand,DrugBank,drugbank_id
BE0009234,Proteasome subunit alpha type,target,Q8IBI3,,Plasmodium falciparum (isolate 3D7),,endopeptidase activity,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009235,Haloacid dehalogenase-like hydrolase,target,Q8IJ74,,Plasmodium falciparum (isolate 3D7),,metal ion binding,,ligand,DrugBank,drugbank_id
BE0009236,"Insulinase, putative",target,Q8III5,,Plasmodium falciparum (isolate 3D7),,metal ion binding,,ligand,DrugBank,drugbank_id
BE0009237,40S ribosomal protein S21,target,Q8IHS5,,Plasmodium falciparum (isolate 3D7),,structural constituent of ribosome,,ligand,DrugBank,drugbank_id
BE0009238,Ubiquitin-conjugating enzyme E2,target,Q8IDP1,,Plasmodium falciparum (isolate 3D7),,ligase activity,,ligand,DrugBank,drugbank_id
BE0009239,Eukaryotic translation initiation factor 3 subunit C,target,Q8I5Y3,,Plasmodium falciparum (isolate 3D7),"Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is involved in protein synthesis of a specialized repertoire of mRNAs and, together with other initiation factors, stimulates binding of mRNA and methionyl-tRNAi to the 40S ribosome. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation.",RNA binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009240,"60S ribosomal protein L24, putative",target,Q8IEM3,,Plasmodium falciparum (isolate 3D7),,mRNA binding,,ligand,DrugBank,drugbank_id
BE0009241,60S ribosomal protein L23,target,Q8IE82,,Plasmodium falciparum (isolate 3D7),,rRNA binding,,ligand,DrugBank,drugbank_id
BE0009242,Large ribosomal subunit protein uL22,target,Q8IDI5,,Plasmodium falciparum (isolate 3D7),,structural constituent of ribosome,,ligand,DrugBank,drugbank_id
BE0009244,Plasmepsin III,target,Q8IM15,PMIII,Plasmodium falciparum (isolate 3D7),"During the asexual blood stage, catalyzes the cleavage of denatured host hemoglobin (Hb) or globins (PubMed:16624575). Digestion of host Hb is an essential step which provides the parasite with amino acids for protein synthesis, and regulates osmolarity (Probable).",aspartic-type endopeptidase activity,,ligand,DrugBank,drugbank_id
BE0009245,Endoplasmic reticulum chaperone GRP170,target,C0H5H0,,Plasmodium falciparum (isolate 3D7),,adenyl-nucleotide exchange factor activity,,ligand,DrugBank,drugbank_id
BE0009246,"60S ribosomal protein L10, putative",target,Q8ILV2,,Plasmodium falciparum (isolate 3D7),,structural constituent of ribosome,,ligand,DrugBank,drugbank_id
BE0009247,"Esterase, putative",target,Q8IM74,,Plasmodium falciparum (isolate 3D7),,hydrolase activity,,ligand,DrugBank,drugbank_id
BE0009248,Polyadenylate-binding protein,target,Q8I5H4,,Plasmodium falciparum (isolate 3D7),Binds the poly(A) tail of mRNA.,mRNA 3'-UTR binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009249,Ubiquitin-60S ribosomal protein L40,target,Q8ID50,,Plasmodium falciparum (isolate 3D7),Component of the 60S subunit of the ribosome.,protein tag activity,,ligand,DrugBank,drugbank_id
BE0009741,ribose-phosphate diphosphokinase,target,Q8IE67,,Plasmodium falciparum (isolate 3D7),,magnesium ion binding,,ligand,DrugBank,drugbank_id
BE0009251,Thioredoxin peroxidase 1,target,Q8IL80,,Plasmodium falciparum (isolate 3D7),"Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively.",antioxidant activity,,ligand,DrugBank,drugbank_id
BE0009252,Protein transport protein SEC31,target,O96221,,Plasmodium falciparum (isolate 3D7),,structural molecule activity,,ligand,DrugBank,drugbank_id
BE0009253,Dipeptidyl aminopeptidase 1,target,Q8IIJ9,DPAP1,Plasmodium falciparum (isolate 3D7),"Thiol protease that cleaves dipeptides from the N-terminus of protein substrates (PubMed:15304495, PubMed:20833209). Active against a broad range of dipeptide substrates composed of both polar and hydrophobic amino acids (PubMed:20833209). Proline cannot occupy the P1 position and arginine or lysine cannot occupy the P2 position of the substrate (PubMed:20833209). Involved in host hemoglobin degradation by generating dipeptides from hemoglobin-derived oligopeptides (PubMed:15304495).",cysteine-type peptidase activity,,ligand,DrugBank,drugbank_id
BE0009254,Ring-infected erythrocyte surface antigen,target,P13830,RESA,Plasmodium falciparum (isolate FC27 / Papua New Guinea),May disrupt the normal intermolecular interactions of the cytoplasmic domain of band 3 and thereby facilitate the invagination of the red cell membrane which is necessary for the formation of the parasitophorous vacuole.,,Cell membrane,ligand,DrugBank,drugbank_id
BE0009255,RNA helicase,target,Q9TY94,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009256,Calcium-dependent protein kinase 4,target,Q8IBS5,CDPK4,Plasmodium falciparum (isolate 3D7),"Calcium-dependent protein kinase which acts as a sensor and effector of intracellular Ca(2+) levels probably in part downstream of cGMP-activated PKG kinase (PubMed:19307175, PubMed:19666141). Plays a central role in the host erythrocytes and hepatocytes infection cycles, sexual reproduction and mosquito transmission of the parasite. During the liver stage, involved in sporozoite motility and thus in sporozoite invasion of host hepatocytes, probably together with CDPK1 and CDPK5. Involved in mer",ATP binding,,ligand,DrugBank,drugbank_id
BE0009257,GTP-binding nuclear protein Ran,target,P38545,,Plasmodium falciparum,GTP-binding protein involved in nucleocytoplasmic transport. Required for the import of protein into the nucleus and also for RNA export. Involved in chromatin condensation and control of cell cycle (By similarity).,GTP binding,Nucleus,ligand,DrugBank,drugbank_id
BE0009258,Nucleoside transporter 2,target,Q8IB78,,Plasmodium falciparum (isolate 3D7),,nucleoside transmembrane transporter activity,,ligand,DrugBank,drugbank_id
BE0009259,Anamorsin homolog,target,C0H4X5,,Plasmodium falciparum (isolate 3D7),"Component of the cytosolic iron-sulfur (Fe-S) protein assembly (CIA) machinery. Required for the maturation of extramitochondrial Fe-S proteins. Part of an electron transfer chain functioning in an early step of cytosolic Fe-S biogenesis, facilitating the de novo assembly of a [4Fe-4S] cluster on the cytosolic Fe-S scaffold complex. Electrons are transferred from NADPH via a FAD- and FMN-containing diflavin oxidoreductase. Together with the diflavin oxidoreductase, also required for the assembly","2 iron, 2 sulfur cluster binding",Cytoplasm,ligand,DrugBank,drugbank_id
BE0009260,"Glutamine synthetase, putative",target,C0H551,,Plasmodium falciparum (isolate 3D7),,glutamine synthetase activity,,ligand,DrugBank,drugbank_id
BE0009261,"60S ribosomal protein L30e, putative",target,Q8IJK8,,Plasmodium falciparum (isolate 3D7),,RNA binding,,ligand,DrugBank,drugbank_id
BE0009262,non-specific serine/threonine protein kinase,target,Q8IIR9,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009263,Threonine--tRNA ligase,target,Q8IIA4,,Plasmodium falciparum (isolate 3D7),,ATP binding,,ligand,DrugBank,drugbank_id
BE0009264,cAMP-dependent protein kinase regulatory subunit,target,Q7KQK0,,Plasmodium falciparum (isolate 3D7),,AMP-activated protein kinase activity,,ligand,DrugBank,drugbank_id
BE0009266,Thioredoxin-like protein,target,Q8IKL4,tlp1,Plasmodium falciparum (isolate 3D7),,,,ligand,DrugBank,drugbank_id
BE0009267,60S ribosomal protein L21,target,Q8ILK3,,Plasmodium falciparum (isolate 3D7),,structural constituent of ribosome,,ligand,DrugBank,drugbank_id
BE0009268,"60S ribosomal protein L14, putative",target,Q8ILE8,,Plasmodium falciparum (isolate 3D7),,RNA binding,,ligand,DrugBank,drugbank_id
BE0009269,Inner membrane complex sub-compartment protein 3,target,Q8IKM6,,Plasmodium falciparum (isolate 3D7),,,,ligand,DrugBank,drugbank_id
BE0009270,"HSP40, subfamily A",target,Q8IL88,,Plasmodium falciparum (isolate 3D7),,Hsp70 protein binding,,ligand,DrugBank,drugbank_id
BE0009271,Pyridoxal 5'-phosphate synthase subunit Pdx1,target,C6KT50,pdx1,Plasmodium falciparum (isolate 3D7),"Catalyzes the formation of pyridoxal 5'-phosphate from ribose 5-phosphate (RBP), glyceraldehyde 3-phosphate (G3P) and ammonia. The ammonia is provided by Pdx2. Can also use ribulose 5-phosphate and dihydroxyacetone phosphate as substrates, resulting from enzyme-catalyzed isomerization of RBP and G3P, respectively.",amine-lyase activity,Cytoplasm,ligand,DrugBank,drugbank_id
BE0009917,Receptor tyrosine-protein kinase erbB-3,target,P21860,ERBB3,Humans,Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins. Binds to neuregulin-1 (NRG1) and is activated by it; ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase (PubMed:20682778). May also be activated by CSPG5 (PubMed:15358134). Involved in the regulation of myeloid cell differentiation (PubMed:27416908),ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000358,Calcineurin subunit B type 1,target,P63098,PPP3R1,Humans,"Regulatory subunit of calcineurin, a calcium-dependent, calmodulin stimulated protein phosphatase. Confers calcium sensitivity",calcium ion binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0003404,Aurora kinase B,target,Q96GD4,AURKB,Humans,"Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis (PubMed:11516652, PubMed:12925766, PubMed:14610074, PubMed:14722118, PubMed:29449677). The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly (PubMed:11516652, PubMed:12925766, PubMed:14610074, PubMed:14722118, PubMed:2",ATP binding,Nucleus,modulator,DrugBank,drugbank_id
BE0000991,Aurora kinase A,target,O14965,AURKA,Humans,"Mitotic serine/threonine kinase that contributes to the regulation of cell cycle progression (PubMed:11039908, PubMed:12390251, PubMed:17125279, PubMed:17360485, PubMed:18615013, PubMed:26246606). Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cyt",ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",modulator,DrugBank,drugbank_id
BE0004601,Aurora kinase C,target,Q9UQB9,AURKC,Humans,"Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Also plays a role in meiosis and more particularly in spermatogenesis. Has redundant cellular functions with AURKB and can rescue an AURKB knockdown. Like AURKB, ",ATP binding,Nucleus,modulator,DrugBank,drugbank_id
BE0003772,Mitogen-activated protein kinase 9,target,P45984,MAPK9,Humans,"Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual sp",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001097,Mitogen-activated protein kinase 10,target,P53779,MAPK10,Humans,"Serine/threonine-protein kinase involved in various processes such as neuronal proliferation, differentiation, migration and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK10/JNK3. In turn, MAPK10/JNK3 phosphorylates a number of transcription f",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009456,LIM domain kinase 2,target,P53671,LIMK2,Humans,"Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics (PubMed:10436159, PubMed:11018042). Acts downstream of several Rho family GTPase signal transduction pathways (PubMed:10436159, PubMed:11018042). Involved in astral microtubule organization and mitotic spindle orientation during early stages of mitosis by mediating phosphorylation of TPPP (PubMed:22328514). Displays serine/threonine-specific phosphorylation of myelin basic protein and histon",ATP binding,"Cytoplasm, cytoskeleton, spindle",inhibitor,DrugBank,drugbank_id
BE0010122,Dual specificity mitogen-activated protein kinase kinase 4,target,P45985,MAP2K4,Humans,"Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their ",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009388,Serine/threonine-protein kinase 36,target,Q9NRP7,STK36,Humans,"Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors (PubMed:10806483). Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization (PubMed:10806483). GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for th",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0012496,Proto-oncogene Mas,target,P04201,MAS1,Humans,"Receptor for angiotensin 1-7 (By similarity). Acts specifically as a functional antagonist of AGTR1 (angiotensin-2 type 1 receptor), although it up-regulates AGTR1 receptor levels. Positive regulation of AGTR1 levels occurs through activation of the G-proteins GNA11 and GNAQ, and stimulation of the protein kinase C signaling cascade. The antagonist effect on AGTR1 function is probably due to AGTR1 being physically altered by MAS1",angiotensin receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0009378,Hydrogen potassium ATPase,target,P20648,ATP4A,Humans,"The catalytic subunit of the gastric H(+)/K(+) ATPase pump which transports H(+) ions in exchange for K(+) ions across the apical membrane of parietal cells. Uses ATP as an energy source to pump H(+) ions to the gastric lumen while transporting K(+) ion from the lumen into the cell (By similarity). Remarkably generates a million-fold proton gradient across the gastric parietal cell membrane, acidifying the gastric juice down to pH 1 (By similarity). Within a transport cycle, the transfer of a H(",ATP binding,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0009525,Serine/threonine-protein kinase D1,target,Q15139,PRKD1,Humans,"Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of MAPK8/JNK1 and Ras signaling, Golgi membrane integrity and trafficking, cell survival through NF-kappa-B activation, cell migration, cell differentiation by mediating HDAC7 nuclear export, cell proliferation via MAPK1/3 (ERK1/2) signaling, and plays a role in cardiac hypertrophy, VEGFA-induced angiogenesis, genotoxic-ind",ATP binding,Cytoplasm,activator,DrugBank,drugbank_id
BE0009926,Protein unc-13 homolog B,target,Q9Z1N9,Unc13b,Mouse,"Plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway. Is involved in neurotransmitter release by acting in synaptic vesicle priming prior to vesicle fusion and participates in the activity-depending refilling of readily releasable vesicle pool (RRP) (By similarity). Essential for synaptic vesicle maturation in a subset of excitatory/glutamatergic but not inhibitory/GABA-mediated synapses. In collaboration with UNC13A, facilitates neurona",calcium ion binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0000264,Activin receptor type-1,target,Q04771,ACVR1,Humans,"Bone morphogenetic protein (BMP) type I receptor that is involved in a wide variety of biological processes, including bone, heart, cartilage, nervous, and reproductive system development and regulation (PubMed:20628059, PubMed:22977237). As a type I receptor, forms heterotetrameric receptor complexes with the type II receptors AMHR2, ACVR2A or ACVR2B (PubMed:17911401). Upon binding of ligands such as BMP7 or GDF2/BMP9 to the heteromeric complexes, type II receptors transphosphorylate ACVR1 intr",activin binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0018249,Interleukin-17 receptor A,target,Q96F46,IL17RA,Humans,"Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Receptor for IL17A (PubMed:17911633, PubMed:9367539). Receptor for IL17F (PubMed:17911633, PubMed:19838198). Binds to IL17A with higher affinity than to IL17F (PubMed:17911633). Binds IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RC (PubMed:16785495). Also binds heterodimers formed by IL17A and IL17F as pa",interleukin-17 receptor activity,Cell membrane,antagonist|inhibitor,DrugBank,drugbank_id
BE0020027,Interleukin-17 receptor B,target,Q9NRM6,IL17RB,Humans,Receptor for the pro-inflammatory cytokines IL17B and IL17E. May play a role in controlling the growth and/or differentiation of hematopoietic cells,cytokine receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0017016,Interleukin-17 receptor C,target,Q8NAC3,IL17RC,Humans,"Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (By similarity). Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Receptor for IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RA (PubMed:16785495). Receptor for the heterodimer formed by IL1",coreceptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0017358,Interleukin-17 receptor D,target,Q8NFM7,IL17RD,Humans,"Feedback inhibitor of fibroblast growth factor mediated Ras-MAPK signaling and ERK activation (PubMed:12807873, PubMed:12958313). Regulates the nuclear ERK signaling pathway by spatially blocking nuclear translocation of activated ERK without inhibiting cytoplasmic phosphorylation of ERK (PubMed:15239952). Mediates JNK activation and may be involved in apoptosis (By similarity). May inhibit FGF-induced FGFR1 tyrosine phosphorylation (By similarity). Might have a role in the early stages of fate ",interleukin-17 receptor activity,Golgi apparatus membrane,antagonist,DrugBank,drugbank_id
BE0017393,Interleukin-17 receptor E,target,Q8NFR9,IL17RE,Humans,Specific functional receptor for IL17C. May be signaling through the NF-kappa-B and MAPK pathways. May require TRAF3IP2 /ACT1 for signaling. May be a crucial regulator in innate immunity to bacterial pathogens. Isoform 2 and isoform 4 may be either cytoplasmic inactive or dominant active forms. Isoform 3 and isoform 5 may act as soluble decoy receptors,interleukin-17 receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0002838,Envelope glycoprotein gp160,target,P12488,env,HIV-1,"Envelope glycoprotein gp160
    Oligomerizes in the host endoplasmic reticulum into predominantly trimers. In a second time, gp160 transits in the host Golgi, where glycosylation is completed. The precursor is then proteolytically cleaved in the trans-Golgi and thereby activated by cellular furin or furin-like proteases to produce gp120 and gp41.",structural molecule activity,Virion membrane,inhibitor,DrugBank,drugbank_id
BE0004281,Elongation factor 2,target,P13639,EEF2,Humans,"Catalyzes the GTP-dependent ribosomal translocation step during translation elongation (PubMed:26593721). During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively (PubMed:26593721). Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome (PubMed:26593721)",5S rRNA binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009665,Sclerostin,target,Q9BQB4,SOST,Humans,Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation,BMP binding,"Secreted, extracellular space, extracellular matrix",inhibitor,DrugBank,drugbank_id
BE0002438,Interleukin-13,target,P35225,IL13,Humans,"Cytokine that plays important roles in allergic inflammation and immune response to parasite infection (PubMed:8096327, PubMed:8097324). Synergizes with IL2 in regulating interferon-gamma synthesis (PubMed:8096327). Stimulates B-cell proliferation, and activation of eosinophils, basophils, and mast cells (PubMed:7903680, PubMed:8759755). Plays an important role in controlling IL33 activity by modulating the production of transmembrane and soluble forms of interleukin-1 receptor-like 1/IL1RL1 (By",cytokine activity,Secreted,antibody,DrugBank,drugbank_id
BE0018900,Target of rapamycin complex 2 subunit MAPKAP1,target,Q9BPZ7,MAPKAP1,Humans,"Component of the mechanistic target of rapamycin complex 2 (mTORC2), which transduces signals from growth factors to pathways involved in proliferation, cytoskeletal organization, lipogenesis and anabolic output (PubMed:15467718, PubMed:16919458, PubMed:16962653, PubMed:17043309, PubMed:21806543, PubMed:28264193, PubMed:28968999, PubMed:30837283, PubMed:35926713). In response to growth factors, mTORC2 phosphorylates and activates AGC protein kinase family members, including AKT (AKT1, AKT2 and A",enzyme-substrate adaptor activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009867,ATP-citrate synthase,target,P53396,ACLY,Humans,"Catalyzes the cleavage of citrate into oxaloacetate and acetyl-CoA, the latter serving as common substrate in multiple biochemical reactions in protein, carbohydrate and lipid metabolism",ATP binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0009868,Long-chain fatty acid transport protein 2,enzyme,O14975,SLC27A2,Humans,"Mediates the import of long-chain fatty acids (LCFA) into the cell by facilitating their transport across cell membranes, playing an important role in hepatic fatty acid uptake (PubMed:10198260, PubMed:10749848, PubMed:11980911, PubMed:20530735, PubMed:22022213, PubMed:24269233). Also functions as an acyl-CoA ligase catalyzing the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates, which prevents fatty acid efflux from cells and might drive",arachidonate-CoA ligase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0009503,NUAK family SNF1-like kinase 2,enzyme,Q9H093,NUAK2,Humans,"Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Phosphorylates LATS1 and LATS2. Plays a key role in neural tube closure during embryonic development through LATS2 phosphorylation and regulation of the nuclear l",ATP binding,,activator,DrugBank,drugbank_id
BE0009694,Exportin-1,target,O14980,XPO1,Humans,"Mediates the nuclear export of cellular proteins (cargos) bearing a leucine-rich nuclear export signal (NES) and of RNAs. In the nucleus, in association with RANBP3, binds cooperatively to the NES on its target protein and to the GTPase RAN in its active GTP-bound form (Ran-GTP). Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP ",DNA-binding transcription factor binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003729,Phosphatidylinositol 3-kinase catalytic subunit type 3,target,Q8NEB9,PIK3C3,Humans,"Catalytic subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis (PubMed:14617358, PubMed:33637724, PubMed:7628435). As part of PI3KC3-C1, promotes endoplasmic reticulum membrane curvature formation prior to vesicle budding (PubMed:32690950). Involved in ",1-phosphatidylinositol-3-kinase activity,Midbody,inhibitor,DrugBank,drugbank_id
BE0009501,NT-3 growth factor receptor,target,Q16288,NTRK3,Humans,"Receptor tyrosine kinase involved in nervous system and probably heart development. Upon binding of its ligand NTF3/neurotrophin-3, NTRK3 autophosphorylates and activates different signaling pathways, including the phosphatidylinositol 3-kinase/AKT and the MAPK pathways, that control cell survival and differentiation",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0000772,Activated CDC42 kinase 1,target,Q07912,TNK2,Humans,"Non-receptor tyrosine-protein and serine/threonine-protein kinase that is implicated in cell spreading and migration, cell survival, cell growth and proliferation. Transduces extracellular signals to cytosolic and nuclear effectors. Phosphorylates AKT1, AR, MCF2, WASL and WWOX. Implicated in trafficking and clathrin-mediated endocytosis through binding to epidermal growth factor receptor (EGFR) and clathrin. Binds to both poly- and mono-ubiquitin and regulates ligand-induced degradation of EGFR,",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0003781,Oxysterols receptor LXR-alpha,target,Q13133,NR1H3,Humans,"Nuclear receptor that exhibits a ligand-dependent transcriptional activation activity (PubMed:19481530, PubMed:25661920, PubMed:37478846). Interaction with retinoic acid receptor (RXR) shifts RXR from its role as a silent DNA-binding partner to an active ligand-binding subunit in mediating retinoid responses through target genes defined by LXRES (PubMed:37478846). LXRES are DR4-type response elements characterized by direct repeats of two similar hexanuclotide half-sites spaced by four nucleotid",cholesterol binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0001598,Oxysterols receptor LXR-beta,target,P55055,NR1H2,Humans,"Nuclear receptor that exhibits a ligand-dependent transcriptional activation activity (PubMed:25661920). Binds preferentially to double-stranded oligonucleotide direct repeats having the consensus half-site sequence 5'-AGGTCA-3' and 4-nt spacing (DR-4). Regulates cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8; DLDLR and LRP8. Interplays functionally with RORA for the regulation of genes involved in liver metabolism (By similarity). Induces LPCAT3-dependent phos",apolipoprotein A-I receptor binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0008672,Arylamine N-acetyltransferase,target,,,Helicobacter pylori,,,,inhibitor,DrugBank,drugbank_id
BE0010960,Presenilin-1,target,P49768,PSEN1,Humans,"Catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:10206644, PubMed:10545183, PubMed:10593990, PubMed:10811883, PubMed:10899933, PubMed:12679784, PubMed:12740439, PubMed:15274632, PubMed:20460383, PubMed:25043039, PubMed:26280335, PubMed:28269784, PubMed:30598546, PubMed:30630874). Requires the presence of the other members of the","aspartic endopeptidase activity, intramembrane cleaving",Endoplasmic reticulum,inhibitor,DrugBank,drugbank_id
BE0011014,Presenilin-2,target,P49810,PSEN2,Humans,"Probable catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein). Requires the other members of the gamma-secretase complex to have a protease activity. May play a role in intracellular signaling and gene expression or in linking chromatin to the nuclear membrane. May function in the cytoplasmic partitioning of proteins. The holoprotein functi","aspartic endopeptidase activity, intramembrane cleaving",Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0017775,Nicastrin,target,Q92542,NCSTN,Humans,"Essential subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:10993067, PubMed:12679784, PubMed:25043039, PubMed:26280335, PubMed:30598546, PubMed:30630874). The gamma-secretase complex plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, and by regulating","aspartic endopeptidase activity, intramembrane cleaving",Membrane,modulator,DrugBank,drugbank_id
BE0003410,Gamma-secretase subunit PEN-2,target,Q9NZ42,PSENEN,Humans,"Essential subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:12522139, PubMed:12679784, PubMed:12740439, PubMed:12763021, PubMed:24941111, PubMed:30598546, PubMed:30630874). The gamma-secretase complex plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, ",endopeptidase activator activity,Endoplasmic reticulum membrane,modulator,DrugBank,drugbank_id
BE0017533,Gamma-secretase subunit APH-1B,target,Q8WW43,APH1B,Humans,"Probable subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral proteins such as Notch receptors and APP (amyloid-beta precursor protein). It probably represents a stabilizing cofactor for the presenilin homodimer that promotes the formation of a stable complex. Probably present in a minority of gamma-secretase complexes compared to APH1A",endopeptidase activator activity,Membrane,modulator,DrugBank,drugbank_id
BE0003409,Gamma-secretase subunit APH-1A,target,Q96BI3,APH1A,Humans,"Non-catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:12297508, PubMed:12522139, PubMed:12679784, PubMed:12763021, PubMed:25043039, PubMed:26280335, PubMed:30598546, PubMed:30630874). Required for normal gamma-secretase assembly (PubMed:12471034, PubMed:12522139, PubMed:12763021, PubMed:19369254). The gamma-secretase complex play",endopeptidase activator activity,Endoplasmic reticulum membrane,modulator,DrugBank,drugbank_id
BE0001646,Cathepsin S,target,P25774,CTSS,Humans,Thiol protease. Key protease responsible for the removal of the invariant chain from MHC class II molecules and MHC class II antigen presentation (PubMed:30612035). The bond-specificity of this proteinase is in part similar to the specificities of cathepsin L,collagen binding,Lysosome,inhibitor,DrugBank,drugbank_id
BE0009379,Calcium-dependent protein kinase 1,target,P62344,CDPK1,Plasmodium falciparum (isolate 3D7),"Calcium-dependent protein kinase which acts as a sensor and effector of intracellular Ca(2+) levels probably in part downstream of cGMP-activated PKG kinase (PubMed:18768477, PubMed:19307175, PubMed:28680058, PubMed:29716996). By phosphorylating various proteins, required for microneme secretion and thus merozoite egress from and invasion of host erythrocytes (PubMed:23204525, PubMed:28680058, PubMed:29716996). During gametogenesis, essential for the development of both male and female gametes (",14-3-3 protein binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0001580,Serine/threonine-protein kinase PknB,target,P9WI81,pknB,Mycobacterium tuberculosis,"Protein kinase that regulates many aspects of mycobacterial physiology, and is critical for growth in vitro and survival of the pathogen in the host (PubMed:24706757). Is a key component of a signal transduction pathway that regulates cell growth, cell shape and cell division via phosphorylation of target proteins such as GarA, GlmU, PapA5, FhaB (Rv0019c), FhaA (Rv0020c), MviN, PstP, EmbR, Rv1422, Rv1747, RseA and RmlA (PubMed:15978616, PubMed:15985609, PubMed:15987910, PubMed:16817899, PubMed:1",acetyltransferase activator activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009380,Ribosomal protein S6 kinase alpha-6,target,Q9UK32,RPS6KA6,Humans,Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis,ATP binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0009381,"Atypical kinase COQ8A, mitochondrial",target,Q8NI60,COQ8A,Humans,"Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:21296186, PubMed:25498144, PubMed:25540914, PubMed:27499294, PubMed:36302899, PubMed:38425362). Its substrate specificity is still unclear: may act as a protein kinase that mediates phosphorylation of COQ3 (By similarity). According to other reports, acts as a small molecule kinase, possibly a lipid kinase that phosphorylates ",ADP binding,Mitochondrion membrane,inhibitor,DrugBank,drugbank_id
BE0009382,Serine/threonine-protein kinase NIM1,target,Q8IY84,NIM1K,Humans,,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0004109,Serine/threonine-protein kinase 26,target,Q9P289,STK26,Humans,"Serine/threonine-protein kinase that acts as a mediator of cell growth (PubMed:11641781, PubMed:17360971). Modulates apoptosis (PubMed:11641781, PubMed:17360971). In association with STK24 negatively regulates Golgi reorientation in polarized cell migration upon RHO activation (PubMed:27807006). Phosphorylates ATG4B at 'Ser-383', thereby increasing autophagic flux (PubMed:29232556). Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009383,Serine/threonine-protein kinase 24,target,Q9Y6E0,STK24,Humans,"Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated ",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009384,Serine/threonine-protein kinase 3,target,Q13188,STK3,Humans,"Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation (PubMed:11278283, PubMed:8566796, PubMed:8816758). Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex wit",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009386,Serine/threonine-protein kinase 33,target,Q9BYT3,STK33,Humans,"Serine/threonine protein kinase required for spermatid differentiation and male fertility (PubMed:37146716, PubMed:38781365). Promotes sperm flagella assembly during spermatogenesis by mediating phosphorylation of fibrous sheath proteins AKAP3 and AKAP4 (By similarity). Also phosphorylates vimentin/VIM, thereby regulating the dynamic behavior of the intermediate filament cytoskeleton (By similarity)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009387,Serine/threonine-protein kinase 35,target,Q8TDR2,STK35,Humans,,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009389,Serine/threonine-protein kinase 38,target,Q15208,STK38,Humans,"Serine/threonine-protein kinase that acts as a negative regulator of MAP3K1/2 signaling (PubMed:12493777, PubMed:15197186, PubMed:17906693, PubMed:7761441). Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2 (PubMed:12493777, PubMed:15197186, PubMed:17906693, PubMed:7761441). Acts as an ufmylation 'reader' in a kinase-independent manner: specifically recognizes and binds mono-ufmylated histone H4 in response to DNA damage, promo",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009390,Serine/threonine-protein kinase 38-like,target,Q9Y2H1,STK38L,Humans,Involved in the regulation of structural processes in differentiating and mature neuronal cells,actin binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009391,STE20/SPS1-related proline-alanine-rich protein kinase,target,Q9UEW8,STK39,Humans,"Effector serine/threonine-protein kinase component of the WNK-SPAK/OSR1 kinase cascade, which is involved in various processes, such as ion transport, response to hypertonic stress and blood pressure (PubMed:16669787, PubMed:18270262, PubMed:21321328, PubMed:34289367). Specifically recognizes and binds proteins with a RFXV motif (PubMed:16669787, PubMed:21321328). Acts downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4): following activation by WNK kinases, catalyzes phosphorylation of ion cotr",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009392,Serine/threonine-protein kinase TAO1,target,Q7L7X3,TAOK1,Humans,"Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transi",alpha-tubulin binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004632,Serine/threonine-protein kinase TAO2,target,Q9UL54,TAOK2,Humans,"Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activat",ATP binding,Cytoplasmic vesicle membrane,inhibitor,DrugBank,drugbank_id
BE0009393,Serine/threonine-protein kinase TAO3,target,Q9H2K8,TAOK3,Humans,"Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of the MAPK8/JNK cascade and diminishes its activation in response to epidermal growth factor (EGF). Positively regulates c",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009394,Serine/threonine-protein kinase TBK1,target,Q9UHD2,TBK1,Humans,"Serine/threonine kinase that plays an essential role in regulating inflammatory responses to foreign agents (PubMed:10581243, PubMed:11839743, PubMed:12692549, PubMed:12702806, PubMed:14703513, PubMed:15367631, PubMed:15485837, PubMed:18583960, PubMed:21138416, PubMed:23453971, PubMed:23453972, PubMed:23746807, PubMed:25636800, PubMed:26611359, PubMed:32404352, PubMed:34363755, PubMed:32298923). Following activation of toll-like receptors by viral or bacterial components, associates with TRAF3 a",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009395,Dual specificity testis-specific protein kinase 1,target,Q15569,TESK1,Humans,Dual specificity protein kinase activity catalyzing autophosphorylation and phosphorylation of exogenous substrates on both serine/threonine and tyrosine residues (By similarity). Regulates the cellular cytoskeleton by enhancing actin stress fiber formation via phosphorylation of cofilin and by preventing microtubule breakdown via inhibition of TAOK1/MARKK kinase activity (By similarity). Inhibits podocyte motility via regulation of actin cytoskeletal dynamics and phosphorylation of CFL1 (By sim,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003782,TGF-beta receptor type-1,target,P36897,TGFBR1,Humans,"Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing,",activin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0001861,TGF-beta receptor type-2,target,P37173,TGFBR2,Humans,"Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and thus regulates a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extr",activin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009396,Tyrosine-protein kinase receptor Tie-1,target,P35590,TIE1,Humans,Transmembrane tyrosine-protein kinase that may modulate TEK/TIE2 activity and contribute to the regulation of angiogenesis,ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009397,Serine/threonine-protein kinase tousled-like 1,target,Q9UKI8,TLK1,Humans,"Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway dependent and appears to regulate processes involved in chromatin assembly. Isoform 3 phosphorylates and enhances the stability of the t-SNARE SNAP23, augmenting its assembly with syntaxin. Isoform 3 protects the cells from the ionizing radiation by facilitating the repair of DSBs. In vitro, phosphorylates histone H3 at 'Ser-10'",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009398,Serine/threonine-protein kinase tousled-like 2,target,Q86UE8,TLK2,Humans,"Serine/threonine-protein kinase involved in the process of chromatin assembly and probably also DNA replication, transcription, repair, and chromosome segregation (PubMed:10523312, PubMed:11470414, PubMed:12660173, PubMed:12955071, PubMed:29955062, PubMed:33323470, PubMed:9427565). Phosphorylates the chromatin assembly factors ASF1A and ASF1B (PubMed:11470414, PubMed:20016786, PubMed:29955062, PubMed:35136069). Phosphorylation of ASF1A prevents its proteasome-mediated degradation, thereby enhanc",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009399,TRAF2 and NCK-interacting protein kinase,target,Q9UKE5,TNIK,Humans,"Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009400,Non-receptor tyrosine-protein kinase TNK1,target,Q13470,TNK1,Humans,Involved in negative regulation of cell growth. Has tumor suppressor properties. Plays a negative regulatory role in the Ras-MAPK pathway. May function in signaling pathways utilized broadly during fetal development and more selectively in adult tissues and in cells of the lymphohematopoietic system. Could specifically be involved in phospholipid signal transduction,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009401,Serine/threonine-protein kinase TNNI3K,target,Q59H18,TNNI3K,Humans,May play a role in cardiac physiology,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009402,Testis-specific serine/threonine-protein kinase 1,target,Q9BXA7,TSSK1B,Humans,"Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003791,Dual specificity protein kinase TTK,target,P33981,TTK,Humans,"Involved in mitotic spindle assembly checkpoint signaling, a process that delays anaphase until chromosomes are bioriented on the spindle, and in the repair of incorrect mitotic kinetochore-spindle microtubule attachments (PubMed:18243099, PubMed:28441529, PubMed:29162720). Phosphorylates MAD1L1 to promote the mitotic spindle assembly checkpoint (PubMed:18243099, PubMed:29162720). Phosphorylates CDCA8/Borealin leading to enhanced AURKB activity at the kinetochore (PubMed:18243099). Phosphorylate",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009403,Tyrosine-protein kinase TXK,target,P42681,TXK,Humans,"Non-receptor tyrosine kinase that plays a redundant role with ITK in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation leads to the recruitment of TXK to the cell membrane, where it is phosphorylated at Tyr-420. Phosphorylation leads to TXK full activation. Also contributes to signaling from many r",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009405,Serine/threonine-protein kinase ULK1,target,O75385,ULK1,Humans,"Serine/threonine-protein kinase involved in autophagy in response to starvation (PubMed:18936157, PubMed:21460634, PubMed:21795849, PubMed:23524951, PubMed:25040165, PubMed:29487085, PubMed:31123703). Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes (PubMed:18936157, PubMed:21460634, PubMed:21795849, PubMed:25040165). Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative ",ATP binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0009406,Serine/threonine-protein kinase ULK2,target,Q8IYT8,ULK2,Humans,"Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and a negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK, also acts as a negative regulator of AMPK through phosphor",ATP binding,Cytoplasmic vesicle membrane,inhibitor,DrugBank,drugbank_id
BE0009407,Serine/threonine-protein kinase ULK3,target,Q6PHR2,ULK3,Humans,"Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nucl",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003335,Wee1-like protein kinase,target,P30291,WEE1,Humans,"Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15' (PubMed:15070733, PubMed:7743995, PubMed:8348613, PubMed:8428596). Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase (PubMed:7743995, PubMed:8348613, PubMed:8428596). Phosphoryla",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009408,Mitogen-activated protein kinase kinase kinase 19,target,Q56UN5,MAP3K19,Humans,,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0001312,Tyrosine-protein kinase ZAP-70,target,P43403,ZAP70,Humans,"Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates motility, adhesion and cytokine expression of mature T-cells, as well as thymocyte development. Also contributes to the development and activation of primary B-lymphocytes. When antigen presenting cells (APC) activate T-cell receptor (TCR), a serie of phosphorylations lead to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD247/CD3Z through ITAM motif at the plasma membrane.",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009409,AP2-associated protein kinase 1,target,Q2M2I8,AAK1,Humans,"Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis (PubMed:11877457, PubMed:11877461, PubMed:12952931, PubMed:14617351, PubMed:17494869, PubMed:25653444). Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1 (PubMed:17494869). Preferentially, may phosphorylate substrates on threonine residu",AP-2 adaptor complex binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0000665,Activin receptor type-1B,target,P36896,ACVR1B,Humans,"Transmembrane serine/threonine kinase activin type-1 receptor forming an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating a many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcino",activin binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009410,"Atypical kinase COQ8B, mitochondrial",target,Q96D53,COQ8B,Humans,"Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:24270420, PubMed:36302899, PubMed:38425362). Its substrate specificity is still unclear: may act as a protein kinase that mediates phosphorylation of COQ3 (PubMed:38425362). According to other reports, acts as a small molecule kinase, possibly a lipid kinase that phosphorylates a prenyl lipid in the ubiquinone biosynthesis pat",ATP binding,Mitochondrion membrane,inhibitor,DrugBank,drugbank_id
BE0009411,Ankyrin repeat and protein kinase domain-containing protein 1,target,Q8NFD2,ANKK1,Humans,,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009413,Tyrosine-protein kinase Blk,target,P51451,BLK,Humans,"Non-receptor tyrosine kinase involved in B-lymphocyte development, differentiation and signaling (By similarity). B-cell receptor (BCR) signaling requires a tight regulation of several protein tyrosine kinases and phosphatases, and associated coreceptors (By similarity). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (By similarity). Signaling through BLK plays an important role in transmitting signals through surface immunog",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009414,BMP-2-inducible protein kinase,target,Q9NSY1,BMP2K,Humans,May be involved in osteoblast differentiation,AP-2 adaptor complex binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009415,Bone morphogenetic protein receptor type-1B,target,O00238,BMPR1B,Humans,"On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for BMP7/OP-1 and GDF5. Positively regulates chondrocyte differentiation through GDF5 interaction",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009324,Bone morphogenetic protein receptor type-2,target,Q13873,BMPR2,Humans,"On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Can also mediate signaling through the activation of the p38MAPK cascade (PubMed:12045205). Binds to BMP7, BMP2 and, less efficiently, BMP4. Binding is weak but enhanced by the presence of type I receptors for BMPs. Mediates inducti","activin receptor activity, type II",Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009416,Cytoplasmic tyrosine-protein kinase BMX,target,P51813,BMX,Humans,"Non-receptor tyrosine kinase that plays central but diverse modulatory roles in various signaling processes involved in the regulation of actin reorganization, cell migration, cell proliferation and survival, cell adhesion, and apoptosis. Participates in signal transduction stimulated by growth factor receptors, cytokine receptors, G-protein coupled receptors, antigen receptors and integrins. Induces tyrosine phosphorylation of BCAR1 in response to integrin regulation. Activation of BMX by integ",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009417,Calcium/calmodulin-dependent protein kinase type 1,target,Q14012,CAMK1,Humans,"Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, regulates transcription activators activity, cell cycle, hormone production, cell differentiation, actin filament organization and neurite outgrowth. Recognizes the substrate consensus sequence [MVLIF]-x-R-x(2)-[ST]-x(3)-[MVLIF]. Regulates axonal extension and growth cone motility in hippocampal and cerebellar nerve cells. Upon NMDA receptor-mediated Ca(2+) e",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004324,Calcium/calmodulin-dependent protein kinase type 1D,target,Q8IU85,CAMK1D,Humans,"Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and promotes basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Activates the transcription factor CREB1 in hippocampal neuron nuclei.",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004147,Calcium/calmodulin-dependent protein kinase type 1G,target,Q96NX5,CAMK1G,Humans,Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade. In vitro phosphorylates transcription factor CREB1 (By similarity),ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004076,Calcium/calmodulin-dependent protein kinase type II subunit alpha,target,Q9UQM7,CAMK2A,Humans,"Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in various processes, such as synaptic plasticity, neurotransmitter release and long-term potentiation (PubMed:14722083). Member of the NMDAR signaling complex in excitatory synapses, it regulates NMDAR-dependent potentiation of the AMPAR and therefore excitatory synaptic transmission (By similarity). Regulates dendritic spine development (PubMed:281303",ATP binding,Synapse,inhibitor,DrugBank,drugbank_id
BE0003792,Calcium/calmodulin-dependent protein kinase type II subunit beta,target,Q13554,CAMK2B,Humans,"Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in dendritic spine and synapse formation, neuronal plasticity and regulation of sarcoplasmic reticulum Ca(2+) transport in skeletal muscle (PubMed:16690701). In neurons, plays an essential structural role in the reorganization of the actin cytoskeleton during plasticity by binding and bundling actin filaments in a kinase-independent manner. This structu",actin binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0004108,Calcium/calmodulin-dependent protein kinase type II subunit delta,target,Q13557,CAMK2D,Humans,"Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis",ATP binding,"Cell membrane, sarcolemma",inhibitor,DrugBank,drugbank_id
BE0009418,Calcium/calmodulin-dependent protein kinase kinase 1,target,Q8N5S9,CAMKK1,Humans,"Calcium/calmodulin-dependent protein kinase that belongs to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4. Involved in regulating cell apoptosis. Promotes cell survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-antagonist of cell death",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009419,Calcium/calmodulin-dependent protein kinase kinase 2,target,Q96RR4,CAMKK2,Humans,"Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Isoform 1, isoform 2 and isoform 3 phosphorylate CAMK1 and CAMK4. Isoform 3 phosphorylates CAMK1D. Isoform 4, isoform 5 and isoform 6 lacking part of the calmodulin-binding domain are inactive. Efficiently phosphorylates 5'-AMP-activated protein kinase (AMPK) trimer, including that consisting of PRKAA1, PRKAB1 and PRKAG1. This phosphorylation is stim",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009420,Kappa-casein,target,P07498,CSN3,Humans,"Kappa-casein stabilizes micelle formation, preventing casein precipitation in milk",,Secreted,inhibitor,DrugBank,drugbank_id
BE0009421,Serine/threonine-protein kinase MRCK gamma,target,Q6DT37,CDC42BPG,Humans,"May act as a downstream effector of CDC42 in cytoskeletal reorganization. Contributes to the actomyosin contractility required for cell invasion, through the regulation of MYPT1 and thus MLC2 phosphorylation (By similarity)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009422,Cyclin-dependent kinase-like 1,target,Q00532,CDKL1,Humans,,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009423,Cyclin-dependent kinase-like 2,target,Q92772,CDKL2,Humans,,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009424,Citron Rho-interacting kinase,target,O14578,CIT,Humans,Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Displays serine/threonine protein kinase activity. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001824,Dual specificity protein kinase CLK1,target,P49759,CLK1,Humans,"Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1 (PubMed:10480872, PubMed:19168442). Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells (PubMed:19168442)",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009425,Dual specificity protein kinase CLK2,target,P49760,CLK2,Humans,Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on ,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0004043,Dual specificity protein kinase CLK3,target,P49761,CLK3,Humans,Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Phosphorylates SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009426,Dual specificity protein kinase CLK4,target,Q9HAZ1,CLK4,Humans,Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009427,Casein kinase I isoform alpha,target,P48729,CSNK1A1,Humans,"Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates (PubMed:11955436, PubMed:1409656, PubMed:18305108, PubMed:23902688). It can phosphorylate a large number of proteins (PubMed:11955436, PubMed:1409656, PubMed:18305108, PubMed:23902688). Participates in Wnt signaling (PubMed:11955436). Phosphorylates CTNNB1 at 'Ser-45' (PubMed:11955436). May phosphorylate PER1 and PER2 (By similarity). May play a role in segregating chromoso",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003984,Casein kinase II subunit alpha',target,P19784,CSNK2A2,Humans,"Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed:11239457, PubMed:11704824, PubMed:16193064, PubMed:30898438). Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection (PubMed:11704824, PubMed:16193064, PubMed:30898438). May act as a regulatory node which i",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0001776,Death-associated protein kinase 1,target,P53355,DAPK1,Humans,"Calcium/calmodulin-dependent serine/threonine kinase involved in multiple cellular signaling pathways that trigger cell survival, apoptosis, and autophagy. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Phosphorylates PIN1 resulting in inhibition of its catalytic activity, nuclear localization, and",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009428,Death-associated protein kinase 2,target,Q9UIK4,DAPK2,Humans,"Calcium/calmodulin-dependent serine/threonine kinase involved in multiple cellular signaling pathways that trigger cell survival, apoptosis, and autophagy. Regulates both type I apoptotic and type II autophagic cell death signals, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Acts as a mediator of anoikis and a suppressor of beta-catenin-dependent anchorage-independent g",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003788,Death-associated protein kinase 3,target,O43293,DAPK3,Humans,"Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, translation and actin cytoskeleton reorganization. Involved in the regulation of smooth muscle contraction. Regulates both type I (caspase-dependent) apoptotic and type II (caspase-independent) autophagic cell deaths signal, depending on the cellular setting. Involved in regulation of starvation-induced autophagy. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smoo",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009429,Serine/threonine-protein kinase DCLK1,target,O15075,DCLK1,Humans,Probable kinase that may be involved in a calcium-signaling pathway controlling neuronal migration in the developing brain. May also participate in functions of the mature nervous system,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009430,Serine/threonine-protein kinase DCLK2,target,Q8N568,DCLK2,Humans,Protein kinase with a significantly reduced C(a2+)/CAM affinity and dependence compared to other members of the CaMK family. May play a role in the down-regulation of CRE-dependent gene activation probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the resulting retention of TORC2 in the cytoplasm (By similarity),ATP binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0009431,Serine/threonine-protein kinase DCLK3,target,Q9C098,DCLK3,Humans,,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004012,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,target,Q13627,DYRK1A,Humans,"Dual-specificity kinase which possesses both serine/threonine and tyrosine kinase activities (PubMed:20981014, PubMed:21127067, PubMed:23665168, PubMed:30773093, PubMed:8769099). Exhibits a substrate preference for proline at position P+1 and arginine at position P-3 (PubMed:23665168). Plays an important role in double-strand breaks (DSBs) repair following DNA damage (PubMed:31024071). Mechanistically, phosphorylates RNF169 and increases its ability to block accumulation of TP53BP1 at the DSB si",actin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009432,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,target,Q9Y463,DYRK1B,Humans,"Dual-specificity kinase which possesses both serine/threonine and tyrosine kinase activities. Plays an essential role in ribosomal DNA (rDNA) double-strand break repair and rDNA copy number maintenance (PubMed:33469661). During DNA damage, mediates transcription silencing in part via phosphorylating and enforcing DSB accumulation of the histone methyltransferase EHMT2 (PubMed:32611815). Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates co",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009433,Eukaryotic translation initiation factor 2-alpha kinase 1,target,Q9BQI3,EIF2AK1,Humans,"Metabolic-stress sensing protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) in response to various stress conditions (PubMed:32132706, PubMed:32132707, PubMed:37327776, PubMed:37550454, PubMed:38340717). Key activator of the integrated stress response (ISR) required for adaptation to various stress, such as heme deficiency, oxidative stress, osmotic shock, mitochondrial dysfunction and heat shock (PubMed:32132706, PubMed:321327",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009435,eIF-2-alpha kinase GCN2,target,Q9P2K8,EIF2AK4,Humans,"Metabolic-stress sensing protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) in response to low amino acid availability (PubMed:25329545, PubMed:32610081). Plays a role as an activator of the integrated stress response (ISR) required for adaptation to amino acid starvation (By similarity). EIF2S1/eIF-2-alpha phosphorylation in response to stress converts EIF2S1/eIF-2-alpha into a global protein synthesis inhibitor, leading to a ",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009436,Ephrin type-A receptor 1,target,P21709,EPHA1,Humans,"Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Binds with a low affinity EFNA3 and EFNA4 and with a high affinity to EFNA1 which most probably constitutes its cognate/fun",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009437,Ephrin type-A receptor 3,target,P29320,EPHA3,Humans,"Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Highly promiscuous for ephrin-A ligands it binds preferentially EFNA5. Upon activation by EFNA5 regulates cell-cell adhesion,",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009438,Ephrin type-A receptor 4,target,P54764,EPHA4,Humans,"Receptor tyrosine kinase which binds membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Highly promiscuous, it has the unique property among Eph receptors to bind and to be physiologically activated by both GPI-anchored ephrin-",amyloid-beta binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009439,Ephrin type-A receptor 6,target,Q9UF33,EPHA6,Humans,"Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling (By similarity)",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0004140,Ephrin type-A receptor 7,target,Q15375,EPHA7,Humans,"Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 is a cognate/functional ligand for EPHA7 and their interaction regulates brain dev",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009440,Ephrin type-A receptor 8,target,P29322,EPHA8,Humans,"Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. The GPI-anchored ephrin-A EFNA2, EFNA3, and EFNA5 are able to activate EPHA8 through phosphorylation. With EFNA5 may regulate",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0004549,Ephrin type-B receptor 2,target,P29323,EPHB2,Humans,"Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Functions in axon guidance during development. Involved in the guidance of commissural axons, that form a major interhemisph",amyloid-beta binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009442,Ephrin type-B receptor 6,target,O15197,EPHB6,Humans,"Kinase-defective receptor for members of the ephrin-B family. Binds to ephrin-B1 and ephrin-B2. Modulates cell adhesion and migration by exerting both positive and negative effects upon stimulation with ephrin-B2. Inhibits JNK activation, T-cell receptor-induced IL-2 secretion and CD25 expression upon stimulation with ephrin-B2",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0003839,Serine/threonine-protein kinase/endoribonuclease IRE1,target,O75460,ERN1,Humans,"Serine/threonine-protein kinase and endoribonuclease that acts as a key sensor for the endoplasmic reticulum unfolded protein response (UPR) (PubMed:11175748, PubMed:11779464, PubMed:12637535, PubMed:19328063, PubMed:21317875, PubMed:28128204, PubMed:30118681, PubMed:36739529, PubMed:9637683). In unstressed cells, the endoplasmic reticulum luminal domain is maintained in its inactive monomeric state by binding to the endoplasmic reticulum chaperone HSPA5/BiP (PubMed:21317875). Accumulation of mi",ADP binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009443,Tyrosine-protein kinase Fer,target,P16591,FER,Humans,"Tyrosine-protein kinase that acts downstream of cell surface receptors for growth factors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, lamellipodia formation, cell adhesion, cell migration and chemotaxis. Acts downstream of EGFR, KIT, PDGFRA and PDGFRB. Acts downstream of EGFR to promote activation of NF-kappa-B and cell proliferation. May play a role in the regulation of the mitotic cell cycle. Plays a role in the insulin receptor signaling pathway and in ",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009444,Tyrosine-protein kinase Fes/Fps,target,P07332,FES,Humans,"Tyrosine-protein kinase that acts downstream of cell surface receptors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, cell attachment and cell spreading. Plays a role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Acts down-stream of the activated FCER1 receptor and the mast/stem cell growth factor receptor KIT. Plays a role in the regulation of mast cell degranulation. Plays a role in the regulation of cell differe",ATP binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0009445,Cyclin-G-associated kinase,target,O14976,GAK,Humans,"Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1 (PubMed:10625686). May play a role in clathrin-mediated endocytosis and intracellular trafficking, and in the dynamics of clathrin assembly/disassembly (PubMed:18489706)",ATP binding,"Cytoplasm, perinuclear region",inhibitor,DrugBank,drugbank_id
BE0009447,Homeodomain-interacting protein kinase 2,target,Q9H2X6,HIPK2,Humans,"Serine/threonine-protein kinase involved in transcription regulation, p53/TP53-mediated cellular apoptosis and regulation of the cell cycle. Acts as a corepressor of several transcription factors, including SMAD1 and POU4F1/Brn3a and probably NK homeodomain transcription factors. Phosphorylates PDX1, ATF1, PML, p53/TP53, CREB1, CTBP1, CBX4, RUNX1, EP300, CTNNB1, HMGA1, ZBTB4 and DAZAP2. Inhibits cell growth and promotes apoptosis through the activation of p53/TP53 both at the transcription level",ATP binding,"Nucleus, PML body",inhibitor,DrugBank,drugbank_id
BE0009448,Homeodomain-interacting protein kinase 3,target,Q9H422,HIPK3,Humans,"Serine/threonine-protein kinase involved in transcription regulation, apoptosis and steroidogenic gene expression. Phosphorylates JUN and RUNX2. Seems to negatively regulate apoptosis by promoting FADD phosphorylation. Enhances androgen receptor-mediated transcription. May act as a transcriptional corepressor for NK homeodomain transcription factors. The phosphorylation of NR5A1 activates SF1 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation. In osteoblas",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009449,Serine/threonine-protein kinase ICK,target,Q9UPZ9,CILK1,Humans,Required for ciliogenesis (PubMed:24797473). Phosphorylates KIF3A (By similarity). Involved in the control of ciliary length (PubMed:24853502). Regulates the ciliary localization of SHH pathway components as well as the localization of IFT components at ciliary tips (By similarity). May play a key role in the development of multiple organ systems and particularly in cardiac development (By similarity). Regulates intraflagellar transport (IFT) speed and negatively regulates cilium length in a cAM,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009450,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,target,Q14164,IKBKE,Humans,"Serine/threonine kinase that plays an essential role in regulating inflammatory responses to viral infection, through the activation of the type I IFN, NF-kappa-B and STAT signaling. Also involved in TNFA and inflammatory cytokines, like Interleukin-1, signaling. Following activation of viral RNA sensors, such as RIG-I-like receptors, associates with DDX3X and phosphorylates interferon regulatory factors (IRFs), IRF3 and IRF7, as well as DDX3X. This activity allows subsequent homodimerization an",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009451,Insulin receptor-related protein,target,P14616,INSRR,Humans,Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB,ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0009452,Interleukin-1 receptor-associated kinase 1,target,P51617,IRAK1,Humans,"Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediate",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009453,Interleukin-1 receptor-associated kinase 3,target,Q9Y616,IRAK3,Humans,"Putative inactive protein kinase which regulates signaling downstream of immune receptors including IL1R and Toll-like receptors (PubMed:10383454, PubMed:29686383). Inhibits dissociation of IRAK1 and IRAK4 from the Toll-like receptor signaling complex by either inhibiting the phosphorylation of IRAK1 and IRAK4 or stabilizing the receptor complex (By similarity). Upon IL33-induced lung inflammation, positively regulates expression of IL6, CSF3, CXCL2 and CCL5 mRNAs in dendritic cells (PubMed:2968",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004344,Interleukin-1 receptor-associated kinase 4,target,Q9NWZ3,IRAK4,Humans,"Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009454,Serine/threonine-protein kinase SIK3,target,Q9Y2K2,SIK3,Humans,"Positive regulator of mTOR signaling that functions by triggering the degradation of DEPTOR, an mTOR inhibitor. Involved in the dynamic regulation of mTOR signaling in chondrocyte differentiation during skeletogenesis (PubMed:30232230). Negatively regulates cAMP signaling pathway possibly by acting on CRTC2/TORC2 and CRTC3/TORC3 (Probable). Prevents HDAC4 translocation to the nucleus (By similarity)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009455,Serine/threonine-protein kinase LATS1,target,O95835,LATS1,Humans,"Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:10518011, PubMed:10831611, PubMed:18158288, PubMed:26437443, PubMed:28068668). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn p",ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",inhibitor,DrugBank,drugbank_id
BE0009457,Leucine-rich repeat serine/threonine-protein kinase 2,target,Q5S007,LRRK2,Humans,"Serine/threonine-protein kinase which phosphorylates a broad range of proteins involved in multiple processes such as neuronal plasticity, innate immunity, autophagy, and vesicle trafficking (PubMed:17114044, PubMed:20949042, PubMed:21850687, PubMed:22012985, PubMed:23395371, PubMed:24687852, PubMed:25201882, PubMed:26014385, PubMed:26824392, PubMed:27830463, PubMed:28720718, PubMed:29125462, PubMed:29127255, PubMed:29212815, PubMed:30398148, PubMed:30635421). Is a key regulator of RAB GTPases b",actin binding,Cytoplasmic vesicle,inhibitor,DrugBank,drugbank_id
BE0009458,Leukocyte tyrosine kinase receptor,target,P29376,LTK,Humans,"Receptor with a tyrosine-protein kinase activity (PubMed:10445845, PubMed:20548102, PubMed:30061385). Following activation by ALKAL1 or ALKAL2 ligands at the cell surface, transduces an extracellular signal into an intracellular response (PubMed:30061385, PubMed:34646012). Ligand-binding to the extracellular domain induces tyrosine kinase activation, leading to activation of the mitogen-activated protein kinase (MAPK) pathway (PubMed:20548102). Phosphorylates almost exclusively at the first tyro",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009459,Dual specificity mitogen-activated protein kinase kinase 3,target,P46734,MAP2K3,Humans,Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009460,Dual specificity mitogen-activated protein kinase kinase 5,target,Q13163,MAP2K5,Humans,"Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity)",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009461,Dual specificity mitogen-activated protein kinase kinase 6,target,P52564,MAP2K6,Humans,"Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. With MAP3K3/MKK3, catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 MAPK11, MAPK12, MAPK13 and MAPK14 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. Especially, MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 and MAPK13 induced by environment",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0003430,Mitogen-activated protein kinase kinase kinase 1,target,Q13233,MAP3K1,Humans,"Component of a protein kinase signal transduction cascade (PubMed:9808624). Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4 (PubMed:9808624). May phosphorylate the MAPK8/JNK1 kinase (PubMed:17761173). Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway (PubMed:9808624)",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009462,Mitogen-activated protein kinase kinase kinase 10,target,Q02779,MAP3K10,Humans,Activates the JUN N-terminal pathway,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009463,Mitogen-activated protein kinase kinase kinase 11,target,Q16584,MAP3K11,Humans,"Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle",ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",inhibitor,DrugBank,drugbank_id
BE0009464,Mitogen-activated protein kinase kinase kinase 12,target,Q12852,MAP3K12,Humans,"Part of a non-canonical MAPK signaling pathway (PubMed:28111074). Activated by APOE, enhances the AP-1-mediated transcription of APP, via a MAP kinase signal transduction pathway composed of MAP2K7 and MAPK1/ERK2 and MAPK3/ERK1 (PubMed:28111074). May be an activator of the JNK/SAPK pathway",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009465,Mitogen-activated protein kinase kinase kinase 13,target,O43283,MAP3K13,Humans,"Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009466,Mitogen-activated protein kinase kinase kinase 15,target,Q6ZN16,MAP3K15,Humans,"Serine/threonine kinase which acts as a component of the MAP kinase signal transduction pathway (PubMed:20362554, PubMed:26732173). Once activated, acts as an upstream activator of the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases (PubMed:20362554, PubMed:26732173). May function in a signal transduction pathway that is activated by various cell stresses and leads to apoptosis (PubMed:20362554). Involved in phosphorylation of WNK4 in",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009467,Mitogen-activated protein kinase kinase kinase 3,target,Q99759,MAP3K3,Humans,"Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009468,Mitogen-activated protein kinase kinase kinase 4,target,Q9Y6R4,MAP3K4,Humans,"Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6",ATP binding,"Cytoplasm, perinuclear region",inhibitor,DrugBank,drugbank_id
BE0009469,Mitogen-activated protein kinase kinase kinase 6,target,O95382,MAP3K6,Humans,"Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0004386,Mitogen-activated protein kinase kinase kinase 9,target,P80192,MAP3K9,Humans,"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription f",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009470,Mitogen-activated protein kinase kinase kinase kinase 1,target,Q92918,MAP4K1,Humans,"Serine/threonine-protein kinase, which plays a role in the response to environmental stress (PubMed:24362026). Appears to act upstream of the JUN N-terminal pathway (PubMed:8824585). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009471,Mitogen-activated protein kinase kinase kinase kinase 2,target,Q12851,MAP4K2,Humans,"Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidi",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009472,Mitogen-activated protein kinase kinase kinase kinase 3,target,Q8IVH8,MAP4K3,Humans,"Serine/threonine kinase that plays a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway (PubMed:9275185). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expa",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009473,Mitogen-activated protein kinase kinase kinase kinase 4,target,O95819,MAP4K4,Humans,"Serine/threonine kinase that plays a role in the response to environmental stress and cytokines such as TNF-alpha. Appears to act upstream of the JUN N-terminal pathway (PubMed:9890973). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish ",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009474,Mitogen-activated protein kinase kinase kinase kinase 5,target,Q9Y4K4,MAP4K5,Humans,May play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003391,Mitogen-activated protein kinase 13,target,O15264,MAPK13,Humans,"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK13 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors such as ELK1 and ATF2. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 ",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009475,Mitogen-activated protein kinase 15,target,Q8TD08,MAPK15,Humans,"Atypical MAPK protein that regulates several process such as autophagy, ciliogenesis, protein trafficking/secretion and genome integrity, in a kinase activity-dependent manner (PubMed:20733054, PubMed:21847093, PubMed:22948227, PubMed:24618899, PubMed:29021280). Controls both, basal and starvation-induced autophagy throught its interaction with GABARAP, MAP1LC3B and GABARAPL1 leading to autophagosome formation, SQSTM1 degradation and reduced MAP1LC3B inhibitory phosphorylation (PubMed:22948227).",ATP binding,"Cytoplasm, cytoskeleton, cilium basal body",inhibitor,DrugBank,drugbank_id
BE0009476,Mitogen-activated protein kinase 4,target,P31152,MAPK4,Humans,"Atypical MAPK protein. Phosphorylates microtubule-associated protein 2 (MAP2) and MAPKAPK5. The precise role of the complex formed with MAPKAPK5 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPKAPK5, ERK4/MAPK4 is phosphorylated at Ser-186 and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK4/MAPK4. May promote entry in the cell cycle (By similarity)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009477,Mitogen-activated protein kinase 7,target,Q13164,MAPK7,Humans,"Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of S",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009478,MAP kinase-activated protein kinase 5,target,Q8IW41,MAPKAPK5,Humans,"Tumor suppressor serine/threonine-protein kinase involved in mTORC1 signaling and post-transcriptional regulation. Phosphorylates FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB. Acts as a tumor suppressor by mediating Ras-induced senescence and phosphorylating p53/TP53. Involved in post-transcriptional regulation of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3 leads to promote nuclear localization of FOXO3, enabling expression of miR-34b and miR-34c, 2 post-",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009479,Serine/threonine-protein kinase MARK1,target,Q9P0L2,MARK1,Humans,"Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2 and MAP4. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating ",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009480,Serine/threonine-protein kinase MARK2,target,Q7KZI7,MARK2,Humans,"Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosph",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009481,MAP/microtubule affinity-regulating kinase 3,target,P27448,MARK3,Humans,"Serine/threonine-protein kinase (PubMed:16822840, PubMed:16980613, PubMed:23666762). Involved in the specific phosphorylation of microtubule-associated proteins for MAP2 and MAP4. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Phosphorylates CDC25C on 'Ser-216' (PubMed:12941695). Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleu",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009482,MAP/microtubule affinity-regulating kinase 4,target,Q96L34,MARK4,Humans,"Serine/threonine-protein kinase (PubMed:14594945, PubMed:15009667, PubMed:23184942, PubMed:23666762). Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:14594945, PubMed:23666762). Also phosphorylates the microtubule-associated proteins MAP2 and MAP4 (PubMed:14594945). Involved in regulation of the microtubule network, causing reorganization of microtubules into bundles (PubMed:14594945, PubMed:25123532). Required for the initiation of axoneme extension during cilium assembly (Pu",ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",inhibitor,DrugBank,drugbank_id
BE0009483,CLIP-associating protein 1,target,Q7Z460,CLASP1,Humans,Microtubule plus-end tracking protein that promotes the stabilization of dynamic microtubules. Involved in the nucleation of noncentrosomal microtubules originating from the trans-Golgi network (TGN). Required for the polarization of the cytoplasmic microtubule arrays in migrating cells towards the leading edge of the cell. May act at the cell cortex to enhance the frequency of rescue of depolymerizing microtubules by attaching their plus-ends to cortical platforms composed of ERC1 and PHLDB2. T,dystroglycan binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0009484,Microtubule-associated serine/threonine-protein kinase 1,target,Q9Y2H9,MAST1,Humans,Microtubule-associated protein essential for correct brain development (PubMed:30449657). Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins (By similarity),ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009485,Megakaryocyte-associated tyrosine-protein kinase,target,P42679,MATK,Humans,Could play a significant role in the signal transduction of hematopoietic cells. May regulate tyrosine kinase activity of SRC-family members in brain by specifically phosphorylating their C-terminal regulatory tyrosine residue which acts as a negative regulatory site. It may play an inhibitory role in the control of T-cell proliferation,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009486,Maternal embryonic leucine zipper kinase,target,Q14680,MELK,Humans,"Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. ",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009487,Misshapen-like kinase 1,target,Q8N4C8,MINK1,Humans,"Serine/threonine kinase which acts as a negative regulator of Ras-related Rap2-mediated signal transduction to control neuronal structure and AMPA receptor trafficking (PubMed:10708748, PubMed:16337592). Required for normal synaptic density, dendrite complexity, as well as surface AMPA receptor expression in hippocampal neurons (By similarity). Can activate the JNK and MAPK14/p38 pathways and mediates stimulation of the stress-activated protein kinase MAPK14/p38 MAPK downstream of the Raf/ERK pa",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009488,MAP kinase-interacting serine/threonine-protein kinase 1,target,Q9BUB5,MKNK1,Humans,"May play a role in the response to environmental stress and cytokines. Appears to regulate translation by phosphorylating EIF4E, thus increasing the affinity of this protein for the 7-methylguanosine-containing mRNA cap",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009489,MAP kinase-interacting serine/threonine-protein kinase 2,target,Q9HBH9,MKNK2,Humans,"Serine/threonine-protein kinase that phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. May play a role in the response to environmental stress and cytokines. Appears to regulate translation by phosphorylating EIF4E, thus increasing the affinity of this protein for the 7-methylguanosine-containing mRNA cap. Required for mediating PP2A-inhibition-induced EIF4E phosphorylation. Triggers EIF4E shuttling from cytoplasm to nucleus. Isoform 1 displays a high basal kinase activity, but isoform 2 exhibits a ve",ATP binding,"Nucleus, PML body",inhibitor,DrugBank,drugbank_id
BE0009491,"Muscle, skeletal receptor tyrosine-protein kinase",target,O15146,MUSK,Humans,"Receptor tyrosine kinase which plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between the motor neuron and the skeletal muscle (PubMed:25537362). Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces phosphorylation and activation of MUSK, the kinase of the complex. The activation of MUSK in myotubes regulates the formation of NMJs through the regulation of different processes including the specific expression of genes in s",ATP binding,Postsynaptic cell membrane,inhibitor,DrugBank,drugbank_id
BE0009493,Myosin light chain kinase 3,target,Q32MK0,MYLK3,Humans,Kinase that phosphorylates MYL2 in vitro. Promotes sarcomere formation in cardiomyocytes and increases cardiomyocyte contractility (By similarity),ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009494,Myosin light chain kinase family member 4,target,Q86YV6,MYLK4,Humans,,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009495,Myosin-IIIa,target,Q8NEV4,MYO3A,Humans,"Actin-dependent motor protein with a protein kinase activity, playing an essential role in hearing (PubMed:12032315, PubMed:29880844, PubMed:34788109). Probably also plays a role in vision. Required for normal cochlear hair bundle development and hearing. Plays an important role in the early steps of cochlear hair bundle morphogenesis. Influences the number and lengths of stereocilia to be produced and limits the growth of microvilli within the forming auditory hair bundles thereby contributing ",actin binding,"Cytoplasm, cytoskeleton",inhibitor,DrugBank,drugbank_id
BE0009496,Serine/threonine-protein kinase Nek1,target,Q96PY6,NEK1,Humans,"Phosphorylates serines and threonines, but also appears to possess tyrosine kinase activity (PubMed:20230784). Involved in DNA damage checkpoint control and for proper DNA damage repair (PubMed:20230784). In response to injury that includes DNA damage, NEK1 phosphorylates VDAC1 to limit mitochondrial cell death (PubMed:20230784). May be implicated in the control of meiosis (By similarity). Involved in cilium assembly (PubMed:21211617)",14-3-3 protein binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0003796,Serine/threonine-protein kinase Nek2,target,P51955,NEK2,Humans,"Protein kinase which is involved in the control of centrosome separation and bipolar spindle formation in mitotic cells and chromatin condensation in meiotic cells. Regulates centrosome separation (essential for the formation of bipolar spindles and high-fidelity chromosome separation) by phosphorylating centrosomal proteins such as CROCC, CEP250 and NINL, resulting in their displacement from the centrosomes. Regulates kinetochore microtubule attachment stability in mitosis via phosphorylation o",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009497,Serine/threonine-protein kinase Nek3,target,P51956,NEK3,Humans,Protein kinase which influences neuronal morphogenesis and polarity through effects on microtubules. Regulates microtubule acetylation in neurons. Contributes to prolactin-mediated phosphorylation of PXN and VAV2. Implicated in prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells through mechanisms involving RAC1 activation and phosphorylation of PXN and VAV2,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009498,Serine/threonine-protein kinase Nek4,target,P51957,NEK4,Humans,"Protein kinase that seems to act exclusively upon threonine residues (By similarity). Required for normal entry into proliferative arrest after a limited number of cell divisions, also called replicative senescence. Required for normal cell cycle arrest in response to double-stranded DNA damage",ATP binding,"Cell projection, cilium",inhibitor,DrugBank,drugbank_id
BE0009499,Serine/threonine-protein kinase Nek5,target,Q6P3R8,NEK5,Humans,,ATP binding,"Cell projection, cilium",inhibitor,DrugBank,drugbank_id
BE0009500,Serine/threonine-protein kinase Nek9,target,Q8TD19,NEK9,Humans,"Pleiotropic regulator of mitotic progression, participating in the control of spindle dynamics and chromosome separation (PubMed:12101123, PubMed:12840024, PubMed:14660563, PubMed:19941817). Phosphorylates different histones, myelin basic protein, beta-casein, and BICD2 (PubMed:11864968). Phosphorylates histone H3 on serine and threonine residues and beta-casein on serine residues (PubMed:11864968). Important for G1/S transition and S phase progression (PubMed:12840024, PubMed:14660563, PubMed:1",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009502,NUAK family SNF1-like kinase 1,target,O60285,NUAK1,Humans,"Serine/threonine-protein kinase involved in various processes such as cell adhesion, regulation of cell ploidy and senescence, cell proliferation and tumor progression. Phosphorylates ATM, CASP6, LATS1, PPP1R12A and p53/TP53. Acts as a regulator of cellular senescence and cellular ploidy by mediating phosphorylation of 'Ser-464' of LATS1, thereby controlling its stability. Controls cell adhesion by regulating activity of the myosin protein phosphatase 1 (PP1) complex. Acts by mediating phosphory",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009504,Serine/threonine-protein kinase OSR1,target,O95747,OXSR1,Humans,"Effector serine/threonine-protein kinase component of the WNK-SPAK/OSR1 kinase cascade, which is involved in various processes, such as ion transport, response to hypertonic stress and blood pressure (PubMed:16669787, PubMed:18270262, PubMed:21321328, PubMed:34289367). Specifically recognizes and binds proteins with a RFXV motif (PubMed:16669787, PubMed:17721439, PubMed:21321328). Acts downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4): following activation by WNK kinases, catalyzes phosphoryl",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009505,Serine/threonine-protein kinase PAK 1,target,Q13153,PAK1,Humans,"Protein kinase involved in intracellular signaling pathways downstream of integrins and receptor-type kinases that plays an important role in cytoskeleton dynamics, in cell adhesion, migration, proliferation, apoptosis, mitosis, and in vesicle-mediated transport processes (PubMed:10551809, PubMed:11896197, PubMed:12876277, PubMed:14585966, PubMed:15611088, PubMed:17726028, PubMed:17989089, PubMed:30290153, PubMed:17420447). Can directly phosphorylate BAD and protects cells against apoptosis (By ",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009506,Serine/threonine-protein kinase PAK 2,target,Q13177,PAK2,Humans,"Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequen",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009507,Serine/threonine-protein kinase PAK 3,target,O75914,PAK3,Humans,"Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, or cell cycle regulation. Plays a role in dendrite spine morphogenesis as well as synapse formation and plasticity. Acts as a downstream effector of the small GTPases CDC42 and RAC1. Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Pho",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009508,Serine/threonine-protein kinase PAK 4,target,O96013,PAK4,Humans,"Serine/threonine-protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell adhesion turnover, cell migration, growth, proliferation or cell survival (PubMed:26598620). Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, lea",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009509,Serine/threonine-protein kinase PAK 6,target,Q9NQU5,PAK6,Humans,Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Also inhibits ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009510,Serine/threonine-protein kinase PAK 5,target,Q9P286,PAK5,Humans,"Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates the proto-oncogene RAF1 and stimulates its kinase activity. Promotes cell survival by phosphorylati",ATP binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0004077,Cyclin-dependent kinase 16,target,Q00536,CDK16,Humans,"Protein kinase that plays a role in vesicle-mediated transport processes and exocytosis. Regulates GH1 release by brain neurons. Phosphorylates NSF, and thereby regulates NSF oligomerization. Required for normal spermatogenesis. Regulates neuron differentiation and dendrite development (By similarity). Plays a role in the regulation of insulin secretion in response to changes in blood glucose levels. Can phosphorylate CCNY at 'Ser-336' (in vitro)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009511,Cyclin-dependent kinase 17,target,Q00537,CDK17,Humans,May play a role in terminally differentiated neurons. Has a Ser/Thr-phosphorylating activity for histone H1 (By similarity),ATP binding,,inhibitor,DrugBank,drugbank_id
BE0000437,Cyclin-dependent kinase 15,target,Q96Q40,CDK15,Humans,Serine/threonine-protein kinase that acts like an antiapoptotic protein that counters TRAIL/TNFSF10-induced apoptosis by inducing phosphorylation of BIRC5 at 'Thr-34',ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009512,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",target,Q16816,PHKG1,Humans,"Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase. In vitro, phosphorylates PYGM, TNNI3, MAPT/TAU, GAP43 and NRGN/RC3 (By similarity)",ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009513,Phosphatidylinositol 4-kinase beta,target,Q9UBF8,PI4KB,Humans,"Phosphorylates phosphatidylinositol (PI) in the first committed step in the production of the second messenger inositol-1,4,5,-trisphosphate (PIP). May regulate Golgi disintegration/reorganization during mitosis, possibly via its phosphorylation. Involved in Golgi-to-plasma membrane trafficking (By similarity) (PubMed:10559940, PubMed:11277933, PubMed:12749687, PubMed:9405935). May play an important role in the inner ear development",1-phosphatidylinositol 4-kinase activity,Endomembrane system,inhibitor,DrugBank,drugbank_id
BE0009514,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,target,O00750,PIK3C2B,Humans,"Phosphorylates PtdIns and PtdIns4P with a preference for PtdIns (PubMed:10805725, PubMed:11533253, PubMed:9830063). Does not phosphorylate PtdIns(4,5)P2 (PubMed:9830063). May be involved in EGF and PDGF signaling cascades (PubMed:10805725)",1-phosphatidylinositol-3-kinase activity,Microsome,inhibitor,DrugBank,drugbank_id
BE0009515,Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma,target,O75747,PIK3C2G,Humans,"Generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act as second messengers (By similarity). May play a role in SDF1A-stimulated chemotaxis (By similarity)",1-phosphatidylinositol-3-kinase activity,Membrane,inhibitor,DrugBank,drugbank_id
BE0009516,Serine/threonine-protein kinase pim-3,target,Q86V86,PIM3,Humans,"Proto-oncogene with serine/threonine kinase activity that can prevent apoptosis, promote cell survival and protein translation. May contribute to tumorigenesis through: the delivery of survival signaling through phosphorylation of BAD which induces release of the anti-apoptotic protein Bcl-X(L), the regulation of cell cycle progression, protein synthesis and by regulation of MYC transcriptional activity. Additionally to this role on tumorigenesis, can also negatively regulate insulin secretion b",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009517,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,target,P78356,PIP4K2B,Humans,"Participates in the biosynthesis of phosphatidylinositol 4,5-bisphosphate (PubMed:26774281, PubMed:9038203). Preferentially utilizes GTP, rather than ATP, for PI(5)P phosphorylation and its activity reflects changes in direct proportion to the physiological GTP concentration (PubMed:26774281). Its GTP-sensing activity is critical for metabolic adaptation (PubMed:26774281). PIP4Ks negatively regulate insulin signaling through a catalytic-independent mechanism. They interact with PIP5Ks and suppre",1-phosphatidylinositol-4-phosphate 5-kinase activity,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009518,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,target,Q8TBX8,PIP4K2C,Humans,"Phosphatidylinositol 5-phosphate 4-kinase with low enzymatic activity. May be a GTP sensor, has higher GTP-dependent kinase activity than ATP-dependent kinase activity. PIP4Ks negatively regulate insulin signaling through a catalytic-independent mechanism. They interact with PIP5Ks and suppress PIP5K-mediated PtdIns(4,5)P2 synthesis and insulin-dependent conversion to PtdIns(3,4,5)P3 (PubMed:31091439)",1-phosphatidylinositol-4-phosphate 5-kinase activity,Endoplasmic reticulum,inhibitor,DrugBank,drugbank_id
BE0009519,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,target,Q99640,PKMYT1,Humans,"Acts as a negative regulator of entry into mitosis (G2 to M transition) by phosphorylation of the CDK1 kinase specifically when CDK1 is complexed to cyclins (PubMed:10373560, PubMed:10504341, PubMed:9001210, PubMed:9268380). Mediates phosphorylation of CDK1 predominantly on 'Thr-14'. Also involved in Golgi fragmentation (PubMed:9001210, PubMed:9268380). May be involved in phosphorylation of CDK1 on 'Tyr-15' to a lesser degree, however tyrosine kinase activity is unclear and may be indirect (PubM",ATP binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0009520,Serine/threonine-protein kinase N1,target,Q16512,PKN1,Humans,"PKC-related serine/threonine-protein kinase involved in various processes such as regulation of the intermediate filaments of the actin cytoskeleton, cell migration, tumor cell invasion and transcription regulation. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. Regulates the cytoskeletal network by phosphorylating proteins such as VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit their pol",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009521,Serine/threonine-protein kinase N2,target,Q16513,PKN2,Humans,"PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to imp",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009522,Serine/threonine-protein kinase PLK2,target,Q9NYY3,PLK2,Humans,"Tumor suppressor serine/threonine-protein kinase involved in synaptic plasticity, centriole duplication and G1/S phase transition. Polo-like kinases act by binding and phosphorylating proteins that are already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates CPAP, NPM1, RAPGEF2, RASGRF1, SNCA, SIPA1L1 and SYNGAP1. Plays a key role in synaptic plasticity and memory by regulating the Ras and Rap protein signaling: required for overactivity-dependent spine remod",ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole",inhibitor,DrugBank,drugbank_id
BE0009523,Serine/threonine-protein kinase PLK3,target,Q9H4B4,PLK3,Humans,"Serine/threonine-protein kinase involved in cell cycle regulation, response to stress and Golgi disassembly. Polo-like kinases act by binding and phosphorylating proteins that are already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates ATF2, BCL2L1, CDC25A, CDC25C, CHEK2, HIF1A, JUN, p53/TP53, p73/TP73, PTEN, TOP2A and VRK1. Involved in cell cycle regulation: required for entry into S phase and cytokinesis. Phosphorylates BCL2L1, leading to regulate the G2 c",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009524,Serine/threonine-protein kinase PLK4,target,O00444,PLK4,Humans,"Serine/threonine-protein kinase that plays a central role in centriole duplication. Able to trigger procentriole formation on the surface of the parental centriole cylinder, leading to the recruitment of centriole biogenesis proteins such as SASS6, CPAP, CCP110, CEP135 and gamma-tubulin. When overexpressed, it is able to induce centrosome amplification through the simultaneous generation of multiple procentrioles adjoining each parental centriole during S phase. Phosphorylates 'Ser-151' of FBXW5",ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole",inhibitor,DrugBank,drugbank_id
BE0004475,cAMP-dependent protein kinase catalytic subunit beta,target,P22694,PRKACB,Humans,"Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance o",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0002417,Protein kinase C delta type,target,Q05655,PRKCD,Humans,"Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regula",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0003889,Protein kinase C iota type,target,P41743,PRKCI,Humans,"Calcium- and diacylglycerol-independent serine/ threonine-protein kinase that plays a general protective role against apoptotic stimuli, is involved in NF-kappa-B activation, cell survival, differentiation and polarity, and contributes to the regulation of microtubule dynamics in the early secretory pathway. Is necessary for BCR-ABL oncogene-mediated resistance to apoptotic drug in leukemia cells, protecting leukemia cells against drug-induced apoptosis. In cultured neurons, prevents amyloid bet",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0001385,Protein kinase C theta type,target,Q04759,PRKCQ,Humans,"Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and pa",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009526,cGMP-dependent protein kinase 2,target,Q13237,PRKG2,Humans,Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular si,ATP binding,Apical cell membrane,inhibitor,DrugBank,drugbank_id
BE0009527,Serine/threonine-protein kinase PRP4 homolog,target,Q13523,PRP4K,Humans,"Serine/threonine kinase involved in spliceosomal assembly as well as mitosis and signaling regulation (PubMed:10799319, PubMed:12077342, PubMed:17513757, PubMed:17998396). Connects chromatin mediated regulation of transcription and pre-mRNA splicing (PubMed:12077342). During spliceosomal assembly, interacts with and phosphorylates PRPF6 and PRPF31, components of the U4/U6-U5 tri-small nuclear ribonucleoprotein (snRNP), to facilitate the formation of the spliceosome B complex. Plays a role in reg",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009528,Serine/threonine-protein kinase RIO1,target,Q9BRS2,RIOK1,Humans,Involved in the final steps of cytoplasmic maturation of the 40S ribosomal subunit. Involved in processing of 18S-E pre-rRNA to the mature 18S rRNA. Required for the recycling of NOB1 and PNO1 from the late 40S precursor (PubMed:22072790). The association with the very late 40S subunit intermediate may involve a translation-like checkpoint point cycle preceeding the binding to the 60S ribosomal subunit (By similarity). Despite the protein kinase domain is proposed to act predominantly as an ATPa,ATP binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0009529,Serine/threonine-protein kinase RIO2,target,Q9BVS4,RIOK2,Humans,"Serine/threonine-protein kinase involved in the final steps of cytoplasmic maturation of the 40S ribosomal subunit. Involved in export of the 40S pre-ribosome particles (pre-40S) from the nucleus to the cytoplasm. Its kinase activity is required for the release of NOB1, PNO1 and LTV1 from the late pre-40S and the processing of 18S-E pre-rRNA to the mature 18S rRNA (PubMed:19564402). Regulates the timing of the metaphase-anaphase transition during mitotic progression, and its phosphorylation, mos",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009530,Serine/threonine-protein kinase RIO3,target,O14730,RIOK3,Humans,Involved in regulation of type I interferon (IFN)-dependent immune response which plays a critical role in the innate immune response against DNA and RNA viruses. May act as an adapter protein essential for the recruitment of TBK1 to IRF3 (PubMed:24807708). Phosphorylates IFIH1 on 'Ser-828' interfering with IFIH1 filament assembly on long dsRNA and resulting in attenuated IFIH1-signaling (PubMed:25865883). Can inhibit CASP10 isoform 7-mediated activation of the NF-kappaB signaling pathway (PubMe,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009531,Receptor-interacting serine/threonine-protein kinase 1,target,Q13546,RIPK1,Humans,"Serine-threonine kinase which is a key regulator of TNF-mediated apoptosis, necroptosis and inflammatory pathways (PubMed:17703191, PubMed:24144979, PubMed:31827280, PubMed:31827281, PubMed:32657447, PubMed:35831301). Exhibits kinase activity-dependent functions that regulate cell death and kinase-independent scaffold functions regulating inflammatory signaling and cell survival (PubMed:11101870, PubMed:19524512, PubMed:19524513, PubMed:29440439, PubMed:30988283). Has kinase-independent scaffold",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009532,Receptor-interacting serine/threonine-protein kinase 2,target,O43353,RIPK2,Humans,"Serine/threonine/tyrosine-protein kinase that plays an essential role in modulation of innate and adaptive immune responses (PubMed:14638696, PubMed:17054981, PubMed:21123652, PubMed:28656966, PubMed:9575181, PubMed:9642260). Acts as a key effector of NOD1 and NOD2 signaling pathways: upon activation by bacterial peptidoglycans, NOD1 and NOD2 oligomerize and recruit RIPK2 via CARD-CARD domains, leading to the formation of RIPK2 filaments (PubMed:17054981, PubMed:17562858, PubMed:21123652, PubMed",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009533,Receptor-interacting serine/threonine-protein kinase 4,target,P57078,RIPK4,Humans,"Serine/threonine protein kinase (By similarity). Required for embryonic skin development and correct skin homeostasis in adults, via phosphorylation of PKP1 and subsequent promotion of keratinocyte differentiation and cell adhesion (By similarity). It is a direct transcriptional target of TP63 (PubMed:22197488). Plays a role in NF-kappa-B activation (PubMed:12446564)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0004274,Ribosomal protein S6 kinase alpha-1,target,Q15418,RPS6KA1,Humans,"Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:10679322, PubMed:12213813, PubMed:15117958, PubMed:16223362, PubM",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009535,Serine/threonine-protein kinase SBK1,target,Q52WX2,SBK1,Humans,May be involved in signal-transduction pathways related to the control of brain development,ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009536,Uncharacterized serine/threonine-protein kinase SBK3,target,P0C264,SBK3,Humans,,ATP binding,,inhibitor,DrugBank,drugbank_id
BE0009537,Serine/threonine-protein kinase Sgk3,target,Q96BR1,SGK3,Humans,"Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, proliferation, survival and migration. Up-regulates Na(+) channels: SCNN1A/ENAC and SCN5A, K(+) channels: KCNA3/KV1.3, KCNE1, KCNQ1 and KCNH2/HERG, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channel: BSND, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, amino ",ATP binding,Cytoplasmic vesicle,inhibitor,DrugBank,drugbank_id
BE0009538,Serine/threonine-protein kinase SIK2,target,Q9H0K1,SIK2,Humans,"Serine/threonine-protein kinase that plays a role in many biological processes such as fatty acid oxidation, autophagy, immune response or glucose metabolism (PubMed:23322770, PubMed:26983400). Phosphorylates 'Ser-794' of IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing TORCs, the CREB-specific coactivators (PubMed:15454081). Phosphorylates EP300 and thus inhibits its histone acet",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009539,SNF-related serine/threonine-protein kinase,target,Q9NRH2,SNRK,Humans,May play a role in hematopoietic cell proliferation or differentiation. Potential mediator of neuronal apoptosis,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009540,Tyrosine-protein kinase Srms,target,Q9H3Y6,SRMS,Humans,"Non-receptor tyrosine-protein kinase which phosphorylates DOK1 on tyrosine residues (PubMed:23822091). Also phosphorylates KHDRBS1/SAM68 and VIM on tyrosine residues (PubMed:29496907). Phosphorylation of KHDRBS1 is EGF-dependent (PubMed:29496907). Phosphorylates OTUB1, promoting deubiquitination of RPTOR (PubMed:35927303)",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009541,Serine/threonine-protein kinase 10,target,O94804,STK10,Humans,"Serine/threonine-protein kinase involved in regulation of lymphocyte migration. Phosphorylates MSN, and possibly PLK1. Involved in regulation of lymphocyte migration by mediating phosphorylation of ERM proteins such as MSN. Acts as a negative regulator of MAP3K1/MEKK1. May also act as a cell cycle regulator by acting as a polo kinase kinase: mediates phosphorylation of PLK1 in vitro; however such data require additional evidences in vivo",ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009542,Serine/threonine-protein kinase 16,target,O75716,STK16,Humans,"Membrane-associated protein kinase that phosphorylates on serine and threonine residues. In vitro substrates include DRG1, ENO1 and EIF4EBP1. Also autophosphorylates. May be involved in secretory vesicle trafficking or intracellular signaling. May have a role in regulating stromal-epithelial interactions that occur during ductal morphogenesis in the mammary gland. May be involved in TGF-beta signaling. Able to autophosphorylate on Tyr residue; it is however unclear whether it has tyrosine-protei",ATP binding,"Cytoplasm, perinuclear region",inhibitor,DrugBank,drugbank_id
BE0009543,Serine/threonine-protein kinase 17A,target,Q9UEE5,STK17A,Humans,Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species,ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009544,Serine/threonine-protein kinase 32A,target,Q8WU08,STK32A,Humans,,ATP binding,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0010298,Phosphatidylinositol 3-kinase,target,P27986,PIK3R1,Humans,"Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed:17626883, PubMed:19805105, PubMed:75",1-phosphatidylinositol-3-kinase regulator activity,,inhibitor,DrugBank,drugbank_id
BE0010048,Cytochrome P450 4F3,enzyme,Q08477,CYP4F3,Humans,"A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids and their oxygenated derivatives (oxylipins) (PubMed:11461919, PubMed:15145985, PubMed:16547005, PubMed:16820285, PubMed:18065749, PubMed:18182499, PubMed:18577768, PubMed:8486631, PubMed:9675028). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 ",20-aldehyde-leukotriene B4 20-monooxygenase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0009559,Envelope phospholipase OPG057,target,P33815,OPG057,Variola virus (isolate Human/India/Ind3/1967),"Major envelope protein that plays a role in the biogenesis of the viral double membrane and in egress of virus from the host cell. Produces the wrapped form of virus that is required for cell-to-cell spread. Acts as a lipase with broad specificity including phospholipase C, phospholipase A, and triacylglycerol lipase activities.",hydrolase activity,Virion membrane,inhibitor,DrugBank,drugbank_id
BE0010661,Tumor necrosis factor ligand superfamily member 4,target,P23510,TNFSF4,Humans,Cytokine that binds to TNFRSF4. Co-stimulates T-cell proliferation and cytokine production,cytokine activity,Membrane,modulator,DrugBank,drugbank_id
BE0010028,Angiopoietin-2,target,O15123,ANGPT2,Humans,"Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling (PubMed:15284220, PubMed:19116766, PubMed:19223473, PubMed:9204896). Can induce tyrosine phosphorylation of TEK/TIE2 in the absence of ANGPT1 (PubMed:15284220, PubMed:19116766, PubMed:19223473, PubMed:9204896). In the absence of angiogenic inducers, such as VEGF, ANGPT2-mediated loosening of cell-matrix contacts may induce endothelial cell apoptosis with consequent vascular regression. In concert with VEGF,",metal ion binding,Secreted,modulator,DrugBank,drugbank_id
BE0010681,Angiopoietin-1,target,Q15389,ANGPT1,Humans,"Binds and activates TEK/TIE2 receptor by inducing its dimerization and tyrosine phosphorylation. Plays an important role in the regulation of angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Required for normal angiogenesis and heart development during embryogenesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis a",identical protein binding,Secreted,modulator,DrugBank,drugbank_id
BE0010221,CMV DNA Terminase Complex,target,F5HC79,TRM1,Human Cytomegalovirus,"Component of the molecular motor that translocates viral genomic DNA in empty capsid during DNA packaging. Forms a tripartite terminase complex together with TRM2 and TRM3 in the host cytoplasm. Once the complex reaches the host nucleus, it interacts with the capsid portal vertex. This portal forms a ring in which genomic DNA is translocated into the capsid. TRM1 carries an endonuclease activity that plays an important role for the cleavage of concatemeric viral DNA into unit length genomes.",ATP binding,Host nucleus,inhibitor,DrugBank,drugbank_id
BE0003463,Tumor necrosis factor receptor superfamily member 9,target,Q07011,TNFRSF9,Humans,"Receptor for TNFSF9/4-1BBL. Conveys a signal that enhances CD8(+) T-cell survival, cytotoxicity, and mitochondrial activity, thereby promoting immunity against viruses and tumors (Probable)",signaling receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0010707,Baculoviral IAP repeat-containing protein 7,target,Q96CA5,BIRC7,Humans,"Apoptotic regulator capable of exerting proapoptotic and anti-apoptotic activities and plays crucial roles in apoptosis, cell proliferation, and cell cycle control (PubMed:11024045, PubMed:11084335, PubMed:11162435, PubMed:16729033, PubMed:17294084). Its anti-apoptotic activity is mediated through the inhibition of CASP3, CASP7 and CASP9, as well as by its E3 ubiquitin-protein ligase activity (PubMed:11024045, PubMed:16729033). As it is a weak caspase inhibitor, its anti-apoptotic activity is th",cysteine-type endopeptidase inhibitor activity,Nucleus,modulator,DrugBank,drugbank_id
BE0010810,Baculoviral IAP repeat-containing protein 1,target,Q13075,NAIP,Humans,"Anti-apoptotic protein which acts by inhibiting the activities of CASP3, CASP7 and CASP9. Can inhibit the autocleavage of pro-CASP9 and cleavage of pro-CASP3 by CASP9. Capable of inhibiting CASP9 autoproteolysis at 'Asp-315' and decreasing the rate of auto proteolysis at 'Asp-330'. Acts as a mediator of neuronal survival in pathological conditions. Prevents motor-neuron apoptosis induced by a variety of signals. Possible role in the prevention of spinal muscular atrophy that seems to be caused b",ATP binding,,modulator,DrugBank,drugbank_id
BE0010674,Baculoviral IAP repeat-containing protein 3,target,Q13489,BIRC3,Humans,"Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canon",cysteine-type endopeptidase inhibitor activity involved in apoptotic process,Cytoplasm,modulator,DrugBank,drugbank_id
BE0010675,Baculoviral IAP repeat-containing protein 2,target,Q13490,BIRC2,Humans,"Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling, and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-cano",cysteine-type endopeptidase inhibitor activity involved in apoptotic process,Cytoplasm,modulator,DrugBank,drugbank_id
BE0009746,Beta-lactamase SHV,target,A0A068JFB7,blaSHV,Escherichia coli,,beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0009745,Beta-lactamase,target,Q9X757,MIR-1,Klebsiella pneumoniae,,beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0009360,Beta-lactamase,target,Q53IN1,fox-7,Klebsiella pneumoniae,,beta-lactamase activity,,inhibitor,DrugBank,drugbank_id
BE0003472,Activin receptor type-2A,target,P27037,ACVR2A,Humans,"On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A (PubMed:17911401, PubMed:10652306). Mediates induction of adipogenesis by GDF6 (By similarity)",activin binding,Cell membrane,binder,DrugBank,drugbank_id
BE0010786,Growth/differentiation factor 11,target,O95390,GDF11,Humans,"Secreted signal that acts globally to regulate anterior/posterior axial patterning during development. May play critical roles in patterning both mesodermal and neural tissues (By similarity). It is required for proper vertebral patterning and orofacial development (PubMed:31215115). Signals through activin receptors type-2, ACVR2A and ACVR2B, and activin receptors type-1, ACVR1B, ACVR1C and TGFBR1 leading to the phosphorylation of SMAD2 and SMAD3 (PubMed:28257634)",cytokine activity,Secreted,binder,DrugBank,drugbank_id
BE0015530,Tyrosine-protein kinase STYK1,target,Q6J9G0,STYK1,Humans,"Probable tyrosine protein-kinase, which has strong transforming capabilities on a variety of cell lines. When overexpressed, it can also induce tumor cell invasion as well as metastasis in distant organs. May act by activating both MAP kinase and phosphatidylinositol 3'-kinases (PI3K) pathways (By similarity)",ATP binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0010068,DNA polymerase,target,P0DOO6,OPG071,Variola virus,"Catalyzes DNA synthesis. Acquires processivity by associating with a heterodimeric processivity factor comprised of the viral OPG148 and OPG116 proteins, thereby forming the DNA polymerase holoenzyme. Displays 3'- to 5' exonuclease activity. Might participate in viral DNA recombination. Does not perform OPG116/D4synthesis across an abasic site.",3'-5'-DNA exonuclease activity,,inhibitor,DrugBank,drugbank_id
BE0010070,Variola virus DNA,target,,,Variola virus,,,,incorporation into and destabilization,DrugBank,drugbank_id
BE0013106,DNA polymerase delta catalytic subunit,target,P28340,POLD1,Humans,"As the catalytic component of the trimeric (Pol-delta3 complex) and tetrameric DNA polymerase delta complexes (Pol-delta4 complex), plays a crucial role in high fidelity genome replication, including in lagging strand synthesis, and repair (PubMed:16510448, PubMed:19074196, PubMed:20334433, PubMed:24022480, PubMed:24035200, PubMed:31449058). Exhibits both DNA polymerase and 3'- to 5'-exonuclease activities (PubMed:16510448, PubMed:19074196, PubMed:20334433, PubMed:24022480, PubMed:24035200). Req",3'-5'-DNA exonuclease activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0020436,DNA polymerase delta subunit 4,target,Q9HCU8,POLD4,Humans,"As a component of the tetrameric DNA polymerase delta complex (Pol-delta4), plays a role in high fidelity genome replication and repair. Within this complex, increases the rate of DNA synthesis and decreases fidelity by regulating POLD1 polymerase and proofreading 3' to 5' exonuclease activity (PubMed:16510448, PubMed:19074196, PubMed:20334433). Pol-delta4 participates in Okazaki fragment processing, through both the short flap pathway, as well as a nick translation system (PubMed:24035200). Und",,Nucleus,inhibitor,DrugBank,drugbank_id
BE0010884,DNA polymerase subunit gamma-1,target,P54098,POLG,Humans,"Catalytic subunit of DNA polymerase gamma solely responsible for replication of mitochondrial DNA (mtDNA). Replicates both heavy and light strands of the circular mtDNA genome using a single-stranded DNA template, RNA primers and the four deoxyribonucleoside triphosphates as substrates (PubMed:11477093, PubMed:11897778, PubMed:15917273, PubMed:19837034, PubMed:9558343). Has 5' -> 3' polymerase activity. Functionally interacts with TWNK and SSBP1 at the replication fork to form a highly processiv",3'-5' exonuclease activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0010885,DNA polymerase subunit gamma-2,target,Q9UHN1,POLG2,Humans,Accessory subunit of DNA polymerase gamma solely responsible for replication of mitochondrial DNA (mtDNA). Acts as an allosteric regulator of the holoenzyme activities. Enhances the polymerase activity and the processivity of POLG by increasing its interactions with the DNA template. Suppresses POLG exonucleolytic proofreading especially toward homopolymeric templates bearing mismatched termini. Binds to single-stranded DNA,DNA polymerase binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0016315,DNA polymerase nu,target,Q7Z5Q5,POLN,Humans,"DNA polymerase with very low fidelity that catalyzes considerable misincorporation by inserting dTTP opposite a G template, and dGTP opposite a T template (PubMed:16787914, PubMed:17118716). Is the least accurate of the DNA polymerase A family (i.e. POLG, POLN and POLQ) (PubMed:17118716). Can perform accurate translesion DNA synthesis (TLS) past a 5S-thymine glycol. Can perform efficient strand displacement past a nick or a gap and gives rise to an amount of product similar to that on non-damage",cyclin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0010760,DNA polymerase theta,target,O75417,POLQ,Humans,"Low-fidelity DNA polymerase with a helicase activity that promotes microhomology-mediated end-joining (MMEJ), an alternative non-homologous end-joining (NHEJ) machinery required to repair double-strand breaks in DNA during mitosis (PubMed:14576298, PubMed:18503084, PubMed:24648516, PubMed:25642963, PubMed:25643323, PubMed:25775267, PubMed:26636256, PubMed:27311885, PubMed:27591252, PubMed:30655289, PubMed:31562312, PubMed:32873648, PubMed:34140467, PubMed:34179826, PubMed:36455556, PubMed:374406",5'-deoxyribose-5-phosphate lyase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0002420,Interleukin-4 receptor subunit alpha,target,P24394,IL4R,Humans,"Receptor for both interleukin 4 and interleukin 13 (PubMed:17030238). Couples to the JAK1/2/3-STAT6 pathway. The IL4 response is involved in promoting Th2 differentiation. The IL4/IL13 responses are involved in regulating IgE production and, chemokine and mucus production at sites of allergic inflammation. In certain cell types, can signal through activation of insulin receptor substrates, IRS1/IRS2",cytokine receptor activity,Cell membrane,inhibitor|antibody,DrugBank,drugbank_id
BE0001172,RAC-beta serine/threonine-protein kinase,target,P31751,AKT2,Humans,"Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0010514,RAC-gamma serine/threonine-protein kinase,target,Q9Y243,AKT3,Humans,"AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an impo",ATP binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009680,B-cell antigen receptor complex-associated protein beta chain,target,P40259,CD79B,Humans,"Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation",identical protein binding,Cell membrane,binder,DrugBank,drugbank_id
BE0009630,Excretory Secretory (ES) proteins,target,Q6IX08,,Fasciola hepatica,,phosphoserine residue binding,,inhibitor,DrugBank,drugbank_id
BE0009679,Endothelial PAS domain-containing protein 1,target,Q99814,EPAS1,Humans,Transcription factor involved in the induction of oxygen regulated genes. Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Regulates the vascular endothelial growth factor (VEGF) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. May also play a role in the formation of the endothelium that gives rise to the blood brain barrier. ,"DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,stabilization,DrugBank,drugbank_id
BE0004746,Anoctamin-1,target,Q5XXA6,ANO1,Humans,"Calcium-activated chloride channel (CaCC) (PubMed:20056604, PubMed:22178883, PubMed:22946059, PubMed:32487539). Plays a role in transepithelial anion transport and smooth muscle contraction. Required for the normal functioning of the interstitial cells of Cajal (ICCs) which generate electrical pacemaker activity in gastrointestinal smooth muscles. Acts as a major contributor to basal and stimulated chloride conductance in airway epithelial cells and plays an important role in tracheal cartilage ",calcium-activated cation channel activity,Apical cell membrane,antagonist,DrugBank,drugbank_id
BE0003466,Ribosome-binding protein 1,target,Q9P2E9,RRBP1,Humans,Acts as a ribosome receptor and mediates interaction between the ribosome and the endoplasmic reticulum membrane,RNA binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0003420,Bcl-2-like protein 2,target,Q92843,BCL2L2,Humans,Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX,channel activity,Mitochondrion membrane,inhibitor,DrugBank,drugbank_id
BE0003510,Bcl-2-like protein 1,target,Q07817,BCL2L1,Humans,"Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis",BH3 domain binding,Mitochondrion inner membrane,inhibitor,DrugBank,drugbank_id
BE0003421,Bcl2-associated agonist of cell death,target,Q92934,BAD,Humans,"Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways",cysteine-type endopeptidase activator activity,Mitochondrion outer membrane,,DrugBank,drugbank_id
BE0009009,Calcitonin gene-related peptide type 1 receptor,target,Q16602,CALCRL,Humans,"G protein-coupled receptor which specificity is determined by its interaction with receptor-activity-modifying proteins (RAMPs) (PubMed:32296767, PubMed:33602864, PubMed:8626685). Together with RAMP1, form the receptor complex for calcitonin-gene-related peptides CALCA/CGRP1 and CALCB/CGRP2 (PubMed:33602864). Together with RAMP2 or RAMP3, function as receptor complexes for adrenomedullin (ADM and ADM2) (PubMed:32296767, PubMed:9620797). Ligand binding causes a conformation change that triggers s",adrenomedullin binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0009866,RNA-directed RNA polymerase catalytic subunit,target,Q809M3,PB1,Influenza A virus (strain A/Silky Chicken/Hong Kong/SF189/2001 H5N1 genotype A),"RNA-dependent RNA polymerase which is responsible for replication and transcription of virus RNA segments. The transcription of viral mRNAs occurs by a unique mechanism called cap-snatching. 5' methylated caps of cellular mRNAs are cleaved after 10-13 nucleotides by PA. In turn, these short capped RNAs are used as primers by PB1 for transcription of viral mRNAs. During virus replication, PB1 initiates RNA synthesis and copy vRNA into complementary RNA (cRNA) which in turn serves as a template fo",nucleotide binding,Host nucleus,,DrugBank,drugbank_id
BE0010067,GTP-binding protein RHO1,target,P06780,RHO1,Baker's yeast,"Acts as a central regulator in the cell wall integrity signaling pathway, which is regulated by the cell cycle and in response to various types of cell wall stress. Integrates signals from different cell surface sensors, and activates a set of effectors, regulating processes including beta-glucan synthesis at the site of wall remodeling, gene expression related to cell wall biogenesis, organization of the actin cytoskeleton, and protein- and secretory vesicle-targeting to the growth site. Activa",enzyme activator activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009787,C-C chemokine receptor type 4,target,P51679,CCR4,Humans,"High affinity receptor for the C-C type chemokines CCL17/TARC, CCL22/MDC and CKLF isoform 1/CKLF1. The activity of this receptor is mediated by G(i) proteins which activate a phosphatidylinositol-calcium second messenger system. Can function as a chemoattractant homing receptor on circulating memory lymphocytes and as a coreceptor for some primary HIV-2 isolates. In the CNS, could mediate hippocampal-neuron survival",C-C chemokine binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0009548,Gastrin,target,P01350,GAST,Humans,Gastrin stimulates the stomach mucosa to produce and secrete hydrochloric acid and the pancreas to secrete its digestive enzymes. It also stimulates smooth muscle contraction and increases blood circulation and water secretion in the stomach and intestine,hormone activity,Secreted,inhibition of synthesis,DrugBank,drugbank_id
BE0001035,Protein-glutamine gamma-glutamyltransferase 2,target,P21980,TGM2,Humans,"Calcium-dependent acyltransferase that catalyzes the formation of covalent bonds between peptide-bound glutamine and various primary amines, such as gamma-amino group of peptide-bound lysine, or mono- and polyamines, thereby producing cross-linked or aminated proteins, respectively (PubMed:23941696, PubMed:31991788, PubMed:9252372). Involved in many biological processes, such as bone development, angiogenesis, wound healing, cellular differentiation, chromatin modification and apoptosis (PubMed:",calcium ion binding,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0011989,Lysine-specific demethylase 4A,target,O75164,KDM4A,Humans,"Histone demethylase that specifically demethylates 'Lys-9' and 'Lys-36' residues of histone H3, thereby playing a central role in histone code (PubMed:26741168, PubMed:21768309). Does not demethylate histone H3 'Lys-4', H3 'Lys-27' nor H4 'Lys-20'. Demethylates trimethylated H3 'Lys-9' and H3 'Lys-36' residue, while it has no activity on mono- and dimethylated residues. Demethylation of Lys residue generates formaldehyde and succinate. Participates in transcriptional repression of ASCL2 and E2F-",histone demethylase activity,Nucleus,inhibitor,DrugBank,drugbank_id
BE0000950,Bifunctional epoxide hydrolase 2,target,P34913,EPHX2,Humans,"Bifunctional enzyme (PubMed:12574510). The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides (PubMed:12574510, PubMed:12869654, PubMed:22798687). Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides (By similarity). Also determines steady-state levels of physiological mediators (PubMed:12574510, PubMed:12869654, PubMed:21217101, PubMed:22798687)",10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0020789,"rRNA methyltransferase 2, mitochondrial",target,Q9UI43,MRM2,Humans,"S-adenosyl-L-methionine-dependent 2'-O-ribose methyltransferase that catalyzes the formation of 2'-O-methyluridine at position 1369 (Um1369) in the 16S mitochondrial large subunit ribosomal RNA (mtLSU rRNA), a universally conserved modification in the peptidyl transferase domain of the mtLSU rRNA (PubMed:25009282, PubMed:25074936, PubMed:35177605). This activity may require prior 2'-O-methylguanosine modification at position 1370 (Gm1370) by MRM3 (PubMed:35177605). Essential for late-stage assem",rRNA (uridine-2'-O-)-methyltransferase activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0005510,Adhesion G-protein coupled receptor D1,target,Q6QNK2,ADGRD1,Humans,"Adhesion G-protein coupled receptor (aGPCR) for androgen hormone 5alpha-dihydrotestosterone (5alpha-DHT), also named 17beta-hydroxy-5alpha-androstan-3-one, the most potent hormone among androgens (PubMed:39884271). Also activated by methenolone drug (PubMed:39884271). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase (PubMed:39884271). ADGRD1 is cou",G protein-coupled receptor activity,Cell membrane,,DrugBank,drugbank_id
BE0010426,GTPase NRas,target,P01111,NRAS,Humans,Ras proteins bind GDP/GTP and possess intrinsic GTPase activity,G protein activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0005076,"Actin, aortic smooth muscle",target,P62736,ACTA2,Humans,Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells,ATP binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0009021,"ATP synthase F(0) complex subunit e, mitochondrial",target,P56385,ATP5ME,Humans,"Subunit e, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside ",protein-containing complex binding,Mitochondrion,,DrugBank,drugbank_id
BE0004474,Cytochrome b5 type B,target,O43169,CYB5B,Humans,Cytochrome b5 is a membrane-bound hemoprotein functioning as an electron carrier for several membrane-bound oxygenases,heme binding,Mitochondrion outer membrane,,DrugBank,drugbank_id
BE0009023,Diablo IAP-binding mitochondrial protein,target,Q9NR28,DIABLO,Humans,"Promotes apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway. Acts by opposing the inhibitory activity of inhibitor of apoptosis proteins (IAP). Inhibits the activity of BIRC6/BRUCE by inhibiting its binding to caspases (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106)",,Mitochondrion,,DrugBank,drugbank_id
BE0009024,F-box only protein 41,target,Q8TF61,FBXO41,Humans,Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex,,,,DrugBank,drugbank_id
BE0009025,Heterogeneous nuclear ribonucleoprotein F,target,P52597,HNRNPF,Humans,"Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Plays a role in the regulation of alternative splicing events. Binds G-rich sequences in pre-mRNAs and keeps target RNA in an unfolded state",RNA binding,"Nucleus, nucleoplasm",,DrugBank,drugbank_id
BE0009027,Heat shock 70 kDa protein 4,target,P34932,HSPA4,Humans,,adenyl-nucleotide exchange factor activity,Cytoplasm,,DrugBank,drugbank_id
BE0009028,"10 kDa heat shock protein, mitochondrial",target,P61604,HSPE1,Humans,"Co-chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp60, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (PubMed:11422376, PubMed:1346131, PubMed:7912672). The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-b",ATP binding,Mitochondrion matrix,,DrugBank,drugbank_id
BE0009029,Heat shock protein 105 kDa,target,Q92598,HSPH1,Humans,"Acts as a nucleotide-exchange factor (NEF) for chaperone proteins HSPA1A and HSPA1B, promoting the release of ADP from HSPA1A/B thereby triggering client/substrate protein release (PubMed:24318877). Prevents the aggregation of denatured proteins in cells under severe stress, on which the ATP levels decrease markedly. Inhibits HSPA8/HSC70 ATPase and chaperone activities (By similarity)",adenyl-nucleotide exchange factor activity,Cytoplasm,,DrugBank,drugbank_id
BE0009030,Nuclear migration protein nudC,target,Q9Y266,NUDC,Humans,"Plays a role in neurogenesis and neuronal migration (By similarity). Necessary for correct formation of mitotic spindles and chromosome separation during mitosis (PubMed:12679384, PubMed:12852857, PubMed:25789526). Necessary for cytokinesis and cell proliferation (PubMed:12679384, PubMed:12852857)",cadherin binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0009031,Pappalysin-1,target,Q13219,PAPPA,Humans,"Metalloproteinase which specifically cleaves IGFBP-4 and IGFBP-5, resulting in release of bound IGF. Cleavage of IGFBP-4 is dramatically enhanced by the presence of IGF, whereas cleavage of IGFBP-5 is slightly inhibited by the presence of IGF",metalloendopeptidase activity,Secreted,,DrugBank,drugbank_id
BE0003912,Proteasome subunit alpha type-3,target,P25788,PSMA3,Humans,"Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged protein",ubiquitin protein ligase binding,Cytoplasm,,DrugBank,drugbank_id
BE0009032,26S proteasome regulatory subunit 6A,target,P17980,PSMC3,Humans,"Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC3 belongs to t",ATP binding,Cytoplasm,,DrugBank,drugbank_id
BE0009033,Protein S100-A10,target,P60903,S100A10,Humans,"Because S100A10 induces the dimerization of ANXA2/p36, it may function as a regulator of protein phosphorylation in that the ANXA2 monomer is the preferred target (in vitro) of tyrosine-specific kinase",calcium ion binding,,,DrugBank,drugbank_id
BE0009034,Splicing factor 3A subunit 3,target,Q12874,SF3A3,Humans,"Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:10882114, PubMed:11533230, PubMed:32494006, PubMed:34822310, PubMed:8022796). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing ",RNA binding,Nucleus speckle,,DrugBank,drugbank_id
BE0009035,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,target,Q969G3,SMARCE1,Humans,"Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). Durin",chromatin binding,Nucleus,,DrugBank,drugbank_id
BE0009036,Tumor protein D54,target,O43399,TPD52L2,Humans,,protein homodimerization activity,,,DrugBank,drugbank_id
BE0009038,Tropomyosin alpha-3 chain,target,P06753,TPM3,Humans,"Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments",actin filament binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0009039,Tropomyosin alpha-4 chain,target,P67936,TPM4,Humans,"Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments (By similarity). Binds calcium (PubMed:1836432). Plays a role in platelet biogenesis",actin filament binding,"Cytoplasm, cytoskeleton",,DrugBank,drugbank_id
BE0004965,Thioredoxin,target,P10599,TXN,Humans,"Participates in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyzes dithiol-disulfide exchange reactions (PubMed:17182577, PubMed:19032234, PubMed:2176490). Plays a role in the reversible S-nitrosylation of cysteine residues in target proteins, and thereby contributes to the response to intracellular nitric oxide. Nitrosylates the active site Cys of CASP3 in response to nitric oxide (NO), and thereby inhibits caspase-3 activity (PubM",protein homodimerization activity,Nucleus,,DrugBank,drugbank_id
BE0005767,Ubiquitin carboxyl-terminal hydrolase isozyme L1,target,P09936,UCHL1,Humans,"Deubiquitinase that plays a role in the regulation of several processes such as maintenance of synaptic function, cardiac function, inflammatory response or osteoclastogenesis (PubMed:22212137, PubMed:23359680). Abrogates the ubiquitination of multiple proteins including WWTR1/TAZ, EGFR, HIF1A and beta-site amyloid precursor protein cleaving enzyme 1/BACE1 (PubMed:22212137, PubMed:25615526). In addition, recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin to maintain ",alpha-2A adrenergic receptor binding,Cytoplasm,,DrugBank,drugbank_id
BE0009040,Ubiquitin carboxyl-terminal hydrolase 14,target,P54578,USP14,Humans,"Proteasome-associated deubiquitinase which releases ubiquitin from the proteasome targeted ubiquitinated proteins (PubMed:35145029). Ensures the regeneration of ubiquitin at the proteasome (PubMed:18162577, PubMed:28396413). Is a reversibly associated subunit of the proteasome and a large fraction of proteasome-free protein exists within the cell (PubMed:18162577). Required for the degradation of the chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (PubMed:19106094).",cysteine-type deubiquitinase activity,Cytoplasm,,DrugBank,drugbank_id
BE0004572,Transitional endoplasmic reticulum ATPase,target,P55072,VCP,Humans,"Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and",ADP binding,"Cytoplasm, cytosol",,DrugBank,drugbank_id
BE0004570,14-3-3 protein epsilon,target,P62258,YWHAE,Humans,"Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways (PubMed:21189250). Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif (PubMed:35343654). Binding generally results in the modulation of the activity of the binding partner (By similarity). Positively regulates phosphorylated protein HSF1 nuclear export to the cytoplasm (PubMed:12917326). Plays a positive role in the antiviral si",cadherin binding,Nucleus,,DrugBank,drugbank_id
BE0009041,14-3-3 protein eta,target,Q04917,YWHAH,Humans,"Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negatively regulates the kinase activity of PDPK1",actin binding,,,DrugBank,drugbank_id
BE0009042,14-3-3 protein theta,target,P27348,YWHAQ,Humans,"Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negatively regulates the kinase activity of PDPK1",14-3-3 protein binding,Cytoplasm,,DrugBank,drugbank_id
BE0001174,14-3-3 protein zeta/delta,target,P63104,YWHAZ,Humans,"Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways (PubMed:14578935, PubMed:15071501, PubMed:15644438, PubMed:16376338, PubMed:16959763, PubMed:31024343, PubMed:9360956). Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif (PubMed:35662396). Binding generally results in the modulation of the activity of the binding partner (PubMed:35662396). Promotes cytosolic retention and inact",cadherin binding,Cytoplasm,,DrugBank,drugbank_id
BE0027700,DNA gyrase subunit B,target,Q5F5Z6,gyrB,Neisseria gonorrhoeae (strain ATCC 700825 / FA 1090),"A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to modulate DNA topology and maintain chromosomes in an underwound state. Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Also able to catalyze the interconversion of other topological isomers of dsDNA rings, including catenanes and knotted rings. Type II topoisomerases break an",ATP binding,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009718,Large ribosomal subunit protein uL22,target,P61182,rplV,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),"This protein binds specifically to 23S rRNA; its binding is stimulated by other ribosomal proteins, e.g. L4, L17, and L20. It is important during the early stages of 50S assembly. It makes multiple contacts with different domains of the 23S rRNA in the assembled 50S subunit and ribosome (By similarity).",rRNA binding,,inhibitor|binder,DrugBank,drugbank_id
BE0009554,Nuclear factor NF-kappa-B complex,target,Q00653,NFKB2,Humans,"NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B ","DNA-binding transcription activator activity, RNA polymerase II-specific",Nucleus,inhibitor,DrugBank,drugbank_id
BE0003459,Mesothelin,target,Q13421,MSLN,Humans,Membrane-anchored forms may play a role in cellular adhesion,,Cell membrane,,DrugBank,drugbank_id
BE0009562,Histone-lysine N-methyltransferase EZH2,target,Q15910,EZH2,Humans,"Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27",chromatin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009849,Histone-lysine N-methyltransferase EZH1,target,Q92800,EZH1,Humans,"Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH1 complex, which methylates 'Lys-27' of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Required for embryonic stem cell derivation and self-renewal, suggesting that it is involved in safeguarding embryonic stem cell identity. Compared to EZH2-containing complexes, it is less abundant in",chromatin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0009918,Tumor-associated calcium signal transducer 2,target,P09758,TACSTD2,Humans,May function as a growth factor receptor,,Membrane,antibody,DrugBank,drugbank_id
BE0010184,Interleukin-17F,target,Q96PD4,IL17F,Humans,"Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (PubMed:21350122). IL17A-IL17F signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter through SEFIR domains. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrob",cytokine activity,Secreted,antibody,DrugBank,drugbank_id
BE0010820,"Histone-lysine N-methyltransferase, H3 lysine-79 specific",target,Q8TEK3,DOT1L,Humans,Histone methyltransferase. Methylates 'Lys-79' of histone H3. Nucleosomes are preferred as substrate compared to free histones (PubMed:12123582). Binds to DNA (PubMed:12628190),DNA binding,Nucleus,modulator,DrugBank,drugbank_id
BE0003477,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,target,P16615,ATP2A2,Humans,"This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen (PubMed:12542527, PubMed:16402920). Involved in autophagy in response to starvation. Upon interaction with VMP1 and activation, controls ER-isolation membrane contacts for autophagosome formation (PubMed:28890335). Also modulates ER contacts with lipid droplets, mitochondria and endosomes (PubMed:28890335). In coordination with FLVCR2 medi",ATP binding,Endoplasmic reticulum membrane,inhibitor,DrugBank,drugbank_id
BE0020283,Probable glucose sensor protein SLC5A4,target,Q9NY91,SLC5A4,Humans,"Does not function as sodium/D-glucose symporter (PubMed:13130073, PubMed:20421923, PubMed:22766068). However, may function as a D-glucose sensor by generating a D-glucose-induced depolarization which is pH-independent, Na(+)-dependent at neutral pH and probably H(+)-dependent at acidic pH (PubMed:13130073, PubMed:17110502, PubMed:20421923, PubMed:22766068)",solute,Cell membrane,blocker,DrugBank,drugbank_id
BE0009798,Nectin-4,target,Q96NY8,NECTIN4,Humans,"Seems to be involved in cell adhesion through trans-homophilic and -heterophilic interactions, the latter including specifically interactions with NECTIN1. Does not act as receptor for alpha-herpesvirus entry into cells",identical protein binding,Cell membrane,binder|antibody,DrugBank,drugbank_id
BE0010784,Delta-like protein 3,target,Q9NYJ7,DLL3,Humans,Inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm (By similarity),calcium ion binding,Membrane,inhibitor,DrugBank,drugbank_id
BE0003383,Growth hormone secretagogue receptor type 1,target,Q92847,GHSR,Humans,"Receptor for ghrelin, coupled to G-alpha-11 proteins. Stimulates growth hormone secretion. Also binds other growth hormone releasing peptides (GHRP) (e.g. Met-enkephalin and GHRP-6) as well as non-peptide, low molecular weight secretagogues (e.g. L-692,429, MK-0677, adenosine)",G protein-coupled receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0008679,Flavin-dependent monooxygenase,enzyme,Q93L51,tetX2,Bacteroides thetaiotaomicron,"An FAD-requiring monooxygenase active on tetracycline antibiotic derivatives, which leads to their inactivation (PubMed:15452119, PubMed:16128584). Hydroxylates carbon 11a of oxytetracycline and tigecycline (PubMed:15452119, PubMed:26097034). Acts on many tetracycline analogs (chlorotetracycline, demeclocycline, doxycycline, minocycline, oxytetracyclinee), probably by monooxygenization (PubMed:15452119, PubMed:16128584). Tigecycline, a new generation tetracycline antibiotic, is rendered less eff",FAD binding,,substrate,DrugBank,drugbank_id
BE0003941,Porin,transporter,Q9K597,ompC,Escherichia coli,,porin activity,Cell outer membrane,substrate,DrugBank,drugbank_id
BE0010188,Asialoglycoprotein receptor 1,target,P07306,ASGR1,Humans,"Mediates the endocytosis of plasma glycoproteins to which the terminal sialic acid residue on their complex carbohydrate moieties has been removed. The receptor recognizes terminal galactose and N-acetylgalactosamine units. After ligand binding to the receptor, the resulting complex is internalized and transported to a sorting organelle, where receptor and ligand are disassociated. The receptor then returns to the cell membrane surface",asialoglycoprotein receptor activity,Membrane,ligand,DrugBank,drugbank_id
BE0009336,A disintegrin and metalloproteinase with thrombospondin motifs 13,enzyme,Q76LX8,ADAMTS13,Humans,Cleaves the vWF multimers in plasma into smaller forms thereby controlling vWF-mediated platelet thrombus formation,calcium ion binding,Secreted,substrate,DrugBank,drugbank_id
BE0008671,Toxin B,target,P18177,tcdB,Peptoclostridium difficile,"Toxin B
    Precursor of a cytotoxin that targets and disrupts the colonic epithelium, inducing the host inflammatory and innate immune responses and resulting in diarrhea and pseudomembranous colitis (PubMed:20844489, PubMed:24919149). TcdB constitutes the main toxin that mediates the pathology of C.difficile infection, an opportunistic pathogen that colonizes the colon when the normal gut microbiome is disrupted (PubMed:19252482, PubMed:20844489). Compared to TcdA, TcdB is more virulent and mo",cysteine-type peptidase activity,,antibody|neutralizer,DrugBank,drugbank_id
BE0005577,Glutathione,target,,,Humans,,,,ligand,DrugBank,drugbank_id
BE0009368,Sodium/myo-inositol cotransporter,transporter,P53794,SLC5A3,Humans,"Electrogenic Na(+)-coupled sugar symporter that actively transports myo-inositol and its stereoisomer scyllo-inositol across the plasma membrane, with a Na(+) to sugar coupling ratio of 2:1 (By similarity). Maintains myo-inositol concentration gradient that defines cell volume and fluid balance during osmotic stress, in particular in the fetoplacental unit and central nervous system (By similarity). Forms coregulatory complexes with voltage-gated K(+) ion channels, allosterically altering ion se",D-glucose,Apical cell membrane,substrate,DrugBank,drugbank_id
BE0003675,Large ribosomal subunit protein bL32,target,P49228,rpmF,Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422),"Forms a cluster with L17 and L22, and with L22, a pair of 'tweezers' that hold together all the domains of the 23S rRNA. Interacts with the antibiotic troleandomycin which blocks the peptide exit tunnel.",metal ion binding,,inhibitor,DrugBank,drugbank_id
BE0003674,Large ribosomal subunit protein uL4,target,P60723,rplD,Escherichia coli (strain K12),"One of the primary rRNA binding proteins, this protein initially binds near the 5'-end of the 23S rRNA (PubMed:3298242). It is important during the early stages of 50S assembly (PubMed:3298242). It makes multiple contacts with different domains of the 23S rRNA in the assembled 50S subunit and ribosome (PubMed:6170935, PubMed:7556101).",DNA binding,,inhibitor,DrugBank,drugbank_id
BE0021113,Short transient receptor potential channel 5,target,Q9UL62,TRPC5,Humans,"Forms a receptor-activated non-selective calcium permeant cation channel (PubMed:16284075, PubMed:38959890, PubMed:37137991). Mediates calcium-dependent phosphatidylserine externalization and apoptosis in neurons via its association with PLSCR1 (By similarity). Acts on distinct neuronal populations in the hypothalamus to regulate innate behaviors including feeding, anxiety (flight/fight/fear), socialization, and maternal care (By similarity)",actin binding,Cell membrane,activator,DrugBank,drugbank_id
BE0000375,Sodium- and chloride-dependent creatine transporter 1,target,P48029,SLC6A8,Humans,"Creatine:sodium symporter which mediates the uptake of creatine (PubMed:17465020, PubMed:22644605, PubMed:25861866, PubMed:7945388, PubMed:7953292, PubMed:9882430). Plays an important role in supplying creatine to the brain via the blood-brain barrier (By similarity)",creatine transmembrane transporter activity,Cell membrane,,DrugBank,drugbank_id
BE0000714,Creatine kinase M-type,target,P06732,CKM,Humans,"Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa",ATP binding,Cytoplasm,ligand,DrugBank,drugbank_id
BE0000171,"Creatine kinase U-type, mitochondrial",target,P12532,CKMT1A,Humans,"Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa",ATP binding,Mitochondrion inner membrane,ligand,DrugBank,drugbank_id
BE0000410,"Creatine kinase S-type, mitochondrial",target,P17540,CKMT2,Humans,"Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa",ATP binding,Mitochondrion inner membrane,ligand,DrugBank,drugbank_id
BE0000082,Creatine kinase B-type,target,P12277,CKB,Humans,"Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate) (PubMed:8186255). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa (Probable). Acts as a key regulator of adaptive thermogenesis as part of the futile creatine cycle: localizes to the mitochondria of thermogenic fat cells and acts by mediating phosphorylation of cr",ATP binding,"Cytoplasm, cytosol",ligand,DrugBank,drugbank_id
BE0003133,Dihydropteroate synthase,target,Q81VW8,folP,Bacillus anthracis,"Catalyzes the condensation of para-aminobenzoate (pABA) with 6-hydroxymethyl-7,8-dihydropterin diphosphate (DHPt-PP) to form 7,8-dihydropteroate (H2Pte), the immediate precursor of folate derivatives.",dihydropteroate synthase activity,,inhibitor,DrugBank,drugbank_id
BE0004850,Transferrin receptor,target,P02786,TFRC,Humans,"Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes (PubMed:26214738). Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the h",double-stranded RNA binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0009858,Hepcidin,enzyme,P81172,HAMP,Humans,"Liver-produced hormone that constitutes the main circulating regulator of iron absorption and distribution across tissues. Acts by promoting endocytosis and degradation of ferroportin/SLC40A1, leading to the retention of iron in iron-exporting cells and decreased flow of iron into plasma (PubMed:22682227, PubMed:29237594, PubMed:32814342). Controls the major flows of iron into plasma: absorption of dietary iron in the intestine, recycling of iron by macrophages, which phagocytose old erythrocyte",hormone activity,Secreted,substrate,DrugBank,drugbank_id
BE0009859,Plasma membrane ascorbate-dependent reductase CYBRD1,enzyme,Q53TN4,CYBRD1,Humans,"Plasma membrane reductase that uses cytoplasmic ascorbate as an electron donor to reduce extracellular Fe(3+) into Fe(2+) (PubMed:30272000). Probably functions in dietary iron absorption at the brush border of duodenal enterocytes by producing Fe(2+), the divalent form of iron that can be transported into enterocytes (PubMed:30272000). It is also able to reduce extracellular monodehydro-L-ascorbate and may be involved in extracellular ascorbate regeneration by erythrocytes in blood (PubMed:17068",identical protein binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0009856,Ferroportin,transporter,Q9NP59,SLC40A1,Humans,"Transports Fe(2+) from the inside of a cell to the outside of the cell, playing a key role for maintaining systemic iron homeostasis (PubMed:15692071, PubMed:22178646, PubMed:22682227, PubMed:24304836, PubMed:29237594, PubMed:29599243, PubMed:30247984). Transports iron from intestinal, splenic, hepatic cells, macrophages and erythrocytes into the blood to provide iron to other tissues (By similarity). Controls therefore dietary iron uptake, iron recycling by macrophages and erythrocytes, and rel",ferrous iron transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0013264,Microtubule-associated protein 1B,target,P46821,MAP1B,Humans,"Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B is required for proper microtubule dynamics and plays a role in the cytoskeletal changes that accompany neuronal differentiation and neurite extension (PubMed:33268592). Possibly MAP1B binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DA",actin binding,"Cytoplasm, cytoskeleton",modulator,DrugBank,drugbank_id
BE0009579,Polyamine deacetylase HDAC10,target,Q969S8,HDAC10,Humans,"Polyamine deacetylase (PDAC), which acts preferentially on N(8)-acetylspermidine, and also on acetylcadaverine and acetylputrescine (PubMed:28516954). Exhibits attenuated catalytic activity toward N(1),N(8)-diacetylspermidine and very low activity, if any, toward N(1)-acetylspermidine (PubMed:28516954). Histone deacetylase activity has been observed in vitro (PubMed:11677242, PubMed:11726666, PubMed:11739383, PubMed:11861901). Has also been shown to be involved in MSH2 deacetylation (PubMed:2622",acetylputrescine deacetylase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0009374,Phospholipid membrane,target,,,Escherichia coli (strain K12),,,,disruptor,DrugBank,drugbank_id
BE0001421,Beta-galactosidase,target,P00722,lacZ,Escherichia coli (strain K12),,alkali metal ion binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0001038,Chymase,target,P23946,CMA1,Humans,"Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion",endopeptidase activity,Secreted,modulator,DrugBank,drugbank_id
BE0009323,Nucleotide-binding oligomerization domain-containing protein 2,target,Q9HC29,NOD2,Humans,"Pattern recognition receptor (PRR) that detects bacterial peptidoglycan fragments and other danger signals and plays an important role in gastrointestinal immunity (PubMed:12514169, PubMed:12527755, PubMed:12626759, PubMed:15044951, PubMed:15998797, PubMed:27283905, PubMed:27748583, PubMed:31649195). Specifically activated by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan found in every bacterial peptidoglycan type (PubMed:12514169, PubMed:12527755, PubMed:12626759, PubMed:128719",actin binding,Cell membrane,ligand,DrugBank,drugbank_id
BE0009920,Transmembrane protease serine 2,target,O15393,TMPRSS2,Humans,"Plasma membrane-anchored serine protease that cleaves at arginine residues (PubMed:32703818, PubMed:35676539, PubMed:37990007, PubMed:38964328). Participates in proteolytic cascades of relevance for the normal physiologic function of the prostate (PubMed:25122198). Androgen-induced TMPRSS2 activates several substrates that include pro-hepatocyte growth factor/HGF, the protease activated receptor-2/F2RL1 or matriptase/ST14 leading to extracellular matrix disruption and metastasis of prostate canc",serine-type endopeptidase activity,Cell membrane,inhibitor,DrugBank,drugbank_id
BE0009923,Cholecystokinin,target,P06307,CCK,Humans,"This peptide hormone induces gall bladder contraction and the release of pancreatic enzymes in the gut. Its function in the brain is not clear. Binding to CCK-A receptors stimulates amylase release from the pancreas, binding to CCK-B receptors stimulates gastric acid secretion",hormone activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0009367,Sodium channel protein,target,Q86DI9,,Pediculus humanus,"Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient.",calcium ion binding,Cell membrane,modulator,DrugBank,drugbank_id
BE0004762,Cytochrome P450 2A1,enzyme,P11711,Cyp2a1,Rat,"Highly active in the 7-alpha-hydroxylation of testosterone, progesterone and androstenedione.",arachidonic acid epoxygenase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0001073,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",enzyme,P16118,PFKFB1,Humans,"Synthesis and degradation of fructose 2,6-bisphosphate",6-phosphofructo-2-kinase activity,,inducer,DrugBank,drugbank_id
BE0003294,DNA topoisomerase 4 subunit B,target,P20083,parE,Escherichia coli (strain K12),"Topoisomerase IV is essential for chromosome segregation; it is the principal protein responsible for decatenating newly replicated chromosomes (PubMed:9334322). It relaxes supercoiled DNA (PubMed:15105144, PubMed:21300644, PubMed:23294697, PubMed:23352267). MukB stimulates the relaxation activity of topoisomerase IV and also has a modest effect on decatenation (PubMed:20921377).",ATP binding,Cytoplasmic,inhibitor,DrugBank,drugbank_id
BE0004527,"Isocitrate dehydrogenase [NADP], mitochondrial",target,P48735,IDH2,Humans,"Plays a role in intermediary metabolism and energy production (PubMed:19228619, PubMed:22416140). It may tightly associate or interact with the pyruvate dehydrogenase complex (PubMed:19228619, PubMed:22416140)",isocitrate dehydrogenase (NADP+) activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0000771,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",target,P51553,IDH3G,Humans,"Regulatory subunit which plays a role in the allosteric regulation of the enzyme catalyzing the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of",ATP binding,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0000559,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial",target,O43837,IDH3B,Humans,"Plays a structural role to facilitate the assembly and ensure the full activity of the enzyme catalyzing the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperativ",electron transfer activity,Mitochondrion,inhibitor,DrugBank,drugbank_id
BE0002481,Granulocyte-macrophage colony-stimulating factor,target,P04141,CSF2,Humans,"Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes",cytokine activity,Secreted,gene replacement,DrugBank,drugbank_id
BE0001379,Iron(3+)-hydroxamate-binding protein FhuD,target,P07822,fhuD,Escherichia coli (strain K12),"Part of the ABC transporter complex FhuCDB involved in iron(3+)-hydroxamate import. Binds the iron(3+)-hydroxamate complex and transfers it to the membrane-bound permease. Required for the transport of all iron(3+)-hydroxamate siderophores such as ferrichrome, gallichrome, desferrioxamine, coprogen, aerobactin, shizokinen, rhodotorulic acid and the antibiotic albomycin.",,Periplasm,binder,DrugBank,drugbank_id
BE0000006,17-beta-hydroxysteroid dehydrogenase type 2,target,P37059,HSD17B2,Humans,"Catalyzes the NAD-dependent oxidation of the highly active 17beta-hydroxysteroids, such as estradiol (E2), testosterone (T), and dihydrotestosterone (DHT), to their less active forms and thus regulates the biological potency of these steroids. Oxidizes estradiol to estrone, testosterone to androstenedione, and dihydrotestosterone to 5alpha-androstan-3,17-dione. Also has 20-alpha-HSD activity","17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase [NAD(P)+] activity",Endoplasmic reticulum membrane,,DrugBank,drugbank_id
BE0020499,Interleukin-37,target,Q9NZH6,IL37,Humans,"Immune regulatory cytokine that acts as a suppressor of innate inflammatory and immune responses involved in curbing excessive inflammation. Signaling can occur via two mechanisms, intracellularly through nuclear translocation with SMAD3 and extracellularly after secretion and binding to its receptor composed of IL18R1 and IL18RAP. Suppresses, or reduces, pro-inflammatory cytokine production, including IL1A and IL6, as well as CCL12, CSF1, CSF2, CXCL13, IL1B, IL23A and IL1RN, but spares anti-inf",cytokine activity,"Cytoplasm, cytosol",inhibitor,DrugBank,drugbank_id
BE0009341,Transuranium elements,target,,,Humans,,,,chelator,DrugBank,drugbank_id
BE0009157,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D,target,Q6IQ20,NAPEPLD,Humans,"D-type phospholipase that hydrolyzes N-acyl-phosphatidylethanolamines (NAPEs) to produce bioactive N-acylethanolamines/fatty acid ethanolamides (NAEs/FAEs) and phosphatidic acid (PubMed:14634025, PubMed:16527816, PubMed:25684574, PubMed:27571266). Cleaves the terminal phosphodiester bond of diacyl- and alkenylacyl-NAPEs, primarily playing a role in the generation of long-chain saturated and monounsaturated NAEs in the brain (By similarity). May control NAPE homeostasis in dopaminergic neuron mem",bile acid binding,Golgi apparatus membrane,inhibitor,DrugBank,drugbank_id
BE0010448,Fibroblast growth factor 23,target,Q9GZV9,FGF23,Humans,Regulator of phosphate homeostasis (PubMed:11062477). Inhibits renal tubular phosphate transport by reducing SLC34A1 levels (PubMed:11409890). Up-regulates EGR1 expression in the presence of KL (By similarity). Acts directly on the parathyroid to decrease PTH secretion (By similarity). Regulator of vitamin-D metabolism (PubMed:15040831). Negatively regulates osteoblast differentiation and matrix mineralization (PubMed:18282132),growth factor activity,Secreted,modulator,DrugBank,drugbank_id
BE0010284,Adenosine receptor,target,P30542,ADORA1,Humans,Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase,G protein-coupled adenosine receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0001103,Calcitonin gene-related peptide 1,target,P06881,CALCA,Humans,"CGRP1/CALCA is a peptide hormone that induces vasodilation mediated by the CALCRL-RAMP1 receptor complex (PubMed:1318039, PubMed:33602864, PubMed:9620797). Dilates a variety of vessels including the coronary, cerebral and systemic vasculature. Its abundance in the CNS also points toward a neurotransmitter or neuromodulator role (PubMed:3492492). It also elevates platelet cAMP (PubMed:1318039). CGRP1 can also bind and activate CALCR-RAMP1 (AMYR1) receptor complex (PubMed:38603770)",hormone activity,Secreted,binder|antibody,DrugBank,drugbank_id
BE0002370,Calcitonin gene-related peptide 2,target,P10092,CALCB,Humans,"CALCB/CGRP2 is a peptide hormone that induces vasodilation mediated by the CALCRL-RAMP1 receptor complex (PubMed:1318039, PubMed:9620797). Dilates a variety of vessels including the coronary, cerebral and systemic vasculature. Its abundance in the CNS also points toward a neurotransmitter or neuromodulator role (PubMed:3492492)",calcitonin receptor binding,Secreted,binder|antibody,DrugBank,drugbank_id
BE0003378,Glucose-dependent insulinotropic receptor,target,Q8TDV5,GPR119,Humans,Receptor for the endogenous fatty-acid ethanolamide oleoylethanolamide (OEA) and lysophosphatidylcholine (LPC). Functions as a glucose-dependent insulinotropic receptor. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. Seems to act through a G(s) mediated pathway,G protein-coupled receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0009155,Diacylglycerol lipase alpha,target,F5GY58,DAGLA,Humans,,,,inhibitor,DrugBank,drugbank_id
BE0009551,NAM/NAG peptide subunits of peptidoglycan,target,,,Gram positive bacteria,,,,ligand,DrugBank,drugbank_id
BE0009553,Inositol phosphorylceramide synthase,target,O13332,AUR1,Yeast,"Catalyzes the addition of a phosphorylinositol group onto ceramide to form inositol phosphorylceramide, an essential step in sphingolipid biosynthesis.",inositol phosphoceramide synthase activity,Golgi apparatus,inhibitor,DrugBank,drugbank_id
BE0009861,Claudin-16,transporter,Q9Y5I7,CLDN16,Humans,"Forms paracellular channels: coassembles with CLDN19 into tight junction strands with cation-selective channels through the strands, conveying epithelial permeability in a process known as paracellular tight junction permeability (PubMed:16234325, PubMed:18188451, PubMed:28028216). Involved in the maintenance of ion gradients along the nephron. In the thick ascending limb (TAL) of Henle's loop, facilitates sodium paracellular permeability from the interstitial compartment to the lumen, contribut",identical protein binding,"Cell junction, tight junction",,DrugBank,drugbank_id
BE0009863,Solute carrier family 41 member 1,transporter,Q8IVJ1,SLC41A1,Humans,"Na(+)/Mg(2+) ion exchanger that acts as a predominant Mg(2+) efflux system at the plasma membrane (PubMed:18367447, PubMed:22031603, PubMed:23661805, PubMed:23976986). Transporter activity is driven by the inwardly directed electrochemical gradient for Na(+) ions, thus directly depends on the extracellular Na(+) ion concentration set by Na(+)/K(+) pump (PubMed:22031603, PubMed:23661805). Generates circadian cellular Mg(2+) fluxes that feed back to regulate clock-controlled gene expression and me",inorganic cation transmembrane transporter activity,Cell membrane,,DrugBank,drugbank_id
BE0009864,"Magnesium transporter MRS2 homolog, mitochondrial",transporter,Q9HD23,MRS2,Humans,"Magnesium transporter that mediates the influx of magnesium into the mitochondrial matrix and regulates magnesium metabolism (PubMed:11401429, PubMed:18384665, PubMed:37543649, PubMed:37938562, PubMed:39609651). Also permeable to calcium, sodium and potassium ions (PubMed:39609651). Required for normal expression of the mitochondrial respiratory complex I subunits (PubMed:18384665). May play a role in maintaining the inner mitochondrial membrane potential (PubMed:39609651)",magnesium ion transmembrane transporter activity,Mitochondrion inner membrane,,DrugBank,drugbank_id
BE0009911,Haptoglobin,target,P00738,HP,Humans,"As a result of hemolysis, hemoglobin is found to accumulate in the kidney and is secreted in the urine. Haptoglobin captures, and combines with free plasma hemoglobin to allow hepatic recycling of heme iron and to prevent kidney damage. Haptoglobin also acts as an antioxidant, has antibacterial activity, and plays a role in modulating many aspects of the acute phase response. Hemoglobin/haptoglobin complexes are rapidly cleared by the macrophage CD163 scavenger receptor expressed on the surface ",antioxidant activity,Secreted,binder,DrugBank,drugbank_id
BE0009910,Histidine-rich glycoprotein,target,P04196,HRG,Humans,"Plasma glycoprotein that binds a number of ligands such as heme, heparin, heparan sulfate, thrombospondin, plasminogen, and divalent metal ions. Binds heparin and heparin/glycosaminoglycans in a zinc-dependent manner. Binds heparan sulfate on the surface of liver, lung, kidney and heart endothelial cells. Binds to N-sulfated polysaccharide chains on the surface of liver endothelial cells. Inhibits rosette formation. Acts as an adapter protein and is implicated in regulating many processes such a",cysteine-type endopeptidase inhibitor activity,Secreted,cofactor,DrugBank,drugbank_id
BE0009915,C->U-editing enzyme APOBEC-1,target,P41238,APOBEC1,Humans,Cytidine deaminase catalyzing the cytidine to uridine postranscriptional editing of a variety of mRNAs (PubMed:30844405). Form complexes with cofactors that confer differential editing activity and selectivity. Responsible for the postranscriptional editing of a CAA codon for Gln to a UAA codon for stop in the apolipoprotein B mRNA (PubMed:24916387). Also involved in CGA (Arg) to UGA (Stop) editing in the NF1 mRNA (PubMed:11727199). May also play a role in the epigenetic regulation of gene expre,cytidine deaminase activity,Cytoplasm,cofactor|chelator,DrugBank,drugbank_id
BE0009916,Semenogelin-2,target,Q02383,SEMG2,Humans,Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa,protease binding,Secreted,cofactor,DrugBank,drugbank_id
BE0009891,Proton-coupled zinc antiporter SLC30A1,transporter,Q9Y6M5,SLC30A1,Humans,"Zinc ion:proton antiporter that could function at the plasma membrane mediating zinc efflux from cells against its electrochemical gradient protecting them from intracellular zinc accumulation and toxicity (PubMed:31471319). Alternatively, could prevent the transport to the plasma membrane of CACNB2, the L-type calcium channels regulatory subunit, through a yet to be defined mechanism. By modulating the expression of these channels at the plasma membrane, could prevent calcium and zinc influx in",calcium channel inhibitor activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0009892,Proton-coupled zinc antiporter SLC30A2,transporter,Q9BRI3,SLC30A2,Humans,"Electroneutral proton-coupled antiporter concentrating zinc ions into a variety of intracellular organelles including endosomes, zymogen granules and mitochondria. Thereby, plays a crucial role in cellular zinc homeostasis to confer upon cells protection against its potential cytotoxicity (PubMed:17065149, PubMed:21289295, PubMed:22733820, PubMed:25657003, PubMed:25808614, PubMed:30893306). Regulates the zinc concentration of milk, through the transport of zinc ions into secretory vesicles of ma",identical protein binding,"Cytoplasmic vesicle, secretory vesicle membrane",substrate,DrugBank,drugbank_id
BE0009895,Probable proton-coupled zinc antiporter SLC30A3,transporter,Q99726,SLC30A3,Humans,Probable proton-coupled zinc ion antiporter mediating the import of zinc from cytoplasm into synaptic vesicles and participating to cellular zinc ion homeostasis in the brain,antiporter activity,"Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane",substrate,DrugBank,drugbank_id
BE0009886,Probable proton-coupled zinc antiporter SLC30A4,transporter,O14863,SLC30A4,Humans,Probable proton-coupled zinc ion antiporter mediating zinc import from cytoplasm potentially into the endocytic compartment (PubMed:19521526). Controls zinc deposition in milk (By similarity),antiporter activity,Endosome membrane,substrate,DrugBank,drugbank_id
BE0009907,Zinc transporter 6,transporter,Q6NXT4,SLC30A6,Humans,"Has probably no intrinsic transporter activity but together with SLC30A5 forms a functional zinc ion:proton antiporter heterodimer, mediating zinc entry into the lumen of organelles along the secretory pathway (PubMed:15994300, PubMed:19366695, PubMed:19759014). As part of that zinc ion:proton antiporter, contributes to zinc ion homeostasis within the early secretory pathway and regulates the activation and folding of enzymes like alkaline phosphatases and enzymes involved in phosphatidylinosito",antiporter activity,"Golgi apparatus, trans-Golgi network membrane",substrate,DrugBank,drugbank_id
BE0009898,Proton-coupled zinc antiporter SLC30A5,transporter,Q8TAD4,SLC30A5,Humans,"Together with SLC30A6 forms a functional proton-coupled zinc ion antiporter mediating zinc entry into the lumen of organelles along the secretory pathway (PubMed:11904301, PubMed:15525635, PubMed:15994300, PubMed:19366695, PubMed:22529353). By contributing to zinc ion homeostasis within the early secretory pathway, regulates the activation and folding of enzymes like alkaline phosphatases and enzymes involved in phosphatidylinositol glycan anchor biosynthesis (PubMed:15525635, PubMed:15994300, P",antiporter activity,"Golgi apparatus, Golgi stack membrane",substrate,DrugBank,drugbank_id
BE0009885,Zinc transporter 7,transporter,Q8NEW0,SLC30A7,Humans,"Zinc ion transporter mediating zinc entry from the cytosol into the lumen of organelles along the secretory pathway (PubMed:15525635, PubMed:15994300). By contributing to zinc ion homeostasis within the early secretory pathway, regulates the activation and folding of enzymes like alkaline phosphatases (PubMed:15525635, PubMed:15994300)",identical protein binding,Golgi apparatus membrane,substrate,DrugBank,drugbank_id
BE0009896,Proton-coupled zinc antiporter SLC30A8,transporter,Q8IWU4,SLC30A8,Humans,"Proton-coupled zinc ion antiporter mediating the entry of zinc into the lumen of pancreatic beta cell secretory granules, thereby regulating insulin secretion",protein homodimerization activity,"Cytoplasmic vesicle, secretory vesicle membrane",substrate,DrugBank,drugbank_id
BE0009890,"Proton-coupled zinc antiporter SLC30A9, mitochondrial",transporter,Q6PML9,SLC30A9,Humans,"Mitochondrial proton-coupled zinc ion antiporter mediating the export of zinc from the mitochondria and involved in zinc homeostasis, zinc mobilization as well as mitochondrial morphology and health (PubMed:28334855, PubMed:34397090, PubMed:34433664, PubMed:35614220). In nucleus, functions as a secondary coactivator for nuclear receptors by cooperating with p160 coactivators subtypes. Plays a role in transcriptional activation of Wnt-responsive genes (By similarity)",antiporter activity,Mitochondrion membrane,substrate,DrugBank,drugbank_id
BE0009899,Calcium/manganese antiporter SLC30A10,transporter,Q6XR72,SLC30A10,Humans,"Calcium:manganese antiporter of the plasma membrane mediating the efflux of intracellular manganese coupled to an active extracellular calcium exchange (PubMed:30755481). Required for intracellular manganese homeostasis, an essential cation for the function of several enzymes, including some crucially important for the metabolism of neurotransmitters and other neuronal metabolic pathways. Manganese can also be cytotoxic and induce oxidative stress, mitochondrial dysfunction and apoptosis (PubMed",calcium,Cell membrane,substrate,DrugBank,drugbank_id
BE0009902,Zinc transporter ZIP1,transporter,Q9NY26,SLC39A1,Humans,"Transporter for the divalent cation Zn(2+). Mediates the influx of Zn(2+) into cells from extracellular space (PubMed:11301334, PubMed:12888280, PubMed:16844077). Functions as the major importer of zinc from circulating blood plasma into prostate cells (PubMed:12888280)",inorganic cation transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0009889,Zinc transporter ZIP2,transporter,Q9NP94,SLC39A2,Humans,"Transporter for the divalent cation Zn(2+) (PubMed:10681536, PubMed:29791142, PubMed:30914478). Mediates the influx of Zn(2+) into cells from extracellular space. The Zn(2+) uniporter activity is independent of H(+)-driving force, but is modulated by extracellular pH and membrane potential. Also transports other divalent cations Zn(2+), Cd2(+), Cu2(+), Co2(+) in the order of decreasing affinity, respectively (PubMed:29791142, PubMed:30914478). In the skin, aids in the differentiation of keratino",metal ion transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0009904,Zinc transporter ZIP3,transporter,Q9BRY0,SLC39A3,Humans,Transporter for the divalent cation Zn(2+). Mediates the influx of Zn(2+) into cells from extracellular space. Controls Zn(2+) accumulation into dentate gyrus granule cells in the hippocampus. Mediates Zn(2+) reuptake from the secreted milk within the alveolar lumen,zinc ion transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0009894,Zinc transporter ZIP4,transporter,Q6P5W5,SLC39A4,Humans,"Selective transporter that mediates the uptake of Zn(2+) (PubMed:17202136, PubMed:22242765, PubMed:27321477, PubMed:28875161, PubMed:31164399, PubMed:31914589, PubMed:31979155, PubMed:33837739, PubMed:36473915). Plays an essential role for dietary zinc uptake from small intestine (By similarity). The Zn(2+) uniporter activity is regulated by zinc availability (PubMed:17202136, PubMed:32348750). Also exhibits polyspecific binding and transport of Cu(2+), Cd(2+) and possibly Ni(2+) but at higher c",identical protein binding,Cell membrane,substrate,DrugBank,drugbank_id
BE0009888,Zinc transporter ZIP5,transporter,Q6ZMH5,SLC39A5,Humans,"Uniporter that transports zinc(2+) into polarized cells of enterocytes, pancreatic acinar and endoderm cells across the basolateral membrane and participates, notably, in zinc excretion from the intestine by the uptake of zinc from the blood into the intestine (By similarity). The transport mechanism is temperature- and concentration-dependent and saturable (By similarity). In addition, is also a high affinity copper transporter in vitro (PubMed:36454509). Also may regulate glucose-stimulated in",monoatomic cation,Basolateral cell membrane,substrate,DrugBank,drugbank_id
BE0009887,Zinc transporter ZIP6,transporter,Q13433,SLC39A6,Humans,"Zinc-influx transporter which plays a role in zinc homeostasis and in the induction of epithelial-to-mesenchymal transition (EMT) (PubMed:12839489, PubMed:18272141, PubMed:21422171, PubMed:23919497, PubMed:27274087, PubMed:34394081). When associated with SLC39A10, the heterodimer formed by SLC39A10 and SLC39A6 mediates cellular zinc uptake to trigger cells to undergo epithelial- to-mesenchymal transition (EMT) (PubMed:27274087). The SLC39A10-SLC39A6 heterodimer also controls NCAM1 phosphorylatio",monoatomic cation,Cell membrane,substrate,DrugBank,drugbank_id
BE0009893,Zinc transporter SLC39A7,transporter,Q92504,SLC39A7,Humans,"Transports Zn(2+) from the endoplasmic reticulum (ER)/Golgi apparatus to the cytosol, playing an essential role in the regulation of cytosolic zinc levels (PubMed:14525538, PubMed:15705588, PubMed:28205653, PubMed:29980658). Acts as a gatekeeper of zinc release from intracellular stores, requiring post-translational activation by phosphorylation, resulting in activation of multiple downstream pathways leading to cell growth and proliferation (PubMed:22317921, PubMed:28205653, PubMed:29980658). H",zinc ion transmembrane transporter activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0009901,Metal cation symporter ZIP8,transporter,Q9C0K1,SLC39A8,Humans,"Electroneutral divalent metal cation:bicarbonate symporter of the plasma membrane mediating the cellular uptake of zinc and manganese, two divalent metal cations important for development, tissue homeostasis and immunity (PubMed:12504855, PubMed:22898811, PubMed:23403290, PubMed:26637978, PubMed:29337306, PubMed:29453449). Transports an electroneutral complex composed of a divalent metal cation and two bicarbonate anions or alternatively a bicarbonate and a selenite anion (PubMed:27166256, PubMe",monoatomic cation,Cell membrane,substrate,DrugBank,drugbank_id
BE0009905,Zinc transporter ZIP9,transporter,Q9NUM3,SLC39A9,Humans,"Transports zinc ions across cell and organelle membranes into the cytoplasm and regulates intracellular zinc homeostasis (PubMed:19420709, PubMed:25014355, PubMed:28219737). Participates in the zinc ions efflux out of the secretory compartments (PubMed:19420709). Regulates intracellular zinc level, resulting in the enhancement of AKT1 and MAPK3/MAPK1 (Erk1/2) phosphorylation in response to the BCR activation (PubMed:23505453). Also functions as a membrane androgen receptor that mediates, through",androgen binding,"Golgi apparatus, trans-Golgi network membrane",substrate,DrugBank,drugbank_id
BE0009884,Zinc transporter ZIP10,transporter,Q9ULF5,SLC39A10,Humans,"Zinc-influx transporter (PubMed:17359283, PubMed:27274087, PubMed:30520657). When associated with SLC39A6, the heterodimer formed by SLC39A10 and SLC39A6 mediates cellular zinc uptake to trigger cells to undergo epithelial-to-mesenchymal transition (EMT) (PubMed:23186163). SLC39A10-SLC39A6 heterodimers play also an essentiel role in initiating mitosis by importing zinc into cells to initiate a pathway resulting in the onset of mitosis (PubMed:32797246). Plays an important for both mature B-cell ",monoatomic cation,Cell membrane,substrate,DrugBank,drugbank_id
BE0009906,Zinc transporter ZIP11,transporter,Q8N1S5,SLC39A11,Humans,Zinc importer that regulates cytosolic zinc concentrations either via zinc influx from the extracellular compartment or efflux from intracellular organelles such as Golgi apparatus. May transport copper ions as well. The transport mechanism remains to be elucidated,copper ion transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0009897,Zinc transporter ZIP12,transporter,Q504Y0,SLC39A12,Humans,Uniporter that promotes Zn(2+) import from the extracellular space to the cytoplasm across the cell membrane. The transport activity is temperature dependent. May play a role in neurulation and neurite extension. May play a key role in maintaining intracellular zinc content at levels that reduce the inhibitory effects of rises in oxidative stress on spermatogonia and spermatozoa viability during spermatogenesis,monoatomic cation,Membrane,substrate,DrugBank,drugbank_id
BE0009900,Zinc transporter ZIP13,transporter,Q96H72,SLC39A13,Humans,"Functions as a zinc transporter transporting Zn(2+) from the Golgi apparatus to the cytosol and thus influences the zinc level at least in areas of the cytosol (PubMed:21917916, PubMed:23213233). May regulate beige adipocyte differentiation (By similarity)",protein homodimerization activity,Golgi apparatus membrane,substrate,DrugBank,drugbank_id
BE0009903,Metal cation symporter ZIP14,transporter,Q15043,SLC39A14,Humans,"Electroneutral transporter of the plasma membrane mediating the cellular uptake of the divalent metal cations zinc, manganese and iron that are important for tissue homeostasis, metabolism, development and immunity (PubMed:15642354, PubMed:27231142, PubMed:29621230). Functions as an energy-dependent symporter, transporting through the membranes an electroneutral complex composed of a divalent metal cation and two bicarbonate anions (By similarity). Beside these endogenous cellular substrates, ca",cadmium ion transmembrane transporter activity,Cell membrane,substrate,DrugBank,drugbank_id
BE0000967,Tissue factor pathway inhibitor,target,P10646,TFPI,Humans,"Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma",endopeptidase inhibitor activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0009563,Transthyretin mRNA,target,,,Humans,,,,antisense oligonucleotide,DrugBank,drugbank_id
BE0002230,Isoaspartyl peptidase/L-asparaginase,target,Q7L266,ASRGL1,Humans,"Has both L-asparaginase and beta-aspartyl peptidase activity. May be involved in the production of L-aspartate, which can act as an excitatory neurotransmitter in some brain regions. Is highly active with L-Asp beta-methyl ester. Besides, has catalytic activity toward beta-aspartyl dipeptides and their methyl esters, including beta-L-Asp-L-Phe, beta-L-Asp-L-Phe methyl ester (aspartame), beta-L-Asp-L-Ala, beta-L-Asp-L-Leu and beta-L-Asp-L-Lys. Does not have aspartylglucosaminidase activity and is",asparaginase activity,Cytoplasm,inhibitor,DrugBank,drugbank_id
BE0010016,Replicase polyprotein 1ab,target,P0DTD1,rep,SARS-CoV-2,"Replicase polyprotein 1ab
    Multifunctional protein involved in the transcription and replication of viral RNAs. Contains the proteinases responsible for the cleavages of the polyprotein.",3'-5'-RNA exonuclease activity,Host membrane,inhibitor,DrugBank,drugbank_id
BE0003801,Replicase polyprotein 1ab,target,P0C6X7,rep,SARS-CoV,"Isoform Replicase polyprotein 1ab
    Multifunctional protein involved in the transcription and replication of viral RNAs. Contains the proteinases responsible for the cleavages of the polyprotein.",3'-5'-RNA exonuclease activity,Host membrane,inhibitor,DrugBank,drugbank_id
BE0010019,Replicase polyprotein 1ab,target,K9N7C7,rep,Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012),"The replicase polyprotein of coronaviruses is a multifunctional protein: it contains the activities necessary for the transcription of negative stranded RNA, leader RNA, subgenomic mRNAs and progeny virion RNA as well as proteinases responsible for the cleavage of the polyprotein into functional products.",3'-5'-RNA exonuclease activity,Host membrane,inhibitor,DrugBank,drugbank_id
BE0009862,RNA-directed RNA polymerase L,target,Q05318,L,Zaire ebolavirus (strain Mayinga-76),"RNA-directed RNA polymerase that catalyzes the transcription of viral mRNAs, their capping and polyadenylation. The template is composed of the viral RNA tightly encapsidated by the nucleoprotein (N). The viral polymerase binds to the genomic RNA at the 3' leader promoter, and transcribes subsequently all viral mRNAs with a decreasing efficiency. The first gene is the most transcribed, and the last the least transcribed. The viral phosphoprotein acts as a processivity factor. Capping is concommi",ATP binding,Virion,inhibitor,DrugBank,drugbank_id
BE0002769,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",target,Q16740,CLPP,Humans,"Protease component of the ClpXP complex that cleaves peptides and various proteins in an ATP-dependent process. Has low peptidase activity in the absence of CLPX. The ClpXP complex can degrade CSN1S1, CSN2 and CSN3, as well as synthetic peptides (in vitro) and may be responsible for a fairly general and central housekeeping function rather than for the degradation of specific substrates (PubMed:11923310, PubMed:15522782). Cleaves PINK1 in the mitochondrion (PubMed:22354088)",ATP-dependent peptidase activity,Mitochondrion matrix,activator,DrugBank,drugbank_id
BE0010189,Lymphocyte activation gene 3 protein,target,P18627,LAG3,Humans,"Lymphocyte activation gene 3 protein: Inhibitory receptor on antigen activated T-cells (PubMed:20421648, PubMed:7805750, PubMed:8647185). Delivers inhibitory signals upon binding to ligands, such as FGL1 (By similarity). FGL1 constitutes a major ligand of LAG3 and is responsible for LAG3 T-cell inhibitory function (By similarity). Following TCR engagement, LAG3 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation (By similarity). May inhibit antigen-specif",antigen binding,Cell membrane,antibody,DrugBank,drugbank_id
BE0011002,Human telomerase RNA component,target,,,Humans,,,,binder,DrugBank,drugbank_id
BE0002478,Telomerase-binding protein EST1A,target,Q86US8,SMG6,Humans,"Component of the telomerase ribonucleoprotein (RNP) complex that is essential for the replication of chromosome termini (PubMed:19179534). May have a general role in telomere regulation (PubMed:12676087, PubMed:12699629). Promotes in vitro the ability of TERT to elongate telomeres (PubMed:12676087, PubMed:12699629). Overexpression induces telomere uncapping, chromosomal end-to-end fusions (telomeric DNA persists at the fusion points) and did not perturb TRF2 telomeric localization (PubMed:126760",DNA polymerase binding,"Nucleus, nucleolus",,DrugBank,drugbank_id
BE0002479,N-terminal kinase-like protein,target,Q96KG9,SCYL1,Humans,Regulates COPI-mediated retrograde protein traffic at the interface between the Golgi apparatus and the endoplasmic reticulum (PubMed:18556652). Involved in the maintenance of the Golgi apparatus morphology (PubMed:26581903),ATP binding,"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome",,DrugBank,drugbank_id
BE0004294,Myosin-7,target,P12883,MYH7,Humans,"Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle",actin filament binding,"Cytoplasm, myofibril",inhibitory allosteric modulator,DrugBank,drugbank_id
BE0000809,Glutathione S-transferase A3,enzyme,Q16772,GSTA3,Humans,"Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Catalyzes isomerization reactions that contribute to the biosynthesis of steroid hormones. Efficiently catalyze obligatory double-bond isomerizations of delta(5)-androstene-3,17-dione and delta(5)-pregnene-3,20-dione, precursors to testosterone and progesterone, respectively. Has substantial activity toward aflatoxin B1-8,9-epoxide (By similarity)",glutathione transferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0002285,Glutathione S-transferase Mu 5,enzyme,P46439,GSTM5,Humans,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,glutathione transferase activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0004541,Glutathione S-transferase theta-2,enzyme,P0CG29,GSTT2,Humans,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles (PubMed:1417752). Has a sulfatase activity (PubMed:1417752),glutathione transferase activity,"Cytoplasm, cytosol",substrate,DrugBank,drugbank_id
BE0002282,Microsomal glutathione S-transferase 1,enzyme,P10620,MGST1,Humans,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,glutathione peroxidase activity,Endoplasmic reticulum membrane,substrate,DrugBank,drugbank_id
BE0002279,"Glutathione S-transferase 3, mitochondrial",enzyme,O14880,MGST3,Humans,"Displays both glutathione S-transferase and glutathione peroxidase activities toward oxyeicosanoids, as part of cellular detoxification as well as synthesis of bioactive metabolites (PubMed:36370807, PubMed:9278457). Catalyzes conjugate addition of reduced glutathione to the alpha, beta-unsaturated C=C carbonyl group of eisosanoids such as leukotriene A4 and 15-deoxy-Delta12,14-prostaglandin J2 to form GSH adducts relevant to the inflammatory response (PubMed:36370807, PubMed:9278457). Catalyzes",glutathione peroxidase activity,Mitochondrion outer membrane,substrate,DrugBank,drugbank_id
BE0000939,Cathepsin B,enzyme,P07858,CTSB,Humans,Thiol protease which is believed to participate in intracellular degradation and turnover of proteins (PubMed:12220505). Cleaves matrix extracellular phosphoglycoprotein MEPE (PubMed:12220505). Involved in the solubilization of cross-linked TG/thyroglobulin in the thyroid follicle lumen (By similarity). Has also been implicated in tumor invasion and metastasis (PubMed:3972105),collagen binding,Lysosome,substrate,DrugBank,drugbank_id
BE0010630,Growth/differentiation factor 2,target,Q9UK05,GDF2,Humans,Potent circulating inhibitor of angiogenesis. Signals through the type I activin receptor ACVRL1 but not other Alks. Signaling through SMAD1 in endothelial cells requires TGF-beta coreceptor endoglin/ENG,cytokine activity,Secreted,modulator,DrugBank,drugbank_id
BE0010095,C5a anaphylatoxin chemotactic receptor 1,target,P21730,C5AR1,Humans,"Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a (PubMed:10636859, PubMed:15153520, PubMed:1847994, PubMed:29300009, PubMed:7622471, PubMed:8182049, PubMed:9553099). The ligand interacts with at least two sites on the receptor: a high-affinity site on the extracellular N-terminus, and a second site in the transmembrane region which activates downstream signaling events (PubMed:7622471, PubMed:8182049, PubMed:9553099). Receptor activation stimulates chemotaxis, granule enzy",complement component C5a receptor activity,Cell membrane,antagonist,DrugBank,drugbank_id
BE0009790,ALAS1 mRNA,target,,,Humans,,,,cleavage,DrugBank,drugbank_id
BE0010181,Thymic stromal lymphopoietin,target,Q969D9,TSLP,Humans,"Cytokine that induces the release of T-cell-attracting chemokines from monocytes and, in particular, enhances the maturation of CD11c(+) dendritic cells. Can induce allergic inflammation by directly activating mast cells",cytokine activity,Secreted,binder|antibody,DrugBank,drugbank_id
BE0010015,"Cytochrome P450 2C12, female-specific",enzyme,P11510,Cyp2c12,Rat,This P450 is active in 15-beta-hydroxylation of steroid sulfates.,arachidonic acid epoxygenase activity,Endoplasmic reticulum membrane,inducer,DrugBank,drugbank_id
BE0009818,P2X purinoceptor 3,target,P56373,P2RX3,Humans,"Extracellular ATP-activated non-selective cation channel (PubMed:10440098, PubMed:27626375, PubMed:29674445, PubMed:31232692). Plays particularly important role in sensory neurons where its activation is critical for gustatory, nociceptive responses, visceral reflexes and sensory hypersensitization (By similarity)",ATP binding,Cell membrane,antagonist|inhibitor,DrugBank,drugbank_id
BE0009820,P2X purinoceptor 2,target,Q9UBL9,P2RX2,Humans,"ATP-gated nonselective transmembrane cation channel permeable to potassium, sodium and calcium (PubMed:10570044, PubMed:31636190). Activation by extracellular ATP induces a variety of cellular responses, such as excitatory postsynaptic responses in sensory neurons, neuromuscular junctions (NMJ) formation, hearing, perception of taste and peristalsis (By similarity). In the inner ear, regulates sound transduction and auditory neurotransmission, outer hair cell electromotility, inner ear gap junct",ATP binding,Cell membrane,antagonist,DrugBank,drugbank_id
BE0010573,Claudin-18,target,P56856,CLDN18,Humans,"Involved in alveolar fluid homeostasis via regulation of alveolar epithelial tight junction composition and therefore ion transport and solute permeability, potentially via downstream regulation of the actin cytoskeleton organization and beta-2-adrenergic signaling (By similarity). Required for lung alveolarization and maintenance of the paracellular alveolar epithelial barrier (By similarity). Acts to maintain epithelial progenitor cell proliferation and organ size, via regulation of YAP1 local",identical protein binding,"Cell junction, tight junction",inhibitor,DrugBank,drugbank_id
BE0010136,Interferon alpha/beta receptor (IFNAR),target,P17181,IFNAR1,Humans,"Together with IFNAR2, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa) (PubMed:10049744, PubMed:14532120, PubMed:15337770, PubMed:2153461, PubMed:21854986, PubMed:24075985, PubMed:31270247, PubMed:33252644, PubMed:35442418, PubMed:7813427). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the inter",cytokine binding,Cell membrane,binder,DrugBank,drugbank_id
BE0011012,Gastric inhibitory polypeptide receptor,target,P48546,GIPR,Humans,This is a receptor for GIP. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase,G protein-coupled peptide receptor activity,Cell membrane,agonist,DrugBank,drugbank_id
BE0011013,Interleukin-31 receptor subunit alpha,target,Q8NI17,IL31RA,Humans,"Associates with OSMR to form the interleukin-31 receptor which activates STAT3 and to a lower extent STAT1 and STAT5 (PubMed:11877449, PubMed:14504285, PubMed:15194700, PubMed:15627637). May function in skin immunity (PubMed:15184896). Mediates IL31-induced itch, probably in a manner dependent on cation channels TRPA1 and TRPV1 (By similarity). Positively regulates numbers and cycling status of immature subsets of myeloid progenitor cells in bone marrow in vivo and enhances myeloid progenitor ce",cytokine binding,Cell membrane,antagonist|antibody,DrugBank,drugbank_id
BE0000434,Serine/threonine-protein kinase A-Raf,target,P10398,ARAF,Humans,Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. Phosphorylates PFKFB2 (PubMed:36402789),ATP binding,,modulator,DrugBank,drugbank_id
BE0010027,IgG heavy chain,target,P01857,IGHG1,,"Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which resu",antigen binding,Secreted,cleavage,DrugBank,drugbank_id
BE0010187,Melanocyte protein PMEL,target,P40967,PMEL,Humans,"Forms physiological amyloids that play a central role in melanosome morphogenesis and pigmentation. The maturation of unpigmented premelanosomes from stage I to II is marked by assembly of processed amyloidogenic fragments into parallel fibrillar sheets, which elongate the vesicle into a striated ellipsoidal shape. In pigmented stage III and IV melanosomes, the amyloid matrix serves as a platform where eumelanin precursors accumulate at high local concentrations for pigment formation. May preven",identical protein binding,Endoplasmic reticulum membrane,binder,DrugBank,drugbank_id
BE0010010,Tumor necrosis factor receptor superfamily member 17,target,Q02223,TNFRSF17,Humans,Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK,signaling receptor activity,Cell membrane,antibody,DrugBank,drugbank_id
BE0010202,T-cell surface glycoprotein CD3,target,P04234,CD3D,Humans,"Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinase",identical protein binding,Cell membrane,antibody,DrugBank,drugbank_id
BE0001840,Complement factor D,target,P00746,CFD,Humans,"Serine protease that initiates the alternative pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:21205667, PubMed:22362762, PubMed:6769474, PubMed:874324, PubMed:9748277). In contrast to other complement pathways (classical, lectin and GZMK) that are directly activated by pathogens or antigen-antibody complexes, the alternative complement pathway is initiated by the spont",serine-type endopeptidase activity,Secreted,inhibitor,DrugBank,drugbank_id
BE0010225,Coagulation factor VIII (F8),target,,,Humans,,,,gene replacement,DrugBank,drugbank_id
BE0010198,Interleukin-1 receptor-like 2,target,Q9HB29,IL1RL2,Humans,"Receptor for interleukin-36 (IL36A, IL36B and IL36G). After binding to interleukin-36 associates with the coreceptor IL1RAP to form the interleukin-36 receptor complex which mediates interleukin-36-dependent activation of NF-kappa-B, MAPK and other pathways (By similarity). The IL-36 signaling system is thought to be present in epithelial barriers and to take part in local inflammatory response; it is similar to the IL-1 system. Seems to be involved in skin inflammatory response by induction of ",interleukin-1 receptor activity,Membrane,antagonist,DrugBank,drugbank_id
BE0010022,Spike glycoprotein,target,P0DTC2,S,SARS-CoV-2,"Spike protein S1
    Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2 (PubMed:32142651, PubMed:32155444, PubMed:33607086). When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane (PubMed:34561887). When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis leading to fusion of the virion membrane with the host endosom",host cell surface receptor binding,Virion membrane,antagonist,DrugBank,drugbank_id
BE0010023,Envelope glycoprotein,target,Q05320,GP,Zaire ebolavirus (strain Mayinga-76),"Envelope glycoprotein
    Trimeric GP1,2 complexes form the virion surface spikes and mediate the viral entry processes, with GP1 acting as the receptor-binding subunit and GP2 as the membrane fusion subunit. At later times of infection, down-regulates the expression of various host cell surface molecules that are essential for immune surveillance and cell adhesion (PubMed:11836430). Down-modulates several integrins including ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGAV and ITGB1 (PubMed:1111",identical protein binding,Virion membrane,antagonist,DrugBank,drugbank_id
BE0011003,Phosphodiesterase 3,target,Q14432,PDE3A,Humans,"Cyclic nucleotide phosphodiesterase with specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (PubMed:1315035, PubMed:25961942, PubMed:8155697, PubMed:8695850). Also has activity toward cUMP (PubMed:27975297). Independently of its catalytic activity it is part of an E2/17beta-estradiol-induced pro-apoptotic signaling pathway. E2 stabilizes the PDE3A/SLFN12 complex in the cytosol, promoting the dephosphorylation of SLFN12 and acti","3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity",Membrane,inhibitor,DrugBank,drugbank_id
BE0011004,Phosphodiesterase 4,target,P27815,PDE4A,Humans,"Hydrolyzes the second messenger 3',5'-cyclic AMP (cAMP), which is a key regulator of many important physiological processes","3',5'-cyclic-AMP phosphodiesterase activity","Cytoplasm, perinuclear region",inhibitor,DrugBank,drugbank_id
BE0010649,Leukocyte surface antigen CD47,target,Q08722,CD47,Humans,"Adhesive protein that mediates cell-to-cell interactions (PubMed:11509594, PubMed:15383453). Acts as a receptor for thrombospondin THBS1 and as modulator of integrin signaling through the activation of heterotrimeric G proteins (PubMed:19004835, PubMed:7691831, PubMed:8550562). Involved in signal transduction, cardiovascular homeostasis, inflammation, apoptosis, angiogenesis, cellular self-renewal, and immunoregulation (PubMed:11509594, PubMed:15383453, PubMed:19004835, PubMed:27742621, PubMed:3",cell-cell adhesion mediator activity,Cell membrane,inhibitor|binder,DrugBank,drugbank_id
BE0000046,Pyruvate kinase PKLR,target,P30613,PKLR,Humans,"Pyruvate kinase that catalyzes the conversion of phosphoenolpyruvate to pyruvate with the synthesis of ATP, and which plays a key role in glycolysis",ATP binding,,activator,DrugBank,drugbank_id
BE0027652,Tetrahydrobiopterin,target,,,Humans,,,,other,DrugBank,drugbank_id
BE0000909,Sepiapterin reductase,enzyme,P35270,SPR,Humans,"Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin",aldo-keto reductase (NADPH) activity,Cytoplasm,substrate,DrugBank,drugbank_id
BE0010290,G-protein coupled receptor family C group 5 member D,target,Q9NZD1,GPRC5D,Humans,G-protein coupled receptor involved in hard keratin expression and likely plays a role in the development of hair and nails,G protein-coupled receptor activity,Cell membrane,antibody,DrugBank,drugbank_id
BE0010964,Coagulation factor IX (F9),target,,,Humans,,,,gene replacement,DrugBank,drugbank_id
BE0010442,Menin,target,O00255,MEN1,Humans,"Essential component of a MLL/SET1 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3 (H3K4). Functions as a transcriptional regulator. Binds to the TERT promoter and represses telomerase expression. Plays a role in TGFB1-mediated inhibition of cell-proliferation, possibly regulating SMAD3 transcriptional activity. Represses JUND-mediated transcriptional activation on AP1 sites, as well as that mediated by NFKB subunit RELA. Positively regulates ",chromatin binding,Nucleus,inhibitor,DrugBank,drugbank_id
BE0014590,"Myosin-binding protein C, cardiac-type",target,Q14896,MYBPC3,Humans,"Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role",actin binding,,inhibitor,DrugBank,drugbank_id
BE0010308,Granulocyte colony-stimulating factor,target,P09919,CSF3,Humans,"Granulocyte/macrophage colony-stimulating factors are cytokines that act in hematopoiesis by controlling the production, differentiation, and function of 2 related white cell populations of the blood, the granulocytes and the monocytes-macrophages. This CSF induces granulocytes",cytokine activity,Secreted,modulator,DrugBank,drugbank_id
BE0027561,Fusion glycoprotein F0,target,P12568,F,Human respiratory syncytial virus,"Fusion glycoprotein F0
    Inactive precursor that is cleaved at two sites by a furin-like protease to give rise to the mature F1 and F2 fusion glycoproteins.",,Host Golgi apparatus membrane,binder,DrugBank,drugbank_id
BE0004821,Hyaluronan,target,,,Humans,,,,degradation,DrugBank,drugbank_id
